Citrus Sinensis ID: 020467
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 326 | 2.2.26 [Sep-21-2011] | |||||||
| O80345 | 479 | Cyclin-dependent kinase F | yes | no | 0.987 | 0.672 | 0.645 | 1e-117 | |
| A2YCH5 | 479 | Cyclin-dependent kinase F | N/A | no | 0.944 | 0.643 | 0.490 | 7e-71 | |
| Q5Z754 | 479 | Cyclin-dependent kinase F | yes | no | 0.944 | 0.643 | 0.490 | 3e-70 | |
| A8WIP6 | 344 | Cyclin-dependent kinase 2 | yes | no | 0.453 | 0.430 | 0.4 | 3e-22 | |
| Q9JHU3 | 346 | Cyclin-dependent kinase 2 | yes | no | 0.453 | 0.427 | 0.388 | 1e-21 | |
| Q4KM34 | 346 | Cyclin-dependent kinase 2 | yes | no | 0.453 | 0.427 | 0.388 | 1e-21 | |
| Q5R7I7 | 346 | Cyclin-dependent kinase 2 | yes | no | 0.453 | 0.427 | 0.382 | 1e-21 | |
| P06242 | 306 | Serine/threonine-protein | yes | no | 0.407 | 0.434 | 0.435 | 2e-21 | |
| Q8IZL9 | 346 | Cyclin-dependent kinase 2 | no | no | 0.453 | 0.427 | 0.382 | 4e-21 | |
| Q00537 | 523 | Cyclin-dependent kinase 1 | no | no | 0.423 | 0.263 | 0.429 | 5e-21 |
| >sp|O80345|CDKF1_ARATH Cyclin-dependent kinase F-1 OS=Arabidopsis thaliana GN=CDKF-1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 421 bits (1082), Expect = e-117, Method: Compositional matrix adjust.
Identities = 209/324 (64%), Positives = 254/324 (78%), Gaps = 2/324 (0%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFR 60
M++ SWSIHTRPEIIAKYEI E VGSGAY+DVY+ RRLSD LIVALKE+ DYQSAFR
Sbjct: 1 MDKQPATSWSIHTRPEIIAKYEIFERVGSGAYADVYRARRLSDGLIVALKEIFDYQSAFR 60
Query: 61 EIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
EI+AL IL SPNVVV+HEYFWRE+E+AVLVLEFLR+DLA VI + K+K++ G G SV
Sbjct: 61 EIDALTILNGSPNVVVMHEYFWREEENAVLVLEFLRSDLAAVIRDGKRKKKVEGGDGFSV 120
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPD 180
GEIKRWM+QIL+GVDACHRN IVHRDLKPGN+LI DDGVLKLADFGQARIL+ ++ A D
Sbjct: 121 GEIKRWMIQILTGVDACHRNLIVHRDLKPGNMLISDDGVLKLADFGQARILMEHDIVASD 180
Query: 181 GNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSI 240
N Q + SE P+V + E++ +G QE+ MS+++YFR ++ELKAK +
Sbjct: 181 ENQQAYKLED-KDGETSEPPEVIPDYENSPRQGSDGQEREAMSKDEYFRQVEELKAKQVV 239
Query: 241 -DETDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFR 299
D+TDKD++VHDGD SC ATCT S+++DDL + ++SYDA++ D QG +TSCVGTRWFR
Sbjct: 240 RDDTDKDSNVHDGDISCLATCTVSEMDDDLGRNSFSYDADEAVDDTQGLMTSCVGTRWFR 299
Query: 300 APELLYGSTSYGLEVDLWSLAAYL 323
PELLYGST YGLEVDLWSL
Sbjct: 300 PPELLYGSTMYGLEVDLWSLGCVF 323
|
CDK-activating kinase that modulates CDKD-2 and CDKD-3 activities by phosphorylation of the T-loop. Activates CDKD-2 C-terminal domain (CTD) kinase activity. Activates CDKA-1 probably by phosphorylation. Posseses a CDK kinase activity independently of association with cyclin CYCH1-1. Phosphorylates the CTD of the large subunit of RNA polymerase II. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|A2YCH5|CDKF1_ORYSI Cyclin-dependent kinase F-1 OS=Oryza sativa subsp. indica GN=CDKF-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 267 bits (683), Expect = 7e-71, Method: Compositional matrix adjust.
Identities = 158/322 (49%), Positives = 206/322 (63%), Gaps = 14/322 (4%)
Query: 8 SWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQI 67
SWSIH RP++ ++YE+L GSGAY+DVY+GRR SD VALKEVHD SA RE +AL
Sbjct: 11 SWSIHGRPDVTSRYEVLGRAGSGAYADVYRGRRRSDGAPVALKEVHDAVSARREADALLA 70
Query: 68 LQNSPNVVVLHEYFWRED-EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
S +VV L ++F D +D VLVLE+L DL+ V+ + R + KRW
Sbjct: 71 AAPSRHVVALLDHFPGGDHDDDVLVLEWLPLDLSAVVRAAAAARPSA----PPAAQRKRW 126
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPC 186
M+Q+L GV ACH +VHRDLKP NLLI +DGVLK+AD GQARIL E G P
Sbjct: 127 MLQVLEGVAACHSAGVVHRDLKPANLLISEDGVLKVADLGQARIL--QETGTYQG-MHPY 183
Query: 187 EPNAPYQDNMSEAPQVDLEVEDASPEGD----VNQEQGIMSREDYFRALDELKAKNSIDE 242
E ++ + +S+ V V++ P D QE ++ DY +D+L+AK++ +
Sbjct: 184 EQSSGVEPWVSQQRAVLHGVKENHPSHDSETQTGQEPERLTAADYLHEMDQLRAKSTHGD 243
Query: 243 TDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGG-DGRQGALTSCVGTRWFRAP 301
DK + DG+ SC ATC+T+D++DD F+ +YSYDAE+G + GA TSCVGTRWFRAP
Sbjct: 244 VDK-MSLQDGNASCLATCSTADIDDDPFRASYSYDAEEGMLEEESGAFTSCVGTRWFRAP 302
Query: 302 ELLYGSTSYGLEVDLWSLAAYL 323
ELLYGST+YG EVDLWSL L
Sbjct: 303 ELLYGSTNYGQEVDLWSLGCIL 324
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q5Z754|CDKF1_ORYSJ Cyclin-dependent kinase F-1 OS=Oryza sativa subsp. japonica GN=CDKF-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (678), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 158/322 (49%), Positives = 207/322 (64%), Gaps = 14/322 (4%)
Query: 8 SWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQI 67
SWSIH RP++ ++YE+L GSGAY+DVY+GRR SD VALKEVHD SA RE +AL
Sbjct: 11 SWSIHGRPDVTSRYEVLGRAGSGAYADVYRGRRRSDGAPVALKEVHDAVSARREADALLA 70
Query: 68 LQNSPNVVVLHEYFWRED-EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
S +VV L ++F D +D VLVLE+L DL+ V+ + R + + KRW
Sbjct: 71 AAPSRHVVALLDHFPGGDHDDDVLVLEWLPLDLSAVVRAAAAARPSA----LPAAQRKRW 126
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPC 186
M+Q+L GV ACH +VHRDLKP NLLI +DGVLK+AD GQARIL E G P
Sbjct: 127 MLQVLEGVAACHSAGVVHRDLKPANLLISEDGVLKVADLGQARIL--QETGTYQG-MHPY 183
Query: 187 EPNAPYQDNMSEAPQVDLEVEDASPEGD----VNQEQGIMSREDYFRALDELKAKNSIDE 242
E ++ + +S+ V V++ P D QE ++ DY +D+L+AK++ +
Sbjct: 184 EQSSGVEPWVSQQRAVLHGVKENHPSHDSETQTGQEPERLTAADYLHEMDQLRAKSTHGD 243
Query: 243 TDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGG-DGRQGALTSCVGTRWFRAP 301
DK + DG+ SC ATC+T+D++DD F+ +YSYDAE+G + GA TSCVGTRWFRAP
Sbjct: 244 VDK-MSLQDGNASCLATCSTADIDDDPFRASYSYDAEEGMLEEESGAFTSCVGTRWFRAP 302
Query: 302 ELLYGSTSYGLEVDLWSLAAYL 323
ELLYGST+YG EVDLWSL L
Sbjct: 303 ELLYGSTNYGQEVDLWSLGCIL 324
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|A8WIP6|CDK20_DANRE Cyclin-dependent kinase 20 OS=Danio rerio GN=cdk20 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 106 bits (264), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 66/165 (40%), Positives = 95/165 (57%), Gaps = 17/165 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + VALK+V + A REI+ALQ ++++
Sbjct: 3 QYSILGRIGEGAHGIVFKAKHIETGETVALKKVALRRLEDGIPNQALREIKALQEIEDNQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L + F VLV E++ +DL+ VI S+ R ++ ++K +M+ +L
Sbjct: 63 YVVKLKDVF-PHGTGFVLVFEYMLSDLSEVIRNSQ--------RPLTASQVKSYMMMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFD 177
GV CH N+I+HRDLKP NLLI G LK+ADFG AR L NE D
Sbjct: 114 GVAFCHENSIMHRDLKPANLLISSTGHLKIADFGLAR-LFSNEGD 157
|
Involved in cell growth. Activates cdk2, a kinase involved in the control of the cell cycle, by phosphorylating residue 'Thr-160' (By similarity). Required for high-level Shh responses in the developing neural tube. Together with bromi, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing gli2 to be properly activated in response to SHH signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9JHU3|CDK20_MOUSE Cyclin-dependent kinase 20 OS=Mus musculus GN=Cdk20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 104 bits (259), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 66/170 (38%), Positives = 93/170 (54%), Gaps = 22/170 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + IVALK+V + A REI+ALQ +++S
Sbjct: 3 QYCILGRIGEGAHGIVFKAKHVETGEIVALKKVALRRLEDGIPNQALREIKALQEIEDSQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L F VL EF+ +DLA V+ ++ R ++ ++K ++ +L
Sbjct: 63 YVVQLKAVF-PHGAGFVLAFEFMLSDLAEVVRHAQ--------RPLAPAQVKSYLQMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGN 182
GV CH N IVHRDLKP NLLI G LK+ADFG AR+ +PDG
Sbjct: 114 GVAFCHANNIVHRDLKPANLLISASGQLKIADFGLARVF------SPDGG 157
|
Involved in cell growth. Activates CDK2, a kinase involved in the control of the cell cycle, by phosphorylating residue 'Thr-160' (By similarity). Required for high-level Shh responses in the developing neural tube. Together with BROMI, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to SHH signaling. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q4KM34|CDK20_RAT Cyclin-dependent kinase 20 OS=Rattus norvegicus GN=Cdk20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 103 bits (258), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 66/170 (38%), Positives = 93/170 (54%), Gaps = 22/170 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + IVALK+V + A REI+ALQ +++S
Sbjct: 3 QYCILGRIGEGAHGIVFKAKHVETGEIVALKKVALRRLEDGIPNQALREIKALQEIEDSQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L F VL EF+ +DLA V+ ++ R ++ ++K ++ +L
Sbjct: 63 YVVQLKAVF-PHGAGFVLAFEFMLSDLAEVVRHAQ--------RPLAPAQVKSYLQMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGN 182
GV CH N IVHRDLKP NLLI G LK+ADFG AR+ +PDG
Sbjct: 114 GVAFCHANNIVHRDLKPANLLISASGQLKIADFGLARVF------SPDGG 157
|
Required for high-level Shh responses in the developing neural tube. Together with BROMI, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to SHH signaling. Involved in cell growth. Activates CDK2, a kinase involved in the control of the cell cycle, by phosphorylating residue 'Thr-160'. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q5R7I7|CDK20_PONAB Cyclin-dependent kinase 20 OS=Pongo abelii GN=CDK20 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 103 bits (258), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 65/170 (38%), Positives = 94/170 (55%), Gaps = 22/170 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + IVALK+V + A REI+ALQ ++++
Sbjct: 3 QYCILGRIGEGAHGIVFKAKHVETGEIVALKKVALRRLEDGIPNQALREIKALQEMEDNQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L F VL EF+ +DLA V+ ++ R ++ ++K ++ +L
Sbjct: 63 YVVQLKAVF-PHSAGFVLAFEFMLSDLAEVVRHAQ--------RPLAQAQVKSYLQMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGN 182
GV CH N IVHRDLKP NLLI G LK+ADFG AR+ +PDG+
Sbjct: 114 GVSFCHANNIVHRDLKPANLLISASGQLKIADFGLARVF------SPDGS 157
|
Required for high-level Shh responses in the developing neural tube. Together with BROMI, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to SHH signaling. Involved in cell growth. Activates CDK2, a kinase involved in the control of the cell cycle, by phosphorylating residue 'Thr-160'. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P06242|KIN28_YEAST Serine/threonine-protein kinase KIN28 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=KIN28 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 103 bits (257), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 67/154 (43%), Positives = 88/154 (57%), Gaps = 21/154 (13%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPNVVVLHE 79
VG G Y+ VY G + S +A+KE+ + SA RE++ LQ +Q+ PNV+ L +
Sbjct: 13 VGEGTYAVVYLGCQHSTGRKIAIKEIKTSEFKDGLDMSAIREVKYLQEMQH-PNVIELID 71
Query: 80 YFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGI--SVGEIKRWMVQILSGVDAC 137
F D + LVLEFL TDL VI D+ I + +IK WM+ L GV C
Sbjct: 72 IFMAYD-NLNLVLEFLPTDLEVVIK----------DKSILFTPADIKAWMLMTLRGVYHC 120
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
HRN I+HRDLKP NLL DG +K+ADFG AR +
Sbjct: 121 HRNFILHRDLKPNNLLFSPDGQIKVADFGLARAI 154
|
Catalytic component of the TFIIK complex (KIN28-CCL1 dimer) which is the protein kinase component of transcription factor IIH (TFIIH) and phosphorylates the C-terminal domain of RNA polymerase II during transition from transcription to elongation after preinitiation complex (PIC) formation, thereby positively regulating transcription. TFIIH (or factor B) is essential for both basal and activated transcription, and is involved in nucleotide excision repair (NER) of damaged DNA. TFIIH has DNA-dependent ATPase activity and is essential for polymerase II transcription in vitro. Essential for cell proliferation. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8IZL9|CDK20_HUMAN Cyclin-dependent kinase 20 OS=Homo sapiens GN=CDK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 102 bits (254), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 65/170 (38%), Positives = 94/170 (55%), Gaps = 22/170 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + IVALK+V + A REI+ALQ ++++
Sbjct: 3 QYCILGRIGEGAHGIVFKAKHVETGEIVALKKVALRRLEDGFPNQALREIKALQEMEDNQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L F VL EF+ +DLA V+ ++ R ++ ++K ++ +L
Sbjct: 63 YVVQLKAVF-PHGGGFVLAFEFMLSDLAEVVRHAQ--------RPLAQAQVKSYLQMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGN 182
GV CH N IVHRDLKP NLLI G LK+ADFG AR+ +PDG+
Sbjct: 114 GVAFCHANNIVHRDLKPANLLISASGQLKIADFGLARVF------SPDGS 157
|
Required for high-level Shh responses in the developing neural tube. Together with BROMI, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to SHH signaling (By similarity). Involved in cell growth. Activates CDK2, a kinase involved in the control of the cell cycle, by phosphorylating residue 'Thr-160'. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens GN=CDK17 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 102 bits (253), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 67/156 (42%), Positives = 95/156 (60%), Gaps = 18/156 (11%)
Query: 21 YEILECVGSGAYSDVYKGR-RLSDNLIVALKEVHDYQ------SAFREIEALQILQNSPN 73
Y LE +G G Y+ VYKGR +L++NL VALKE+ +A RE+ L+ L+++ N
Sbjct: 192 YIKLEKLGEGTYATVYKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHA-N 249
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V LH+ D+ LV E+L DL K+ +D G+ +S+ +K ++ QIL G
Sbjct: 250 IVTLHD-IVHTDKSLTLVFEYLDKDL-------KQYMDDCGNI-MSMHNVKLFLYQILRG 300
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ CHR ++HRDLKP NLLI + G LKLADFG AR
Sbjct: 301 LAYCHRRKVLHRDLKPQNLLINEKGELKLADFGLAR 336
|
May play a role in terminally differentiated neurons. Has a Ser/Thr-phosphorylating activity for histone H1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 326 | ||||||
| 449443157 | 482 | PREDICTED: cyclin-dependent kinase F-1-l | 0.984 | 0.665 | 0.702 | 1e-124 | |
| 225445192 | 471 | PREDICTED: cyclin-dependent kinase F-1 [ | 0.941 | 0.651 | 0.693 | 1e-120 | |
| 224143576 | 478 | predicted protein [Populus trichocarpa] | 0.972 | 0.663 | 0.671 | 1e-117 | |
| 147781538 | 435 | hypothetical protein VITISV_023714 [Viti | 0.941 | 0.705 | 0.669 | 1e-117 | |
| 297803154 | 480 | cdk-activating kinase 1at [Arabidopsis l | 0.990 | 0.672 | 0.641 | 1e-116 | |
| 15235518 | 479 | cyclin-dependent kinase F-1 [Arabidopsis | 0.987 | 0.672 | 0.645 | 1e-115 | |
| 255546431 | 467 | cak1, putative [Ricinus communis] gi|223 | 0.898 | 0.627 | 0.672 | 1e-112 | |
| 6984233 | 480 | CDK-activating kinase [Euphorbia esula] | 0.950 | 0.645 | 0.644 | 1e-108 | |
| 255639015 | 465 | unknown [Glycine max] | 0.950 | 0.666 | 0.615 | 1e-107 | |
| 357520963 | 479 | Protein kinase [Medicago truncatula] gi| | 0.892 | 0.607 | 0.619 | 1e-103 |
| >gi|449443157|ref|XP_004139347.1| PREDICTED: cyclin-dependent kinase F-1-like [Cucumis sativus] gi|449515446|ref|XP_004164760.1| PREDICTED: cyclin-dependent kinase F-1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1157), Expect = e-124, Method: Compositional matrix adjust.
Identities = 229/326 (70%), Positives = 261/326 (80%), Gaps = 5/326 (1%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFR 60
ME KSWSIH+RP+II KYEILE VGSGAYSDVY+ RRLSD +IVALKE+HDYQSAFR
Sbjct: 1 MEPSSAKSWSIHSRPDIIHKYEILERVGSGAYSDVYRARRLSDGVIVALKEIHDYQSAFR 60
Query: 61 EIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGD--RGI 118
EIEALQILQ SPN+VVLHEYFWREDEDAVLVLEF+RTDLATVIAE+KK D D RG+
Sbjct: 61 EIEALQILQGSPNIVVLHEYFWREDEDAVLVLEFMRTDLATVIAEAKKIGSDGVDSGRGL 120
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDA 178
+VGE+KRWM+QILSG+DACHRN IVHRDLKP NLLI DDG+LKLADFGQARIL+ ++
Sbjct: 121 AVGELKRWMIQILSGLDACHRNMIVHRDLKPSNLLISDDGMLKLADFGQARILMDPDYVE 180
Query: 179 PDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKN 238
+ SQPCE N+ Q S+ V E EG+ N+EQ +S+E+YFR LDELKAKN
Sbjct: 181 SNEISQPCEINSSDQVPSSQPSAVLPGTESLVREGNRNEEQETISKEEYFRVLDELKAKN 240
Query: 239 SIDETDKDTHVHDGDTSCFATCTTSDVEDDLFKG-TYSYDAEDG--GDGRQGALTSCVGT 295
S +E DK+T +DGDTSC ATCTTSD+EDD FKG +YSY+ E G D G LTSCVGT
Sbjct: 241 SANEFDKETCTYDGDTSCLATCTTSDLEDDPFKGSSYSYEMEGGVPADDGHGPLTSCVGT 300
Query: 296 RWFRAPELLYGSTSYGLEVDLWSLAA 321
RWFRAPELLYGSTSYGLE+DLWSL
Sbjct: 301 RWFRAPELLYGSTSYGLEIDLWSLGC 326
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225445192|ref|XP_002284217.1| PREDICTED: cyclin-dependent kinase F-1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1123), Expect = e-120, Method: Compositional matrix adjust.
Identities = 219/316 (69%), Positives = 258/316 (81%), Gaps = 9/316 (2%)
Query: 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ 66
+SWSIHTRPEII KYEILE VG+GAYSDVYKGRRLSD+LIVALKE+HDYQSAFREIEALQ
Sbjct: 6 RSWSIHTRPEIIQKYEILERVGAGAYSDVYKGRRLSDDLIVALKEIHDYQSAFREIEALQ 65
Query: 67 ILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
+LQ+SPNVVVLHEYFW EDEDAVLVLEFLRTDLA++I ++K+ ED GIS GEIKRW
Sbjct: 66 VLQSSPNVVVLHEYFWSEDEDAVLVLEFLRTDLASLIKDAKRNWED----GISGGEIKRW 121
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPC 186
MVQIL VDACHRN+IVHRDLKP NLLI + GVLKLADFGQARIL+ FD P +
Sbjct: 122 MVQILHAVDACHRNSIVHRDLKPSNLLISETGVLKLADFGQARILIEPGFDNPHLH---- 177
Query: 187 EPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKD 246
EP+ P Q + + +V E +++ EG NQE+G MS+E+Y L++LKAK+SID+ DK+
Sbjct: 178 EPHDPNQVTIIQHAEVIPEADNSHQEGSGNQERGTMSKEEYASDLEDLKAKSSIDDIDKE 237
Query: 247 THVHDGDTSCFATCTTSDV-EDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLY 305
T+ HDG+ SC ATCTTSD+ EDD FKG+Y Y+AE+GGD G LTSCVGTRWF+APELLY
Sbjct: 238 TNFHDGNASCLATCTTSDIEEDDPFKGSYYYEAEEGGDDTSGKLTSCVGTRWFKAPELLY 297
Query: 306 GSTSYGLEVDLWSLAA 321
GST+YG E+DLWSL
Sbjct: 298 GSTNYGPEIDLWSLGC 313
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143576|ref|XP_002325003.1| predicted protein [Populus trichocarpa] gi|222866437|gb|EEF03568.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1097), Expect = e-117, Method: Compositional matrix adjust.
Identities = 215/320 (67%), Positives = 249/320 (77%), Gaps = 3/320 (0%)
Query: 4 PLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIE 63
P KSWSIHTRPEII+KYEI E +GSGAYSDVYK RR SDNL VALKE+HDYQSA REIE
Sbjct: 6 PPAKSWSIHTRPEIISKYEIQERIGSGAYSDVYKARRHSDNLTVALKEIHDYQSASREIE 65
Query: 64 ALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
ALQ+LQN PNVVVLHEYFWREDEDAVLVLEFLRTDLA VI + +K+ D G G+SVGE+
Sbjct: 66 ALQVLQNCPNVVVLHEYFWREDEDAVLVLEFLRTDLAAVIKQGEKR--DDG-VGVSVGEV 122
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNS 183
KRWMVQIL GVDACHRN IVHRDLKP NLL+ DDGVLKLADFGQARIL+ F A D N
Sbjct: 123 KRWMVQILCGVDACHRNMIVHRDLKPSNLLVSDDGVLKLADFGQARILMDPGFVAADENI 182
Query: 184 QPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDET 243
QP E N +Q++ + +V E++ +S EG N++QG +SRE+ FR + K + S+D+
Sbjct: 183 QPYEQNPLFQEHATPPAEVVPEIDSSSQEGHRNEKQGTISREESFREMGNYKIQGSLDDI 242
Query: 244 DKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPEL 303
DK+ + DGDTSCFAT T SD+ DD+ K SY+AED + G+LTSCVGTRWFRAPEL
Sbjct: 243 DKEMSIRDGDTSCFATGTASDLGDDMLKSYCSYEAEDAENDGCGSLTSCVGTRWFRAPEL 302
Query: 304 LYGSTSYGLEVDLWSLAAYL 323
LYGST YGLEVDLWSL
Sbjct: 303 LYGSTDYGLEVDLWSLGCIF 322
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147781538|emb|CAN73707.1| hypothetical protein VITISV_023714 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1096), Expect = e-117, Method: Compositional matrix adjust.
Identities = 219/327 (66%), Positives = 257/327 (78%), Gaps = 20/327 (6%)
Query: 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ 66
+SWSIHTRPEII KYEILE VG+GAYSDVYKGRRLSD+LIVALKE+HDYQSAFREIEALQ
Sbjct: 6 RSWSIHTRPEIIQKYEILERVGAGAYSDVYKGRRLSDDLIVALKEIHDYQSAFREIEALQ 65
Query: 67 ILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
+LQ+SPNVVVLHEYFW EDEDAVLVLEFLRTDLA++I ++K+ ED GIS GEIKRW
Sbjct: 66 VLQSSPNVVVLHEYFWSEDEDAVLVLEFLRTDLASLIKDAKRNWED----GISGGEIKRW 121
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG-----------QARILLGNE 175
MVQIL VDACHRN+IVHRDLKP NLLI + GVLKLADFG QARIL+
Sbjct: 122 MVQILHAVDACHRNSIVHRDLKPSNLLISETGVLKLADFGQVKVFNLAVDFQARILIEPG 181
Query: 176 FDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELK 235
FD P + EP+ P Q + + +V E +++ EG NQE G MS+E+Y L++LK
Sbjct: 182 FDNPHLH----EPHDPNQVTIIQHAEVIPEADNSHQEGSGNQEXGTMSKEEYASDLEDLK 237
Query: 236 AKNSIDETDKDTHVHDGDTSCFATCTTSDV-EDDLFKGTYSYDAEDGGDGRQGALTSCVG 294
AK+SID+ DK+T+ HDG+ SC ATCTTSD+ EDD FKG+Y Y+AE+GGD G LTSCVG
Sbjct: 238 AKSSIDDIDKETNFHDGNASCLATCTTSDIEEDDPFKGSYYYEAEEGGDDTCGKLTSCVG 297
Query: 295 TRWFRAPELLYGSTSYGLEVDLWSLAA 321
TRWF+APELLYGST+YG E+DLWSL
Sbjct: 298 TRWFKAPELLYGSTNYGPEIDLWSLGC 324
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297803154|ref|XP_002869461.1| cdk-activating kinase 1at [Arabidopsis lyrata subsp. lyrata] gi|297315297|gb|EFH45720.1| cdk-activating kinase 1at [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1087), Expect = e-116, Method: Compositional matrix adjust.
Identities = 208/324 (64%), Positives = 255/324 (78%), Gaps = 1/324 (0%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFR 60
M++ SWSIHTRPEIIAKYEI E VGSGAY+DVY+ RRLSD LIVALKE+ DYQSAFR
Sbjct: 1 MDKQPASSWSIHTRPEIIAKYEIFERVGSGAYADVYRARRLSDGLIVALKEIFDYQSAFR 60
Query: 61 EIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
EI+AL IL PNVVV+HEYFWREDE+AVLVLEFLR+DLA VI ++K+K++ G G SV
Sbjct: 61 EIDALTILNGHPNVVVMHEYFWREDENAVLVLEFLRSDLAAVIRDAKRKKKVEGGDGFSV 120
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPD 180
GEIKRWM+QIL+GVDACHRN IVHRDLKPGN+LI DDGVLKLADFGQARIL+ + A D
Sbjct: 121 GEIKRWMIQILTGVDACHRNLIVHRDLKPGNMLISDDGVLKLADFGQARILMEPDIVASD 180
Query: 181 GNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSI 240
N Q + ++ +E P+V + E++ +G QEQ MS+++YFR ++ELKAK +
Sbjct: 181 ENQQVYKLEENDGESSTEPPEVIPDYENSPRQGSDGQEQVAMSKDEYFRQVEELKAKQVV 240
Query: 241 -DETDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFR 299
D+TDKD++VHDGD SC ATCT S+++DDL + ++SYDA++ + QG +TSCVGTRWFR
Sbjct: 241 RDDTDKDSNVHDGDISCLATCTVSEMDDDLGRNSFSYDADEAVEDTQGLMTSCVGTRWFR 300
Query: 300 APELLYGSTSYGLEVDLWSLAAYL 323
PELLYGST YGLEVDLWSL
Sbjct: 301 PPELLYGSTMYGLEVDLWSLGCVF 324
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15235518|ref|NP_194627.1| cyclin-dependent kinase F-1 [Arabidopsis thaliana] gi|30688174|ref|NP_849468.1| cyclin-dependent kinase F-1 [Arabidopsis thaliana] gi|75318628|sp|O80345.1|CDKF1_ARATH RecName: Full=Cyclin-dependent kinase F-1; Short=CDKF;1; AltName: Full=CDK-activating kinase 1-At; Short=CAK1-At gi|3218550|dbj|BAA28775.1| Cdk-activating kinase 1At [Arabidopsis thaliana] gi|4972044|emb|CAB43912.1| Cdk-activating kinase CAK1At [Arabidopsis thaliana] gi|7269796|emb|CAB79656.1| Cdk-activating kinase CAK1At [Arabidopsis thaliana] gi|14596057|gb|AAK68756.1| Cdk-activating kinase CAK1At [Arabidopsis thaliana] gi|17978693|gb|AAL47340.1| Cdk-activating kinase CAK1At [Arabidopsis thaliana] gi|222423384|dbj|BAH19664.1| AT4G28980 [Arabidopsis thaliana] gi|332660167|gb|AEE85567.1| cyclin-dependent kinase F-1 [Arabidopsis thaliana] gi|332660168|gb|AEE85568.1| cyclin-dependent kinase F-1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1082), Expect = e-115, Method: Compositional matrix adjust.
Identities = 209/324 (64%), Positives = 254/324 (78%), Gaps = 2/324 (0%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFR 60
M++ SWSIHTRPEIIAKYEI E VGSGAY+DVY+ RRLSD LIVALKE+ DYQSAFR
Sbjct: 1 MDKQPATSWSIHTRPEIIAKYEIFERVGSGAYADVYRARRLSDGLIVALKEIFDYQSAFR 60
Query: 61 EIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
EI+AL IL SPNVVV+HEYFWRE+E+AVLVLEFLR+DLA VI + K+K++ G G SV
Sbjct: 61 EIDALTILNGSPNVVVMHEYFWREEENAVLVLEFLRSDLAAVIRDGKRKKKVEGGDGFSV 120
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPD 180
GEIKRWM+QIL+GVDACHRN IVHRDLKPGN+LI DDGVLKLADFGQARIL+ ++ A D
Sbjct: 121 GEIKRWMIQILTGVDACHRNLIVHRDLKPGNMLISDDGVLKLADFGQARILMEHDIVASD 180
Query: 181 GNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSI 240
N Q + SE P+V + E++ +G QE+ MS+++YFR ++ELKAK +
Sbjct: 181 ENQQAYKLED-KDGETSEPPEVIPDYENSPRQGSDGQEREAMSKDEYFRQVEELKAKQVV 239
Query: 241 -DETDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFR 299
D+TDKD++VHDGD SC ATCT S+++DDL + ++SYDA++ D QG +TSCVGTRWFR
Sbjct: 240 RDDTDKDSNVHDGDISCLATCTVSEMDDDLGRNSFSYDADEAVDDTQGLMTSCVGTRWFR 299
Query: 300 APELLYGSTSYGLEVDLWSLAAYL 323
PELLYGST YGLEVDLWSL
Sbjct: 300 PPELLYGSTMYGLEVDLWSLGCVF 323
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255546431|ref|XP_002514275.1| cak1, putative [Ricinus communis] gi|223546731|gb|EEF48229.1| cak1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1053), Expect = e-112, Method: Compositional matrix adjust.
Identities = 209/311 (67%), Positives = 238/311 (76%), Gaps = 18/311 (5%)
Query: 11 IHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQN 70
IHTR EII+KYEI E VG+GAYSDVYK RRLSDNLIVALKE+HDYQSAFREIE LQILQN
Sbjct: 17 IHTRSEIISKYEIEERVGAGAYSDVYKARRLSDNLIVALKEIHDYQSAFREIETLQILQN 76
Query: 71 SPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
PNVVVLHEYFWREDEDAVLVLEFLRTDLA VI + KK GISVGE+KRWMVQI
Sbjct: 77 CPNVVVLHEYFWREDEDAVLVLEFLRTDLAAVIKQGKKN-------GISVGEVKRWMVQI 129
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNA 190
L GVDACHRNTIVHRDLKP NLLI DDG LKLADFGQARIL+ F A D N QP E N
Sbjct: 130 LCGVDACHRNTIVHRDLKPSNLLISDDGRLKLADFGQARILMDPGFVATDENPQPYEHNL 189
Query: 191 PYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTHVH 250
Q+ + A +V PE + + ++G++ R++ FR ++E KA + ++ET +
Sbjct: 190 VNQEPLVPAAEV-------IPEMEKSPQEGVVRRDESFREMNEFKAPDYLEETS----IR 238
Query: 251 DGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSY 310
DGDTSCFAT T SD+ DD K +Y+YD ++GGD R +LTSCVGTRWFRAPELLYGST Y
Sbjct: 239 DGDTSCFATGTASDIGDDFLKSSYTYDVDEGGDDRHASLTSCVGTRWFRAPELLYGSTDY 298
Query: 311 GLEVDLWSLAA 321
GLEVDLWSL
Sbjct: 299 GLEVDLWSLGC 309
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|6984233|gb|AAF34804.1|AF230740_1 CDK-activating kinase [Euphorbia esula] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1018), Expect = e-108, Method: Compositional matrix adjust.
Identities = 207/321 (64%), Positives = 237/321 (73%), Gaps = 11/321 (3%)
Query: 4 PLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIE 63
P KSWSIHTRPEIIAKYEI E VGSGAYSDVYK RRLSDNLIVALKE+HDYQSAFREIE
Sbjct: 10 PHAKSWSIHTRPEIIAKYEIQERVGSGAYSDVYKARRLSDNLIVALKEIHDYQSAFREIE 69
Query: 64 ALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
AL I+QN PN+VVLHEYFWREDEDAVLVLEFLRTDLA++I E KK G G++ GEI
Sbjct: 70 ALHIVQNCPNIVVLHEYFWREDEDAVLVLEFLRTDLASLIKEGKKN----GGIGVNAGEI 125
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF--DAPDG 181
KRWM+QILSG+DACHRN +VHRDLKP NLLI DDGVLKLADFGQARIL+ F A D
Sbjct: 126 KRWMMQILSGLDACHRNMVVHRDLKPSNLLISDDGVLKLADFGQARILMEPGFVATATDE 185
Query: 182 NSQPCEPN-APYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSI 240
P E N A + + +P+ +V E NQEQ I+ + FR E K + +
Sbjct: 186 TMHPDEQNLAVNEQKVVTSPENIPQVNPVPIEVQSNQEQVIVKGYESFRETGESKPYDYL 245
Query: 241 DETDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRA 300
DET + DGDTSC AT T SD+ DD + TY+Y+ ++ + R G+LTSCVGTRWFRA
Sbjct: 246 DETS----IRDGDTSCLATGTASDMGDDFMRSTYNYETDEVDNERYGSLTSCVGTRWFRA 301
Query: 301 PELLYGSTSYGLEVDLWSLAA 321
PELLYGST YGLE+DLWSL
Sbjct: 302 PELLYGSTDYGLEIDLWSLGC 322
|
Source: Euphorbia esula Species: Euphorbia esula Genus: Euphorbia Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255639015|gb|ACU19808.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1012), Expect = e-107, Method: Compositional matrix adjust.
Identities = 197/320 (61%), Positives = 235/320 (73%), Gaps = 10/320 (3%)
Query: 4 PLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIE 63
P PK+WSIHTR EI AKY++L VGSG Y+DVY RRLSD V LKEVHD QSA REIE
Sbjct: 3 PPPKTWSIHTRSEITAKYQVLSRVGSGVYADVYCARRLSDGAAVGLKEVHDSQSASREIE 62
Query: 64 ALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
AL++L+ S NVVVLHE+FWREDEDAVLVLEFL TDLATVI G+ G+ V E
Sbjct: 63 ALRLLKGSRNVVVLHEFFWREDEDAVLVLEFLGTDLATVI----------GEGGVGVAEA 112
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNS 183
KRWMVQ LS VD CHRN IVHRDLKP N L+ DDG LKLADFGQARIL+ + FDAP N
Sbjct: 113 KRWMVQALSAVDECHRNMIVHRDLKPANFLVSDDGALKLADFGQARILVESGFDAPQENP 172
Query: 184 QPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDET 243
P E +A ++ + P+ ++ + + N QG +S E+YFR LDE+K K+ +T
Sbjct: 173 PPYEDDASNSESSLQHPETISQLVNLNQTVYENPNQGTVSHEEYFRVLDEMKTKSYSYDT 232
Query: 244 DKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPEL 303
DKDT+++DG+TSC ATCTTSD++DDL KG+++Y+AE+ G G LTSCVGTRWFRAPEL
Sbjct: 233 DKDTNIYDGNTSCLATCTTSDIDDDLCKGSFTYEAEEVGGNELGCLTSCVGTRWFRAPEL 292
Query: 304 LYGSTSYGLEVDLWSLAAYL 323
LYGST YGLEVDLWSL
Sbjct: 293 LYGSTDYGLEVDLWSLGCVF 312
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520963|ref|XP_003630770.1| Protein kinase [Medicago truncatula] gi|355524792|gb|AET05246.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 382 bits (981), Expect = e-103, Method: Compositional matrix adjust.
Identities = 195/315 (61%), Positives = 231/315 (73%), Gaps = 24/315 (7%)
Query: 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ 66
KSWSIHTR EIIAKY+++E +GSGAY+DVY+GRRLSD+L VALKE+HDYQSAFREIEALQ
Sbjct: 8 KSWSIHTRSEIIAKYQVMERIGSGAYADVYRGRRLSDDLTVALKEIHDYQSAFREIEALQ 67
Query: 67 ILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
+LQ SPNVVVLHEYFWR+DEDAVLVLE+L TDLATVI+ + K+ I VGE+KRW
Sbjct: 68 MLQGSPNVVVLHEYFWRDDEDAVLVLEYLTTDLATVISNAAKE-----GIPIPVGELKRW 122
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPC 186
M+QIL G+DACHRN IVHRDLKP NLLI D GVLKLADFGQARIL+ + FDA + N PC
Sbjct: 123 MIQILCGLDACHRNMIVHRDLKPSNLLISDCGVLKLADFGQARILIESGFDAFEENPPPC 182
Query: 187 EPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKD 246
E + ++ P+ + S G NQEQG S E+YF LDELK K S+D+ DK+
Sbjct: 183 EEDGSNHESSLHHPEAFPHTNNLSQLGFENQEQG-SSHEEYFSVLDELKTKKSVDDVDKN 241
Query: 247 THVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYG 306
T++ DG+TSC AT + +G D G LTSCVGTRWFRAPELLYG
Sbjct: 242 TNIPDGNTSCLAT------------------SMEGEDKEHGCLTSCVGTRWFRAPELLYG 283
Query: 307 STSYGLEVDLWSLAA 321
S +YGLE+DLWSL
Sbjct: 284 SANYGLEIDLWSLGC 298
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 326 | ||||||
| TAIR|locus:2119961 | 479 | CAK1AT "CDK-activating kinase | 0.969 | 0.659 | 0.658 | 3.8e-110 | |
| ZFIN|ZDB-GENE-041212-84 | 344 | cdk20 "cyclin-dependent kinase | 0.453 | 0.430 | 0.406 | 7.7e-31 | |
| UNIPROTKB|G4MTA2 | 350 | MGG_04660 "CMGC/CDK/CDK5 prote | 0.429 | 0.4 | 0.423 | 2e-30 | |
| SGD|S000002266 | 306 | KIN28 "Serine/threonine protei | 0.414 | 0.441 | 0.434 | 2e-30 | |
| UNIPROTKB|A6H7E6 | 346 | CCRK "Uncharacterized protein" | 0.453 | 0.427 | 0.394 | 2.6e-30 | |
| CGD|CAL0000482 | 343 | orf19.6239 [Candida albicans ( | 0.478 | 0.454 | 0.380 | 4.2e-30 | |
| MGI|MGI:2145349 | 346 | Cdk20 "cyclin-dependent kinase | 0.450 | 0.424 | 0.396 | 8.6e-30 | |
| RGD|1305219 | 346 | Cdk20 "cyclin-dependent kinase | 0.450 | 0.424 | 0.396 | 8.6e-30 | |
| UNIPROTKB|Q4KM34 | 346 | Cdk20 "Cyclin-dependent kinase | 0.450 | 0.424 | 0.396 | 8.6e-30 | |
| UNIPROTKB|F1PPV7 | 346 | CDK20 "Uncharacterized protein | 0.453 | 0.427 | 0.388 | 8.6e-30 |
| TAIR|locus:2119961 CAK1AT "CDK-activating kinase 1AT" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1088 (388.1 bits), Expect = 3.8e-110, P = 3.8e-110
Identities = 210/319 (65%), Positives = 254/319 (79%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFRE 61
+QP SWSIHTRPEIIAKYEI E VGSGAY+DVY+ RRLSD LIVALKE+ DYQSAFRE
Sbjct: 3 KQPAT-SWSIHTRPEIIAKYEIFERVGSGAYADVYRARRLSDGLIVALKEIFDYQSAFRE 61
Query: 62 IEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVG 121
I+AL IL SPNVVV+HEYFWRE+E+AVLVLEFLR+DLA VI + K+K++ G G SVG
Sbjct: 62 IDALTILNGSPNVVVMHEYFWREEENAVLVLEFLRSDLAAVIRDGKRKKKVEGGDGFSVG 121
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDG 181
EIKRWM+QIL+GVDACHRN IVHRDLKPGN+LI DDGVLKLADFGQARIL+ ++ A D
Sbjct: 122 EIKRWMIQILTGVDACHRNLIVHRDLKPGNMLISDDGVLKLADFGQARILMEHDIVASDE 181
Query: 182 NSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSI- 240
N Q + SE P+V + E++ +G QE+ MS+++YFR ++ELKAK +
Sbjct: 182 NQQAYKLEDK-DGETSEPPEVIPDYENSPRQGSDGQEREAMSKDEYFRQVEELKAKQVVR 240
Query: 241 DETDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRA 300
D+TDKD++VHDGD SC ATCT S+++DDL + ++SYDA++ D QG +TSCVGTRWFR
Sbjct: 241 DDTDKDSNVHDGDISCLATCTVSEMDDDLGRNSFSYDADEAVDDTQGLMTSCVGTRWFRP 300
Query: 301 PELLYGSTSYGLEVDLWSL 319
PELLYGST YGLEVDLWSL
Sbjct: 301 PELLYGSTMYGLEVDLWSL 319
|
|
| ZFIN|ZDB-GENE-041212-84 cdk20 "cyclin-dependent kinase 20" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 257 (95.5 bits), Expect = 7.7e-31, Sum P(2) = 7.7e-31
Identities = 67/165 (40%), Positives = 95/165 (57%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDY--QSAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + VALK+V D A REI+ALQ ++++
Sbjct: 3 QYSILGRIGEGAHGIVFKAKHIETGETVALKKVALRRLEDGIPNQALREIKALQEIEDNQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L + F VLV E++ +DL+ VI S+ R ++ ++K +M+ +L
Sbjct: 63 YVVKLKDVF-PHGTGFVLVFEYMLSDLSEVIRNSQ--------RPLTASQVKSYMMMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFD 177
GV CH N+I+HRDLKP NLLI G LK+ADFG AR L NE D
Sbjct: 114 GVAFCHENSIMHRDLKPANLLISSTGHLKIADFGLAR-LFSNEGD 157
|
|
| UNIPROTKB|G4MTA2 MGG_04660 "CMGC/CDK/CDK5 protein kinase" [Magnaporthe oryzae 70-15 (taxid:242507)] | Back alignment and assigned GO terms |
|---|
Score = 269 (99.8 bits), Expect = 2.0e-30, Sum P(2) = 2.0e-30
Identities = 66/156 (42%), Positives = 95/156 (60%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQ-----SAFREIEALQILQNSPNV 74
++ LE +G G Y+ V+KGR +VALKE+H D + +A REI ++ L++ N+
Sbjct: 10 FQQLEKLGEGTYATVFKGRNRHTGELVALKEIHLDSEEGTPSTAIREISLMKELKHE-NI 68
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRG-ISVGEIKRWMVQILSG 133
V LH+ E++ +LV E + DL KK + +GDRG + IK +M Q+L G
Sbjct: 69 VGLHDVIHTENK-LMLVFEHMDGDL-------KKYMDTKGDRGALQPMVIKSFMYQLLKG 120
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+D CH+N ++HRDLKP NLLI + G LKL DFG AR
Sbjct: 121 IDFCHQNRVLHRDLKPQNLLINNKGALKLGDFGLAR 156
|
|
| SGD|S000002266 KIN28 "Serine/threonine protein kinase" [Saccharomyces cerevisiae (taxid:4932)] | Back alignment and assigned GO terms |
|---|
Score = 250 (93.1 bits), Expect = 2.0e-30, Sum P(2) = 2.0e-30
Identities = 66/152 (43%), Positives = 88/152 (57%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPNVVVLHE 79
VG G Y+ VY G + S +A+KE+ + SA RE++ LQ +Q+ PNV+ L +
Sbjct: 13 VGEGTYAVVYLGCQHSTGRKIAIKEIKTSEFKDGLDMSAIREVKYLQEMQH-PNVIELID 71
Query: 80 YFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR 139
F D + LVLEFL TDL VI +D+ + +IK WM+ L GV CHR
Sbjct: 72 IFMAYD-NLNLVLEFLPTDLEVVI-------KDKSIL-FTPADIKAWMLMTLRGVYHCHR 122
Query: 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
N I+HRDLKP NLL DG +K+ADFG AR +
Sbjct: 123 NFILHRDLKPNNLLFSPDGQIKVADFGLARAI 154
|
|
| UNIPROTKB|A6H7E6 CCRK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 245 (91.3 bits), Expect = 2.6e-30, Sum P(2) = 2.6e-30
Identities = 67/170 (39%), Positives = 93/170 (54%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDY--QSAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + IVALK+V D REI+ALQ +++S
Sbjct: 3 QYCILGRIGEGAHGIVFKAKHVETGEIVALKKVALRRLEDGIPNQVLREIKALQEIEDSQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L F VL EF+ +DLA V+ ++ R ++ ++K ++ +L
Sbjct: 63 YVVQLKAVF-PHGAGFVLAFEFMLSDLAEVVRHTQ--------RPLAQAQVKSYLQMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGN 182
GV CH N IVHRDLKP NLLI G LK+ADFG AR+ +PDGN
Sbjct: 114 GVAFCHANNIVHRDLKPANLLISASGQLKIADFGLARVF------SPDGN 157
|
|
| CGD|CAL0000482 orf19.6239 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 251 (93.4 bits), Expect = 4.2e-30, Sum P(2) = 4.2e-30
Identities = 67/176 (38%), Positives = 98/176 (55%)
Query: 10 SIHTRPEI--IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFR 60
S+ ++P ++ Y + VG G Y+ VY G+++S +A+KE+ SA R
Sbjct: 11 SVTSKPATKQVSNYTKEKKVGEGTYAVVYLGKQISTKRQIAIKEIKTGLFKDGLDMSALR 70
Query: 61 EIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
E++ LQ L++ PNV+ L + F + LVLEFL DL +I + +
Sbjct: 71 EVKYLQELKH-PNVIELVDVF-SATNNLNLVLEFLPCDLEVLIKDKSIVFKS-------- 120
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLG-NE 175
+IK W++ L G+ CHRN I+HRDLKP NLL+ DG LK+ADFG AR L+ NE
Sbjct: 121 ADIKSWLLMTLRGIHHCHRNFILHRDLKPNNLLLAPDGQLKIADFGLARALVNPNE 176
|
|
| MGI|MGI:2145349 Cdk20 "cyclin-dependent kinase 20" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 243 (90.6 bits), Expect = 8.6e-30, Sum P(2) = 8.6e-30
Identities = 67/169 (39%), Positives = 93/169 (55%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDY--QSAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + IVALK+V D A REI+ALQ +++S
Sbjct: 3 QYCILGRIGEGAHGIVFKAKHVETGEIVALKKVALRRLEDGIPNQALREIKALQEIEDSQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L F VL EF+ +DLA V+ ++ R ++ ++K ++ +L
Sbjct: 63 YVVQLKAVF-PHGAGFVLAFEFMLSDLAEVVRHAQ--------RPLAPAQVKSYLQMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDG 181
GV CH N IVHRDLKP NLLI G LK+ADFG AR+ +PDG
Sbjct: 114 GVAFCHANNIVHRDLKPANLLISASGQLKIADFGLARVF------SPDG 156
|
|
| RGD|1305219 Cdk20 "cyclin-dependent kinase 20" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 243 (90.6 bits), Expect = 8.6e-30, Sum P(2) = 8.6e-30
Identities = 67/169 (39%), Positives = 93/169 (55%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDY--QSAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + IVALK+V D A REI+ALQ +++S
Sbjct: 3 QYCILGRIGEGAHGIVFKAKHVETGEIVALKKVALRRLEDGIPNQALREIKALQEIEDSQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L F VL EF+ +DLA V+ ++ R ++ ++K ++ +L
Sbjct: 63 YVVQLKAVF-PHGAGFVLAFEFMLSDLAEVVRHAQ--------RPLAPAQVKSYLQMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDG 181
GV CH N IVHRDLKP NLLI G LK+ADFG AR+ +PDG
Sbjct: 114 GVAFCHANNIVHRDLKPANLLISASGQLKIADFGLARVF------SPDG 156
|
|
| UNIPROTKB|Q4KM34 Cdk20 "Cyclin-dependent kinase 20" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 243 (90.6 bits), Expect = 8.6e-30, Sum P(2) = 8.6e-30
Identities = 67/169 (39%), Positives = 93/169 (55%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDY--QSAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + IVALK+V D A REI+ALQ +++S
Sbjct: 3 QYCILGRIGEGAHGIVFKAKHVETGEIVALKKVALRRLEDGIPNQALREIKALQEIEDSQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L F VL EF+ +DLA V+ ++ R ++ ++K ++ +L
Sbjct: 63 YVVQLKAVF-PHGAGFVLAFEFMLSDLAEVVRHAQ--------RPLAPAQVKSYLQMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDG 181
GV CH N IVHRDLKP NLLI G LK+ADFG AR+ +PDG
Sbjct: 114 GVAFCHANNIVHRDLKPANLLISASGQLKIADFGLARVF------SPDG 156
|
|
| UNIPROTKB|F1PPV7 CDK20 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 241 (89.9 bits), Expect = 8.6e-30, Sum P(2) = 8.6e-30
Identities = 66/170 (38%), Positives = 94/170 (55%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDY--QSAFREIEALQILQNSP 72
+Y IL +G GA+ V+K + + IVALK+V D A REI+ALQ ++++
Sbjct: 3 QYCILGRIGEGAHGVVFKAKHVETGEIVALKKVALRRLEDGIPNQALREIKALQEIEDNQ 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+VV L F VL EF+ +DLA V+ ++ R + ++K ++ +L
Sbjct: 63 HVVQLKAVF-PHGAGFVLAFEFMLSDLAEVVRHAQ--------RPLVQAQVKSYLQMLLK 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGN 182
GV CH N IVHRDLKP NLLI G LK+ADFG AR+ +PDG+
Sbjct: 114 GVAFCHANNIVHRDLKPANLLISASGQLKIADFGLARVF------SPDGS 157
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O80345 | CDKF1_ARATH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.6450 | 0.9877 | 0.6722 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00016715001 | SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (471 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | GSVIVG00022766001 | SubName- Full=Chromosome chr14 scaffold_27, whole genome shotgun sequence; (332 aa) | • | • | 0.475 | ||||||
 | GSVIVG00022138001 | SubName- Full=Putative uncharacterized protein (Chromosome chr6 scaffold_25, whole genome shotg [...] (88 aa) | • | • | 0.407 | ||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 326 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-43 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-40 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-39 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-38 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-35 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-32 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-31 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-30 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-28 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-26 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-25 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-25 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-25 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-24 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-24 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-24 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-24 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-22 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-22 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-21 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-06 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-06 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-05 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.001 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.001 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.001 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.001 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.002 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.002 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.002 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.002 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.003 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.003 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.003 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.004 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-43
Identities = 65/164 (39%), Positives = 92/164 (56%), Gaps = 20/164 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNV 74
YEILE +G G++ VY R +VA+K + D + REI+ L+ L PN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 75 VVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
V L++ F EDED + LV+E+ DL ++ KKR +S E + ++ QILS
Sbjct: 60 VRLYDVF--EDEDKLYLVMEYCEGGDLFDLL----KKR-----GRLSEDEARFYLRQILS 108
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
++ H IVHRDLKP N+L+ +DG +KLADFG AR L E
Sbjct: 109 ALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK 152
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-42
Identities = 64/156 (41%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQ------SAFREIEALQILQNSPN 73
YE LE +G G Y VYK R IVALK++ D + +A REI L+ L++ PN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PN 59
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V L + + LV E+ DL + D+ +S IK M Q+L G
Sbjct: 60 IVKLLDVI-HTERKLYLVFEYCDMDLKKYL--------DKRPGPLSPNLIKSIMYQLLRG 110
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ CH + I+HRDLKP N+LI DGVLKLADFG AR
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 59/162 (36%), Positives = 90/162 (55%), Gaps = 19/162 (11%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPN 73
YE+L +GSG++ VYK + IVA+K + Q+A REI L+ L + PN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 74 VVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+V L + F + + LV+E+ DL ++ ED E K+ +QIL
Sbjct: 60 IVRLIDAF-EDKDHLYLVMEYCEGGDLFDYLSRGGPLSED---------EAKKIALQILR 109
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174
G++ H N I+HRDLKP N+L+ ++GV+K+ADFG A+ LL +
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS 151
|
Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 9e-40
Identities = 58/157 (36%), Positives = 87/157 (55%), Gaps = 17/157 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV---HDYQ----SAFREIEALQILQNSPN 73
YE + +G G Y VYK R +VALK++ ++ + +A REI+ LQ L++ PN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59
Query: 74 VVVLHE-YFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+V L E + +V E++ DL ++ + K + +IK +M Q+L
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--------FTESQIKCYMKQLLE 111
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
G+ H N I+HRD+K N+LI +DGVLKLADFG AR
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 63/159 (39%), Positives = 90/159 (56%), Gaps = 17/159 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
+Y+IL +G GA+ V+K + VALK+V + A REI+ALQ Q+ P
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-P 59
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L + F VLV+E++ +DL+ V+ + +R + ++K +M +L
Sbjct: 60 YVVKLLDVF-PHGSGFVLVMEYMPSDLSEVLRDE--------ERPLPEAQVKSYMRMLLK 110
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
GV H N I+HRDLKP NLLI DGVLK+ADFG AR+
Sbjct: 111 GVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF 149
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 4e-38
Identities = 64/161 (39%), Positives = 90/161 (55%), Gaps = 20/161 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV---HDY-------QSAFREIEALQILQ 69
+YE + +G G Y+ VYK R IVA+K++ +A REI+ LQ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
+ PN++ L + F + LV EF+ TDL VI +D+ ++ +IK +M+
Sbjct: 61 H-PNIIGLLDVF-GHKSNINLVFEFMETDLEKVI-------KDKSIV-LTPADIKSYMLM 110
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
L G++ H N I+HRDLKP NLLI DGVLKLADFG AR
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 65/158 (41%), Positives = 87/158 (55%), Gaps = 17/158 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPN 73
Y+ L +G G Y VYK R IVA+K++ ++A REI+ L+ L N PN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
++ L + F R D LV EF+ TDL +I RG+ IK ++ Q+L G
Sbjct: 60 IIKLLDVF-RHKGDLYLVFEFMDTDLYKLI--------KDRQRGLPESLIKSYLYQLLQG 110
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ CH + I+HRDLKP NLLI +GVLKLADFG AR
Sbjct: 111 LAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF 148
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 28/197 (14%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEV------HDYQSAFREIEALQILQNSPNVVVLHEY 80
+G G + VY R VA+K + + REIE L+ L N PN+V L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 81 FWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR 139
F ++ LV+E+ L ++ E++ K +S EI R ++QIL G++ H
Sbjct: 60 F-EDENHLYLVMEYCEGGSLKDLLKENEGK--------LSEDEILRILLQILEGLEYLHS 110
Query: 140 NTIVHRDLKPGNLLIG-DDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSE 198
N I+HRDLKP N+L+ D+G +KLADFG +++ + + Y
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKL-----LTSDKSLLKTIVGTPAYM----- 160
Query: 199 APQVDLEVEDASPEGDV 215
AP+V L S + D+
Sbjct: 161 APEVLLGKGYYSEKSDI 177
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-35
Identities = 67/163 (41%), Positives = 86/163 (52%), Gaps = 20/163 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQ--NS 71
YE L +G GAY VYK R L+ VALK+V S REI L+ L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 72 PNVVVLHE--YFWREDE--DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWM 127
PN+V L + + R D LV E + DLAT +++ K G+ IK M
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKP-------GLPPETIKDLM 113
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
Q+L GVD H + IVHRDLKP N+L+ DG +K+ADFG ARI
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 51/161 (31%), Positives = 88/161 (54%), Gaps = 17/161 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSP 72
KYEI++ +G G++ VY RR SD + LKE+ + + A E++ L+ L N P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 73 NVVVLHEYFWREDEDAVL-VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
N++ +E F E++ + V+E+ DL+ I + KK+ + +I W VQ+
Sbjct: 60 NIIKYYESF--EEKGKLCIVMEYADGGDLSQKIKKQKKEG-----KPFPEEQILDWFVQL 112
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ H I+HRD+KP N+ + +G++KL DFG +++L
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 65/156 (41%), Positives = 92/156 (58%), Gaps = 16/156 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQ-----SAFREIEALQILQNSPNV 74
++ LE +G G Y+ VYKGR + IVALKE+H D + +A REI ++ L++ N+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENI 60
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRG-ISVGEIKRWMVQILSG 133
V LH+ E++ +LV E++ DL KK + G RG + +K + Q+L G
Sbjct: 61 VRLHDVIHTENK-LMLVFEYMDKDL-------KKYMDTHGVRGALDPNTVKSFTYQLLKG 112
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ CH N ++HRDLKP NLLI G LKLADFG AR
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-32
Identities = 59/182 (32%), Positives = 90/182 (49%), Gaps = 30/182 (16%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQS-------AFREIEALQILQNSP 72
KYE+L VG GAY V K R + IVA+K+ + + A RE++ L+ L++
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-E 60
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L E F R+ LV E++ L ++ S G+ ++ ++ Q+L
Sbjct: 61 NIVNLKEAFRRKGR-LYLVFEYVERTLLELLEASPG--------GLPPDAVRSYIWQLLQ 111
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAPY 192
+ CH + I+HRD+KP N+L+ + GVLKL DFG AR L P +P
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL-------------RARPASPL 158
Query: 193 QD 194
D
Sbjct: 159 TD 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 61/157 (38%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPN 73
Y+ +E +G G Y VYK R IVALK++ +A REI L+ L + PN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH-PN 59
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V L + + LV EFL DL KK + G+ IK ++ Q+L G
Sbjct: 60 IVRLLDVV-HSENKLYLVFEFLDLDL-------KKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
+ CH + ++HRDLKP NLLI +G LKLADFG AR
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 61/156 (39%), Positives = 91/156 (58%), Gaps = 18/156 (11%)
Query: 21 YEILECVGSGAYSDVYKGR-RLSDNLIVALKEVHDYQ------SAFREIEALQILQNSPN 73
Y+ L+ +G G+Y+ VYKGR +L+ L VALKE+ +A RE L+ L+++ N
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASLLKDLKHA-N 64
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V LH+ + LV E+L TDL + D G+S+ ++ ++ Q+L G
Sbjct: 65 IVTLHDII-HTKKTLTLVFEYLDTDLKQYM--------DDCGGGLSMHNVRLFLFQLLRG 115
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ CH+ ++HRDLKP NLLI + G LKLADFG AR
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 51/155 (32%), Positives = 85/155 (54%), Gaps = 14/155 (9%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV-HDYQS-----AFREIEALQILQNSPNV 74
Y++++ +G G + VY R +VA+K++ + S RE+++L+ L PN+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
V L E F RE+++ V E++ +L ++ +DR + S I+ + QIL G+
Sbjct: 61 VKLKEVF-RENDELYFVFEYMEGNLYQLM-------KDRKGKPFSESVIRSIIYQILQGL 112
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
H++ HRDLKP NLL+ V+K+ADFG AR
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 65/178 (36%), Positives = 92/178 (51%), Gaps = 23/178 (12%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQIL 68
+ ++KYE L +G G + +V+K R IVALK+V +A REI+ LQ+L
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL 68
Query: 69 QNSPNVVVLHEY-------FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVG 121
NVV L E + R LV EF DLA +++ K ++
Sbjct: 69 -KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK--------FTLS 119
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAP 179
EIK+ M +L+G+ HRN I+HRD+K N+LI DG+LKLADFG AR ++ P
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 23/167 (13%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ----ILQ--NSPN 73
++ E +G G++ VY ++A+K V + E+EAL+ IL PN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 74 VVVLHEYFW-REDEDAV---LVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
+V Y+ DE+ + LE++ L++++ + K E I+++
Sbjct: 61 IV---RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP---------VIRKYTR 108
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
QIL G+ H N IVHRD+K N+L+ DGV+KLADFG A+ L E
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 56/157 (35%), Positives = 83/157 (52%), Gaps = 17/157 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV--HDYQSAF-----REIEALQILQNSPN 73
YE L + G Y VY+ R IVALK++ + F REI L LQ+ PN
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PN 65
Query: 74 VVVLHEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+V + E + D + +V+E++ DL +++ + + E+K M+Q+LS
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM--------ETMKQPFLQSEVKCLMLQLLS 117
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
GV H N I+HRDLK NLL+ + G+LK+ DFG AR
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 60/160 (37%), Positives = 87/160 (54%), Gaps = 17/160 (10%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQN 70
+ ++E L +G G Y VY+ R + IVALK+V S+ REI L L++
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 71 SPNVVVLHEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
PN+V L E + D++ LV+E+ DLA+++ D S ++K M+Q
Sbjct: 66 -PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--------DNMPTPFSESQVKCLMLQ 116
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+L G+ H N I+HRDLK NLL+ D G LK+ADFG AR
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-28
Identities = 63/159 (39%), Positives = 84/159 (52%), Gaps = 19/159 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALK----EVHDY---QSAFREIEALQILQNSP 72
Y +E +G G Y VYKGR IVA+K E + +A REI L+ LQ+ P
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-P 59
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKRED--RGDRGISVGEIKRWMVQI 130
N+V L + +E L+ EFL DL KK D + + +K ++ QI
Sbjct: 60 NIVCLQDVLMQESR-LYLIFEFLSMDL--------KKYLDSLPKGQYMDAELVKSYLYQI 110
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
L G+ CH ++HRDLKP NLLI + GV+KLADFG AR
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 62/156 (39%), Positives = 87/156 (55%), Gaps = 16/156 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQS------AFREIEALQILQNSPN 73
++ +E +G G Y VYK R +VALK++ D ++ A REI L+ L N PN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPN 60
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V L + E++ LV EFL DL KK + GI + IK ++ Q+L G
Sbjct: 61 IVKLLDVIHTENK-LYLVFEFLHQDL-------KKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ CH + ++HRDLKP NLLI +G +KLADFG AR
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 63/157 (40%), Positives = 86/157 (54%), Gaps = 17/157 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQ----SAFREIEALQILQNSP 72
KYE LE +G G Y V+K + + IVALK V D + SA REI L+ L++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-K 59
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L++ + + LV E+ DL KK D + I +K +M Q+L
Sbjct: 60 NIVRLYDVLHSDKK-LTLVFEYCDQDL--------KKYFDSCNGDIDPEIVKSFMFQLLK 110
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
G+ CH + ++HRDLKP NLLI +G LKLADFG AR
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNV 74
+EILE +G G + +VYK R VA+K + + EI+ L+ PN+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNI 59
Query: 75 VVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
V + + ++DE +V+EF L ++ + + ++ +I ++L G
Sbjct: 60 VKYYGSYLKKDE-LWIVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKG 110
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ H N I+HRD+K N+L+ DG +KL DFG
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDGEVKLIDFG 143
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 56/168 (33%), Positives = 88/168 (52%), Gaps = 24/168 (14%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSP 72
YE+LE +G G++ V K RR SD I+ KE+ + Q E+ L+ L++ P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH-P 59
Query: 73 NVV-VLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGE--IKRWMV 128
N+V R ++ +V+E+ DLA +I + KK+R+ + E I R +
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK-------YIEEEFIWRILT 112
Query: 129 QILSGVDACHR-----NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
Q+L + CH NT++HRDLKP N+ + + +KL DFG A+IL
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-26
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 21/161 (13%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ--------SAFREIEALQILQNSP 72
++ + +G G++S V + N A+K + Q E E L L P
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 73 NVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
++ L+ F +DE+ + VLE+ +L I +K + + + +I
Sbjct: 63 GIIKLYYTF--QDEENLYFVLEYAPNGELLQYI----RKY-----GSLDEKCTRFYAAEI 111
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
L ++ H I+HRDLKP N+L+ D +K+ DFG A++L
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 64/156 (41%), Positives = 94/156 (60%), Gaps = 18/156 (11%)
Query: 21 YEILECVGSGAYSDVYKGR-RLSDNLIVALKEV---HDYQ---SAFREIEALQILQNSPN 73
Y L+ +G G Y+ V+KGR +L++NL VALKE+ H+ +A RE+ L+ L+++ N
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHA-N 64
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V LH+ + LV E+L +DL K+ D +S+ +K +M Q+L G
Sbjct: 65 IVTLHDII-HTERCLTLVFEYLDSDL--------KQYLDNCGNLMSMHNVKIFMFQLLRG 115
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ CH+ I+HRDLKP NLLI + G LKLADFG AR
Sbjct: 116 LSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 64/168 (38%), Positives = 89/168 (52%), Gaps = 17/168 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQS-------AFREIEALQILQNSP 72
KYE L +G G+Y V+K R IVA+K+ + + A REI L+ L++ P
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-P 60
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L E F R LV E+ D TV+ E ++ RG+ IK+ + Q L
Sbjct: 61 NLVNLIEVF-RRKRKLHLVFEYC--DH-TVLNEL-----EKNPRGVPEHLIKKIIWQTLQ 111
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPD 180
V+ CH++ +HRD+KP N+LI G +KL DFG ARIL G D D
Sbjct: 112 AVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 105 bits (261), Expect = 1e-25
Identities = 52/162 (32%), Positives = 87/162 (53%), Gaps = 20/162 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQNS 71
Y IL +G G++ +VY R D +VALK + + + REI+ L L +
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
PN+V L+++F +++ LV+E++ L ++ + +K +S E + QI
Sbjct: 58 PNIVKLYDFF-QDEGSLYLVMEYVDGGSLEDLLKKIGRKG------PLSESEALFILAQI 110
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIG-DDGVLKLADFGQARIL 171
LS ++ H I+HRD+KP N+L+ D V+KL DFG A++L
Sbjct: 111 LSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152
|
Length = 384 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 56/156 (35%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-YQSA-----FREIEALQILQNSPNV 74
Y+IL +G G +S+V K + A+K + ++S REI+AL+ L PN+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 75 VVLHEY-FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+ L E F R+ LV E + +L +I K ++ R + +K +M Q+L
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELI---KGRK-----RPLPEKRVKSYMYQLLKS 112
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+D HRN I HRD+KP N+LI D +LKLADFG R
Sbjct: 113 LDHMHRNGIFHRDIKPENILI-KDDILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 67/156 (42%), Positives = 97/156 (62%), Gaps = 18/156 (11%)
Query: 21 YEILECVGSGAYSDVYKGR-RLSDNLIVALKEV---HDYQ---SAFREIEALQILQNSPN 73
Y LE +G G Y+ V+KGR +L++NL VALKE+ H+ +A RE+ L+ L+++ N
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHA-N 65
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V LH+ D+ LV E+L DL K+ +D G+ +S+ +K ++ QIL G
Sbjct: 66 IVTLHDIV-HTDKSLTLVFEYLDKDL-------KQYMDDCGNI-MSMHNVKIFLYQILRG 116
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ CHR ++HRDLKP NLLI + G LKLADFG AR
Sbjct: 117 LAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 64/175 (36%), Positives = 91/175 (52%), Gaps = 25/175 (14%)
Query: 20 KYEILECVGSGAYSDVYKGRRL--SDNLIVALK----EVHDY----QSAFREIEALQILQ 69
KYEI C+G G Y VYK +R D A+K + Y QSA REI L+ L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 70 NSPNVVVLHEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
+ NVV L E F + +V L+ ++ DL +I K R+ + I +K +
Sbjct: 61 H-ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQII---KFHRQAKR-VSIPPSMVKSLLW 115
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLADFGQARILLGNEFDAP 179
QIL+GV H N ++HRDLKP N+L+ + GV+K+ D G AR+ F+AP
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-----FNAP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 56/162 (34%), Positives = 90/162 (55%), Gaps = 15/162 (9%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPN 73
+++L+ +G G+Y VYK +RLSDN ALKEV + + A EI L + + PN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PN 60
Query: 74 VVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
++ E F + +V+E+ DL+ I++ KKKR + I EI R +Q+L
Sbjct: 61 IISYKEAFL-DGNKLCIVMEYAPFGDLSKAISKRKKKR-----KLIPEQEIWRIFIQLLR 114
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174
G+ A H I+HRDLK N+L+ + ++K+ D G +++L N
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 67/156 (42%), Positives = 98/156 (62%), Gaps = 18/156 (11%)
Query: 21 YEILECVGSGAYSDVYKGR-RLSDNLIVALKEV---HDYQ---SAFREIEALQILQNSPN 73
Y L+ +G G Y+ VYKGR +L+DNL VALKE+ H+ +A RE+ L+ L+++ N
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHA-N 65
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V LH+ E + LV E+L DL K+ +D G+ I++ +K ++ Q+L G
Sbjct: 66 IVTLHDIIHTE-KSLTLVFEYLDKDL-------KQYLDDCGNS-INMHNVKLFLFQLLRG 116
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
++ CHR ++HRDLKP NLLI + G LKLADFG AR
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 68/176 (38%), Positives = 89/176 (50%), Gaps = 20/176 (11%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQI 67
I+ KYEIL+ +G GAY V+K +VALK++ D Q FREI LQ
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE 62
Query: 68 LQNSPNVVVLHEYFWRE-DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
L + PN+V L E D+D LV E++ TDL VI ED R I
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI--RANILEDVHKRYI-------- 112
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGN 182
M Q+L + H ++HRDLKP N+L+ D +KLADFG AR L +E + N
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPEN 166
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-24
Identities = 58/159 (36%), Positives = 87/159 (54%), Gaps = 17/159 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQS-------AFREIEALQILQNSP 72
KYE L VG G+Y V K + IVA+K+ + + A REI L+ L++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE- 60
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L E F R + LV EF+ TV+ + +K G+ +++++ QIL
Sbjct: 61 NLVNLIEVF-RRKKRLYLVFEFVDH---TVLDDLEKY-----PNGLDESRVRKYLFQILR 111
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G++ CH + I+HRD+KP N+L+ GV+KL DFG AR L
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-24
Identities = 62/172 (36%), Positives = 89/172 (51%), Gaps = 21/172 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALK----EVHDY---QSAFREIEALQILQNSP 72
YE LE +G G Y VYK R + +VALK E+ + +A REI LQ+L S
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 73 NVVVLHEYFWREDEDA----VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
+V L + E+++ LV E+L +DL + + + R + IK +M
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG----RPLPAKTIKSFMY 117
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDD-GVLKLADFGQARILLGNEFDAP 179
Q+L GV CH++ ++HRDLKP NLL+ G+LK+AD G LG F P
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG-----LGRAFSIP 164
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 16/163 (9%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQ 69
+ ++I + +G G +S VYK L D +VALK+V + Q +EI+ L+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL- 59
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
+ PNV+ F E+ + +VLE DL+ +I KK+ R I I ++ V
Sbjct: 60 DHPNVIKYLASFI-ENNELNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFV 113
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
Q+ S ++ H I+HRD+KP N+ I GV+KL D G R
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 5e-24
Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 21/167 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSP 72
+YE+L+ +GSGAY V VA+K++ + + REI+ L+ L++
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH-E 59
Query: 73 NVVVLHEYF----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
N++ L + + D +V E + TDL VI +S + ++ I+ ++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVI-KSPQP--------LTDDHIQYFLY 110
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
QIL G+ H ++HRDLKP N+L+ + LK+ DFG AR + +E
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 56/171 (32%), Positives = 93/171 (54%), Gaps = 23/171 (13%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKE--VHDYQ-----SAFREIEALQILQN 70
+ YEIL +G G + +VYK R++ +VALK+ +H+ + +A REI+ L+ L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65
Query: 71 SPNVVVLHEYFWREDEDAV-------LVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
PNVV L + + + +V ++ DL+ ++ K ++ +I
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--------LTESQI 117
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174
K +M+Q+L G++ H N I+HRD+K N+LI + G+LK+ADFG AR G
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-23
Identities = 61/158 (38%), Positives = 83/158 (52%), Gaps = 17/158 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
+YE +E +G G Y VYK R N +ALK++ Q +A REI L+ +Q+
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG- 61
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L + E + LV E+L DL KK + D + IK ++ QIL
Sbjct: 62 NIVRLQDVVHSE-KRLYLVFEYLDLDL-------KKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIG-DDGVLKLADFGQAR 169
G+ CH + ++HRDLKP NLLI LKLADFG AR
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 56/160 (35%), Positives = 83/160 (51%), Gaps = 23/160 (14%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFR-----EIEALQILQNSPNVV 75
E ++ +G G+ VYK R I ALK++H D FR E++ L SP VV
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTL-RSCESPYVV 62
Query: 76 VLHEYFWREDEDAVLVLEFLRTD---LATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ F++E + +VLE++ D LA ++ + K E + I R QIL
Sbjct: 63 KCYGAFYKE-GEISIVLEYM--DGGSLADLLKKVGKIPEP------VLAYIAR---QILK 110
Query: 133 GVDACHRNT-IVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+D H I+HRD+KP NLLI G +K+ADFG +++L
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 21/165 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-------HDYQSAFREIEALQILQNSP 72
Y++ + +G GA+ VYKG L VA+K++ +S +EI+ L+ L P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59
Query: 73 NVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
N+V E D++ ++LE+ L +I + E + ++ Q+
Sbjct: 60 NIVKYIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPES---------LVAVYVYQV 108
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
L G+ H ++HRD+K N+L DGV+KLADFG A L
Sbjct: 109 LQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-22
Identities = 60/155 (38%), Positives = 88/155 (56%), Gaps = 16/155 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ------SAFREIEALQILQNSPNV 74
YE LE +G G+Y+ VYKG+ + +VALK + + +A RE L+ L+++ N+
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA-NI 65
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
V+LH+ E LV E++ TDL + D+ G+ +K ++ Q+L G+
Sbjct: 66 VLLHDII-HTKETLTLVFEYVHTDLCQYM--------DKHPGGLHPENVKLFLFQLLRGL 116
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
H+ I+HRDLKP NLLI D G LKLADFG AR
Sbjct: 117 SYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 6e-22
Identities = 53/166 (31%), Positives = 84/166 (50%), Gaps = 26/166 (15%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV---HDYQSAFREIEALQILQN- 70
PE + ++ILE +G G+Y VYK +VA+K V D Q +EI IL+
Sbjct: 1 PEEV--FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEI---SILKQC 55
Query: 71 -SPNVVVLHEYF--WREDEDAVLVLEFLRTDLATVIAESKKKR--EDRGDRGISVGEIKR 125
SP +V +Y+ + ++ D +V+E+ + I + K E+ EI
Sbjct: 56 DSPYIV---KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE---------EIAA 103
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ Q L G++ H N +HRD+K GN+L+ ++G KLADFG + L
Sbjct: 104 ILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 56/159 (35%), Positives = 86/159 (54%), Gaps = 17/159 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
K+E+L VG GAY V K R IVA+K+ D + + RE++ L+ L+
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE- 60
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L E F R + LV E++ ++ ++ E G+ +++ ++ Q++
Sbjct: 61 NIVELKEAFRRRGK-LYLVFEYVEKNMLELLEEMPN--------GVPPEKVRSYIYQLIK 111
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ CH+N IVHRD+KP NLLI + VLKL DFG AR L
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQ--NSP 72
++Y+ +E +GSGAY V VA+K++ A R + L+IL+
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 73 NVVVLHEYFWREDE---DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
N++ + + D +V++ + +DL +I D+ ++ I+ ++ Q
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHII---------HSDQPLTEEHIRYFLYQ 115
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+L G+ H ++HRDLKP NLL+ +D L++ DFG AR L
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-21
Identities = 57/155 (36%), Positives = 82/155 (52%), Gaps = 16/155 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ------SAFREIEALQILQNSPNV 74
Y LE +G G+Y+ VYKG + +VALK + +A RE L+ L+++ N+
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA-NI 65
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
V+LH+ E V E++ TDLA + + G+ ++ +M Q+L G+
Sbjct: 66 VLLHDII-HTKETLTFVFEYMHTDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGL 116
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
H I+HRDLKP NLLI G LKLADFG AR
Sbjct: 117 AYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 6e-21
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 24/156 (15%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQ--NSPNVVV 76
+G G++ V R+ + A+K + + + E IL N P +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTE---RNILSRINHPFIVK 57
Query: 77 LHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
LH Y ++ +E LVLE+ +L + +++ + E+R + + +I+ ++
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER---------ARFYAAEIVLALE 107
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
H I++RDLKP N+L+ DG +KL DFG A+ L
Sbjct: 108 YLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 62/164 (37%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQ--N 70
+YE + +G GAY VYK R VALK V S RE+ L+ L+ +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 71 SPNVVVLHEY--FWREDED--AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
PN+V L + R D + LV E + DL T + + G+ IK
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPP-------GLPAETIKDL 113
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
M Q L G+D H N IVHRDLKP N+L+ G +KLADFG ARI
Sbjct: 114 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 59/169 (34%), Positives = 89/169 (52%), Gaps = 25/169 (14%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQ------SAFREIEALQILQN 70
+ K++I+ +G G Y VYK R +VALK+V D + +A REI+ L+ L N
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-N 64
Query: 71 SPNVVVLHEY---------FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVG 121
N+V L E F ++ LV E++ DL ++ ES G S
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ES-------GLVHFSED 116
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
IK +M Q+L G++ CH+ +HRD+K N+L+ + G +KLADFG AR+
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 61/165 (36%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDN-LIVALKEVHDYQ-------SAFREIEALQILQN- 70
+YE + +G GAY V+K R L + VALK V S RE+ L+ L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 71 -SPNVVVLHEY--FWREDEDA--VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
PNVV L + R D + LV E + DL T + + + G+ IK
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL-------DKVPEPGVPTETIKD 114
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
M Q+L G+D H + +VHRDLKP N+L+ G +KLADFG ARI
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 16/163 (9%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQ 69
+A + I + +G G +S+VY+ L D + VALK+V + +EI+ L+ L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL- 59
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMV 128
N PNV+ + F ED + +VLE DL+ +I KK++ R I + ++ V
Sbjct: 60 NHPNVIKYYASFI-EDNELNIVLELADAGDLSRMIKHFKKQK-----RLIPEKTVWKYFV 113
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
Q+ S ++ H ++HRD+KP N+ I GV+KL D G R
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 5e-18
Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 14/156 (8%)
Query: 25 ECVGSGAYSDVYKGR---RLSDNLIVALKEVHDY-----QSAF-REIEALQILQNSPNVV 75
+ +G GA+ +VYKG+ + VA+K + + + F +E ++ L + PNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH-PNVV 59
Query: 76 VLHEYFWREDEDAV-LVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
L +E+ + LVLE++ DL + +S+ +S+ ++ + +QI G
Sbjct: 60 RL--LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
++ VHRDL N L+G+D V+K++DFG +R
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-18
Identities = 55/163 (33%), Positives = 86/163 (52%), Gaps = 16/163 (9%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQ 69
+A ++I + +G G +S+VY+ L D VALK+V + Q +EI+ L+ L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL- 59
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMV 128
N PNV+ + F ED + +VLE DL+ +I KK++ R I + ++ V
Sbjct: 60 NHPNVIKYLDSFI-EDNELNIVLELADAGDLSQMIKYFKKQK-----RLIPERTVWKYFV 113
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
Q+ S V+ H ++HRD+KP N+ I GV+KL D G R
Sbjct: 114 QLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 23/155 (14%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEV--HD-----YQSAFREIEALQILQNSPNVVVLHE 79
+G G + VY L ++A+KE+ D + E++ L++L PN+V +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLV---K 63
Query: 80 YFWRE--DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
Y+ E E + +E+ L ++ + E I+ + +Q+L G+
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---------IRVYTLQLLEGLAY 114
Query: 137 CHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
H + IVHRD+KP N+ + +GV+KL DFG A L
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV--------HDYQSAFREIEALQILQNSP 72
+E+L +G GA+ V ++ + A+K + ++ E LQ L N P
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+V L F +++E+ LV++ L DL +++ K E++ +K W+ +I+
Sbjct: 61 FLVNLWYSF-QDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ---------VKFWICEIV 110
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
++ H I+HRD+KP N+L+ + G + + DF A +
Sbjct: 111 LALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 13/152 (8%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNV 74
YE++E +G GA + VY L +N VA+K + +E++A+ N PNV
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMS-QCNHPNV 61
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
V + F ++ LV+ +L I +S R G+ I + ++L G+
Sbjct: 62 VKYYTSF-VVGDELWLVMPYLSGGSLLDIMKSSYPRG-----GLDEAIIATVLKEVLKGL 115
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ H N +HRD+K GN+L+G+DG +K+ADFG
Sbjct: 116 EYLHSNGQIHRDIKAGNILLGEDGSVKIADFG 147
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 30/154 (19%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEV--------HDYQSAFREIEALQILQNSPNVVVLH 78
+ GAY V+ ++ S I A+K + + E + L Q+ P VV L+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLY 59
Query: 79 EYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVG-----EIKRWMVQILS 132
F + ++ LV+E+L DLA+++ +VG + ++ +I+
Sbjct: 60 YSF-QGKKNLYLVMEYLPGGDLASLL--------------ENVGSLDEDVARIYIAEIVL 104
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ H N I+HRDLKP N+LI +G LKL DFG
Sbjct: 105 ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFG 138
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 23/166 (13%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALK---EVHDYQSAFR-EIEALQILQNSPNVV 75
+E++E +G G Y VYK R +VA+K + D + + E L+ N PN+
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIA 66
Query: 76 VLHEYFWREDEDAV-----LVLEFLR----TDLA-TVIAESKKKREDRGDRGISVGEIKR 125
+ F +++ LV+E TDL + + K+ +E+ + I R
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW------IAYILR 120
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ L G+ H N ++HRD+K N+L+ + +KL DFG + L
Sbjct: 121 ---ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 54/166 (32%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQS------AFREIEALQIL 68
E+ +Y L+ VGSGAY V VA+K++ +QS A+RE+ L+ +
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71
Query: 69 QNSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
Q+ NV+ L + F E +D LV+ +++TDL ++ +S ++
Sbjct: 72 QHE-NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP-----------LSEDKV 119
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ + Q+L G+ H I+HRDLKPGNL + +D LK+ DFG AR
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 18/162 (11%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQIL 68
EI +Y L+ VG GA+ V R VA+K++ + +RE++ L+ L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
++ N++ L + F ED V E L TDL ++ + + E + I+ ++
Sbjct: 67 RHE-NIISLSDIFISPLEDIYFVTELLGTDLHRLL--TSRPLEKQF--------IQYFLY 115
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
QIL G+ H +VHRDLKP N+LI ++ LK+ DFG ARI
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 57/166 (34%), Positives = 88/166 (53%), Gaps = 23/166 (13%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQS------AFREIEALQIL 68
E+ +Y L+ VGSGAY V VA+K+++ +QS A+RE+ L+ +
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71
Query: 69 QNSPNVVVLHEYFWRED-----EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
++ NV+ L + F + D LV+ F+ TDL ++ + +K EDR I
Sbjct: 72 KHE-NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM-KHEKLSEDR---------I 120
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ + Q+L G+ H I+HRDLKPGNL + +D LK+ DFG AR
Sbjct: 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 41/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVV 75
Y+ LE +G GA +VYK + VA+K++ + + EI ++ ++ PN+V
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-PNIV 78
Query: 76 VLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
++ + ++ +V+E++ L +I ++ + ++ +I ++L G+
Sbjct: 79 DYYDSY-LVGDELWVVMEYMDGGSLTDIITQNFVR--------MNEPQIAYVCREVLQGL 129
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ H ++HRD+K N+L+ DG +KLADFG A L
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 29/159 (18%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ----ILQ--NSPN 73
+ +LEC+G G++ +VYK N +VA+K + D + A EIE +Q L SP
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 74 VVVLHEYF------WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWM 127
+ + F W +++E+ + + K E + I R
Sbjct: 61 ITKYYGSFLKGSKLW-------IIMEYCGGGSCLDLLKPGKLDET------YIAFILR-- 105
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++L G++ H +HRD+K N+L+ ++G +KLADFG
Sbjct: 106 -EVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFG 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 21/165 (12%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQIL 68
E+ KY ++ +G GAY V + N VA+K++ D + REI+ L+ L
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL 61
Query: 69 QNSPNVVVLHEYFW----REDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIK 124
+ NV+ + + D +V E + TDL +I S+ +D +
Sbjct: 62 DHE-NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDD---------HCQ 111
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
++ Q+L G+ H ++HRDLKP NLL+ + LK+ DFG AR
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 58/158 (36%), Positives = 75/158 (47%), Gaps = 34/158 (21%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEY 80
+GSGA VYK + ALK ++ + REIE L+ + N PNVV H+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDM 140
Query: 81 FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGD-RGISVG------EIKRWMVQILSG 133
F E VL LEF+ D G G + ++ R QILSG
Sbjct: 141 FDHNGEIQVL-LEFM----------------DGGSLEGTHIADEQFLADVAR---QILSG 180
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ HR IVHRD+KP NLLI +K+ADFG +RIL
Sbjct: 181 IAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
|
Length = 353 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 22/156 (14%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDYQSAFREIEALQILQNSPNV 74
YE+++ +GSG Y DVYK R ++ +VA+K + D++ +EI L+ PN+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNI 62
Query: 75 VVLHEYFWREDEDAVLVLEFLR----TDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
V + R D+ +V+E+ D+ V +S +I +
Sbjct: 63 VAYFGSYLRRDK-LWIVMEYCGGGSLQDIYQVT-----------RGPLSELQIAYVCRET 110
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
L G+ H +HRD+K N+L+ +DG +KLADFG
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 30/162 (18%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEV----------HDYQ---------SAFREIEALQI 67
+G G Y V K IVA+K+V D Q + RE++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 68 LQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWM 127
+ N++ L + + D LV++ + +DL V+ DR R ++ ++K +
Sbjct: 77 I-KHENIMGLVDVYVEGDF-INLVMDIMASDLKKVV--------DRKIR-LTESQVKCIL 125
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+QIL+G++ H+ +HRDL P N+ I G+ K+ADFG AR
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 54/163 (33%), Positives = 85/163 (52%), Gaps = 16/163 (9%)
Query: 27 VGSGAYSDVYKGRRL--SDNLIVALKEVHDY---QSAFREIEALQILQNSPNVVVLHEYF 81
VG G Y VYK +R D+ ALK++ SA REI L+ L++ PNV+ L + F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKH-PNVISLQKVF 67
Query: 82 WRE-DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN 140
D L+ ++ DL +I + + ++ + G +K + QIL G+ H N
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 141 TIVHRDLKPGNLLI----GDDGVLKLADFGQARILLGNEFDAP 179
++HRDLKP N+L+ + G +K+AD G AR+ F++P
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARL-----FNSP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 27 VGSGAYSDVYKGRRL--SDNLIVALKEVHDY---QSAFREIEALQILQNSPNVVVLHEYF 81
VG G Y VYK +R D ALK++ SA REI L+ L++ PNV+ L + F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKH-PNVIALQKVF 67
Query: 82 WREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN 140
+ V L+ ++ DL +I + + ++ + +K + QIL G+ H N
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 141 TIVHRDLKPGNLLI----GDDGVLKLADFGQARILLGNEFDAP 179
++HRDLKP N+L+ + G +K+AD G AR+ F++P
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARL-----FNSP 165
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 52/169 (30%), Positives = 79/169 (46%), Gaps = 23/169 (13%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKE-------VHDYQSAFREIEAL 65
T E+ +Y+ L VGSGAY V VA+K+ + +RE+ L
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 66 QILQNSPNVVVLHEYFW----RED-EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
+ + + NV+ L + F ED +D LV + DL ++ +K +D
Sbjct: 69 KHMDH-ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-CQKLSDD-------- 118
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
I+ + QIL G+ H I+HRDLKP N+ + +D LK+ DFG AR
Sbjct: 119 -HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-------HDYQSAFREIEALQILQNSP 72
KYE + VG GA+ V+ RR +D +V +K++ + +A E + L++L + P
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-P 59
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
N++ +E F ED+ ++V+E+ LA I + R + + I + VQIL
Sbjct: 60 NIIEYYENFL-EDKALMIVMEYAPGGTLAEYI-------QKRCNSLLDEDTILHFFVQIL 111
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADFGQARIL 171
+ H I+HRDLK N+L+ V+K+ DFG ++IL
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-15
Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 36/161 (22%)
Query: 28 GSGAYSDVYKGR---RLSDNLI-VALKEVHDYQSA------FREIEALQILQNSPNVVVL 77
G GA+ +VYKG + + VA+K + + S RE ++ L + PN+V L
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH-PNIVKL 66
Query: 78 HEYFWREDEDAVLVLE---------FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
E+E ++V+E +LR + +S+ ++ + +
Sbjct: 67 L-GVCTEEEPLMIVMEYMPGGDLLDYLR---------------KNRPKELSLSDLLSFAL 110
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
QI G++ +HRDL N L+G++ V+K++DFG +R
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 51/164 (31%), Positives = 83/164 (50%), Gaps = 24/164 (14%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEV------HDYQSAFREIEA-LQILQN--SPNVV 75
E +GSG++ VY+G L D A+KEV Q A +++E + +L PN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 76 VLHEYFW--REDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+Y RE+++ + LE + LA ++ + E I+ + QIL
Sbjct: 66 ---QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP---------VIRLYTRQILL 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
G++ H VHRD+K N+L+ +GV+KLADFG A+ ++ F
Sbjct: 114 GLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 37/169 (21%)
Query: 21 YEILECVGSGAYSDV----YKGRRLSDNLIVALKEVHDYQS-------AFREIEALQILQ 69
YE+++ +G GAY V S+ VA+K++ + S A RE++ L+ +
Sbjct: 2 YELIKELGQGAYGIVCSARNAET--SEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 70 NSPNVVVLHEYFWREDEDAV---------LVLEFLRTDLATVIAESKKKREDRGDRGISV 120
N+ L+ D D V L E + DL +I R + ++
Sbjct: 60 GHKNITCLY------DMDIVFPGNFNELYLYEELMEADLHQII---------RSGQPLTD 104
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ ++ QIL G+ H ++HRDLKPGNLL+ D LK+ DFG AR
Sbjct: 105 AHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-15
Identities = 51/154 (33%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEA----LQILQNSPNVVV 76
+EI+E +G G Y VYK D + A+K + EIEA LQ L N PNVV
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 77 LHEYFWREDE----DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ F++ D+ LVLE T + + R D + I + L
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM----ISYILYGALL 139
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G+ H N I+HRD+K N+L+ +G +KL DFG
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 29/169 (17%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQ 69
++ +Y+ L +G GAY V + VA+K++ + Q REI+ L+ +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK 61
Query: 70 NSPNVVVLH--------EYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVG 121
+ N++ + E F D +V E + TDL +I +S
Sbjct: 62 HE-NIIGILDIIRPPSFESF----NDVYIVQELMETDLYKLIKTQH----------LSND 106
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
I+ ++ QIL G+ H ++HRDLKP NLL+ + LK+ DFG ARI
Sbjct: 107 HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPN 73
+EIL +G G++ V+K R +D + A+K++ + + A E L L +S
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSY 60
Query: 74 VVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
++ +E F + +V+E+ DL ++ + + + ++ R+ +QIL
Sbjct: 61 IIRYYESFL-DKGKLNIVMEYAENGDLHKLLKMQRGRP-------LPEDQVWRFFIQILL 112
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+ H I+HRD+K NL + +K+ D G A++L
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 43/153 (28%), Positives = 80/153 (52%), Gaps = 21/153 (13%)
Query: 28 GSGAYSDVYKGR---RLSDNLI-VALKEVHDYQSA------FREIEALQILQNSPNVVVL 77
G GA+ +VYKG+ + + VA+K + + S RE ++ L + PNVV L
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH-PNVVKL 66
Query: 78 HEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
E+E +V+E++ DL + + +++ K +S+ ++ + +QI G++
Sbjct: 67 L-GVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--------LSLSDLLSFALQIARGMEY 117
Query: 137 CHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+HRDL N L+G++ V+K++DFG +R
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 24/167 (14%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPN 73
Y + +G GA+ + RR D+ +V KEV+ + A EI L +LQ+ PN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PN 60
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTD---LATVIAESKKKREDRGDRGISVGEIKRWMV-Q 129
++ + +F +D L++E + L I K + + E+ W + Q
Sbjct: 61 IIAYYNHF---MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE--------EMVLWYLFQ 109
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
I+S V H+ I+HRD+K N+ + G++KL DFG ++I LG+E+
Sbjct: 110 IVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-LGSEY 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 40/170 (23%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEV----HDYQS---AFREIE------------ALQI 67
+G GA+ V+ D VALK++ + S FRE++ AL I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 68 LQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWM 127
LQ P++ E + +V E +++DL +I + +S +K ++
Sbjct: 68 LQ-PPHIDPFEEIY--------VVTELMQSDLHKIIVSPQP---------LSSDHVKVFL 109
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFD 177
QIL G+ H I+HRD+KPGNLL+ + VLK+ DFG AR+ E D
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPD 156
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 22/170 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSP 72
+Y+I E +G G+Y V VA+K+++ D REI+ L++L++
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 73 NVVVLHEYF---WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
V + H RE +D +V E + +DL VI K +D ++ + ++ Q
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI----KANDD-----LTPEHHQFFLYQ 111
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAP 179
+L + H + HRDLKP N+L D LK+ DFG AR+ D P
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN---DTP 158
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV------HDYQSAFREIEALQILQNSPN 73
+Y +L VG G++ + ++ + A+KE+ + + +E L +++ PN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH-PN 59
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKK--REDRGDRGISVGEIKRWMVQI 130
+V E F D +V+E+ DL I + K ED I +W VQ+
Sbjct: 60 IVAFKESF-EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED---------TILQWFVQM 109
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
GV H ++HRD+K N+ + +G +KL DFG AR+L
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 48/155 (30%), Positives = 83/155 (53%), Gaps = 22/155 (14%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+EI+ +G GA+ VYK + L A K E+ D+ EI+ L ++ P
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKH-P 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTD-LATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
N+V L+E ++ E+ +++EF L +++ E +RG++ +I+ Q+L
Sbjct: 63 NIVGLYEAYFYEN-KLWILIEFCDGGALDSIMLEL--------ERGLTEPQIRYVCRQML 113
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ H + ++HRDLK GN+L+ DG +KLADFG
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG 148
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 40/155 (25%), Positives = 79/155 (50%), Gaps = 20/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV-------HDYQSAFREIEALQILQNSPN 73
+E+++ +G GA+ +V+ R + A+K + + + R + +SP
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 74 VVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+V L+ F +DE+ + LV+E++ DL ++ E+ + ++ +++
Sbjct: 63 IVKLYYSF--QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE---------TARFYIAELV 111
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+D+ H+ +HRD+KP N+LI DG +KLADFG
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFG 146
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 20/162 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ---IL---QNSPN 73
+YEI++ +G G++ +Y + SD+ +KE+ + +E EA + IL PN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGI--SVGEIKRWMVQI 130
+V F +E+ +V+E+ DL KR +R RG+ S +I W VQI
Sbjct: 61 IVTFFASF-QENGRLFIVMEYCDGGDLM--------KRINR-QRGVLFSEDQILSWFVQI 110
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARIL 171
G+ H I+HRD+K N+ + +G V KL DFG AR L
Sbjct: 111 SLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 3e-13
Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 29/169 (17%)
Query: 22 EILECVGSGAYSDVYKGRRLSD----NLIVALKEV-----HDYQSAF-REIEALQILQNS 71
E+ + +G GA+ +VYKG D VA+K + + + F E ++ L +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH- 60
Query: 72 PNVVVLHEYFWREDEDAVLVLEF-----LRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
PN+V L + E +V E+ L L +K ++ +++ ++ +
Sbjct: 61 PNIVRLLGVC-TQGEPLYIVTEYMPGGDLLDFL--------RKHGEK----LTLKDLLQM 107
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+QI G++ VHRDL N L+ ++ V+K++DFG +R + ++
Sbjct: 108 ALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156
|
Length = 258 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEA----LQILQN 70
P+ +EI+E +G G Y V+K + A+K + EIEA L+ L +
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD 73
Query: 71 SPNVVVLHEYFWRED----EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
PNVV + ++++D + LVLE T + + KR +R + I I
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI----IAYI 129
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ + L G+ H N +HRD+K N+L+ +G +KL DFG
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 9e-13
Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 40/170 (23%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK---------EVHDYQSAFREIEALQILQNS 71
Y+ LE +G GAY VY+G+ + +VALK +V D Q RE+ L L+ S
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ---REVALLSQLRQS 59
Query: 72 --PNVVVLHEYF--WREDEDAVLVLEF-----LRTDL-ATVIAESKKKREDRGDRGISVG 121
PN+ +Y+ + + +++E+ +RT + A IAE + ISV
Sbjct: 60 QPPNIT---KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE----------KYISV- 105
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
I R ++ L + H+ ++HRD+K N+L+ + G +KL DFG A +L
Sbjct: 106 -IIREVLVALKYI---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 25/139 (17%)
Query: 47 VALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFW----REDED---------AVLVLE 93
+ L + + A REI+ ++ L + N+V ++E ED +V E
Sbjct: 38 IVLTDPQSVKHALREIKIIRRLDHD-NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE 96
Query: 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLL 153
++ TDLA V+ + +S + +M Q+L G+ H ++HRDLKP N+
Sbjct: 97 YMETDLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVF 146
Query: 154 IG-DDGVLKLADFGQARIL 171
I +D VLK+ DFG ARI+
Sbjct: 147 INTEDLVLKIGDFGLARIV 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKE--------VHDYQSAFREIEALQ 66
PE + + L +G G++ VY R + N +VA+K+ +Q +E+ LQ
Sbjct: 13 PEKL--FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 67 ILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKK-REDRGDRGISVGEIKR 125
L++ PN + + RE A LV+E+ + ++ KK +E EI
Sbjct: 71 QLRH-PNTIEYKGCYLRE-HTAWLVMEYCLGSASDILEVHKKPLQEV---------EIAA 119
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
L G+ H + +HRD+K GN+L+ + G +KLADFG A +
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 23/166 (13%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-HDYQS------AFREIEALQIL 68
E+ +Y+ L VGSGAY V L VA+K++ +QS +RE+ L+ +
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 69 QNSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
++ NV+ L + F E D LV + DL ++ + +K +D +
Sbjct: 74 KHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDD---------HV 122
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ + QIL G+ H I+HRDLKP NL + +D LK+ DFG AR
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQ--------NSP 72
++IL VG G Y V+ ++ IVALK + F+ E +L S
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKK-SLLFKLNEVRHVLTERDILTTTKSE 61
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+V L Y +++DE L +E++ D T++ ED + +M ++
Sbjct: 62 WLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED---------HARFYMAEMF 111
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
VDA H +HRDLKP N LI G +KL DFG +
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 27/171 (15%)
Query: 24 LECVGSGAYSDVYKGRR-----------LSDNLIVALKEVHDYQSAFREIEALQILQNSP 72
L+ + GA+ VY ++ L + ++A +V + ++ E + I SP
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKA---ERAIMMIQGESP 57
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
V L+ F +D LV+E+L D A++I ED K+++ +++
Sbjct: 58 YVAKLYYSFQSKD-YLYLVMEYLNGGDCASLIKTLGGLPEDW---------AKQYIAEVV 107
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE--FDAPD 180
GV+ H+ I+HRD+KP NLLI G LKL DFG +R L N+ PD
Sbjct: 108 LGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 41/199 (20%)
Query: 9 WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-------EVHDYQSAFRE 61
W + R +I K+++ G G Y +VY+G +L VA+K EV ++ +E
Sbjct: 1 WEME-RTDITMKHKL----GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF---LKE 52
Query: 62 IEALQILQNSPNVVVLHEYFWREDEDAVL--------VLEFLRTDLATVIAESKKKREDR 113
++ +++ PN+V L RE ++ +L++LR
Sbjct: 53 AAVMKEIKH-PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR----------------E 95
Query: 114 GDRGISVGEIKRWMV-QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172
+R + +M QI S ++ + +HRDL N L+G++ ++K+ADFG +R++
Sbjct: 96 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 155
Query: 173 GNEFDAPDGNSQPCEPNAP 191
G+ + A G P + AP
Sbjct: 156 GDTYTAHAGAKFPIKWTAP 174
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 9e-12
Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 44/175 (25%)
Query: 21 YEILECVGSGAYSDV----YKGR-------RLSDNLIVALKEVHDYQSAFREIEALQILQ 69
+E ++ +G+G++ V +KG LS IV LK+V + E LQ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQV---EHVLNEKRILQSI- 58
Query: 70 NSPNVVVLHEYFWREDEDAV-LVLEF---------LRTDLATVIAESKKKREDRGDRGIS 119
P +V L+ F +D+ + LV+E+ LR K R
Sbjct: 59 RHPFLVNLYGSF--QDDSNLYLVMEYVPGGELFSHLR----------KSGR-------FP 99
Query: 120 VGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174
+ + Q++ ++ H IV+RDLKP NLL+ DG +K+ DFG A+ + G
Sbjct: 100 EPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFRE--IEALQILQ--NSPNVVV 76
E L +G+G V K I+A+K + + A ++ + L IL NSP +V
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 77 LHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
+ F+ D + +E++ L ++ E + + +R + + V +L G+
Sbjct: 64 FYGAFYNNG-DISICMEYMDGGSLDKILKEVQGRIPER--------ILGKIAVAVLKGLT 114
Query: 136 ACHRN-TIVHRDLKPGNLLIGDDGVLKLADFG 166
H I+HRD+KP N+L+ G +KL DFG
Sbjct: 115 YLHEKHKIIHRDVKPSNILVNSRGQIKLCDFG 146
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 46/169 (27%), Positives = 86/169 (50%), Gaps = 28/169 (16%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNL-IVALKEVHDYQSAFRE------------IEALQI 67
Y +LE +GSGA+ VYK R+ ++ ++ALKE++ + AF + + + I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 68 LQ---NSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEI 123
++ PN+V ++ F E++ +V++ + L K+K++ E
Sbjct: 62 IKEQLRHPNIVRYYKTF-LENDRLYIVMDLIEGAPLGEHFNSLKEKKQ-------RFTEE 113
Query: 124 KRW--MVQILSGVDACHRNT-IVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ W VQ++ + H+ IVHRDL P N+++G+D + + DFG A+
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 34/202 (16%)
Query: 24 LECVGSGAYSDVYKGRRLSDNLIVALKEV--------HDYQSAFREIEALQILQNSPNVV 75
L +G G++ VY R + ++ +VA+K++ +Q +E+ LQ L++ PN +
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTI 78
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
+ RE A LV+E+ + ++ KK ++ ++ G L G+
Sbjct: 79 QYRGCYLRE-HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA--------LQGLA 129
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL-GNEFDAPDGNSQPCEPNAPYQD 194
H + ++HRD+K GN+L+ + G++KL DFG A I+ N F PY
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----------VGTPYW- 177
Query: 195 NMSEAPQVDLEVEDASPEGDVN 216
AP+V L +++ +G V+
Sbjct: 178 ---MAPEVILAMDEGQYDGKVD 196
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDYQ--------SAFREIEALQILQNSPNVVVLH 78
+G G + V + S N ALK V F E E L+ N P +V L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59
Query: 79 EYFWREDEDAVLVLEF-LRTDLATVIAESKKKREDRGDRGISVGEIKRWMV-QILSGVDA 136
F ++ + +++E+ L +L T++ DRG+ R+ + ++ +
Sbjct: 60 RTF-KDKKYIYMLMEYCLGGELWTILR----------DRGLFDEYTARFYIACVVLAFEY 108
Query: 137 CHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
H I++RDLKP NLL+ +G +KL DFG A+ L
Sbjct: 109 LHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+EI+ +G GA+ VYK + + A K E+ DY EIE L +
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV---EIEILATCNHPY 70
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
V +L ++W D +++EF I DRG++ +I+ Q+L
Sbjct: 71 IVKLLGAFYW--DGKLWIMIEFCPGGAVDAIMLEL-------DRGLTEPQIQVICRQMLE 121
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ H I+HRDLK GN+L+ DG +KLADFG
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFG 155
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 16/170 (9%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFRE 61
E+ L K SI + + KY E +G GA VY ++ VA+K+++ Q +E
Sbjct: 2 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE 61
Query: 62 IEALQIL----QNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDR 116
+ +IL +PN+V + + DE V V+E+L L V+ E+
Sbjct: 62 LIINEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTET---------- 110
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ G+I + L +D H N ++HRD+K N+L+G DG +KL DFG
Sbjct: 111 CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 18/155 (11%)
Query: 24 LECVGSGAYSDVYKGRRLSDNLIVALKEV--------HDYQSAFREIEALQILQNSPNVV 75
L +G G++ VY R + N +VA+K++ +Q +E++ LQ +++ PN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH-PNSI 88
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
+ RE A LV+E+ + ++ KK ++ I+ G L G+
Sbjct: 89 EYKGCYLRE-HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA--------LQGLA 139
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
H + ++HRD+K GN+L+ + G +KLADFG A I
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-11
Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSP 72
KY ++ +G G++ + D +KE++ + + + +E+ L +++ P
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH-P 59
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGE--IKRWMVQ 129
N+V E F E+ + +V+++ DL I RG+ E I W VQ
Sbjct: 60 NIVQYQESF-EENGNLYIVMDYCEGGDLYKKI---------NAQRGVLFPEDQILDWFVQ 109
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
I + H I+HRD+K N+ + DG +KL DFG AR+L
Sbjct: 110 ICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 7e-11
Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV-HDYQSAFREIEALQILQNSPNVVVLHE 79
Y++ +G+G++ VY+ + + VA+K+V D Q RE+ ++ L N N++ L +
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNL-NHINIIFLKD 126
Query: 80 YFW----REDEDAV---LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
Y++ +++E + +V+EF+ + + K R + + + +K + Q+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYM-----KHYARNNHALPLFLVKLYSYQLCR 181
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARILLGNE 175
+ H I HRDLKP NLLI + LKL DFG A+ LL +
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
|
Length = 440 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 20/154 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+EI+ +G GA+ VYK + ++ A K E+ DY EI+ L + P
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV---EIDILASC-DHP 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L + F+ E+ +L+ + V+ E +R ++ +I+ Q L
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--------ERPLTEPQIRVVCKQTLE 114
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ H N I+HRDLK GN+L DG +KLADFG
Sbjct: 115 ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFG 148
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 44/166 (26%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 20 KYEILECVGSGAYSDVY--------KGRRLSDNLIVALKEVHDYQSAFREIEALQILQ-- 69
+Y + + +G G++ VY RL + + E++ ++ EA Q+L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA-QLLSKL 59
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
+ P +V H F E + ++ E+ DL + E K + +S ++ W +
Sbjct: 60 DHPAIVKFHASFL-ERDAFCIITEYCEGRDLDCKLEELKHTGKT-----LSENQVCEWFI 113
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174
Q+L GV H+ I+HRDLK N+ + ++ +LK+ DFG +R+L+G+
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGS 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 43/159 (27%), Positives = 80/159 (50%), Gaps = 23/159 (14%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVVV 76
+E++E VG+G Y VYKGR + + A+K + + + +EI L+ + N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 77 LHEYFWRE-----DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV--- 128
+ F ++ D+ LV+EF T + ++ K G ++ E W+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--------GNTLKE--EWIAYIC 117
Query: 129 -QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+IL G+ H++ ++HRD+K N+L+ ++ +KL DFG
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 156
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 38/177 (21%), Positives = 79/177 (44%), Gaps = 19/177 (10%)
Query: 20 KYEILECVGSGAYSDVYKG--RRLSDN---LIVALKEVHDYQSAFREIEALQILQ----- 69
K ++ +G G++ VY+G + + VA+K V++ ++ RE ++ L
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE-NASMRER--IEFLNEASVM 63
Query: 70 ---NSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGI-SVGEIK 124
N +VV L + ++V+E + + DL + + + + E+ G ++ +
Sbjct: 64 KEFNCHHVVRLLGVVSTG-QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDG 181
+ +I G+ VHRDL N ++ +D +K+ DFG R + ++ G
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 26/176 (14%)
Query: 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-HDYQS------AFREIEALQILQ 69
++ +Y+ L+ +GSGA V + VA+K++ +Q+ A+RE+ L+ +
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV- 77
Query: 70 NSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVI-AESKKKREDRGDRGISVGEI 123
N N++ L F E +D LV+E + +L VI E +R +
Sbjct: 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER------------M 125
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAP 179
+ Q+L G+ H I+HRDLKP N+++ D LK+ DFG AR N P
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 25/172 (14%)
Query: 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKE-------VHDYQSAFREIEALQILQ 69
++ +Y+ L+ +GSGA V VA+K+ V + A+RE+ ++++
Sbjct: 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV- 72
Query: 70 NSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIK 124
N N++ L F E +D LV+E + +L VI + + +R +
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-----QMDLDHER------MS 121
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
+ Q+L G+ H I+HRDLKP N+++ D LK+ DFG AR G F
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSF 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREI---EALQILQNS-PNVV 75
KY E +G GA VY ++ VA+K+++ Q +E+ E L + +N PN+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 76 VLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
+ + DE V V+E+L L V+ E+ + G+I + L +
Sbjct: 80 NYLDSYLVGDELWV-VMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQAL 128
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ H N ++HRD+K N+L+G DG +KL DFG
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 41/160 (25%), Positives = 91/160 (56%), Gaps = 17/160 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPN 73
+EIL+ +G GA+ +V + + + + A+K ++ ++ + FRE + + ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 74 VVVLHEYFWREDEDAVLVLEF-LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ LH Y ++++ + LV+++ + DL T+++ K EDR ++ + ++ +++
Sbjct: 63 ITTLH-YAFQDENNLYLVMDYYVGGDLLTLLS----KFEDRLPEDMA----RFYLAEMVI 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172
+D+ H+ VHRD+KP N+L+ +G ++LADFG L+
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 43/170 (25%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 21 YEILECVGSGAYSDVYKGRRLS---DNLIVA---LKEVHDYQSA------FREIEALQIL 68
+E+L +G+GAY V+ R++ + A LK+ Q A E + L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWM 127
+ P +V LH Y ++ D L+L+++ +L T + + + E E++ ++
Sbjct: 62 RRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---------EVRVYI 111
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFD 177
+I+ +D H+ I++RD+K N+L+ +G + L DFG ++ L E +
Sbjct: 112 AEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 4e-10
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 16/170 (9%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFRE 61
E+ L K SI + + KY E +G GA VY ++ VA+++++ Q +E
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 62 IEALQIL----QNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDR 116
+ +IL +PN+V + + DE V V+E+L L V+ E+
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTET---------- 111
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ G+I + L ++ H N ++HRD+K N+L+G DG +KL DFG
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 18/40 (45%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 280 DGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+ R + V TRW+RAPELLYG+ Y VDLW++
Sbjct: 150 SEEEPRL--YSHQVATRWYRAPELLYGARKYDPGVDLWAV 187
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEAL----QILQN--SPNVV 75
+ +G GA+ VY + +A+K+V D +E+ AL Q+L+N +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 76 VLHEYF--WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+Y+ R+DE + +E++ K + + ++ +++ QIL G
Sbjct: 68 ---QYYGCLRDDETLSIFMEYM--------PGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
V+ H N IVHRD+K N+L G +KL DFG ++ L
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEA----LQILQNSPNVVV 76
+E++E VG+G Y VYKGR + + A+K + + EI+ L+ + N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 77 LHEYFWRE-----DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+ F ++ D+ LV+EF T + ++ K + D + I R +IL
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED---WIAYICR---EIL 131
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G+ H + ++HRD+K N+L+ ++ +KL DFG
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 28/63 (44%), Positives = 39/63 (61%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEP 188
QI SG+ R VHRDL+ N+L+G++ V K+ADFG AR++ NE+ A G P +
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 189 NAP 191
AP
Sbjct: 170 TAP 172
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-HDYQS------AFREIEALQILQ 69
++ +Y+ L+ +GSGA V + VA+K++ +Q+ A+RE+ ++ +
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV- 73
Query: 70 NSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIA-ESKKKREDRGDRGISVGEI 123
N N++ L F E +D LV+E + +L VI E +R +
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHER------------M 121
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ Q+L G+ H I+HRDLKP N+++ D LK+ DFG AR
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 22/157 (14%)
Query: 24 LECVGSGAYSDVYKGRRLSDNLIVALKEV--------HDYQSAFREIEALQILQNSPNVV 75
L +G G++ VY N +VA+K++ +Q +E++ LQ L++ PN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH-PNTI 84
Query: 76 VLHEY--FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
EY + ++ A LV+E+ + ++ KK ++ I+ G L G
Sbjct: 85 ---EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA--------LQG 133
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
+ H + ++HRD+K GN+L+ + G +KLADFG A
Sbjct: 134 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 25/160 (15%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ------SAF----REIEALQI 67
+++++ +G GA+ +V R S + A+K + ++ SAF R+I A
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA- 100
Query: 68 LQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRW 126
NS +V LH Y +++D+ +V+E++ DL ++ + I + +
Sbjct: 101 --NSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM----------SNYDIPEKWARFY 147
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+++ +DA H +HRD+KP N+L+ G LKLADFG
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 15/121 (12%)
Query: 48 ALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAES 106
L++ +Y I I PN+V LH+Y ED LVL+ L + I++
Sbjct: 25 GLRKSSEYSRERLTI----IPHCVPNMVCLHKYIVSEDS-VFLVLQHAEGGKLWSHISKF 79
Query: 107 KKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
E+ +KRW +++ +DA HR IV RDL P N+L+ D G ++L F
Sbjct: 80 LNIPEE---------CVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS 130
Query: 167 Q 167
+
Sbjct: 131 R 131
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-HDYQS------AFREIEALQIL 68
E+ +Y+ L VGSGAY V VA+K++ +QS +RE+ L+ +
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71
Query: 69 QNSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
++ NV+ L + F + LV + DL ++ K +S +
Sbjct: 72 KHE-NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----------LSDEHV 120
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ + Q+L G+ H I+HRDLKP N+ + +D L++ DFG AR
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEAL----QILQN--SPNV 74
Y + VG G+Y +V R +D +K+++ ++ RE +A Q+L PN+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 75 VVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
V E + ED +V+ F DL + E K K + ++ W VQI
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-------LPENQVVEWFVQIAMA 114
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ H I+HRDLK N+ + ++K+ D G AR+L
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 50/174 (28%), Positives = 86/174 (49%), Gaps = 17/174 (9%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ---ILQ--NSPNVVVLHE 79
E +G G + DVYKG L N VA+K + + LQ IL+ + PN+V L
Sbjct: 1 EKIGKGNFGDVYKG-VLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 80 YFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH 138
+ + +V+E + L T + +K+++R ++V ++ + + +G++
Sbjct: 60 VCV-QKQPIYIVMELVPGGSLLTFL----RKKKNR----LTVKKLLQMSLDAAAGMEYLE 110
Query: 139 RNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQ-PCEPNAP 191
+HRDL N L+G++ VLK++DFG +R G + DG Q P + AP
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP 164
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 40/154 (25%), Positives = 86/154 (55%), Gaps = 17/154 (11%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPN 73
+EIL+ +G GA+ +V + + + A+K ++ ++ + FRE + + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 74 VVVLHEYFWREDEDAVLVLEF-LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ LH Y ++++ + LV+++ + DL T+++ K EDR + + ++ +++
Sbjct: 63 ITNLH-YAFQDENNLYLVMDYYVGGDLLTLLS----KFEDR----LPEDMARFYLAEMVL 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+D+ H+ VHRD+KP N+L+ +G ++LADFG
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 52/175 (29%), Positives = 91/175 (52%), Gaps = 26/175 (14%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----------EVHDYQSAFREIEALQ 66
I ++ I++ + GA+ VY GR+ +++ + A+K VH Q+ E +AL
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQA---ERDALA 59
Query: 67 ILQNSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKR 125
L SP +V L+ Y + + LV+E+L D+ +++ E+ + IS
Sbjct: 60 -LSKSPFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS------ 111
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPD 180
++ +D HR+ I+HRDLKP N+LI ++G +KL DFG +++ L E + D
Sbjct: 112 ---EVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMD 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 23/155 (14%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDYQSAFREIEALQILQNSPNVV 75
+E+++ +GSG Y DVYK R ++ + A+K + D+ +EI ++ ++ N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH-SNIV 69
Query: 76 VLHEYFWREDEDAVLVLEFL----RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+ R D+ + +EF D+ V +S +I + L
Sbjct: 70 AYFGSYLRRDK-LWICMEFCGGGSLQDIYHVTGP------------LSESQIAYVSRETL 116
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G+ H +HRD+K N+L+ D+G +KLADFG
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFG 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 45/172 (26%), Positives = 85/172 (49%), Gaps = 10/172 (5%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEALQILQNSPNVVVLHEY 80
++++ +G+G + +V+ G + N VA+K + S +E QI++ + ++ Y
Sbjct: 9 QLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLY 67
Query: 81 FWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR 139
+E +V E++ + L + +D R + + + Q+ +G+ R
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFL-------KDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAP 191
+HRDL+ N+L+GD V K+ADFG AR++ NE+ A G P + AP
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 17/151 (11%)
Query: 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ----ILQ--NSPNVVVL 77
LE +G G++ +V+KG +VA+K + D + A EIE +Q +L +SP V
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 78 HEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
+ + + D +++E+L A + E E +I + +IL G+D
Sbjct: 68 YGSYLK-DTKLWIIMEYLGGGSALDLLEPGPLDET---------QIATILREILKGLDYL 117
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
H +HRD+K N+L+ + G +KLADFG A
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 49/180 (27%), Positives = 77/180 (42%), Gaps = 35/180 (19%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDN--------LIVALKEVHD---YQSAFREIEA 64
++ LE +G GA+ VYKG N I LKE + Q +E E
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61
Query: 65 LQILQNSPNVV-------------VLHEYFWREDEDAVLVLEFL--RTDLATVIAESKKK 109
+ LQ+ PN+V +L EY D + EFL + + V AES
Sbjct: 62 MSDLQH-PNIVCLLGVCTKEQPTCMLFEYLAHGD-----LHEFLVRNSPHSDVGAESG-- 113
Query: 110 REDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
++ + + +QI +G++ + VHRDL N L+G+ +K++DFG +R
Sbjct: 114 -DETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 39/154 (25%), Positives = 84/154 (54%), Gaps = 17/154 (11%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPN 73
+EI++ +G GA+ +V + I A+K ++ ++ + FRE + + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 74 VVVLHEYFWREDEDAVLVLEF-LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ LH Y ++++ LV+++ + DL T+++ K EDR ++ + ++ +++
Sbjct: 63 ITTLH-YAFQDENYLYLVMDYYVGGDLLTLLS----KFEDRLPEDMA----RFYIAEMVL 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ + H+ VHRD+KP N+L+ +G ++LADFG
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 28/161 (17%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEV-----------HDYQSAFREIEALQILQNSPN 73
E +G GAY VY G LI A+K+V +Y+ E++ L+ L++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLI-AVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEI--KRWMVQI 130
V L +D + +EF+ +++++ +R + E ++ QI
Sbjct: 65 VQYLGTCL--DDNTISIFMEFVPGGSISSIL-----------NRFGPLPEPVFCKYTKQI 111
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
L GV H N +VHRD+K N+++ +G++KL DFG AR L
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 7e-09
Identities = 18/34 (52%), Positives = 22/34 (64%)
Query: 285 RQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
T+ V T W+R PELL G+T YG EVD+WS
Sbjct: 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWS 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-09
Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 24/157 (15%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEV-----------HDYQSAFREIEALQILQNSPN 73
+ +G+GA+S Y+ R + ++A+K+V ++ +EI + L N P+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPH 64
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
++ + ED L +E++ ++ ++++ +E + + + Q+L
Sbjct: 65 IIRMLGAT-CEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-----AVII----NYTEQLLR 114
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQA 168
G+ H N I+HRD+K NLLI G L++ADFG A
Sbjct: 115 GLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDYQSA-FREIEALQILQNSPN 73
K L +G GA V K R + +I ALK + D Q RE+E + + SP
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPY 60
Query: 74 VVVLHEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGE--IKRWMVQI 130
+V + F E ++ + +E+ + ++ + KK ++ RG +GE + + +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYC--EGGSLDSIYKKVKK----RGGRIGEKVLGKIAESV 114
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
L G+ H I+HRD+KP N+L+ G +KL DFG
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 19/36 (52%), Positives = 24/36 (66%)
Query: 284 GRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
LT V TRW+RAPELL G T+YG VD+W++
Sbjct: 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAI 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 20/42 (47%), Positives = 26/42 (61%)
Query: 278 AEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+E + LT V TRW+RAPE+L GST Y VD+WS+
Sbjct: 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 27/63 (42%), Positives = 38/63 (60%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEP 188
QI G+ R +HRDL+ N+L+GD+ V K+ADFG AR++ NE+ A G P +
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 189 NAP 191
AP
Sbjct: 170 TAP 172
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 31/163 (19%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVH--------------DYQSAFR-EIEALQILQ 69
E +G G Y VY ++ ++A+K+V D A R EIE L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 70 NSPNVVVLHEY--FWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRW 126
+ N+V +Y F +E + LE++ + + + + E ++ +
Sbjct: 67 H-LNIV---QYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---------VRFF 113
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
Q+L G+ H I+HRDLK NLL+ DG+ K++DFG ++
Sbjct: 114 TEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-HDYQS------AFREIEALQILQ 69
++ +Y+ L+ +GSGA V VA+K++ +Q+ A+RE+ ++ +
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV- 80
Query: 70 NSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIA-ESKKKREDRGDRGISVGEI 123
N N++ L F E +D +V+E + +L VI E +R +
Sbjct: 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------------M 128
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ Q+L G+ H I+HRDLKP N+++ D LK+ DFG AR
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 19/154 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPN 73
Y++++ +G GA+ +V R S + A+K + ++ + F E + NSP
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L F ++D+ +V+E++ DL +++ + + K + +++
Sbjct: 105 VVQLFCAF-QDDKYLYMVMEYMPGGDLVNLMS----------NYDVPEKWAKFYTAEVVL 153
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+DA H ++HRD+KP N+L+ G LKLADFG
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSLA 320
+T V TRW+RAPELL+G+ YG+ VD+WS+
Sbjct: 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPN 73
YE+++ +G GA+ +V R S + A+K + ++ + F E + NSP
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
VV L Y +++D +V+E++ DL +++ + + + + +++
Sbjct: 105 VVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS----------NYDVPEKWARFYTAEVVL 153
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+DA H +HRD+KP N+L+ G LKLADFG
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 41/155 (26%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV-------HDYQSAFREIEALQILQNSPN 73
+ ++ +G GA+ +V ++ I A+K + D + + + +SP
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKR-WMVQIL 131
VV L+ Y +++ + L++EFL DL T++ + ED + R +M + +
Sbjct: 63 VVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED----------VTRFYMAECV 111
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++A H+ +HRD+KP N+LI G +KL+DFG
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDE 86
+G G Y VY R LS + +A+KE+ + S R ++ L + LH Y +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLH------EEIALHSYLKHRN- 66
Query: 87 DAVLVLEFLRTDLAT----VIAE-------SKKKREDRGDRGISVGEIKRWMVQILSGVD 135
++++L +D + E S R G + I + QIL G+
Sbjct: 67 ----IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 136 ACHRNTIVHRDLKPGNLLIGD-DGVLKLADFGQARILLG 173
H N IVHRD+K N+L+ GV+K++DFG ++ L G
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 44/150 (29%), Positives = 77/150 (51%), Gaps = 13/150 (8%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFRE--IEALQILQN--SPNVVV 76
E + +G+G V K + + ++A K VH +S+ R+ + LQI+ SP +V
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVS 67
Query: 77 LHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
+ F E+ + + +EF+ D ++ KK + +G+I +V+ L+ +
Sbjct: 68 FYGAFLNEN-NICMCMEFM--DCGSLDRIYKKGGPIPVE---ILGKIAVAVVEGLTYLYN 121
Query: 137 CHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
HR I+HRD+KP N+L+ G +KL DFG
Sbjct: 122 VHR--IMHRDIKPSNILVNSRGQIKLCDFG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 23/157 (14%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVV 75
YE+++ VGSG Y DVYK R L + A+K + D+ +EI ++ ++ V
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 76 VLHEYFWREDEDAVLVLEFL----RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
Y RE + +E+ D+ V +S +I + L
Sbjct: 71 YFGSYLSREK--LWICMEYCGGGSLQDIYHVTGP------------LSELQIAYVCRETL 116
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
G+ H +HRD+K N+L+ D+G +KLADFG A
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 40/182 (21%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVVVL 77
++L +G+G + +V++G ++ VA+K + D + E + ++ L++ P ++ L
Sbjct: 9 QLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRH-PKLIQL 66
Query: 78 HEYFWREDEDAVL--------VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
+ E+ ++ +LE+L+ R + + ++ Q
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGG---------------AGRALKLPQLIDMAAQ 111
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPN 189
+ SG+ +HRDL N+L+G++ + K+ADFG AR++ + ++A +G P +
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 190 AP 191
AP
Sbjct: 172 AP 173
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 14/169 (8%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHD-YQSAFREIEALQILQ--NSPNVVVLHEYFWR 83
+GSG + V+ G L VA+K + + S IE Q++ + P +V L+
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT- 69
Query: 84 EDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWM-VQILSGVDACHRNTI 142
E LV EF+ + ++ RG E M + + G+ + +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQ--------RGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 143 VHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAP 191
+HRDL N L+G++ V+K++DFG R +L +++ + G P + ++P
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 22/154 (14%)
Query: 24 LECVGSGAYSDVYKGRRLS---DNLIVALK-------EVHDYQSAFREIEALQILQNSPN 73
L+ +G G++ V+ R+++ + A+K +V D E + L + N P
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPF 59
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+V LH F E + L+L+FLR DL T +++ E+ ++K ++ ++
Sbjct: 60 IVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEE---------DVKFYLAELAL 109
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+D H I++RDLKP N+L+ ++G +KL DFG
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 143
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 13/151 (8%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFRE--IEALQILQ--NSPNVV 75
+E + +G+G V K + LI+A K +H + + A R I LQ+L NSP +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
+ F+ + E ++ + L V+ E+K+ E+ +G++ +++ L+ +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE------ILGKVSIAVLRGLAYLR 120
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
H+ I+HRD+KP N+L+ G +KL DFG
Sbjct: 121 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFG 149
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 17/37 (45%), Positives = 20/37 (54%)
Query: 283 DGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
T V TRW+RAPELL G Y VD+WS+
Sbjct: 149 GSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV 185
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 42/168 (25%), Positives = 89/168 (52%), Gaps = 23/168 (13%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDN------LIVALKEVHDYQSA------FREIEALQIL 68
+E+L+ +G+GAY V+ R++S + + LK+ Q A E + L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWM 127
+ SP +V LH Y ++ D L+L+++ +L T +++ ++ +E E++ +
Sbjct: 62 RQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ---------EVQIYS 111
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+I+ ++ H+ I++RD+K N+L+ +G + L DFG ++ +E
Sbjct: 112 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREI-EALQILQ--NSPNVV 75
E+L+ +G G Y VYK + +A+KE+ D +S F +I L IL SP +V
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIV 62
Query: 76 VLHEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
+ F+ E AV + +E++ D ++ K GI ++R ++ G+
Sbjct: 63 DFYGAFFIEG--AVYMCMEYM--DAGSL---DKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 135 DAC-HRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ I+HRD+KP N+L+ +G +KL DFG
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFG 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 28/175 (16%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVH---------DYQSAF-----REIEALQILQNSP 72
+GSG++ VY G S ++A+K+V D + + REI L+ LQ+
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-E 66
Query: 73 NVVVLHEYFWRE-DEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
N+V +Y D D + + LE++ + + E+ ++ ++ QI
Sbjct: 67 NIV---QYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE--------TLVRNFVRQI 115
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQP 185
L G++ H I+HRD+K N+L+ + G +K++DFG ++ L N ++P
Sbjct: 116 LKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 23 ILECVGSGAYSDVYKG--RRLS---DNLIVALKEVHDYQSAF------REIEALQILQNS 71
+ +G GA+ V+ G L D +VA+K + + S RE E L Q+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLRT-DLATVI-------AESKKKREDRGDRGISVGEI 123
N+V + D ++V E++ DL + A K G+ +S ++
Sbjct: 69 -NIVKFYGVCTEGDP-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS--QL 124
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ VQI SG+ VHRDL N L+G D V+K+ DFG +R
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 37/160 (23%), Positives = 74/160 (46%), Gaps = 22/160 (13%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+ + +GSG + +V++G + + VA+K + D+Q E++AL+ L++
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH-K 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+++ L E ++ E + L + + + + V + Q+
Sbjct: 63 HLISLFA-VCSVGEPVYIITELMEKGSLLAFLRSPE-------GQVLPVASLIDMACQVA 114
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+ +HRDL N+L+G+D V K+ADFG AR++
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 19/36 (52%), Positives = 23/36 (63%)
Query: 284 GRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
G T V TRW+RAPELL G T YG VD+W++
Sbjct: 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAI 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 24/65 (36%), Positives = 37/65 (56%)
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPC 186
QI G+ +HRDL N+L+G++ V K+ADFG AR++ +E+ A +G P
Sbjct: 109 AAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168
Query: 187 EPNAP 191
+ AP
Sbjct: 169 KWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-08
Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 30/182 (16%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAF-REIEALQILQNSPNVVVL 77
++++ +G+G + +V+ G + + VA+K + AF E ++ LQ+ P +V L
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH-PRLVRL 66
Query: 78 HEYFWRED--------EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
+ +E E+ LV +FL+T E K +++ ++ Q
Sbjct: 67 YAVVTQEPIYIITEYMENGSLV-DFLKTP------EGIK---------LTINKLIDMAAQ 110
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPN 189
I G+ R +HRDL+ N+L+ + K+ADFG AR++ NE+ A +G P +
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT 170
Query: 190 AP 191
AP
Sbjct: 171 AP 172
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 17/156 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPN 73
+++ VG G + +V R + I A+K + S F E + + NSP
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ L +Y +++ ++ LV+E+ DL +++ + ED+ D + + ++ +++
Sbjct: 63 IPQL-QYAFQDKDNLYLVMEYQPGGDLLSLLN----RYEDQFDEDM----AQFYLAELVL 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
+ + H+ VHRD+KP N+LI G +KLADFG A
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 21/153 (13%)
Query: 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ----ILQ--NSPNVVVL 77
LE +G G++ +VYKG +VA+K + D + A EIE +Q +L +SP +
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYIT-- 65
Query: 78 HEYF--WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
Y+ + + +++E+L A + + E I + +IL G+D
Sbjct: 66 -RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEE---------TYIATILREILKGLD 115
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
H +HRD+K N+L+ + G +KLADFG A
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 28/53 (52%), Positives = 36/53 (67%), Gaps = 2/53 (3%)
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
R I+V IK M Q+L+G+ HR IVHRD+KP NLL+ DG +K+ DFG A
Sbjct: 306 RDINV--IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 30/176 (17%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNV----VVL 77
E +G G + V +G VA+K + Q+ E + L + V V+L
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK--VAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 78 HE--YFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
H Y E ++ FLRT RG +SV ++ ++ + + G++
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRT---------------RGRALVSVIQLLQFSLDVAEGME 114
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAP 191
+VHRDL N+L+ +DGV K++DFG AR+ D + P + AP
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAP 166
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 30/164 (18%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQNSPN 73
+ ++ +G G + DV G VA+K + D Q+ E + L++ PN
Sbjct: 5 SKELKLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH-PN 61
Query: 74 VVVL--------HEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
+V L Y E ++++LR+ RG I++ +
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS---------------RGRAVITLAQQLG 106
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ + + G++ VHRDL N+L+ +D V K++DFG A+
Sbjct: 107 FALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ----ILQNSPNVVVLHE 79
LE +G G++ +V+KG +VA+K + D + A EIE +Q +L + V
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 80 Y-FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH 138
Y + + +++E+L A + + E +I + +IL G+D H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE---------FQIATMLKEILKGLDYLH 118
Query: 139 RNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
+HRD+K N+L+ + G +KLADFG A
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 24/63 (38%), Positives = 37/63 (58%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEP 188
QI G+ R +HRDL+ N+L+ + + K+ADFG AR++ NE+ A +G P +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 189 NAP 191
AP
Sbjct: 171 TAP 173
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 2e-07
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 16/152 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQIL----QNSPNVV 75
KY E +G GA V+ ++ VA+K+++ + +E+ +IL +PN+V
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 76 VLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
+ F DE +V+E+L L V+ E+ + +I + L +
Sbjct: 80 NFLDSFLVGDE-LFVVMEYLAGGSLTDVVTET----------CMDEAQIAAVCRECLQAL 128
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ H N ++HRD+K N+L+G DG +KL DFG
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGMDGSVKLTDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 110 REDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ D G + + ++ + QI G+ + +HRDL+ N+L+ V K+ADFG AR
Sbjct: 92 KSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150
Query: 170 ILLGNEFDAPDGNSQPCEPNAP 191
++ NE+ A +G P + AP
Sbjct: 151 VIEDNEYTAREGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 20/63 (31%), Positives = 35/63 (55%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEP 188
+ ++ N +HRDL N L+G+D V+K++DFG AR +L +++ + G P +
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKW 167
Query: 189 NAP 191
P
Sbjct: 168 APP 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 18/39 (46%), Positives = 22/39 (56%)
Query: 281 GGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
GG G T+ V TRW+R PELL G Y VD+W +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGI 213
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 23/155 (14%)
Query: 27 VGSGAYSDVYKGRR-----------LSDNLIVALKEVHDYQSAFREIEALQILQNSPNVV 75
+G G + VY+ R+ LS IVA KEV + R I +L SP +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV-AHTIGERNILVRTLLDESPFIV 59
Query: 76 VLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
L ++ ++ D D LV +++ +L + + + EDR K ++ +++ +
Sbjct: 60 GL-KFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA---------KFYIAELVLAL 109
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ H+ IV+RDLKP N+L+ G + L DFG ++
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALK----EVHDYQSAFREIEALQILQNSP--N 73
KY I +GSGA V +R+SD A+K E R + L N +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 74 VVVLHEYFWREDED-------AVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKR 125
+V HE F ++D LVL++ DL I K + +R E
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI-----KSRAKTNRTFREHEAGL 147
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+Q+L V H ++HRD+K N+L+ +G++KL DFG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188
|
Length = 496 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 37/153 (24%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEA-----LQILQNSPNVV 75
+ ++ +G GA+ +V R++ + A+K + R A IL + N
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 76 VLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
V+ Y+ +D+D + V++++ D+ +++ ED + ++ ++
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA---------RFYIAELTCA 113
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
V++ H+ +HRD+KP N+LI DG +KL DFG
Sbjct: 114 VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 36/121 (29%), Positives = 59/121 (48%), Gaps = 10/121 (8%)
Query: 49 LKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESK 107
LK+ Q A E + L+ + +S +V L Y + +D LV+ + DL I
Sbjct: 31 LKKRKGEQMALNEKKILEKV-SSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNV- 87
Query: 108 KKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167
G+ G + QI+ G++ H+ IV+RDLKP N+L+ D G ++++D G
Sbjct: 88 ------GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL 141
Query: 168 A 168
A
Sbjct: 142 A 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 13/151 (8%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFRE--IEALQILQ--NSPNVV 75
+E + +G+G V+K LI+A K +H + + A R I LQ+L NSP +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
+ F+ + E ++ + L V+ ++ + E +G++ +++ L+ +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ------ILGKVSIAVIKGLTYLR 120
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
H+ I+HRD+KP N+L+ G +KL DFG
Sbjct: 121 EKHK--IMHRDVKPSNILVNSRGEIKLCDFG 149
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSA------FREIEALQILQNSPNVV 75
E L +GSG VYK R ++A+K++ + +++ + + P +V
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
+ YF D D + +E + T + KR +G++ +V+ L +
Sbjct: 78 KCYGYFIT-DSDVFICMELMST-----CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
H ++HRD+KP N+L+ G +KL DFG
Sbjct: 132 EKH--GVIHRDVKPSNILLDASGNVKLCDFG 160
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 42/133 (31%), Positives = 58/133 (43%), Gaps = 16/133 (12%)
Query: 46 IVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL--RTDLATVI 103
A +E H RE L + PN+V L + V E++ RT L V+
Sbjct: 13 TDAPEEEHQRARFRRETALCARLYH-PNIVALLDSGEAPPGLLFAVFEYVPGRT-LREVL 70
Query: 104 AESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV---L 160
A D + GE R M+Q+L + H IVHRDLKP N+++ GV
Sbjct: 71 A---------ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 161 KLADFGQARILLG 173
K+ DFG +L G
Sbjct: 122 KVLDFGIGTLLPG 134
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (119), Expect = 7e-07
Identities = 16/33 (48%), Positives = 20/33 (60%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLA 320
T V T W+RAPE+L GS Y VD+WS+
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVG 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 18/30 (60%), Positives = 22/30 (73%)
Query: 290 TSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
T V TRW+RAPELL G T YG VD+W++
Sbjct: 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAV 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEAL----QILQNSPNVVVLHE 79
+G GA+ VY +A+K+V + +E+ AL Q+L+N + ++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 80 Y-FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH 138
Y R+ + L + + K + + ++ +++ QIL GV H
Sbjct: 70 YGCLRDPMERTLSI------FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 139 RNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
N IVHRD+K N+L G +KL DFG ++ L
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (120), Expect = 8e-07
Identities = 19/42 (45%), Positives = 26/42 (61%)
Query: 278 AEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
D + +G LT V TRW+RAPELL S+ Y +D+WS+
Sbjct: 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSV 193
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 39/153 (25%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK------EVHDYQSAFREIEALQILQNSPNV 74
+E L+ +G GA+ +V ++ I A+K + Q A E +++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 75 VVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
VV Y +++ + L++EFL D+ T++ + E+ + ++ + +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE---------ATQFYIAETVLA 113
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+DA H+ +HRD+KP NLL+ G +KL+DFG
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-07
Identities = 18/43 (41%), Positives = 32/43 (74%)
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
+ QI+SG++ H+ I++RDLKP N+L+ +DG ++++D G A
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 40/168 (23%), Positives = 84/168 (50%), Gaps = 23/168 (13%)
Query: 21 YEILECVGSGAYSDVYKGRRLS---DNLIVALK---------EVHDYQSAFREIEALQIL 68
+E+L+ +G+GAY V+ R+++ + A+K + + E L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWM 127
+ SP +V LH Y ++ + L+L+++ ++ T + + ED E++ +
Sbjct: 62 RQSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---------EVRFYS 111
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+I+ ++ H+ IV+RD+K N+L+ +G + L DFG ++ L E
Sbjct: 112 GEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 27 VGSGAYSDVYKGRRLSDN---LIVALKEVHDYQSA------FREIEALQILQNSPNVVVL 77
+G G + V KG L + + VA+K + A RE + L + P +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH-PCIVRL 61
Query: 78 HEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
+ E +LV+E L ++ KK+RE I V ++K Q+ G+
Sbjct: 62 IGVC--KGEPLMLVMELAP--LGPLLKYLKKRRE------IPVSDLKELAHQVAMGMAYL 111
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL-LGNEF 176
VHRDL N+L+ + K++DFG +R L G+++
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 17/154 (11%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNS---PNVV 75
E++E +G GAY V K R + I+A+K + + Q R + L I S P V
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGE--IKRWMVQILSG 133
+ +RE D + +E + T L + K G+++ E + + V I+
Sbjct: 64 TFYGALFREG-DVWICMEVMDTSLDKFYKKVYDK-------GLTIPEDILGKIAVSIVKA 115
Query: 134 VDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFG 166
++ H +++HRD+KP N+LI +G +KL DFG
Sbjct: 116 LEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 19/43 (44%), Positives = 29/43 (67%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+I+ ++ H IV+RDLKP N+L+ +G +KL DFG A+ L
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 25/80 (31%), Positives = 43/80 (53%), Gaps = 1/80 (1%)
Query: 113 RGDRGISVGEIKRWMVQ-ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
R +G ++ M Q + G++ RN+ +HRDL N L+ GV+K++DFG R +
Sbjct: 91 RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150
Query: 172 LGNEFDAPDGNSQPCEPNAP 191
L +E+ + G P + + P
Sbjct: 151 LDDEYTSSSGAKFPVKWSPP 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 14/151 (9%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEAL----QILQNSPNVVVLHE 79
+G GA+ +VY +A+K+V D Q +E+ AL Q+L+N + ++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 80 Y-FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH 138
Y R+ E+ L + + K + + ++ +R+ QIL GV H
Sbjct: 70 YGCLRDPEEKKLSI------FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 139 RNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
N IVHRD+K N+L G +KL DFG ++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 20/163 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV--------HDYQSAFREIEALQILQNSP 72
+E ++ + +GAY VY R A+K++ + Q F E + L +N P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN-P 61
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
VV + F +V+E++ D AT++ + + V + + + +
Sbjct: 62 FVVSMFCSF-ETKRHLCMVMEYVEGGDCATLL---------KNIGALPVDMARMYFAETV 111
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174
++ H IVHRDLKP NLLI G +KL DFG ++I L +
Sbjct: 112 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 43/190 (22%)
Query: 14 RPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVHDY-----QSAFREIE 63
R +I+ K+E+ G GA+ V+ D ++VA+K + + Q RE E
Sbjct: 4 RRDIVLKWEL----GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE 59
Query: 64 ALQILQNSPNVVVLHEYFWR------EDEDAVLVLEFLR-TDL----------ATVIAES 106
L +LQ H++ R E ++V E++R DL A ++A
Sbjct: 60 LLTVLQ--------HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 107 KKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
ED +++G++ QI SG+ VHRDL N L+G V+K+ DFG
Sbjct: 112 ----EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFG 167
Query: 167 QARILLGNEF 176
+R + ++
Sbjct: 168 MSRDIYSTDY 177
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 13/151 (8%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFRE--IEALQILQ--NSPNVV 75
+E L +G+G V K LI+A K +H + + A R I L++L NSP +V
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
+ F+ + E ++ + L V+ ++ + E+ +G+I +++ L+ +
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN------ILGKISIAVLRGLTYLR 116
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
H+ I+HRD+KP N+L+ G +KL DFG
Sbjct: 117 EKHK--IMHRDVKPSNILVNSRGEIKLCDFG 145
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 17/33 (51%), Positives = 21/33 (63%), Gaps = 1/33 (3%)
Query: 287 GALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
LT+ VGT + APE+L G YG VD+WSL
Sbjct: 151 EKLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSL 182
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 18/36 (50%), Positives = 24/36 (66%)
Query: 284 GRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+LT+ VGT W+ APE+L G YG +VD+WSL
Sbjct: 150 KSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSL 185
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 18/33 (54%), Positives = 22/33 (66%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAA 321
T V TRW+RAPE+L STSY VD+W+L
Sbjct: 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGC 187
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 18/45 (40%), Positives = 24/45 (53%), Gaps = 5/45 (11%)
Query: 280 DGGDGRQ-----GALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
D G R+ T V T W+RAPELL G+ Y +D+WS+
Sbjct: 149 DFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 17/31 (54%), Positives = 22/31 (70%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+TS V T W+RAPELL G+ Y VD+WS+
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220
|
Length = 335 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 29/167 (17%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIV--ALKEVHDYQSA------FREIEALQILQNSPNVVV 76
+ +G G + V K R D L + A+K + +Y S E+E L L + PN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 77 L--------HEYFWREDEDAVLVLEFLR------TDLATVIAESKKKREDRGDRGISVGE 122
L + Y E +L+FLR TD A IA S +S +
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-------LSSQQ 125
Query: 123 IKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ + + G+D + +HRDL N+L+G++ V K+ADFG +R
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 36/155 (23%), Positives = 78/155 (50%), Gaps = 20/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEY 80
+E L+ +G GA+ +V ++ + A+K + ++ E E + ++ +++V +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR--KADMLEKEQVGHIRAERDILVEADS 60
Query: 81 FW--------REDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
W ++ + L++EFL D+ T++ + E+ E + ++ + +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE---------ETQFYIAETV 111
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+D+ H+ +HRD+KP NLL+ G +KL+DFG
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 30/168 (17%)
Query: 20 KYE---ILECVGSGAYSDV----YKG--------RRLSDNLIVALKEVHDYQSAFREIEA 64
KYE + +G+G++ V YK +R + I+ K+V F E +
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQV---DHVFSERKI 84
Query: 65 LQILQNSPNVVVLHEYFWREDEDAVLVLEF-LRTDLATVIAESKKKREDRGDRGISVGEI 123
L + N P V L+ F +++ LVLEF + + T + +K+ D G
Sbjct: 85 LNYI-NHPFCVNLYGSF-KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG--------- 133
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ QI+ + IV+RDLKP NLL+ DG +K+ DFG A+++
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181
|
Length = 340 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 19/35 (54%), Positives = 23/35 (65%), Gaps = 1/35 (2%)
Query: 284 GRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
+ ALTS V T W+RAPE+L S SY VD+WS
Sbjct: 158 SFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWS 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 17/156 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEAL-----QILQNSPNV 74
+Y +L G G + +V + + + A K++ + R+ E++ QIL+ +
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 75 VVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
V+ + E +DA+ LVL + DL I G+ G G + +I
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH-------MGEAGFEEGRAVFYAAEICC 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
G++ H+ IV+RDLKP N+L+ D G ++++D G A
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 19 AKYEILECVGSGAYSDVYKGRRLSDN----LIVALKEVHDY--QSAFREI--EALQILQ- 69
+ E ++ +GSGA+ VYKG + + + VA+K + + A +EI EA +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
+ P+VV L L+ + + L ++ + +++ G + + W VQ
Sbjct: 67 DHPHVVRL--LGICLSSQVQLITQLMP--LGCLLDYVRNHKDNIGSQ-----YLLNWCVQ 117
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
I G+ +VHRDL N+L+ +K+ DFG A++L +E
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 15/155 (9%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEAL-----QILQNSPNV 74
+Y +L G G + +V + + + A K + + R+ E++ QIL+ +
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 75 VVLHEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
V++ + E +DA+ LVL + + K + G+ G + +IL G
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNG------GDLKFHIYNMGNPGFEEERALFYAAEILCG 114
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
++ HR V+RDLKP N+L+ D G ++++D G A
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 25/159 (15%)
Query: 27 VGSGAYSDVYKGRR--LSDN--LIVALKE-----VHDYQSAF-REIEALQILQNSPNVVV 76
+G G + V R L DN VA+K ++S F REIE L+ L N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVK 70
Query: 77 LHEYFWREDEDAV---LVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
E L++E+L L + + + I++ + + QI
Sbjct: 71 YK--GVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--------INLKRLLLFSSQICK 120
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+D +HRDL N+L+ + ++K++DFG A++L
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 10/80 (12%)
Query: 91 VLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKP 149
V+E+L DL I S + E R + + +I+ G+ H+ I++RDLK
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARA---------RFYAAEIICGLQFLHKKGIIYRDLKL 124
Query: 150 GNLLIGDDGVLKLADFGQAR 169
N+L+ DG +K+ADFG +
Sbjct: 125 DNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 21/55 (38%), Positives = 33/55 (60%)
Query: 114 GDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
G+RG+ + + + QI G+ H IV+RD+KP N+L+ D G +L+D G A
Sbjct: 88 GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 38/154 (24%), Positives = 77/154 (50%), Gaps = 18/154 (11%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK-----EVHDYQSAFREIEALQILQNSPNVV 75
+ ++ +G GA+ +V R++ N + A+K +V A IL + N
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 76 VLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKR-WMVQILS 132
V+ Y+ +D+D + V++++ D+ +++ GI ++ R ++ ++
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----------LGIFEEDLARFYIAELTC 112
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+++ H+ +HRD+KP N+LI DG +KL DFG
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 21/175 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQ--NSPNVVVLH 78
Y +++ + G+ V+ + V LK Q IEA+ +LQ N P+V+ +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAM-LLQNVNHPSVIRMK 123
Query: 79 EYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH 138
+ +VL +DL T + + R + + + QIL G+ H
Sbjct: 124 DTLVSG-AITCMVLPHYSSDLYTYLT--------KRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 139 RNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPD--GNSQPCEPNAP 191
I+HRD+K N+ I D + + D G A+ AP G + E NAP
Sbjct: 175 AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF----PVVAPAFLGLAGTVETNAP 225
|
Length = 357 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 41/157 (26%), Positives = 82/157 (52%), Gaps = 24/157 (15%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK-----EVHDYQS-----AFREIEALQILQN 70
+E ++ +G GA+ +V ++ I A+K E+ + + A R+I A +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA---D 59
Query: 71 SPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
+P VV L+ Y ++++ L++E+L D+ T++ + E+ E + ++ +
Sbjct: 60 NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE---------ETRFYIAE 109
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ +D+ H+ +HRD+KP NLL+ G +KL+DFG
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 24/176 (13%)
Query: 7 KSWSIHTRPEI----IAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----EVHDYQS 57
K+ + T+P+ ++ +E+ E +G+G++ V + A+K E+ +
Sbjct: 2 KAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ 61
Query: 58 AFREIEALQILQ--NSPNVVVLHEYFWREDEDAV-LVLEF-LRTDLATVIAESKKKREDR 113
+ IL + P +V + F +DE+ V +LEF + +L T + ++ + D
Sbjct: 62 VQHVAQEKSILMELSHPFIVNMMCSF--QDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119
Query: 114 GDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
K + +++ + H I++RDLKP NLL+ + G +K+ DFG A+
Sbjct: 120 A---------KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ---ILQ--NSPNVVVLHE 79
E +G G + +V+ GR +DN VA+K + + + LQ IL+ + PN+V L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 80 YFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH 138
+ + +V+E ++ D T + G R + V E+ + + +G++
Sbjct: 61 -VCTQKQPIYIVMELVQGGDFLTFL-------RTEGPR-LKVKELIQMVENAAAGMEYLE 111
Query: 139 RNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+HRDL N L+ + VLK++DFG +R
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 16/38 (42%), Positives = 23/38 (60%)
Query: 286 QGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323
+T V T W+RAPELL G T+Y +D+W++ L
Sbjct: 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 38/144 (26%), Positives = 68/144 (47%), Gaps = 14/144 (9%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREI--EALQILQN--SPNVVVLHEYFW 82
+G G+ V S VA+K++ + RE+ + I+++ PN+V ++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 83 REDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTI 142
DE V V+EFL T I + E+ +I + +L + H +
Sbjct: 87 VGDELWV-VMEFLEGGALTDIVTHTRMNEE---------QIATVCLAVLKALSFLHAQGV 136
Query: 143 VHRDLKPGNLLIGDDGVLKLADFG 166
+HRD+K ++L+ DG +KL+DFG
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 39/151 (25%), Positives = 76/151 (50%), Gaps = 16/151 (10%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ---ILQ--NSPNVVVLHE 79
E +G G + +V+KG L D VA+K + +I+ L IL+ + PN+V L
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 80 YFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH 138
+ + +V+E + D + + +KK+++ + ++ ++ + +G+
Sbjct: 60 -VCTQRQPIYIVMELVPGGDFLSFL---RKKKDE-----LKTKQLVKFALDAAAGMAYLE 110
Query: 139 RNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+HRDL N L+G++ VLK++DFG +R
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 12/152 (7%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEAL----QILQNSPNVVVLHE 79
+G GA+ VY + +A K+V + +E+ AL Q+L+N + ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 80 YFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR 139
Y D + F+ + K + + ++ +++ QIL G+ H
Sbjct: 70 YGCLRDRAEKTLTIFME-----YMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
N IVHRD+K N+L G +KL DFG ++ L
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 35/149 (23%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNVVVL 77
L +G GA+ V K I+A+K + + + +++ + + P +V
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 78 HEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
+ +RE D + +E + L + + I +G+I V+ L+ +
Sbjct: 69 YGALFREG-DCWICMELMDISLDKFYKYVYEVLKSVIPEEI-LGKIAVATVKALNYLKEE 126
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ I+HRD+KP N+L+ +G +KL DFG
Sbjct: 127 LK--IIHRDVKPSNILLDRNGNIKLCDFG 153
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 21/150 (14%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQI-------LQN--SPNVVVL 77
+G G++ V + +D A+K V ++ ++ E I L+N P +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVK-VLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 78 HEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
H Y ++ + VL+++ +L + + E R + + +I S +
Sbjct: 62 H-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA---------RFYAAEIASALGY 111
Query: 137 CHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
H I++RDLKP N+L+ G + L DFG
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFG 141
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEAL-----QILQ--NSPN 73
Y +L G G + +V + + + A K++ + R+ EA+ QIL+ NS
Sbjct: 5 YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 74 VVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
VV L + E +DA+ LVL + DL K + G+ G + +I
Sbjct: 62 VVSLAYAY--ETKDALCLVLTLMNGGDL-------KFHIYNMGNPGFDEERAVFYAAEIT 112
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
G++ HR IV+RDLKP N+L+ D G ++++D G A
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 41/177 (23%), Positives = 77/177 (43%), Gaps = 31/177 (17%)
Query: 24 LECVGSGAYSDVYKGRR----LSDNLIVALKEVHDYQSA-----FREIEALQILQNSPNV 74
+E +G A+ +YKG + +VA+K + D + F++ +L + PN+
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 75 V-------------VLHEYFWREDEDAVLVLEFLRTDLATVIAE--SKKKREDRGDRGIS 119
V +L EY + D L++ +D+ E + K D GD
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD---- 125
Query: 120 VGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
+QI +G++ + VH+DL N+LIG+ +K++D G +R + ++
Sbjct: 126 ---FLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 34/186 (18%)
Query: 14 RPEIIAKYEILECVGSGAYSDV-----YKGRRLSDNLIVALKEVHDYQSAFR-----EIE 63
R +I+ K E+ G GA+ V Y D ++VA+K + D A R E E
Sbjct: 4 RRDIVLKREL----GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 59
Query: 64 ALQILQNSPNV------------VVLHEYFWREDEDAVLVLEFLRTDLA-TVIAESKKKR 110
L LQ+ V +++ EY D + +FLR +I + R
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN-----KFLRAHGPDAMILVDGQPR 114
Query: 111 EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
+ +G+ G+S ++ QI SG+ VHRDL N L+G + ++K+ DFG +R
Sbjct: 115 QAKGELGLS--QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 172
Query: 171 LLGNEF 176
+ ++
Sbjct: 173 VYSTDY 178
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 24/61 (39%), Positives = 33/61 (54%), Gaps = 1/61 (1%)
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFD-APDGNSQ 184
W VQI G+ +VHRDL N+L+ +K+ DFG AR+L G+E + DG
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 185 P 185
P
Sbjct: 174 P 174
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 15/35 (42%), Positives = 21/35 (60%)
Query: 286 QGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLA 320
+ +T V TRW+RAPELL Y +D+WS+
Sbjct: 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG 199
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 37/152 (24%), Positives = 64/152 (42%), Gaps = 19/152 (12%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSPNVVVLH 78
+G G++ V + + A+K + D E L + P + LH
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 79 EYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
F +D V+E++ DL I S+K E R + + ++ +
Sbjct: 63 CCFQTKDR-LFFVMEYVNGGDLMFQIQRSRKFDEPRS---------RFYAAEVTLALMFL 112
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
HR+ +++RDLK N+L+ +G KLADFG +
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 37/149 (24%), Positives = 64/149 (42%), Gaps = 19/149 (12%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQNSPNVVVLH 78
+G G++ V + + A+K + D + E L + P + LH
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 79 EYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
F +D V+E++ DL I S + E R + + +I+ G+
Sbjct: 63 SCFQTKDR-LFFVMEYVNGGDLMFHIQRSGRFDEPRA---------RFYAAEIVLGLQFL 112
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
H I++RDLK N+L+ +G +K+ADFG
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFG 141
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 19/152 (12%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSPNVVVLH 78
+G G++ V R + A+K + D + E L + +N P + L+
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 79 EYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
++ + V+EF+ DL I +S++ E R + + +I S +
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA---------RFYAAEITSALMFL 112
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
H I++RDLK N+L+ +G KLADFG +
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 59 FREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGI 118
F E+ ++ Q+ NVV ++ + DE V V+EFL T I + E+
Sbjct: 65 FNEVVIMRDYQHE-NVVEMYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEE------ 116
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+I + +L + H ++HRD+K ++L+ DG +KL+DFG
Sbjct: 117 ---QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 39/187 (20%)
Query: 27 VGSGAYSDVYKGRRL-----SDNLIVALKEVHDYQSA------FREIEALQILQNSPNVV 75
+G GA+ V++ R +VA+K + + SA RE AL + PN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE-AALMAEFDHPNIV 71
Query: 76 -------------VLHEYFWREDEDAVLVLEFLRT-------DLATVIAESKKKREDRGD 115
+L EY D + EFLR L+ + ++K +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLN-----EFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+S E Q+ +G+ VHRDL N L+G++ V+K+ADFG +R + +
Sbjct: 127 --LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 176 FDAPDGN 182
+ N
Sbjct: 185 YYKASEN 191
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 17/161 (10%)
Query: 25 ECVGSGAYSDVYKGRRLSDNL-----IVALKEV---HDYQSAFREIEALQILQNSPNVVV 76
+ +G G + V + D L I LKE +D++ E+E L L + PN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 77 L------HEYFWREDEDAVL--VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
L Y + E A +L+FLR + + +E ++ ++ ++
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKS-RVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ +G+ +HRDL N+L+G++ K+ADFG +R
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 23/72 (31%), Positives = 34/72 (47%)
Query: 105 ESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164
E ++ E IS + QI SG+ VHRDL N L+G + +K+AD
Sbjct: 114 EPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIAD 173
Query: 165 FGQARILLGNEF 176
FG +R L ++
Sbjct: 174 FGMSRNLYSGDY 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 16/41 (39%), Positives = 23/41 (56%)
Query: 286 QGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326
G +T V TRW+RAPE++ SY +D+WS+ L
Sbjct: 163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 16/32 (50%), Positives = 21/32 (65%)
Query: 287 GALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
G LT V TRW+RAPE++ S Y +D+WS
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWS 195
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 278 AEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323
A + +G T V TRW+R+PELL G+ YG VD+WS+ L
Sbjct: 147 ARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 18/37 (48%), Positives = 26/37 (70%)
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ G+ H N IV+RDLK NLL+ +G +K+ADFG
Sbjct: 110 VVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFG 146
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 14/32 (43%), Positives = 19/32 (59%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSLA 320
L + VGT + APE+L G Y + D+WSL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 15/30 (50%), Positives = 20/30 (66%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
+T V TRW+RAPELL + Y +D+WS
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWS 194
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 18/49 (36%), Positives = 30/49 (61%)
Query: 143 VHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAP 191
+HRDL N L+ D G +K++DFG +R +L +E+ + G+ P + P
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 23 ILECVGSGAYSDVYKGR-RLSDN--LIVALKEVHDYQSAFREI----EALQILQ-NSPNV 74
I + +G G + +V +GR +L + VA+K + S + + EA + Q + PN+
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
+ L E + +++ E++ + K RE+ G +VG++ + I SG+
Sbjct: 68 IRL-EGVVTKSRPVMIITEYMENG-----SLDKFLRENDGK--FTVGQLVGMLRGIASGM 119
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
VHRDL N+L+ + V K++DFG +R L
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 16/38 (42%), Positives = 25/38 (65%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+I+S + H +V+RDLK NL++ DG +K+ DFG
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG 140
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 17/41 (41%), Positives = 26/41 (63%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
Q+ G++ +HRDL N+L+ +D V+K+ADFG AR
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
NVV ++ + DE V V+EFL T I + E+ +I + +L
Sbjct: 80 NVVDMYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEE---------QIATVCLSVLR 129
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ H ++HRD+K ++L+ DG +KL+DFG
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFG 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 20/47 (42%), Positives = 27/47 (57%), Gaps = 1/47 (2%)
Query: 123 IKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADFGQA 168
I+ M QIL +D H IVHRD+KP N++ + G K+ D G A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 32/118 (27%), Positives = 57/118 (48%), Gaps = 11/118 (9%)
Query: 60 REIEALQILQNSPNVVVLHEYFWREDEDA--VLVLEFLRTDLATVIAESKKKREDRGDRG 117
+EIE L+ L + +V ++ ED L++EFL + S K+ R
Sbjct: 55 KEIEILRNLYHEN--IVKYKGICTEDGGNGIKLIMEFLP-------SGSLKEYLPRNKNK 105
Query: 118 ISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
I++ + ++ VQI G+D VHRDL N+L+ + +K+ DFG + + ++
Sbjct: 106 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQI-------LQN--SPNVVVL 77
+G G++ V +R SD A+K + ++ ++ E I L+N P +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQK-KTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 78 HEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
H Y ++ E VL+++ +L + + E R + + ++ S +
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA---------RFYAAEVASAIGY 111
Query: 137 CHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
H I++RDLKP N+L+ G + L DFG
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFG 141
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 16/41 (39%), Positives = 28/41 (68%)
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ ++ +++ H+ +HRD+KP N+LI DG +KL DFG
Sbjct: 106 YIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 15/27 (55%), Positives = 19/27 (70%)
Query: 293 VGTRWFRAPELLYGSTSYGLEVDLWSL 319
V T W+RAPE+L GS Y VD+WS+
Sbjct: 160 VVTLWYRAPEILLGSRQYSTPVDIWSI 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 16/33 (48%), Positives = 22/33 (66%)
Query: 287 GALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+ T + T W+RAPE+L GST Y VD+WS+
Sbjct: 166 KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSV 198
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 2/62 (3%)
Query: 110 REDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
RE++ G ++ W VQI G+ +VHRDL N+L+ +K+ DFG AR
Sbjct: 100 RENKDRIGSQ--DLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
Query: 170 IL 171
+L
Sbjct: 158 LL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 38/169 (22%), Positives = 79/169 (46%), Gaps = 27/169 (15%)
Query: 27 VGSGAYSDVYKG-----RRLSDNLIVALKEVHD--YQSAFREI-EALQILQ--NSPNVVV 76
+G G + V K + + VA+K + + S R++ +L+ N P+V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 77 LHEYFWREDEDAVLVLEFLR-TDLATVIAESKK---------------KREDRGDRGISV 120
L+ +D +L++E+ + L + + ES+K ++ +R +++
Sbjct: 68 LYGA-CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
G++ + QI G+ +VHRDL N+L+ + +K++DFG +R
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 37/160 (23%), Positives = 65/160 (40%), Gaps = 22/160 (13%)
Query: 27 VGSGAYSDVYKGRRLSDN---LIVALK-----EVHDYQSAF-REIEALQILQNSPNVVVL 77
+G G++ V +G + + VA+K ++ D F +E + L + N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH-ENLIRL 61
Query: 78 HEYFWREDEDAVLVLEF--LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
Y ++V E L + L + + + + VQI +G+
Sbjct: 62 --YGVVLTHPLMMVTELAPLGSLLDRL--------RKDALGHFLISTLCDYAVQIANGMR 111
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+HRDL N+L+ D +K+ DFG R L NE
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 6/108 (5%)
Query: 61 EIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
EI AL L N N++ + E E ++ ++ DL + + + +DR +
Sbjct: 213 EILALGRL-NHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRP----LL 266
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
+ + M Q+L V+ H ++HRD+K N+ + DG + L DFG A
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
|
Length = 501 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 15/28 (53%), Positives = 19/28 (67%)
Query: 293 VGTRWFRAPELLYGSTSYGLEVDLWSLA 320
V T W+RAPE+L GS Y VD+WS+
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 40/168 (23%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 27 VGSGAYSDVYKGRRL------SDNLIVALKEVHDYQSAFREIEALQILQ-----NSPNVV 75
+GSGA+ +VY+G S + VA+K + + + E L+ N PN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 76 -VLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+L +E +++E + DL + + +++ +R G +++ E+ + + G
Sbjct: 63 KLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKG 118
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDG-----VLKLADFGQARILLGNEF 176
+ +HRDL N L+ + G V+K+ DFG AR + +++
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 42/149 (28%), Positives = 65/149 (43%), Gaps = 14/149 (9%)
Query: 27 VGSGAYSDVY----KGRRLSDN----LIVALKEVHD--YQSAF-REIEALQILQNSPNVV 75
+G G + +V+ KG L+ AL++ D QS F RE++ + L + NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVV 71
Query: 76 VLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
L RE E ++LE+ DL + +K K E +S + QI G+
Sbjct: 72 RLLG-LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLA 163
D VHRDL N L+ +K++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVS 159
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 46/190 (24%), Positives = 83/190 (43%), Gaps = 45/190 (23%)
Query: 14 RPEIIAKYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHD-----YQSAFREIE 63
R I+ K E+ G GA+ V+ + D ++VA+K + D + RE E
Sbjct: 4 RHNIVLKREL----GEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE 59
Query: 64 ALQILQNSPNVVVLHEYFWR------EDEDAVLVLEFLR-TDL----------ATVIAES 106
L LQ HE+ + E + ++V E+++ DL A ++AE
Sbjct: 60 LLTNLQ--------HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 107 KKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ E + + + + QI +G+ VHRDL N L+G++ ++K+ DFG
Sbjct: 112 NRPAELTQSQMLHIAQ------QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFG 165
Query: 167 QARILLGNEF 176
+R + ++
Sbjct: 166 MSRDVYSTDY 175
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 14/32 (43%), Positives = 20/32 (62%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSLA 320
+T V TRW+RAPE++ Y VD+WS+
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 203
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 23/170 (13%)
Query: 18 IAKYEILEC--VGSGAYSDVYKGRRLSDNLI-------VALKEVHDYQSAFREIEALQ-- 66
+A+ +I +G G++ VY+G ++ ++ VA+K V++ S IE L
Sbjct: 3 VAREKITMSRELGQGSFGMVYEG--IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 67 -ILQ--NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
+++ N +VV L + V++ R DL + + + + E + + +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME--NNPVQAPPSL 118
Query: 124 KRWMVQ----ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
K+ M+Q I G+ + N VHRDL N ++ +D +K+ DFG R
Sbjct: 119 KK-MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 18/55 (32%), Positives = 31/55 (56%)
Query: 115 DRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ +S ++ Q+ G++ +HRDL N+L+ +D V+K+ADFG AR
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 20/69 (28%), Positives = 36/69 (52%)
Query: 104 AESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163
+E K D G G++ ++ + Q+ G++ VHRDL N+L+ ++K+
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 164 DFGQARILL 172
DFG AR ++
Sbjct: 280 DFGLARDIM 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 17/161 (10%)
Query: 25 ECVGSGAYSDVYKGRRLSDNL-----IVALKEV---HDYQSAFREIEALQILQNSPNVVV 76
+ +G G + V K R D L I +KE D++ E+E L L + PN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 77 L------HEYFWREDEDAVL--VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
L Y + E A +L+FLR + + + +S ++ +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ G+D + +HRDL N+L+G++ V K+ADFG +R
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 25/79 (31%), Positives = 38/79 (48%), Gaps = 8/79 (10%)
Query: 90 LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKP 149
LVL R+DL T + R + + ++ Q+LS +D H I+HRD+K
Sbjct: 237 LVLPKYRSDLYTYLG--------ARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKT 288
Query: 150 GNLLIGDDGVLKLADFGQA 168
N+L+ + L DFG A
Sbjct: 289 ENVLVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 19/152 (12%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEV-----HDYQS---AFREIEALQILQNSPNVVVLH 78
+G G+Y+ V R ++ I A+K V HD + E + ++P +V LH
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 79 EYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
F LV+E++ DL + +K E+ + + +I ++
Sbjct: 63 SCFQTTSR-LFLVIEYVNGGDLMFHMQRQRKLPEEHA---------RFYAAEICIALNFL 112
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
H I++RDLK N+L+ DG +KL D+G +
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 19/50 (38%), Positives = 29/50 (58%)
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
W VQI G++ +VHRDL N+L+ +K+ DFG A++L +E
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 15/29 (51%), Positives = 23/29 (79%)
Query: 291 SCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
S + +R++RAPEL+ G+T+Y +DLWSL
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSL 257
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
N P+++ L F ++ L+L +TDL +A R I++ +I
Sbjct: 141 NHPSIIQLKGTF-TYNKFTCLILPRYKTDLYCYLAAK---------RNIAICDILAIERS 190
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
+L + H N I+HRD+K N+ I G + L DFG A
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 20/52 (38%), Positives = 31/52 (59%)
Query: 115 DRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+R S + + +I+S +D H IV+RDLK NL++ DG +K+ DFG
Sbjct: 89 ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFG 140
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 16/47 (34%), Positives = 32/47 (68%)
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
E++ + +I+ G++ H +V+RDLKP N+L+ + G ++++D G A
Sbjct: 98 EMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 16/43 (37%), Positives = 28/43 (65%)
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
+ ++ G++ R IV+RDLKP N+L+ D G ++++D G A
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 18/44 (40%), Positives = 28/44 (63%)
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ +I+ G+ H IV+RDLK N+L+ DG +K+ADFG +
Sbjct: 101 YAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 17/50 (34%), Positives = 33/50 (66%)
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
S E++ + +I+ G++ H +V+RDLKP N+L+ + G ++++D G A
Sbjct: 95 SEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 17/41 (41%), Positives = 26/41 (63%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
Q+ G++ +HRDL N+L+ +D V+K+ADFG AR
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 14/29 (48%), Positives = 18/29 (62%)
Query: 290 TSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
T+ V T W+R PELL G YG +D+W
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWG 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 9e-04
Identities = 16/32 (50%), Positives = 20/32 (62%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
T V T W+RAPE+L GS Y VD+WS+
Sbjct: 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV 190
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 15/27 (55%), Positives = 18/27 (66%)
Query: 293 VGTRWFRAPELLYGSTSYGLEVDLWSL 319
V T W+RAPE+L G Y VD+WSL
Sbjct: 161 VVTLWYRAPEILLGCKYYSTAVDIWSL 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 13/29 (44%), Positives = 19/29 (65%)
Query: 290 TSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
T + TRW+RAPE L YG ++D+W+
Sbjct: 156 TEYISTRWYRAPECLLTDGYYGPKMDIWA 184
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 21/35 (60%), Positives = 24/35 (68%), Gaps = 1/35 (2%)
Query: 286 QGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLA 320
Q ALTS V T W+RAPE+L S SY VDLWS+
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVG 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 15/31 (48%), Positives = 22/31 (70%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+T V T+++RAPE+L GS Y VD+WS+
Sbjct: 161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSV 191
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 16/38 (42%), Positives = 24/38 (63%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
QI+ +D H ++HRDLK N+ + G++KL DFG
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFG 214
|
Length = 478 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 16/41 (39%), Positives = 27/41 (65%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+I+ G+ H I++RDLK N+++ DG +K+ADFG +
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 34/147 (23%), Positives = 63/147 (42%), Gaps = 18/147 (12%)
Query: 28 GSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSPNVVVLHE 79
G G V+ R + ALK + + + E E L L + P + L+
Sbjct: 10 GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYA 68
Query: 80 YFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH 138
F + + LV+++ +L ++ K +S + + ++L ++ H
Sbjct: 69 SF-QTETYLCLVMDYCPGGELFRLLQRQPGKC-------LSEEVARFYAAEVLLALEYLH 120
Query: 139 RNTIVHRDLKPGNLLIGDDGVLKLADF 165
IV+RDLKP N+L+ + G + L+DF
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDF 147
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 19/48 (39%), Positives = 28/48 (58%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
QI SG+ VHRDL N L+G++ +K+ADFG +R L ++
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY 193
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 17/41 (41%), Positives = 26/41 (63%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
Q+ G++ +HRDL N+L+ +D V+K+ADFG AR
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172
R V ++ G+ I+HRD+KP N+L+ G +KL DFG + L+
Sbjct: 99 RIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 21/59 (35%), Positives = 32/59 (54%)
Query: 118 ISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
+S+ + VQI SG+ VHRDL N L+G+ +K+ADFG +R L ++
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 15/38 (39%), Positives = 26/38 (68%)
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+I+S ++ H +V+RD+K NL++ DG +K+ DFG
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 140
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 16/41 (39%), Positives = 27/41 (65%)
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ +I ++ H+ I++RDLKP N+L+ G +KL DFG
Sbjct: 105 YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFG 145
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 34/164 (20%), Positives = 71/164 (43%), Gaps = 17/164 (10%)
Query: 25 ECVGSGAYSDVYKGRRLSDN------LIVALKEVHDYQSAFREIEALQILQ--NSPNVVV 76
+G G + VY G + + + +L + D + + ++ I++ + PNV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 77 LHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
L + ++VL +++ DL I +V ++ + +Q+ G++
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSET--------HNPTVKDLIGFGLQVAKGME 112
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAP 179
VHRDL N ++ + +K+ADFG AR + E+ +
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 19/152 (12%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEV--------HDYQSAFREIEALQILQNSPNVVVLH 78
+G G+Y+ V R I A+K V D E + N P +V LH
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 79 EYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
F E V+E++ DL + +K E+ + + +I ++
Sbjct: 63 SCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHA---------RFYSAEISLALNYL 112
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
H I++RDLK N+L+ +G +KL D+G +
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 24 LECVGSGAYSDVYKGRRLSD----NLIVALKEVHDY--QSAFREIEALQILQNSPNVVVL 77
L+ +GSG + V+KG + + + VA+K + D + F+EI + S +
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD---- 67
Query: 78 HEYFWR-----EDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
H Y R LV + L +++ ++ R+ + + W VQI
Sbjct: 68 HAYIVRLLGICPGASLQLVTQLS--PLGSLLDHVRQHRDS-----LDPQRLLNWCVQIAK 120
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+ + +VHR+L N+L+ D ++++ADFG A +L
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 18/52 (34%), Positives = 29/52 (55%)
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
SVG +I + ++ H ++HRDLKP N+L+G G + + D+G A
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160
|
Length = 932 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 16/52 (30%), Positives = 31/52 (59%)
Query: 118 ISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+++ ++ + QI G+ H +HRDL N+L+ +D ++K+ DFG A+
Sbjct: 104 LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 35/149 (23%), Positives = 68/149 (45%), Gaps = 14/149 (9%)
Query: 22 EILECVGSGAYSDV----YKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVL 77
++L+ +G G + DV Y+G +++ + +K Q+ E + L++S N+V L
Sbjct: 9 KLLQTIGKGEFGDVMLGDYRGNKVA---VKCIKNDATAQAFLAEASVMTQLRHS-NLVQL 64
Query: 78 HEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
E +V E++ S+ + GD + ++ + + ++
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL------KFSLDVCEAMEYL 118
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
N VHRDL N+L+ +D V K++DFG
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFG 147
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 19/33 (57%), Positives = 22/33 (66%), Gaps = 1/33 (3%)
Query: 286 QGALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
Q ALT V T W+RAPE+L ST Y VD+WS
Sbjct: 161 QMALTPVVVTLWYRAPEVLLQST-YATPVDMWS 192
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 14/30 (46%), Positives = 21/30 (70%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
+T V TR++RAPE++ Y +EVD+WS
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWS 191
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 18/42 (42%), Positives = 24/42 (57%), Gaps = 2/42 (4%)
Query: 280 DGGDGRQG--ALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
D G RQ +T V TRW+RAPE++ Y VD+WS+
Sbjct: 161 DFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 24/160 (15%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVH----------DYQSAFREIEALQILQNSPNVVV 76
+G G++ V + R+ I ALK + + A R + A Q+ N P +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLA-QV--NCPFIVP 57
Query: 77 LHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
L ++ ++ E LVL F+ +L + + R + + ++L ++
Sbjct: 58 L-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA---------RFYTAELLCALE 107
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
H+ +++RDLKP N+L+ G + L DFG ++ + ++
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 19/155 (12%)
Query: 24 LECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSPNVV 75
L +G G++ V R + + A+K + D + E L + P +
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 76 VLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
LH F D V+E++ DL I + K +E + + +I G+
Sbjct: 65 QLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQA---------VFYAAEISVGL 114
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
HR I++RDLK N+++ +G +K+ADFG +
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.003
Identities = 24/86 (27%), Positives = 37/86 (43%), Gaps = 19/86 (22%)
Query: 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVH 144
E+ +V+E++ DL V+ + + VGEI V H+ IVH
Sbjct: 409 EEKTIVMEYIGGKDLKDVLEGNPELVRK-------VGEI----------VAKLHKAGIVH 451
Query: 145 RDLKPGNLLIGDDGVLKLADFGQARI 170
DL N ++ DD + L DFG +
Sbjct: 452 GDLTTSNFIVRDDRLY-LIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 14/32 (43%), Positives = 20/32 (62%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSLA 320
+T V TRW+RAPE++ Y VD+WS+
Sbjct: 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 205
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 19/71 (26%), Positives = 37/71 (52%)
Query: 99 LATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158
++ ++SK + + + + ++ R+ Q+ G+D +HRD+ N+L+ D
Sbjct: 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR 249
Query: 159 VLKLADFGQAR 169
V K+ DFG AR
Sbjct: 250 VAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.004
Identities = 25/98 (25%), Positives = 57/98 (58%), Gaps = 13/98 (13%)
Query: 59 FREIEAL--QILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGD 115
F IE + Q+++++PN + L+ Y + VL++++++ DL ++ K+E +
Sbjct: 54 FNAIEPMVHQLMKDNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLL-----KKEGK-- 105
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLL 153
+S E+K+ + Q++ ++ H++ I+H D+K N+L
Sbjct: 106 --LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL 141
|
Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 326 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.78 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.83 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.5 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.17 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.67 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.57 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.53 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.45 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.44 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.34 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.27 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.23 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.23 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.23 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.11 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.93 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.91 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.83 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.83 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.7 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.59 | |
| PLN02236 | 344 | choline kinase | 96.52 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.4 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.2 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.15 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.78 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.56 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.04 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.37 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.7 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.39 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.71 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.63 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 91.42 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 91.08 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 90.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 90.33 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 90.16 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 90.15 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 89.06 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=308.07 Aligned_cols=194 Identities=41% Similarity=0.691 Sum_probs=172.1
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-C
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE-D 85 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~ 85 (326)
.+...+.|+.+++||+|.||.||+|++..+++.||+|++.. .....+||.+|+++ +||||+++.+..... .
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLS 190 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCC
Confidence 34567889999999999999999999999999999998852 23457999999999 799999999998665 5
Q ss_pred CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 86 EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 86 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+|||+|||+.+|.-++....-. |++.++..|+.||+.||.|||.+||+|||||.+|||||.+|.+||+||
T Consensus 191 ~siYlVFeYMdhDL~GLl~~p~vk--------ft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDF 262 (560)
T KOG0600|consen 191 GSIYLVFEYMDHDLSGLLSSPGVK--------FTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADF 262 (560)
T ss_pred ceEEEEEecccchhhhhhcCCCcc--------cChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccc
Confidence 689999999999998887764322 999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCC
Q 020467 166 GQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDK 245 (326)
Q Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
|+++++..+.
T Consensus 263 GLAr~y~~~~---------------------------------------------------------------------- 272 (560)
T KOG0600|consen 263 GLARFYTPSG---------------------------------------------------------------------- 272 (560)
T ss_pred cceeeccCCC----------------------------------------------------------------------
Confidence 9999774433
Q ss_pred CCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhcc
Q 020467 246 DTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQN 325 (326)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 325 (326)
....++.|-|.||+|||.++|...|+.++|+||+||||.|
T Consensus 273 ----------------------------------------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~E 312 (560)
T KOG0600|consen 273 ----------------------------------------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAE 312 (560)
T ss_pred ----------------------------------------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHH
Confidence 1236788999999999999999999999999999999998
Q ss_pred C
Q 020467 326 F 326 (326)
Q Consensus 326 l 326 (326)
|
T Consensus 313 l 313 (560)
T KOG0600|consen 313 L 313 (560)
T ss_pred H
Confidence 6
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=307.85 Aligned_cols=234 Identities=26% Similarity=0.387 Sum_probs=173.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
-.++|+++++||+|+||.||+|+.+.+|..+|+|++++. .....|..+|... .++.|+++|-.| ++..++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsF-QD~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSF-QDKEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEe-cCCCee
Confidence 468999999999999999999999999999999999742 3356777788775 799999999999 778889
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
||+|||++ |++..++..... +++..++.++.+++.|+..||+.|+|||||||+|+|||..|++||+|||+
T Consensus 217 YLiMEylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred EEEEEecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccc
Confidence 99999998 699998877543 99999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCC
Q 020467 168 ARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDT 247 (326)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
+..+.........+. ..+.. ....
T Consensus 288 s~gl~~~~~~~~~~~----------------------------------------------~~~~~----------~~~~ 311 (550)
T KOG0605|consen 288 STGLDKKHRIESYRL----------------------------------------------DEQMQ----------INLS 311 (550)
T ss_pred cchhhhhhhhhhhcc----------------------------------------------hhhhh----------hhhc
Confidence 966533221000000 00000 0000
Q ss_pred ccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 248 HVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
.+......+.+++.....+.++...+. +.++...-+.||||.|+|||++.+.. |+..||+||||||||||
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~w~--------~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 312 EAKPSDFPKFNTPRSTMSRREQLQTWK--------RNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEM 381 (550)
T ss_pred cCCCccccccccccchhhHHHHHHHHH--------hhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHH
Confidence 001111111111222211222211111 12344456689999999999999977 99999999999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=297.41 Aligned_cols=149 Identities=35% Similarity=0.582 Sum_probs=133.3
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
+..++|.+.++||.|+|++||+|+++.++..||||.+.. .+.+..|+.+|+.+ +|+||+.+++++ ..++.+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~-~~~~~i 84 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCI-EDDDFI 84 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEE-ecCCeE
Confidence 467899999999999999999999999999999998853 23457899999999 599999999998 667789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC------CcEE
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD------GVLK 161 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~------~~~~ 161 (326)
|+||||+. |+|..++...+. +++..+..++.||+.||++||+++||||||||+||||+.. -.+|
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 99999998 799999987654 9999999999999999999999999999999999999865 4689
Q ss_pred EEeecccccccCCc
Q 020467 162 LADFGQARILLGNE 175 (326)
Q Consensus 162 l~Dfg~~~~~~~~~ 175 (326)
|+|||+++.+.+..
T Consensus 156 IADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 156 IADFGFARFLQPGS 169 (429)
T ss_pred ecccchhhhCCchh
Confidence 99999999885443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=295.88 Aligned_cols=192 Identities=35% Similarity=0.614 Sum_probs=168.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeE-EEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHE-YFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~-~~~~~~~~~ 88 (326)
...+|+++++||.|.||+||++.+..+++.+|.|.++ ..+....|+.+|+.+ +||||+++++ .|.++...+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhh
Confidence 4677999999999999999999999999999999885 345678899999999 6999999999 454555569
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCCeEEcCCCcEEEE
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR--NT--IVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~--~~--iiH~dlkp~Nili~~~~~~~l~ 163 (326)
+++||+++ |+|...+..-+... ..+++..+|.++.|++.||.++|. .+ |+||||||.||+|+.+|.+||.
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qk-----r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQK-----RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhcc-----ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 99999998 89998887665543 339999999999999999999998 44 9999999999999999999999
Q ss_pred eecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCC
Q 020467 164 DFGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDET 243 (326)
Q Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
|||+++.+.++.
T Consensus 171 DfGL~r~l~s~~-------------------------------------------------------------------- 182 (375)
T KOG0591|consen 171 DFGLGRFLSSKT-------------------------------------------------------------------- 182 (375)
T ss_pred cchhHhHhcchh--------------------------------------------------------------------
Confidence 999999885443
Q ss_pred CCCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhh
Q 020467 244 DKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323 (326)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il 323 (326)
..+.+.||||+||+||.+.+.+ |+++||||||||++
T Consensus 183 -------------------------------------------tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCll 218 (375)
T KOG0591|consen 183 -------------------------------------------TFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLL 218 (375)
T ss_pred -------------------------------------------HHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHH
Confidence 2356789999999999998877 99999999999999
Q ss_pred ccC
Q 020467 324 QNF 326 (326)
Q Consensus 324 ~el 326 (326)
|||
T Consensus 219 yEM 221 (375)
T KOG0591|consen 219 YEM 221 (375)
T ss_pred HHH
Confidence 997
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=292.63 Aligned_cols=188 Identities=29% Similarity=0.488 Sum_probs=166.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.-.++|++++.||+|+||+|+.++.+.+++.+|+|++++ .....+|..++..+ +||+|+.++-.| ++...
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysF-Qt~~k 99 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSF-QTEEK 99 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEec-ccCCe
Confidence 347899999999999999999999999999999998863 34567899999998 699999999998 77788
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
+|+|++|+. |.|..++.+... +++..+..++..|+.||.|||+.|||||||||+|||+|.+|+++|+|||
T Consensus 100 LylVld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccc
Confidence 999999997 599999887554 9999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCC
Q 020467 167 QARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKD 246 (326)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
+++......
T Consensus 171 L~k~~~~~~----------------------------------------------------------------------- 179 (357)
T KOG0598|consen 171 LCKEDLKDG----------------------------------------------------------------------- 179 (357)
T ss_pred cchhcccCC-----------------------------------------------------------------------
Confidence 998643222
Q ss_pred CccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 247 THVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
.+.....||+-|||||++.+.+ |+.+||+||||++||||
T Consensus 180 ----------------------------------------~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeM 218 (357)
T KOG0598|consen 180 ----------------------------------------DATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEM 218 (357)
T ss_pred ----------------------------------------CccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHH
Confidence 1233457999999999999876 99999999999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=291.22 Aligned_cols=187 Identities=39% Similarity=0.673 Sum_probs=167.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|+.+.++|+|+||.||+|+++.+|+.||||++.+ .+-.++|+++|+++ .|+|++.++.+| ......++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVF-rrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVF-RRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHH-HhcceeEEE
Confidence 578899999999999999999999999999999853 33468999999999 599999999999 556679999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+||++.++.+.+.... ++++...+..++.|++.|+.|+|++++|||||||+||+|+.+|.+|||||||++.+
T Consensus 80 FE~~dhTvL~eLe~~p--------~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYP--------NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTL 151 (396)
T ss_pred eeecchHHHHHHHhcc--------CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence 9999999988887754 34999999999999999999999999999999999999999999999999999987
Q ss_pred cCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCCccCC
Q 020467 172 LGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTHVHD 251 (326)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (326)
...
T Consensus 152 ~~p----------------------------------------------------------------------------- 154 (396)
T KOG0593|consen 152 SAP----------------------------------------------------------------------------- 154 (396)
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 421
Q ss_pred CCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 252 GDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
...-+.+|.|.||+|||.+.|...|+.++||||+||++.||
T Consensus 155 ----------------------------------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl 195 (396)
T KOG0593|consen 155 ----------------------------------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAEL 195 (396)
T ss_pred ----------------------------------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHH
Confidence 12346789999999999999988899999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=306.05 Aligned_cols=191 Identities=32% Similarity=0.605 Sum_probs=172.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.+.+||+++++||.|.||.||+|..+.++..||||.++. ...-.+|+..|+++..|+||+++.+++.+..+.++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 467899999999999999999999999999999998863 33457899999999559999999999966666899
Q ss_pred EEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 90 LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 90 lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||||+.+|+++++.... .|++..++.|+.||+.||+|+|.+|+.|||+||+|||+.....+||+|||+++
T Consensus 87 fVfE~Md~NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeHHhhhhhHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccc
Confidence 9999999999999987633 39999999999999999999999999999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCCcc
Q 020467 170 ILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTHV 249 (326)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (326)
...+.
T Consensus 159 ev~Sk--------------------------------------------------------------------------- 163 (538)
T KOG0661|consen 159 EVRSK--------------------------------------------------------------------------- 163 (538)
T ss_pred ccccC---------------------------------------------------------------------------
Confidence 76332
Q ss_pred CCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 250 HDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
.+.+++|.|.||+|||+++....|+.++|+||+|||++|+
T Consensus 164 -------------------------------------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl 203 (538)
T KOG0661|consen 164 -------------------------------------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAEL 203 (538)
T ss_pred -------------------------------------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHH
Confidence 2357889999999999999999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=289.14 Aligned_cols=148 Identities=30% Similarity=0.462 Sum_probs=132.1
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------------hhhHHHHHHHHHHHhcCCCeeEEeEEE
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------------YQSAFREIEALQILQNSPNVVVLHEYF 81 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------------~~~~~~E~~~l~~l~~h~ni~~l~~~~ 81 (326)
+..+.+.|.+.+.||+|+||.|-+|..+.+++.||||++++ .....+|+++|+++ +||||++++++|
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f 245 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFF 245 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeee
Confidence 34577889999999999999999999999999999999863 12246999999999 799999999999
Q ss_pred EecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---
Q 020467 82 WREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD--- 157 (326)
Q Consensus 82 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~--- 157 (326)
+.....||||||++ |+|.+.+..++. +.+.....+++||+.|+.|||++||+||||||+|||+..+
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc
Confidence 66777899999998 799999987665 7777889999999999999999999999999999999876
Q ss_pred CcEEEEeeccccccc
Q 020467 158 GVLKLADFGQARILL 172 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~~ 172 (326)
-.+||.|||++++..
T Consensus 316 ~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEecccchhhccc
Confidence 689999999998864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=277.55 Aligned_cols=187 Identities=43% Similarity=0.727 Sum_probs=167.1
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|...++||+|.||.||+|++..+++.||||+++. .....+|++.|+.+ +|+||+.++++| .....+.+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F-~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVF-PHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhc-cCCCceEEE
Confidence 578999999999999999999999999999999863 44578999999999 599999999999 666679999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+||++.+|...+..... .++...+..|+.+++.||+|||++.|+||||||+|+||+++|.+||+|||+++.+
T Consensus 80 fEfm~tdLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFF 151 (318)
T ss_pred EEeccccHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence 99999999988876543 2899999999999999999999999999999999999999999999999999887
Q ss_pred cCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCCccCC
Q 020467 172 LGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTHVHD 251 (326)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (326)
.+..
T Consensus 152 ~~p~---------------------------------------------------------------------------- 155 (318)
T KOG0659|consen 152 GSPN---------------------------------------------------------------------------- 155 (318)
T ss_pred CCCC----------------------------------------------------------------------------
Confidence 4332
Q ss_pred CCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 252 GDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
...+..|-|.+|+|||.+.|++.|+..+|+||+|||+.||
T Consensus 156 -----------------------------------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AEL 195 (318)
T KOG0659|consen 156 -----------------------------------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAEL 195 (318)
T ss_pred -----------------------------------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHH
Confidence 1123337899999999999999999999999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.78 Aligned_cols=184 Identities=30% Similarity=0.526 Sum_probs=164.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++++.++.||+|+.|+||++.++.+++.+|+|++. ....+.+|++++... +||+|+.+|+.|..+...+.++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEeeh
Confidence 47888999999999999999999999999999994 255678999999999 79999999999955544699999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+ |+|...+...+. +++..+..++.+++.||.|||+ ++||||||||+|+|++..|.+||||||.+..
T Consensus 158 EYMDgGSLd~~~k~~g~---------i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGR---------IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred hhcCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 9998 688888776533 9999999999999999999995 8999999999999999999999999999988
Q ss_pred ccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCCccC
Q 020467 171 LLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTHVH 250 (326)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (326)
+.++.
T Consensus 229 lvnS~--------------------------------------------------------------------------- 233 (364)
T KOG0581|consen 229 LVNSI--------------------------------------------------------------------------- 233 (364)
T ss_pred hhhhh---------------------------------------------------------------------------
Confidence 74432
Q ss_pred CCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 251 DGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
+...+||..|||||-+.+.. |+.++||||||+.++||
T Consensus 234 --------------------------------------a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~ 270 (364)
T KOG0581|consen 234 --------------------------------------ANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLEL 270 (364)
T ss_pred --------------------------------------cccccccccccChhhhcCCc-CCcccceecccHHHHHH
Confidence 45669999999999999877 99999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=294.84 Aligned_cols=145 Identities=30% Similarity=0.520 Sum_probs=132.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.+|...+.||+|+|..||.+++..+|+.||+|++.+ .+...+|+++.+.+ .||||++++++| ++.+++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~F-EDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFF-EDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEe-ecCCceEE
Confidence 679999999999999999999999999999999853 56688999999999 699999999999 88889999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+.|++. ++|..+++..+. +++.+++.+++||+.||.|||+.+|+|||||..|++++++.++||+|||++.
T Consensus 96 vLELC~~~sL~el~Krrk~---------ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKP---------LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred EEEecCCccHHHHHHhcCC---------CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceee
Confidence 999998 688877774433 9999999999999999999999999999999999999999999999999999
Q ss_pred cccCC
Q 020467 170 ILLGN 174 (326)
Q Consensus 170 ~~~~~ 174 (326)
.+..+
T Consensus 167 ~le~~ 171 (592)
T KOG0575|consen 167 QLEYD 171 (592)
T ss_pred eecCc
Confidence 88544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=292.24 Aligned_cols=150 Identities=31% Similarity=0.483 Sum_probs=136.2
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..-.++|.+++.||.|.|++|++|+++.++++||||++.+ ......|-..|.++.+||.|++++-.| .+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-QD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-QDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-eccc
Confidence 3457899999999999999999999999999999998853 445678888999998999999999999 6777
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
.+|+|++|.+ |+|++++.+-+. |.+..++.++.+|+.||+|||++|||||||||+|||+|.+++++|.||
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeec
Confidence 8999999998 899999988655 899999999999999999999999999999999999999999999999
Q ss_pred cccccccCC
Q 020467 166 GQARILLGN 174 (326)
Q Consensus 166 g~~~~~~~~ 174 (326)
|.++.+...
T Consensus 219 GsAK~l~~~ 227 (604)
T KOG0592|consen 219 GSAKILSPS 227 (604)
T ss_pred cccccCChh
Confidence 999987543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=278.78 Aligned_cols=190 Identities=35% Similarity=0.594 Sum_probs=168.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWRE-DEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~ 88 (326)
-+++|+.+.+|++|.||.||+|+++.+++.||+|+++-. -...+|+.+|.++ +|+||+.+-.+.... -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEecccccee
Confidence 468899999999999999999999999999999998632 2358999999999 599999999987432 3569
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
|+||||++.+|..++..-. +.+...++..++.|++.||+|||.+.|+|||||++|+|++..|.+|++|||++
T Consensus 153 y~VMe~~EhDLksl~d~m~--------q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMK--------QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeeHHHHHhhHHHHHHhcc--------CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchh
Confidence 9999999999998887654 23899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCCc
Q 020467 169 RILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTH 248 (326)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (326)
+......
T Consensus 225 R~ygsp~------------------------------------------------------------------------- 231 (419)
T KOG0663|consen 225 REYGSPL------------------------------------------------------------------------- 231 (419)
T ss_pred hhhcCCc-------------------------------------------------------------------------
Confidence 8763332
Q ss_pred cCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 249 VHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
.+.+..|-|.+|+|||.++|++-|++++|+||+|||+.||
T Consensus 232 --------------------------------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~ 271 (419)
T KOG0663|consen 232 --------------------------------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAEL 271 (419)
T ss_pred --------------------------------------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHH
Confidence 4467889999999999999999999999999999999886
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=267.59 Aligned_cols=145 Identities=25% Similarity=0.438 Sum_probs=131.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
--.++|++++.||.|.||.|.+++.+.++..+|+|+++. .+...+|..+|+.+ .||+++++++.| .+...
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~-~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTF-KDNSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEee-ccCCe
Confidence 456889999999999999999999999999999998864 33457889999999 599999999998 66778
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
++|+|||.+ |.|..++.+... +++..++.++.||+.||+|||+.+|++|||||+|||||.+|+++|.|||
T Consensus 119 lymvmeyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEecc
Confidence 999999998 688888877544 9999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
+++..
T Consensus 190 FAK~v 194 (355)
T KOG0616|consen 190 FAKRV 194 (355)
T ss_pred ceEEe
Confidence 99876
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=273.82 Aligned_cols=192 Identities=43% Similarity=0.647 Sum_probs=165.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCC-eeEEeEEEEecCC---
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPN-VVVLHEYFWREDE--- 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~n-i~~l~~~~~~~~~--- 86 (326)
...|+.+++||+|+||+||+|+.+.+|+.||+|.++.. ....+|+.+++.+ +|+| |+.+++++..+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence 45678888999999999999999999999999998632 3358999999999 5888 9999999965553
Q ss_pred --ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 87 --DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 87 --~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..++++||++.+|..++....... ..++...+..++.||+.||.|||+++|+||||||+||+|+++|.+||+|
T Consensus 89 ~~~l~lvfe~~d~DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred cceEEEEEEeecccHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence 789999999999999987755321 2377789999999999999999999999999999999999999999999
Q ss_pred ecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCC
Q 020467 165 FGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETD 244 (326)
Q Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
||+++...-+.
T Consensus 164 FGlAra~~ip~--------------------------------------------------------------------- 174 (323)
T KOG0594|consen 164 FGLARAFSIPM--------------------------------------------------------------------- 174 (323)
T ss_pred cchHHHhcCCc---------------------------------------------------------------------
Confidence 99998542111
Q ss_pred CCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhc
Q 020467 245 KDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQ 324 (326)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 324 (326)
...+..++|.+|+|||++.|+..|+..+||||+|||++
T Consensus 175 ------------------------------------------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfa 212 (323)
T KOG0594|consen 175 ------------------------------------------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFA 212 (323)
T ss_pred ------------------------------------------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHH
Confidence 12456689999999999999988999999999999999
Q ss_pred cC
Q 020467 325 NF 326 (326)
Q Consensus 325 el 326 (326)
||
T Consensus 213 Em 214 (323)
T KOG0594|consen 213 EM 214 (323)
T ss_pred HH
Confidence 86
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=286.49 Aligned_cols=155 Identities=31% Similarity=0.510 Sum_probs=135.6
Q ss_pred ccccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhh----HHHHHHHHHHHhcC-----CCeeEEeE
Q 020467 9 WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQS----AFREIEALQILQNS-----PNVVVLHE 79 (326)
Q Consensus 9 ~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~----~~~E~~~l~~l~~h-----~ni~~l~~ 79 (326)
|.+..+..+.-+|.+.+.||+|.||+|-+|++..+++.||||+++.... ...|+.+|..+..| -|++++++
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 4455566778899999999999999999999999999999999987554 45678888888633 38999999
Q ss_pred EEEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC--
Q 020467 80 YFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-- 157 (326)
Q Consensus 80 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-- 157 (326)
+| ...++.|||+|.+..+|+++++.+.. .+++...++.++.||+.||.+||..+|||.||||+|||+...
T Consensus 256 ~F-~fr~HlciVfELL~~NLYellK~n~f-------~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r 327 (586)
T KOG0667|consen 256 YF-YFRNHLCIVFELLSTNLYELLKNNKF-------RGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR 327 (586)
T ss_pred cc-ccccceeeeehhhhhhHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc
Confidence 99 66789999999999999999988764 349999999999999999999999999999999999999854
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
..+|++|||.+...
T Consensus 328 ~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFE 341 (586)
T ss_pred CceeEEeccccccc
Confidence 48999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=288.39 Aligned_cols=185 Identities=35% Similarity=0.579 Sum_probs=167.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+ ...+.+|+++++.+ .||||+.++++| +...++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esf-Et~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESF-ETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhh-cccceEEEE
Confidence 679999999999999999999999999999998853 23478899999999 599999999999 778899999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.||..|+|...+..... ++++.+..++.+++.||.|||+++|+|||+||.||+++..|.+|+||||+++..
T Consensus 80 te~a~g~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred ehhhhhhHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence 99999999999987654 999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCCccCC
Q 020467 172 LGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTHVHD 251 (326)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (326)
..+.
T Consensus 151 ~~~t---------------------------------------------------------------------------- 154 (808)
T KOG0597|consen 151 STNT---------------------------------------------------------------------------- 154 (808)
T ss_pred ccCc----------------------------------------------------------------------------
Confidence 4332
Q ss_pred CCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 252 GDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
...+...|||.|||||++.+.. |+..+|+||||||+|||
T Consensus 155 -----------------------------------~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~ 193 (808)
T KOG0597|consen 155 -----------------------------------SVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYEL 193 (808)
T ss_pred -----------------------------------eeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHH
Confidence 2245668999999999999766 99999999999999996
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.07 Aligned_cols=192 Identities=35% Similarity=0.621 Sum_probs=163.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC----ceEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEALQILQNSPNVVVLHEYFWREDE----DAVLV 91 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~----~~~lv 91 (326)
..=.|.-.+++|.|.||.||.|....+++.||||+.- +.....+|+++++++ .||||+++.-+|..... ...+|
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4456888999999999999999999999999999764 455567899999988 69999999988854433 24689
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEEeeccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-GVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-~~~~l~Dfg~~~~ 170 (326)
|||++.+|...+..-... ...++.-.+.-+..||+.||.|||+.||+||||||.|+|+|.+ |.+||||||.++.
T Consensus 101 leymP~tL~~~~r~~~~~-----~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRA-----NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhchHHHHHHHHHHhhc-----CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999999999988752111 1227888889999999999999999999999999999999965 8999999999999
Q ss_pred ccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCCccC
Q 020467 171 LLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTHVH 250 (326)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (326)
+..++
T Consensus 176 L~~~e--------------------------------------------------------------------------- 180 (364)
T KOG0658|consen 176 LVKGE--------------------------------------------------------------------------- 180 (364)
T ss_pred eccCC---------------------------------------------------------------------------
Confidence 85443
Q ss_pred CCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 251 DGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
+..++.-|.+|+|||.+.|+..|+.+.||||.|||+.||
T Consensus 181 -------------------------------------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aEL 219 (364)
T KOG0658|consen 181 -------------------------------------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAEL 219 (364)
T ss_pred -------------------------------------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHH
Confidence 235667899999999999999999999999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=271.86 Aligned_cols=193 Identities=36% Similarity=0.595 Sum_probs=170.0
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEe----
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWR---- 83 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~---- 83 (326)
-.+..+|...+.||.|+||.|..|.+..+++.||||++. .-++..+|++.++.++ |+||+.+.+++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRD 96 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccccc
Confidence 345677888899999999999999999999999999886 2456789999999995 9999999999854
Q ss_pred cCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 84 EDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 84 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
+-+.+|+|+|+|+.+|.+.++.+.. ++...+..+++|++.||.|+|+.+++||||||.|++++.+..+||+
T Consensus 97 ~f~DvYiV~elMetDL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~ 167 (359)
T KOG0660|consen 97 KFNDVYLVFELMETDLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKIC 167 (359)
T ss_pred ccceeEEehhHHhhHHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEec
Confidence 2356999999999999999887544 8899999999999999999999999999999999999999999999
Q ss_pred eecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCC
Q 020467 164 DFGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDET 243 (326)
Q Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
|||+++......
T Consensus 168 DFGLAR~~~~~~-------------------------------------------------------------------- 179 (359)
T KOG0660|consen 168 DFGLARYLDKFF-------------------------------------------------------------------- 179 (359)
T ss_pred cccceeeccccC--------------------------------------------------------------------
Confidence 999998763221
Q ss_pred CCCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhh
Q 020467 244 DKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323 (326)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il 323 (326)
....++++|.|.+|+|||++.....|+.++||||+||||
T Consensus 180 -----------------------------------------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~ 218 (359)
T KOG0660|consen 180 -----------------------------------------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCIL 218 (359)
T ss_pred -----------------------------------------cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHH
Confidence 123468899999999999998888899999999999999
Q ss_pred ccC
Q 020467 324 QNF 326 (326)
Q Consensus 324 ~el 326 (326)
.||
T Consensus 219 AEm 221 (359)
T KOG0660|consen 219 AEM 221 (359)
T ss_pred HHH
Confidence 986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=274.44 Aligned_cols=146 Identities=34% Similarity=0.545 Sum_probs=130.4
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
...++|.+.+.||+|.||.|+.|.+..++..||+|.+.. ...+.+|+.+++++..||||+++++++ ...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~-~t~ 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF-ATP 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-ecC
Confidence 457899999999999999999999999999999997643 223457999999996699999999999 555
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEE
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-GVLKLA 163 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-~~~~l~ 163 (326)
..++++|||+. |+|++.+...+. +.+..+..++.|++.|++|||+.||+||||||+||+++.+ +++||+
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~---------l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGR---------LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCC---------CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEe
Confidence 56999999998 599999987333 8999999999999999999999999999999999999999 999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 164 DFG~s~~~ 171 (370)
T KOG0583|consen 164 DFGLSAIS 171 (370)
T ss_pred cccccccc
Confidence 99999876
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=280.89 Aligned_cols=189 Identities=25% Similarity=0.413 Sum_probs=162.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
--.++|.++++||+|.||+|+++..+.+++.+|||.+++ .+....|.+++.....||.+++++..| ....+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-QT~~~ 443 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-QTKEH 443 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-ccCCe
Confidence 346899999999999999999999999999999998863 455678888888887899999999999 66778
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+|+||||..|+..-.+.. ...+++..+..|++.++.||+|||++|||+||||.+|||+|.+|++||+|||+
T Consensus 444 l~fvmey~~Ggdm~~~~~---------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH---------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred EEEEEEecCCCcEEEEEe---------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccc
Confidence 999999998543222221 12399999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCC
Q 020467 168 ARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDT 247 (326)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
++......
T Consensus 515 cKe~m~~g------------------------------------------------------------------------ 522 (694)
T KOG0694|consen 515 CKEGMGQG------------------------------------------------------------------------ 522 (694)
T ss_pred ccccCCCC------------------------------------------------------------------------
Confidence 98653222
Q ss_pred ccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 248 HVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
..+...-||+.|||||++.+.. |+.++|+|||||+||||
T Consensus 523 ---------------------------------------~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeM 561 (694)
T KOG0694|consen 523 ---------------------------------------DRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEM 561 (694)
T ss_pred ---------------------------------------CccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHH
Confidence 2233456999999999999877 99999999999999997
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=278.37 Aligned_cols=188 Identities=29% Similarity=0.531 Sum_probs=166.0
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-----chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.+....|+..++||+|+.|.||.|....+++.||||++. ..+.+++|+.+++.. +|+||+.+++.|... ..+|
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~-deLW 346 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG-DELW 346 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc-ceeE
Confidence 456788999999999999999999999999999999885 356689999999999 699999999998544 6799
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+|||||+ |+|.+.+.... +++.++..+++.++.||+|||.+||+|||||.+|||++.+|.+||.|||||
T Consensus 347 VVMEym~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred EEEeecCCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeee
Confidence 9999998 57777765533 899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCCc
Q 020467 169 RILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTH 248 (326)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (326)
..+....
T Consensus 417 aqi~~~~------------------------------------------------------------------------- 423 (550)
T KOG0578|consen 417 AQISEEQ------------------------------------------------------------------------- 423 (550)
T ss_pred ecccccc-------------------------------------------------------------------------
Confidence 8873322
Q ss_pred cCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 249 VHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
.+....|||++|||||++.... |++++||||||++.+||
T Consensus 424 --------------------------------------~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEM 462 (550)
T KOG0578|consen 424 --------------------------------------SKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEM 462 (550)
T ss_pred --------------------------------------CccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHH
Confidence 2345679999999999998766 99999999999999997
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.69 Aligned_cols=145 Identities=30% Similarity=0.477 Sum_probs=124.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.+.+.+.+.||.|+||+||++.+..+. .||+|.+... ..+.+|+.++.++ +||||+++++++........+
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceEE
Confidence 455667778999999999999885432 2999999753 3789999999999 699999999999544447999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCeEEcCCC-cEEEEeecc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT-IVHRDLKPGNLLIGDDG-VLKLADFGQ 167 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~-iiH~dlkp~Nili~~~~-~~~l~Dfg~ 167 (326)
||||++ |+|..++.... ...++...+..|+.||+.|+.|||+.+ ||||||||+|+|++.++ ++||+|||+
T Consensus 118 VtEy~~~GsL~~~l~~~~-------~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKR-------KRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred EEEeCCCCcHHHHHhhcc-------cCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 999998 78888886631 123999999999999999999999999 99999999999999998 999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
++..
T Consensus 191 sr~~ 194 (362)
T KOG0192|consen 191 SREK 194 (362)
T ss_pred ceee
Confidence 9765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.05 Aligned_cols=145 Identities=27% Similarity=0.418 Sum_probs=130.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.+.|++++.||.|.-|+||+|....++..+|+|++.+ ..+...|.++|.++ .||.++.+|..| +.....+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~f-et~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASF-ETDKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhhee-eccceeE
Confidence 4678999999999999999999999999999999863 34556788889888 799999999999 7777899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||++ |+|..+..++.. ..+++..++.++..++.||+|||-.|||+|||||+||||.++|++-|+||.++
T Consensus 154 l~meyCpGGdL~~LrqkQp~-------~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPG-------KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred EEEecCCCccHHHHHhhCCC-------CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccc
Confidence 9999998 688888877664 34999999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
..+
T Consensus 227 ~~~ 229 (459)
T KOG0610|consen 227 LRC 229 (459)
T ss_pred ccC
Confidence 776
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=270.56 Aligned_cols=189 Identities=34% Similarity=0.573 Sum_probs=168.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.++|..++++|+|+||.+++++++..++.+++|.+.- ......|+.+++++ .||||+.+++.|..++...+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEE
Confidence 5789999999999999999999999999999998852 33678899999998 599999999999666666999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|+|++ |++.+.+...+... ++++.+..|+.|++.|+.|||+.+|+|||||+.||+++.++.++|.|||+++
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~-------f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVL-------FPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred EEeecCCCCHHHHHHHHhhcc-------ccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhh
Confidence 999998 68888888776332 9999999999999999999999999999999999999999999999999999
Q ss_pred cccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCCCCcc
Q 020467 170 ILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDKDTHV 249 (326)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (326)
.+.+..
T Consensus 155 ~l~~~~-------------------------------------------------------------------------- 160 (426)
T KOG0589|consen 155 ILNPED-------------------------------------------------------------------------- 160 (426)
T ss_pred hcCCch--------------------------------------------------------------------------
Confidence 874443
Q ss_pred CCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 250 HDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
......+||+.||.||++.+.+ |+.++|||||||++|||
T Consensus 161 -------------------------------------~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm 199 (426)
T KOG0589|consen 161 -------------------------------------SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEM 199 (426)
T ss_pred -------------------------------------hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHH
Confidence 1245678999999999999877 99999999999999997
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=265.12 Aligned_cols=142 Identities=28% Similarity=0.461 Sum_probs=125.1
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||.|+||.||++.+..+++.||||.+.. ...+.+|+++++.+ +|+||+++++++ .+....|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~-~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSF-QDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEE-EcCCeeEE
Confidence 479999999999999999999999999999998753 23356788888888 699999999998 66678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 79 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 999996 68888876532 28899999999999999999999999999999999999999999999999986
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 150 ~~ 151 (377)
T cd05629 150 GF 151 (377)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.36 Aligned_cols=143 Identities=41% Similarity=0.657 Sum_probs=126.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+.. .....+|+.+++.+ +|+||+++++++ ......+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDII-HTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEE-ecCCeEEEE
Confidence 5789999999999999999999988999999998853 23457899999999 699999999998 556689999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+.++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 82 ~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 82 FEYVHTDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EECCCcCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence 99999999888765322 288889999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=267.96 Aligned_cols=149 Identities=23% Similarity=0.436 Sum_probs=127.4
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
+.+++++.||+|.||.||+|.+..+ ..||+|.++. ...+.+|+++++++ .|++|+++++++ ..+..++|||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~-~~~~piyIVtE~ 282 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVC-TKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEE-ecCCceEEEEEe
Confidence 3456688999999999999998543 3588888763 45677999999999 699999999999 444479999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccccC
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLG 173 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 173 (326)
|. |+|.+++..... ..+...++..++.|||+|++||+++++|||||..+|||++++..+||+|||+++....
T Consensus 283 m~~GsLl~yLr~~~~-------~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREG-------GLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred cccCcHHHHhhhcCC-------CccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 98 899999987322 2388999999999999999999999999999999999999999999999999996555
Q ss_pred Cccc
Q 020467 174 NEFD 177 (326)
Q Consensus 174 ~~~~ 177 (326)
+.+.
T Consensus 356 ~~Y~ 359 (468)
T KOG0197|consen 356 DEYT 359 (468)
T ss_pred Ccee
Confidence 5543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=265.55 Aligned_cols=142 Identities=27% Similarity=0.450 Sum_probs=125.6
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||+||+|.+..+++.||+|.+... ..+.+|+.++..+ +|++|+++++.+ .+...+++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~-~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSF-QDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEE-ecCCeEEE
Confidence 4799999999999999999999989999999998632 2456788888888 699999999998 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++..... +++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 79 v~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDT---------LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred EEcCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 999997 588888765432 8999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 150 ~~ 151 (363)
T cd05628 150 GL 151 (363)
T ss_pred cc
Confidence 65
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=256.01 Aligned_cols=147 Identities=33% Similarity=0.571 Sum_probs=131.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
-.+.|++.+.||.|..++||+|+.+.++..||||+++ ....+.+|+..+..+ +||||+.++..| .....+|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sF-vv~~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSF-VVDSELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEE-EecceeEE
Confidence 3688999999999999999999999999999999985 235678889998888 799999999999 55668999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
||+||. |++.+.+..... .++.+..+..++++++.||.|||.+|.||||||+.||||+.+|.++|+|||.+.
T Consensus 102 VmpfMa~GS~ldIik~~~~-------~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYP-------DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred eehhhcCCcHHHHHHHHcc-------ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence 999998 788888876543 339999999999999999999999999999999999999999999999999877
Q ss_pred ccc
Q 020467 170 ILL 172 (326)
Q Consensus 170 ~~~ 172 (326)
.+.
T Consensus 175 ~l~ 177 (516)
T KOG0582|consen 175 SLF 177 (516)
T ss_pred eec
Confidence 663
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=263.64 Aligned_cols=142 Identities=23% Similarity=0.438 Sum_probs=125.5
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++++.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+++++.+ .|+||+++++.+ ...+.+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~-~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSF-QDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEE-EcCCEEEE
Confidence 479999999999999999999999999999998853 23456788999998 699999999998 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus 79 v~E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999997 68888876532 28888999999999999999999999999999999999999999999999986
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 150 ~~ 151 (376)
T cd05598 150 GF 151 (376)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=264.11 Aligned_cols=142 Identities=27% Similarity=0.478 Sum_probs=125.8
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||+|.+..+++.||||.+... ..+.+|+.++..+ +|+||+++++.+ ......++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~-~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSF-QDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEE-EcCCeEEE
Confidence 4799999999999999999999999999999998632 2346788899988 699999999998 66778999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++.
T Consensus 79 v~E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred EECCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccce
Confidence 999997 67887776533 28999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 150 ~~ 151 (364)
T cd05599 150 GL 151 (364)
T ss_pred ec
Confidence 65
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=262.26 Aligned_cols=144 Identities=25% Similarity=0.423 Sum_probs=127.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++.+ ...+..
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSF-QDENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEE-EcCCEE
Confidence 46889999999999999999999999999999998853 23466889999999 699999999998 566789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+.+..... +++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGR---------FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccC
Confidence 99999987 688887765432 88889999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 165 ~~~~ 168 (329)
T PTZ00263 165 AKKV 168 (329)
T ss_pred ceEc
Confidence 8654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=257.65 Aligned_cols=144 Identities=40% Similarity=0.667 Sum_probs=126.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.++||.|+||.||+|.+..++..||+|.++. .....+|+.+++.+ +|+||+++++++ ......+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDII-HTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEE-cCCCeEEEE
Confidence 4679999999999999999999998999999998752 23466899999999 699999999998 556679999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||+.++|.+++..... .++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 82 ~e~~~~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 82 FEYLDSDLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred EeCCCcCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 99999999888764322 2788899999999999999999999999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=260.81 Aligned_cols=142 Identities=32% Similarity=0.521 Sum_probs=125.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+..|+.++..+ +|+||+++++++ ......++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~-~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAF-QDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEE-EcCCEEEE
Confidence 479999999999999999999998999999998853 23456788888888 599999999998 66778999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++..... +++..+..++.||+.||.|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus 79 v~e~~~g~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGV---------LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred EEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 999997 688888765332 8899999999999999999999999999999999999999999999999886
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 150 ~~ 151 (333)
T cd05600 150 GI 151 (333)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=260.97 Aligned_cols=142 Identities=27% Similarity=0.459 Sum_probs=125.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.++..+ +|++++++++.+ .....+++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~-~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSF-QDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEE-EcCCEEEE
Confidence 479999999999999999999999999999998853 23456688888888 699999999998 66678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++..... +++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 79 v~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDT---------LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 999997 688888765332 8899999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 150 ~~ 151 (360)
T cd05627 150 GL 151 (360)
T ss_pred cc
Confidence 65
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=265.22 Aligned_cols=142 Identities=23% Similarity=0.439 Sum_probs=125.0
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.+|+++++||+|+||.||+|.+..+++.+|+|.+... ..+.+|+.+++.+ +|+||+++++.+ ......++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~-~~~~~~~l 78 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSF-QDKDNLYF 78 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEE-EeCCEEEE
Confidence 3699999999999999999999999999999988632 3456788889888 699999999998 55678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++.
T Consensus 79 v~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 999997 68888776532 28889999999999999999999999999999999999999999999999986
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 150 ~~ 151 (382)
T cd05625 150 GF 151 (382)
T ss_pred cc
Confidence 44
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=260.47 Aligned_cols=189 Identities=33% Similarity=0.586 Sum_probs=169.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..+..+|++.+.||+|.||.|-+|.....|+.||||.+++ .-.+.+|++++..+ +||||+.+|.+| ++..
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVF-ENkd 126 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVF-ENKD 126 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhh-cCCc
Confidence 4467899999999999999999999989999999998863 23467999999999 799999999999 7788
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
.+.+||||.. |.|++++.+... +++..++.+++||+.|+.|+|.++++|||||.+|||+|.+++++|+||
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeecc
Confidence 8999999987 899999998665 999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCC
Q 020467 166 GQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDK 245 (326)
Q Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
|++..+..+++
T Consensus 198 GLSNly~~~kf--------------------------------------------------------------------- 208 (668)
T KOG0611|consen 198 GLSNLYADKKF--------------------------------------------------------------------- 208 (668)
T ss_pred chhhhhccccH---------------------------------------------------------------------
Confidence 99987644442
Q ss_pred CCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhcc
Q 020467 246 DTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQN 325 (326)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 325 (326)
+...-|++.|.+||++.|.++-++.+|-|||||+||.
T Consensus 209 -------------------------------------------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYt 245 (668)
T KOG0611|consen 209 -------------------------------------------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYT 245 (668)
T ss_pred -------------------------------------------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHH
Confidence 3445699999999999999877899999999999996
Q ss_pred C
Q 020467 326 F 326 (326)
Q Consensus 326 l 326 (326)
|
T Consensus 246 L 246 (668)
T KOG0611|consen 246 L 246 (668)
T ss_pred H
Confidence 4
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=262.23 Aligned_cols=141 Identities=21% Similarity=0.413 Sum_probs=124.5
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.|++++.||+|+||+||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++.+ .+...++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~-~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSF-QDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEE-ecCCEEEEE
Confidence 68999999999999999999999999999998853 22356788889888 699999999998 556789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+||||+.++.++|+|||++..
T Consensus 80 ~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 80 MDYIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 99997 68888876533 288889999999999999999999999999999999999999999999999865
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
+
T Consensus 151 ~ 151 (381)
T cd05626 151 F 151 (381)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=259.54 Aligned_cols=142 Identities=26% Similarity=0.366 Sum_probs=125.0
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++ .+....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTE-HDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhh-ccCCeEEE
Confidence 479999999999999999999998999999998852 23456788999999 699999999988 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++..... +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 79 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGR---------FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred EEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcch
Confidence 999997 688888765432 8889999999999999999999999999999999999999999999999886
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 150 ~~ 151 (291)
T cd05612 150 KL 151 (291)
T ss_pred hc
Confidence 54
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=266.41 Aligned_cols=141 Identities=27% Similarity=0.380 Sum_probs=126.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeeccc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT 97 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~ 97 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.... ....+|+++++.+ +|+||+++++++ ......+++++++.+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-~~~~~E~~il~~l-~HpnIv~~~~~~-~~~~~~~lv~e~~~~ 167 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-GGTATEAHILRAI-NHPSIIQLKGTF-TYNKFTCLILPRYKT 167 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-hhhHHHHHHHHhC-CCCCCCCEeEEE-EECCeeEEEEecCCC
Confidence 4689999999999999999999999999999997653 4567899999999 699999999998 556678999999999
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+|..++..... ++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 168 ~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 168 DLYCYLAAKRN---------IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred CHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 98887765322 88899999999999999999999999999999999999999999999998854
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=252.82 Aligned_cols=146 Identities=29% Similarity=0.442 Sum_probs=128.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC-ceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDE-DAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~-~~~lv 91 (326)
..+|...+.||+|.||.||++.+..++..+|+|.+.. ...+.+|+.+|.++. |+||+++++....... .++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEee
Confidence 5678999999999999999999988899999998864 345789999999995 9999999997423333 68999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEEeecccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADFGQAR 169 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~~~~~l~Dfg~~~ 169 (326)
|||+. |+|.+++...+. .+++..+..+..|++.||.|||++||+|+||||+|||++. ++.++|+|||.+.
T Consensus 95 mEy~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred eeccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 99998 799999887552 2999999999999999999999999999999999999999 7999999999987
Q ss_pred ccc
Q 020467 170 ILL 172 (326)
Q Consensus 170 ~~~ 172 (326)
...
T Consensus 167 ~~~ 169 (313)
T KOG0198|consen 167 KLE 169 (313)
T ss_pred ccc
Confidence 653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=258.51 Aligned_cols=135 Identities=24% Similarity=0.373 Sum_probs=117.7
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.||+|.+.. .....+|+.+++.+ +|+||+++++.+ ......+++|||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~-~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSF-QTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEE-EcCCEEEEEEeCCC
Confidence 468999999999999999999999998863 12456788888888 699999999988 66678999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 79 ~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 79 GGELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence 57877776533 288999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=261.51 Aligned_cols=144 Identities=28% Similarity=0.484 Sum_probs=125.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
...++|++.+.||+|+||.||++.+..+++.+|+|.+.. ...+.+|+.+++.+ +|+||+++++.+ .....
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~-~~~~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAF-QDDKY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEE-EcCCE
Confidence 346889999999999999999999999999999998753 22355777888777 799999999998 56678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~----------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY----------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecc
Confidence 999999997 6888877532 17888999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 188 ~a~~~ 192 (370)
T cd05621 188 TCMKM 192 (370)
T ss_pred cceec
Confidence 98754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=259.87 Aligned_cols=144 Identities=28% Similarity=0.440 Sum_probs=124.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCC-eEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDN-LIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~-~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+.. ...+.+|+.+++.+ +||||+++++++ .....
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~-~~~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSF-KDESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEE-EeCCE
Confidence 4678999999999999999999876554 6899998752 23456788999988 699999999998 55668
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKR---------FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCC
Confidence 999999996 688888765432 8899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 177 ~a~~~ 181 (340)
T PTZ00426 177 FAKVV 181 (340)
T ss_pred CCeec
Confidence 88654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=258.79 Aligned_cols=147 Identities=30% Similarity=0.532 Sum_probs=124.9
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------------------hhhHHHHHHHHHHHhcCCCe
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------------------YQSAFREIEALQILQNSPNV 74 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------------------~~~~~~E~~~l~~l~~h~ni 74 (326)
.....++|++.+.||+|.||.|-+|++..+++.||||++.+ .+...+|+.+++++ +|+||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nV 170 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNV 170 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCe
Confidence 34568999999999999999999999999999999998852 24678999999999 69999
Q ss_pred eEEeEEEEecC--CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 020467 75 VVLHEYFWRED--EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGN 151 (326)
Q Consensus 75 ~~l~~~~~~~~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~N 151 (326)
++++.+. ++. ..+|||+||+. |.+. ..-.. ...+.+.+++.++.+++.||.|||.+|||||||||+|
T Consensus 171 V~LiEvL-DDP~s~~~YlVley~s~G~v~-w~p~d--------~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN 240 (576)
T KOG0585|consen 171 VKLIEVL-DDPESDKLYLVLEYCSKGEVK-WCPPD--------KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN 240 (576)
T ss_pred eEEEEee-cCcccCceEEEEEeccCCccc-cCCCC--------cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 9999998 433 46999999997 3321 11110 1128899999999999999999999999999999999
Q ss_pred eEEcCCCcEEEEeecccccc
Q 020467 152 LLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 152 ili~~~~~~~l~Dfg~~~~~ 171 (326)
+|++++|++||+|||.+..+
T Consensus 241 LLl~~~g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEF 260 (576)
T ss_pred eEEcCCCcEEeeccceeeec
Confidence 99999999999999988765
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=266.05 Aligned_cols=149 Identities=28% Similarity=0.470 Sum_probs=134.2
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
+..+-|++++-||.|..|.|.+|++..||+.+|||.+.. ...+.+|+.+++.+ .|||++++|++| ++..+
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVw-e~~~~ 86 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVW-ENKQH 86 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeee-ccCce
Confidence 456779999999999999999999999999999999864 34578899999888 699999999999 77788
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
+|++.||+. |.|++++...+. +++.++.+++.||+.|+.|+|..+|+|||+||+|+|+|..+++||+|||
T Consensus 87 lylvlEyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccc
Confidence 999999997 799999877554 9999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCc
Q 020467 167 QARILLGNE 175 (326)
Q Consensus 167 ~~~~~~~~~ 175 (326)
++..-.++.
T Consensus 158 MAsLe~~gk 166 (786)
T KOG0588|consen 158 MASLEVPGK 166 (786)
T ss_pred eeecccCCc
Confidence 997654443
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=257.05 Aligned_cols=142 Identities=26% Similarity=0.496 Sum_probs=122.4
Q ss_pred CeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 20 KYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
+|++.+.||+|+||.||++.+. .+++.+|+|.+.. ......|+.++..+.+|++|+.+++++ .....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-QTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-ecCCE
Confidence 5899999999999999998764 4688999998853 123567888898887799999999988 55667
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+.+..... +++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDN---------FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCc
Confidence 999999997 588887765332 8899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 151 ~~~~~ 155 (332)
T cd05614 151 LSKEF 155 (332)
T ss_pred CCccc
Confidence 88654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=258.57 Aligned_cols=142 Identities=31% Similarity=0.551 Sum_probs=124.5
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----Cce
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED----EDA 88 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~----~~~ 88 (326)
+|++.+.||+|+||.||+|.+..++..||+|.+.. ...+.+|+.+++.+ +|+||+++++++.... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999998752 23467899999998 6999999999874332 247
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+++|||++++|.+.+..... +++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++
T Consensus 80 ~lv~e~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 80 YVVFELMESDLHQVIKANDD---------LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEEecCCCCHHHHHHhccc---------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccc
Confidence 99999999999888765432 889999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 151 ~~~ 153 (338)
T cd07859 151 RVA 153 (338)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=260.47 Aligned_cols=145 Identities=28% Similarity=0.472 Sum_probs=125.4
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.-..++|++.+.||+|+||.||+|.+..+++.+|+|.+.. ...+.+|+.+++.+ +|+||+++++.+ ....
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~-~~~~ 116 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAF-QDDR 116 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-EcCC
Confidence 3346899999999999999999999999999999998753 12345677777777 799999999998 5667
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++... .+++..+..++.||+.||.|||+.+|+||||||+||+++.++.++|+||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 8999999997 6887777532 1788889999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++..+
T Consensus 187 G~a~~~ 192 (371)
T cd05622 187 GTCMKM 192 (371)
T ss_pred CceeEc
Confidence 998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=255.43 Aligned_cols=141 Identities=23% Similarity=0.409 Sum_probs=121.0
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
+|++.+.||+|+||.||+|.+..+++.||+|.+... .....|..++..+.+|++++.+++++ ......+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-QTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-ecCCEEEEE
Confidence 588999999999999999999989999999988632 22455666776766789999999988 556689999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+.+..... +++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++..
T Consensus 80 ~E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGR---------FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred EcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 99997 688777754332 88899999999999999999999999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=249.44 Aligned_cols=143 Identities=25% Similarity=0.394 Sum_probs=122.3
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.++..+ +|++++.+++.+ ...+..+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~-~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAY-ETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEE-ccCCeEEEE
Confidence 37889999999999999999999999999998752 12356788999998 699999999988 556679999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+||+. ++|...+..... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 79 ~e~~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred EEecCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 99998 577666643221 1288899999999999999999999999999999999999999999999998865
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 152 ~ 152 (285)
T cd05631 152 I 152 (285)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=251.99 Aligned_cols=143 Identities=39% Similarity=0.690 Sum_probs=125.5
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|++.+.||+|+||.||+|.+..+++.+|+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAF-RRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhE-ecCCEEEEE
Confidence 579999999999999999999998999999998753 23467899999998 699999999998 556689999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||+.+++.+.+.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..+
T Consensus 79 ~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 79 FEYVEKNMLELLEEMP--------NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred EecCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999987777665432 22889999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=254.95 Aligned_cols=141 Identities=24% Similarity=0.410 Sum_probs=120.8
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
+|++.+.||+|+||.||+|.+..+++.||+|.+.. ......|.+++..+.+|++++.+++++ ...+..|++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-QTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-EcCCEEEEE
Confidence 58999999999999999999998999999998853 223556777888886566788888888 556679999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+.+..... +++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..
T Consensus 80 ~E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGK---------FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred EcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 99997 688777754332 88899999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=257.57 Aligned_cols=143 Identities=27% Similarity=0.510 Sum_probs=126.3
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||+|.+..+++.||+|++.. ...+..|+.++..+ +|+||+++++++ ...+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSF-QDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhhe-ecCCeEEE
Confidence 479999999999999999999998999999999853 23456788888888 699999999988 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 79 v~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred EEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 999996 68888876542 28899999999999999999999999999999999999999999999999987
Q ss_pred ccc
Q 020467 170 ILL 172 (326)
Q Consensus 170 ~~~ 172 (326)
...
T Consensus 150 ~~~ 152 (350)
T cd05573 150 KMN 152 (350)
T ss_pred cCc
Confidence 653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=258.34 Aligned_cols=143 Identities=27% Similarity=0.474 Sum_probs=124.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
-.++|++.+.||+|+||.||++.+..+++.+|+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~-~~~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAF-QDDKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEE-ecCCEE
Confidence 35789999999999999999999999999999998853 12355788888888 699999999988 667789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||+
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY----------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 99999997 6888776532 178888999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 189 ~~~~ 192 (370)
T cd05596 189 CMKM 192 (370)
T ss_pred eeec
Confidence 8654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=255.73 Aligned_cols=154 Identities=22% Similarity=0.381 Sum_probs=125.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.++||+|+||.||+|.+. .++..||+|.+.. ...+.+|+.++..+.+|+||+++++++.....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 578999999999999999999752 3456799998853 23467899999999779999999998865566
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh-----------------------------------------------------hh
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR-----------------------------------------------------ED 112 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~-----------------------------------------------------~~ 112 (326)
.++++|||+. ++|.+++....... ..
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 7899999997 68888876532100 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 113 RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 113 ~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.....++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~ 224 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence 01124778889999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=247.80 Aligned_cols=198 Identities=34% Similarity=0.562 Sum_probs=166.4
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCC----CeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSD----NLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~----~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
+-...|+++..||+|.||.||+|....+ .+.+|||.++. .....+|+..++.+ .|+|++.+..+|...
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc
Confidence 3457899999999999999999965543 23789998863 35678999999999 599999999999666
Q ss_pred CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC----CcE
Q 020467 85 DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD----GVL 160 (326)
Q Consensus 85 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~----~~~ 160 (326)
...+|++++|.+.+|+..+........ .-++...+..++.||+.++.|||++-|+||||||.|||+..+ |.+
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 778999999999999999876543322 238999999999999999999999999999999999999987 899
Q ss_pred EEEeecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCC
Q 020467 161 KLADFGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSI 240 (326)
Q Consensus 161 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (326)
||+|+|+++.+.+.-..
T Consensus 176 KIaDlGlaR~~~~plkp--------------------------------------------------------------- 192 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKP--------------------------------------------------------------- 192 (438)
T ss_pred EeecccHHHHhhccccc---------------------------------------------------------------
Confidence 99999999887433210
Q ss_pred CCCCCCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeeh
Q 020467 241 DETDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLA 320 (326)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG 320 (326)
--.....|-|.+|+|||.++|.+.|+.++||||+|
T Consensus 193 ---------------------------------------------l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 193 ---------------------------------------------LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIG 227 (438)
T ss_pred ---------------------------------------------cccCCceEEEEEecChHHhcccccccchhhhHHHH
Confidence 00123457899999999999999999999999999
Q ss_pred hhhccC
Q 020467 321 AYLQNF 326 (326)
Q Consensus 321 ~il~el 326 (326)
||+.||
T Consensus 228 CIfaEl 233 (438)
T KOG0666|consen 228 CIFAEL 233 (438)
T ss_pred HHHHHH
Confidence 999886
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=253.55 Aligned_cols=143 Identities=28% Similarity=0.446 Sum_probs=124.4
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||+|.+..+++.+|+|.++.. ..+.+|+.+++.+ +|+||+++++++ ......++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~-~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAF-QDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEE-ecCCeEEE
Confidence 4799999999999999999999999999999998632 2345677777776 799999999988 55678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus 79 v~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred EECCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence 999996 688888765421 28999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 151 ~~ 152 (330)
T cd05601 151 RL 152 (330)
T ss_pred EC
Confidence 65
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=251.94 Aligned_cols=143 Identities=24% Similarity=0.435 Sum_probs=123.5
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||++.+..+++.||+|.+... ..+.+|..++..+ .|++|+.+++.+ ...+..|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~-~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAF-QDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-EcCCEEEE
Confidence 5799999999999999999999989999999988531 2245566777666 699999999998 66678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus 79 v~Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred EEeCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEecccee
Confidence 999997 688888865321 28889999999999999999999999999999999999999999999999986
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 151 ~~ 152 (331)
T cd05624 151 KM 152 (331)
T ss_pred ec
Confidence 54
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=252.79 Aligned_cols=143 Identities=25% Similarity=0.453 Sum_probs=124.0
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||++.+..+++.||+|.+.. ...+.+|+.++..+ +|+||+.+++++ ......++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAF-QDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEE-ecCCeEEE
Confidence 579999999999999999999999999999999853 12345677777777 699999999998 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++.
T Consensus 79 v~e~~~g~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFE--------DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred EEecCCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence 999986 68888875432 128899999999999999999999999999999999999999999999999886
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 151 ~~ 152 (331)
T cd05597 151 RL 152 (331)
T ss_pred ec
Confidence 54
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=264.04 Aligned_cols=149 Identities=29% Similarity=0.450 Sum_probs=124.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-------Cce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-YQSAFREIEALQILQNSPNVVVLHEYFWRED-------EDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-------~~~ 88 (326)
..++|++.+.||+|+||.||+|.+..+++.||||.+.. .....+|+.+++.+ +|+||+++++++.... ..+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceEE
Confidence 34689999999999999999999988999999998754 33456799999999 6999999998763321 236
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEEeecc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-~~~l~Dfg~ 167 (326)
+++|||+++++.+++...... ...++...+..++.||+.||.|||+.+|+||||||+|||++.++ .++|+|||+
T Consensus 143 ~lvmE~~~~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 143 NVVMEFIPQTVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEecCCccHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 789999999888777543221 22388999999999999999999999999999999999999665 699999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 218 a~~~ 221 (440)
T PTZ00036 218 AKNL 221 (440)
T ss_pred chhc
Confidence 8765
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=256.92 Aligned_cols=144 Identities=31% Similarity=0.515 Sum_probs=124.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||++.+..+++.+|+|.+.. .....+|+.+++.+ +|+||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCcc
Confidence 467999999999999999999999998999999998852 33466888999888 6999999999884332
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...+++|||+.+++...+... ++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 97 EFQDVYLVMELMDANLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred ccceeEEEEeCCCcCHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEe
Confidence 247999999998887766321 7888899999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 166 Dfg~a~~~ 173 (359)
T cd07876 166 DFGLARTA 173 (359)
T ss_pred cCCCcccc
Confidence 99988643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=252.83 Aligned_cols=137 Identities=26% Similarity=0.427 Sum_probs=116.2
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.||+|.++.. .....|..++....+|+||+++++++ ......+++|||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-QTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-EcCCEEEEEEcCCC
Confidence 4689999999999999999999999988532 22345666666655799999999998 55668999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
++|...+.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 80 gg~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 80 GGDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 68877765432 2889999999999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=251.54 Aligned_cols=133 Identities=26% Similarity=0.497 Sum_probs=116.6
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.++..+ +|+||+++++++ ......+++|||+. +
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSF-QSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEE-ecCCeEEEEEcCCCCC
Confidence 6899999999999998999999998853 23356788889888 699999999988 56678999999997 6
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+|.+.+..... +++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 79 ~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 79 ELFHHLQREGR---------FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred cHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 88887765332 88899999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=251.34 Aligned_cols=143 Identities=25% Similarity=0.479 Sum_probs=123.3
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.++||+|+||.||++.+..+++.+|+|.+... ..+..|+.++..+ +|++|+++++.+ ......++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAF-QDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEE-ecCCEEEE
Confidence 4799999999999999999999989999999988531 2245667777776 699999999988 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus 79 v~ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred EEeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence 999986 788888865322 28888999999999999999999999999999999999999999999999886
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 151 ~~ 152 (332)
T cd05623 151 KL 152 (332)
T ss_pred ec
Confidence 54
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=253.97 Aligned_cols=135 Identities=22% Similarity=0.368 Sum_probs=117.0
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||++.+..++..||+|.+... ..+.+|+.+++.+ +|+||+++++.+ ......+++|||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~-~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAF-QTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEE-ecCCEEEEEEeCCC
Confidence 4689999999999999999999999988531 2345788888888 699999999998 55668999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 79 ~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 79 GGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence 57776665433 288999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=251.59 Aligned_cols=135 Identities=24% Similarity=0.382 Sum_probs=115.7
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||++.+..+++.||+|.+.. ......|++++..+ +|+||+.+++++ ......+++|||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~-~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSF-QTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEE-EcCCEEEEEEeCCC
Confidence 468999999999999999999999998853 12345677778777 699999999988 56668999999998
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+.... .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++..
T Consensus 79 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 79 GGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 57776665432 28899999999999999999997 7999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=242.45 Aligned_cols=151 Identities=30% Similarity=0.431 Sum_probs=134.7
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------------hhhHHHHHHHHHHHhcCCCeeEEeEEE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------------YQSAFREIEALQILQNSPNVVVLHEYF 81 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------------~~~~~~E~~~l~~l~~h~ni~~l~~~~ 81 (326)
.++.+.|...+.||.|..+.|.+|..+.+++++++|++.. .+.-..|+.+|+++.+||+|+.+.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 4577889999999999999999999999999999998842 233467899999999999999999999
Q ss_pred EecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 020467 82 WREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 82 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 160 (326)
+.....++|++.++ |.|.+++...-. +++...+.+++|+++++.|||..+|+||||||+|||++++.++
T Consensus 93 -es~sF~FlVFdl~prGELFDyLts~Vt---------lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 93 -ESDAFVFLVFDLMPRGELFDYLTSKVT---------LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNI 162 (411)
T ss_pred -cCcchhhhhhhhcccchHHHHhhhhee---------ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccce
Confidence 77788999999998 899999866433 8999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCc
Q 020467 161 KLADFGQARILLGNE 175 (326)
Q Consensus 161 ~l~Dfg~~~~~~~~~ 175 (326)
+|+|||++..+..++
T Consensus 163 ~isDFGFa~~l~~Ge 177 (411)
T KOG0599|consen 163 KISDFGFACQLEPGE 177 (411)
T ss_pred EEeccceeeccCCch
Confidence 999999999885443
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=251.81 Aligned_cols=136 Identities=24% Similarity=0.416 Sum_probs=117.0
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.||+|.+... .....|.+++..+.+|+||+++++++ ......+++|||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-QTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-EcCCeEEEEEeCCC
Confidence 4689999999999999989999999988632 23456777777766899999999998 56668999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+..... +++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 80 GGDLMFQIQRSRK---------FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 577777654332 88889999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=252.52 Aligned_cols=135 Identities=24% Similarity=0.396 Sum_probs=117.1
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||++.+..+++.||+|.+.. .....+|+.+++.+ +|+||+++++.+ ......+++|||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSF-QTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEE-EcCCEEEEEEeCCC
Confidence 468999999999999999999999998853 23456788888888 699999999988 56678999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..
T Consensus 79 ~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 79 GGELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 57776665432 288999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=246.88 Aligned_cols=146 Identities=40% Similarity=0.634 Sum_probs=121.8
Q ss_pred cCeEEEeeeccccCcEEEEEEEcC-CCeEEEEEEccc-------hhhHHHHHHHHHHHh--cCCCeeEEeEEEEe----c
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLS-DNLIVALKEVHD-------YQSAFREIEALQILQ--NSPNVVVLHEYFWR----E 84 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~-------~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~----~ 84 (326)
++|++.+.||+|+||.||+|.+.. ++..||+|.++. .....+|+..++.+. .|+||+++++++.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 568899998752 124566777777664 59999999998842 2
Q ss_pred CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 85 DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 85 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
....+++|||+.++|.+++..... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 346899999999999888865332 2288899999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 154 fg~~~~~ 160 (290)
T cd07862 154 FGLARIY 160 (290)
T ss_pred ccceEec
Confidence 9998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=251.64 Aligned_cols=141 Identities=24% Similarity=0.418 Sum_probs=120.8
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
+|++.+.||+|+||.||+|.+..+++.||+|.+... .....|..++..+.+|++++++++.+ ......+++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-QTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-ecCCEEEEE
Confidence 478899999999999999999999999999988631 23456777777776678888898887 556679999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+.+.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 80 ~Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 80 MEYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 99997 68877765432 289999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=251.52 Aligned_cols=136 Identities=25% Similarity=0.406 Sum_probs=117.0
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.+|+|.+... .....|+.++..+.+|+||+++++++ ...+..+++|||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-QTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-EeCCEEEEEEeCCC
Confidence 4689999999999999999999999988631 23456777777776799999999998 55678999999998
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 80 GGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 57776665432 289999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=251.86 Aligned_cols=136 Identities=25% Similarity=0.408 Sum_probs=118.1
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.||+|.++.. ..+..|..++..+.+|+||+++++++ ...+..+++|||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-QTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-EcCCEEEEEEeCCC
Confidence 4689999999999999999999999988631 23557788888886799999999998 56678999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+..... +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 80 ~g~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 80 GGDLMFHMQRQRK---------LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 588777654322 89999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=251.35 Aligned_cols=136 Identities=26% Similarity=0.423 Sum_probs=117.2
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.||+|.+.. ......|..++..+.+|+||+++++++ ......+++|||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-QTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-EcCCEEEEEEcCCC
Confidence 468999999999999998999999998853 223456777777766799999999998 66678999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+..... +++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..
T Consensus 80 ~g~L~~~i~~~~~---------l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 80 GGDLMFHIQKSRR---------FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred CchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 588777655332 88999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=249.16 Aligned_cols=144 Identities=42% Similarity=0.672 Sum_probs=126.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.++||+|+||.||+|.+..++..+|+|.++. .....+|+.+++++ +|+||+++++++ ......+++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIV-HTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEE-eeCCeEEEE
Confidence 4789999999999999999999988999999998752 23466899999999 699999999998 556679999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||+.++|.+.+..... .++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 83 ~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 83 FEYLDKDLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred EeCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence 99999988887765432 2788889999999999999999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=245.00 Aligned_cols=145 Identities=41% Similarity=0.612 Sum_probs=123.1
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHh--cCCCeeEEeEEEEec----CC
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQ--NSPNVVVLHEYFWRE----DE 86 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~----~~ 86 (326)
+|++.+.||+|+||.||+|.+..+++.||+|.+.. .....+|+.+++.+. +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999998752 123556777777764 599999999987432 23
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
..++++|++.++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPP-------PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence 5799999999988888765322 228899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 154 ~~~~~ 158 (288)
T cd07863 154 LARIY 158 (288)
T ss_pred ccccc
Confidence 88654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=258.07 Aligned_cols=142 Identities=33% Similarity=0.531 Sum_probs=123.5
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----Cce
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED----EDA 88 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~----~~~ 88 (326)
+|++.+.||+|+||.||++.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++.... ...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 47889999999999999999988999999998753 23567899999998 6999999999984332 268
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++++||+.++|.+.+.... .++...+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEEeeccccCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999999988888775432 2899999999999999999999999999999999999999999999999988
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 151 ~~~ 153 (372)
T cd07853 151 RVE 153 (372)
T ss_pred eec
Confidence 654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=250.34 Aligned_cols=136 Identities=26% Similarity=0.407 Sum_probs=113.2
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||+||+|.+..+++.+|+|.+... ..+..|...+.+..+|+||+++++.+ ......+++|||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-QTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-ecCCEEEEEEcCCC
Confidence 4689999999999999999999999988532 22344444433333799999999988 55678999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 80 GGELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 57776665432 288999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=255.66 Aligned_cols=156 Identities=27% Similarity=0.429 Sum_probs=132.3
Q ss_pred CCccccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEE
Q 020467 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYF 81 (326)
Q Consensus 7 ~~~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~ 81 (326)
..|+........++|.-...||+|+||.||+|.... +..||||++.. ...+.+|+.++.++ +|+|+++++++|
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYC 140 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEE
Confidence 344555566778999999999999999999998644 48899998853 35689999999999 599999999999
Q ss_pred EecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEEcCC
Q 020467 82 WREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN---TIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 82 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~iiH~dlkp~Nili~~~ 157 (326)
.+.....++|+||+. |+|.+.+...... .+++..+..|+.+++.||+|||.. .|+|||||++|||+|.+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 544435999999998 7999888764321 389999999999999999999974 49999999999999999
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
...||+|||++...
T Consensus 214 ~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLG 227 (361)
T ss_pred CCEEccCccCcccC
Confidence 99999999999654
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=260.38 Aligned_cols=143 Identities=26% Similarity=0.341 Sum_probs=126.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeeccc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT 97 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~ 97 (326)
..+|.+.+.||+|+||.||+|.+..+++.|++|... .....+|+++++++ +|+||+++++++ ......+++|+++.+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-~~~~~~E~~iL~~L-~HpnIv~l~~~~-~~~~~~~lv~e~~~~ 244 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-YASSVHEARLLRRL-SHPAVLALLDVR-VVGGLTCLVLPKYRS 244 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-ccCHHHHHHHHHHC-CCCCCCcEEEEE-EECCEEEEEEEccCC
Confidence 457999999999999999999999999999999654 34467899999999 699999999988 445678999999999
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|..++..... .++...+..++.|++.||.|||+.||+||||||+||||+.++.++|+|||++..+
T Consensus 245 ~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 245 DLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 99888764321 3899999999999999999999999999999999999999999999999998754
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=253.92 Aligned_cols=144 Identities=31% Similarity=0.510 Sum_probs=124.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.. .....+|+.+++.+ +|+||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeecccccc
Confidence 367999999999999999999999988999999998853 23456788888888 6999999999884332
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...+++|||+.+++.+.+... ++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+
T Consensus 93 ~~~~~~lv~e~~~~~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 93 EFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ccceeEEEhhhhcccHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEe
Confidence 347999999998887766431 7888899999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 162 Dfg~~~~~ 169 (355)
T cd07874 162 DFGLARTA 169 (355)
T ss_pred eCcccccC
Confidence 99998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=250.03 Aligned_cols=139 Identities=26% Similarity=0.408 Sum_probs=116.6
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHh--cCCCeeEEeEEEEecCCceEE
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQ--NSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~~~~~~l 90 (326)
|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.++..+. .|+||+++++++ ......++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-QTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-EcCCEEEE
Confidence 67899999999999999999999999999998532 23445555543322 599999999998 66678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|...+... .+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.
T Consensus 80 v~E~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 80 VMEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EEcCCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 999998 5666555321 28999999999999999999999999999999999999999999999999875
Q ss_pred c
Q 020467 170 I 170 (326)
Q Consensus 170 ~ 170 (326)
.
T Consensus 150 ~ 150 (324)
T cd05589 150 E 150 (324)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=249.89 Aligned_cols=136 Identities=25% Similarity=0.415 Sum_probs=116.3
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.||+|.++.. .....|..++....+|++|+++++++ ...+..+++|||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-QTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-EeCCEEEEEECCCC
Confidence 4689999999999999999999999988632 23455666776655799999999998 55678999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+..... ++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 80 ~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 80 GGDLMFHIQDKGR---------FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 588777654322 88899999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=256.32 Aligned_cols=144 Identities=23% Similarity=0.355 Sum_probs=127.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc--CCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL--SDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
+..+|.+.+.||.|+||.||+|... .+++.|++|.+.......+|+++++.+ +|+||+++++++ ......+++|++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~-~~~~~~~lv~e~ 167 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTI-SHRAIINLIHAY-RWKSTVCMVMPK 167 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhc-CCCCccceeeeE-eeCCEEEEEehh
Confidence 3567999999999999999999754 356889999988777778999999999 699999999998 556679999999
Q ss_pred cccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+.++|.+++.... .++...+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+
T Consensus 168 ~~~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 168 YKCDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred cCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999988884322 2899999999999999999999999999999999999999999999999998654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=254.24 Aligned_cols=144 Identities=30% Similarity=0.497 Sum_probs=124.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.. .....+|+.+++.+ +|+||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeeccccccc
Confidence 357899999999999999999999998999999998853 23466788888888 6999999999874322
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...+++|||+++++.+.+... ++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 168 (364)
T cd07875 100 EFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168 (364)
T ss_pred ccCeEEEEEeCCCCCHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEE
Confidence 357999999999888776431 7788899999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 169 DfG~a~~~ 176 (364)
T cd07875 169 DFGLARTA 176 (364)
T ss_pred eCCCcccc
Confidence 99998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=249.66 Aligned_cols=134 Identities=28% Similarity=0.452 Sum_probs=113.2
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHh--cCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQ--NSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
||+|+||+||+|.+..+++.||+|.+... .....|..++.... +|++|+.+++.+ ......+++|||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-QTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-ecCCeEEEEEcCCC
Confidence 68999999999999999999999998532 12334555555554 699999999998 66678999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..
T Consensus 80 ~g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 80 GGELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred CChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 57877765432 288999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=249.47 Aligned_cols=136 Identities=26% Similarity=0.417 Sum_probs=118.0
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.+|+|.+... ..+..|..++.++.+|++|+.+++++ ...+.++++|||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-QTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-EeCCEEEEEEeCCC
Confidence 4699999999999999999999999998632 23557778888887799999999988 56678999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+.... .+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 80 GGDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 67877665432 289999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=249.33 Aligned_cols=135 Identities=24% Similarity=0.419 Sum_probs=112.4
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHH-HHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEA-LQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~-l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
+.||+|+||.||+|.+..+++.+|+|.+... .....|... ++.+ .|+||+++++++ ......+++|||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~-~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSF-QTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEE-EcCCeEEEEEeCC
Confidence 4689999999999999989999999988532 122334333 3445 799999999998 5667899999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
. ++|.+.+.... .+.+..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 79 ~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 79 NGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 8 57777775432 278888899999999999999999999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=261.68 Aligned_cols=143 Identities=21% Similarity=0.335 Sum_probs=120.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHh-----cCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQ-----NSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~-----~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.++||+|+||.||+|.+..+++.||||+++. ......|++++..+. +|.+++.+++++......+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 4789999999999999999999988999999999853 223456777777764 2345889999886666779
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCC---------
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDG--------- 158 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~--------- 158 (326)
+++|++++++|.+++..... ++...+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 208 ~iv~~~~g~~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKHGP---------FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EEEEeccCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 99999999999988865432 8899999999999999999997 5999999999999998765
Q ss_pred -------cEEEEeecccc
Q 020467 159 -------VLKLADFGQAR 169 (326)
Q Consensus 159 -------~~~l~Dfg~~~ 169 (326)
.++|+|||++.
T Consensus 279 ~~~~~~~~vkl~DfG~~~ 296 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCC 296 (467)
T ss_pred ccCCCCceEEECCCCccc
Confidence 48999999764
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=248.91 Aligned_cols=135 Identities=24% Similarity=0.425 Sum_probs=113.4
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHH-HHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEAL-QILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l-~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
+.||+|+||+||+|.+..+++.||+|.+... ..+..|...+ +.+ +|+||+++++.+ ......+++|||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~-~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSF-QTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEE-EeCCEEEEEEcCC
Confidence 4689999999999999999999999998532 2233444433 445 799999999988 5667899999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
. ++|...+..... +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 79 ~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 79 NGGELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred CCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 7 578777755332 88899999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=254.66 Aligned_cols=145 Identities=30% Similarity=0.485 Sum_probs=125.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||.|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccc
Confidence 456899999999999999999999988999999998853 23456799999999 6999999998874322
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...++++++++++|.+.+... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKCQ----------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEc
Confidence 347899999988887766432 28999999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 161 Dfg~~~~~ 168 (343)
T cd07878 161 DFGLARQA 168 (343)
T ss_pred CCccceec
Confidence 99998654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=251.27 Aligned_cols=148 Identities=34% Similarity=0.493 Sum_probs=132.3
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..+.+.|++.+.||.|.||.||.|..+.+|+.+|+|.+.. .....+|+.+++.+..||||+.++++| +...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-e~~~ 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-EDPD 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-EcCC
Confidence 4577889999999999999999999999999999998853 246789999999997799999999999 6677
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC----CcEE
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD----GVLK 161 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~----~~~~ 161 (326)
.++++||++. |.|.+.+... . +++..+..++.|++.++.|||+.|++|||+||+|+|+... +.++
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~---------~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK---------H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc---------c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEE
Confidence 8999999998 7998888765 1 8999999999999999999999999999999999999753 4799
Q ss_pred EEeecccccccC
Q 020467 162 LADFGQARILLG 173 (326)
Q Consensus 162 l~Dfg~~~~~~~ 173 (326)
++|||++.....
T Consensus 180 ~~DFGla~~~~~ 191 (382)
T KOG0032|consen 180 LIDFGLAKFIKP 191 (382)
T ss_pred EeeCCCceEccC
Confidence 999999987643
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=248.32 Aligned_cols=135 Identities=26% Similarity=0.429 Sum_probs=112.7
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHH-HHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIE-ALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~-~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
+.||+|+||.||+|.+..+++.+|+|.+... ..+..|.. +++.+ +|+||+++++.+ ...+..+++|||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~-~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSF-QTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEE-EcCCEEEEEEcCC
Confidence 4689999999999999989999999988531 22344444 34455 799999999988 6667899999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
. ++|...+.... .+++..+..++.||+.||.|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 79 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 79 NGGELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 7 57776665432 288889999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=279.90 Aligned_cols=146 Identities=28% Similarity=0.465 Sum_probs=125.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchh--------hHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ--------SAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--------~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|.+++.||+|+||.|..++++.+++.||+|++++.. .+..|..++.-. +.+-|+.+.=.| .+.+++|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAF-QD~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAF-QDERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHh-cCccceE
Confidence 578999999999999999999999999999999987532 234455555444 577788877777 7778899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+||+|++ |+|..++..-. .+++..+..|+..|+.||..||+.|+|||||||.|||||..|+++|+|||.|
T Consensus 152 lVMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred EEEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence 9999997 79999987654 2999999999999999999999999999999999999999999999999999
Q ss_pred ccccCC
Q 020467 169 RILLGN 174 (326)
Q Consensus 169 ~~~~~~ 174 (326)
..+..+
T Consensus 223 lkm~~d 228 (1317)
T KOG0612|consen 223 LKMDAD 228 (1317)
T ss_pred HhcCCC
Confidence 877433
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=248.04 Aligned_cols=147 Identities=35% Similarity=0.572 Sum_probs=119.6
Q ss_pred EeeeccccCcEEEEEEEc--CCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCceEEEeeeccc
Q 020467 24 LECVGSGAYSDVYKGRRL--SDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWRE-DEDAVLVLEFLRT 97 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~~lv~e~~~~ 97 (326)
.++||+|+||.||+|.+. .+++.+|+|.+.. .....+|+.+++.+ +|+||+++++++... ....+++++|+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 458999999999999865 4678899998864 34567899999999 699999999988543 3468999999999
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili----~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+++..............++...+..++.||+.||.|||+.+|+||||||+|||+ +..+.++|+|||++...
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 998887644322111112248899999999999999999999999999999999999 45678999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=248.68 Aligned_cols=143 Identities=29% Similarity=0.455 Sum_probs=125.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.+.||+|+||.||++.+..++..+++|.+.. ...+.+|+++++.+ +|+||+++++++ ...+..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAF-YSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEE-EECCEEEEE
Confidence 4789999999999999999999999999999998753 23577899999999 699999999998 556679999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
|||+. ++|.+++..... +++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred eecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 99998 588888765432 88999999999999999999986 69999999999999999999999999876
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 153 ~~ 154 (331)
T cd06649 153 QL 154 (331)
T ss_pred cc
Confidence 54
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=266.39 Aligned_cols=145 Identities=24% Similarity=0.405 Sum_probs=125.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-----chhhHHHHHHHHHHHhcCCCeeEEeEEE-Eec-----CC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVVVLHEYF-WRE-----DE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----~~~~~~~E~~~l~~l~~h~ni~~l~~~~-~~~-----~~ 86 (326)
.-++++.+.|.+|||+.||+|.+...+..||+|++- ......+|+++++.|++|+||+.+++.. ... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 356789999999999999999998887899999763 2445789999999999999999999932 111 13
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEEE
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~l~ 163 (326)
.++|+|||+. ++|.+++.+.... .|++.+++.|+.++++|+.+||... |||||||.+||||+.++++|||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~-------~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT-------RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc-------cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 4789999999 7999999865432 2999999999999999999999876 9999999999999999999999
Q ss_pred eecccc
Q 020467 164 DFGQAR 169 (326)
Q Consensus 164 Dfg~~~ 169 (326)
|||.+.
T Consensus 189 DFGSat 194 (738)
T KOG1989|consen 189 DFGSAT 194 (738)
T ss_pred cccccc
Confidence 999875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=247.86 Aligned_cols=135 Identities=26% Similarity=0.425 Sum_probs=115.2
Q ss_pred eeeccccCcEEEEEEEc---CCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 25 ECVGSGAYSDVYKGRRL---SDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+.||+|+||.||++.+. .+++.||+|.+.. .....+|+.+++.+ +|+||+++++.+ ...+..+++|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~-~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAF-QTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEE-ecCCeEEEEE
Confidence 67999999999999863 4688999998753 12345788899998 699999999998 5566799999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
||+. ++|.+.+.... .+.+..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 80 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 80 EYLSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred eCCCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 9998 57877775433 278888999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=248.33 Aligned_cols=136 Identities=27% Similarity=0.454 Sum_probs=116.5
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.||+|.++.. .....|..++....+|+||+++++++ ......+++|||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-QTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-EeCCEEEEEEeCCC
Confidence 4689999999999999999999999988632 23455667776655799999999998 55667999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|.+++..... ++...+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..
T Consensus 80 ~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 80 GGDLMFHIQSCHK---------FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 688877765322 88889999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=253.54 Aligned_cols=142 Identities=24% Similarity=0.361 Sum_probs=125.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeeccc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT 97 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~ 97 (326)
..+|++.+.||+|+||.||+|.+..++..||+|.... .....|+.+++++ +|+||+++++++ ......+++++++.+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~e~~~~ 141 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-GTTLIEAMLLQNV-NHPSVIRMKDTL-VSGAITCMVLPHYSS 141 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-cccHHHHHHHHhC-CCCCCcChhheE-EeCCeeEEEEEccCC
Confidence 3579999999999999999999988899999997654 3446789999999 699999999998 456678999999999
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+|.+++.... ..++...+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..
T Consensus 142 ~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 142 DLYTYLTKRS--------RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred cHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 9988876532 2288999999999999999999999999999999999999999999999998864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=234.49 Aligned_cols=149 Identities=32% Similarity=0.536 Sum_probs=132.4
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
.....++|++.+.||.|-||.||.|+.+.++-.||+|++.+ ...+.+|+++...+ .||||+++|++| .+.
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~f-hd~ 94 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYF-HDS 94 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhhe-ecc
Confidence 34467899999999999999999999999999999998853 44567888888888 699999999999 667
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
...|+++||.. |++++.+....+.. +.+...+.++.|++.||.|+|..+++||||||+|+|++..+.++++|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKR-------FDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhccccc-------ccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccC
Confidence 78999999997 89999988655432 88889999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||.+...
T Consensus 168 fGwsV~~ 174 (281)
T KOG0580|consen 168 FGWSVHA 174 (281)
T ss_pred CCceeec
Confidence 9988664
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=245.70 Aligned_cols=136 Identities=29% Similarity=0.504 Sum_probs=116.8
Q ss_pred eeeccccCcEEEEEEEc---CCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 25 ECVGSGAYSDVYKGRRL---SDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
+.||+|+||.||++.+. .+++.+|+|++.. ......|+++++++ +|+||+++++++ ......+++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAF-QTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEE-EcCCEEEEEEcC
Confidence 57999999999998763 5688999998863 23356788889888 699999999998 556789999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+. ++|.+.+.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 80 LRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred CCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 97 68887775432 2899999999999999999999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=239.82 Aligned_cols=143 Identities=27% Similarity=0.408 Sum_probs=123.1
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
+|++.+.||+|+||.||++.+..+++.||+|.+... ..+.+|+.+++.+ +|+||+++++.+ ......+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAY-ETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeee-cCCCeEEEE
Confidence 488999999999999999999888999999988531 2356789999999 699999999988 556689999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++..
T Consensus 79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred EeccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 99997 677766654321 2388999999999999999999999999999999999999999999999998765
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 152 ~ 152 (285)
T cd05605 152 I 152 (285)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=246.25 Aligned_cols=136 Identities=24% Similarity=0.445 Sum_probs=117.4
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..+++.||+|.+.. ......|..+++.+.+|+||+++++++ ......+++|||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-QTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-EcCCEEEEEEcCCC
Confidence 468999999999999998999999998863 223456777777776799999999998 56668999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|...+..... +++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 80 GGDLMFHIQRSGR---------FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 677777654322 89999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=242.83 Aligned_cols=152 Identities=25% Similarity=0.394 Sum_probs=123.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC----------------CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS----------------DNLIVALKEVHD------YQSAFREIEALQILQNSPNVV 75 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~----------------~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~ 75 (326)
.++|++.++||+|+||.||+|.+.. ++..||+|.+.. ...+.+|+.++.++ .|+||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence 5689999999999999999997532 345799998753 23567899999999 699999
Q ss_pred EEeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhhh----------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 020467 76 VLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKRE----------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVH 144 (326)
Q Consensus 76 ~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~----------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH 144 (326)
++++++ ......+++|||+. ++|.+++........ ......++...+..++.|++.||.|||+.+|+|
T Consensus 83 ~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 83 RLLGVC-VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEE-ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999998 45567999999997 688888754321110 001123677889999999999999999999999
Q ss_pred ccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 145 RDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 145 ~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||||+||+++.++.++|+|||++..+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~ 188 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNL 188 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceec
Confidence 999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-34 Score=252.14 Aligned_cols=147 Identities=27% Similarity=0.429 Sum_probs=127.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
....|+.+++||+|.||.||+|.+..+++.||+|++.- ...+..|+.++..+ .++||.++|+.+ -.+..+|+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsy-l~g~~Lwi 88 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSY-LKGTKLWI 88 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhhe-eecccHHH
Confidence 45568888999999999999999999999999999862 34567899999999 589999999998 56778999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. |++.+++..... +.+..+..++++++.||.|||..+.+|||||+.||++..+|.++|+|||.+.
T Consensus 89 iMey~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred HHHHhcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceee
Confidence 999998 577777765432 4777788899999999999999999999999999999999999999999988
Q ss_pred cccCC
Q 020467 170 ILLGN 174 (326)
Q Consensus 170 ~~~~~ 174 (326)
.+...
T Consensus 160 ql~~~ 164 (467)
T KOG0201|consen 160 QLTNT 164 (467)
T ss_pred eeech
Confidence 76443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=256.61 Aligned_cols=147 Identities=29% Similarity=0.520 Sum_probs=129.8
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc--------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~--------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.+....|.-++.||.|.||.||-|++..+.+.||||.++ ++..+..|+..|+++ .|||++.+.++|.. ..
T Consensus 22 ~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLr-e~ 99 (948)
T KOG0577|consen 22 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLR-EH 99 (948)
T ss_pred CCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeec-cc
Confidence 345567888999999999999999999999999999885 366788999999999 59999999998844 44
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
..|+||||+-|+-.+++.-.... +.+-.+..|+.+.+.||.|||+.+.||||||..|||+.+.|.+||+|||
T Consensus 100 TaWLVMEYClGSAsDlleVhkKp--------lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 100 TAWLVMEYCLGSASDLLEVHKKP--------LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred hHHHHHHHHhccHHHHHHHHhcc--------chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeecccc
Confidence 68999999998888887655432 8888999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
.+...
T Consensus 172 SAsi~ 176 (948)
T KOG0577|consen 172 SASIM 176 (948)
T ss_pred chhhc
Confidence 98764
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=242.68 Aligned_cols=144 Identities=40% Similarity=0.696 Sum_probs=127.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.+.||.|+||.||+|.+..++..|++|.+.. .....+|+..++.+ +|+||+++++++ ......+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~-~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDII-HTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEE-ecCCeEEEE
Confidence 5789999999999999999999988999999998752 23466899999999 699999999998 566789999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+||+.++|.+.+..... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~e~~~~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 83 FEYLDKDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred EeccccCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 99999998888765322 2788899999999999999999999999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=247.48 Aligned_cols=190 Identities=27% Similarity=0.450 Sum_probs=164.3
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
+-..+.|...+.||+|+||.|+-|....+|+.+|+|.+.+ .....+|..++.++ +.+.|+.+-=+| +...
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAf-eTkd 258 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAF-ETKD 258 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeee-cCCC
Confidence 3446778999999999999999999999999999987642 34467889999999 588888876556 7778
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
.+++|+..|. |+|.-++...++ +.+++..+..++.+|+.||++||+.+||+||+||+|||+|+.|+++|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeecc
Confidence 8999999997 677767665543 34999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCC
Q 020467 166 GQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDK 245 (326)
Q Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
|++..+..+.
T Consensus 332 GLAvei~~g~---------------------------------------------------------------------- 341 (591)
T KOG0986|consen 332 GLAVEIPEGK---------------------------------------------------------------------- 341 (591)
T ss_pred ceEEecCCCC----------------------------------------------------------------------
Confidence 9998774332
Q ss_pred CCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhcc
Q 020467 246 DTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQN 325 (326)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 325 (326)
+.+..|||.+|||||++.... |+..+|+|||||++||
T Consensus 342 ------------------------------------------~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYe 378 (591)
T KOG0986|consen 342 ------------------------------------------PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYE 378 (591)
T ss_pred ------------------------------------------ccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHH
Confidence 346679999999999999877 9999999999999999
Q ss_pred C
Q 020467 326 F 326 (326)
Q Consensus 326 l 326 (326)
|
T Consensus 379 m 379 (591)
T KOG0986|consen 379 M 379 (591)
T ss_pred H
Confidence 7
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=246.04 Aligned_cols=151 Identities=34% Similarity=0.461 Sum_probs=131.0
Q ss_pred ccccCeEE--EeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 16 EIIAKYEI--LECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 16 ~~~~~y~i--~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
++..-|++ .+.||+|.||+||-|.++.+|+.||||++.+ ...+.+|+.+|+.+ +||.|+.+...| +...
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~-ET~e 636 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMF-ETPE 636 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEee-cCCc
Confidence 34444555 4789999999999999999999999999853 45678999999999 799999999988 7777
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEE
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD---GVLKLA 163 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~---~~~~l~ 163 (326)
.+++|||-+.|+.++.+..+... .+++.....++.||+.||.|||-.+|+|-||||+|||+.+. -.+|||
T Consensus 637 rvFVVMEKl~GDMLEMILSsEkg-------RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSEKG-------RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred eEEEEehhhcchHHHHHHHhhcc-------cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeec
Confidence 89999999999999988765442 39999999999999999999999999999999999999864 389999
Q ss_pred eecccccccCCc
Q 020467 164 DFGQARILLGNE 175 (326)
Q Consensus 164 Dfg~~~~~~~~~ 175 (326)
|||+++.+..+.
T Consensus 710 DFGfARiIgEks 721 (888)
T KOG4236|consen 710 DFGFARIIGEKS 721 (888)
T ss_pred cccceeecchhh
Confidence 999999875444
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-34 Score=236.53 Aligned_cols=146 Identities=34% Similarity=0.499 Sum_probs=126.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
-+.++|++.+.||+|+|+.|+++.+..+|+.+++|.++ ..+.+.+|+++.+.+ .||||+++.+.+ .+....
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti-~~~~~~ 85 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI-QEESFH 85 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhh-ccccee
Confidence 36688999999999999999999999999999999775 366788999999999 599999999988 556689
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEEe
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD---GVLKLAD 164 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~---~~~~l~D 164 (326)
|+++|++. ++|...+-..-- +++..+..++.||++||.|+|.++|+|||+||+|+++.+. .-+||+|
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~---------ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREF---------YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred EEEEecccchHHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecc
Confidence 99999998 577766654422 7889999999999999999999999999999999999753 4699999
Q ss_pred eccccccc
Q 020467 165 FGQARILL 172 (326)
Q Consensus 165 fg~~~~~~ 172 (326)
||++..+.
T Consensus 157 FGvAi~l~ 164 (355)
T KOG0033|consen 157 FGLAIEVN 164 (355)
T ss_pred cceEEEeC
Confidence 99998774
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=248.15 Aligned_cols=151 Identities=28% Similarity=0.481 Sum_probs=133.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..|.+-|.+.+-||+|.|..|-+|++.-+|..||||++.+ ...++.|+++++.+ +||||+++|.+. +.+..
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEVi-DTQTK 91 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVI-DTQTK 91 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehh-cccce
Confidence 3477889999999999999999999999999999999964 34578999999999 599999999998 66778
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-CCCcEEEEee
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG-DDGVLKLADF 165 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~-~~~~~~l~Df 165 (326)
+|+++|+=+ |+|++++.+... ++.+..+.+++.||+.|+.|+|+..+|||||||+|+++- .-|.+||.||
T Consensus 92 lyLiLELGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeec
Confidence 999999987 699999987643 399999999999999999999999999999999998775 6789999999
Q ss_pred cccccccCCc
Q 020467 166 GQARILLGNE 175 (326)
Q Consensus 166 g~~~~~~~~~ 175 (326)
||+..+.++.
T Consensus 164 GFSNkf~PG~ 173 (864)
T KOG4717|consen 164 GFSNKFQPGK 173 (864)
T ss_pred cccccCCCcc
Confidence 9998764443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=239.82 Aligned_cols=138 Identities=28% Similarity=0.434 Sum_probs=116.3
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
||+|+||+||++.+..+++.+|+|.+... ..+..|+.+++.+ +|+|++++.+++ ......+++|||+. +
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~-~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAF-QTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEE-cCCCeEEEEEeCCCCC
Confidence 68999999999999989999999988531 2345788889888 799999999988 55667999999997 5
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|...+...... ...+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++..+
T Consensus 79 ~L~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 79 DLRYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred CHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 776665432211 123889999999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=242.14 Aligned_cols=147 Identities=35% Similarity=0.561 Sum_probs=119.0
Q ss_pred EeeeccccCcEEEEEEEcC--CCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEe-cCCceEEEeeeccc
Q 020467 24 LECVGSGAYSDVYKGRRLS--DNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWR-EDEDAVLVLEFLRT 97 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~--~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~-~~~~~~lv~e~~~~ 97 (326)
..+||+|+||.||+|.... ++..+|+|.+.. .....+|+.+++.+ +|+|++++++++.. .....++++||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3589999999999998653 568899998864 23567899999999 69999999998853 34568999999999
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili----~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+.+..............+++..+..++.|++.||.|||+.+++||||||+||++ +.++.++|+|||++...
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 998887643222111112238889999999999999999999999999999999999 45678999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=255.32 Aligned_cols=147 Identities=26% Similarity=0.353 Sum_probs=124.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC-CeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD-NLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~-~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
...|.+.+.||+|++|.||+|....+ +..|++|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~-~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDF-KSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEE-EECCEEEEE
Confidence 44599999999999999999988766 77888887632 23456789999998 699999999998 556689999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+.+...... ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++..
T Consensus 144 ~E~~~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EECCCCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 99997 6888877543221 12388899999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
+
T Consensus 219 ~ 219 (478)
T PTZ00267 219 Y 219 (478)
T ss_pred c
Confidence 5
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=245.72 Aligned_cols=143 Identities=27% Similarity=0.450 Sum_probs=125.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.++||+|+||.||++.+..++..+++|.+.. ...+.+|+++++.+ +|+||+++++++ ...+..+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAF-YSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEE-EECCEEEEE
Confidence 4789999999999999999999988999999997753 23467899999999 699999999998 456689999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
|||+. ++|.+++..... ++...+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred EecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 99997 688888765332 78889999999999999999975 79999999999999999999999999876
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 153 ~~ 154 (333)
T cd06650 153 QL 154 (333)
T ss_pred hh
Confidence 54
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-33 Score=219.71 Aligned_cols=142 Identities=42% Similarity=0.672 Sum_probs=127.4
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|.-.++||+|.||+|++|+...+.+.||+|.++- .....+|+.+++.++ |.||++++++. .+.+.+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvl-hsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVL-HSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhh-ccCceeEEeH
Confidence 46667899999999999999999999999998852 346789999999995 99999999998 6677899999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|++..+|..++..... .+....+..++.|++.+|.++|++++.|||+||.|.+|+.+|.++++|||+++-+
T Consensus 81 e~cdqdlkkyfdslng--------~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNG--------DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred HHhhHHHHHHHHhcCC--------cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence 9999988888765443 3889999999999999999999999999999999999999999999999999865
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=255.76 Aligned_cols=152 Identities=32% Similarity=0.430 Sum_probs=126.3
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.....++|++.+.||+|+||+||+|.+..+++.||||.+.. ...+.+|+..+..+ .|+|+++++..+.....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDP 105 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccc
Confidence 34567899999999999999999999998999999998752 23456778888777 69999998887643221
Q ss_pred -------ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 87 -------DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 87 -------~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
.++++|||+. ++|.+.+...... ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC
Confidence 3679999997 6898887653321 23388999999999999999999999999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||+++.+
T Consensus 181 ~vkL~DFGls~~~ 193 (496)
T PTZ00283 181 LVKLGDFGFSKMY 193 (496)
T ss_pred CEEEEecccCeec
Confidence 9999999998764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=255.47 Aligned_cols=191 Identities=36% Similarity=0.526 Sum_probs=163.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED----- 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~----- 85 (326)
....|...+.||+|+||.||+++++.+|+.||||.++. .+.+.+|+++++++. |+||++++++=....
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccc
Confidence 34668889999999999999999999999999998863 567899999999995 999999998742222
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC--CC--cE
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD--DG--VL 160 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~--~~--~~ 160 (326)
..-.++|||+. |+|...+....+ ..++++..+..++.+++.||.|||++||+||||||.||++-. +| ..
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN------~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPEN------AYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCccc------ccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Confidence 24689999997 799888876544 456999999999999999999999999999999999999853 23 67
Q ss_pred EEEeecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCC
Q 020467 161 KLADFGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSI 240 (326)
Q Consensus 161 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (326)
||+|||.++.+..+.
T Consensus 164 KLtDfG~Arel~d~s----------------------------------------------------------------- 178 (732)
T KOG4250|consen 164 KLTDFGAARELDDNS----------------------------------------------------------------- 178 (732)
T ss_pred eeecccccccCCCCC-----------------------------------------------------------------
Confidence 999999998874443
Q ss_pred CCCCCCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeeh
Q 020467 241 DETDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLA 320 (326)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG 320 (326)
..++.+||..|.+||.+...+.|+.-+|.||||
T Consensus 179 -----------------------------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~G 211 (732)
T KOG4250|consen 179 -----------------------------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFG 211 (732)
T ss_pred -----------------------------------------------eeeeecCchhhcChHHHhhccCcCceeehhhhh
Confidence 256789999999999998656699999999999
Q ss_pred hhhccC
Q 020467 321 AYLQNF 326 (326)
Q Consensus 321 ~il~el 326 (326)
|++||+
T Consensus 212 vtlY~c 217 (732)
T KOG4250|consen 212 VTLYEC 217 (732)
T ss_pred hHHHHH
Confidence 999985
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=240.14 Aligned_cols=142 Identities=42% Similarity=0.654 Sum_probs=125.3
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||+|++|.||+|.+..+++.+++|.+.. .....+|+.+++.+ +|+|++++++++ .+....++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVL-HSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHh-ccCCceEEEE
Confidence 58999999999999999999999999999998752 23457899999999 699999999998 5666899999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+.++|.+.+.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 e~~~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 79 EYCDQDLKKYFDSCN--------GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF 149 (284)
T ss_pred ecCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence 999999888776432 12899999999999999999999999999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=247.70 Aligned_cols=153 Identities=22% Similarity=0.373 Sum_probs=124.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-----CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.. ...+.+|+.+++.+.+|+||+++++++ ....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-THGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-cCCC
Confidence 5679999999999999999998643 335799998853 234678999999886799999999998 5566
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh-------------------------------------------------------
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR------------------------------------------------------- 110 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~------------------------------------------------------- 110 (326)
..+++|||+. ++|.+++.......
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 8999999997 68888875432110
Q ss_pred ------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 111 ------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 111 ------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.......++...+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~ 262 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence 0001123788889999999999999999999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=237.03 Aligned_cols=143 Identities=41% Similarity=0.700 Sum_probs=126.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.+.||.|++|.||+|.+..+++.|++|.+.. .....+|+.+++.+ +|+||+++++++ ......+++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDII-HTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEE-ecCCeEEEE
Confidence 5789999999999999999999988899999998752 23456799999999 699999999998 566789999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+.++|.+++..... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~e~~~~~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 82 FEYLDTDLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred EecCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence 99999999887765432 278899999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=249.54 Aligned_cols=140 Identities=38% Similarity=0.525 Sum_probs=120.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
..++|++.++||.|+||.||+|.+..+++.||||.+.. ...+.+|+++++.+ +|+||+++++++ .....+++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMF-DHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEe-ccCCeEEE
Confidence 35789999999999999999999988999999998842 24567899999999 699999999998 56678999
Q ss_pred Eeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+.+ +|... ....+..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++.
T Consensus 150 v~e~~~~~~L~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 150 LLEFMDGGSLEGT-------------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred EEecCCCCccccc-------------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccce
Confidence 9999985 44321 115677788899999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 217 ~~ 218 (353)
T PLN00034 217 IL 218 (353)
T ss_pred ec
Confidence 54
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=236.27 Aligned_cols=144 Identities=40% Similarity=0.679 Sum_probs=125.5
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||+|++|.||+|.+..++..|++|.+.. .....+|+.+++.+ .|+|++++++++ ......+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVL-MQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEE-eeCCeEEEEE
Confidence 58899999999999999999988899999998752 23467899999999 599999999998 5567899999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+.++|.+++..... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 79 EFLSMDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred ecCCCCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 9999888887754321 123889999999999999999999999999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=250.03 Aligned_cols=142 Identities=26% Similarity=0.386 Sum_probs=122.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
...+...+.+.||+|.||+||+|.+.++ ||||.++. .+.+.+|+..+++- .|.||+-+.+++ .+.. +
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~-~~p~-~ 462 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGAC-MNPP-L 462 (678)
T ss_pred cCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhh-cCCc-e
Confidence 3567788999999999999999998764 89998862 45678999999999 599999999998 4443 4
Q ss_pred EEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
.|++.+++| +|+.++.-.... |....+..|+.|+++|+.|||.++|||+|||..||++.++++++|.|||+
T Consensus 463 AIiTqwCeGsSLY~hlHv~etk--------fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETK--------FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred eeeehhccCchhhhhccchhhh--------hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence 899999986 888887654432 88889999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+.+-
T Consensus 535 atvk 538 (678)
T KOG0193|consen 535 ATVK 538 (678)
T ss_pred eeee
Confidence 8653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=247.08 Aligned_cols=142 Identities=22% Similarity=0.440 Sum_probs=124.1
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchh--------hHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ--------SAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--------~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.-|..++-||-|+||+|-++....+...||+|.+++.. ....|..+|... ..+-+++||=.| .+...+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySF-QDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSF-QDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEe-ccCCceEE
Confidence 55888999999999999999988899999999886422 235667777776 678899999888 67778999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
||+|++ |++..++.+-+- |.+..++.++..+.+|+++.|.+|+|||||||.|||||.+|++||.|||+|.
T Consensus 707 VMdYIPGGDmMSLLIrmgI---------FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGI---------FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred EEeccCCccHHHHHHHhcc---------CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 999998 689888877543 8999999999999999999999999999999999999999999999999986
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
-+
T Consensus 778 Gf 779 (1034)
T KOG0608|consen 778 GF 779 (1034)
T ss_pred cc
Confidence 54
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=236.93 Aligned_cols=149 Identities=27% Similarity=0.422 Sum_probs=125.5
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCC-----CeeEEeEEEEec
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSP-----NVVVLHEYFWRE 84 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~-----ni~~l~~~~~~~ 84 (326)
...+.++|.+...+|+|.||.|-.|++..++..||+|+++. .+...-|++++.++..+. -++++.++| +-
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-dy 162 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-DY 162 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-hc
Confidence 34468999999999999999999999998999999999874 344567899999985332 367777777 77
Q ss_pred CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-------
Q 020467 85 DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD------- 157 (326)
Q Consensus 85 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~------- 157 (326)
.++.++|+|.++.++.+++..+.... ++...++.+..|++.++++||+.+++|.||||+||++.+.
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~-------fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIP-------FPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccc-------cchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 78899999999999999998766533 8999999999999999999999999999999999999542
Q ss_pred -------------CcEEEEeeccccc
Q 020467 158 -------------GVLKLADFGQARI 170 (326)
Q Consensus 158 -------------~~~~l~Dfg~~~~ 170 (326)
..++++|||.+..
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf 261 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATF 261 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcce
Confidence 2467888887754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-34 Score=240.24 Aligned_cols=192 Identities=31% Similarity=0.534 Sum_probs=160.0
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecC--
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWRED-- 85 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-- 85 (326)
|+..-+.+..+.||.|+||.||.+.+..+++.|++|++. ..+..++|++++-.+ .|.|++..+++.....
T Consensus 49 Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 49 PQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPS 127 (449)
T ss_pred ccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCch
Confidence 444556677789999999999999999999999999874 356688999999888 5999999988762211
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
..+|+++|.|..+|.+.+... +.++.+.+.-+++||+.+|.|||+.+|.||||||.|.+++++..+|||
T Consensus 128 fFqEiYV~TELmQSDLHKIIVSP---------Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 128 FFQELYVLTELMQSDLHKIIVSP---------QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred HHHHHHHHHHHHHhhhhheeccC---------CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEec
Confidence 135777888877777666543 338888899999999999999999999999999999999999999999
Q ss_pred eecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCC
Q 020467 164 DFGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDET 243 (326)
Q Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
|||+++....+.
T Consensus 199 DFGLARvee~d~-------------------------------------------------------------------- 210 (449)
T KOG0664|consen 199 DFGLARTWDQRD-------------------------------------------------------------------- 210 (449)
T ss_pred ccccccccchhh--------------------------------------------------------------------
Confidence 999998764333
Q ss_pred CCCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhh
Q 020467 244 DKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323 (326)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il 323 (326)
....+..+-|.+|+|||++.|.+.|+.++||||+|||+
T Consensus 211 ------------------------------------------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIF 248 (449)
T KOG0664|consen 211 ------------------------------------------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIF 248 (449)
T ss_pred ------------------------------------------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHH
Confidence 12245567899999999999999999999999999999
Q ss_pred ccC
Q 020467 324 QNF 326 (326)
Q Consensus 324 ~el 326 (326)
.||
T Consensus 249 aEL 251 (449)
T KOG0664|consen 249 AEL 251 (449)
T ss_pred HHH
Confidence 885
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=246.12 Aligned_cols=153 Identities=20% Similarity=0.344 Sum_probs=125.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEE-----cCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRR-----LSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|+||.||+|.+ ..++..||+|.++. ...+.+|+.++..+.+|+||+++++++ ....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-TVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-ccCC
Confidence 46899999999999999999964 34567899998853 234678999999986799999999998 6666
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh-------------------------------------------------------
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR------------------------------------------------------- 110 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~------------------------------------------------------- 110 (326)
..+++|||+. ++|.+++.......
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 7999999998 68888876432100
Q ss_pred -----------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 111 -----------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 111 -----------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.......++...+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++...
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence 0001124778889999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=234.84 Aligned_cols=143 Identities=40% Similarity=0.600 Sum_probs=124.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.+.||+|+||.||+|.+..++..+++|.+... ....+|+.+++.+ .|+||+++++++ ......+++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~-~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDII-HTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEE-ecCCeEEEE
Confidence 57899999999999999999999888999999987531 2456899999998 699999999998 556679999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+||+.+++.+.+..... .++...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 82 FEYMHTDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred EecccCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 99999888877654321 277888889999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=233.71 Aligned_cols=143 Identities=27% Similarity=0.424 Sum_probs=122.3
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.|++.+.||+|+||.||++.+..+++.+|+|.+.. ......|+.+++++ +|++++.+++.+ ......+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~-~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAY-ETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEE-ecCCEEEEE
Confidence 37888999999999999999999999999998752 12356788999888 699999999988 555689999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+.+..... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 79 ~e~~~g~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred EEecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 99997 678777654322 2288999999999999999999999999999999999999999999999998764
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 152 ~ 152 (285)
T cd05630 152 V 152 (285)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=219.80 Aligned_cols=152 Identities=25% Similarity=0.424 Sum_probs=127.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.+...-+..||+|++|.|-+-++..+|..+|+|++.. .....+|+.+..+...+|.++++|+.+.. ....|++
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egdvwIc 123 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGDVWIC 123 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-cccEEEe
Confidence 4556667899999999999999999999999999863 34556777776666679999999998744 4469999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
||.|..+|..+..+-... +..+++..+-.++..++.||.|||++ .++|||+||+||||+.+|++|+||||.+..
T Consensus 124 ME~M~tSldkfy~~v~~~-----g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 124 MELMDTSLDKFYRKVLKK-----GGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred HHHhhhhHHHHHHHHHhc-----CCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 999999888776554332 34599999999999999999999965 899999999999999999999999999988
Q ss_pred ccCCc
Q 020467 171 LLGNE 175 (326)
Q Consensus 171 ~~~~~ 175 (326)
+.++.
T Consensus 199 L~dSi 203 (282)
T KOG0984|consen 199 LVDSI 203 (282)
T ss_pred ehhhh
Confidence 75443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=260.32 Aligned_cols=152 Identities=23% Similarity=0.393 Sum_probs=126.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.++||+|+||.||+|.+..+++.||+|.+.. ...+.+|+++++.+ .|||++++++++ ...+..+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~-~d~~~ly 78 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSIC-SDGDPVY 78 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEE-eeCCEEE
Confidence 3689999999999999999999999999999998853 23567899999999 699999999998 5566799
Q ss_pred EEeeecc-cCHHHHHHHhhhhhh--hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 90 LVLEFLR-TDLATVIAESKKKRE--DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
++|||+. ++|.+++........ ......++...+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 9999997 588887764321110 0011225667788999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 98765
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=231.15 Aligned_cols=140 Identities=34% Similarity=0.584 Sum_probs=123.7
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchh-------hHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-------~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
|++.+.||+|+||.||++.+..+++.+|+|.+.... ...+|+..++.+ .|+||+++++++ ......+++|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~-~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVF-QDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEE-EESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccc-ccccccccccc
Confidence 789999999999999999999999999999986421 224488899999 699999999998 44677899999
Q ss_pred eccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
++.+ +|.+++..... ++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKP---------LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EETTEBHHHHHHHHSS---------BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccccccccc---------cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9996 89888873332 899999999999999999999999999999999999999999999999998653
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=242.95 Aligned_cols=154 Identities=20% Similarity=0.385 Sum_probs=125.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|+||.||+|... .+++.|++|.++. ...+..|+.++.++.+|+||+++++++.....
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 468999999999999999999643 3457899998753 23456789999998779999999998866667
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh----------------------------------------------------hhc
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR----------------------------------------------------EDR 113 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~----------------------------------------------------~~~ 113 (326)
.++++++|+. ++|.+++....... ...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7899999998 68887775422100 000
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 114 GDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 114 ~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
....++...+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++..+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence 0124788999999999999999999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=232.89 Aligned_cols=136 Identities=30% Similarity=0.445 Sum_probs=116.2
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
||+|+||.||++....+++.+++|.+.. ......|+++++.+ +|+||+++++.+ ......+++|||+. +
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~-~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAF-ESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEE-ecCCeEEEEEecCCCC
Confidence 6899999999999998999999998852 22345688999999 699999999988 56678999999997 5
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+++..... ..++...+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++...
T Consensus 79 ~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 79 DLKYHIYNVGE-------RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred CHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 77777654322 12788888999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=260.34 Aligned_cols=154 Identities=22% Similarity=0.409 Sum_probs=127.6
Q ss_pred cCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 12 ~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
...+...++|++++.||.|+||.||+|.+..++..+++|.+.. ...+..|+.++..+ .|+||++++++|...
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEec
Confidence 3446678999999999999999999999999999999998752 34567899999999 699999999988543
Q ss_pred -CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCCeEEc
Q 020467 85 -DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-------TIVHRDLKPGNLLIG 155 (326)
Q Consensus 85 -~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-------~iiH~dlkp~Nili~ 155 (326)
...+|++|||+. ++|.+++...... ...+++..++.|+.||+.||.|||+. +|+|+||||+||||+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 346899999998 6898888653221 12389999999999999999999984 499999999999996
Q ss_pred CC-----------------CcEEEEeecccccc
Q 020467 156 DD-----------------GVLKLADFGQARIL 171 (326)
Q Consensus 156 ~~-----------------~~~~l~Dfg~~~~~ 171 (326)
.. +.++|+|||++..+
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l 192 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccc
Confidence 42 35899999998654
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=232.51 Aligned_cols=143 Identities=27% Similarity=0.406 Sum_probs=122.3
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.|+..+.||+|+||+||++.+..+++.+|+|.+.. .....+|+++++.+ +|++++.+++.+ ...+..+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~-~~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAY-ETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEE-ecCCEEEEE
Confidence 37888999999999999999998999999998752 12356789999998 699999999888 556689999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+.+..... ..++...+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++..
T Consensus 79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGN-------PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred EEeccCccHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 99998 577766654321 1389999999999999999999999999999999999999999999999998865
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 152 ~ 152 (285)
T cd05632 152 I 152 (285)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=232.16 Aligned_cols=143 Identities=31% Similarity=0.436 Sum_probs=126.1
Q ss_pred ccCeEE-EeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEI-LECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i-~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.+-|++ .+.||+|+|+.|--|....++.++|||++.+ ..+.++|++++...++|+||++++++| ++...+|+|
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-Edd~~FYLV 154 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-EDDTRFYLV 154 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-cccceEEEE
Confidence 344544 4589999999999999999999999999853 567899999999999999999999999 777789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEEeecc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---VLKLADFGQ 167 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---~~~l~Dfg~ 167 (326)
||-|. |.|+..+.+..- +++.++..+..+|+.||.|||..||.|||+||+|||-.... -+|||||.+
T Consensus 155 fEKm~GGplLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKH---------FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EecccCchHHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence 99997 689888877654 99999999999999999999999999999999999997654 479999998
Q ss_pred ccc
Q 020467 168 ARI 170 (326)
Q Consensus 168 ~~~ 170 (326)
..-
T Consensus 226 gSg 228 (463)
T KOG0607|consen 226 GSG 228 (463)
T ss_pred ccc
Confidence 754
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=233.46 Aligned_cols=139 Identities=27% Similarity=0.393 Sum_probs=119.4
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++|++.+.||+|++|.||+|.+..+++.+++|.+.. ...+.+|+++++++ +|+|++++++.+ ...+..++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAF-FVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEE-EECCEEEEEE
Confidence 468899999999999999999988999999998753 23466788889888 699999999998 5566789999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+.+....... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 e~~~~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 79 EFMDGGSLDVYR------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred ecCCCCChHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 999864333221 1778888999999999999999999999999999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=231.54 Aligned_cols=143 Identities=18% Similarity=0.316 Sum_probs=120.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.+.||+|+||.||+|.+. ..+..+++|.++.. ..+.+|+..+..+ .|+|++++++++ ......
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVI-TRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEE-ecCCCc
Confidence 457999999999999999999764 34678999987642 2456788888888 699999999998 556789
Q ss_pred EEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+++ +|.+++.... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++++|||.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHE--------GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcc
Confidence 999999984 6766665432 1288999999999999999999999999999999999999999999999997
Q ss_pred ccc
Q 020467 168 ARI 170 (326)
Q Consensus 168 ~~~ 170 (326)
...
T Consensus 154 ~~~ 156 (266)
T cd05064 154 LQE 156 (266)
T ss_pred ccc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=233.00 Aligned_cols=149 Identities=39% Similarity=0.635 Sum_probs=126.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC----c
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE----D 87 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~----~ 87 (326)
++|++.+.||+|+||.||+|.+..+++.|++|.+.. ...+.+|+.+++.+.+|+|++++++++..... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 579999999999999999999988999999998752 23467899999999778999999998844332 3
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEEeec
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~~~~~l~Dfg 166 (326)
.+++|||+.++|.+++...... ....+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCcCHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999999998887654321 0123799999999999999999999999999999999999998 8899999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 157 ~~~~~ 161 (295)
T cd07837 157 LGRAF 161 (295)
T ss_pred cceec
Confidence 87654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=255.23 Aligned_cols=158 Identities=28% Similarity=0.451 Sum_probs=133.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
...+..+.+.||+|+||+||+|... .....||||.+++ ...+.+|++.+..+ +|+||++++++| .++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC-~~~ 561 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVC-REG 561 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEE-ccC
Confidence 4577888999999999999999643 3457799998864 45688999999999 699999999999 667
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhc-C----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDR-G----DRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~-~----~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
+..++|+|||. |+|.+++.......... . ...++..+.+.++.||+.|+.||.++.+|||||..+|+||.++-.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 78999999998 89999987654432211 1 334889999999999999999999999999999999999999999
Q ss_pred EEEEeecccccccCCcc
Q 020467 160 LKLADFGQARILLGNEF 176 (326)
Q Consensus 160 ~~l~Dfg~~~~~~~~~~ 176 (326)
+||+|||+++..-..+|
T Consensus 642 VKIsDfGLsRdiYssDY 658 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDY 658 (774)
T ss_pred EEecccccchhhhhhhh
Confidence 99999999987655543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=222.15 Aligned_cols=148 Identities=34% Similarity=0.484 Sum_probs=128.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-----chhhHHHHHHHHHHHhcCCCeeEEeEEEEec----CCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVVVLHEYFWRE----DEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~----~~~~ 88 (326)
.+||++.++||.|+|+.||++....++..+|+|++. ..+..++|++..+++ +|||+++++++...+ ....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCceeE
Confidence 479999999999999999999999999999999873 345678999999999 699999988875322 2348
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEEEee
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
|++++|+. |+|++.+....... ..+++.+...|+.+++.||++||+.. ++||||||.||++.+.+.++|.||
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg-----~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKG-----NFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcC-----CccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 99999986 88999987765432 24999999999999999999999988 999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|.+...
T Consensus 174 GS~~~a 179 (302)
T KOG2345|consen 174 GSATQA 179 (302)
T ss_pred cCcccc
Confidence 988654
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=230.06 Aligned_cols=158 Identities=26% Similarity=0.415 Sum_probs=131.7
Q ss_pred ccccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEe-
Q 020467 9 WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWR- 83 (326)
Q Consensus 9 ~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~- 83 (326)
+.+...+...++|++.+.||+|+||.||+|.+..+++.+++|.+.. ...+.+|+.+++.+.+|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3455566788999999999999999999999988899999998753 23466788889898679999999998742
Q ss_pred ---cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 84 ---EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 84 ---~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
.+...+++|||+. ++|.+++...... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC
Confidence 2346899999997 5787766532211 123788899999999999999999999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 163 ~kl~dfg~~~~~ 174 (286)
T cd06638 163 VKLVDFGVSAQL 174 (286)
T ss_pred EEEccCCceeec
Confidence 999999998654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=240.33 Aligned_cols=144 Identities=33% Similarity=0.544 Sum_probs=124.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----C
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED----E 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~----~ 86 (326)
+.++|++.+.||+|++|.||+|.+..+++.|++|.+.. ...+.+|+.+++.+ +|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccc
Confidence 56899999999999999999999999999999998752 23456789999999 5999999998874322 3
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
..+++++|+.+++...+... .+++..+..++.|++.||.+||+.+++||||||+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 82 DVYIVQELMETDLYKLIKTQ----------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred eEEEEehhcccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccc
Confidence 47999999999887776432 28899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 152 ~~~~~ 156 (336)
T cd07849 152 LARIA 156 (336)
T ss_pred ceeec
Confidence 88654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=226.89 Aligned_cols=143 Identities=29% Similarity=0.550 Sum_probs=123.9
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
+|++.+.||.|+||.||++.+..+++.+++|.++. .....+|+.+++.+ .|+|++++++.+ ......++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESF-EADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEE-EECCEEEEEEe
Confidence 58999999999999999999998999999998742 23456788888888 699999999998 56678999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||++...
T Consensus 79 ~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 79 YCDGGDLMQKIKLQRG-------KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred eCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence 997 688877754322 23788999999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=231.27 Aligned_cols=143 Identities=40% Similarity=0.644 Sum_probs=123.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|++.+.||+|++|.||+|.+..+++.|++|++.. ...+.+|+.+++.+ .|+|++++++++ ......+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~-~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVF-RRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEE-eeCCEEEEE
Confidence 579999999999999999999988899999998742 23356899999998 599999999998 556679999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||+.+++.+.+.... ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 ~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 79 FEYCDHTVLNELEKNP--------RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred EeccCccHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceec
Confidence 9999976665554322 12899999999999999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=255.07 Aligned_cols=151 Identities=23% Similarity=0.361 Sum_probs=117.0
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCC-eEEEE------------------EEcc----chhhHHHHHHHHHHHhcC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDN-LIVAL------------------KEVH----DYQSAFREIEALQILQNS 71 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~-~~vai------------------K~~~----~~~~~~~E~~~l~~l~~h 71 (326)
..+.++|+++++||+|+||+||+|...... ...+. |.+. ....+.+|+.+++.+ +|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CC
Confidence 346789999999999999999998654221 11111 1111 123456899999999 69
Q ss_pred CCeeEEeEEEEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 020467 72 PNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGN 151 (326)
Q Consensus 72 ~ni~~l~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~N 151 (326)
+||+++++++ ......+++++++.+++..++....... ........+..++.||+.||.|||+.+|+||||||+|
T Consensus 223 pnIv~l~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~----~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~N 297 (501)
T PHA03210 223 ENILKIEEIL-RSEANTYMITQKYDFDLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN 297 (501)
T ss_pred CCcCcEeEEE-EECCeeEEEEeccccCHHHHHhhccccc----cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9999999998 5566789999999988888775432210 1113456678899999999999999999999999999
Q ss_pred eEEcCCCcEEEEeecccccc
Q 020467 152 LLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 152 ili~~~~~~~l~Dfg~~~~~ 171 (326)
||++.++.++|+|||++..+
T Consensus 298 ILl~~~~~vkL~DFGla~~~ 317 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPF 317 (501)
T ss_pred EEECCCCCEEEEeCCCceec
Confidence 99999999999999998765
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=232.31 Aligned_cols=142 Identities=28% Similarity=0.468 Sum_probs=125.7
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|++|.||++.+..+++.+++|.+.. ...+.+|+++++++ .|+||+++++.+ ......++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSF-QDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEE-EcCCeEEE
Confidence 479999999999999999999988899999998753 23466788999999 599999999998 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+.+..... ++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 79 v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 149 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGR---------FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK 149 (290)
T ss_pred EEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence 999994 788888765432 8899999999999999999999999999999999999999999999999876
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 150 ~~ 151 (290)
T cd05580 150 RV 151 (290)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=230.45 Aligned_cols=147 Identities=26% Similarity=0.426 Sum_probs=124.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++|++.+.||+|+||.||++.+..+++.||+|.+.. ......|+..+.+..+|+|++++++++ ......++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-FREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-ecCCcEEEEh
Confidence 479999999999999999999999999999998753 223455666555555899999999998 5566799999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+.++|.+++...... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..+
T Consensus 80 e~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 80 EVMDTSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhcccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999888877653321 12389999999999999999999997 9999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=241.29 Aligned_cols=153 Identities=24% Similarity=0.378 Sum_probs=125.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-----CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.++||+|+||.||+|.+.. +...||+|.+.. ...+.+|+.++.++..||||+++++++ ....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-TKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-ccCC
Confidence 5788999999999999999998643 235799998853 245678999999995699999999998 5567
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh-------------------------------------------------------
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR------------------------------------------------------- 110 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~------------------------------------------------------- 110 (326)
..+++|||+. ++|.+++.......
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 8999999997 68888876532110
Q ss_pred --------------------------------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 111 --------------------------------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 111 --------------------------------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
.......++...+..++.|++.||.|||+.+++|+||||+||+++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 000112477888899999999999999999999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 275 ~~kL~DfGla~~~ 287 (400)
T cd05105 275 IVKICDFGLARDI 287 (400)
T ss_pred EEEEEeCCcceec
Confidence 9999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=241.15 Aligned_cols=148 Identities=29% Similarity=0.487 Sum_probs=132.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.-...|.+.+.||+|.|+.|.++.+..++..||||.+++ .....+|+++++.+ +||||++++.+. +....+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~-~t~~~l 130 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVI-ETEATL 130 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeee-eeccee
Confidence 356889999999999999999999999999999999863 34478999999999 799999999998 666689
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
|+||||.. +.+.+++..... ..+..+..++.|++.|++|||+..|+|||||.+|++++.+.+++|+|||+
T Consensus 131 ylV~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred EEEEEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecccc
Confidence 99999986 799999887654 66788999999999999999999999999999999999999999999999
Q ss_pred cccccCC
Q 020467 168 ARILLGN 174 (326)
Q Consensus 168 ~~~~~~~ 174 (326)
+..+...
T Consensus 202 S~~~~~~ 208 (596)
T KOG0586|consen 202 STFFDYG 208 (596)
T ss_pred ceeeccc
Confidence 9887533
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=235.72 Aligned_cols=147 Identities=26% Similarity=0.370 Sum_probs=126.1
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc--chhhHHHHHHHHHH-HhcCCCeeEEeEEEEecC---Cce
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--DYQSAFREIEALQI-LQNSPNVVVLHEYFWRED---EDA 88 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~--~~~~~~~E~~~l~~-l~~h~ni~~l~~~~~~~~---~~~ 88 (326)
.-+..+.++.+.||+|.||+||+|.+. |+.||||++. +...|++|.++++. +.+|+||+.+++.-..+. ..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 346789999999999999999999985 5679999996 57789999998877 337999999988653222 248
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEEcCCCc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN--------TIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------~iiH~dlkp~Nili~~~~~ 159 (326)
|++++|.+ |+|++++.... ++......++..++.||++||.. .|.|||||..|||+.+++.
T Consensus 285 wLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred EEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 99999998 89999998743 89999999999999999999942 5999999999999999999
Q ss_pred EEEEeecccccccC
Q 020467 160 LKLADFGQARILLG 173 (326)
Q Consensus 160 ~~l~Dfg~~~~~~~ 173 (326)
+.|+|+|++.....
T Consensus 355 C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 355 CCIADLGLAVRHDS 368 (513)
T ss_pred EEEeeceeeEEecc
Confidence 99999999976533
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=242.24 Aligned_cols=188 Identities=29% Similarity=0.454 Sum_probs=165.8
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------------hhhHHHHHHHHHHHh--cCCCeeEEeE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------------YQSAFREIEALQILQ--NSPNVVVLHE 79 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------------~~~~~~E~~~l~~l~--~h~ni~~l~~ 79 (326)
..-...|+.++.||.|+||.||+|.++.+..+|+||.+.+ ....-.|+++|..+. .|+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 3345779999999999999999999999999999998753 233458999999984 3899999999
Q ss_pred EEEecCCceEEEeeecc--cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC
Q 020467 80 YFWREDEDAVLVLEFLR--TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 80 ~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~ 157 (326)
+| ++..++|++||..+ -+|++++...+. +.+..+..++.|++.|+++||+.||+|||||-+|++++.+
T Consensus 637 fF-Eddd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 637 FF-EDDDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN 706 (772)
T ss_pred ee-ecCCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhccccccccCceecccccccEEEecC
Confidence 99 77888999999987 388898887655 9999999999999999999999999999999999999999
Q ss_pred CcEEEEeecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhc
Q 020467 158 GVLKLADFGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAK 237 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (326)
|-++|+|||.+....++.
T Consensus 707 g~~klidfgsaa~~ksgp-------------------------------------------------------------- 724 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGP-------------------------------------------------------------- 724 (772)
T ss_pred CeEEEeeccchhhhcCCC--------------------------------------------------------------
Confidence 999999999988764444
Q ss_pred cCCCCCCCCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeee
Q 020467 238 NSIDETDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLW 317 (326)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Diw 317 (326)
....+||..|.|||++.|.++.+..-|||
T Consensus 725 ---------------------------------------------------fd~f~gtv~~aapevl~g~~y~gk~qdiw 753 (772)
T KOG1152|consen 725 ---------------------------------------------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIW 753 (772)
T ss_pred ---------------------------------------------------cceeeeeccccchhhhCCCccCCCcchhh
Confidence 34568999999999999988788999999
Q ss_pred eehhhhcc
Q 020467 318 SLAAYLQN 325 (326)
Q Consensus 318 SlG~il~e 325 (326)
+||++||.
T Consensus 754 algillyt 761 (772)
T KOG1152|consen 754 ALGILLYT 761 (772)
T ss_pred hhhheeeE
Confidence 99999995
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-33 Score=231.92 Aligned_cols=153 Identities=22% Similarity=0.352 Sum_probs=129.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++.+-+..||.|+||+|++-.++.+|+.+|||+++ +..+++.|.+...+-.+++||+++|+++ ...+..|++
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~-F~EGdcWiC 141 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL-FSEGDCWIC 141 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh-hcCCceeee
Confidence 456677889999999999999999999999999985 3456777888777777899999999998 455579999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
||+|+.++..+.+.-...... .+++.-+..+....+.||.||-. ..|||||+||+|||++..|.+||||||++..
T Consensus 142 MELMd~SlDklYk~vy~vq~~----~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 142 MELMDISLDKLYKRVYSVQKS----RIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred HHHHhhhHHHHHHHHHHHHhc----cCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 999999888777655443322 28999999999999999999985 4899999999999999999999999999988
Q ss_pred ccCCc
Q 020467 171 LLGNE 175 (326)
Q Consensus 171 ~~~~~ 175 (326)
+..+.
T Consensus 218 Lv~Si 222 (361)
T KOG1006|consen 218 LVDSI 222 (361)
T ss_pred HHHHH
Confidence 75443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=236.52 Aligned_cols=143 Identities=27% Similarity=0.479 Sum_probs=120.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe----EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL----IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..+|++.+.||+|+||.||+|.+..++. .|++|.+.. ...+.+|+.+++.+ .|+||+++++++.. . .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~-~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT-S-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcC-C-C
Confidence 4679999999999999999998765544 489998752 23466788888888 69999999998843 3 4
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++++|+. ++|.+++..... .++...+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccc
Confidence 678888887 788888765432 27888899999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 155 ~a~~~ 159 (316)
T cd05108 155 LAKLL 159 (316)
T ss_pred ccccc
Confidence 98765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=232.57 Aligned_cols=152 Identities=27% Similarity=0.461 Sum_probs=124.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCC-----eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDN-----LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~-----~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|++|.||+|.....+ ..+++|.+.. ...+.+|+..+..+ +|+|++++++++ ....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~-~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVC-TKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEE-cCCC
Confidence 457999999999999999999875444 6799998853 23467889999988 699999999998 5556
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDR-------GDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~-------~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
..++++||+. ++|.+++.......... ....++...+..++.|++.||.|||+.+++|+||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 7899999997 68888886543211100 013478889999999999999999999999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 162 ~~~L~dfg~~~~~ 174 (283)
T cd05048 162 TVKISDFGLSRDI 174 (283)
T ss_pred cEEECCCcceeec
Confidence 9999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=226.97 Aligned_cols=149 Identities=29% Similarity=0.374 Sum_probs=131.7
Q ss_pred ccccCeEEE-eeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEe---cCCceEEE
Q 020467 16 EIIAKYEIL-ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWR---EDEDAVLV 91 (326)
Q Consensus 16 ~~~~~y~i~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~---~~~~~~lv 91 (326)
.+.++|.+. ++||-|-.|.|..|.++.+++.+|+|++.+.....+|++.-.+...|+||+.++++|.. ....+.+|
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 478889885 48999999999999999999999999999999999999998888899999999999832 22457899
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEEeecc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DGVLKLADFGQ 167 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~~~~l~Dfg~ 167 (326)
||.|. |.|+..+...+. ..++++++..|+.||+.|+.|||+.+|.||||||+|+|... +..+||+||||
T Consensus 138 mE~meGGeLfsriq~~g~-------~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGD-------QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eecccchHHHHHHHHccc-------ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 99998 688888877654 34999999999999999999999999999999999999975 55899999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
++.-
T Consensus 211 AK~t 214 (400)
T KOG0604|consen 211 AKET 214 (400)
T ss_pred cccc
Confidence 9864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=229.98 Aligned_cols=144 Identities=29% Similarity=0.425 Sum_probs=125.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
..++|++.+.||+|+||.||+|.+..+++.+++|.+.. .....+|+.+++.+ .|+|++++++.+ ......+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~-~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSY-LSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEE-EeCCEEEEE
Confidence 45689999999999999999999988999999998753 23456788888888 699999999998 556679999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+||++ ++|.+++.... .+++..+..++.|++.||.|||+.+|+|+|++|+||+++.++.++|+|||++..
T Consensus 85 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCcccee
Confidence 99998 57877775432 288999999999999999999999999999999999999999999999999875
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 156 ~ 156 (267)
T cd06646 156 I 156 (267)
T ss_pred e
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=244.04 Aligned_cols=138 Identities=32% Similarity=0.525 Sum_probs=120.6
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
+.+.-++-||.|+.|.||+|+. .++.||||+++.. ...+|+-|+++ .|+||+.|.++| .....++|+|||+. |
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el--kETdIKHLRkL-kH~NII~FkGVC-tqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL--KETDIKHLRKL-KHPNIITFKGVC-TQSPCYCIIMEFCAQG 197 (904)
T ss_pred HHhhhhhhhccCcccceeeeec--cCceehhHHHhhh--hhhhHHHHHhc-cCcceeeEeeee-cCCceeEEeeeccccc
Confidence 3444577899999999999975 5688999988643 24578889999 599999999999 66778999999998 8
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
-|++.+..... ++...+..|..+|+.++.|||.+.|||||||.=||||..+..+||+|||.++.+
T Consensus 198 qL~~VLka~~~---------itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 198 QLYEVLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred cHHHHHhccCc---------cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 89888876443 899999999999999999999999999999999999999999999999998876
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=231.53 Aligned_cols=142 Identities=44% Similarity=0.676 Sum_probs=125.9
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||+|++|.||+|.+..++..+++|.+.. ...+.+|+.+++.+ .|+|++++++++ ......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVF-PHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEE-ecCCeeEEEe
Confidence 58999999999999999999988899999998853 23567889999999 599999999998 5567899999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||++++|.+++.... ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 79 EYMPSDLSEVLRDEE--------RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred cccCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 999889988876533 22889999999999999999999999999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=234.42 Aligned_cols=146 Identities=40% Similarity=0.608 Sum_probs=126.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEecC-Cce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWRED-EDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-~~~ 88 (326)
..++|++.+.||.|++|.||+|.+..+++.||+|.+... ....+|+.+++.+ .|+|++++++++.... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence 467899999999999999999999989999999987521 2346799999999 6999999999985433 468
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+++|||+.++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 84 FLVMEYCEQDLASLLDNMP--------TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEEEecCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcccee
Confidence 9999999998888876532 22889999999999999999999999999999999999999999999999988
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 156 ~~~ 158 (309)
T cd07845 156 RTY 158 (309)
T ss_pred eec
Confidence 754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=234.26 Aligned_cols=142 Identities=44% Similarity=0.675 Sum_probs=124.5
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch----------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
+|++.+.||.|++|.||+|.+..+++.|++|.+... ..+..|+++++.+ .|+|++++++++ ......+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~-~~~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVF-GHKSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhhee-ecCCEEE
Confidence 588999999999999999999888999999988532 2345788999999 599999999998 4467899
Q ss_pred EEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 90 LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 90 lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++|||+.++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 79 lv~e~~~~~L~~~i~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~ 150 (298)
T cd07841 79 LVFEFMETDLEKVIKDKS--------IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR 150 (298)
T ss_pred EEEcccCCCHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeee
Confidence 999999888888876533 128899999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 151 ~~ 152 (298)
T cd07841 151 SF 152 (298)
T ss_pred ec
Confidence 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=229.29 Aligned_cols=146 Identities=38% Similarity=0.601 Sum_probs=125.0
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||.|+||.||+|.+..+++.|++|.+.. ...+.+|+++++.+ +|+|++++++.+ ...+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSF-IEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeE-EECCeEEE
Confidence 689999999999999999999988999999997642 23457789999999 699999999998 45567899
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++||+. ++|.+++...... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~ 154 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccce
Confidence 999998 5887777543221 1237889999999999999999999999999999999999999999999999887
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 155 ~~ 156 (267)
T cd08228 155 FF 156 (267)
T ss_pred ec
Confidence 54
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=227.35 Aligned_cols=142 Identities=27% Similarity=0.427 Sum_probs=123.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
++|++.+.||.|++|.||.|.+..+++.+++|.+.. ...+.+|+++++++ +|+||+++++++ ......
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCL-RDDETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEE-ccCCeE
Confidence 579999999999999999999988899999998742 13456788889888 699999999998 555689
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
++++||+. ++|.+.+..... ++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGA---------LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 99999997 578777765332 78889999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 151 ~~~~ 154 (263)
T cd06625 151 SKRL 154 (263)
T ss_pred ceec
Confidence 8654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=232.88 Aligned_cols=145 Identities=37% Similarity=0.601 Sum_probs=126.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-CceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED-EDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-~~~~ 89 (326)
.++|++.+.||.|++|.||+|.+..+++.+++|.+.. .....+|+.+++++ .|+|++++++++.... ...+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence 4689999999999999999999988899999998852 12346789999999 5999999999884332 6899
Q ss_pred EEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 90 LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 90 lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+++||+.++|.+++..... .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 83 lv~e~~~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 83 MVMEYVEHDLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred EEehhcCcCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 9999999988888765332 28999999999999999999999999999999999999999999999999887
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 155 ~~ 156 (293)
T cd07843 155 EY 156 (293)
T ss_pred ec
Confidence 54
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=224.99 Aligned_cols=144 Identities=30% Similarity=0.480 Sum_probs=123.5
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||.|++|.||.+.+..+++.+++|.+.. ...+.+|+++++++ .|+|++++++.+.......++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999988899999998752 23456788888888 69999999988754555689999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+.+..... ..+++.++..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 80 GFCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred cccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 9997 678777765322 23889999999999999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=229.65 Aligned_cols=144 Identities=39% Similarity=0.603 Sum_probs=123.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|++.+.||.|++|.||+|.+..+++.+++|.+.. ...+.+|+++++++ .|+|++++++++ ......+++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVV-HSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEE-ecCCeEEEE
Confidence 689999999999999999999988899999998752 23467899999999 699999999998 566789999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEEeeccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~~~~~l~Dfg~~~~ 170 (326)
|||+++++.+.+..... ..++...+..++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++..
T Consensus 80 ~e~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPD-------FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred EecccccHHHHHHhCCC-------CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 99999888887754332 12577888899999999999999999999999999999985 55789999998865
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 153 ~ 153 (294)
T PLN00009 153 F 153 (294)
T ss_pred c
Confidence 4
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=231.15 Aligned_cols=143 Identities=27% Similarity=0.451 Sum_probs=124.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.++|++.+.||+|+||.||+|.+..+++.+++|.++. ...+.+|+.+++.+ .|+|++++++.+ ......++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~-~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSY-LRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEE-EeCCEEEEEE
Confidence 4689999999999999999999988999999998753 22456788888888 699999999998 5567899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||++ ++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 86 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 86 EFCGGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred eccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 9998 58888775433 2899999999999999999999999999999999999999999999999988654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=235.04 Aligned_cols=146 Identities=30% Similarity=0.466 Sum_probs=129.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc---chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~---~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+..+-|.++++||+|.||.||+|.++.+|+.+|||.+. +.+.+..|+.++++. ..++++++|+.+ .....+|+||
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSY-FK~sDLWIVM 107 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSY-FKHSDLWIVM 107 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhh-ccCCceEeeh
Confidence 34456889999999999999999999999999999885 466778899999988 589999999998 5566899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||++ |++.+.+..... ++.+..+..++...+.+|+|||...-+|||||..|||++.+|+.+|+|||.+..+
T Consensus 108 EYCGAGSiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred hhcCCCcHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchh
Confidence 9998 788887765432 3999999999999999999999999999999999999999999999999998776
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=232.28 Aligned_cols=142 Identities=29% Similarity=0.449 Sum_probs=124.0
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++|++.+.||+|+||.||++.+..++..+++|.+.. ...+.+|++++.++ +|+||+++++.+ ......++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAF-YSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-eeCCEEEEEe
Confidence 479999999999999999999988999999998753 23467899999999 699999999998 5567899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
||+. ++|.+++..... +++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 79 ey~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 79 EHMDGGSLDQVLKKAGR---------IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred eccCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccc
Confidence 9997 588888765422 8899999999999999999997 6999999999999999999999999998754
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 150 ~ 150 (308)
T cd06615 150 L 150 (308)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=231.23 Aligned_cols=145 Identities=28% Similarity=0.470 Sum_probs=126.1
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.....+|++.+.||+|++|.||++.+..+++.+++|.+.. ...+.+|+.+++.+ .|+|++++++.+ ......+
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~-~~~~~~~ 93 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSY-LVGDELW 93 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEE-EeCCEEE
Confidence 3567899999999999999999999988999999998752 34567788888887 699999999988 4566899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+++||+. ++|.+++... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 94 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EeecccCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 9999997 5888776432 1788889999999999999999999999999999999999999999999987
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 164 ~~~ 166 (296)
T cd06654 164 AQI 166 (296)
T ss_pred hhc
Confidence 654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=229.67 Aligned_cols=149 Identities=28% Similarity=0.476 Sum_probs=127.3
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-----C
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWRED-----E 86 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-----~ 86 (326)
+..++|++.+.||+|+||.||+|.+..+++.+++|.+.. ...+..|+..+.++.+|+|++++++.+.... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 356789999999999999999999988999999998753 3456788888888867999999999985432 3
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccC
Confidence 5899999998 588887765322 23888999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 156 g~~~~~ 161 (272)
T cd06637 156 GVSAQL 161 (272)
T ss_pred CCceec
Confidence 998654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=231.88 Aligned_cols=146 Identities=29% Similarity=0.469 Sum_probs=126.7
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++.++|++.+.||+|++|.||++.+..+++.|++|.+.. ...+.+|+.+++.+ +|+|++++++.+ ......
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~-~~~~~~ 91 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSY-LVGDEL 91 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEE-ecCCEE
Confidence 34677999999999999999999999988999999998852 33456788888888 799999999998 556689
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||++ ++|.+++... .++...+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 92 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~ 161 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 161 (297)
T ss_pred EEeecccCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999997 5777776432 178889999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 162 ~~~~ 165 (297)
T cd06656 162 CAQI 165 (297)
T ss_pred ceEc
Confidence 7654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=226.07 Aligned_cols=146 Identities=37% Similarity=0.589 Sum_probs=126.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|++|.||+|.+..+++.+++|.++. ...+.+|+++++++ .|++++++++.+ ...+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~-~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASF-IENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeee-ecCCeEEE
Confidence 689999999999999999999988999999997741 34567899999999 699999999998 55667999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++...... ...++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~ 154 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceee
Confidence 999998 5888877543221 1237889999999999999999999999999999999999999999999999876
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 155 ~~ 156 (267)
T cd08224 155 FF 156 (267)
T ss_pred ec
Confidence 54
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=228.01 Aligned_cols=144 Identities=40% Similarity=0.686 Sum_probs=125.8
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
+|++.++||.|++|.||+|.+..++..|++|.+.. .....+|+.+++.+ +|+|++++++.+ ......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVI-HTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeE-eeCCcEEEEEe
Confidence 58999999999999999999988999999998752 34566889999999 699999999998 55667899999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+.++|.+++..... ...+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++...
T Consensus 79 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 79 YMDKDLKKYMDTHGV------RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred cCCccHHHHHHhcCC------CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 999998888764331 123899999999999999999999999999999999999999999999999988644
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=224.53 Aligned_cols=143 Identities=29% Similarity=0.501 Sum_probs=124.4
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|.+.+.||+|++|.||+|.+..+++.+++|.+.. ...+.+|+++++.+ +|+|++++++.+ ...+..++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESF-LDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeee-ccCCEEEEEE
Confidence 48899999999999999999988999999998742 34566788889888 699999999998 5566899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++..... ..++...++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 79 EYAENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EeCCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 9996 688887765321 23888999999999999999999999999999999999999999999999988755
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=233.08 Aligned_cols=147 Identities=39% Similarity=0.627 Sum_probs=125.6
Q ss_pred CeEEEeeeccccCcEEEEEEEcC--CCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCce
Q 020467 20 KYEILECVGSGAYSDVYKGRRLS--DNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DEDA 88 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~--~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~ 88 (326)
+|++.+.||+|++|.||+|.+.. ++..||+|.+.. .....+|+.++..+ +|+|++++++++... ....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 58999999999999999999887 789999998865 23567889999999 699999999998443 1679
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC----CCcEEEEe
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD----DGVLKLAD 164 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~----~~~~~l~D 164 (326)
+++|||+++++.+.+....... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 9999999988887775443211 123889999999999999999999999999999999999999 89999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++..+
T Consensus 156 fg~~~~~ 162 (316)
T cd07842 156 LGLARLF 162 (316)
T ss_pred Ccccccc
Confidence 9988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=226.15 Aligned_cols=152 Identities=23% Similarity=0.377 Sum_probs=124.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC-----CeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD-----NLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|+||.||+|.+... +..+++|.+... ..+.+|+.+++.+ +|+|++++++++ ....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVV-STGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEE-cCCC
Confidence 57899999999999999999987543 478999987632 2456788888888 699999999998 5567
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKRED-RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..+++|||+. ++|.+++......... .....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 7999999997 7888887653321111 1122367888999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 163 fg~~~~~ 169 (277)
T cd05032 163 FGMTRDI 169 (277)
T ss_pred cccchhh
Confidence 9988654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=227.04 Aligned_cols=145 Identities=24% Similarity=0.449 Sum_probs=125.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
..+|.+.+.||+|++|.||+|.+..++..+++|.+... ..+.+|++.++.+ .|+|++++++++ ......+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVC-TREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEE-cCCCCcEEEEE
Confidence 45699999999999999999999888999999988642 3467899999998 699999999998 55667899999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... ..++...+..++.|++.+|.|||+.+++|+||+|+||++++++.++|+|||++...
T Consensus 83 ~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 83 FMTYGNLLDYLRECNR-------QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred eCCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 997 688887754321 22788899999999999999999999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=236.43 Aligned_cols=144 Identities=31% Similarity=0.521 Sum_probs=125.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.|++|.+.. ...+.+|+.+++++ +|+|++++++++....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCcc
Confidence 367899999999999999999999998999999998752 23456789999998 6999999999884332
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...+++|||+.++|.+.+... ++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 92 EFQDVYLVMELMDANLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred ccCcEEEEEeccCCCHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEc
Confidence 357999999999888776432 7788889999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 161 Dfg~~~~~ 168 (353)
T cd07850 161 DFGLARTA 168 (353)
T ss_pred cCccceeC
Confidence 99998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=226.37 Aligned_cols=157 Identities=29% Similarity=0.445 Sum_probs=131.4
Q ss_pred cccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 10 ~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
.+.......++|.+.+.||+|+||.||++.+..+++.+++|.+.. ...+.+|+.+++++.+|+|++++++++....
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 345556678999999999999999999999988999999998853 2445678888888867999999999985432
Q ss_pred ----CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 020467 86 ----EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 86 ----~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 160 (326)
...++++||+. ++|.+++...... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCE
Confidence 35899999997 5887776543211 1238899999999999999999999999999999999999999999
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
+|+|||++...
T Consensus 168 kl~dfg~~~~~ 178 (291)
T cd06639 168 KLVDFGVSAQL 178 (291)
T ss_pred EEeecccchhc
Confidence 99999988764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=226.90 Aligned_cols=153 Identities=22% Similarity=0.379 Sum_probs=125.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC-----CeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD-----NLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|++|.||++..... ...+++|.+... ..+.+|+.+++++.+|+||+++++++ ....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC-TQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-cCCC
Confidence 56899999999999999999987533 378999987531 24667888888886699999999998 5566
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh-------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
..+++|||+. ++|..++....... .......++...+..++.|++.||.|||+.+|+|+||+|+||+++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 7999999987 68888876432100 001123488999999999999999999999999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++..+
T Consensus 170 ~~kL~Dfg~~~~~ 182 (293)
T cd05053 170 VMKIADFGLARDI 182 (293)
T ss_pred eEEeCcccccccc
Confidence 9999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=229.29 Aligned_cols=155 Identities=26% Similarity=0.455 Sum_probs=129.4
Q ss_pred cccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEe--
Q 020467 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWR-- 83 (326)
Q Consensus 10 ~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~-- 83 (326)
++.......++|++.+.||.|+||.||+|.+..+++.+++|.+.. ...+..|+.++.++.+|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 444444567899999999999999999999988999999998753 23456788888888779999999998843
Q ss_pred ---cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 84 ---EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 84 ---~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
.....+++|||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG-------NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC
Confidence 2356899999998 588877765332 22788889999999999999999999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 160 ~~l~dfg~~~~~ 171 (282)
T cd06636 160 VKLVDFGVSAQL 171 (282)
T ss_pred EEEeeCcchhhh
Confidence 999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=231.33 Aligned_cols=143 Identities=38% Similarity=0.661 Sum_probs=122.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|++.+.||+|++|.||+|.+..+++.+++|.+.. ...+.+|+++++.+ +|+|++++++++ ......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVF-RRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhc-ccCCeEEEE
Confidence 479999999999999999999988899999998742 23456889999998 699999999998 567789999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+||+.+++.+.+.... ..++...+..++.|++.+|.|||+.+++|+||+|+||++++++.++|+|||++..+
T Consensus 79 ~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 79 FEFVDHTVLDDLEKYP--------NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred EecCCccHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 9999975554443221 12889999999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=230.59 Aligned_cols=143 Identities=41% Similarity=0.689 Sum_probs=125.6
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||.|++|.||+|.+..+++.+++|.+.. ...+.+|+++++++ +|+|++++++++ .+....+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVI-HTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhc-ccCCcEEEEe
Confidence 58899999999999999999988999999998752 23567899999999 699999999998 5667899999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+.++|.+++..... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 e~~~~~l~~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 79 EFLHQDLKKFMDASPL-------SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred eccccCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999888877754322 23889999999999999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=227.63 Aligned_cols=142 Identities=37% Similarity=0.603 Sum_probs=122.0
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecC-CceEEEee
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWRED-EDAVLVLE 93 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-~~~~lv~e 93 (326)
|++.+.||+|++|.||+|.+..++..+++|.++.. ....+|+..+.++.+|+|++++++++.... +..++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67899999999999999999889999999987531 233568888888867999999999984431 67899999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+.+++.+.+..... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. +.++|+|||++..+
T Consensus 81 ~~~~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 81 LMDMNLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred cCCccHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 999998888765321 2899999999999999999999999999999999999999 99999999988654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=228.27 Aligned_cols=143 Identities=39% Similarity=0.690 Sum_probs=125.4
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|++.+.||+|++|.||+|.+..+++.|++|.++. ...+.+|+++++.+ .|+|++++++.+ ...+..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAF-RRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheE-EECCEEEEE
Confidence 479999999999999999999988899999998753 24567899999999 599999999998 456679999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+||+++++...+.... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 79 FEYVERTLLELLEASP--------GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred EecCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 9999987776654332 22889999999999999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=230.60 Aligned_cols=147 Identities=42% Similarity=0.634 Sum_probs=126.4
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
+..++|++.+.||+|++|.||+|.+..+++.|++|.+.. .....+|+++++++ .|+|++++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccc
Confidence 567889999999999999999999988999999998742 12346789999999 6999999999874332
Q ss_pred ----CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 020467 86 ----EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 86 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 161 (326)
...+++|||+.+++.+.+..... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~k 159 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILK 159 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEE
Confidence 24699999999988887754321 289999999999999999999999999999999999999999999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 160 l~dfg~~~~~ 169 (310)
T cd07865 160 LADFGLARAF 169 (310)
T ss_pred ECcCCCcccc
Confidence 9999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=227.90 Aligned_cols=143 Identities=26% Similarity=0.376 Sum_probs=121.6
Q ss_pred CeEEEeeeccccCcEEEEEEE----cCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCce
Q 020467 20 KYEILECVGSGAYSDVYKGRR----LSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DEDA 88 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~----~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~ 88 (326)
-|++++.||+|+||.||+|.. ..++..+++|.+.. ...+.+|+.+++.+ .|+|++++++++... ....
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCce
Confidence 468899999999999999974 35678899998852 23567899999999 699999999988554 3568
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcc
Confidence 99999996 688887754321 278889999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 156 ~~~~ 159 (284)
T cd05079 156 TKAI 159 (284)
T ss_pred cccc
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=229.08 Aligned_cols=144 Identities=28% Similarity=0.483 Sum_probs=125.4
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
....+|++.+.||.|++|.||++.+..+++.+++|.+.. ...+.+|+..++.+ +|+|++.+++.+ ......++
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~~l 93 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSF-LVGDELFV 93 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeE-ecCceEEE
Confidence 455789999999999999999999988999999998752 34567788999888 699999999998 55668999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++||+. ++|..++... .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 94 v~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 94 VMEYLAGGSLTDVVTET----------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred EEEecCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccch
Confidence 999997 5776666432 28899999999999999999999999999999999999999999999999876
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 164 ~~ 165 (296)
T cd06655 164 QI 165 (296)
T ss_pred hc
Confidence 54
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=229.71 Aligned_cols=151 Identities=25% Similarity=0.415 Sum_probs=123.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe--EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL--IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~--~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.+.||+|+||.||+|.+..++. .+++|.+.. ...+.+|+.++.++.+|+|++++++++ ...+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-CCCCCce
Confidence 5689999999999999999999876664 457776643 224567899999986799999999998 5566799
Q ss_pred EEeeecc-cCHHHHHHHhhhhhh-------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 020467 90 LVLEFLR-TDLATVIAESKKKRE-------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 161 (326)
+++||+. ++|.+++........ ......++...+..++.|++.||+|||+.|++||||||+||+++.++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 9999997 688888865432110 00112478999999999999999999999999999999999999999999
Q ss_pred EEeecccc
Q 020467 162 LADFGQAR 169 (326)
Q Consensus 162 l~Dfg~~~ 169 (326)
|+|||++.
T Consensus 165 l~dfg~~~ 172 (303)
T cd05088 165 IADFGLSR 172 (303)
T ss_pred eCccccCc
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=224.66 Aligned_cols=137 Identities=27% Similarity=0.460 Sum_probs=118.2
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
+.||+|+||.||+|.+..+++.+++|.+.. ...+.+|+++++.+ .|+||+++++++ ......+++|||+. +
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVC-TQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE-cCCCCeEEEEeeccCC
Confidence 468999999999999988899999998753 23467889999998 699999999998 55667999999997 5
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~L~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 144 (252)
T cd05084 79 DFLTFLRTEG--------PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREE 144 (252)
T ss_pred cHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccc
Confidence 8877775422 12788999999999999999999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=224.77 Aligned_cols=143 Identities=25% Similarity=0.374 Sum_probs=122.3
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCc
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DED 87 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~ 87 (326)
++|++.+.||+|+||.||.+.+..++..|++|.+.. ...+.+|+.+++++ .|+||+++++.+... ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 579999999999999999999988999999997641 12456788999999 699999999987443 345
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
++++|||+. ++|.+++..... ++......++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGA---------LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCc
Confidence 789999997 588877754322 7888899999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 152 ~~~~~ 156 (265)
T cd06652 152 ASKRL 156 (265)
T ss_pred ccccc
Confidence 88754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=227.37 Aligned_cols=144 Identities=24% Similarity=0.417 Sum_probs=122.5
Q ss_pred cCeEEEeeeccccCcEEEEEEE----cCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEe-cCCce
Q 020467 19 AKYEILECVGSGAYSDVYKGRR----LSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWR-EDEDA 88 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~----~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~-~~~~~ 88 (326)
.+|++.+.||+|+||.||++.. ..++..|++|.+.. ...+.+|+++++.+ .|+|++++++++.. .....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCce
Confidence 4799999999999999999973 45688999999853 23567899999998 69999999998643 33568
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
++++||+. ++|.+++..... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 99999997 689888764321 278899999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 155 ~~~~ 158 (284)
T cd05081 155 TKVL 158 (284)
T ss_pred cccc
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=224.04 Aligned_cols=144 Identities=30% Similarity=0.504 Sum_probs=125.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.++|++.+.||.|++|.||+|.+..+++.+++|.+.. ...+.+|+.+++.+ +|+|++++++.+ ......+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~-~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSY-LRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEE-EeCCEEEEEE
Confidence 4789999999999999999999988889999998753 34577889999998 699999999988 5566799999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 80 EYCGGGSLQDIYQVTR--------GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred eCCCCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhh
Confidence 9998 47776665432 12889999999999999999999999999999999999999999999999988654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=229.14 Aligned_cols=144 Identities=32% Similarity=0.478 Sum_probs=122.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
..+.|+++++||.|+||.||+|.+..+++.+++|.+.. ...+.+|+.+++.+ .|+|++++++.+ ...+..+++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAF-YWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEE-EeCCeEEEE
Confidence 35779999999999999999999988899999998853 23456788888888 599999999998 455689999
Q ss_pred eeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+.+ +|...+.... ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 88 IEFCPGGAVDAIMLELD--------RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred EecCCCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999985 5555543322 1288999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=224.01 Aligned_cols=144 Identities=23% Similarity=0.391 Sum_probs=123.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch---hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY---QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~---~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.++|++.+.||+|++|.||++.. .+..+++|.+... ..+.+|+.+++++ .|++++++++++....+..++++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35799999999999999999976 4677899988642 3467899999998 6999999999876666778999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+. ++|.+++..... ..+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 82 MAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence 97 688888765332 22788899999999999999999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=227.41 Aligned_cols=152 Identities=24% Similarity=0.461 Sum_probs=123.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEE----cCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRR----LSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~----~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++.+.||+|+||.||+|.. ...+..+++|.+.. ...+.+|+.+++.+ .|+|++++++++ .....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVV-TQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEE-ecCCc
Confidence 36799999999999999999975 24567899998853 23467799999999 699999999998 55667
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhh--------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKR--------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~--------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
.+++|||+. ++|.+++....... .......++...+..++.|++.||.|||+.+++|+||+|+||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 999999997 68888875332100 000012378888999999999999999999999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 162 ~~kl~dfg~~~~~ 174 (283)
T cd05090 162 HVKISDLGLSREI 174 (283)
T ss_pred cEEeccccccccc
Confidence 9999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=223.71 Aligned_cols=142 Identities=24% Similarity=0.423 Sum_probs=121.8
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
++|++.+.||+|+||.||++... .+..+++|.+.. ...+.+|+.+++++ +|+|++++++++ ......+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVC-TQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEE-ccCCCEEEEEEc
Confidence 56899999999999999999865 345789998753 34567899999999 699999999998 566779999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+. ++|.+.+..... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 81 MENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred CCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 97 688877754321 2788999999999999999999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=223.84 Aligned_cols=144 Identities=22% Similarity=0.422 Sum_probs=123.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.++||+|++|.||+|... ++..+++|.+.. ...+.+|+.+++++ +|+|++++++.+ ...+..++++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVV-TKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEE-cCCCCcEEEEe
Confidence 578999999999999999999864 456789998753 34567899999998 699999999988 55677899999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 82 YMAKGSLLDFLKSDEG-------GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred cCCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 996 688888765322 22788889999999999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=235.40 Aligned_cols=154 Identities=21% Similarity=0.374 Sum_probs=125.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|+||.||+|.+. .+++.||||.++. ...+.+|+.++..+.+|+|++++++++.....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 468999999999999999999743 4578899998853 23466899999999779999999998866666
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh-------------------------------------------------------
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR------------------------------------------------------- 110 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~------------------------------------------------------- 110 (326)
..+++|||+. ++|.+++.......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 7899999998 68888875421100
Q ss_pred ---hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 111 ---EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 111 ---~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.......++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 0000123678888999999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=226.40 Aligned_cols=153 Identities=23% Similarity=0.361 Sum_probs=122.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
..++|++.+.||+|++|.||.|.+. .++..+++|.+.. ...+.+|+.+++.+ +|+|++++++++ ...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~-~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVV-SQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE-cCC
Confidence 3678999999999999999999764 2356799998753 22356788888888 699999999998 566
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDR-GDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...+++|||+. ++|.+++.......... ....++...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 68999999987 68888775432211000 01225677889999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++..+
T Consensus 162 dfg~~~~~ 169 (277)
T cd05062 162 DFGMTRDI 169 (277)
T ss_pred CCCCcccc
Confidence 99988654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=229.42 Aligned_cols=153 Identities=20% Similarity=0.356 Sum_probs=124.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-------CCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-------DNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
.++|.+.+.||+|+||.||++.+.. +...+++|.+... ..+..|+.+++.+..|+|++++++++ ..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-TQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-ec
Confidence 5789999999999999999997643 2356999988632 24667888998886799999999998 55
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhh-------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD 156 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~ 156 (326)
....+++|||+. ++|.+++....... .......++...+..++.|++.||+|||+.|++|+||+|+||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 567999999997 68988886542210 0011223788899999999999999999999999999999999999
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 176 ~~~~kL~dfg~a~~~ 190 (307)
T cd05098 176 DNVMKIADFGLARDI 190 (307)
T ss_pred CCcEEECCCcccccc
Confidence 999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=225.83 Aligned_cols=146 Identities=20% Similarity=0.363 Sum_probs=122.0
Q ss_pred ccccCeEEEeee--ccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 16 EIIAKYEILECV--GSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 16 ~~~~~y~i~~~L--g~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
+..++|++.+.+ |+|+||.||++....++..+++|.+........|+.....+.+|+|++++++.+ ...+..+++||
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~-~~~~~~~iv~e 89 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSV-TTLKGHVLIMD 89 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEE-ecCCeeEEEEE
Confidence 456788888877 999999999999999999999999865332233444444444799999999998 44568999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++...
T Consensus 90 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 90 YIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 997 68988886543 289999999999999999999999999999999999999988 9999999987654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=222.01 Aligned_cols=143 Identities=30% Similarity=0.506 Sum_probs=125.2
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||.|+||.||.+.+..+++.+++|.+.. ...+.+|+++++++ +|+|++++++++ .+....+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~-~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHF-MDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEE-ecCCeEEEEE
Confidence 69999999999999999999999999999997642 23467899999998 699999999999 5567899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+.+..... ..++...+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 79 EYANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred EecCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 9997 688888765421 22888999999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=234.25 Aligned_cols=145 Identities=32% Similarity=0.532 Sum_probs=125.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED---- 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~---- 85 (326)
+.++|.+.+.||.|++|.||+|.+..+++.|++|.+.. .....+|+.+++.+ +|+|++++++++....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheeccccccc
Confidence 45789999999999999999999999999999998752 23456788999998 6999999999874332
Q ss_pred CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 86 EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 86 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
...++++||++++|.+.+.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcC
Confidence 3589999999999888776532 2899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 153 g~~~~~ 158 (337)
T cd07858 153 GLARTT 158 (337)
T ss_pred cccccc
Confidence 988654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=229.22 Aligned_cols=144 Identities=23% Similarity=0.375 Sum_probs=124.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|++|.||+|.+..+++.+++|.+.. ...+..|++++..+ .|+||+++++.+ ......++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASF-QTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeee-ecCCEEEE
Confidence 479999999999999999999988899999998853 22456788899888 599999999998 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++..... ..+++..+..++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus 79 v~e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEEecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 999987 588887764321 238899999999999999999999999999999999999999999999999887
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 152 ~~ 153 (316)
T cd05574 152 QS 153 (316)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=228.58 Aligned_cols=153 Identities=22% Similarity=0.392 Sum_probs=124.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-------CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-------SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-------~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
.++|.+.+.||+|+||.||.|.+. ..+..+++|.+.. ...+.+|+.+++.+..|+||+++++.+ ..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-TQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE-ec
Confidence 678999999999999999999742 2345789998753 234678899998886799999999998 55
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhhh-------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKRED-------RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD 156 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~ 156 (326)
....+++|||+. ++|.+++......... .....++...+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 667899999997 6888888653211000 01123788889999999999999999999999999999999999
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 173 ~~~~kl~D~g~~~~~ 187 (304)
T cd05101 173 NNVMKIADFGLARDV 187 (304)
T ss_pred CCcEEECCCccceec
Confidence 999999999998755
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=229.09 Aligned_cols=144 Identities=31% Similarity=0.493 Sum_probs=125.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.++|++.+.||.|++|.||++.+..++..+++|.+.. ...+..|+++++++ +|+|++++++.+ ......+++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAY-FYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEE-ecCCeEEEEe
Confidence 5789999999999999999999988899999998753 23466789999999 599999999998 5566899999
Q ss_pred eeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+.+ +|.+++.... ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~L~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 82 EFCDGGALDSIMLELE--------RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred eccCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 99984 7777765432 22899999999999999999999999999999999999999999999999987553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=236.48 Aligned_cols=145 Identities=28% Similarity=0.342 Sum_probs=123.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc--chhhHHHHHHHHHHH-hcCCCeeEEeEEEEec---CCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--DYQSAFREIEALQIL-QNSPNVVVLHEYFWRE---DEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~--~~~~~~~E~~~l~~l-~~h~ni~~l~~~~~~~---~~~~~lv 91 (326)
.+..++.++||+|.||.||+|.. .++.||||++. ..+.+.+|.+++... ..|+||++++++-... ...+|+|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 56788899999999999999965 56899999996 467788888887663 2699999999874221 2369999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeccCCCCCeEEcCCCcEE
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR---------NTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~---------~~iiH~dlkp~Nili~~~~~~~ 161 (326)
++|.+ |+|.+++..+. +++.+...++..|+.||+|||+ ..|+|||||.+|||+..++.+.
T Consensus 287 t~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred eeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 99998 89999998653 8999999999999999999995 2599999999999999999999
Q ss_pred EEeecccccccCC
Q 020467 162 LADFGQARILLGN 174 (326)
Q Consensus 162 l~Dfg~~~~~~~~ 174 (326)
|+|||++.++...
T Consensus 357 IaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 357 IADFGLALRLEPG 369 (534)
T ss_pred eeccceeEEecCC
Confidence 9999999988533
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=224.61 Aligned_cols=151 Identities=26% Similarity=0.458 Sum_probs=128.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-----C
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWRED-----E 86 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-----~ 86 (326)
...++|++.+.||+|++|.||+|.+..+++.+++|.+.. ...+.+|+.+++++..|+|++++++++.... .
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 457899999999999999999999988889999998763 3456788999999877999999999985432 3
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++...... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999998 4777776543311 123889999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 158 ~~~~~~ 163 (275)
T cd06608 158 GVSAQL 163 (275)
T ss_pred ccceec
Confidence 988654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=237.12 Aligned_cols=143 Identities=29% Similarity=0.465 Sum_probs=122.8
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCC---eE-EEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDN---LI-VALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~---~~-vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
++..+.++||+|+||.||+|.....+ .. ||+|.... ...+++|.++++.+ +|+||+++|++. ....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa-~~~~ 234 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVA-VLEE 234 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-cCCC
Confidence 34566799999999999999875432 23 89997752 34678999999998 799999999998 5566
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
.++++||++. |+|.+++.+.... ++..+...++.+.+.||+|||+++++||||..+|+|++.++.+||+||
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~--------v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKS--------LPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCC--------CCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcc
Confidence 7999999998 6999999876542 899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 307 GLs~~~ 312 (474)
T KOG0194|consen 307 GLSRAG 312 (474)
T ss_pred ccccCC
Confidence 997653
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=249.32 Aligned_cols=146 Identities=29% Similarity=0.445 Sum_probs=124.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
..+-|.|+..||.|+||.||+|..+.++...|.|++.. ...+..|+++|... .||+|+++++.|.. .+.+|++
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~-enkLwil 107 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYF-ENKLWIL 107 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhc-cCceEEE
Confidence 45668999999999999999999988888888888752 45678899999999 59999999998844 4569999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.||++|+.-+.+.-.. ++.+++.++..+++|++.||.|||+.+|||||||..|||+..+|.++|+|||.+...
T Consensus 108 iEFC~GGAVDaimlEL-------~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL-------GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred EeecCCchHhHHHHHh-------ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc
Confidence 9999975555443221 345999999999999999999999999999999999999999999999999987654
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=226.37 Aligned_cols=143 Identities=29% Similarity=0.454 Sum_probs=119.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe----EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL----IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++.+.||+|+||+||+|.+..++. .||+|.+.. ...+.+|+..+..+ +|+|++.+++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT--ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC--CC
Confidence 4679999999999999999998766554 488998752 23456778888887 69999999998842 34
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++++|+. ++|.+++..... .++...+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG 154 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFG 154 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCC
Confidence 778999987 788888765321 28899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 155 ~~~~~ 159 (279)
T cd05109 155 LARLL 159 (279)
T ss_pred ceeec
Confidence 98765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=227.18 Aligned_cols=152 Identities=24% Similarity=0.385 Sum_probs=123.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC----------------CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD----------------NLIVALKEVHD------YQSAFREIEALQILQNSPNVV 75 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~----------------~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~ 75 (326)
.++|++.+.||+|+||.||+|.+... +..+++|.+.. ...+.+|+++++++ .|+|++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEe
Confidence 46899999999999999999876543 35688998753 23466789999999 699999
Q ss_pred EEeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 020467 76 VLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKRED--RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNL 152 (326)
Q Consensus 76 ~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Ni 152 (326)
++++++ ......++++|++. ++|.+++......... .....++...+..++.|++.||.|||+.+++|+||||+||
T Consensus 83 ~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 83 RLLGVC-TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEE-ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999998 45568999999997 6888887654311100 0112388999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeecccccc
Q 020467 153 LIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 153 li~~~~~~~l~Dfg~~~~~ 171 (326)
+++.++.++|+|||++..+
T Consensus 162 li~~~~~~~l~dfg~~~~~ 180 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred eecCCCceEEccccceeec
Confidence 9999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=223.47 Aligned_cols=144 Identities=24% Similarity=0.422 Sum_probs=123.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC---CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD---NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.+.||+|+||.||+|.+... ...+++|.+.. ...+.+|+..++.+ +|+||+++++.+ ......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVV-TKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEE-ecCCce
Confidence 36799999999999999999987543 45799998753 23456788999888 699999999988 556679
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||+
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccch
Confidence 99999997 588887755322 288999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 153 ~~~~ 156 (266)
T cd05033 153 SRRL 156 (266)
T ss_pred hhcc
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=229.67 Aligned_cols=146 Identities=36% Similarity=0.626 Sum_probs=125.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED---- 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~---- 85 (326)
..++|++.++||.|++|.||+|.+..+++.+++|.+.. .....+|+++++.+ +|+||+++++.+....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence 36899999999999999999999988999999998742 23467899999999 6999999998874433
Q ss_pred ---CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 020467 86 ---EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 86 ---~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l 162 (326)
..++++++|+..++...+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|
T Consensus 85 ~~~~~~~lv~~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 85 RKRGSVYMVTPYMDHDLSGLLENPS--------VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred ccCceEEEEEecCCcCHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 2479999999988877765432 22899999999999999999999999999999999999999999999
Q ss_pred Eeecccccc
Q 020467 163 ADFGQARIL 171 (326)
Q Consensus 163 ~Dfg~~~~~ 171 (326)
+|||++...
T Consensus 157 ~dfg~~~~~ 165 (311)
T cd07866 157 ADFGLARPY 165 (311)
T ss_pred CcCccchhc
Confidence 999988765
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=226.99 Aligned_cols=152 Identities=24% Similarity=0.385 Sum_probs=124.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEE-----cCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRR-----LSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|.+.+.||.|+||.||++.. ..++..+++|.+.. ...+.+|+.+++++ .|+|++++++++ .....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVC-VEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE-ecCCc
Confidence 46799999999999999999975 23456789998753 33567899999999 699999999998 55678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhh----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKRE----DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~----~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l 162 (326)
.++++||+. ++|.+++........ ......+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999997 688888764431100 011123899999999999999999999999999999999999999999999
Q ss_pred Eeecccccc
Q 020467 163 ADFGQARIL 171 (326)
Q Consensus 163 ~Dfg~~~~~ 171 (326)
+|||++...
T Consensus 162 ~dfg~~~~~ 170 (288)
T cd05093 162 GDFGMSRDV 170 (288)
T ss_pred ccCCccccc
Confidence 999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=257.02 Aligned_cols=148 Identities=30% Similarity=0.425 Sum_probs=119.9
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED---- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~---- 85 (326)
.-..+|+.++.||+||||.||+++++-+|+.||||++.- ...+.+|+.+++++ +|||+++++..|.+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccc
Confidence 356788899999999999999999999999999999863 34578999999999 7999998887331100
Q ss_pred --------------------------------------------------------------------------------
Q 020467 86 -------------------------------------------------------------------------------- 85 (326)
Q Consensus 86 -------------------------------------------------------------------------------- 85 (326)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHH
Q 020467 86 ----------------------------------EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131 (326)
Q Consensus 86 ----------------------------------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~ 131 (326)
..+||-|||++.++...+...+... -....++.++++|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-------~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-------SQRDEAWRLFREIL 707 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-------hhhHHHHHHHHHHH
Confidence 0136777777766665554433210 13667899999999
Q ss_pred HHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 132 ~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+||.|+|++|||||||||.||++++++.+||.|||++...
T Consensus 708 EGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 708 EGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred HHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 9999999999999999999999999999999999998763
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=219.67 Aligned_cols=149 Identities=26% Similarity=0.437 Sum_probs=122.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++.+.+..||.|..|.||+++.+.++..+|||.+.. .++++..+.++.+-..+|+|++.+++|.. ....+++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~Ic 169 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVFIC 169 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHHHH
Confidence 3556778899999999999999999999999999864 33445555555444358999999999954 4579999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
||.|..-+..++..... .+++..+-++...++.||.||-. ++|+|||+||+|||+|..|++||||||++..
T Consensus 170 MelMs~C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 170 MELMSTCAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred HHHHHHHHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 99998766666665432 39999999999999999999984 5899999999999999999999999999988
Q ss_pred ccCCc
Q 020467 171 LLGNE 175 (326)
Q Consensus 171 ~~~~~ 175 (326)
+..+.
T Consensus 242 lvdSk 246 (391)
T KOG0983|consen 242 LVDSK 246 (391)
T ss_pred eeccc
Confidence 75444
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=228.36 Aligned_cols=146 Identities=29% Similarity=0.486 Sum_probs=127.1
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++.++|++.+.||+|++|.||+|.+..+++.|++|.+.. ...+.+|+++++.+ +|+|++++.+++ ....
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~-~~~~ 88 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCY-LREH 88 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-EeCC
Confidence 3566889999999999999999999988899999998742 13467889999998 699999999998 5566
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
..++++||+.+++.+.+..... .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~~lv~e~~~g~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 89 TAWLVMEYCLGSASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred eEEEEHHhhCCCHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecC
Confidence 7899999999988877754321 28899999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 167 QARI 170 (326)
Q Consensus 167 ~~~~ 170 (326)
++..
T Consensus 161 ~~~~ 164 (307)
T cd06607 161 SASL 164 (307)
T ss_pred ccee
Confidence 8754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=231.75 Aligned_cols=143 Identities=31% Similarity=0.526 Sum_probs=123.1
Q ss_pred CeEEEeeeccccCcEEEEEEEcCC--CeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec---CCc
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSD--NLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE---DED 87 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~--~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~---~~~ 87 (326)
+|++.+.||+|+||.||++.+... +..+|+|.+.. .....+|+.+++++.+|+||+++++.+... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999998877 88999998753 234677899999987799999999875322 245
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
.++++++++++|.+.+.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEecccCCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 78999999999888875432 288999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 152 a~~~ 155 (332)
T cd07857 152 ARGF 155 (332)
T ss_pred ceec
Confidence 8765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=226.12 Aligned_cols=143 Identities=26% Similarity=0.414 Sum_probs=117.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe----EEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL----IVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++.+.||.|+||.||+|.+..++. .+++|.+... ..+..|+..+..+ .|+||+++++++ . ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~-~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGIC-P-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEE-C-CCc
Confidence 4678999999999999999999866654 4777877431 2334455566667 699999999986 3 345
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++++|+. ++|.+++..... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCc
Confidence 778899987 799888865322 28899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 155 ~~~~~ 159 (279)
T cd05111 155 VADLL 159 (279)
T ss_pred cceec
Confidence 98765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=227.60 Aligned_cols=152 Identities=27% Similarity=0.410 Sum_probs=124.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|.+.+.||+|+||.||+|.+. .+++.+++|.+.. ...+.+|+++++.+ .|+|++++++++ ....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVC-TEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEE-ecCC
Confidence 467899999999999999999764 3357899998853 34567899999999 699999999998 5557
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhh-----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKRE-----DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 160 (326)
..+++|||+. ++|.+++........ ......++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 8999999997 688888865432110 0012237888999999999999999999999999999999999999999
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
+|+|||++...
T Consensus 162 kl~d~g~~~~~ 172 (280)
T cd05049 162 KIGDFGMSRDV 172 (280)
T ss_pred EECCcccceec
Confidence 99999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=230.52 Aligned_cols=144 Identities=36% Similarity=0.549 Sum_probs=126.4
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.+.++|++.+.||.|+||.||+|.+..+++.+++|.+.. ...+..|+.+++.+ .|+|++++++++.......
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcE
Confidence 467899999999999999999999999999999997642 34567899999999 6999999999986656678
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++++||++++|...+... .++...+..++.|++.||.|||+.+++|+||+|.||+++.++.++|+|||.+
T Consensus 86 ~lv~e~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 86 YFVTELLGTDLHRLLTSR----------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEeehhccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 999999998887776532 2778888899999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 169 RI 170 (326)
Q Consensus 169 ~~ 170 (326)
..
T Consensus 156 ~~ 157 (328)
T cd07856 156 RI 157 (328)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=227.66 Aligned_cols=150 Identities=21% Similarity=0.371 Sum_probs=122.8
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCe--EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNL--IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~--~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||+|....++. .+++|.++. ...+.+|+.++.++.+|+||+++++++ ......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-ENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-ccCCcceE
Confidence 689999999999999999998866553 467777753 234677899998886799999999988 55667999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhh-------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 020467 91 VLEFLR-TDLATVIAESKKKRE-------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l 162 (326)
++||+. ++|.+++........ ......++...+..++.|++.||.|||+.+++|+||||+||+++.++.++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999997 689888865331110 001124888999999999999999999999999999999999999999999
Q ss_pred Eeecccc
Q 020467 163 ADFGQAR 169 (326)
Q Consensus 163 ~Dfg~~~ 169 (326)
+|||++.
T Consensus 161 ~dfg~~~ 167 (297)
T cd05089 161 ADFGLSR 167 (297)
T ss_pred CCcCCCc
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=231.56 Aligned_cols=144 Identities=33% Similarity=0.524 Sum_probs=123.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||++.+..+++.||+|.+.. .....+|+.++.++ +|+||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeeccccc
Confidence 356899999999999999999999988999999998753 23456788999998 6999999999874322
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...++++++++++|.+.+... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccEEEEehhcccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEe
Confidence 347889999888887766432 28889999999999999999999999999999999999999999999
Q ss_pred eeccccc
Q 020467 164 DFGQARI 170 (326)
Q Consensus 164 Dfg~~~~ 170 (326)
|||++..
T Consensus 163 dfg~~~~ 169 (345)
T cd07877 163 DFGLARH 169 (345)
T ss_pred ccccccc
Confidence 9998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=225.34 Aligned_cols=142 Identities=32% Similarity=0.505 Sum_probs=120.8
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
-|++.+.||+|+||.||++.+..++..+++|.+.. ...+.+|+++++.+ .|+|++++++.+ ...+..++++||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~-~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAF-YYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEE-eeCCEEEEEEEe
Confidence 37888999999999999999988899999998753 23456788888888 699999999998 556689999999
Q ss_pred ccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+.+ +|...+.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~~~~l~~~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 84 CAGGAVDAVMLELE--------RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred cCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence 985 5555544321 23889999999999999999999999999999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=233.84 Aligned_cols=145 Identities=29% Similarity=0.557 Sum_probs=125.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe---cCC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWR---EDE 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~---~~~ 86 (326)
+.++|++.+.||.|++|.||+|.+..+++.|++|.+.. ...+.+|+.+++++ +|+||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCc
Confidence 34789999999999999999999999999999998753 23456789999999 59999999988743 234
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
..++++||+.++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred eEEEEEehhhhhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccc
Confidence 689999999988887775432 28999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 153 ~~~~~ 157 (334)
T cd07855 153 MARGL 157 (334)
T ss_pred cceee
Confidence 88654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=222.11 Aligned_cols=143 Identities=22% Similarity=0.351 Sum_probs=121.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.+.||+|++|.||++.+.. +..+++|.+.. ...+.+|+.+++++ +|+||+++++++ ......+++||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVC-TKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEE-ccCCCcEEEEE
Confidence 3579999999999999999997653 44699998764 34567899999999 699999999998 55667899999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 80 YMSNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred cCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence 997 578877754321 2889999999999999999999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=222.91 Aligned_cols=143 Identities=25% Similarity=0.415 Sum_probs=121.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.++||+|++|.||+|.+..+ ..+++|.+.. ...+.+|+++++.+ +|+|++++++.+ . ....+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~-~-~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S-EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEE-C-CCCcEEEEE
Confidence 46799999999999999999987655 4599998863 34567899999998 699999999876 3 345799999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+..+
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 81 YMSKGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred cCCCCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 998 588888764321 22788899999999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=221.71 Aligned_cols=144 Identities=24% Similarity=0.442 Sum_probs=124.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.+.||+|++|.||+|.+. .++.|++|.++. ...+.+|+.+++++ +|+|++++++++ ...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVC-TLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEE-ecCCCeeeeee
Confidence 467999999999999999999864 456799998863 34577899999999 599999999988 55667899999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... ..++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 82 LMKYGSLLEYLQGGAG-------RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred cccCCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 994 788888765331 23889999999999999999999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=240.22 Aligned_cols=136 Identities=29% Similarity=0.483 Sum_probs=118.6
Q ss_pred eeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-cCH
Q 020467 26 CVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-TDL 99 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~~L 99 (326)
+||+|.||+||.|++..+...+|||.+.. .+.+..|+..-+.+ .|.||+++++.+ .+++++-++||-++ |+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~-senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSV-SENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhcc-CCCCeEEEEeecCCCCcH
Confidence 79999999999999999999999999853 45678899999999 499999999998 55667888999987 688
Q ss_pred HHHHHHhhhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-CCCcEEEEeecccccc
Q 020467 100 ATVIAESKKKREDRGDRGI--SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG-DDGVLKLADFGQARIL 171 (326)
Q Consensus 100 ~~~l~~~~~~~~~~~~~~l--~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~-~~~~~~l~Dfg~~~~~ 171 (326)
..++.... +++ ++..+..+.+||++||.|||++.|||||||-.|++|+ -.|.+||+|||.++.+
T Consensus 660 SsLLrskW--------GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 660 SSLLRSKW--------GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred HHHHHhcc--------CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhh
Confidence 77776543 235 7788899999999999999999999999999999998 4789999999999876
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=227.91 Aligned_cols=152 Identities=25% Similarity=0.400 Sum_probs=122.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC--------------CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD--------------NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVL 77 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~--------------~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l 77 (326)
.++|++.+.||+|+||.||+|.+..+ ...|++|.++. ...+.+|+++++++ .|+|++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence 46899999999999999999976432 23589998863 23467899999999 69999999
Q ss_pred eEEEEecCCceEEEeeecc-cCHHHHHHHhhhhh---hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 020467 78 HEYFWREDEDAVLVLEFLR-TDLATVIAESKKKR---EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLL 153 (326)
Q Consensus 78 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~---~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nil 153 (326)
++++ ......+++|||+. ++|.+++....... .......++...+..++.|++.||+|||+.+++|+||||+||+
T Consensus 83 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 83 LGVC-VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEE-cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9998 56678999999997 68888775432110 0001123678889999999999999999999999999999999
Q ss_pred EcCCCcEEEEeecccccc
Q 020467 154 IGDDGVLKLADFGQARIL 171 (326)
Q Consensus 154 i~~~~~~~l~Dfg~~~~~ 171 (326)
++.++.++|+|||++..+
T Consensus 162 l~~~~~~kl~dfg~~~~~ 179 (295)
T cd05097 162 VGNHYTIKIADFGMSRNL 179 (295)
T ss_pred EcCCCcEEeccccccccc
Confidence 999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=225.59 Aligned_cols=141 Identities=30% Similarity=0.520 Sum_probs=122.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|+||.||++.+..+++.|++|.+.. ...+.+|+.+++.+ +|+||+++++.+ ......++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSF-ETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEE-ecCCEEEE
Confidence 479999999999999999999999999999998753 22455788888888 699999999988 55667999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 79 v~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 79 VMEYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 999997 58887775532 28889999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 170 I 170 (326)
Q Consensus 170 ~ 170 (326)
.
T Consensus 150 ~ 150 (305)
T cd05609 150 I 150 (305)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=224.30 Aligned_cols=142 Identities=23% Similarity=0.392 Sum_probs=119.9
Q ss_pred cCe-EEEeeeccccCcEEEEEEE----cCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CC
Q 020467 19 AKY-EILECVGSGAYSDVYKGRR----LSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DE 86 (326)
Q Consensus 19 ~~y-~i~~~Lg~G~~g~Vy~a~~----~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~ 86 (326)
+|| ++.+.||+|+||+||++.. ..++..+++|.+.. ...+.+|+++++.+ .|+|++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence 566 9999999999999988653 34678899998853 23457899999999 699999999987543 34
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~----------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~df 151 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH----------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDF 151 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeec
Confidence 5889999997 5787777542 1899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++..+
T Consensus 152 g~~~~~ 157 (283)
T cd05080 152 GLAKAV 157 (283)
T ss_pred cccccc
Confidence 998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=227.73 Aligned_cols=147 Identities=20% Similarity=0.334 Sum_probs=124.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEE-----cCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRR-----LSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
..++|.+.+.||+|+||.||++.+ ..++..+++|.++. ...+.+|+.+++++.+|+||+++++.+ ...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~~ 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC-TIG 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE-ecC
Confidence 356899999999999999999975 23456899998753 234678999999996699999999988 556
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
+..+++|||+. ++|.+++..... ..++..++..++.|++.||.|||+.+++|+||+|+||+++.++.++++|
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE-------SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECC
Confidence 67999999997 688887754321 1278999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++..+
T Consensus 185 fg~~~~~ 191 (302)
T cd05055 185 FGLARDI 191 (302)
T ss_pred Ccccccc
Confidence 9988654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=224.24 Aligned_cols=150 Identities=26% Similarity=0.395 Sum_probs=124.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-----CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|++|.||+|.+.. ++..|++|.+.. ...+.+|+.+++.+ +|+||+++++++ ....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVS-FERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-ccCC
Confidence 5789999999999999999998876 678899998753 23467788899888 699999999988 4455
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEE
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---VLKL 162 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---~~~l 162 (326)
..+++|||+. ++|.+++........ ....++...+..++.|++.+|.|||+.+++|+||+|+||+++.++ .++|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 7899999996 688888765432111 112388899999999999999999999999999999999998765 5899
Q ss_pred Eeecccccc
Q 020467 163 ADFGQARIL 171 (326)
Q Consensus 163 ~Dfg~~~~~ 171 (326)
+|||++..+
T Consensus 161 ~dfg~~~~~ 169 (277)
T cd05036 161 ADFGMARDI 169 (277)
T ss_pred ccCcccccc
Confidence 999998765
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=225.83 Aligned_cols=135 Identities=19% Similarity=0.265 Sum_probs=115.0
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe--c-CCceEEEee
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWR--E-DEDAVLVLE 93 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~--~-~~~~~lv~e 93 (326)
..|++|+++.||+|.. +++.||+|.++. ...+.+|+.++.++ .|+||+++++++.. . ....+++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 4689999999999987 688999998863 23455899999999 69999999999854 2 346899999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... ++......++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++..+
T Consensus 103 y~~~g~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 103 YCTRGYLREVLDKEKD---------LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred eCCCCcHHHHHhhCCC---------CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 998 578888765322 7888899999999999999998 49999999999999999999999999998754
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=225.83 Aligned_cols=152 Identities=24% Similarity=0.383 Sum_probs=123.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC----------------CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS----------------DNLIVALKEVHD------YQSAFREIEALQILQNSPNVV 75 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~----------------~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~ 75 (326)
.++|++.++||+|+||.||++.+.. +...+++|.+.. ...+.+|+.+++.+ +|+|++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence 4679999999999999999985432 345689998863 23467899999999 699999
Q ss_pred EEeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhhh--hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 020467 76 VLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKRE--DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNL 152 (326)
Q Consensus 76 ~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Ni 152 (326)
++++++ ......+++|||+. ++|.+++........ ......++...+..++.|++.||.|||+.+++|+||||+||
T Consensus 83 ~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 83 RLLAVC-ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEE-ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999998 55667899999997 688888765432110 01112377888999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeecccccc
Q 020467 153 LIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 153 li~~~~~~~l~Dfg~~~~~ 171 (326)
+++.++.++|+|||++..+
T Consensus 162 li~~~~~~~l~dfg~~~~~ 180 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred EEcCCCCEEeccCcccccc
Confidence 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=225.21 Aligned_cols=146 Identities=36% Similarity=0.598 Sum_probs=124.4
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|++|.||++.+..++..+++|.+.. ...+.+|+.+++.+ +|+|++++++.+ ......++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~-~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASF-IEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhhee-EeCCeEEE
Confidence 578999999999999999999988999999997642 23566788999998 699999999998 44567899
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++||+. ++|.+++...... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 154 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence 999997 5888777542211 1238899999999999999999999999999999999999999999999999876
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 155 ~~ 156 (267)
T cd08229 155 FF 156 (267)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=221.27 Aligned_cols=144 Identities=31% Similarity=0.527 Sum_probs=126.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.++|++.+.||.|++|.||+|....+++.+++|.+.. ...+.+|+++++.+ +|+|++++++.+ ......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~-~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSY-FKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeee-ecCCcEEEEEec
Confidence 4689999999999999999999888889999998864 34677889999999 799999999998 556789999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+. ++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 80 CGAGSVSDIMKITN--------KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred CCCCcHHHHHHhCc--------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence 98 57777765422 22889999999999999999999999999999999999999999999999998765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=222.43 Aligned_cols=142 Identities=25% Similarity=0.405 Sum_probs=121.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.+|++.+.||+|++|.||++.+. ++..+++|.+.. ...+.+|+++++.+ .|+|++++++++ ......+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVC-TKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEE-cCCCceEEEEec
Confidence 46889999999999999999875 456789998753 23567899999998 699999999988 566678999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+. ++|.+++..... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 81 MANGCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred CCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceec
Confidence 96 688887764321 2889999999999999999999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=221.81 Aligned_cols=143 Identities=24% Similarity=0.383 Sum_probs=122.8
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCc
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DED 87 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~ 87 (326)
.+|++.+.||+|++|.||+|.+..++..+++|.+.. ...+.+|+.+++.+ +|+|++++++.+... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 468999999999999999999988999999998742 12456788899999 699999999988543 356
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.++++||+. ++|.+.+..... ++....+.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGA---------LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCC
Confidence 789999997 588887765322 7888899999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 152 ~~~~~ 156 (266)
T cd06651 152 ASKRL 156 (266)
T ss_pred Ccccc
Confidence 88654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=231.17 Aligned_cols=145 Identities=36% Similarity=0.537 Sum_probs=125.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|++|.||++.+..++..||+|.+.. ...+.+|+.+++.+ .|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcccc
Confidence 467889999999999999999999988999999998742 23466899999999 6999999999884433
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
..++++|++++++|.+++... .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~----------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMKHE----------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccceEEEEEecCCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEe
Confidence 236899999988887776432 28899999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 161 dfg~~~~~ 168 (343)
T cd07880 161 DFGLARQT 168 (343)
T ss_pred eccccccc
Confidence 99987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=220.05 Aligned_cols=143 Identities=29% Similarity=0.516 Sum_probs=124.6
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||+|+||.+|.+.+..+++.+++|.+.. ...+.+|+.+++++ +|+|++++++.+ ...+..++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESF-EENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeee-cCCCeEEEEE
Confidence 58999999999999999999988999999998752 23567888999999 699999999998 6667899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+.+..... ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++++|||++...
T Consensus 79 e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 79 DYCEGGDLYKKINAQRG-------VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred ecCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 9997 588887764322 12788899999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=221.20 Aligned_cols=143 Identities=25% Similarity=0.401 Sum_probs=122.7
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCc
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DED 87 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~ 87 (326)
.+|++.+.||+|++|.||++.+..++..+++|.+.. ...+.+|+++++++ .|+|++++++.+... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 479999999999999999999988999999997631 12456788999999 699999999988443 345
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
+++++||+. ++|.+.+..... ++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGA---------LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccc
Confidence 789999997 578777764322 7888899999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 152 ~~~~~ 156 (264)
T cd06653 152 ASKRI 156 (264)
T ss_pred ccccc
Confidence 98754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=223.77 Aligned_cols=152 Identities=24% Similarity=0.389 Sum_probs=122.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|+||.||+|... ..+..|++|.+... ..+.+|+..++.+ +|+|++++++++ ....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVV-SKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE-cCCC
Confidence 578999999999999999998654 23557999987532 2356788888888 699999999998 5566
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKRE-DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~-~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..+++|||+. ++|.+++........ ...........+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 7999999997 789888865322110 00112356678889999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 163 fg~~~~~ 169 (288)
T cd05061 163 FGMTRDI 169 (288)
T ss_pred CCccccc
Confidence 9988654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=224.16 Aligned_cols=141 Identities=26% Similarity=0.472 Sum_probs=124.3
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++|++.+.||.|++|.||+|.+..++..+++|.+.. ...+.+|+.+++.+ .|+|++++++.+ ......++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSF-LKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEE-EECCeEEEEE
Confidence 478999999999999999999988999999998753 23456788999999 599999999988 4557899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 e~~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 79 EYCGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred EeeCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence 9997 5887777643 2889999999999999999999999999999999999999999999999998765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=230.86 Aligned_cols=156 Identities=30% Similarity=0.517 Sum_probs=131.7
Q ss_pred ccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch------------hhHHHHHHHHHHHhcCCCeeEEe
Q 020467 11 IHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY------------QSAFREIEALQILQNSPNVVVLH 78 (326)
Q Consensus 11 ~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~------------~~~~~E~~~l~~l~~h~ni~~l~ 78 (326)
+.+++-+-++|.++.+||+|+|+.||+|.+....+.||+|+.... +...+|..+-+.+ .|+.|+++|
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlY 533 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLY 533 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeee
Confidence 345566789999999999999999999999999999999987532 2345777788778 799999999
Q ss_pred EEEEecCCceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCeEEc
Q 020467 79 EYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN--TIVHRDLKPGNLLIG 155 (326)
Q Consensus 79 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--~iiH~dlkp~Nili~ 155 (326)
++|.-+...++-|+||++| +|..+++.... +++..++.|+.||+.||.||... .|||-||||.|||+-
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv 604 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLV 604 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEe
Confidence 9998888889999999997 55545554433 89999999999999999999965 799999999999996
Q ss_pred C---CCcEEEEeecccccccCCcc
Q 020467 156 D---DGVLKLADFGQARILLGNEF 176 (326)
Q Consensus 156 ~---~~~~~l~Dfg~~~~~~~~~~ 176 (326)
. .|.++|.|||+++.+..+.+
T Consensus 605 ~GtacGeIKITDFGLSKIMdddSy 628 (775)
T KOG1151|consen 605 NGTACGEIKITDFGLSKIMDDDSY 628 (775)
T ss_pred cCcccceeEeeecchhhhccCCcc
Confidence 4 57899999999998866654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=225.37 Aligned_cols=145 Identities=20% Similarity=0.238 Sum_probs=109.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCC---CeEEEEEEccc-hhhHHHH------------H---HHHHHHhcCCCeeEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSD---NLIVALKEVHD-YQSAFRE------------I---EALQILQNSPNVVVL 77 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~-~~~~~~E------------~---~~l~~l~~h~ni~~l 77 (326)
..++|++.++||+|+||.||+|.+..+ +..+++|.... ......| + ..+..+ .|++++.+
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~ 88 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKY 88 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcE
Confidence 457899999999999999999998766 66677775431 1111111 1 122223 58999999
Q ss_pred eEEEEecCC---ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 020467 78 HEYFWREDE---DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154 (326)
Q Consensus 78 ~~~~~~~~~---~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili 154 (326)
++.+..... ..+++++++..++.+.+..... .++..+..++.|++.||.|||+.+++||||||+|||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill 159 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV 159 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 987633322 3467777777777666554321 5677889999999999999999999999999999999
Q ss_pred cCCCcEEEEeecccccc
Q 020467 155 GDDGVLKLADFGQARIL 171 (326)
Q Consensus 155 ~~~~~~~l~Dfg~~~~~ 171 (326)
+.++.++|+|||+++.+
T Consensus 160 ~~~~~~~l~DFGla~~~ 176 (294)
T PHA02882 160 DGNNRGYIIDYGIASHF 176 (294)
T ss_pred cCCCcEEEEEcCCceee
Confidence 99999999999998765
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=232.23 Aligned_cols=146 Identities=42% Similarity=0.615 Sum_probs=126.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~ 87 (326)
.+.++|++.+.||+|+||.||+|.+..++..+++|.+.. .....+|+.+++++.+|+||+++++++... ...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 467899999999999999999999988899999997732 234567899999996699999999988543 346
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
.+++|||+.++|...+... .+.+..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 84 ~~lv~e~~~~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYMETDLHAVIRAN----------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 8999999999888777543 177888899999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 154 ~~~~ 157 (337)
T cd07852 154 ARSL 157 (337)
T ss_pred hhcc
Confidence 8765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=220.96 Aligned_cols=143 Identities=26% Similarity=0.465 Sum_probs=121.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.++||+|++|.||+|.+. .+..+++|.+.. ...+.+|+.+++++ +|++++++++++ . ....+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~-~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVV-S-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEE-C-CCCcEEEEE
Confidence 468999999999999999999765 456689998863 34577899999999 699999999887 3 345889999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... ..++...+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++..+
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 81 YMSKGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred ecCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 997 688888764321 23888999999999999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=225.73 Aligned_cols=153 Identities=20% Similarity=0.387 Sum_probs=124.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-------CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-------SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-------~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
.++|.+.+.||+|+||.||++.+. .....+++|.+.. ...+..|+.+++.+..|+||+++++++ ..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC-TQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE-cc
Confidence 578999999999999999999753 2345789998763 224567888888886699999999998 55
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhh-------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKRE-------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD 156 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~ 156 (326)
....++++||+. ++|.+++........ ......++...+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 567899999997 688888865321100 001123788899999999999999999999999999999999999
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 170 ~~~~kL~Dfg~~~~~ 184 (314)
T cd05099 170 DNVMKIADFGLARGV 184 (314)
T ss_pred CCcEEEccccccccc
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-31 Score=226.08 Aligned_cols=144 Identities=24% Similarity=0.400 Sum_probs=124.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|..+++||+|.||+|.+|+.+.+++.+|||++++ ...-..|.++|+.. .||.+..+-=.| +....+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsF-Qt~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSF-QTQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhh-ccCceE
Confidence 56899999999999999999999999999999998864 12235677788887 599988776666 666789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
++||||.. |.|..++.... .+++...+.+-..|+.||.|||+.+||+||+|.+|+|+|.+|++||.|||+
T Consensus 244 CFVMeyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred EEEEEEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeeccc
Confidence 99999986 68877776643 389999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
|+.-
T Consensus 315 CKE~ 318 (516)
T KOG0690|consen 315 CKEE 318 (516)
T ss_pred chhc
Confidence 9754
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=228.13 Aligned_cols=153 Identities=20% Similarity=0.378 Sum_probs=123.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-------CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-------DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
..+|++.+.||+|+||.||+|.+.. +...+++|.+.. ...+.+|+++++++..|+||+++++++ ..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~ 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC-TQ 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE-cc
Confidence 4579999999999999999997642 234689998753 235678899999986799999999998 55
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhh-------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKRE-------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD 156 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~ 156 (326)
....++++||+. ++|.+++........ ......++...+..++.|++.||.|||+.|++||||+|+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 567899999997 688888765321100 001123778889999999999999999999999999999999999
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 170 ~~~~kL~Dfg~~~~~ 184 (334)
T cd05100 170 DNVMKIADFGLARDV 184 (334)
T ss_pred CCcEEECCcccceec
Confidence 999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=223.99 Aligned_cols=152 Identities=24% Similarity=0.394 Sum_probs=124.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..+|.+.+.||+|+||.||+|.+. .++..+++|.+.. ...+.+|+..++++ +|+||+++++++ .....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVC-GDGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEE-ccCCc
Confidence 467999999999999999999753 3456788898763 24567889999998 699999999998 55667
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhh-------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKRE-------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
.+++|||+. ++|.+++........ ......++...++.++.|++.||.|||+.+++||||+|+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999997 688888765321100 001123788999999999999999999999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 162 ~~l~dfg~a~~~ 173 (291)
T cd05094 162 VKIGDFGMSRDV 173 (291)
T ss_pred EEECCCCccccc
Confidence 999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=223.88 Aligned_cols=142 Identities=40% Similarity=0.636 Sum_probs=124.3
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCceEEEe
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWRE-DEDAVLVL 92 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~~lv~ 92 (326)
|++.+.||.|++|.||+|.+..+++.+++|.+... ..+.+|+++++.+ .|+|++++++++... ....++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 67899999999999999999888999999988642 2466789999999 599999999998544 26899999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|++++|.+++.... ..+++..+..++.|++.||.+||+.+++|+||+|+||++++++.++|+|||++...
T Consensus 80 e~~~~~l~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 80 EYMDHDLTGLLDSPE--------VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred ccccccHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 999988887775432 12889999999999999999999999999999999999999999999999988755
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=220.51 Aligned_cols=141 Identities=28% Similarity=0.457 Sum_probs=122.2
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------------hhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------------QSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
+|++...||.|++|.||.|.+..+++.+++|.+... ..+.+|+.+++.+ .|+||+++++++ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSS-LDA 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEE-EeC
Confidence 588889999999999999998888899999977421 2456788889999 699999999998 556
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
...++++||+. ++|.+++..... ++...+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~d 149 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGA---------FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISD 149 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecc
Confidence 67899999997 578777755332 78888999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++..+
T Consensus 150 fg~~~~~ 156 (267)
T cd06628 150 FGISKKL 156 (267)
T ss_pred cCCCccc
Confidence 9998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=219.79 Aligned_cols=144 Identities=22% Similarity=0.423 Sum_probs=122.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
..++|++.++||+|+||.||+|... +++.+++|.+.. ...+.+|+.+++++ +|+|++++++++ . ....++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVV-T-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEE-c-cCCcEEEE
Confidence 3578999999999999999999854 567899998863 34577899999999 699999999886 3 34689999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+.+..... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 80 EYMENGSLVDFLKTPEG-------IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EcCCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 9996 688887754332 22888899999999999999999999999999999999999999999999998665
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=221.76 Aligned_cols=141 Identities=29% Similarity=0.486 Sum_probs=122.8
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
+|+..+.||+|++|.||++.+..+++.+++|.+.. ...+.+|+++++++ .|+|++++++++ ...+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGAT-CEDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhcee-ccCCeE
Confidence 48889999999999999999988999999998852 23567889999998 699999999998 666789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEEeec
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFG 166 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-~~~l~Dfg 166 (326)
+++++|+. ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred EEEEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence 99999998 57877776432 278899999999999999999999999999999999998776 69999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
.+...
T Consensus 150 ~~~~~ 154 (268)
T cd06630 150 AAARL 154 (268)
T ss_pred ccccc
Confidence 98765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=226.17 Aligned_cols=147 Identities=37% Similarity=0.615 Sum_probs=126.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
...++|++.+.||.|++|.||+|.+..+++.|++|.++. .....+|+++++.+ +|+|++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhh
Confidence 457889999999999999999999988899999998852 12456788999999 6999999999884332
Q ss_pred ------CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 86 ------EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 86 ------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
...++++||+++++...+.... ..++...+..++.|++.||+|||+.+|+|+||+|+||+++.++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDHDLMGLLESGL--------VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hccccCCcEEEEEcccCccHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc
Confidence 3689999999988877765432 12899999999999999999999999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++..+
T Consensus 155 ~kl~dfg~~~~~ 166 (302)
T cd07864 155 IKLADFGLARLY 166 (302)
T ss_pred EEeCcccccccc
Confidence 999999988765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=232.69 Aligned_cols=153 Identities=24% Similarity=0.332 Sum_probs=124.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|.+.++||+|+||.||+|.+. .+++.||+|.+... ..+.+|+.++.++..|+||+++++++ ....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~-~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC-TKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE-ccCC
Confidence 467899999999999999999853 34578999998632 24678999999985599999999998 5556
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh-------------------------------------------------------
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR------------------------------------------------------- 110 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~------------------------------------------------------- 110 (326)
..++++||+. ++|.+++.......
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 7999999998 79998886542100
Q ss_pred ----------------------------------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 020467 111 ----------------------------------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD 156 (326)
Q Consensus 111 ----------------------------------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~ 156 (326)
.......++...+..++.|++.||.|||+.+++|+||||+||+++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 0001123677788999999999999999999999999999999999
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 275 ~~~~kL~DfGla~~~ 289 (401)
T cd05107 275 GKLVKICDFGLARDI 289 (401)
T ss_pred CCEEEEEecCcceec
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=221.10 Aligned_cols=144 Identities=24% Similarity=0.411 Sum_probs=122.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC---CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD---NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.+.||+|+||.||+|.+..+ +..+++|.+.. ...+.+|+.+++++ +|+||+++++++ ......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVV-TKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE-ecCCcc
Confidence 36799999999999999999987543 34789998753 23567788889888 699999999998 556679
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++..... .++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCc
Confidence 99999997 578877754321 278889999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 153 ~~~~ 156 (267)
T cd05066 153 SRVL 156 (267)
T ss_pred cccc
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=225.00 Aligned_cols=142 Identities=43% Similarity=0.680 Sum_probs=124.4
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
|++.+.||.|++|.||+|.+..++..|++|++.. ...+.+|+..++.+ +|+|++++++++ ......++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~-~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVV-HSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhhee-ccCCeEEEEEe
Confidence 6778999999999999999988999999998752 23467899999999 599999999998 55678999999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+.++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 79 FLDLDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred ccCcCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 999888888765432 12889999999999999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=229.35 Aligned_cols=147 Identities=29% Similarity=0.471 Sum_probs=127.5
Q ss_pred cccccCeEE-EeeeccccCcEEEEEEEcCCCeEEEEEEccch-------------------hhHHHHHHHHHHHhcCCCe
Q 020467 15 PEIIAKYEI-LECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------------------QSAFREIEALQILQNSPNV 74 (326)
Q Consensus 15 ~~~~~~y~i-~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------------------~~~~~E~~~l~~l~~h~ni 74 (326)
.++.++|.. .+.||.|+||.||+|.+..+++.|++|.+... ..+.+|+++++.+ .|+|+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 82 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENI 82 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcce
Confidence 457788875 56799999999999999889999999987521 1356899999999 69999
Q ss_pred eEEeEEEEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 020467 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154 (326)
Q Consensus 75 ~~l~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili 154 (326)
+++++++ ......+++|||+.++|.+.+.... .++......++.|++.||.|||+.+++|+||+|+||++
T Consensus 83 v~~~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill 152 (335)
T PTZ00024 83 MGLVDVY-VEGDFINLVMDIMASDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152 (335)
T ss_pred eeeeEEE-ecCCcEEEEEeccccCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence 9999998 5566899999999999988876432 28899999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccc
Q 020467 155 GDDGVLKLADFGQARILL 172 (326)
Q Consensus 155 ~~~~~~~l~Dfg~~~~~~ 172 (326)
+.++.++|+|||++....
T Consensus 153 ~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 153 NSKGICKIADFGLARRYG 170 (335)
T ss_pred CCCCCEEECCccceeecc
Confidence 999999999999987653
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=221.28 Aligned_cols=137 Identities=20% Similarity=0.301 Sum_probs=107.4
Q ss_pred eeeccccCcEEEEEEEcC------------CCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 25 ECVGSGAYSDVYKGRRLS------------DNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~------------~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
+.||+|+||.||+|.... ....+++|.+.. ...+..|+.++..+ +||||+++++++ .....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~-~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVC-VRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEE-ecCCC
Confidence 468999999999997432 234588888753 22455667778777 699999999998 45567
Q ss_pred eEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc-------
Q 020467 88 AVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV------- 159 (326)
Q Consensus 88 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~------- 159 (326)
.+++|||+.+ +|..++.... ..++...+..++.|++.||.|||+.+|+||||||+||+++.++.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS--------DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 8999999985 5555543321 22888899999999999999999999999999999999987664
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++++|||++...
T Consensus 151 ~~l~d~g~~~~~ 162 (262)
T cd05077 151 IKLSDPGIPITV 162 (262)
T ss_pred eEeCCCCCCccc
Confidence 899999977543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=228.61 Aligned_cols=139 Identities=22% Similarity=0.311 Sum_probs=117.7
Q ss_pred EEeeeccc--cCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 23 ILECVGSG--AYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 23 i~~~Lg~G--~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
++++||+| +|++||++.+..+++.||+|.+... ..+.+|+.+++.+ +|+||+++++++ ...+..++++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~-~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATF-IADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEE-EECCEEEEEEe
Confidence 46789999 6789999999999999999988632 2456688888888 699999999998 55667999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|+. ++|.+++..... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+++.||+....
T Consensus 80 ~~~~~~l~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 80 FMAYGSAKDLICTHFM-------DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred ccCCCcHHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence 998 688887754321 2288899999999999999999999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=231.44 Aligned_cols=144 Identities=33% Similarity=0.504 Sum_probs=122.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC------
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWRED------ 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~------ 85 (326)
+.++|++.+.||.|+||.||+|.+..+++.|++|.+.. .....+|+++++.+ +|+|++++++.+....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccc
Confidence 46889999999999999999999999999999998743 34567899999999 6999999998764332
Q ss_pred -------CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-C
Q 020467 86 -------EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-D 157 (326)
Q Consensus 86 -------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~ 157 (326)
...++++||+.++|.+.+... .+++..+..++.|++.||.|||+.|++||||+|+||+++. +
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQG----------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC
Confidence 247899999998887776432 2889999999999999999999999999999999999984 5
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
+.++|+|||.+..+
T Consensus 152 ~~~kl~dfg~~~~~ 165 (342)
T cd07854 152 LVLKIGDFGLARIV 165 (342)
T ss_pred ceEEECCcccceec
Confidence 57899999988654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=219.75 Aligned_cols=144 Identities=24% Similarity=0.432 Sum_probs=122.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe---EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL---IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.+.||+|+||.||+|....+++ .|++|.+.. ...+..|+.+++.+ .|+|++++++++ ......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~-~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVV-TKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEE-CCCCce
Confidence 4569999999999999999998875543 699998753 23567788999888 699999999998 566678
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcc
Confidence 99999997 577777654321 278899999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 153 ~~~~ 156 (269)
T cd05065 153 SRFL 156 (269)
T ss_pred cccc
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=222.25 Aligned_cols=141 Identities=28% Similarity=0.511 Sum_probs=122.2
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHh--cCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQ--NSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.|++.+.||.|+||.||+|.+..+++.+++|.+.. ...+.+|+.+++.+. .|+|++++++.+ ......+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-LKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-eeCCEEEEE
Confidence 47888999999999999999988999999998742 234677888888885 499999999988 556679999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+++... .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL 150 (277)
T ss_pred EecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence 99997 5777766432 288999999999999999999999999999999999999999999999998876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 151 ~ 151 (277)
T cd06917 151 L 151 (277)
T ss_pred c
Confidence 5
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=220.30 Aligned_cols=147 Identities=22% Similarity=0.409 Sum_probs=119.0
Q ss_pred eEEEeeeccccCcEEEEEEEcC---CCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC----
Q 020467 21 YEILECVGSGAYSDVYKGRRLS---DNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE---- 86 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~---- 86 (326)
|++.+.||+|+||.||.|.... ++..+|+|.++. ...+.+|+..++.+ +|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 5678999999999999998654 347899998753 13467788888888 69999999998744332
Q ss_pred -ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 87 -DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 87 -~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..++++||+. ++|...+....... ....++...+..++.|++.||.|||+.+++|+||||+||++++++.++|+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence 3789999987 68877775432111 012388999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 157 fg~~~~~ 163 (273)
T cd05035 157 FGLSKKI 163 (273)
T ss_pred ccceeec
Confidence 9988765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=222.07 Aligned_cols=136 Identities=24% Similarity=0.469 Sum_probs=110.8
Q ss_pred eeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHH--hcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 26 CVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQIL--QNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l--~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
.||+|+||.||++.+..+++.+|+|.+... ....+|..++..+ .+|++++.+++.+ ...+..+++|||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-HTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-ecCCeEEEEEecC
Confidence 479999999999999888999999977421 1223344333333 2689999999988 5556799999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
. ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 80 NGGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 8 57777665432 2899999999999999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=238.98 Aligned_cols=145 Identities=28% Similarity=0.518 Sum_probs=124.3
Q ss_pred cccCe-EEEeeeccccCcEEEEEEEcCCCeEEEEEEcc---------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 17 IIAKY-EILECVGSGAYSDVYKGRRLSDNLIVALKEVH---------DYQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 17 ~~~~y-~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~---------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..+|| +..+.||+|+|-+||+|.|..+|.+||.-.++ ..+.+..|+.+|+.| +|+||+++|++|....+
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDN 115 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCC
Confidence 34555 34568999999999999999999999975443 246788999999999 59999999999954443
Q ss_pred -ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCeEEcC-CCcEE
Q 020467 87 -DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN--TIVHRDLKPGNLLIGD-DGVLK 161 (326)
Q Consensus 87 -~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--~iiH~dlkp~Nili~~-~~~~~ 161 (326)
.+.+++|.+. |+|..++++.+. +..+.+..|++||+.||.|||++ .|||||||..||+|+. .|.+|
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VK 186 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVK 186 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCcee
Confidence 4788999987 899999888665 88999999999999999999987 5999999999999985 58999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|.|+|++..+
T Consensus 187 IGDLGLAtl~ 196 (632)
T KOG0584|consen 187 IGDLGLATLL 196 (632)
T ss_pred ecchhHHHHh
Confidence 9999999876
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=232.71 Aligned_cols=146 Identities=34% Similarity=0.421 Sum_probs=121.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
...|+++++||.||.+.||++.... ...+|+|.+. ....+.+|+..|.++++|.+|++++++= .....+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-v~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-VTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-ccCceEEE
Confidence 4679999999999999999997643 3556676653 2445789999999999999999999986 44567999
Q ss_pred EeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 91 VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 91 v~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+=+.+|...+...... .+.-.+..+-.||+.|+.++|.+||||.||||.|+|+- .|.+||+|||++..
T Consensus 438 vmE~Gd~DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 438 VMECGDIDLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EeecccccHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 9999999999988765432 34347888999999999999999999999999999996 46899999999987
Q ss_pred ccCC
Q 020467 171 LLGN 174 (326)
Q Consensus 171 ~~~~ 174 (326)
+..+
T Consensus 509 I~~D 512 (677)
T KOG0596|consen 509 IQPD 512 (677)
T ss_pred cCcc
Confidence 7444
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=226.01 Aligned_cols=151 Identities=21% Similarity=0.363 Sum_probs=120.0
Q ss_pred cCeEEEeeeccccCcEEEEEEEcC-----CCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.+|.+.+.||.|+||.||+|.+.. .++.+|+|.++.. ..+.+|+.++..+ .|+||+++++++ .....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~-~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVV-TKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEE-cCCCc
Confidence 457888999999999999998653 3578999998632 2356677788878 699999999998 55567
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhh-------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
.+++++|+. ++|.+++....... .......++...+..++.|++.||.|||+.+++||||||+||+++.++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 899999987 67777774321100 0001123788889999999999999999999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 163 ~kl~Dfg~~~~~ 174 (283)
T cd05091 163 VKISDLGLFREV 174 (283)
T ss_pred eEeccccccccc
Confidence 999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=223.34 Aligned_cols=145 Identities=25% Similarity=0.423 Sum_probs=125.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
...+|++.++||.|++|.||+|.+.. +..+++|.+.. ...+..|+.+++.+ +|+|++++++++ ......+++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVC-SVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeE-ecCCCeEEE
Confidence 35679999999999999999999876 78899998863 34567788899888 699999999988 566679999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||++ ++|.+++..... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 81 TELMEKGSLLAFLRSPEG-------QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred EeecccCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhh
Confidence 99997 599888865322 2278889999999999999999999999999999999999999999999998865
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 154 ~ 154 (261)
T cd05148 154 I 154 (261)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=223.08 Aligned_cols=142 Identities=27% Similarity=0.446 Sum_probs=123.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
...|+..+.||.|+||.||.|.+..++..+++|.+.. ...+.+|+.+++.+ .|+|++++++.+ ......+++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSY-LKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-EECCEEEEE
Confidence 4568889999999999999999988899999998753 23467788888888 699999999998 556789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||++ ++|.+++... .++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||++..
T Consensus 81 ~e~~~~~~L~~~i~~~----------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 81 MEYLGGGSALDLLRAG----------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred EecCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEccccccee
Confidence 99997 5887776532 178888999999999999999999999999999999999999999999998865
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
+
T Consensus 151 ~ 151 (277)
T cd06640 151 L 151 (277)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=220.37 Aligned_cols=141 Identities=29% Similarity=0.503 Sum_probs=119.5
Q ss_pred EEEeeeccccCcEEEEEEEc----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 22 EILECVGSGAYSDVYKGRRL----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 22 ~i~~~Lg~G~~g~Vy~a~~~----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.+.+.||.|.||.||+|.+. ..+..|+||.++. ...+.+|++.++++ +|+||+++++++. .....+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~-~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCI-ENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEE-SSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccc-cccccccc
Confidence 56889999999999999887 4567899999853 35678899999999 7999999999995 55669999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+||+. ++|.+++..... ..++...+..|+.|++.||.|||+.+++|++|+++||+++.++.+||+|||+...
T Consensus 80 ~e~~~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp EE--TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred cccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99997 799999887611 2289999999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 153 ~ 153 (259)
T PF07714_consen 153 I 153 (259)
T ss_dssp T
T ss_pred c
Confidence 5
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=220.97 Aligned_cols=141 Identities=28% Similarity=0.529 Sum_probs=124.3
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
+|++.+.||.|+||.||+|.+..++..+++|.+.. ...+.+|+++++++ +|+|++++++.+ ......+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSF-QDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhh-cCCCeEEEE
Confidence 58999999999999999999988899999998852 34567888999998 699999999988 667789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+||+. ++|.+.+.... .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 79 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 79 VDLLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred EeCCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 99997 58877775542 288999999999999999999999999999999999999999999999998765
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 150 ~ 150 (258)
T cd05578 150 V 150 (258)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=221.09 Aligned_cols=152 Identities=16% Similarity=0.305 Sum_probs=126.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC----CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS----DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~----~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++.+.||+|+||.||+|.+.. ++..+++|.+.. ...+.+|+.+++++ .|+|++++++++......
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCC
Confidence 5789999999999999999998765 357889998753 23466788888888 799999999988666677
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++++|.. ++|.+++........ .....++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEA-NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 899999987 688887755322110 011338899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
+++.+
T Consensus 163 ~~~~~ 167 (280)
T cd05043 163 LSRDL 167 (280)
T ss_pred Ccccc
Confidence 98765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=219.72 Aligned_cols=144 Identities=21% Similarity=0.348 Sum_probs=121.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe---EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL---IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|+..+.||+|++|.||+|....++. .+++|.+.. ...+..|+++++.+ .|+|++++.+++ ......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVV-TKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEE-ccCCCc
Confidence 4679999999999999999998765443 689998753 23456788888888 699999999998 556678
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++.... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 82 MIITEYMENGALDKYLRDHD--------GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcc
Confidence 99999998 57777775432 1278889999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 154 ~~~~ 157 (268)
T cd05063 154 SRVL 157 (268)
T ss_pred ceec
Confidence 8654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=216.98 Aligned_cols=146 Identities=33% Similarity=0.540 Sum_probs=125.6
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++|++.+.||.|++|+||+|....++..+++|.+.. ...+.+|++.++.+ .|+|++++++.+ ......++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSF-VVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEE-eeCCEEEEEE
Confidence 579999999999999999999888899999998752 34567888888888 699999999988 5567899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|++. ++|.+.+..... ...+++..+..++.|++.||.+||+.+++|+||+|+||++++++.++|+|||++..+
T Consensus 79 e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 79 PYLSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred eccCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 9997 577777754322 122888999999999999999999999999999999999999999999999998766
Q ss_pred c
Q 020467 172 L 172 (326)
Q Consensus 172 ~ 172 (326)
.
T Consensus 153 ~ 153 (267)
T cd06610 153 A 153 (267)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=217.95 Aligned_cols=143 Identities=26% Similarity=0.428 Sum_probs=120.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.+.||.|++|.||+|.+..+ ..+++|.+.. ...+.+|+.+++++ .|+|++++++++ . ....+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~-~~~~~~v~e 80 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVV-S-EEPIYIVTE 80 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEE-c-CCCcEEEEE
Confidence 36799999999999999999987654 3589998753 24567899999998 699999999887 3 345789999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... ..++...+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 81 FMGKGSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred cCCCCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 998 588888865321 22788889999999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=222.32 Aligned_cols=152 Identities=28% Similarity=0.412 Sum_probs=123.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|.+.++||+|+||.||++... .++..+++|.+.. ...+.+|++.++.+ .|+||+++++++ .....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~ 81 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVC-TEGRP 81 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEE-ecCCc
Confidence 467899999999999999999642 3466788888753 34577889999998 699999999988 55667
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhh------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKR------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 160 (326)
.++++||+. ++|.+++....... .......++...+..++.|++.||+|||+.+++|+||+|+||++++++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 899999997 68888876542110 00011237889999999999999999999999999999999999999999
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
+|+|||++...
T Consensus 162 kL~dfg~~~~~ 172 (280)
T cd05092 162 KIGDFGMSRDI 172 (280)
T ss_pred EECCCCceeEc
Confidence 99999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=222.81 Aligned_cols=145 Identities=28% Similarity=0.465 Sum_probs=125.7
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.+..++|.+.+.||+|+||.||++.+..++..+++|.+.. ...+.+|+.+++.+ .|+|++++++.+ ......+
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~-~~~~~~~ 92 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSY-LVGDELW 92 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhhee-eeCCcEE
Confidence 3456899999999999999999999888889999998752 33567788888888 699999999998 5566799
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+++||+. ++|.+++.... ++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 93 lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred EEEecCCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 9999997 58877765421 788889999999999999999999999999999999999999999999987
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 163 ~~~ 165 (293)
T cd06647 163 AQI 165 (293)
T ss_pred ecc
Confidence 654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=218.51 Aligned_cols=145 Identities=23% Similarity=0.406 Sum_probs=124.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
..++|++.+.||.|++|.||+|.+. .+..+++|.+.. ...+.+|+.+++.+ +|+|++++++++ ......+++|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVC-SEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeee-ecCCceEEEE
Confidence 3678999999999999999999865 457799998863 34577899999998 599999999998 5556799999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++..... ..++...+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 81 e~~~~~~L~~~i~~~~~-------~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG-------KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred eccCCCCHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 9997 588888765331 23888999999999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=219.67 Aligned_cols=143 Identities=27% Similarity=0.458 Sum_probs=122.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe----EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL----IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++.+.||+|+||.||+|.+..++. .+++|.... ...+.+|+..++++ .|+|++++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS--SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--Cc
Confidence 4789999999999999999998765543 588887753 23466788999998 69999999998844 57
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.++++||+. ++|.+++..... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCc
Confidence 899999987 688888765322 28899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 155 ~~~~~ 159 (279)
T cd05057 155 LAKLL 159 (279)
T ss_pred ccccc
Confidence 98765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=228.44 Aligned_cols=142 Identities=35% Similarity=0.554 Sum_probs=121.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED---- 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~---- 85 (326)
+.++|.+.+.||+|++|.||+|.+..+++.+|+|.+.. ...+.+|+.+++.+ .|+||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCC
Confidence 46789999999999999999999988899999998753 23467899999998 6999999999884332
Q ss_pred -CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 -EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..++++++|+..++..... ..++...+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIMG-----------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CceEEEEecccccCHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 2468999999877655431 1288899999999999999999999999999999999999999999999
Q ss_pred eccccc
Q 020467 165 FGQARI 170 (326)
Q Consensus 165 fg~~~~ 170 (326)
||++..
T Consensus 161 fg~~~~ 166 (342)
T cd07879 161 FGLARH 166 (342)
T ss_pred CCCCcC
Confidence 998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=218.27 Aligned_cols=141 Identities=28% Similarity=0.444 Sum_probs=122.3
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---------------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---------------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---------------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
+|.+.+.||.|++|.||+|.+..+++.+++|.+.. .+.+..|+.+++.+ +|+|++++++++ ..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~ 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFE-TT 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEe-cc
Confidence 58899999999999999999888899999998742 12356788888888 699999999988 66
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
....++++||+. ++|.+.+.... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~ 150 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKIS 150 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEe
Confidence 678999999997 68887776542 28888999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 151 d~~~~~~~ 158 (272)
T cd06629 151 DFGISKKS 158 (272)
T ss_pred eccccccc
Confidence 99988653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=220.05 Aligned_cols=140 Identities=24% Similarity=0.315 Sum_probs=113.1
Q ss_pred eeeccccCcEEEEEEEcC--CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLS--DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~--~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.... ....+++|.+.. ...+.+|+..++.+ +|+||+++++.+ ......+++|||+.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~-~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQC-IESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEE-CCCCceEEEEEeCC
Confidence 368999999999996432 445788887652 22456788888888 699999999988 55667999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|.+++....... ........+..++.||+.||+|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 79 ~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 79 LGDLKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred CCcHHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccc
Confidence 68888876543211 11256777889999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=222.14 Aligned_cols=152 Identities=25% Similarity=0.374 Sum_probs=124.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-----CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|+||.||+|.+.. ++..+++|.+.. ...+.+|+.+++.+ .|+|++++++++ ....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~-~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVC-AVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEE-cCCC
Confidence 5789999999999999999998642 578899998753 23466789999998 699999999988 5566
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKRED-------------RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNL 152 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~-------------~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Ni 152 (326)
..++++||+. ++|.+++......... .....++...++.++.|++.||.|||+.+++|+||+|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 7899999998 6888888643211100 0112378888999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeecccccc
Q 020467 153 LIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 153 li~~~~~~~l~Dfg~~~~~ 171 (326)
+++.++.++|+|||++...
T Consensus 162 l~~~~~~~~l~dfg~~~~~ 180 (288)
T cd05050 162 LVGENMVVKIADFGLSRNI 180 (288)
T ss_pred EecCCCceEECccccceec
Confidence 9999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=226.56 Aligned_cols=142 Identities=27% Similarity=0.447 Sum_probs=122.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.+.|+..+.||+|++|.||+|.+..++..+++|.+.. ...+.+|+..++++ +|+|++++++.+ ......+++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 80 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSY-LKGTKLWII 80 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccc-ccCCceEEE
Confidence 4567788899999999999999988899999998752 22467888999888 699999999998 556689999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+||++ ++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 81 MEYLGGGSALDLLKPG----------PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred EEccCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccccc
Confidence 99998 5777666431 278889999999999999999999999999999999999999999999998865
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
+
T Consensus 151 ~ 151 (277)
T cd06642 151 L 151 (277)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=218.45 Aligned_cols=140 Identities=30% Similarity=0.512 Sum_probs=120.5
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
+|++.+.||.|+||.||+|.. .++..+++|.+.. ...+.+|+..++.+ +|+|++++++++ ......
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTC-LDDNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEe-ecCCeE
Confidence 588899999999999999976 4678899997742 13467788999999 699999999998 556789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
++++||+. ++|.+++..... +++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGP---------LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchh
Confidence 99999997 588877755322 78899999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 149 ~~~~ 152 (265)
T cd06631 149 ARRL 152 (265)
T ss_pred hHhh
Confidence 8754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=216.76 Aligned_cols=135 Identities=28% Similarity=0.429 Sum_probs=113.3
Q ss_pred eeccccCcEEEEEEEc--CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-
Q 020467 26 CVGSGAYSDVYKGRRL--SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR- 96 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~- 96 (326)
.||+|+||.||+|.+. .++..+++|.+.. ...+.+|+.+++++ .|+||+++++++ . ....+++|||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~-~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVC-E-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEE-c-CCCeEEEEEeCCC
Confidence 3899999999999764 4456799998853 23467889999998 699999999987 3 346899999997
Q ss_pred cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 97 TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 97 ~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..+
T Consensus 79 ~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 145 (257)
T cd05115 79 GPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145 (257)
T ss_pred CCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccc
Confidence 67877765322 12899999999999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=219.25 Aligned_cols=147 Identities=29% Similarity=0.435 Sum_probs=124.6
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~~lv 91 (326)
++|...+.||.|++|.||++.+..+++.+++|.+.. ...+.+|+++++++ +|+||+++++++... ....+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 579999999999999999999988999999998753 23578899999998 699999999988543 3468999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+++...... ...++...+..++.|++.+|.|||+.+++|+||+|.||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 99997 5887766543221 22378889999999999999999999999999999999999999999999998764
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 155 ~ 155 (287)
T cd06621 155 L 155 (287)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=254.88 Aligned_cols=146 Identities=26% Similarity=0.465 Sum_probs=126.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
+.-||+-...||.|.||.||.|.+..+|...|+|.+. ....+.+|..++..+ +|||++++|++= ......+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVE-vHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVE-VHREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCcee-ecHHHHH
Confidence 3456788889999999999999999999999999874 355678899999999 699999999985 5556789
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
|.|||+. |+|.+++..... ..+.....+..|++.|+.|||+.|||||||||+||+++.+|.+|+.|||.+
T Consensus 1311 IFMEyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccce
Confidence 9999997 788888766543 666777888999999999999999999999999999999999999999999
Q ss_pred ccccC
Q 020467 169 RILLG 173 (326)
Q Consensus 169 ~~~~~ 173 (326)
..+.+
T Consensus 1382 ~ki~~ 1386 (1509)
T KOG4645|consen 1382 VKIKN 1386 (1509)
T ss_pred eEecC
Confidence 87643
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=216.27 Aligned_cols=143 Identities=34% Similarity=0.530 Sum_probs=122.8
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||+|++|.||++.+..+++.+++|.+.. ...+.+|+++++++ +|+|++++++.+ ...+..++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENF-LEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeE-ecCCEEEEEE
Confidence 58999999999999999999988999999998753 23567888999998 699999999988 5567899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEEeeccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-GVLKLADFGQARI 170 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-~~~~l~Dfg~~~~ 170 (326)
||+. ++|.+++..... ..+++..+..++.+++.+|.|||+.+++|+||+|+||+++.+ +.++|+|||++..
T Consensus 79 e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 79 EYAPGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI 151 (256)
T ss_pred ecCCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence 9997 588888765322 227889999999999999999999999999999999999855 4689999998876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 152 ~ 152 (256)
T cd08220 152 L 152 (256)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=223.95 Aligned_cols=145 Identities=27% Similarity=0.487 Sum_probs=123.0
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++|++++.||+|+||.||++.+..++..+++|.+.. ...+.+|+.++.++ .|+|++++++.+ ...+..++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAF-FIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhhe-ecCCeEEEEE
Confidence 478999999999999999999988899999998753 23567889999998 699999999988 5567899999
Q ss_pred eeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 93 EFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 93 e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
||+.+ +|..++..... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 79 e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 79 EYMDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred eecCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99985 66666544211 1238999999999999999999996 5999999999999999999999999998765
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
+
T Consensus 153 ~ 153 (286)
T cd06622 153 L 153 (286)
T ss_pred c
Confidence 4
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=222.34 Aligned_cols=148 Identities=21% Similarity=0.345 Sum_probs=122.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++|+..+.||+|+||.||++.+..+++.+++|.+.. ...+.+|+..+.++..|+||+++++++ ......+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-FREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-ecCCcEEEEE
Confidence 467778899999999999999999999999998852 234567888888885699999999988 4566789999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|+..++.++........ ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++..+
T Consensus 83 e~~~~~l~~l~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDISLDKFYKYVYEVL----KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccCCHHHHHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999877665543211100 12389999999999999999999974 9999999999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=233.53 Aligned_cols=163 Identities=26% Similarity=0.452 Sum_probs=141.9
Q ss_pred CCCCCCccccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc----chhhHHHHHHHHHHHhcCCCeeEEe
Q 020467 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVVVLH 78 (326)
Q Consensus 3 ~~~p~~~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~----~~~~~~~E~~~l~~l~~h~ni~~l~ 78 (326)
.+.+..+.+...++..+-|++.+.||.|.+|.||+++...+++.+|+|+.. ..+.+..|.++++...+|||++.++
T Consensus 3 ~~~~~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fy 82 (953)
T KOG0587|consen 3 AKSLMDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFY 82 (953)
T ss_pred cccccccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEE
Confidence 455556667778889999999999999999999999999999999999875 3556677888999999999999999
Q ss_pred EEEEec----CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 020467 79 EYFWRE----DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLL 153 (326)
Q Consensus 79 ~~~~~~----~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nil 153 (326)
++|... ++.+||||||++ |+.-++++.... ..+.+..+..|++.++.||.+||.+.++|||+|=.|||
T Consensus 83 g~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g-------~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiL 155 (953)
T KOG0587|consen 83 GAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKG-------NRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVL 155 (953)
T ss_pred EEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcc-------cchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEE
Confidence 998543 356999999998 688888876653 33899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEeeccccccc
Q 020467 154 IGDDGVLKLADFGQARILL 172 (326)
Q Consensus 154 i~~~~~~~l~Dfg~~~~~~ 172 (326)
++.++.+||+|||.+..+.
T Consensus 156 LT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 156 LTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EeccCcEEEeeeeeeeeee
Confidence 9999999999999998774
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=226.55 Aligned_cols=144 Identities=23% Similarity=0.340 Sum_probs=121.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
+....|.....||.|+||.||++.+..++..|++|.+.. ...+.+|+..+..+ .|+|++++++.+ ......++
T Consensus 18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~-~~~~~~~i 95 (297)
T cd06659 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSY-LVGEELWV 95 (297)
T ss_pred cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhhe-eeCCeEEE
Confidence 344556667789999999999999988899999998742 33567788888888 699999999988 55678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++||+. ++|..++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 96 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 96 LMEFLQGGALTDIVSQT----------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred EEecCCCCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHh
Confidence 999998 4666654331 27889999999999999999999999999999999999999999999999876
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 166 ~~ 167 (297)
T cd06659 166 QI 167 (297)
T ss_pred hc
Confidence 44
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=217.78 Aligned_cols=144 Identities=45% Similarity=0.662 Sum_probs=121.1
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHh--cCCCeeEEeEEEEecCC----c
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQ--NSPNVVVLHEYFWREDE----D 87 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~~~----~ 87 (326)
|++.+.||+|++|.||+|.+..+++.+++|.+.. .....+|+.+++++. .|+|++++++.+..... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6789999999999999999988899999998852 123456777777664 59999999999854332 3
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
.+++||++.++|.+++..... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPK-------PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcccCHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999999888887765322 1288999999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 154 ~~~~ 157 (287)
T cd07838 154 ARIY 157 (287)
T ss_pred ceec
Confidence 8654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=216.39 Aligned_cols=135 Identities=28% Similarity=0.429 Sum_probs=115.5
Q ss_pred eeeccccCcEEEEEEEcCCC---eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 25 ECVGSGAYSDVYKGRRLSDN---LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~---~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
++||+|+||.||+|.+..++ ..+++|.+.. ...+.+|+.+++.+ .|+|++++++++. ....+++|+|+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~--~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCK--GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEc--CCceEEEEEeC
Confidence 46899999999999875544 7899998863 23467788899888 6999999999763 44689999998
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
. ++|.+++..... +++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 78 PLGPLLKYLKKRRE---------IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred CCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEecccccccee
Confidence 7 688888865432 889999999999999999999999999999999999999999999999988755
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=228.38 Aligned_cols=142 Identities=34% Similarity=0.558 Sum_probs=124.8
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----Cce
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED----EDA 88 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~----~~~ 88 (326)
+|++.+.||.|++|.||+|.+..+++.+++|.+.. ...+.+|+.+++.+ +|+|++++++++.... +..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 68999999999999999999988899999998753 23577899999999 5999999999884443 468
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+++|+|++++|.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||++
T Consensus 80 ~lv~e~~~~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 80 YIVTELMETDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEEecchhhhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 9999999988887775432 2899999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 151 ~~~ 153 (330)
T cd07834 151 RGV 153 (330)
T ss_pred Eee
Confidence 765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=217.65 Aligned_cols=134 Identities=27% Similarity=0.412 Sum_probs=113.9
Q ss_pred eeccccCcEEEEEEE--cCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 26 CVGSGAYSDVYKGRR--LSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~--~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+||+|+||.||+|.+ ..++..+++|.+.. ...+.+|+.+++.+ .|+||+++++++ . ....+++|||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGIC-E-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEE-c-CCCcEEEEecCC
Confidence 589999999999965 45678899998752 23467788889888 699999999987 3 346789999998
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||.||+++.++.++|+|||++..+
T Consensus 79 ~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 79 LGPLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence 67888775432 2889999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=224.17 Aligned_cols=143 Identities=28% Similarity=0.429 Sum_probs=119.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe----EEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL----IVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|+..+.||+|+||.||+|.+..++. .+++|.+... ..+.+|+.+++.+ +|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--~~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLS--PT 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcC--CC
Confidence 4678999999999999999998876664 4688877532 2456788888888 69999999998843 34
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++++|+. ++|.+.+..... .++...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred ceeeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccc
Confidence 678899987 688887764321 27888999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 155 ~~~~~ 159 (303)
T cd05110 155 LARLL 159 (303)
T ss_pred ccccc
Confidence 98765
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=218.93 Aligned_cols=136 Identities=24% Similarity=0.471 Sum_probs=110.3
Q ss_pred eeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHH--hcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 26 CVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQIL--QNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l--~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
.||+|+||.||+|.+..+++.||+|.+... .....|...++.+ ..|++++.+++.+ ......+++|||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-HTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-ecCCEEEEEEecC
Confidence 379999999999999888999999987531 1123333333333 2689999999988 5566799999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
. ++|..++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 80 ~g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 80 NGGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 7 57766664432 2899999999999999999999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=221.02 Aligned_cols=150 Identities=25% Similarity=0.463 Sum_probs=120.9
Q ss_pred CeEEEeeeccccCcEEEEEEEcC-----CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 20 KYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
+|++.+.||+|+||.||+|.+.. ....+++|.+.. ...+.+|+.+++.+ .|+||+++++.+ ......
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGAC-SQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEE-ecCCCc
Confidence 47889999999999999997642 235688887753 23467889999998 699999999988 556678
Q ss_pred EEEeeecc-cCHHHHHHHhhhhh---------------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 020467 89 VLVLEFLR-TDLATVIAESKKKR---------------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNL 152 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Ni 152 (326)
++++||+. ++|.+++....... .......++...+..++.|++.||.|||+.+++||||+|+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999998 68888775432110 001123478899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeecccccc
Q 020467 153 LIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 153 li~~~~~~~l~Dfg~~~~~ 171 (326)
++++++.++|+|||++...
T Consensus 159 ll~~~~~~kl~dfg~~~~~ 177 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDV 177 (290)
T ss_pred EEcCCCcEEeccccccccc
Confidence 9999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=220.18 Aligned_cols=142 Identities=26% Similarity=0.502 Sum_probs=122.1
Q ss_pred CeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 20 KYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
+|++.+.||.|+||.||.|.+. .++..|++|.+.. .....+|+.++..+.+|++|+++++.+ .....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-QTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-ecCCe
Confidence 4889999999999999999874 4688999998853 234567889999987799999999888 55667
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.++++||+. ++|.+++.... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCc
Confidence 899999998 58888776532 27888999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 151 ~~~~~ 155 (290)
T cd05613 151 LSKEF 155 (290)
T ss_pred cceec
Confidence 88654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=215.50 Aligned_cols=144 Identities=22% Similarity=0.392 Sum_probs=122.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
..++|++.++||+|+||.||++.+. .+..+++|.+.. ...+.+|+++++++ +|+|++++++.+.. ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK--EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC--CCeEEEE
Confidence 3678999999999999999999754 455689998753 24567899999998 69999999998844 5689999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++..... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+..+
T Consensus 80 e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 80 EFMAKGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EeCCCCcHHHHHHhCCc-------cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 9997 689888865322 12778889999999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=226.80 Aligned_cols=144 Identities=22% Similarity=0.357 Sum_probs=122.5
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.+.+.|.....||+|+||.||++.+..++..++||.+.. ...+.+|+..++.+ +|+|++++++.+ ......++
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~-~~~~~~~l 96 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSY-LVGDELWV 96 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHhe-ecCCeEEE
Confidence 345667777889999999999999988899999998753 33467888888888 699999999988 55678999
Q ss_pred Eeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+.+ +|.+++... .++...+..++.|++.+|.|||+.+++||||+|+||+++.++.++|+|||++.
T Consensus 97 v~e~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 97 VMEFLEGGALTDIVTHT----------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred EEeCCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 9999985 666655321 27888999999999999999999999999999999999999999999999876
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 167 ~~ 168 (292)
T cd06658 167 QV 168 (292)
T ss_pred hc
Confidence 43
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=223.30 Aligned_cols=145 Identities=30% Similarity=0.498 Sum_probs=125.2
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
++...|...+.||+|+||.||++.+..++..+++|.+.. ...+.+|+++++.+ +|+|++++++++ .....
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~ 99 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCY-LREHT 99 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-eeCCe
Confidence 345668999999999999999999988899999998752 12466788899888 699999999998 55667
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
.+++|||+.+++.+.+..... .++...+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 100 ~~lv~e~~~g~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 100 AWLVMEYCLGSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred EEEEEeCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCC
Confidence 999999999988877654322 288899999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 168 ARI 170 (326)
Q Consensus 168 ~~~ 170 (326)
+..
T Consensus 172 ~~~ 174 (317)
T cd06635 172 ASI 174 (317)
T ss_pred ccc
Confidence 754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=223.16 Aligned_cols=143 Identities=26% Similarity=0.445 Sum_probs=122.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.+.||+|++|+||++.+..+++.+++|.+.. ...+.+|+++++.+ +|+||+++++.+ .....++++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAF-LNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeE-ecCCEEEEE
Confidence 3678999999999999999999988899999997642 23567889999998 699999999998 555789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+||+. ++|.+++.... .++...+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 82 MEFMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred EecCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence 99998 57766665432 28899999999999999999996 699999999999999999999999999875
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 153 ~~ 154 (284)
T cd06620 153 EL 154 (284)
T ss_pred ch
Confidence 43
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=221.28 Aligned_cols=143 Identities=34% Similarity=0.635 Sum_probs=123.9
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
|++.+.||.|++|.||+|....+++.++||.+... ....+|+..++++.+|+|++++++++ ......+++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-RENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-hcCCcEEEEEec
Confidence 67889999999999999999888999999987532 23456888888885599999999998 557789999999
Q ss_pred cccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
++++|.+.+..... ..++...+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 80 MEGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred CCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence 99999888765431 22899999999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=216.47 Aligned_cols=141 Identities=34% Similarity=0.526 Sum_probs=122.6
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
+|+..+.||+|++|.||+|.+..++..+++|.+.. ...+.+|+.+++.+ +|+|++++++++ ......+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~-~~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTE-REEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeE-ecCCeEE
Confidence 57888999999999999999988899999998742 23467888999998 699999999988 5667899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+++||+. ++|.+++.... .++...+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 79 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~ 149 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMA 149 (258)
T ss_pred EEEEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999997 58877775432 2788899999999999999999999999999999999999999999999987
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 150 ~~~ 152 (258)
T cd06632 150 KQV 152 (258)
T ss_pred eec
Confidence 664
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=246.42 Aligned_cols=154 Identities=25% Similarity=0.455 Sum_probs=129.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-C----CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-D----NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-~----~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++.++.+.||+|+||.||.|.... . ...||+|.++. ...+.+|..++..+ +||||+++++++.. ..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~-~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD-SG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC-CC
Confidence 4678889999999999999997643 2 23488998764 45678888889888 69999999999955 66
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..++++|||. |+|..++.+....... ...++..++..++.+++.|+.||+++++|||||..+|+|++....+||+||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 7999999998 7999999876432211 334899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCc
Q 020467 166 GQARILLGNE 175 (326)
Q Consensus 166 g~~~~~~~~~ 175 (326)
|+++.+-..+
T Consensus 847 GlArDiy~~~ 856 (1025)
T KOG1095|consen 847 GLARDIYDKD 856 (1025)
T ss_pred chhHhhhhch
Confidence 9999654443
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=215.89 Aligned_cols=145 Identities=31% Similarity=0.512 Sum_probs=120.6
Q ss_pred eeeccccCcEEEEEEEcCC---CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 25 ECVGSGAYSDVYKGRRLSD---NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
+.||+|+||.||+|.+... +..+++|.+.. ...+.+|++.+..+ .|+|++++++++ ......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVC-TEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeee-cCCCceEEEEEec
Confidence 4689999999999998765 88899998863 34567889999999 499999999998 4577899999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
. ++|.+++..............+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 5 789888776421100000123899999999999999999999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-31 Score=222.79 Aligned_cols=194 Identities=39% Similarity=0.613 Sum_probs=163.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEec-----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWRE----- 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~----- 84 (326)
..+.|+-..+||+|.||.|++|+...+++.|++|.+- -.....+|++++..++ |+|++.++..|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCcc
Confidence 4567888889999999999999999999999987542 1335689999999994 99999988877322
Q ss_pred --CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 020467 85 --DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 85 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l 162 (326)
...+|+|++++..+|+-++....-. ++...+..++.+++.+|.|+|++.|+|||+|++|++|+.+|.++|
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr--------~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVR--------FSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCcccc--------ccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence 1348999999999998888654322 889999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCC
Q 020467 163 ADFGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDE 242 (326)
Q Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
+|||+++.+...+..
T Consensus 166 ADFGlar~fs~~~n~----------------------------------------------------------------- 180 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNV----------------------------------------------------------------- 180 (376)
T ss_pred eccccccceeccccc-----------------------------------------------------------------
Confidence 999999877544311
Q ss_pred CCCCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhh
Q 020467 243 TDKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAY 322 (326)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~i 322 (326)
....-+.+|-|.+|++||.+.|.+.|+++.|||..|||
T Consensus 181 ------------------------------------------~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCi 218 (376)
T KOG0669|consen 181 ------------------------------------------VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCI 218 (376)
T ss_pred ------------------------------------------CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHH
Confidence 11225677889999999999999999999999999999
Q ss_pred hccC
Q 020467 323 LQNF 326 (326)
Q Consensus 323 l~el 326 (326)
|.||
T Consensus 219 maeM 222 (376)
T KOG0669|consen 219 MAEM 222 (376)
T ss_pred HHHH
Confidence 9886
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=218.54 Aligned_cols=147 Identities=22% Similarity=0.384 Sum_probs=117.5
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCe--EEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-----C
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNL--IVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED-----E 86 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~--~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-----~ 86 (326)
+.+.+.||+|+||.||+|.+..++. .+++|.+.. ...+.+|+.+++.+ +|+||+++++.+.... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCC
Confidence 3467899999999999998866654 689997642 23466788889888 6999999999763321 2
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++++|+. ++|.+++...... .....++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLG---DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhccc---CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence 4689999997 6887776433211 01223789999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 157 g~~~~~ 162 (272)
T cd05075 157 GLSKKI 162 (272)
T ss_pred Cccccc
Confidence 998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=214.81 Aligned_cols=143 Identities=24% Similarity=0.442 Sum_probs=121.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
..+|++.+.||.|++|.||++.+. .+..+++|.+.. ...+.+|+++++.+ .|++++++++++ ......++++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVC-TERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEE-ccCCceEEEEE
Confidence 357999999999999999999875 366799998763 34577899999999 699999999998 55667899999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... .++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 80 FMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred cCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeec
Confidence 997 577777654321 2788899999999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=217.34 Aligned_cols=144 Identities=26% Similarity=0.439 Sum_probs=117.0
Q ss_pred eeeccccCcEEEEEEEcCCCe--EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNL--IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~--~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|.+..++. .+++|.+.. ...+..|++++.++.+|+|++++++++ ...+..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-ecCCCceEEEEeCC
Confidence 368999999999999877664 468887753 234667899999997799999999998 55567899999997
Q ss_pred -cCHHHHHHHhhhhhh-------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 97 -TDLATVIAESKKKRE-------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|.+++........ ......++...+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 689888865431100 011123788999999999999999999999999999999999999999999999986
Q ss_pred c
Q 020467 169 R 169 (326)
Q Consensus 169 ~ 169 (326)
.
T Consensus 160 ~ 160 (270)
T cd05047 160 R 160 (270)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=217.94 Aligned_cols=151 Identities=23% Similarity=0.352 Sum_probs=124.4
Q ss_pred cCeEEEeeeccccCcEEEEEEEcC-----CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
++|++.+.||.|+||.||+|.... +.+.+++|.+.. ...+.+|+++++++ .|+|++++++++ .....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLC-REAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEE-CCCCc
Confidence 679999999999999999998643 356789998753 23567899999999 699999999988 55667
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..............++...+..++.|++.+|+|||+.+++|+||||+||+++.++.++++||+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 899999998 6888888654421110111238899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 163 ~~~~~ 167 (275)
T cd05046 163 LSKDV 167 (275)
T ss_pred ccccc
Confidence 87643
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=215.29 Aligned_cols=142 Identities=35% Similarity=0.540 Sum_probs=125.7
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++|++.+.||.|++|.||+|.+..+++.+++|.+.. ...+.+|+..+..+ .|+|++++++.+ ......++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAF-YKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEE-ccCCeEEEEE
Confidence 478999999999999999999988899999998753 24567888899999 599999999998 5567899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
||+. ++|.+++.... .+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 79 e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 79 EYMDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 9998 78888876532 28999999999999999999999 9999999999999999999999999998875
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 150 ~ 150 (264)
T cd06623 150 L 150 (264)
T ss_pred c
Confidence 5
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=216.93 Aligned_cols=140 Identities=23% Similarity=0.290 Sum_probs=113.9
Q ss_pred eeeccccCcEEEEEEEc--CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRL--SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||+|+||.||+|... .++..+++|.++. ...+.+|+.+++.+ +|+|++++++.+ ......+++|||+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQC-TEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-cCCCCcEEEEECCC
Confidence 36899999999999754 3456789998753 23466788899988 699999999988 55667899999998
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|.+++....... ....+...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..
T Consensus 79 ~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 79 LGDLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred CCcHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcccccc
Confidence 68888876533211 11256677888999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=215.01 Aligned_cols=143 Identities=24% Similarity=0.394 Sum_probs=124.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.+.||.|++|.||+|.. .++.+++|.+... ..+.+|+.+++.+ .|+|++++++++ ......+++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVV-LQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEE-cCCCCeEEEEE
Confidence 46799999999999999999976 4788999988643 3567889999999 599999999998 45678999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 81 YMAKGSLVDYLRSRGR-------AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred ecCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccc
Confidence 998 688888765431 12889999999999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=215.46 Aligned_cols=146 Identities=37% Similarity=0.595 Sum_probs=123.8
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DEDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~~lv 91 (326)
+|++.+.||.|++|.||++.+..++..+++|.+.. ...+..|+++++.+ .|+|++++++.+... ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999988999999998752 23456788889888 699999999987543 3457999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH-----RNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH-----~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
+||+. ++|.+++...... ...++...++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+||
T Consensus 80 ~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred ehhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence 99997 6888887654321 123889999999999999999999 889999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++..+
T Consensus 155 g~~~~~ 160 (265)
T cd08217 155 GLAKIL 160 (265)
T ss_pred cccccc
Confidence 988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=220.92 Aligned_cols=134 Identities=31% Similarity=0.473 Sum_probs=117.2
Q ss_pred cc-cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcC-------CCeeEEeEEEEec
Q 020467 17 II-AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNS-------PNVVVLHEYFWRE 84 (326)
Q Consensus 17 ~~-~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h-------~ni~~l~~~~~~~ 84 (326)
+. +||.+.++||=|-|++||+|++....+.||+|+.+. .+....||++|+++..+ ..|+++++.|...
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 44 799999999999999999999999999999999974 34567899999998743 3699999999654
Q ss_pred C---CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCC
Q 020467 85 D---EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 85 ~---~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~ 157 (326)
+ .+++||+|+++.+|+.++..... ++++...+..|++||+.||.|||. .||||.||||+|||+..+
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~Y-------rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNY-------RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCC-------CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 4 57999999999999999987654 349999999999999999999995 599999999999999755
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=217.19 Aligned_cols=144 Identities=25% Similarity=0.435 Sum_probs=126.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|.++++||+|.|.+|..++.+++.+.+|+|++++ ..-...|-.+.....+||.++.+...| .....++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-qtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-QTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-cccceEE
Confidence 5789999999999999999999999999999998863 122355666777777899999999988 5566799
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+|.||+. |+|...+..+.. ++++.++.+...|+.||.|||+.||++||||..|+++|..|++||.|+|++
T Consensus 328 fvieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred EEEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchh
Confidence 9999997 688877776654 999999999999999999999999999999999999999999999999999
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
+..
T Consensus 399 ke~ 401 (593)
T KOG0695|consen 399 KEG 401 (593)
T ss_pred hcC
Confidence 754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=227.56 Aligned_cols=144 Identities=24% Similarity=0.399 Sum_probs=124.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
..+|.++.+||+|.||.|.+|..+.+.+.+|||++++ .+....|-++|+....-|.++++...| ..-..+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-QTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-QTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-hhhhhee
Confidence 5788999999999999999999999999999998863 233456777776665567888888887 5556799
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+||||+. |+|.-.+..-+. +.+..+..++..|+-+|-+||+.||++||||..|||++.+|+++|.|||++
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccc
Confidence 9999997 688877766544 888999999999999999999999999999999999999999999999999
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
+..
T Consensus 498 KEn 500 (683)
T KOG0696|consen 498 KEN 500 (683)
T ss_pred ccc
Confidence 754
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=217.01 Aligned_cols=138 Identities=24% Similarity=0.437 Sum_probs=113.4
Q ss_pred eeeccccCcEEEEEEEcC---CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 25 ECVGSGAYSDVYKGRRLS---DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
+.||+|+||.||+|.+.. ....+++|.+.. ...+.+|+.+++.+ +|+|++++++++....+..+++++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998643 346799998743 23456788888888 69999999998755566688999998
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
. ++|.+++..... ......+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 80 KHGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred CCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccc
Confidence 7 688888754321 1566778889999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=220.72 Aligned_cols=136 Identities=20% Similarity=0.285 Sum_probs=109.1
Q ss_pred eeeccccCcEEEEEEEcCCC-------eEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 25 ECVGSGAYSDVYKGRRLSDN-------LIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~-------~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+.||.|+||.||+|.+...+ ..+++|.... ...+..|..+++.+ .|+|++++++++ ......+++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~-~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVC-VCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEE-EeCCCcEEEE
Confidence 46899999999999875433 3477777643 23456777888887 699999999998 4456789999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--------EEEE
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV--------LKLA 163 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~--------~~l~ 163 (326)
||+. ++|..++..... .++...+..++.|++.||.|||+.+|+||||||+||+++.++. ++++
T Consensus 79 e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred ecCCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEec
Confidence 9997 578777765332 2788899999999999999999999999999999999987765 5888
Q ss_pred eeccccc
Q 020467 164 DFGQARI 170 (326)
Q Consensus 164 Dfg~~~~ 170 (326)
|||++..
T Consensus 151 d~g~~~~ 157 (258)
T cd05078 151 DPGISIT 157 (258)
T ss_pred ccccccc
Confidence 8887643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=216.63 Aligned_cols=136 Identities=22% Similarity=0.342 Sum_probs=113.6
Q ss_pred eeeccccCcEEEEEEEcCCC----------eEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 25 ECVGSGAYSDVYKGRRLSDN----------LIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~----------~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
+.||+|+||.||+|.+..++ ..+++|.+.. ...+.+|+.+++.+ .|+|++++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR--DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec--CCcEE
Confidence 46899999999999987655 4577787653 34567788888888 69999999998855 56899
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-------cEEE
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-------VLKL 162 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-------~~~l 162 (326)
++||+. ++|.+++..... .++...+..++.|++.||+|||+.+|+|+||||+||+++.++ .++|
T Consensus 78 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence 999998 677777765432 288889999999999999999999999999999999999887 7999
Q ss_pred Eeecccccc
Q 020467 163 ADFGQARIL 171 (326)
Q Consensus 163 ~Dfg~~~~~ 171 (326)
+|||++...
T Consensus 150 ~Dfg~a~~~ 158 (259)
T cd05037 150 SDPGIPITV 158 (259)
T ss_pred CCCCccccc
Confidence 999988654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=227.82 Aligned_cols=145 Identities=33% Similarity=0.511 Sum_probs=125.5
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|++|.||+|.+..+++.|++|.+.. .....+|+.+++.+ .|+|++++.+++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhcccccc
Confidence 467899999999999999999999988999999998752 23456789999998 6999999988773332
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...+++++|++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVKCQ----------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccccEEEEEecCCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEc
Confidence 248999999998988877542 28899999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 161 dfg~~~~~ 168 (343)
T cd07851 161 DFGLARHT 168 (343)
T ss_pred cccccccc
Confidence 99998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=217.63 Aligned_cols=141 Identities=28% Similarity=0.476 Sum_probs=121.8
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+-|++.+.||.|+||.||+|.+..++..+|+|.+.. ...+.+|+..+.++ .|+|++++++.+ ......++++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSY-LKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEE-EeCCeEEEEE
Confidence 447889999999999999999888899999998752 23466788888888 699999999998 5566799999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||++ ++|.+++... .++...+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 82 e~~~~~~l~~~i~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 82 EYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred EeCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 9998 4777666432 2788999999999999999999999999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=215.24 Aligned_cols=136 Identities=32% Similarity=0.510 Sum_probs=113.6
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccchh--------hHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ--------SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--------~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+.||.|++|.||+|.+..+++.+++|.+.... ....|...+.....|+|++++++.+ ......++++||+.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-QSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-EcCCeEEEEEeccC
Confidence 56899999999999998889999999885321 1233444444444799999999998 56678999999997
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 81 GGDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 68888775533 288999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=219.14 Aligned_cols=135 Identities=21% Similarity=0.313 Sum_probs=105.9
Q ss_pred eeccccCcEEEEEEEcC------------------------CCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeE
Q 020467 26 CVGSGAYSDVYKGRRLS------------------------DNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVV 76 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~------------------------~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~ 76 (326)
.||+|+||.||+|.... ....|++|.+.. ...+.+|+.+++.+ +|+||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 58999999999986421 124588888753 23455677777777 6999999
Q ss_pred EeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc
Q 020467 77 LHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG 155 (326)
Q Consensus 77 l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~ 155 (326)
+++++ ......+++|||+. ++|..++.... ..++...+..++.|++.||.|||+.+|+||||||+||+++
T Consensus 81 ~~~~~-~~~~~~~lv~ey~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 81 VHGVC-VRGSENIMVEEFVEHGPLDVCLRKEK--------GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred EEEEE-EeCCceEEEEecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 99998 55667899999998 46665554322 2278899999999999999999999999999999999998
Q ss_pred CCC-------cEEEEeeccccc
Q 020467 156 DDG-------VLKLADFGQARI 170 (326)
Q Consensus 156 ~~~-------~~~l~Dfg~~~~ 170 (326)
..+ .++++|||++..
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~ 173 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFT 173 (274)
T ss_pred ccCcccCccceeeecCCccccc
Confidence 643 378999997643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=216.00 Aligned_cols=143 Identities=24% Similarity=0.444 Sum_probs=120.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC---CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD---NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.+.||+|++|.||+|.+... ...+++|.... ...+.+|+.+++.+ .|+|++++++++. . ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~-~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVIT-E-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEc-C-CCc
Confidence 46799999999999999999987543 45688998753 23567788999998 6999999999874 3 457
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~ 153 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL 153 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCce
Confidence 89999997 688888765321 278899999999999999999999999999999999999999999999998
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 154 ~~~~ 157 (270)
T cd05056 154 SRYL 157 (270)
T ss_pred eeec
Confidence 8755
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=217.79 Aligned_cols=148 Identities=28% Similarity=0.442 Sum_probs=129.9
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
..+..+.|++.+.|++|++|.||.+.+..++..+++|.+.. ...+.+|++.++.+ +|+|++++++.+ ......+
T Consensus 14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~ 91 (286)
T cd06614 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSY-LVGDELW 91 (286)
T ss_pred CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEE-EECCEEE
Confidence 44678889999999999999999999988889999998863 34567899999998 699999999998 4457899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+++||+. ++|.+++.... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred EEEeccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchh
Confidence 9999998 78988887643 12899999999999999999999999999999999999999999999999987
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 164 ~~~ 166 (286)
T cd06614 164 AQL 166 (286)
T ss_pred hhh
Confidence 654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=217.09 Aligned_cols=136 Identities=29% Similarity=0.443 Sum_probs=117.1
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
||+|+||+||+|.+..+++.+++|.+.. ...+.+|+++++.+ +|+|++++++.+ ......++++||+. +
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAF-ETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEE-ecCCeEEEEEecCCCC
Confidence 6899999999999888999999998742 22346788999999 599999999998 55667999999998 5
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+++..... ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~L~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 79 DLKYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred cHHHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 88877765432 12889999999999999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=220.70 Aligned_cols=144 Identities=28% Similarity=0.473 Sum_probs=124.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
+..+.|...+.||+|++|.||+|.+..++..+++|.+.. ...+.+|+++++.+ +|+|++++++++ .....
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~ 95 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCY-LKEHT 95 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEE-EeCCE
Confidence 445568888999999999999999988999999998752 13456788899998 699999999998 55677
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
.|++|||+.+++.+.+.... ..++...+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred EEEEEecCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCC
Confidence 99999999998888776432 2288899999999999999999999999999999999999999999999998
Q ss_pred cc
Q 020467 168 AR 169 (326)
Q Consensus 168 ~~ 169 (326)
+.
T Consensus 168 ~~ 169 (313)
T cd06633 168 AS 169 (313)
T ss_pred Cc
Confidence 64
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=212.93 Aligned_cols=136 Identities=26% Similarity=0.476 Sum_probs=114.9
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
+.||+|+||.||+|... ++..+++|.+.. ...+.+|+..++.+ .|+|++++++++ ......+++|||+. +
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVC-TQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEE-ecCCccEEEEECCCCC
Confidence 46899999999999854 678899998753 22466788899888 699999999998 55667999999997 6
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+++..... .+.+..+..++.|++.+|.|+|+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 143 (250)
T cd05085 78 DFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQE 143 (250)
T ss_pred cHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceec
Confidence 88777654321 2788899999999999999999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=215.55 Aligned_cols=144 Identities=25% Similarity=0.406 Sum_probs=122.7
Q ss_pred cCeEEEeeeccccCcEEEEEEEc----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCc
Q 020467 19 AKYEILECVGSGAYSDVYKGRRL----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DED 87 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~ 87 (326)
+.|++.+.||+|+||.||++... .++..+++|.+.. ...+.+|++.++.+ .|+|++++++++... ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCc
Confidence 46888899999999999999854 3478899998853 33577889999998 699999999987432 456
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccc
Confidence 899999997 688888765432 28888999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 155 ~~~~~ 159 (284)
T cd05038 155 LAKVL 159 (284)
T ss_pred ccccc
Confidence 98765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=214.61 Aligned_cols=141 Identities=26% Similarity=0.466 Sum_probs=120.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.++|++.+.||+|+||.||++.. +++.+++|.+.. ...+.+|+.+++.+ +|+|++++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~v~e~ 79 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILH--NGLYIVMEL 79 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcC--CCcEEEEEC
Confidence 36799999999999999999864 677899998863 34567889999988 69999999998843 347899999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+. ++|.+++..... ..++...+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..
T Consensus 80 ~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 80 MSKGNLVNFLRTRGR-------ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred CCCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 97 688888765322 2278889999999999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=234.95 Aligned_cols=147 Identities=22% Similarity=0.416 Sum_probs=128.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC---CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD---NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.+...|.+.||.|.||.|++|+.+.. ...||||.++. ...++.|..++-++ .||||+++.++. ......
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVV-Tks~Pv 705 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVV-TKSKPV 705 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEE-ecCcee
Confidence 46678999999999999999987644 36799999863 55688899999999 699999999998 667789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
++++|||+ |+|..++..+..+ |+..++..+++.|+.|++||.++++|||||..+|||++.+-.+|++|||+
T Consensus 706 MIiTEyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence 99999999 7888888765432 88889999999999999999999999999999999999999999999999
Q ss_pred cccccCC
Q 020467 168 ARILLGN 174 (326)
Q Consensus 168 ~~~~~~~ 174 (326)
++++..+
T Consensus 778 SRvledd 784 (996)
T KOG0196|consen 778 SRVLEDD 784 (996)
T ss_pred eeecccC
Confidence 9987544
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=212.90 Aligned_cols=142 Identities=30% Similarity=0.542 Sum_probs=121.9
Q ss_pred eEEEeeeccccCcEEEEEEEcCCC----eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDN----LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~----~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
+++.+.||.|+||.||++.+...+ ..+++|.+.. ...+..|+..+..+ +|+|++++++++ ...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVC-TEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEE-cCCCeeEE
Confidence 457789999999999999987655 8899998863 33567889999999 799999999998 44567999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|+++. ++|.+++...... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 79 i~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred EEeccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCce
Confidence 999997 5888887654321 17889999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 152 ~~ 153 (258)
T smart00219 152 DL 153 (258)
T ss_pred ec
Confidence 65
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=219.50 Aligned_cols=146 Identities=25% Similarity=0.438 Sum_probs=123.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
..++|++.+.||+|++|.||+|.+..+++.+++|.+.. ......|+..+.+...|+||+++++++ ......++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 91 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-ITDSDVFI 91 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-ecCCeEEE
Confidence 46889999999999999999999988899999998853 223455666666665699999999998 55668999
Q ss_pred EeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+.+.+.+++..... .+++..+..++.|++.+|.|||+ .+++||||+|+||+++.++.++|+|||++.
T Consensus 92 v~e~~~~~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 92 CMELMSTCLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EeeccCcCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999998877777654322 28888999999999999999997 599999999999999999999999999876
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 164 ~~ 165 (296)
T cd06618 164 RL 165 (296)
T ss_pred hc
Confidence 54
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=214.46 Aligned_cols=143 Identities=32% Similarity=0.575 Sum_probs=123.0
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|.+.+.||.|++|.||++.+..++..+++|.+.. ...+.+|+.+++.+ +|+|++++++.+ ......++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~-~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASF-QENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhhee-ccCCeEEEEE
Confidence 58999999999999999999998899999998842 33566899999999 699999999988 6667899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEEeeccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARI 170 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-~~~l~Dfg~~~~ 170 (326)
||+. ++|.+.+..... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++++|||.+..
T Consensus 79 e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 79 EYCDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151 (257)
T ss_pred ecCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchh
Confidence 9997 688887764322 2278899999999999999999999999999999999999876 569999998765
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
+
T Consensus 152 ~ 152 (257)
T cd08225 152 L 152 (257)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=218.92 Aligned_cols=143 Identities=29% Similarity=0.461 Sum_probs=124.5
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
++|++.+.||.|++|.||++.+..+++.+++|.+.. ...+.+|++.++.+ .|+|++++++.+ ...+..++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAF-YNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheee-ecCCEEEEEE
Confidence 468888999999999999999988999999998753 23467888889888 599999999998 5557899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
||+. ++|.+++.... ..+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+..
T Consensus 79 e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 79 EYMDGGSLDKILKEVQ--------GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred EecCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence 9998 68888776532 228899999999999999999999 9999999999999999999999999998765
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 151 ~ 151 (265)
T cd06605 151 L 151 (265)
T ss_pred h
Confidence 4
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=227.58 Aligned_cols=150 Identities=25% Similarity=0.369 Sum_probs=128.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
..+...+.++||+|.||+|.+|.- .....||+|.++. ...+..|+++|.++ .||||+.++++|.. +..+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~-DePicm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQ-DDPLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeec-CCchHH
Confidence 457789999999999999999974 3468899999863 45688999999999 59999999999944 557999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++||++ |+|.+++.++.... +.......++.||+.|++||.+.+++|||+.++|+|++.++++||+|||+++
T Consensus 613 I~EYmEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence 999998 89999998763211 3444566799999999999999999999999999999999999999999999
Q ss_pred cccCCcc
Q 020467 170 ILLGNEF 176 (326)
Q Consensus 170 ~~~~~~~ 176 (326)
.+-.+.+
T Consensus 686 ~lysg~y 692 (807)
T KOG1094|consen 686 NLYSGDY 692 (807)
T ss_pred ccccCCc
Confidence 8766554
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=217.26 Aligned_cols=141 Identities=45% Similarity=0.749 Sum_probs=123.6
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
|++.+.||+|++|.||+|.+..+++.+++|.+.. .....+|+++++++ .|++++++++++ ......++++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVF-RHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhh-ccCCCEEEEEe
Confidence 5678899999999999999988899999998753 23467788999999 599999999998 55678999999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+.+++.+.+..... .++...+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 79 FMDTDLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred ccCCCHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 999998888765321 2889999999999999999999999999999999999999999999999988655
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=216.16 Aligned_cols=143 Identities=22% Similarity=0.377 Sum_probs=122.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
...+|...+.||+|++|.||++.+..+++.+++|.+.. ...+.+|+.+++.+ +|+|++++++++ ...+..+++
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~-~~~~~~~~v 94 (285)
T cd06648 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSY-LVGDELWVV 94 (285)
T ss_pred chHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEE-EcCCeEEEE
Confidence 34567777899999999999999888899999998742 23467788888888 699999999988 556779999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+||+. ++|.+.+.. .. ++...+..++.|++.||.+||+.+++||||+|+||+++.++.++|+|||++..
T Consensus 95 ~e~~~~~~L~~~~~~-~~---------~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 95 MEFLEGGALTDIVTH-TR---------MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EeccCCCCHHHHHHh-CC---------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 99997 588777654 11 78889999999999999999999999999999999999999999999998754
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 165 ~ 165 (285)
T cd06648 165 V 165 (285)
T ss_pred h
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=212.94 Aligned_cols=134 Identities=29% Similarity=0.433 Sum_probs=117.6
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
||.|++|.||+|.+..+++.+++|.+.. ...+.+|+.+++.+ +|+|++++++.+ ......++++||+. +
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTF-KDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeE-EcCCccEEEEecCCCC
Confidence 6899999999999988899999998752 23467788888888 699999999988 66678999999987 6
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+++..... ++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~L~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~ 143 (262)
T cd05572 79 ELWTILRDRGL---------FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143 (262)
T ss_pred cHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence 88888765432 788899999999999999999999999999999999999999999999988755
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=213.33 Aligned_cols=137 Identities=23% Similarity=0.377 Sum_probs=116.3
Q ss_pred eeeccccCcEEEEEEEcC-CC--eEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 25 ECVGSGAYSDVYKGRRLS-DN--LIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~-~~--~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
++||+|++|.||+|.+.. .+ ..+++|.+... ..+.+|+..++++ .|+|++++++.+.. ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT--HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC--CeEEEEEEec
Confidence 468999999999998754 33 36899988642 3466789999999 69999999999844 7799999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
. ++|.+.+..... ..++...++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 78 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 78 PLGSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred CCCcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccc
Confidence 6 788888766431 12889999999999999999999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=211.96 Aligned_cols=143 Identities=29% Similarity=0.420 Sum_probs=119.6
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
+++.....||+|+||.||+|.+..++..+++|.+.. ...+.+|+.+++.+ +|+||+++++++ ...+..++++|
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~e 85 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSD-SENGFFKIFME 85 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeee-ccCCEEEEEEe
Confidence 344445689999999999999888899999998753 33567889999998 699999999998 55678999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEEeecccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGI--SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADFGQAR 169 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l--~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~~~~~l~Dfg~~~ 169 (326)
|+. ++|.+++..... .+ +...+..++.|++.||.|||+.+|+|+||+|+||+++. ++.++|+|||++.
T Consensus 86 ~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 86 QVPGGSLSALLRSKWG--------PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred cCCCCCHHHHHHHhcc--------cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 997 688887764321 13 77788899999999999999999999999999999986 6799999999886
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 158 ~~ 159 (268)
T cd06624 158 RL 159 (268)
T ss_pred ec
Confidence 54
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=217.31 Aligned_cols=143 Identities=27% Similarity=0.454 Sum_probs=126.0
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
++|++.+.||+|++|.||++.+..+++.+++|.+.. ...+.+|..++.++..|+||+++++++ ......++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-QDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-cCCceEEE
Confidence 479999999999999999999988999999998853 234567788888884499999999988 55668999
Q ss_pred Eeeec-ccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~-~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+||++ +++|.+++.... .++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||++.
T Consensus 80 v~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~ 150 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAK 150 (280)
T ss_pred EEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccc
Confidence 99999 478888876543 28999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 151 ~~ 152 (280)
T cd05581 151 VL 152 (280)
T ss_pred cc
Confidence 65
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=210.56 Aligned_cols=136 Identities=29% Similarity=0.488 Sum_probs=116.4
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
++||.|++|.||++.+.. ++.|++|.+.. ...+.+|+++++.+ .|+||+++++++ ......++++||+. +
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVC-VQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEE-ecCCCeEEEEEcCCCC
Confidence 468999999999999876 88999998753 23567888989888 699999999988 55667999999996 6
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+++..... .++...+..++.+++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~l~~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 143 (251)
T cd05041 78 SLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREE 143 (251)
T ss_pred cHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence 78777654321 2788899999999999999999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=219.90 Aligned_cols=145 Identities=29% Similarity=0.503 Sum_probs=124.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..+.|+..+.||.|++|.||+|.+..++..+++|.+.. ...+.+|+++++.+ +|+|++++++++ ......
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~ 90 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCY-LREHTA 90 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEE-EcCCee
Confidence 45668889999999999999999988899999998742 12456788899998 699999999998 556679
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++++||+.+++.+.+..... .++...+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 91 ~lv~e~~~~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 162 (308)
T cd06634 91 WLVMEYCLGSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162 (308)
T ss_pred EEEEEccCCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccc
Confidence 99999999888777654321 2788899999999999999999999999999999999999999999999987
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 163 ~~~ 165 (308)
T cd06634 163 SIM 165 (308)
T ss_pred eee
Confidence 643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=211.05 Aligned_cols=131 Identities=28% Similarity=0.412 Sum_probs=112.6
Q ss_pred ccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-cCHHHHHHHhhh
Q 020467 30 GAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKK 108 (326)
Q Consensus 30 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~ 108 (326)
|.++.||++.+..+++.+++|.+........|...+... .|+|++++++.+ ......+++|||+. ++|.+.+.....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~-~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~ 81 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPH-CVPNMVCLHKYI-VSEDSVFLVLQHAEGGKLWSHISKFLN 81 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhc-CCCceeehhhhe-ecCCeEEEEEecCCCCCHHHHHHHhcC
Confidence 899999999999999999999997655555565555554 589999999988 55678999999998 688888765432
Q ss_pred hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 109 KREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 109 ~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++++|||++...
T Consensus 82 ---------l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~ 135 (237)
T cd05576 82 ---------IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV 135 (237)
T ss_pred ---------CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcc
Confidence 889999999999999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=213.59 Aligned_cols=138 Identities=22% Similarity=0.354 Sum_probs=111.0
Q ss_pred eeccccCcEEEEEEEcC--CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-
Q 020467 26 CVGSGAYSDVYKGRRLS--DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR- 96 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~--~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~- 96 (326)
.||+|+||.||++.... ....+++|.+.. ...+.+|+..++.+ +|+|++++++.+ ......+++|||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~-~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQC-VEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEe-cCCCccEEEEecCCC
Confidence 58999999999996532 234566776542 23567778888888 699999999998 55667899999998
Q ss_pred cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 97 TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 97 ~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|.+++....... ...+...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..
T Consensus 80 ~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 80 GDLKSYLSQEQWHR-----RNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred CcHHHHHHhhhccc-----ccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccc
Confidence 68888886543211 1266677889999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-29 Score=230.00 Aligned_cols=145 Identities=30% Similarity=0.514 Sum_probs=124.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.+.+.|.+...+|.|+|+.|..+.+..+++..++|++.+. ....+|+.++....+|+|++++.+.+ .++.+.|+|||.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-EDGKEIYLVMEL 397 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-cCCceeeeeehh
Confidence 3678899999999999999999999999999999999765 55678888888888999999999999 777889999999
Q ss_pred ccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE-cCCCcEEEEeecccccc
Q 020467 95 LRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI-GDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili-~~~~~~~l~Dfg~~~~~ 171 (326)
+.+ .+.+.+..... +. ..+..|+++|+.|+.|||++|++||||||+|||+ +..++++|+|||+++.+
T Consensus 398 l~g~ell~ri~~~~~---------~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE---------FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ccccHHHHHHHhcch---------hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 985 44444433221 33 6778899999999999999999999999999999 58899999999998875
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=211.33 Aligned_cols=141 Identities=28% Similarity=0.506 Sum_probs=123.6
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||+|++|.||++.+..+++.+++|.+.. ...+.+|+.+++.+ +|+||+++++.+ ......++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~-~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVE-VHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeE-ecCCEEEEEE
Confidence 68999999999999999999888899999998752 33567888999999 699999999987 5667899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+.+.... .++...+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 79 EYCSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149 (264)
T ss_pred ecCCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence 9997 67877775432 2778889999999999999999999999999999999999999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=215.44 Aligned_cols=141 Identities=44% Similarity=0.666 Sum_probs=124.1
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
|++.+.||+|.+|.||+|....+++.+++|.+... .....|+.+++.+ .|+|++++++++ ......++++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVI-HTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhh-hcCCceEEEec
Confidence 66788999999999999999888999999988632 3456788999998 599999999998 55578999999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+.++|.+++.... ..++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~~l~~~i~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 79 YCDMDLKKYLDKRP--------GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred CcCcCHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 99999998887642 12899999999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=208.26 Aligned_cols=141 Identities=32% Similarity=0.541 Sum_probs=123.9
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||+|++|.||++.+..+++.+++|.+... ..+.+|++++.++ .|+|++++++++ ...+..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSI-ETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEE-EeCCEEEEEE
Confidence 588999999999999999999888999999988532 3467888899998 699999999988 5567899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+++. ++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 79 EYAENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKL 149 (254)
T ss_pred ecCCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence 9997 57877776542 2899999999999999999999999999999999999999999999999998765
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=206.92 Aligned_cols=142 Identities=30% Similarity=0.527 Sum_probs=124.4
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
+|++.+.||+|++|.||++.+..+++.+++|.+... ..+.+|+..++.+ .|++++++++.+ ......+++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSY-LKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEE-ecCCeEEEEEec
Confidence 488899999999999999999888999999988543 3577889999998 599999999988 555779999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
++ ++|.+++.... ..++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 79 CSGGSLKDLLKSTN--------QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred CCCCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 98 68877776542 12899999999999999999999999999999999999999999999999988665
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=212.41 Aligned_cols=142 Identities=27% Similarity=0.462 Sum_probs=115.7
Q ss_pred eeccccCcEEEEEEEcCCC------eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 26 CVGSGAYSDVYKGRRLSDN------LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~~~------~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.||+|+||.||+|.+.... +.+++|.+.. ...+.+|+.+++.+ .|+||+++++++ ......+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVC-LLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeee-cCCCCeEEEEe
Confidence 6899999999999875433 6788887642 33567888999988 699999999998 55667999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-----cEEEEeecc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-----VLKLADFGQ 167 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-----~~~l~Dfg~ 167 (326)
|+. ++|.+++........ ....++...+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 80 LMEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred ccCCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 997 688888865432110 122378889999999999999999999999999999999999877 899999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 158 ~~~~ 161 (269)
T cd05044 158 ARDI 161 (269)
T ss_pred cccc
Confidence 8754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=211.97 Aligned_cols=147 Identities=23% Similarity=0.412 Sum_probs=116.7
Q ss_pred eEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC----
Q 020467 21 YEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE---- 86 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~---- 86 (326)
|.+.+.||+|+||.||+|.+. .+++.++||.+.. ...+.+|+++++.+ +|+|++++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 567889999999999999754 3578999998753 22466889999999 69999999998743321
Q ss_pred -ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 87 -DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 87 -~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..+++++|+. ++|..++........ ...++...+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEE---PFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence 2467888887 677766643321100 12378889999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 157 fg~~~~~ 163 (273)
T cd05074 157 FGLSKKI 163 (273)
T ss_pred ccccccc
Confidence 9988754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=209.44 Aligned_cols=145 Identities=38% Similarity=0.639 Sum_probs=123.8
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|++.+.||.|++|.||++.+..+++.+++|.+.. ...+..|+++++.+ .|+||+++++++ ......++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAF-LDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhh-ccCCEEEEEe
Confidence 58999999999999999999988999999998752 23456788889888 599999999988 4457899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++...... ...+++..++.++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 79 EYAPFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred hhcCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 9996 5888877653321 123888999999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=206.77 Aligned_cols=143 Identities=32% Similarity=0.475 Sum_probs=124.5
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEecC-CceEEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWRED-EDAVLV 91 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-~~~~lv 91 (326)
+|.+.+.||+|++|.||+|.+..+++.+++|.+... ..+.+|+..++++ +|+|++++++.+.... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 588899999999999999999888999999988543 3567889999999 5999999999984331 678999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+|++. ++|.+++.... .++...+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred EEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 99995 68888776543 289999999999999999999999999999999999999999999999999876
Q ss_pred cc
Q 020467 171 LL 172 (326)
Q Consensus 171 ~~ 172 (326)
..
T Consensus 151 ~~ 152 (260)
T cd06606 151 LG 152 (260)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=207.61 Aligned_cols=145 Identities=35% Similarity=0.644 Sum_probs=125.3
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
+|.+.+.||.|++|.||++.+..++..+++|.+.. ...+..|+++++.+ +|+|++++.+.+ ......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~-~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESF-EEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEE-ecCCEEEEEE
Confidence 58999999999999999999988899999998853 23467888999999 599999999998 4457899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+++ ++|.+.+...... ...++...+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 79 EYADGGDLSQKIKKQKKE-----GKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred EecCCCcHHHHHHHhhcc-----CCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeec
Confidence 9998 5888887664311 123899999999999999999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=211.23 Aligned_cols=184 Identities=32% Similarity=0.519 Sum_probs=158.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWRED---- 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~---- 85 (326)
...||.-+..++.|+- .|-.+.+...++.|++|... ..++..+|..++..+ +|+|+++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence 4578999999999998 78888888889999999764 255678999999999 6999999999984322
Q ss_pred -CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 -EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
...|++||+|..+|...+.-. +.-..+..++.|+++|++|||+.||+||||||+||++..+..+|+.|
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILME-----------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeecc
Confidence 357999999999998887621 66778899999999999999999999999999999999999999999
Q ss_pred ecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCC
Q 020467 165 FGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETD 244 (326)
Q Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
||++..-...
T Consensus 162 fg~ar~e~~~---------------------------------------------------------------------- 171 (369)
T KOG0665|consen 162 FGLARTEDTD---------------------------------------------------------------------- 171 (369)
T ss_pred chhhcccCcc----------------------------------------------------------------------
Confidence 9998653111
Q ss_pred CCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhc
Q 020467 245 KDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQ 324 (326)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 324 (326)
-..+.++.+.+|+|||++.+-. |...+||||+|||+.
T Consensus 172 ------------------------------------------~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~g 208 (369)
T KOG0665|consen 172 ------------------------------------------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMG 208 (369)
T ss_pred ------------------------------------------cccCchhheeeccCchheeccC-CcccchhhhhhhHHH
Confidence 2367789999999999999988 999999999999999
Q ss_pred cC
Q 020467 325 NF 326 (326)
Q Consensus 325 el 326 (326)
||
T Consensus 209 El 210 (369)
T KOG0665|consen 209 EL 210 (369)
T ss_pred HH
Confidence 86
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=216.82 Aligned_cols=139 Identities=23% Similarity=0.391 Sum_probs=118.0
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
|+...+||+|++|.||++....++..+++|.+.. ...+.+|+.+++.+ +|+|++++++.+ ......+++|||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSY-LVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEE-EeCCEEEEEEecC
Confidence 4445689999999999999988999999998752 33467788888888 699999999998 5567899999999
Q ss_pred cc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 96 RT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.+ +|.+.+... .+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 100 ~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 100 EGGALTDIVTHT----------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred CCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 85 666554321 2788899999999999999999999999999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=214.68 Aligned_cols=144 Identities=31% Similarity=0.535 Sum_probs=126.5
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcC---CCeEEEEEEcc---chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLS---DNLIVALKEVH---DYQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~---~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.+.+.+.|.+.++||.|.|++||++.+.. .++.||+|.+. ....+.+|++++..+.++.||+++.+.+ ...+.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-RNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-ccCCe
Confidence 56788899999999999999999998876 78899999874 4667899999999999999999999988 77778
Q ss_pred eEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEEee
Q 020467 88 AVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADF 165 (326)
Q Consensus 88 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~~~~~l~Df 165 (326)
..+++||++. ...++... ++...+..+++.++.||.++|..|||||||||.|++.+. .+.-.|+||
T Consensus 110 v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred eEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEec
Confidence 9999999985 44444433 778889999999999999999999999999999999985 578899999
Q ss_pred ccccc
Q 020467 166 GQARI 170 (326)
Q Consensus 166 g~~~~ 170 (326)
|++..
T Consensus 178 gLA~~ 182 (418)
T KOG1167|consen 178 GLAQR 182 (418)
T ss_pred hhHHH
Confidence 99874
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=211.12 Aligned_cols=146 Identities=29% Similarity=0.518 Sum_probs=119.6
Q ss_pred CeEEEeeeccccCcEEEEEEEcC-CCeEEEEEEccc---------------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLS-DNLIVALKEVHD---------------YQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~---------------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
.|++.+.||+|+||.||++.+.. +++.+++|.+.. ......|+.++.+..+|+|++++++++ .
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-~ 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-L 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE-c
Confidence 47889999999999999999877 678899997641 122456677676644799999999998 5
Q ss_pred cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEE
Q 020467 84 EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 84 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~ 161 (326)
..+..+++|||+. ++|.+.+...... ...++...++.++.|++.+|.|||+ .+++|+||+|+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEE
Confidence 5678999999997 5887776543221 1238889999999999999999996 6899999999999999999999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||.+...
T Consensus 155 l~dfg~~~~~ 164 (269)
T cd08528 155 ITDFGLAKQK 164 (269)
T ss_pred Eecccceeec
Confidence 9999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=224.70 Aligned_cols=162 Identities=24% Similarity=0.444 Sum_probs=139.4
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.+++...+||-|.||.||.|.|++-.-.||||.++. ...++.|..+++.+ .|||+++++++|.. ...+||++||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~-EpPFYIiTEf 344 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTH-EPPFYIITEF 344 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhcc-CCCeEEEEec
Confidence 456778899999999999999998888899999875 45688899999999 59999999999954 4469999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccccC
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLG 173 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 173 (326)
|. |+|++++.+..... ++.-.++.++.||..|+.||...++|||||..+|.|+.++..+|++|||+++.+..
T Consensus 345 M~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred ccCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 97 89999998876533 77778899999999999999999999999999999999999999999999999988
Q ss_pred CcccCCCCCCCCCCCC
Q 020467 174 NEFDAPDGNSQPCEPN 189 (326)
Q Consensus 174 ~~~~~~~~~~~~~~~~ 189 (326)
+.+-+-.++++|++|+
T Consensus 418 DTYTAHAGAKFPIKWT 433 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWT 433 (1157)
T ss_pred CceecccCccCccccc
Confidence 8765545555544333
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=223.95 Aligned_cols=147 Identities=22% Similarity=0.424 Sum_probs=126.4
Q ss_pred cCeEEEeeeccccCcEEEEEEEc----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 19 AKYEILECVGSGAYSDVYKGRRL----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
+..++.++||.|.||.||.|... .....||||..+. .+.+..|..+++.+ .||||+++++++.+. ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~--P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ--PM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc--ce
Confidence 44566789999999999999753 2345688898863 56688899999999 799999999999544 49
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
|++||+.. |.|..++...+.. ++...+..++.||+.||.|||+..+|||||..+|||+.+..-+||+|||+
T Consensus 466 WivmEL~~~GELr~yLq~nk~s--------L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDS--------LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eEEEecccchhHHHHHHhcccc--------chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 99999998 8999998876543 88899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc
Q 020467 168 ARILLGNEF 176 (326)
Q Consensus 168 ~~~~~~~~~ 176 (326)
++.+..+.+
T Consensus 538 SR~~ed~~y 546 (974)
T KOG4257|consen 538 SRYLEDDAY 546 (974)
T ss_pred hhhccccch
Confidence 998866654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=212.14 Aligned_cols=142 Identities=26% Similarity=0.512 Sum_probs=120.8
Q ss_pred CeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 20 KYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
+|++.+.||+|++|.||++.+. .++..+++|.+.. .....+|+.++.++.+|++++++++.+ .....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-QTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-ecCCE
Confidence 4889999999999999999753 4568899998752 233567888999997799999999988 55667
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+.+.... .+++..+..++.|++.+|.|||+.+++|+||+|.||+++.++.++|+|||
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECc
Confidence 899999997 58877765432 27888999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 151 ~~~~~ 155 (288)
T cd05583 151 LSKEF 155 (288)
T ss_pred ccccc
Confidence 87654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=204.94 Aligned_cols=143 Identities=29% Similarity=0.545 Sum_probs=122.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc--chhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-CceEEEee
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--DYQSAFREIEALQILQNSPNVVVLHEYFWRED-EDAVLVLE 93 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~--~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-~~~~lv~e 93 (326)
-.++|++.+++|+|.+++|+.|....+++.++||.++ +.+.+.+|+.+|..+.+|+||++++++..+.. ....+++|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 3588999999999999999999998899999999997 36678999999999999999999999984332 33678899
Q ss_pred eccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEEeecccccc
Q 020467 94 FLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~~~~~l~Dfg~~~~~ 171 (326)
++.. +...+..+ ++...++.++.+++.||.|+|++||+|||+||.|+|||. .-.++|+|+|++-..
T Consensus 116 ~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 116 YVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9885 43333322 788889999999999999999999999999999999995 458999999999776
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=220.19 Aligned_cols=192 Identities=27% Similarity=0.525 Sum_probs=163.4
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhh----HHHHHHHHHHHhc-----CCCeeEEeEEEEec
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQS----AFREIEALQILQN-----SPNVVVLHEYFWRE 84 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~----~~~E~~~l~~l~~-----h~ni~~l~~~~~~~ 84 (326)
.+-+-++|.+....|+|-|++|-.|.+...+..||||++...+. -+.|+++|++|.. --++++++..| ..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-KH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-hh
Confidence 34456889999999999999999999988889999999986443 4689999999962 23677888877 66
Q ss_pred CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEE
Q 020467 85 DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-GVLKLA 163 (326)
Q Consensus 85 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-~~~~l~ 163 (326)
.+++|||+|-+..+|.++++.-+.. -++....+..|+.||+.||..|-..||+|.||||.|||++.. ..++||
T Consensus 506 knHLClVFE~LslNLRevLKKyG~n------vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRN------VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcc------cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeec
Confidence 7789999999999999999875532 237788899999999999999999999999999999999965 578999
Q ss_pred eecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCC
Q 020467 164 DFGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDET 243 (326)
Q Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
|||.+.....++
T Consensus 580 DfGSA~~~~ene-------------------------------------------------------------------- 591 (752)
T KOG0670|consen 580 DFGSASFASENE-------------------------------------------------------------------- 591 (752)
T ss_pred cCcccccccccc--------------------------------------------------------------------
Confidence 999987653333
Q ss_pred CCCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhh
Q 020467 244 DKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323 (326)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il 323 (326)
.+.+.-+.+|+|||+++|.+ |....|+||+||.|
T Consensus 592 ---------------------------------------------itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctL 625 (752)
T KOG0670|consen 592 ---------------------------------------------ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTL 625 (752)
T ss_pred ---------------------------------------------ccHHHHHHhccCcceeecCc-ccCCccceeeceee
Confidence 45667889999999999988 99999999999999
Q ss_pred ccC
Q 020467 324 QNF 326 (326)
Q Consensus 324 ~el 326 (326)
|||
T Consensus 626 YEl 628 (752)
T KOG0670|consen 626 YEL 628 (752)
T ss_pred EEe
Confidence 996
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=209.85 Aligned_cols=134 Identities=32% Similarity=0.544 Sum_probs=116.9
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-c
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-T 97 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~ 97 (326)
||.|++|.||++.+..+++.+++|.+.. ...+.+|++.++++ .|+|++++++.+ ......++++||+. +
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~-~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSF-QGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHhe-ecCcEEEEEEecCCCC
Confidence 5889999999999988899999998853 23467788888888 599999999888 56678999999997 5
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+++.... .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~ 143 (265)
T cd05579 79 DLASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG 143 (265)
T ss_pred cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence 8888776533 2899999999999999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=215.76 Aligned_cols=137 Identities=19% Similarity=0.341 Sum_probs=114.1
Q ss_pred eeeccc--cCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 25 ECVGSG--AYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G--~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
..||.| +|++||.+.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......++++||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~-~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVF-TTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeE-ecCCceEEEEecc
Confidence 456666 899999999998999999998752 23456677777777 699999999999 5566789999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
. +++.+++..... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+++.||+....
T Consensus 82 ~~~~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 82 AYGSANSLLKTYFP-------EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred cCCCHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 8 588777665322 2288899999999999999999999999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=204.22 Aligned_cols=134 Identities=30% Similarity=0.486 Sum_probs=117.7
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec-cc
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL-RT 97 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~-~~ 97 (326)
||.|++|.||.+.+..+++.+++|.+.. ...+..|+.+++.+ .|+|++++++.+ ......+++||++ ++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAF-QTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHe-ecCCeeEEEEecCCCC
Confidence 6899999999999988899999998753 22567788899888 599999999988 6677899999999 57
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|.+++.... .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 143 (250)
T cd05123 79 ELFSHLSKEG---------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143 (250)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence 8888876543 2889999999999999999999999999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=226.90 Aligned_cols=153 Identities=24% Similarity=0.318 Sum_probs=105.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCC----CeEEEEEEccchhhHHHHHHHHHHHh--cCCCeeEEeEEE-----EecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSD----NLIVALKEVHDYQSAFREIEALQILQ--NSPNVVVLHEYF-----WRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~----~~~vaiK~~~~~~~~~~E~~~l~~l~--~h~ni~~l~~~~-----~~~~ 85 (326)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .|.....++. .+.++..+...+ ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNERVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHHHHHhhchhhHHHHHHhhhcccccccC
Confidence 468999999999999999999999888 89999998764322 1211111111 112221111111 1345
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKRE-----------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLL 153 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~-----------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nil 153 (326)
...+++++|++ ++|.+++........ ...........+..++.|++.||.|||+.+|+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 57899999998 578887764321100 000011223456789999999999999999999999999999
Q ss_pred EcC-CCcEEEEeecccccc
Q 020467 154 IGD-DGVLKLADFGQARIL 171 (326)
Q Consensus 154 i~~-~~~~~l~Dfg~~~~~ 171 (326)
++. ++.++|+|||++..+
T Consensus 288 l~~~~~~~KL~DFGlA~~l 306 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADL 306 (566)
T ss_pred EeCCCCcEEEEeCCCcccc
Confidence 996 579999999998754
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=210.99 Aligned_cols=132 Identities=19% Similarity=0.271 Sum_probs=110.4
Q ss_pred cCcEEEEEEEcCCCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-cCHHHH
Q 020467 31 AYSDVYKGRRLSDNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATV 102 (326)
Q Consensus 31 ~~g~Vy~a~~~~~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~~L~~~ 102 (326)
+++.||.+....+++.||+|+++.. ..+..|+..++.+ .|+||+++++++ ......+++|||+. +++.++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~-~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSF-IVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhhee-ecCCeEEEEEeccCCCCHHHH
Confidence 4456677766778999999987532 3577889999998 599999999988 55667899999998 677777
Q ss_pred HHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 103 IAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 103 l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+..... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++++||+.+..+
T Consensus 90 l~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 90 LKTHFP-------EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred HHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceee
Confidence 765322 12788899999999999999999999999999999999999999999999988655
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=206.65 Aligned_cols=144 Identities=29% Similarity=0.535 Sum_probs=115.9
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
+|.+.+.||+|++|.||++.+...+..+++|..+. ......|+.+++.+ +|+|++++++.+ ......+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASF-LERDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHH-hcCCceE
Confidence 68999999999999999998876665555554431 12345678888888 699999999988 5556789
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+++||+. ++|.+.+...... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++. +.++|+|||++
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~ 152 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVS 152 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCce
Confidence 9999997 5777766542211 123899999999999999999999999999999999999975 56999999987
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 153 ~~~ 155 (260)
T cd08222 153 RLL 155 (260)
T ss_pred eec
Confidence 654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-29 Score=224.18 Aligned_cols=146 Identities=25% Similarity=0.372 Sum_probs=124.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
..+++++.-||-|+||.|=++........+|+|.+++ .+....|-.++... ..+.|+++|..| .+...+|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTf-rd~kyvY 496 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTF-RDSKYVY 496 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHh-ccchhhh
Confidence 4667788889999999999987655554578876642 44567888888888 589999999999 6677889
Q ss_pred EEeeec-ccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++||.+ +|.++..+...+. |....+..++..+++|+.|||+.|||+|||||+|.|++.+|.+||.|||++
T Consensus 497 mLmEaClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred hhHHhhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhH
Confidence 999986 5899998877554 888899999999999999999999999999999999999999999999999
Q ss_pred ccccCC
Q 020467 169 RILLGN 174 (326)
Q Consensus 169 ~~~~~~ 174 (326)
+.+..+
T Consensus 568 Kki~~g 573 (732)
T KOG0614|consen 568 KKIGSG 573 (732)
T ss_pred HHhccC
Confidence 987443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=239.48 Aligned_cols=135 Identities=21% Similarity=0.398 Sum_probs=114.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchh-hHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
+...+...+.||+|+||.||+|.+..++..||+|.+.... ....|++.++++ +||||+++++++ ......+++|||+
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l-~HpnIv~~~~~~-~~~~~~~lv~Ey~ 765 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL-QHPNIVKLIGLC-RSEKGAYLIHEYI 765 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhC-CCCCcceEEEEE-EcCCCCEEEEeCC
Confidence 4456777889999999999999998889999999886432 234568888888 699999999999 5566789999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH---RNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH---~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
. ++|.+++.. +++..+..++.|++.||+||| +.+++|||+||+||+++.++..++. |+
T Consensus 766 ~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 766 EGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 7 688888743 778889999999999999999 6699999999999999988877664 44
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=218.98 Aligned_cols=143 Identities=29% Similarity=0.516 Sum_probs=125.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.++||.|+||.||+|.+..+++.||||++... ..+..|+..+..+ .|+||++++..+ ......+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~-~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSL-QSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEE-EECCEEE
Confidence 57899999999999999999999989999999998632 4566788888887 699999999888 5566899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++.... .+++..++.++.||+.||.|||..+|+||||||+||||+.++.++|+|||++
T Consensus 81 lVmEy~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred EEEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 9999996 68888875432 2788889999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 152 ~~~ 154 (669)
T cd05610 152 KVT 154 (669)
T ss_pred ccc
Confidence 765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=214.53 Aligned_cols=148 Identities=26% Similarity=0.405 Sum_probs=126.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC---CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS---DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++..+.++||+|.||.||+|.|.. +-..||||.+.. ...+.+|+..+.++ .|+|++++|++... ...
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~--qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD--QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc--chh
Confidence 4667889999999999999998863 345789998763 45689999999999 59999999999843 458
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
.||+|+.. |+|.+.+.+... ..|....+..|+.||+.|+.||.++++|||||..+|+++.....+||+|||+
T Consensus 186 mMV~ELaplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred hHHhhhcccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence 89999998 899988876322 2388889999999999999999999999999999999999999999999999
Q ss_pred cccccCCc
Q 020467 168 ARILLGNE 175 (326)
Q Consensus 168 ~~~~~~~~ 175 (326)
.+-+...+
T Consensus 259 mRaLg~ne 266 (1039)
T KOG0199|consen 259 MRALGENE 266 (1039)
T ss_pred eeccCCCC
Confidence 98875443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=208.30 Aligned_cols=154 Identities=27% Similarity=0.387 Sum_probs=112.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc----------------CCCeEEEEEEccch-------------------hhHHHH
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL----------------SDNLIVALKEVHDY-------------------QSAFRE 61 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~----------------~~~~~vaiK~~~~~-------------------~~~~~E 61 (326)
-.++|.+.++||+|+||.||+|... ..++.||||++... .....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4679999999999999999999642 23467999987521 112345
Q ss_pred HHHHHHHhcCCC-----eeEEeEEEEe-------cCCceEEEeeecc-cCHHHHHHHhhhh---------------hhhc
Q 020467 62 IEALQILQNSPN-----VVVLHEYFWR-------EDEDAVLVLEFLR-TDLATVIAESKKK---------------REDR 113 (326)
Q Consensus 62 ~~~l~~l~~h~n-----i~~l~~~~~~-------~~~~~~lv~e~~~-~~L~~~l~~~~~~---------------~~~~ 113 (326)
+.++.++. |.+ ++.++++|.. .....|+|+||+. ++|.+++...... ....
T Consensus 223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 66666664 443 3556666532 1245899999998 6888877542110 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 114 GDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 114 ~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
....+....+..++.|++.+|.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~ 359 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCcccc
Confidence 1122566788899999999999999999999999999999999999999999988643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=213.70 Aligned_cols=145 Identities=33% Similarity=0.410 Sum_probs=115.4
Q ss_pred EEeeeccccCcE-EEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecccCH
Q 020467 23 ILECVGSGAYSD-VYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDL 99 (326)
Q Consensus 23 i~~~Lg~G~~g~-Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~~L 99 (326)
-.+.+|.|..|+ ||+|.. .++.||||++-. .....+|+..++.-..|+||+++++.= .+..+.|++.|.+..+|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-~d~qF~YIalELC~~sL 589 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-QDRQFLYIALELCACSL 589 (903)
T ss_pred cHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-cCCceEEEEehHhhhhH
Confidence 345778888875 799976 678999998853 445789999999888899999998764 55678999999999999
Q ss_pred HHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CC--cEEEEeecccccccCC
Q 020467 100 ATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DG--VLKLADFGQARILLGN 174 (326)
Q Consensus 100 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~--~~~l~Dfg~~~~~~~~ 174 (326)
.++++........ ......+..+.|++.||++||+.+||||||||.||||.. ++ .++|+|||+++.+..+
T Consensus 590 ~dlie~~~~d~~~-----~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 590 QDLIESSGLDVEM-----QSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred HHHHhccccchhh-----cccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 9999875111110 111455778899999999999999999999999999986 33 6789999999988544
Q ss_pred c
Q 020467 175 E 175 (326)
Q Consensus 175 ~ 175 (326)
.
T Consensus 665 ~ 665 (903)
T KOG1027|consen 665 K 665 (903)
T ss_pred c
Confidence 3
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=211.14 Aligned_cols=156 Identities=25% Similarity=0.398 Sum_probs=127.6
Q ss_pred cCeEEEeeeccccCcEEEEEEEc----C---CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 19 AKYEILECVGSGAYSDVYKGRRL----S---DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~----~---~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
++..+.+.||.|+||.||+|... . ....||+|..+. ...+..|++++..+..|+|++.+++++.. .
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-D 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-C
Confidence 34466779999999999999632 1 156799998752 45678999999999889999999999955 7
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGD-------RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~ 157 (326)
...++++||+. |+|.+++............ ..++..++..++.||+.|++||++..++||||..+||++..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence 78999999997 8999999876611111111 138899999999999999999999999999999999999999
Q ss_pred CcEEEEeecccccccCCc
Q 020467 158 GVLKLADFGQARILLGNE 175 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~~~~~ 175 (326)
..+||+|||+++....+.
T Consensus 455 ~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKD 472 (609)
T ss_pred CEEEEccccceeccCCCC
Confidence 999999999998654433
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=212.64 Aligned_cols=145 Identities=27% Similarity=0.442 Sum_probs=123.7
Q ss_pred CeEEEeeeccccCcEEEEEEEcCC----CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSD----NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~----~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.....++||+|+||+||+|.+.-. +.+||+|++.+ ...+..|...+.++ .|+|++++++++..+ ...
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s--~~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS--TLQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc--hHH
Confidence 345577999999999999987533 45788888753 55678888899999 699999999998433 378
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
|+++|++ |.|++++...+.. +-...++.|+.||+.|+.|||.++++||||..+|+|+....++++.|||++
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~--------igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDN--------IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHhcccchHHHHHHHhhcc--------ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchh
Confidence 8999998 8999999876543 888899999999999999999999999999999999999999999999999
Q ss_pred ccccCCc
Q 020467 169 RILLGNE 175 (326)
Q Consensus 169 ~~~~~~~ 175 (326)
+.+..+.
T Consensus 846 ~ll~~d~ 852 (1177)
T KOG1025|consen 846 KLLAPDE 852 (1177)
T ss_pred hccCccc
Confidence 8875544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=182.47 Aligned_cols=141 Identities=39% Similarity=0.610 Sum_probs=122.4
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
|.+.+.||.|++|.||++....+++.+++|.+.. ...+.+|++.++.+ .|+|++++++.+ ......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~-~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVF-EDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeee-ecCCceEEEEec
Confidence 5678899999999999999988889999999863 34567788889888 699999999988 555679999999
Q ss_pred ccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+++ +|.+++...... ++...+..++.+++.+|.+||+.+++|+|++|.||+++.++.++|+|||++...
T Consensus 79 ~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 79 CEGGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred cCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 986 888887653221 678889999999999999999999999999999999999999999999988765
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-25 Score=208.29 Aligned_cols=146 Identities=30% Similarity=0.471 Sum_probs=126.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-----chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
...++|.++.++|.|.||.||+++++.+++..|+|.++ +......|+-+++.. .|+||+.+++.+ -.....|+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsy-lr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSY-LRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhh-hhhcCcEE
Confidence 56889999999999999999999999999999999886 345567788888887 699999999988 44556999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||++ ++|.+...-. +.+++.++...++..+.+|.|||+.|-+|||||=.||++++.|.+++.|||.+.
T Consensus 90 cMEycgggslQdiy~~T---------gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT---------GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred EEEecCCCcccceeeec---------ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchh
Confidence 999998 4665544332 348999999999999999999999999999999999999999999999999887
Q ss_pred ccc
Q 020467 170 ILL 172 (326)
Q Consensus 170 ~~~ 172 (326)
.+.
T Consensus 161 qit 163 (829)
T KOG0576|consen 161 QIT 163 (829)
T ss_pred hhh
Confidence 663
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=173.25 Aligned_cols=135 Identities=39% Similarity=0.654 Sum_probs=118.0
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-cCH
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-TDL 99 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~~L 99 (326)
||+|.+|.||++....+++.+++|.+... ..+.+|++.++.+ .|++++++++++ ......++++|++. ++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~-~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVF-EDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeee-ecCCeEEEEEecCCCCcH
Confidence 68899999999998777999999998754 4578999999999 589999999998 44567999999999 788
Q ss_pred HHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEEeecccccc
Q 020467 100 ATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADFGQARIL 171 (326)
Q Consensus 100 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~~~~~l~Dfg~~~~~ 171 (326)
.+++.... ..++...+..++.+++.+|.+||+.+++|+||+|.||+++. ++.++|+||+.+...
T Consensus 79 ~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 79 KDLLKENE--------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred HHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 88776532 12888999999999999999999999999999999999999 899999999988765
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=182.03 Aligned_cols=130 Identities=38% Similarity=0.631 Sum_probs=113.9
Q ss_pred cCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeeccc-CHHHHH
Q 020467 31 AYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVI 103 (326)
Q Consensus 31 ~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~-~L~~~l 103 (326)
+||.||+|.+..+++.+++|.+.. ...+.+|++.++++ +|+|++++++.+ ......++++|++++ +|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~-~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVF-EDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhhe-eeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988899999999863 35677899999988 799999999988 445679999999986 888877
Q ss_pred HHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 104 AESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 104 ~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
..... ++...+..++.+++.++.+||+.+++|+||+|.||+++.++.++++|||.+...
T Consensus 79 ~~~~~---------~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 137 (244)
T smart00220 79 KKRGR---------LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQL 137 (244)
T ss_pred HhccC---------CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeee
Confidence 65332 788899999999999999999999999999999999999999999999998765
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=170.32 Aligned_cols=147 Identities=27% Similarity=0.447 Sum_probs=129.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
..++|.++++||+|.||.+|.|.....|..||||.-+. ...+..|..++..+++...|+.+..+. .+.....+||+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-TEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-cccccceeeee
Confidence 56899999999999999999999999999999998763 556788999999998888888887776 66778899999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEEeeccccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DGVLKLADFGQARI 170 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~~~~l~Dfg~~~~ 170 (326)
.++.+|.+++.-.... ++..++..++.||+.-++|+|..+++||||||+|+++.- ...+.|+|||+++.
T Consensus 92 LLGPsLEdLfnfC~R~--------ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 92 LLGPSLEDLFNFCSRR--------FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ccCccHHHHHHHHhhh--------hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 9999998888665432 888999999999999999999999999999999999974 45789999999987
Q ss_pred cc
Q 020467 171 LL 172 (326)
Q Consensus 171 ~~ 172 (326)
..
T Consensus 164 y~ 165 (341)
T KOG1163|consen 164 YR 165 (341)
T ss_pred hc
Confidence 63
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-24 Score=189.16 Aligned_cols=161 Identities=14% Similarity=0.211 Sum_probs=128.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC-----CeEEEEEEccchh------hHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD-----NLIVALKEVHDYQ------SAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~------~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..|+++...+.+|.||.||.|.++.. .+.|.+|.++... .+..|...+..+ .|+|+.++.+++.++..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeeccC
Confidence 46788888999999999999977543 2344555554322 234444455555 69999999999988888
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..++++.+++ ++|..++...+ ..+....+.++..++..++.|++.|+.|||+.|+||.||..+|.+|++.-.++|+|-
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr-~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICR-GDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred cceEEEeccCcchHHHHHHHhc-cCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 8899999998 78888887544 233333456888999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccCCC
Q 020467 166 GQARILLGNEFDAPD 180 (326)
Q Consensus 166 g~~~~~~~~~~~~~~ 180 (326)
.+++.+.+..+++.+
T Consensus 441 aLSRDLFP~DYhcLG 455 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLG 455 (563)
T ss_pred hhccccCcccccccC
Confidence 999999888876543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=184.34 Aligned_cols=138 Identities=25% Similarity=0.323 Sum_probs=110.3
Q ss_pred cCccccccCeEEEeeeccccCcEEEEEEEcC-CCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeE-EeE
Q 020467 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLS-DNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVV-LHE 79 (326)
Q Consensus 12 ~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~-l~~ 79 (326)
...+.+.++|++.+.||+|+||+||+|.+.. ++..+|||.+.. ...+.+|+++++.+ .|+|++. +++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~ 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE
Confidence 3456688999999999999999999998875 677789997532 23467999999999 5888874 443
Q ss_pred EEEecCCceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCeEEcCC
Q 020467 80 YFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDL-KPGNLLIGDD 157 (326)
Q Consensus 80 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dl-kp~Nili~~~ 157 (326)
. ...+++|||+.+ +|. ... . .. ...++.+++.+|.|||+.||+|||| ||+|||++.+
T Consensus 90 ~-----~~~~LVmE~~~G~~L~-~~~--~----------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~ 148 (365)
T PRK09188 90 T-----GKDGLVRGWTEGVPLH-LAR--P----------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD 148 (365)
T ss_pred c-----CCcEEEEEccCCCCHH-HhC--c----------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC
Confidence 2 357999999985 453 211 0 11 1457889999999999999999999 9999999999
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
+.++|+|||+++.+
T Consensus 149 ~~ikLiDFGlA~~~ 162 (365)
T PRK09188 149 GEAAVIDFQLASVF 162 (365)
T ss_pred CCEEEEECccceec
Confidence 99999999999876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-24 Score=180.12 Aligned_cols=146 Identities=27% Similarity=0.384 Sum_probs=121.3
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++.+.|.+.+.||+|.||.+-+|.++.++..+++|-+.. ...+.+|.-.--.+..|.||+.-|++-.+..+.++++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 578999999999999999999999999999999998864 3445556544444557899998887754666788999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC--CCcEEEEeeccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD--DGVLKLADFGQA 168 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~--~~~~~l~Dfg~~ 168 (326)
+||.+ |+|..-+...+ +-+.....++.|++.||.|||+.++||||||.+||||-. ...+||||||.+
T Consensus 101 qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred eccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence 99998 78877665432 778888999999999999999999999999999999953 448999999988
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 171 ~k~ 173 (378)
T KOG1345|consen 171 RKV 173 (378)
T ss_pred ccc
Confidence 653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=178.18 Aligned_cols=144 Identities=24% Similarity=0.345 Sum_probs=120.7
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCC-eEEEEEEccc-----hhhHHHHHHHHHHHh---cCCCeeEEeEEEEecCCceEE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDN-LIVALKEVHD-----YQSAFREIEALQILQ---NSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~-~~vaiK~~~~-----~~~~~~E~~~l~~l~---~h~ni~~l~~~~~~~~~~~~l 90 (326)
+|.+.++||+|+||.||.+.+..++ ..+|+|.... ...+..|..++..+. ...++..+++.........|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999987664 6788887643 125778999998886 246888888877434557899
Q ss_pred EeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-----CcEEEEee
Q 020467 91 VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-----GVLKLADF 165 (326)
Q Consensus 91 v~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-----~~~~l~Df 165 (326)
||+.++.+|.++...... +.++..++..++.|++.+|.+||+.|++||||||.|+++... ..+.|+||
T Consensus 99 VM~l~G~sL~dl~~~~~~-------~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPP-------GRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEeccCccHHHHHHhCCC-------CCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999999999998866542 239999999999999999999999999999999999999865 36999999
Q ss_pred ccccc
Q 020467 166 GQARI 170 (326)
Q Consensus 166 g~~~~ 170 (326)
|+++.
T Consensus 172 Glar~ 176 (322)
T KOG1164|consen 172 GLARR 176 (322)
T ss_pred CCCcc
Confidence 99983
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=168.32 Aligned_cols=149 Identities=23% Similarity=0.410 Sum_probs=129.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc---chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~---~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
..-.|.+.++||.|.||.++.|....+++.||||--. +...+..|.+.++.+.+.++|+.+|=+ ...+.+..||++
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYF-GqeG~~NiLVid 104 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYF-GQEGKYNILVID 104 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeee-ccccchhhhhhh
Confidence 3457999999999999999999999999999999653 455678899999999889999998844 367778899999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-----cEEEEeeccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-----VLKLADFGQA 168 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-----~~~l~Dfg~~ 168 (326)
+++.+|.+++.-... .|+...+..++.||+.-++++|++.+|.|||||+|+||...+ .+.++|||++
T Consensus 105 LLGPSLEDLFD~CgR--------~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGR--------RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhCcCHHHHHHHhcC--------cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999999998876643 399999999999999999999999999999999999998543 6899999999
Q ss_pred ccccCC
Q 020467 169 RILLGN 174 (326)
Q Consensus 169 ~~~~~~ 174 (326)
+.....
T Consensus 177 K~YrDp 182 (449)
T KOG1165|consen 177 KEYRDP 182 (449)
T ss_pred hhhcCc
Confidence 887444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-22 Score=201.50 Aligned_cols=77 Identities=18% Similarity=0.205 Sum_probs=68.1
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++++|+++++|.+++.... ..++...+..++.||+.||.|||++||+||||||+||||+..+.++++||+
T Consensus 54 ~~~~~~e~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 54 SIVRALECEDVSLRQWLDNPD--------RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESA 125 (793)
T ss_pred hhhhhhccCCccHHHHHhccc--------ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeecc
Confidence 477889999999999986432 238999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 126 ~~~~~ 130 (793)
T PLN00181 126 SCSDS 130 (793)
T ss_pred ccCcc
Confidence 88653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=157.83 Aligned_cols=136 Identities=15% Similarity=0.234 Sum_probs=107.2
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhh----------HHHHHHHHHHHhcCCCeeEEeEE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQS----------AFREIEALQILQNSPNVVVLHEY 80 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~----------~~~E~~~l~~l~~h~ni~~l~~~ 80 (326)
.-+.++|.+.+.||.|+||.||++.. ++..+++|.++. .+. +.+|+..+.++ .|++|..+.++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEe
Confidence 34678999999999999999999754 466799999862 111 45777888899 59999999888
Q ss_pred EEecC-------CceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 020467 81 FWRED-------EDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNL 152 (326)
Q Consensus 81 ~~~~~-------~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Ni 152 (326)
+.... ...+++|||++| +|.+... +++. ...+++.+|..+|+.|++|||++|+||
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Ni 166 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISED----VKAKIKASIESLHQHGMVSGDPHKGNF 166 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHE
Confidence 64332 357899999996 5654421 3332 356899999999999999999999999
Q ss_pred EEcCCCcEEEEeecccccc
Q 020467 153 LIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 153 li~~~~~~~l~Dfg~~~~~ 171 (326)
+++.++ ++|+|||.....
T Consensus 167 li~~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCT 184 (232)
T ss_pred EEeCCC-EEEEECCCcccc
Confidence 999988 999999977544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.5e-19 Score=147.97 Aligned_cols=135 Identities=25% Similarity=0.276 Sum_probs=103.2
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccchh-------------------------------hHHHHHHHHHHHhcCC
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------------------------------SAFREIEALQILQNSP 72 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-------------------------------~~~~E~~~l~~l~~h~ 72 (326)
.+.||+|++|.||+|.+. +|+.||||.++... ....|.+.+.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence 568999999999999876 89999999876321 1246778888884 77
Q ss_pred CeeEEeEEEEecCCceEEEeeecccC-HHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCC
Q 020467 73 NVVVLHEYFWREDEDAVLVLEFLRTD-LATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPG 150 (326)
Q Consensus 73 ni~~l~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~ 150 (326)
++.....+. .. ..+++|||+++. +........ .++......++.|++.++.++|. .||+||||||+
T Consensus 80 ~i~~p~~~~-~~--~~~lVmE~~~g~~~~~~~l~~~---------~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~ 147 (190)
T cd05145 80 GVPVPEPIL-LK--KNVLVMEFIGDDGSPAPRLKDV---------PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY 147 (190)
T ss_pred CCCCceEEE-ec--CCEEEEEEecCCCchhhhhhhc---------cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence 764333332 21 248999999864 322212111 16778889999999999999999 99999999999
Q ss_pred CeEEcCCCcEEEEeecccccccC
Q 020467 151 NLLIGDDGVLKLADFGQARILLG 173 (326)
Q Consensus 151 Nili~~~~~~~l~Dfg~~~~~~~ 173 (326)
||+++ ++.++|+|||++..+..
T Consensus 148 NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE-CCCEEEEEcccceecCC
Confidence 99999 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=149.56 Aligned_cols=133 Identities=23% Similarity=0.300 Sum_probs=100.2
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccchh--------------h-----------------HHHHHHHHHHHhcCC
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ--------------S-----------------AFREIEALQILQNSP 72 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--------------~-----------------~~~E~~~l~~l~~h~ 72 (326)
.+.||+|++|.||+|.+. +|+.||+|.++... . ...|++.+..+. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 467999999999999886 89999999885321 1 123888888884 66
Q ss_pred CeeEEeEEEEecCCceEEEeeecccC-HHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCC
Q 020467 73 NVVVLHEYFWREDEDAVLVLEFLRTD-LATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC-HRNTIVHRDLKPG 150 (326)
Q Consensus 73 ni~~l~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~L-H~~~iiH~dlkp~ 150 (326)
++....... . ...+++|||++++ +....... ..++...+..++.|++.+|.++ |+.||+||||||+
T Consensus 80 ~v~~p~~~~-~--~~~~iVmE~i~g~~l~~~~~~~---------~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~ 147 (190)
T cd05147 80 GIPCPEPIL-L--KSHVLVMEFIGDDGWAAPRLKD---------APLSESKARELYLQVIQIMRILYQDCRLVHADLSEY 147 (190)
T ss_pred CCCCCcEEE-e--cCCEEEEEEeCCCCCcchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 653322221 1 1248999999864 32222221 1288889999999999999999 7999999999999
Q ss_pred CeEEcCCCcEEEEeecccccc
Q 020467 151 NLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 151 Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+++ ++.++|+|||++...
T Consensus 148 NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HEEEE-CCcEEEEEccccccC
Confidence 99998 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.3e-18 Score=151.45 Aligned_cols=141 Identities=37% Similarity=0.647 Sum_probs=114.4
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
|.+.+.||.|+|+.||.+.+. ..+++|.+.. ...+.+|+..+..+..+++++.+.+.+ ......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-QDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-ecCCEEEEEE
Confidence 788999999999999999876 6678887742 345678888888885444799999998 5555579999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEEeeccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARI 170 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-~~~l~Dfg~~~~ 170 (326)
+++. +++.+++...... ..+.......++.|++.++.++|..+++|||+||+||+++..+ .++++|||.+..
T Consensus 78 ~~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred ecCCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 9998 4665444433210 1388899999999999999999999999999999999999988 799999999875
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
+
T Consensus 152 ~ 152 (384)
T COG0515 152 L 152 (384)
T ss_pred c
Confidence 4
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-18 Score=144.18 Aligned_cols=59 Identities=32% Similarity=0.429 Sum_probs=49.8
Q ss_pred cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 97 TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 97 ~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+|.+++.... ..+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++...
T Consensus 1 GsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~ 59 (176)
T smart00750 1 VSLADILEVRG--------RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFK 59 (176)
T ss_pred CcHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEee
Confidence 46777775432 22899999999999999999999988 999999999999998 9987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.5e-17 Score=138.11 Aligned_cols=132 Identities=17% Similarity=0.168 Sum_probs=100.8
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEcc-----chhhHHHHHHHHHHHh----cCCCeeEEeEEEEecCC--c-eEEE
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQ----NSPNVVVLHEYFWREDE--D-AVLV 91 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----~~~~~~~E~~~l~~l~----~h~ni~~l~~~~~~~~~--~-~~lv 91 (326)
.+.||+|+++.||. ++.+... +||++. ......+|+..++.+. .|+||+++++++..+.+ . +.++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 56899999999995 6666655 588775 2456789999999994 37999999999966532 3 3478
Q ss_pred eeecc---cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCCeEEcCC----CcEEEE
Q 020467 92 LEFLR---TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV-DACHRNTIVHRDLKPGNLLIGDD----GVLKLA 163 (326)
Q Consensus 92 ~e~~~---~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL-~~LH~~~iiH~dlkp~Nili~~~----~~~~l~ 163 (326)
+||.+ ++|.+++.... +++. ..++.+++.++ +|||+++|+||||||+|||++.. ..++|+
T Consensus 84 ~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred ecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 99954 69998886521 4444 35577888777 89999999999999999999843 379999
Q ss_pred e-eccccc
Q 020467 164 D-FGQARI 170 (326)
Q Consensus 164 D-fg~~~~ 170 (326)
| ||....
T Consensus 152 Dg~G~~~~ 159 (210)
T PRK10345 152 DNIGESTF 159 (210)
T ss_pred ECCCCcce
Confidence 9 554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-18 Score=167.07 Aligned_cols=142 Identities=30% Similarity=0.421 Sum_probs=103.7
Q ss_pred cCe-EEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-----h------hHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 19 AKY-EILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-----Q------SAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 19 ~~y-~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-----~------~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
+.| .....+|.|++|.|+.+......+.+..|.++.. . ....|..+-..+ .|+|++.....+.+..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~- 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEID- 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcc-
Confidence 444 4567889999998888776655555555544310 0 022233333344 6899876666552322
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
...-.|||++.+|..++..... +....+..++.|++.|+.|+|+.||.|||+|++|+++..++.++|+|||
T Consensus 395 ~~~~~mE~~~~Dlf~~~~~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 395 GILQSMEYCPYDLFSLVMSNGK---------LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred cchhhhhcccHHHHHHHhcccc---------cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecC
Confidence 2333399998888888776522 7888889999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
.+.++
T Consensus 466 ~~~vf 470 (601)
T KOG0590|consen 466 AASVF 470 (601)
T ss_pred cceee
Confidence 98776
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=141.02 Aligned_cols=138 Identities=25% Similarity=0.218 Sum_probs=104.7
Q ss_pred CeEEEeeeccccCcEEEEEE-EcCCCeEEEEEEccch-----------------------------hhHHHHHHHHHHHh
Q 020467 20 KYEILECVGSGAYSDVYKGR-RLSDNLIVALKEVHDY-----------------------------QSAFREIEALQILQ 69 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~-~~~~~~~vaiK~~~~~-----------------------------~~~~~E~~~l~~l~ 69 (326)
-|.+.+.||+|++|.||+|. +..+++.||+|.++.. .....|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 6678999999987521 11357888888885
Q ss_pred c-CCCeeEEeEEEEecCCceEEEeeecccC-HHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecc
Q 020467 70 N-SPNVVVLHEYFWREDEDAVLVLEFLRTD-LATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT-IVHRD 146 (326)
Q Consensus 70 ~-h~ni~~l~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~-iiH~d 146 (326)
. ...++.++.. . ..+++|||+++. +....... ..+....+..++.|++.+|.+||+.| ++|+|
T Consensus 109 ~~~i~~p~~~~~----~-~~~lV~E~~~g~~L~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~D 174 (237)
T smart00090 109 EAGVPVPKPIAW----R-RNVLVMEFIGGDGLPAPRLKD---------VEPEEEEEFELYDDILEEMRKLYKEGELVHGD 174 (237)
T ss_pred hcCCCCCeeeEe----c-CceEEEEEecCCccccccccc---------CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCC
Confidence 2 1233444432 1 358999999973 43322111 11455567889999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEEeeccccccc
Q 020467 147 LKPGNLLIGDDGVLKLADFGQARILL 172 (326)
Q Consensus 147 lkp~Nili~~~~~~~l~Dfg~~~~~~ 172 (326)
|||+||+++ ++.++|+|||.+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999987653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.8e-17 Score=162.21 Aligned_cols=143 Identities=25% Similarity=0.343 Sum_probs=107.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhh--HHHHHHHHHHHh--cCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQS--AFREIEALQILQ--NSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~E~~~l~~l~--~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.+.|.|.+.||+|+||.||+|.... ++.||+|+-+.... ++--.+++.+|+ --+.|.++...+ .-.+..+++++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~-~~~~~S~lv~e 774 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAH-VFQNASVLVSE 774 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHH-ccCCcceeeee
Confidence 5789999999999999999998765 99999998753111 111112222221 123344444443 33456899999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-------CCcEEEEee
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-------DGVLKLADF 165 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-------~~~~~l~Df 165 (326)
|.. |+|++++...+ .+++..++.+..||+..+.+||..+||||||||.|+||.. ...++|+||
T Consensus 775 y~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 775 YSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred ccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 998 89999987433 2889999999999999999999999999999999999953 346999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|-+..+
T Consensus 846 G~siDm 851 (974)
T KOG1166|consen 846 GRSIDM 851 (974)
T ss_pred ccceee
Confidence 987544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.9e-16 Score=130.59 Aligned_cols=127 Identities=21% Similarity=0.216 Sum_probs=100.0
Q ss_pred EEEeeeccccCcEEEEEEEcCCCeEEEEEEccchh---------hHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ---------SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 22 ~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~---------~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.+...|++|.||+|+.+.. .+..++.+.+.... .+.+|+++++++.++++++.++++ +..+++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEE
Confidence 3467899999999998754 66778877765321 357899999999777889999885 2479999
Q ss_pred eecccC-HHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCeEEcCCCcEEEEeeccccc
Q 020467 93 EFLRTD-LATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDL-KPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 93 e~~~~~-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dl-kp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+|+.|. |.... +.. ...++.|++.+|.++|+.||+|||| ||+|||++.++.++|+|||++..
T Consensus 78 eyI~G~~L~~~~---------------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 78 SYLAGAAMYQRP---------------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred eeecCccHHhhh---------------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 999864 43211 111 1347789999999999999999999 79999999999999999999975
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 142 ~ 142 (218)
T PRK12274 142 G 142 (218)
T ss_pred c
Confidence 3
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.2e-17 Score=141.28 Aligned_cols=151 Identities=19% Similarity=0.244 Sum_probs=92.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHh---------cCCCeeEEeEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQ---------NSPNVVVLHEY 80 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~---------~h~ni~~l~~~ 80 (326)
...+...+.||.|+++.||.+.+..+++.+++|.+.. .+.+.+|.-....+. .|-.++..++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 4467788999999999999999999999999998741 122222221111110 12122222222
Q ss_pred EEe---------cC--C-----ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 020467 81 FWR---------ED--E-----DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVH 144 (326)
Q Consensus 81 ~~~---------~~--~-----~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH 144 (326)
... .. . ..+++|+.+.++|.+++..-...... ...+.......+..|++..+++||..|++|
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH 168 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYGLVH 168 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence 211 11 1 34678888888888886643222111 001233344566689999999999999999
Q ss_pred ccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 145 RDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 145 ~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+||+|+|++++.+|.+.|.||+....
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r 194 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVR 194 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEE
T ss_pred cccceeeEEEcCCCCEEEcChHHHee
Confidence 99999999999999999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-17 Score=161.45 Aligned_cols=114 Identities=31% Similarity=0.489 Sum_probs=80.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
...++|..++.|..|+||-||.++++.+.+.+|+| +++...+.+ ||..+- ...++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR------------nilt~a-------~npfvv---- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR------------NILTFA-------GNPFVV---- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh------------cccccc-------CCccee----
Confidence 35688999999999999999999999999999994 443222222 111111 112222
Q ss_pred ccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 96 RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
++=...++..+. ++.. ++.+++|+|+-||+|||+||.|.+|..-|++++.|||+.+..
T Consensus 136 -gDc~tllk~~g~---------lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 -GDCATLLKNIGP---------LPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred -chhhhhcccCCC---------Ccch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence 333333332221 3332 378899999999999999999999999999999999998764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.8e-15 Score=127.84 Aligned_cols=128 Identities=24% Similarity=0.349 Sum_probs=100.6
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc-------------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
+.||+|++|.||+|.+ .+..+++|.... .....+|+..+..+. |+++.....++ ......+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~-~~~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYF-VDPENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEE-EeCCCCEEE
Confidence 5789999999999986 566788886531 123567888888884 77766555554 334568899
Q ss_pred eeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||++| +|.+.+.. ... ....++.+++.+|.++|+.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~------------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINS------------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHh------------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999975 77766543 112 6788899999999999999999999999999999 78899999998865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-17 Score=154.92 Aligned_cols=138 Identities=28% Similarity=0.434 Sum_probs=110.7
Q ss_pred eccccCcEEEEEEE---cCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 27 VGSGAYSDVYKGRR---LSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~---~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
+|+|.||.|+++.. ...+..+++|..+. ......|..++..+.+|+.++.+.-.+ +.....+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-qt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-QTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-ccccchhHhhhhcc
Confidence 68999999987642 34567788887642 223456777788887799999998877 55667888888887
Q ss_pred -cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccccCC
Q 020467 97 -TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174 (326)
Q Consensus 97 -~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 174 (326)
+.+...+....+ +.......+...++.++.++|+.+++|+|+|++||+++.+|++++.|||+++.....
T Consensus 81 gg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred cchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 477766655443 777888889999999999999999999999999999999999999999999876443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-15 Score=127.51 Aligned_cols=130 Identities=25% Similarity=0.274 Sum_probs=98.9
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch---------------------------hhHHHHHHHHHHHhcCC-
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY---------------------------QSAFREIEALQILQNSP- 72 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~---------------------------~~~~~E~~~l~~l~~h~- 72 (326)
|.+.+.||+|++|.||++... +++.++||.+... .....|...+..+. +.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence 788899999999999999864 7899999975421 12456777777774 55
Q ss_pred -CeeEEeEEEEecCCceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 020467 73 -NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPG 150 (326)
Q Consensus 73 -ni~~l~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~ 150 (326)
.++..++. ...+++|||+.+ ++..... ......++.+++.++.++|+.|++|+||+|+
T Consensus 95 i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~---------------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~ 154 (198)
T cd05144 95 FPVPKPIDW-----NRHAVVMEYIDGVELYRVRV---------------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEF 154 (198)
T ss_pred CCCCceeec-----CCceEEEEEeCCcchhhccc---------------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcc
Confidence 34444332 245899999986 4433211 0234568889999999999999999999999
Q ss_pred CeEEcCCCcEEEEeeccccccc
Q 020467 151 NLLIGDDGVLKLADFGQARILL 172 (326)
Q Consensus 151 Nili~~~~~~~l~Dfg~~~~~~ 172 (326)
||+++.++.++|+|||.+..+.
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.8e-17 Score=160.37 Aligned_cols=138 Identities=24% Similarity=0.398 Sum_probs=111.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++...+.||.+.|=+|.+|++.+ |. |++|++-+ ......|++ . .+.++||++++.-+. ......
T Consensus 22 ~~e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~-~l~~~pn~lPfqk~~-~t~kAA 96 (1431)
T KOG1240|consen 22 SVECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-F-ALMKAPNCLPFQKVL-VTDKAA 96 (1431)
T ss_pred ccceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-H-HhhcCCcccchHHHH-HhhHHH
Confidence 3478899999999999999998754 43 88898742 222334444 3 333799999887765 455567
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
||+-+|...+|++.++..+. +...+..-|+.|++.||.-+|..||+|||||.+||||.+.+.+.|.||...
T Consensus 97 ylvRqyvkhnLyDRlSTRPF---------L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 97 YLVRQYVKHNLYDRLSTRPF---------LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASF 167 (1431)
T ss_pred HHHHHHHhhhhhhhhccchH---------HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhccccc
Confidence 88889999999999987665 677788889999999999999999999999999999999999999999865
Q ss_pred c
Q 020467 169 R 169 (326)
Q Consensus 169 ~ 169 (326)
+
T Consensus 168 K 168 (1431)
T KOG1240|consen 168 K 168 (1431)
T ss_pred C
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.7e-14 Score=121.80 Aligned_cols=125 Identities=26% Similarity=0.326 Sum_probs=93.8
Q ss_pred eeccccCcEEEEEEEcCCCeEEEEEEccc-------------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 26 CVGSGAYSDVYKGRRLSDNLIVALKEVHD-------------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.||+|++|.||++.. .+..+++|.... .....+|++++..+. ++++.....++ ......+++|
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~-~~~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYD-VDPDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEE-EECCCCEEEE
Confidence 379999999999985 567788887531 133457888888885 55443322222 2344578999
Q ss_pred eeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+++ +|.+.+.... . .++.+++.+|.+||+.+++|+|++|+||+++ ++.++++|||++...
T Consensus 77 e~~~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99974 6666543311 0 6789999999999999999999999999999 889999999988664
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.9e-14 Score=139.47 Aligned_cols=132 Identities=25% Similarity=0.327 Sum_probs=100.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEc-----cc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HD--------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~-----~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
...|...++||+|+||.||++.+.... +++|+. .. .....+|++++..+ .|++++....++ ..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~-~~ 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYD-VD 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEE-Ee
Confidence 445567889999999999999775443 333321 11 13456889999999 588887766555 33
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
....+++|||++ ++|.+.+. ....++.+++.+|.+||+.+++|||+||+||++ .++.++|+
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEE
Confidence 456789999997 47766553 134578999999999999999999999999999 67789999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.9e-14 Score=119.20 Aligned_cols=131 Identities=26% Similarity=0.263 Sum_probs=92.7
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccchh-------h----------------------HHHHHHHHHHHhcC-CC
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------S----------------------AFREIEALQILQNS-PN 73 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-------~----------------------~~~E~~~l~~l~~h-~n 73 (326)
.+.||+|+||.||+|.+. +++.|+||++.... . ...|...+..+..+ ..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 78899999875311 0 02344455555322 22
Q ss_pred eeEEeEEEEecCCceEEEeeeccc-CHH-HHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCC
Q 020467 74 VVVLHEYFWREDEDAVLVLEFLRT-DLA-TVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPG 150 (326)
Q Consensus 74 i~~l~~~~~~~~~~~~lv~e~~~~-~L~-~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~ 150 (326)
++..+.. ...+++|||+++ .+. ..+... ........++.+++.++.++|. .+|+|+||+|+
T Consensus 81 ~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~-----------~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~ 144 (187)
T cd05119 81 VPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDV-----------RLLEDPEELYDQILELMRKLYREAGLVHGDLSEY 144 (187)
T ss_pred CCceEec-----CCCEEEEEEeCCCCccChhhhhh-----------hhcccHHHHHHHHHHHHHHHhhccCcCcCCCChh
Confidence 3444432 236899999986 211 111111 1115577899999999999999 99999999999
Q ss_pred CeEEcCCCcEEEEeeccccccc
Q 020467 151 NLLIGDDGVLKLADFGQARILL 172 (326)
Q Consensus 151 Nili~~~~~~~l~Dfg~~~~~~ 172 (326)
||+++ ++.++++|||.+....
T Consensus 145 Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 145 NILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hEEEE-CCcEEEEECccccccc
Confidence 99999 8899999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.8e-15 Score=132.39 Aligned_cols=91 Identities=30% Similarity=0.422 Sum_probs=74.4
Q ss_pred cCCCeeEEeEEEEecC--------------------------CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHH
Q 020467 70 NSPNVVVLHEYFWRED--------------------------EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123 (326)
Q Consensus 70 ~h~ni~~l~~~~~~~~--------------------------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~ 123 (326)
.||||+.+..+|.++- ...|++|..++.+|..++-... .+....
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~----------~s~r~~ 343 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH----------RSYRTG 343 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC----------CchHHH
Confidence 6999999998774321 2368999999999988886543 666777
Q ss_pred HHHHHHHHHHHHHHHhCCceeccCCCCCeEEc--CCC--cEEEEeeccccc
Q 020467 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIG--DDG--VLKLADFGQARI 170 (326)
Q Consensus 124 ~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~--~~~--~~~l~Dfg~~~~ 170 (326)
.-++.|+++|+.|||.+||.|||+|.+||++. +++ .+.++|||.+--
T Consensus 344 ~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 344 RVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred HHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 88999999999999999999999999999995 333 678899998743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-13 Score=120.15 Aligned_cols=129 Identities=20% Similarity=0.223 Sum_probs=95.6
Q ss_pred eec-cccCcEEEEEEEcCCCeEEEEEEccc------------------hhhHHHHHHHHHHHhcCCCe--eEEeEEEEec
Q 020467 26 CVG-SGAYSDVYKGRRLSDNLIVALKEVHD------------------YQSAFREIEALQILQNSPNV--VVLHEYFWRE 84 (326)
Q Consensus 26 ~Lg-~G~~g~Vy~a~~~~~~~~vaiK~~~~------------------~~~~~~E~~~l~~l~~h~ni--~~l~~~~~~~ 84 (326)
.|| .|+.|+||.+.. .+..+++|.+.. .....+|++.+..+. |+++ +..+++....
T Consensus 38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVVR 114 (239)
T ss_pred eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeeee
Confidence 465 788888998865 366788887742 123567899999984 6664 6666654333
Q ss_pred CCc---eEEEeeeccc--CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 85 DED---AVLVLEFLRT--DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 85 ~~~---~~lv~e~~~~--~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
... .++++|++.+ +|.+++.... ++.. .+.+++.+|.+||+.||+|+||||+|||++.++.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGK 180 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC
Confidence 322 3599999985 7776654311 4443 3578999999999999999999999999999899
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999988764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.1e-16 Score=130.11 Aligned_cols=133 Identities=16% Similarity=0.298 Sum_probs=103.9
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
+...++.+|.....|++|+|++.++. ++.|++. ....+..|.-.++.+ .||||..+++.| .+.....++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgac-nsppnlv~i 265 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGAC-NSPPNLVII 265 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhc-cCCCCceEe
Confidence 44566778889999999999987654 4445553 234556667777777 699999999999 667789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEE
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~l 162 (326)
..||+ ++|++.+....... +...++..++.+++.+++|||+.. |.---|+..+++||++-..+|
T Consensus 266 sq~mp~gslynvlhe~t~vv-------vd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltari 332 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVV-------VDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARI 332 (448)
T ss_pred eeeccchHHHHHHhcCccEE-------EecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhe
Confidence 99998 89999998766543 667788999999999999999864 444468899999998876554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.5e-13 Score=108.61 Aligned_cols=131 Identities=22% Similarity=0.233 Sum_probs=104.2
Q ss_pred EEeeeccccCcEEEEEEEcCCCeEEEEEEccchh---hHHHHHHHHHHHhcC-CCeeEEeEEEEecCCceEEEeeecccC
Q 020467 23 ILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ---SAFREIEALQILQNS-PNVVVLHEYFWREDEDAVLVLEFLRTD 98 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~---~~~~E~~~l~~l~~h-~ni~~l~~~~~~~~~~~~lv~e~~~~~ 98 (326)
+.+.|+.|.++.||++.... ..+++|...... .+..|...++.+.++ .++++++.+. ...+..++++||+.+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-ESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCccEEEEEecCCe
Confidence 35789999999999998743 678999886543 578899999999644 5888888776 4456799999999753
Q ss_pred HHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 99 LATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN---TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 99 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.... ++......++.+++.+|..+|.. +++|+|++|+||+++..+.++++||+.+...
T Consensus 79 ~~~~---------------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDE---------------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eccc---------------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 2211 12334566788999999999985 6999999999999999899999999988654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.3e-14 Score=133.36 Aligned_cols=125 Identities=26% Similarity=0.397 Sum_probs=98.9
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..++.|+++. .+|.+++..... ....+......++.|++.++.| ++.+|+|+||.||+...+..++|.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~------~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT------GEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc------ccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhh
Confidence 4688899987 678888764332 1225666788899999999999 99999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCCC
Q 020467 166 GQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETDK 245 (326)
Q Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
|+.........
T Consensus 401 gl~ts~~~~~~--------------------------------------------------------------------- 411 (516)
T KOG1033|consen 401 GLVTSQDKDET--------------------------------------------------------------------- 411 (516)
T ss_pred hheeecccCCc---------------------------------------------------------------------
Confidence 99865432220
Q ss_pred CCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhcc
Q 020467 246 DTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQN 325 (326)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 325 (326)
+..+....+..+||.+||+||.|.|.. |+.++||||||+||+|
T Consensus 412 ------------------------------------~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~E 454 (516)
T KOG1033|consen 412 ------------------------------------VAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAE 454 (516)
T ss_pred ------------------------------------ccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHH
Confidence 001123356668999999999999877 9999999999999998
Q ss_pred C
Q 020467 326 F 326 (326)
Q Consensus 326 l 326 (326)
|
T Consensus 455 L 455 (516)
T KOG1033|consen 455 L 455 (516)
T ss_pred H
Confidence 5
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.7e-11 Score=100.37 Aligned_cols=132 Identities=23% Similarity=0.269 Sum_probs=95.4
Q ss_pred eeeccccCcEEEEEEEcC------CCeEEEEEEccc---------------------------hhh----HHHHHHHHHH
Q 020467 25 ECVGSGAYSDVYKGRRLS------DNLIVALKEVHD---------------------------YQS----AFREIEALQI 67 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~------~~~~vaiK~~~~---------------------------~~~----~~~E~~~l~~ 67 (326)
..||.|--+.||.|.... .+..+|||.++. ... ..+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468899999999997543 347899997741 001 1278888888
Q ss_pred HhcC-CCeeEEeEEEEecCCceEEEeeecccC-HHH-HHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCce
Q 020467 68 LQNS-PNVVVLHEYFWREDEDAVLVLEFLRTD-LAT-VIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC-HRNTIV 143 (326)
Q Consensus 68 l~~h-~ni~~l~~~~~~~~~~~~lv~e~~~~~-L~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~L-H~~~ii 143 (326)
+... -+++.++++ ...+++|||++++ +.. .+... .++......+..+++.+|..| |..|++
T Consensus 83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~glV 147 (197)
T cd05146 83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECNLV 147 (197)
T ss_pred HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence 7533 466676654 3578999999853 211 11111 145556677889999999988 899999
Q ss_pred eccCCCCCeEEcCCCcEEEEeeccccccc
Q 020467 144 HRDLKPGNLLIGDDGVLKLADFGQARILL 172 (326)
Q Consensus 144 H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 172 (326)
|+||++.||++. ++.+.++||+.+....
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999997 4689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.9e-11 Score=113.93 Aligned_cols=142 Identities=24% Similarity=0.366 Sum_probs=94.5
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--h----------------------------------------
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--Q---------------------------------------- 56 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--~---------------------------------------- 56 (326)
..|. .+.||.|++|+||+|+.+ +|+.||||+.+.. .
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred hhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 3344 367999999999999864 6889999987521 0
Q ss_pred ---hHHHHHHHHHHHh---cCCCeeEEeEEEEecCCceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHH
Q 020467 57 ---SAFREIEALQILQ---NSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129 (326)
Q Consensus 57 ---~~~~E~~~l~~l~---~h~ni~~l~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~q 129 (326)
.+.+|...+.++. .+.+-+.+..++.......+++|||+.| ++.+....... ... ...++.+
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--------~~~---~~~ia~~ 264 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--------GLD---RKALAEN 264 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--------CCC---HHHHHHH
Confidence 1223333333332 1233345555554444567999999985 55554432111 021 2334555
Q ss_pred HHH-HHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccccC
Q 020467 130 ILS-GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLG 173 (326)
Q Consensus 130 l~~-aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 173 (326)
++. .+..+|..|++|+|++|.||+++.++.++++|||++..+..
T Consensus 265 ~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 265 LARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 554 46788999999999999999999999999999999987743
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-13 Score=132.19 Aligned_cols=148 Identities=26% Similarity=0.370 Sum_probs=110.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-CCeEEEEEEccch-------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-DNLIVALKEVHDY-------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~~-------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
...|.+.+.||+|+++.|-.+.... ....++.|.+... .....|......+..|.|++++++.. .+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-SSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-CCCcccc
Confidence 5668889999999999998876533 3445666655422 12233555555554599999999987 6667788
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEcCCC-cEEEEeec
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH-RNTIVHRDLKPGNLLIGDDG-VLKLADFG 166 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH-~~~iiH~dlkp~Nili~~~~-~~~l~Dfg 166 (326)
+.+++.. +++...+.... ....+......++.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.||+
T Consensus 98 ~~~~~s~g~~~f~~i~~~~-------~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD-------STGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred cccCcccccccccccccCC-------ccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCch
Confidence 9999965 45554442111 112677778889999999999999 99999999999999999999 99999999
Q ss_pred ccccccC
Q 020467 167 QARILLG 173 (326)
Q Consensus 167 ~~~~~~~ 173 (326)
++.....
T Consensus 171 ~At~~~~ 177 (601)
T KOG0590|consen 171 LATAYRN 177 (601)
T ss_pred hhccccc
Confidence 9877643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.7e-10 Score=93.33 Aligned_cols=138 Identities=21% Similarity=0.274 Sum_probs=100.5
Q ss_pred EEeeeccccCcEEEEEEEcCCCeEEEEEEc-----c--------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 23 ILECVGSGAYSDVYKGRRLSDNLIVALKEV-----H--------DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~-----~--------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.+..+.+|+-+.|+.+.+ .|+.++||.- + ...+..+|++.+.++. --.|.-..-++ .+.+.-.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~-~D~~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIF-IDTYGGQ 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEE-EecCCCe
Confidence 567888999999999976 5677777743 1 1345677888888874 22332222223 4455678
Q ss_pred EEeeeccc--CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEEe
Q 020467 90 LVLEFLRT--DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---VLKLAD 164 (326)
Q Consensus 90 lv~e~~~~--~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---~~~l~D 164 (326)
+.|||+++ ++.+++....... ....-...++.++-..+.-||..+++||||..+||++.+++ .+.++|
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEe
Confidence 89999997 7777776654321 33333478899999999999999999999999999998766 358999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 160 fgls~~s 166 (229)
T KOG3087|consen 160 FGLSSVS 166 (229)
T ss_pred ecchhcc
Confidence 9998765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.8e-11 Score=114.83 Aligned_cols=145 Identities=19% Similarity=0.331 Sum_probs=97.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch----------------------------------------
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY---------------------------------------- 55 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~---------------------------------------- 55 (326)
++...|+. +.||+|++|+||.|+.+.+|+.||||+.+..
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 35567876 8999999999999998877999999988521
Q ss_pred -----hhHHHHHHHHHHHh---cCCCeeEEeEEEEecCCceEEEeeeccc-CHHHH--HHHhhhhhhhcCCCCCCHHHHH
Q 020467 56 -----QSAFREIEALQILQ---NSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATV--IAESKKKREDRGDRGISVGEIK 124 (326)
Q Consensus 56 -----~~~~~E~~~l~~l~---~h~ni~~l~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~~~~~~~~~~~l~~~~~~ 124 (326)
-.+.+|...+.++. .+.+.+.+..++.+-....+++|||+.| .+.+. +...+... ..+....+.
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~-----~~la~~~v~ 270 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM-----KLLAERGVE 270 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH-----HHHHHHHHH
Confidence 01223333333332 2344455666665545678999999985 55543 21111000 013333444
Q ss_pred HHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----cEEEEeecccccccC
Q 020467 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG----VLKLADFGQARILLG 173 (326)
Q Consensus 125 ~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~----~~~l~Dfg~~~~~~~ 173 (326)
.++.|+ ...|++|+|++|.||+++.++ .++++|||++..+..
T Consensus 271 ~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 444444 468999999999999999888 999999999987744
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.5e-10 Score=94.87 Aligned_cols=126 Identities=21% Similarity=0.215 Sum_probs=91.3
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecccCH
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDL 99 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~~L 99 (326)
.+.|+.|.++.||++... +..+++|..... .....|...+..+.....++.++... ....+++||++++..
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~---~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD---PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe---CCCCeEEEEecCCCc
Confidence 457788999999999763 678999987543 23578888888885433345555443 223589999998632
Q ss_pred HHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 100 ATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTI-----VHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 100 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~i-----iH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.... . .. ...++.+++.+|..||..++ +|+|++|.||+++ ++.++++||+.+...
T Consensus 78 l~~~---~----------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 78 LLTE---D----------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc---c----------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 2110 0 11 12356789999999999875 9999999999999 668999999988653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.2e-12 Score=119.67 Aligned_cols=149 Identities=23% Similarity=0.274 Sum_probs=124.1
Q ss_pred ccCeEEEeeecc--ccCcEEEEEEE--cCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGS--GAYSDVYKGRR--LSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~--G~~g~Vy~a~~--~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
...+.+.+.+|. |.+|.||.+.. ..+...+++|.-+ ......+|....+++..|++.++.+..+ +...
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-EGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-ccCC
Confidence 456777888999 99999999987 7788889998743 2344567788888887899999988887 7777
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCCeEEcCC-CcEE
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS----GVDACHRNTIVHRDLKPGNLLIGDD-GVLK 161 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~----aL~~LH~~~iiH~dlkp~Nili~~~-~~~~ 161 (326)
..++-+|+.+.+|..+....... ++...++..+.+... ||.++|..+++|-|++|.||++..+ ..++
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~--------~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNF--------LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cceeeeccccchhHHhhhccccc--------CCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence 89999999998888877664432 778888888888888 9999999999999999999999998 8899
Q ss_pred EEeecccccccCCc
Q 020467 162 LADFGQARILLGNE 175 (326)
Q Consensus 162 l~Dfg~~~~~~~~~ 175 (326)
+.||++...+....
T Consensus 264 ~~df~~v~~i~~~~ 277 (524)
T KOG0601|consen 264 LTDFGLVSKISDGN 277 (524)
T ss_pred cCCcceeEEccCCc
Confidence 99999988775544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-11 Score=114.63 Aligned_cols=93 Identities=24% Similarity=0.354 Sum_probs=79.9
Q ss_pred cCCCeeEEeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccC
Q 020467 70 NSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTI-VHRDL 147 (326)
Q Consensus 70 ~h~ni~~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~i-iH~dl 147 (326)
.|.|+.++++.+ .+++..+++.+|+. |+|.+.+...... +.......++++++.+|.|+|...| .|+.+
T Consensus 5 ~h~n~~~f~g~~-~~~~~~~~i~~~c~rGsl~D~i~~~~~~--------~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 5 DHDNLNKFIGAS-VDGPEMIVIWEYCSRGSLLDILSNEDIK--------LDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred chhhhhhheeeE-ecCCceEEEEeeecCccHHhHHhccccC--------ccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 599999999999 44578999999997 8999998773321 6666777889999999999997755 99999
Q ss_pred CCCCeEEcCCCcEEEEeecccccc
Q 020467 148 KPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 148 kp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+..|.+++..-.+||.|||+....
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~ 99 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLL 99 (484)
T ss_pred ccccceeeeeEEEEechhhhcccc
Confidence 999999999999999999998765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.2e-09 Score=86.32 Aligned_cols=124 Identities=21% Similarity=0.335 Sum_probs=89.2
Q ss_pred eeccccCcEEEEEEEcCCCeEEEEEEcc-------------chhhHHHHHHHHHHHhc-CCCeeEEeEEEEecCCceEEE
Q 020467 26 CVGSGAYSDVYKGRRLSDNLIVALKEVH-------------DYQSAFREIEALQILQN-SPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------------~~~~~~~E~~~l~~l~~-h~ni~~l~~~~~~~~~~~~lv 91 (326)
.+++|+-+.++.+.+. +..+++|.-. ......+|..++.++.. --+.+.+++ .+.....++
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d---vD~~~~~I~ 77 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD---VDPDNGLIV 77 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE---EcCCCCEEE
Confidence 5778999999998663 3346666321 13445678888888752 123334443 445567899
Q ss_pred eeecccCHHH-HHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRTDLAT-VIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||++|.+.. .+... ...++..+-.-+.-||..||+|+||.++||++...+ +.++|||+...
T Consensus 78 me~I~G~~lkd~l~~~----------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA----------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc----------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999986654 44432 134677888889999999999999999999997765 99999999875
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 141 s 141 (204)
T COG3642 141 S 141 (204)
T ss_pred c
Confidence 4
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-09 Score=103.14 Aligned_cols=122 Identities=23% Similarity=0.318 Sum_probs=93.7
Q ss_pred EE-EEEEcCCCeEEEEEEccch-----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecccCHHHHHHHhhh
Q 020467 35 VY-KGRRLSDNLIVALKEVHDY-----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKK 108 (326)
Q Consensus 35 Vy-~a~~~~~~~~vaiK~~~~~-----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~ 108 (326)
+| .|..+.++.+|.+..++.. ....+.++.++.+ .||+|+++++.+ +.....|+++|.+. .|...+.+
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~-e~~~~~ylvTErV~-Pl~~~lk~--- 100 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTT-EEEGTLYLVTERVR-PLETVLKE--- 100 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhh-cccCceEEEeeccc-cHHHHHHH---
Confidence 44 3555667778888776532 3355667788888 599999999998 55568999999876 23344444
Q ss_pred hhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 109 KREDRGDRGISVGEIKRWMVQILSGVDACH-RNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 109 ~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH-~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+.......-+.||+.||.||| +.+++|++++-..|+++..|..+|.+|.++...
T Consensus 101 ---------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 101 ---------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred ---------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 334455667899999999998 668999999999999999999999999987653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.1e-09 Score=87.67 Aligned_cols=121 Identities=28% Similarity=0.318 Sum_probs=76.6
Q ss_pred EEEEEEcCCCeEEEEEEccc-------------------------------hhhHHHHHHHHHHHhcC-CCeeEEeEEEE
Q 020467 35 VYKGRRLSDNLIVALKEVHD-------------------------------YQSAFREIEALQILQNS-PNVVVLHEYFW 82 (326)
Q Consensus 35 Vy~a~~~~~~~~vaiK~~~~-------------------------------~~~~~~E~~~l~~l~~h-~ni~~l~~~~~ 82 (326)
||.|.. ..+..+|+|.++. .....+|.+.|.++... -+++.++.+.
T Consensus 2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 788876 3567899997640 12345788888887533 2567776543
Q ss_pred ecCCceEEEeeecc--cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCCeEEcCCCc
Q 020467 83 REDEDAVLVLEFLR--TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA-CHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 83 ~~~~~~~lv~e~~~--~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~-LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
..+++|||++ |.....+.... +.......++.+++..+.. +|..|++|||+++.||+++.+ .
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e
Confidence 3589999999 63333333322 1123345567777775554 579999999999999999887 9
Q ss_pred EEEEeeccccccc
Q 020467 160 LKLADFGQARILL 172 (326)
Q Consensus 160 ~~l~Dfg~~~~~~ 172 (326)
+.++||+.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999876653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=8.7e-08 Score=84.42 Aligned_cols=126 Identities=20% Similarity=0.109 Sum_probs=87.6
Q ss_pred EEEEEEcCCCeEEEEEEccchh----------------hHHHHHHHHHHHhcCCCe--eEEeEEEEec----CCceEEEe
Q 020467 35 VYKGRRLSDNLIVALKEVHDYQ----------------SAFREIEALQILQNSPNV--VVLHEYFWRE----DEDAVLVL 92 (326)
Q Consensus 35 Vy~a~~~~~~~~vaiK~~~~~~----------------~~~~E~~~l~~l~~h~ni--~~l~~~~~~~----~~~~~lv~ 92 (326)
|..... .|+.+.||...... ...+|...+.++. ..+| +.++.+.... ....++++
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 445433 56678889663211 3668888887774 2232 3334444221 23478999
Q ss_pred eeccc--CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-------CCcEEEE
Q 020467 93 EFLRT--DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-------DGVLKLA 163 (326)
Q Consensus 93 e~~~~--~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-------~~~~~l~ 163 (326)
|++++ +|.+++..... ..........++.+++..+.-||+.||+|+|+++.|||++. +..+.++
T Consensus 115 e~l~~~~sL~~~~~~~~~-------~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 115 EDLAPTISLEDYCADWAT-------NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred eeCCCCccHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 99986 67777643211 11455677789999999999999999999999999999985 4689999
Q ss_pred eeccccc
Q 020467 164 DFGQARI 170 (326)
Q Consensus 164 Dfg~~~~ 170 (326)
||+.+..
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.2e-09 Score=99.01 Aligned_cols=144 Identities=24% Similarity=0.314 Sum_probs=109.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc-CCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL-SDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~-~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
...+|.++..|+.+.|+.|+.+... .++..|++|.... ...-..|+.....+..|.+.+..+..| ......
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccc
Confidence 4677889999999999999987654 6778888887642 233456666777776788888877777 344456
Q ss_pred EEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEEeec
Q 020467 89 VLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-GVLKLADFG 166 (326)
Q Consensus 89 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-~~~~l~Dfg 166 (326)
++-.||+.+ ++........+ +.+...+.+..|++.++.++|+..++|+|++|.||++..+ +..++.||+
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~---------~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQM---------LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cCchhhhcCcchhhhhHHHHh---------cCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccc
Confidence 788899964 44333322222 7788889999999999999999999999999999999886 677788888
Q ss_pred cccc
Q 020467 167 QARI 170 (326)
Q Consensus 167 ~~~~ 170 (326)
....
T Consensus 413 ~~t~ 416 (524)
T KOG0601|consen 413 CWTR 416 (524)
T ss_pred cccc
Confidence 7643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.1e-08 Score=83.29 Aligned_cols=73 Identities=14% Similarity=0.072 Sum_probs=51.4
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcC-CCeeEEeEEEEecC--CceEEEeee
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNS-PNVVVLHEYFWRED--EDAVLVLEF 94 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h-~ni~~l~~~~~~~~--~~~~lv~e~ 94 (326)
.+.|+.|..+.+|++... ++..+++|.... ......|.+++..+..+ .++++++.+..... +..+++|++
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 357889999999999763 357899998753 34567899999988542 34566666552221 246899999
Q ss_pred ccc
Q 020467 95 LRT 97 (326)
Q Consensus 95 ~~~ 97 (326)
+.+
T Consensus 82 i~G 84 (223)
T cd05154 82 VDG 84 (223)
T ss_pred eCC
Confidence 975
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.4e-08 Score=85.09 Aligned_cols=131 Identities=29% Similarity=0.301 Sum_probs=94.3
Q ss_pred EEEeeeccccCcEEEEEEEcCCCeEEEEEEcc---------------------------chhhHHHHHHHHHHHhcC-CC
Q 020467 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH---------------------------DYQSAFREIEALQILQNS-PN 73 (326)
Q Consensus 22 ~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~---------------------------~~~~~~~E~~~l~~l~~h-~n 73 (326)
.+..+||-|--+.||.|.+. .+.+++||-.+ ......+|.+.|.++... -.
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45789999999999999875 67889999543 122356788888888533 24
Q ss_pred eeEEeEEEEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 020467 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLL 153 (326)
Q Consensus 74 i~~l~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nil 153 (326)
++..+++ +...++||++.|..+..+. +.......++..|++-+..+...|++|+|+++-||+
T Consensus 173 VP~P~~~-----nRHaVvMe~ieG~eL~~~r-------------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIl 234 (304)
T COG0478 173 VPKPIAW-----NRHAVVMEYIEGVELYRLR-------------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNIL 234 (304)
T ss_pred CCCcccc-----ccceeeeehcccceeeccc-------------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEE
Confidence 5554432 3578999999872211110 123344556677777777777899999999999999
Q ss_pred EcCCCcEEEEeecccccc
Q 020467 154 IGDDGVLKLADFGQARIL 171 (326)
Q Consensus 154 i~~~~~~~l~Dfg~~~~~ 171 (326)
++++|.+.++||--+...
T Consensus 235 V~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EecCCCEEEEeCcccccC
Confidence 999999999999765443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=87.80 Aligned_cols=144 Identities=17% Similarity=0.198 Sum_probs=110.9
Q ss_pred cCcEEEEEEEcCCCeEEEEEEccch-----hhHHHHHHHHHHHhcCCCeeEEeEEEE---ecCCceEEEeeecc--cCHH
Q 020467 31 AYSDVYKGRRLSDNLIVALKEVHDY-----QSAFREIEALQILQNSPNVVVLHEYFW---REDEDAVLVLEFLR--TDLA 100 (326)
Q Consensus 31 ~~g~Vy~a~~~~~~~~vaiK~~~~~-----~~~~~E~~~l~~l~~h~ni~~l~~~~~---~~~~~~~lv~e~~~--~~L~ 100 (326)
...+.|++....+|..|++|+++-. .....-++.++++ .|.|++++.++|. .....+++|++|++ .+|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3457899998889999999999421 1233457788888 6999999999884 23356899999998 4777
Q ss_pred HHHHHhhhhh------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccccCC
Q 020467 101 TVIAESKKKR------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174 (326)
Q Consensus 101 ~~l~~~~~~~------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 174 (326)
++.-...... ........++..+|.++.|+..||.++|+.|+.-+-|.+.+|+++.+..++|...|+..++..+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 7654332221 1112344888999999999999999999999999999999999999989999888877766444
Q ss_pred c
Q 020467 175 E 175 (326)
Q Consensus 175 ~ 175 (326)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 3
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.5e-08 Score=88.92 Aligned_cols=89 Identities=24% Similarity=0.500 Sum_probs=74.0
Q ss_pred cCCCeeEEeEEEEecC----CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--Cc
Q 020467 70 NSPNVVVLHEYFWRED----EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN--TI 142 (326)
Q Consensus 70 ~h~ni~~l~~~~~~~~----~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--~i 142 (326)
-|.||++++.+|.... ....+.++|+. +++..++.+....... +......+|+.||+.||.|||+. -|
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a-----~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKA-----LFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhh-----hhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 4889999999984333 35788999998 7888888876654433 77888899999999999999976 59
Q ss_pred eeccCCCCCeEEcCCCcEEEE
Q 020467 143 VHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 143 iH~dlkp~Nili~~~~~~~l~ 163 (326)
+|+++..+.|++..+|.+++.
T Consensus 200 ihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccCCcchhheeecCCceEEec
Confidence 999999999999998888864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.7e-06 Score=72.77 Aligned_cols=133 Identities=15% Similarity=0.098 Sum_probs=95.0
Q ss_pred cccCcEEEEEEEcCCCeEEEEEEcc-----------chhhHHHHHHHHHHHhcC-CCeeEEeEEEEec----CCceEEEe
Q 020467 29 SGAYSDVYKGRRLSDNLIVALKEVH-----------DYQSAFREIEALQILQNS-PNVVVLHEYFWRE----DEDAVLVL 92 (326)
Q Consensus 29 ~G~~g~Vy~a~~~~~~~~vaiK~~~-----------~~~~~~~E~~~l~~l~~h-~ni~~l~~~~~~~----~~~~~lv~ 92 (326)
.|+.+.|+.... .|+.+-+|.-. -...+.+|...+..+... -.++.+. ++... ....+||+
T Consensus 28 rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 28 RNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 477778888654 33357788654 145678999988888521 2234433 32111 12378999
Q ss_pred eecc--cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--EEEEeeccc
Q 020467 93 EFLR--TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV--LKLADFGQA 168 (326)
Q Consensus 93 e~~~--~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~--~~l~Dfg~~ 168 (326)
|-++ .+|.+.+..... ...+......++.+++.++.-||+.|+.|+|+.+.||+++.++. +.++||.-+
T Consensus 105 e~L~g~~~L~~~l~~~~~-------~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-------SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EeCCCCccHHHHHhcCCc-------CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9888 588777654321 11566677889999999999999999999999999999987777 999999977
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
+..
T Consensus 178 r~~ 180 (216)
T PRK09902 178 RRR 180 (216)
T ss_pred chh
Confidence 654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=7.6e-07 Score=75.63 Aligned_cols=107 Identities=23% Similarity=0.284 Sum_probs=79.0
Q ss_pred hhHHHHHHHHHHHhc-CCCeeEEeEEEEecC---CceEEEeeeccc--CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHH
Q 020467 56 QSAFREIEALQILQN-SPNVVVLHEYFWRED---EDAVLVLEFLRT--DLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129 (326)
Q Consensus 56 ~~~~~E~~~l~~l~~-h~ni~~l~~~~~~~~---~~~~lv~e~~~~--~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~q 129 (326)
....+|...+..+.. .-..+..+.+..... ...++++|++++ +|.+++..... .+......++.+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~~ 126 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLRA 126 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHHH
Confidence 346777777777642 223445555543322 246899999985 67777765322 445567789999
Q ss_pred HHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEEeecccccc
Q 020467 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDG---VLKLADFGQARIL 171 (326)
Q Consensus 130 l~~aL~~LH~~~iiH~dlkp~Nili~~~~---~~~l~Dfg~~~~~ 171 (326)
++..+.-||+.||+|+|+++.|||++.++ .+.++||+.+...
T Consensus 127 l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 127 LARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999999999999887 8999999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.9e-09 Score=102.24 Aligned_cols=142 Identities=25% Similarity=0.252 Sum_probs=96.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhhH--------HHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSA--------FREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--------~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
-.+.+.+.+-+.++.++.+..+....++....+|.......+ ..+..++... .+|.++...-.+ ......
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~-~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF-PCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC-CCCCCc
Confidence 467788888999999999999877667766666654322111 1111111111 123322211111 234568
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++++|+. +++...+...+ +......+.+...+..++++||...+.|+|++|.|.++..+++..+.+|++
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---------~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---------CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---------CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccc
Confidence 89999996 56666665543 255556677788899999999999899999999999999999999999995
Q ss_pred cc
Q 020467 168 AR 169 (326)
Q Consensus 168 ~~ 169 (326)
..
T Consensus 951 ~~ 952 (1205)
T KOG0606|consen 951 LS 952 (1205)
T ss_pred cc
Confidence 43
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.4e-07 Score=86.00 Aligned_cols=136 Identities=22% Similarity=0.334 Sum_probs=87.7
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc---------------------------------------------hhhHH
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD---------------------------------------------YQSAF 59 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---------------------------------------------~~~~~ 59 (326)
+.|+.+.-|+||.|..+ +|+.||||+.+. .-...
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67889999999999865 489999998750 11123
Q ss_pred HHHHHHHHHh---cCCCeeEEeEEEEecCCceEEEeeeccc-CHHHH--HHHhhhhhhhcCCCCCCHHHHHHHHHHHHHH
Q 020467 60 REIEALQILQ---NSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATV--IAESKKKREDRGDRGISVGEIKRWMVQILSG 133 (326)
Q Consensus 60 ~E~~~l~~l~---~h~ni~~l~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~a 133 (326)
+|..-+.++. ....-+.+..++++-.+...++|||++| .+.+. +...+ +....+.....++.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g----------~d~k~ia~~~~~~f-- 277 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG----------IDRKELAELLVRAF-- 277 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC----------CCHHHHHHHHHHHH--
Confidence 3443333332 2233345556665555678999999986 34333 33322 33222222221111
Q ss_pred HHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccccC
Q 020467 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLG 173 (326)
Q Consensus 134 L~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 173 (326)
+..+-..|+.|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 278 ~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2233358999999999999999999999999999887654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.8e-06 Score=70.39 Aligned_cols=135 Identities=18% Similarity=0.225 Sum_probs=85.4
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------------hhhHHHHHHHHHHHh--cCCCeeEEeE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------------YQSAFREIEALQILQ--NSPNVVVLHE 79 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------------~~~~~~E~~~l~~l~--~h~ni~~l~~ 79 (326)
.+.++|.+.+.+.......|.+.. ..++.+++|..+. .....+.+..+.++. +......++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 356789999999888877776654 3567889997752 111223333333332 1222223222
Q ss_pred EEEe----cCCceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 020467 80 YFWR----EDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154 (326)
Q Consensus 80 ~~~~----~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili 154 (326)
+... -....+++|||++| .|.+.. . +++ .+...+.+++.-+|+.|+.|+|.+|.|+++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-~------------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv 168 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIE-D------------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV 168 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccch-h------------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE
Confidence 2211 12346789999997 333221 1 222 234567788999999999999999999999
Q ss_pred cCCCcEEEEeeccccc
Q 020467 155 GDDGVLKLADFGQARI 170 (326)
Q Consensus 155 ~~~~~~~l~Dfg~~~~ 170 (326)
..+ .++++||+..+.
T Consensus 169 ~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 169 SNN-GIRIIDTQGKRM 183 (229)
T ss_pred ECC-cEEEEECccccc
Confidence 855 599999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.3e-08 Score=97.76 Aligned_cols=35 Identities=43% Similarity=0.695 Sum_probs=32.0
Q ss_pred CcccccccccchhhhccCCCCcceeeeeehhhhccC
Q 020467 291 SCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQNF 326 (326)
Q Consensus 291 ~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 326 (326)
..+||+.|+|||++.+.. |+.++|||||||+||||
T Consensus 539 ~~vGT~~Y~APE~l~~~~-~~~~~DiwSlG~il~El 573 (669)
T cd05610 539 RILGTPDYLAPELLLGKP-HGPAVDWWALGVCLFEF 573 (669)
T ss_pred ceeeCccccCHHHcCCCC-CCcHHHHHHHHHHHHHH
Confidence 357999999999998866 99999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=4e-06 Score=71.74 Aligned_cols=132 Identities=23% Similarity=0.319 Sum_probs=89.5
Q ss_pred eeccccCcEEEEEEEcCCCeEEEEEEccc-----------------------------hhhHHHHHHHHHHHhc-CCCee
Q 020467 26 CVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------------------------YQSAFREIEALQILQN-SPNVV 75 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------------------------~~~~~~E~~~l~~l~~-h~ni~ 75 (326)
.|++|-...||+|.. .++..+|+|++.. ..-...|..-|.++.. +-.++
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 556777888999864 4578899998851 1112356666666542 33445
Q ss_pred EEeEEEEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEE
Q 020467 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLI 154 (326)
Q Consensus 76 ~l~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili 154 (326)
+-+.+. ...++|||++..- ...+... .-.+.......+..+++..+.-|.. .++||+||+.-|||+
T Consensus 134 ~Pi~~~-----~nVLvMEfIg~~g----~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 134 EPIAFR-----NNVLVMEFIGDDG----LPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred Cceeec-----CCeEEEEeccCCC----CCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 555443 4689999998431 0011110 0113333577788888888888886 899999999999999
Q ss_pred cCCCcEEEEeeccccccc
Q 020467 155 GDDGVLKLADFGQARILL 172 (326)
Q Consensus 155 ~~~~~~~l~Dfg~~~~~~ 172 (326)
. ++.+.++||+-+....
T Consensus 201 ~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred E-CCeEEEEECccccccC
Confidence 9 8899999999887664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.3e-05 Score=68.96 Aligned_cols=141 Identities=15% Similarity=0.141 Sum_probs=80.7
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCC-CeeEEeEEEEecCCceEEEeeecccC--
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSP-NVVVLHEYFWREDEDAVLVLEFLRTD-- 98 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~-ni~~l~~~~~~~~~~~~lv~e~~~~~-- 98 (326)
.+|++|..+.||+. .+..+++|.... .....+|.+++..+.... .+++++.+. +..+...++|+++.|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-EDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-ecCCeeeeeeeecCCccc
Confidence 57899999999984 234577898764 345788999998885332 246666665 4555578899999873
Q ss_pred HHHHH-----------HHhhhh-hhhcCC--CCCCHHHHH-HHHH----------HHHHH-HHHHH----hCCceeccCC
Q 020467 99 LATVI-----------AESKKK-REDRGD--RGISVGEIK-RWMV----------QILSG-VDACH----RNTIVHRDLK 148 (326)
Q Consensus 99 L~~~l-----------~~~~~~-~~~~~~--~~l~~~~~~-~i~~----------ql~~a-L~~LH----~~~iiH~dlk 148 (326)
+...+ ..-... ...+.. ......... .+-. .+... ..+|. ...++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 11111 000000 000000 001111100 0100 01111 12222 2257899999
Q ss_pred CCCeEEcCCCcEEEEeecccccc
Q 020467 149 PGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 149 p~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|.||+++.++ +.++||+.+..-
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCcC
Confidence 9999999888 999999987643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.2e-07 Score=86.04 Aligned_cols=44 Identities=25% Similarity=0.473 Sum_probs=39.0
Q ss_pred HHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 128 VQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 128 ~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.+++.|+.|+|.. ++||++|.|++|+++..+..||+.|+++...
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~ 150 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNA 150 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhcc
Confidence 3455999999955 8999999999999999999999999998754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.2e-06 Score=76.30 Aligned_cols=144 Identities=15% Similarity=0.145 Sum_probs=89.5
Q ss_pred EEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhhHH--HHHHHHHHHhcCCCeeEEeEEE------EecCCceEEEee
Q 020467 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAF--REIEALQILQNSPNVVVLHEYF------WREDEDAVLVLE 93 (326)
Q Consensus 22 ~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~E~~~l~~l~~h~ni~~l~~~~------~~~~~~~~lv~e 93 (326)
.+.+.||+|+.+.+|-.-.. +. .+.|+++...... ..+..+.....||-+..-+.|- ...+...-++|+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCCccccCCccceeeecchh--hc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 34667899999999865321 22 3458886533222 2233333333344332211110 011223667788
Q ss_pred eccc--CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLRT--DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~--~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.+.+ .+..++...... .+.....+..+....+.++.+...||..|.+-||++++|+|+.+++.+.|+|-......
T Consensus 91 ~v~g~~pI~~~y~p~tRR---qs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRR---QSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhc---ccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 7764 443333222111 22344778889999999999999999999999999999999999999999987655443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.6e-05 Score=65.30 Aligned_cols=72 Identities=17% Similarity=0.128 Sum_probs=50.1
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccch---hhHHHHHHHHHHHhcCC-CeeEEeEEEEec--CCceEEEeeeccc
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDY---QSAFREIEALQILQNSP-NVVVLHEYFWRE--DEDAVLVLEFLRT 97 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~---~~~~~E~~~l~~l~~h~-ni~~l~~~~~~~--~~~~~lv~e~~~~ 97 (326)
++.|+.|..+.||.+.... ..+++|..... .....|..+++.+..+. .++.++...... ....+++|+++.+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4678899999999997644 47889998765 56778888888886442 356666543222 2236899999885
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.5e-05 Score=65.86 Aligned_cols=70 Identities=26% Similarity=0.162 Sum_probs=49.3
Q ss_pred eeeccccC-cEEEEEEEcCCCeEEEEEEccch--hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeeccc
Q 020467 25 ECVGSGAY-SDVYKGRRLSDNLIVALKEVHDY--QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT 97 (326)
Q Consensus 25 ~~Lg~G~~-g~Vy~a~~~~~~~~vaiK~~~~~--~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~ 97 (326)
+.|..|.. ..||+.... +..+++|..... ....+|+++++.+..+-.+++++.+. ......+++|++++|
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-~~~~~~~lv~e~i~G 76 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYG-SDDGRAWLLTSAVPG 76 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEE-ecCCccEEEEEeeCC
Confidence 34555665 678988643 356888887653 45778999998887665666777766 333457899999986
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.8e-05 Score=72.19 Aligned_cols=141 Identities=21% Similarity=0.351 Sum_probs=89.3
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------------------------------------
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------------------------------------- 54 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------------------------------------- 54 (326)
++...|. .+.|+....++||+|+-+. |+.||||+.+.
T Consensus 159 ~if~~f~-~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 159 DIFSEFD-EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred HHHHhcC-cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 3444443 4688999999999998654 89999998751
Q ss_pred -hhhHHHHHHH----HHHHhcCCC---eeEEeEEEEecCCceEEEeeeccc----CHHHHHHHhhhhhhhcCCCCCCHHH
Q 020467 55 -YQSAFREIEA----LQILQNSPN---VVVLHEYFWREDEDAVLVLEFLRT----DLATVIAESKKKREDRGDRGISVGE 122 (326)
Q Consensus 55 -~~~~~~E~~~----l~~l~~h~n---i~~l~~~~~~~~~~~~lv~e~~~~----~L~~~l~~~~~~~~~~~~~~l~~~~ 122 (326)
.-.+.+|.+- ...+ .|-+ -+.+..+++.-.....++|||++| ++ +.+.+.+ ++...
T Consensus 237 ~ELDF~~EA~Nae~~~~~f-~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl-~~i~~~g----------i~~~~ 304 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENF-KDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDL-DAIDKRG----------ISPHD 304 (538)
T ss_pred hhcchHHHHHhHHHHHHHH-HhcccccceeCCeehhhcCcceEEEEEecCCccCCCH-HHHHHcC----------CCHHH
Confidence 1112233322 2223 2444 233555555555678999999985 33 3444332 44443
Q ss_pred HHHHHHHHHHHHH-HHHhCCceeccCCCCCeEEcC----CCcEEEEeecccccccC
Q 020467 123 IKRWMVQILSGVD-ACHRNTIVHRDLKPGNLLIGD----DGVLKLADFGQARILLG 173 (326)
Q Consensus 123 ~~~i~~ql~~aL~-~LH~~~iiH~dlkp~Nili~~----~~~~~l~Dfg~~~~~~~ 173 (326)
+ +..+.++.. -+-..|++|.|-+|.||++.. +..+.+.|||+...+..
T Consensus 305 i---~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 305 I---LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred H---HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3 333333322 223578999999999999994 56899999999877654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=9.1e-05 Score=60.23 Aligned_cols=130 Identities=20% Similarity=0.239 Sum_probs=89.3
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
......+.|++|.+|.||++.+. +..+++|.-.. ...+..|.+++..++.-.--+.+|.+- ..++.|||+
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg-----~~~i~me~i 94 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG-----EDFIRMEYI 94 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec-----hhhhhhhhh
Confidence 34456778999999999999874 45788887653 456788999999886544455666654 234559999
Q ss_pred cc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCCeEEcCCCcEEEEeecccccc
Q 020467 96 RT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLK-PGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlk-p~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.| .|.+..... . .+-+..+++.---|-..||-|+.|. |...+|-.++.+.|+||..+...
T Consensus 95 ~G~~L~~~~~~~------------~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEIGG------------D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhhcc------------c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 87 665544321 1 1123345555445557799999875 56666666669999999988754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00086 Score=68.74 Aligned_cols=76 Identities=14% Similarity=0.132 Sum_probs=52.0
Q ss_pred EEeeeccccCcEEEEEEEcCCC--eEEEEEEccc------hhhHHHHHHHHHHHhcCCCe--eEEeEEEEecC--CceEE
Q 020467 23 ILECVGSGAYSDVYKGRRLSDN--LIVALKEVHD------YQSAFREIEALQILQNSPNV--VVLHEYFWRED--EDAVL 90 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~~~--~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni--~~l~~~~~~~~--~~~~l 90 (326)
-.+.++.|.+..+|+......+ ..+++|+... .....+|.++++.+..|.++ ++++.++.... +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677888999999988654322 4677777632 23577899999998645554 67776663221 35789
Q ss_pred EeeecccC
Q 020467 91 VLEFLRTD 98 (326)
Q Consensus 91 v~e~~~~~ 98 (326)
+||+++|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99998864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0061 Score=51.11 Aligned_cols=123 Identities=28% Similarity=0.343 Sum_probs=85.2
Q ss_pred ccCeEEEeeeccccC-cEEEEEEEcCCCeEEEEEEccc--------------------------hhhHHHHHHHHHHHhc
Q 020467 18 IAKYEILECVGSGAY-SDVYKGRRLSDNLIVALKEVHD--------------------------YQSAFREIEALQILQN 70 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~-g~Vy~a~~~~~~~~vaiK~~~~--------------------------~~~~~~E~~~l~~l~~ 70 (326)
..+++.++.||.|.. |.||++.- .|+.+|+|.+.. ...+..|.+.+.+++.
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 99999864 678999998320 1235678888777763
Q ss_pred --CCCe--eEEeEEEEecC-----------------CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHH
Q 020467 71 --SPNV--VVLHEYFWRED-----------------EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129 (326)
Q Consensus 71 --h~ni--~~l~~~~~~~~-----------------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~q 129 (326)
+.++ ++++++..-.. ....||.||....- .++... +.+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~~~----~~~ 172 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQIRD----IPQ 172 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccchhH----HHH
Confidence 3344 78888763221 11356666655321 022222 456
Q ss_pred HHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 130 l~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
|..-+..+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 173 ~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 173 MLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 777788999999999999999985 2467898854
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00039 Score=58.01 Aligned_cols=102 Identities=22% Similarity=0.200 Sum_probs=76.5
Q ss_pred HHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 020467 59 FREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137 (326)
Q Consensus 59 ~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~L 137 (326)
..|..+++.+.+.+++++++++| ..+++.||.+ +++..... ... .....++..+..++.++++.+.++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G~~~v~E~~~~~~~~~~~~-~l~-----~~~~~~w~~R~~iA~~lL~~l~~l 75 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----GRFYVVEYVGAGSLYGIYR-PLS-----QFLQSPWEQRAKIALQLLELLEEL 75 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----CCEEEEEeecCcccccccc-ccc-----cccccCHHHHHHHHHHHHHHHHHH
Confidence 35777888887667999999998 3577889988 34432100 000 001167888999999999999999
Q ss_pred Hh---CCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 138 HR---NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 138 H~---~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+. ..+.--|++++|+.+++++.++++|.......
T Consensus 76 ~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 76 DHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred hcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 86 34777899999999999999999999977654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00015 Score=64.55 Aligned_cols=129 Identities=19% Similarity=0.206 Sum_probs=89.4
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc---------------------------chhhHHHHHHHHHHHhcCCC
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---------------------------DYQSAFREIEALQILQNSPN 73 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~---------------------------~~~~~~~E~~~l~~l~~h~n 73 (326)
+.+.++||-|.-+-+|.+-+ ..|.+.++|..+ ..-...+|...++.+..|..
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 45688999999999999976 456777888542 01224567778888765443
Q ss_pred -eeEEeEEEEecCCceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 020467 74 -VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGN 151 (326)
Q Consensus 74 -i~~l~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~N 151 (326)
+++.+++ +..+++|+++.+ .|...-. ......+...++.-+.-|..+|+||+|.+-=|
T Consensus 173 pVPkpiD~-----~RH~Vvmelv~g~Pl~~v~~---------------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFN 232 (465)
T KOG2268|consen 173 PVPKPIDH-----NRHCVVMELVDGYPLRQVRH---------------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFN 232 (465)
T ss_pred CCCCcccc-----cceeeHHHhhcccceeeeee---------------cCChHHHHHHHHHHHHHHHHcCceecccchhe
Confidence 3343332 357889998875 3322210 11223356667777888889999999999999
Q ss_pred eEEcCCCcEEEEeeccccc
Q 020467 152 LLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 152 ili~~~~~~~l~Dfg~~~~ 170 (326)
||+++++.++++||--+..
T Consensus 233 imv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 233 IMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred eEEecCCCEEEeechHhhc
Confidence 9999999999999975543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0037 Score=53.93 Aligned_cols=69 Identities=16% Similarity=0.158 Sum_probs=44.9
Q ss_pred EeeeccccCcEEEEEEEcC-CCeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeeccc
Q 020467 24 LECVGSGAYSDVYKGRRLS-DNLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT 97 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~ 97 (326)
.+.|..|-...+|++.... .++.+++|..... ....+|..++..+..+...++++..+ . -.++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-~----~~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-Q----NGLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-C----CcEEEEeeCC
Confidence 4566777788999886432 2567888977542 22347888888886454455665433 2 2479999875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0077 Score=56.15 Aligned_cols=71 Identities=27% Similarity=0.262 Sum_probs=49.3
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEcc------------chhhHHHHHHHHHHHhcC--CCeeEEeEEEEecCCceE
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVH------------DYQSAFREIEALQILQNS--PNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~------------~~~~~~~E~~~l~~l~~h--~ni~~l~~~~~~~~~~~~ 89 (326)
.+.||.|....||++.....++.++||.-. .......|.+.|..+..+ .++++++.+ +....+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~---D~~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY---DEELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE---CCCCCE
Confidence 467899999999999876444679999732 123356677777776433 356777665 334578
Q ss_pred EEeeeccc
Q 020467 90 LVLEFLRT 97 (326)
Q Consensus 90 lv~e~~~~ 97 (326)
++||+++.
T Consensus 108 lVME~L~~ 115 (401)
T PRK09550 108 TVMEDLSD 115 (401)
T ss_pred EEEecCCC
Confidence 99999863
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.013 Score=49.33 Aligned_cols=125 Identities=22% Similarity=0.304 Sum_probs=80.9
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc---------------------hhhHHHHHHHHHHHh-----cCCCeeEEe
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD---------------------YQSAFREIEALQILQ-----NSPNVVVLH 78 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---------------------~~~~~~E~~~l~~l~-----~h~ni~~l~ 78 (326)
..||+|+.=.||.- +.+ ....||+... .....+|+..+..+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--CCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46889988888863 322 2345666532 345567777666663 267899999
Q ss_pred EEEEecCCceEEEeeecc---c----CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 020467 79 EYFWREDEDAVLVLEFLR---T----DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGN 151 (326)
Q Consensus 79 ~~~~~~~~~~~lv~e~~~---~----~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~N 151 (326)
++.. ..-..-+++|.+. | +|.+++.... ++. . +...+-.-..+|-+.+|+.+|++|.|
T Consensus 84 G~ve-T~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~N 148 (199)
T PF10707_consen 84 GFVE-TNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHN 148 (199)
T ss_pred EEEe-cCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-H---HHHHHHHHHHHHHHcCCeecCCCccc
Confidence 9984 4445677777754 2 6666664322 444 2 23334444568889999999999999
Q ss_pred eEEcCCC----cEEEEe-ecc
Q 020467 152 LLIGDDG----VLKLAD-FGQ 167 (326)
Q Consensus 152 ili~~~~----~~~l~D-fg~ 167 (326)
|++...+ .+.|+| ||.
T Consensus 149 Iv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEEEecCCCceEEEEEeCCCC
Confidence 9997533 467776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.27 E-value=5.8e-05 Score=72.31 Aligned_cols=141 Identities=23% Similarity=0.199 Sum_probs=87.0
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCC-eeEEeEEEEecCCceEEEee
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPN-VVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~n-i~~l~~~~~~~~~~~~lv~e 93 (326)
.+...-+....-+++++++.+++.+...+...+ .+.+.......-++++|.++ +||| .+..++-+ +.....++.++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~l~~rl~~eLLdK~-n~P~~~v~~~~d~-~~E~~~~i~~~ 314 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQTLSRRLAIELLDKV-NNPNPVVRYLEDY-DGEDYLWIPMR 314 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccchhhHHHHHHHHHc-cCCCCcccccccC-Ccccccchhhh
Confidence 344555666667788999999998775554443 66666566677788999999 6999 33333322 33346788888
Q ss_pred ecccC--HHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLRTD--LATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~~--L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+..+. ......... ..+..-+...+++.=..+++++|+.--+|+| ||+..+ +..+..+|+....+
T Consensus 315 i~s~~rs~~~~~~~se--------~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSE--------IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhcCCccccccCChhh--------HhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc
Confidence 87643 111110000 0033333444556667788899988777887 555543 56777777765544
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0029 Score=54.75 Aligned_cols=32 Identities=38% Similarity=0.577 Sum_probs=26.7
Q ss_pred CCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 140 ~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.+++|+|+.+.|++++.++..-++||+.+..-
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 35899999999999987766679999987653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0021 Score=56.29 Aligned_cols=137 Identities=19% Similarity=0.172 Sum_probs=73.3
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccch-----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecccCHHH
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDY-----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLAT 101 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~~L~~ 101 (326)
+..|-...+|+.. .++..+++|..... ....+|..+++.+..+.-.++++... . -+++++|++|....
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---E--HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---C--CEEEEEeccCcccc
Confidence 4457777888876 34567888876432 23467888888886443334444432 1 36889998862211
Q ss_pred -----------HHHHh-hhhhhhc-CCCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceeccCCCC
Q 020467 102 -----------VIAES-KKKREDR-GDRGISVG-EIKRWMVQI---------LSGVDACHR--------NTIVHRDLKPG 150 (326)
Q Consensus 102 -----------~l~~~-~~~~~~~-~~~~l~~~-~~~~i~~ql---------~~aL~~LH~--------~~iiH~dlkp~ 150 (326)
.+... ....... ....+... .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 11110 0000000 00111111 111211111 111121211 25899999999
Q ss_pred CeEEcCCCcEEEEeecccccc
Q 020467 151 NLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 151 Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+++.++ +.++||..+...
T Consensus 157 Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred cEEEeCCC-CEEEeccccCcC
Confidence 99999876 789999987654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.01 Score=53.34 Aligned_cols=76 Identities=21% Similarity=0.184 Sum_probs=53.7
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcC--CCeeEEeEEEEec--CCceEEEe
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNS--PNVVVLHEYFWRE--DEDAVLVL 92 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h--~ni~~l~~~~~~~--~~~~~lv~ 92 (326)
...-.+.|+.|..+.||..... ++ .+++|..+. ...+..|.+.++.+..+ -.++++++.+... .+..+++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3444678999999999998542 23 356676544 24678999999998654 3678888776322 34589999
Q ss_pred eeccc
Q 020467 93 EFLRT 97 (326)
Q Consensus 93 e~~~~ 97 (326)
|++++
T Consensus 93 E~i~G 97 (297)
T PRK10593 93 ERLRG 97 (297)
T ss_pred eccCC
Confidence 99885
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0055 Score=54.86 Aligned_cols=145 Identities=16% Similarity=0.075 Sum_probs=77.6
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcCC-CeeEEeEE-----EEecCCceEEEeeec
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNSP-NVVVLHEY-----FWREDEDAVLVLEFL 95 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h~-ni~~l~~~-----~~~~~~~~~lv~e~~ 95 (326)
.+.|..|....+|+... .+..+++|.... ......|++++..+..+. .++.++.. +....+..+++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 55666777778998754 234688898763 334566788887775332 23444331 112233568899998
Q ss_pred ccCHH-----HHHHHhh-------hhhhhcCC-----CCCCHHH--HH--------HHHHHHHHHHHHHHh-------CC
Q 020467 96 RTDLA-----TVIAESK-------KKREDRGD-----RGISVGE--IK--------RWMVQILSGVDACHR-------NT 141 (326)
Q Consensus 96 ~~~L~-----~~l~~~~-------~~~~~~~~-----~~l~~~~--~~--------~i~~ql~~aL~~LH~-------~~ 141 (326)
+|... ....... ........ ....... .. .....+..++.++.. .+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 75221 0111000 00000000 0000000 00 011112233444432 47
Q ss_pred ceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 142 IVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 142 iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
++|+|+.|.|++++.++.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999887778999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.013 Score=52.59 Aligned_cols=68 Identities=19% Similarity=0.131 Sum_probs=42.9
Q ss_pred eeeccccCcEEEEEEEcC------CCeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 25 ECVGSGAYSDVYKGRRLS------DNLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~------~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
+.|..|-...+|++.... .++.+++|..... ....+|.+++..+..+.-.++++..+ .. .++++|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF-PN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe-CC----Cchhhe
Confidence 455556666888886432 2577889987642 34578888888886544445555554 21 356788
Q ss_pred ccc
Q 020467 95 LRT 97 (326)
Q Consensus 95 ~~~ 97 (326)
+.|
T Consensus 79 i~G 81 (302)
T cd05156 79 IPS 81 (302)
T ss_pred eCC
Confidence 764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.017 Score=52.94 Aligned_cols=68 Identities=25% Similarity=0.184 Sum_probs=43.8
Q ss_pred eeccccCcEEEEEEEcCCCeEEEEEEcc------------chhhHHHHHHHHHHHhcC-C-CeeEEeEEEEecCCceEEE
Q 020467 26 CVGSGAYSDVYKGRRLSDNLIVALKEVH------------DYQSAFREIEALQILQNS-P-NVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 26 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~------------~~~~~~~E~~~l~~l~~h-~-ni~~l~~~~~~~~~~~~lv 91 (326)
.||.|....||++.....++.++||.-. ...+..-|...|+..... | .+++++. .+.....++
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~---~D~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH---FDTEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE---Eccccceeh
Confidence 4788999999999875444678998542 123345677777665322 2 3555554 345556789
Q ss_pred eeecc
Q 020467 92 LEFLR 96 (326)
Q Consensus 92 ~e~~~ 96 (326)
||+++
T Consensus 79 MEdL~ 83 (370)
T TIGR01767 79 MEDLS 83 (370)
T ss_pred HhhCc
Confidence 99885
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0079 Score=54.78 Aligned_cols=133 Identities=26% Similarity=0.310 Sum_probs=86.3
Q ss_pred EEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------------------------------hhhHHHHHHHHHHHhcC
Q 020467 23 ILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------------------------------YQSAFREIEALQILQNS 71 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------------------------------~~~~~~E~~~l~~l~~h 71 (326)
+-..|..|--.-||.|.. .+|..+|||+++. ......|++-|.++. .
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-N 225 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-h
Confidence 345677888889999874 4677799998741 011235666677773 3
Q ss_pred CCeeEEeEEEEecCCceEEEeeecccCHH--HHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCC
Q 020467 72 PNVVVLHEYFWREDEDAVLVLEFLRTDLA--TVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH-RNTIVHRDLK 148 (326)
Q Consensus 72 ~ni~~l~~~~~~~~~~~~lv~e~~~~~L~--~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH-~~~iiH~dlk 148 (326)
..|+ +..... -....|||++++.+-+ -.+.. -.++...+..+-.+++.-+.-|. ..++||.||+
T Consensus 226 aGIP-~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd----------~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLS 292 (520)
T KOG2270|consen 226 AGIP-CPEPIL--LKNHVLVMEFLGRDGWAAPKLKD----------ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLS 292 (520)
T ss_pred cCCC-CCCcee--eecceEeeeeccCCCCcCccccc----------ccCChHHHHHHHHHHHHHHHHHHHHhceeccchh
Confidence 3432 111110 1246899999984211 11111 11666677778788877777776 5699999999
Q ss_pred CCCeEEcCCCcEEEEeecccccc
Q 020467 149 PGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 149 p~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
--|+|+ .+|.+.++|.+-+...
T Consensus 293 EfN~Ly-hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 293 EFNLLY-HDGKLYIIDVSQSVEH 314 (520)
T ss_pred hhhheE-ECCEEEEEEccccccC
Confidence 999988 4678999998876543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.043 Score=49.45 Aligned_cols=145 Identities=17% Similarity=0.062 Sum_probs=76.1
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCC-CeeEEeEEE-----EecCCceEEEeee
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSP-NVVVLHEYF-----WREDEDAVLVLEF 94 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~-ni~~l~~~~-----~~~~~~~~lv~e~ 94 (326)
++.++.|....+|.+.. .++ .+++|..+. ......|.+++..+..+. .++.++... ....+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 55666676678998754 233 577887754 244556777777774221 233433311 1112346889999
Q ss_pred cccCH-----HHHHHHhh-------hhhhhc-CCCC--CC-HH--H--HH----------HHHHHHHHHHHHHH------
Q 020467 95 LRTDL-----ATVIAESK-------KKREDR-GDRG--IS-VG--E--IK----------RWMVQILSGVDACH------ 138 (326)
Q Consensus 95 ~~~~L-----~~~l~~~~-------~~~~~~-~~~~--l~-~~--~--~~----------~i~~ql~~aL~~LH------ 138 (326)
++|.- .......+ ...... .... .. .. . .. .....+...+.++.
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 87521 11111000 000000 0000 00 00 0 00 00111233444443
Q ss_pred -hCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 139 -RNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 139 -~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
..+++|+|+.+.|++++.++...++||+.+..
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 25899999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.091 Score=47.53 Aligned_cols=31 Identities=29% Similarity=0.338 Sum_probs=26.5
Q ss_pred CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 140 ~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
.+++|+|+.|.||+++.+...-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999999766668999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.057 Score=50.42 Aligned_cols=70 Identities=20% Similarity=0.205 Sum_probs=46.8
Q ss_pred EEeeeccccCcEEEEEEEcCCCeEEEEEEcc------------chhhHHHHHHHHHHHhc--CCCeeEEeEEEEecCCce
Q 020467 23 ILECVGSGAYSDVYKGRRLSDNLIVALKEVH------------DYQSAFREIEALQILQN--SPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~------------~~~~~~~E~~~l~~l~~--h~ni~~l~~~~~~~~~~~ 88 (326)
-.+.||.|....||+..+. +..++||.-. ...+...|...|+.+.. ...+++++.++ . ...
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-e--d~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-R--TMA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-C--CCC
Confidence 3678899999999998763 3468888653 23344556666665532 14677887766 2 346
Q ss_pred EEEeeeccc
Q 020467 89 VLVLEFLRT 97 (326)
Q Consensus 89 ~lv~e~~~~ 97 (326)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999854
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.073 Score=48.89 Aligned_cols=143 Identities=15% Similarity=0.191 Sum_probs=77.2
Q ss_pred EeeeccccCcEEEEEEEcC----CCeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 24 LECVGSGAYSDVYKGRRLS----DNLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~----~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
.+.|..|-.-.+|++.... .++.+++|..... -...+|..+++.+..+.--+++++.+ ..+ .+.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-PNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-CCc----eEEEee
Confidence 4455557778899986432 2467889987532 12357888888886555555666655 222 467777
Q ss_pred cc-CHHH----------HHHHh-hhhhhhcCC-C--CCCHHHHHHHHHHH-----------------HHHHHHH----H-
Q 020467 96 RT-DLAT----------VIAES-KKKREDRGD-R--GISVGEIKRWMVQI-----------------LSGVDAC----H- 138 (326)
Q Consensus 96 ~~-~L~~----------~l~~~-~~~~~~~~~-~--~l~~~~~~~i~~ql-----------------~~aL~~L----H- 138 (326)
.+ ++.. .+... ...-..... . ......+..+..++ ...+..| .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 64 2210 11000 000000000 0 01112222222111 1111112 1
Q ss_pred ---hCCceeccCCCCCeEEcC-CCcEEEEeecccccc
Q 020467 139 ---RNTIVHRDLKPGNLLIGD-DGVLKLADFGQARIL 171 (326)
Q Consensus 139 ---~~~iiH~dlkp~Nili~~-~~~~~l~Dfg~~~~~ 171 (326)
...++|+|+++.|||++. ++.+.++||..+...
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 236899999999999986 468999999988654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.031 Score=51.89 Aligned_cols=70 Identities=20% Similarity=0.190 Sum_probs=46.2
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEcc-----------chhhHHHHHHHHHHHhc-CC-CeeEEeEEEEecCCceEE
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVH-----------DYQSAFREIEALQILQN-SP-NVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----------~~~~~~~E~~~l~~l~~-h~-ni~~l~~~~~~~~~~~~l 90 (326)
.+.||.|.-..||++.+...++.++||.-- ...+..-|.+.|+.... .| .+++++. .+.....+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~---~D~e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL---FDSVMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE---ECcHHhhH
Confidence 678899999999999874335678888532 13345667777776542 22 4566654 33445678
Q ss_pred Eeeecc
Q 020467 91 VLEFLR 96 (326)
Q Consensus 91 v~e~~~ 96 (326)
+||+++
T Consensus 111 vMEdL~ 116 (409)
T PRK12396 111 VMEDLS 116 (409)
T ss_pred HHHhCc
Confidence 888875
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.066 Score=48.88 Aligned_cols=30 Identities=33% Similarity=0.610 Sum_probs=26.2
Q ss_pred ceeccCCCCCeEEcC-CCcEEEEeecccccc
Q 020467 142 IVHRDLKPGNLLIGD-DGVLKLADFGQARIL 171 (326)
Q Consensus 142 iiH~dlkp~Nili~~-~~~~~l~Dfg~~~~~ 171 (326)
++|.|+.+.|||+++ ++.++++||..+...
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 789999999999975 568999999988654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.059 Score=48.64 Aligned_cols=32 Identities=31% Similarity=0.468 Sum_probs=28.6
Q ss_pred CceeccCCCCCeEEcCCCcEEEEeeccccccc
Q 020467 141 TIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172 (326)
Q Consensus 141 ~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 172 (326)
.++|||+.+.|++|+..+-+-++||+++..-.
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 59999999999999998889999999987653
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.42 Score=44.52 Aligned_cols=69 Identities=12% Similarity=0.164 Sum_probs=43.9
Q ss_pred EeeeccccCcEEEEEEEcCCC------eEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 24 LECVGSGAYSDVYKGRRLSDN------LIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~------~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.+.|..|-...+|++...... +.|.++.... .-...+|.++++.+..+..-+++++.+ . .+++.+
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f-~----~g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF-G----DFTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec-C----CEEEEE
Confidence 445555778889998643321 2245554322 122357888998887666777887776 2 368899
Q ss_pred eccc
Q 020467 94 FLRT 97 (326)
Q Consensus 94 ~~~~ 97 (326)
|++|
T Consensus 130 fIeG 133 (383)
T PTZ00384 130 WVEG 133 (383)
T ss_pred Eecc
Confidence 9885
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.2 Score=44.75 Aligned_cols=74 Identities=27% Similarity=0.286 Sum_probs=45.7
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHh--cCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQ--NSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
.+-.+.++.|....+|+.. .+++.+.+|.-.. ...+..|.+-|+.+. ..-.+++++.+. ...+..++++||++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G-~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWG-EYDDDAFLLLEFLE 95 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEE-E-SSCCEEEEE---
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEE-eecCCceEEEEeec
Confidence 4456678888889999876 5677888997763 345778888888883 234577888876 33455799999986
Q ss_pred c
Q 020467 97 T 97 (326)
Q Consensus 97 ~ 97 (326)
.
T Consensus 96 ~ 96 (288)
T PF03881_consen 96 M 96 (288)
T ss_dssp -
T ss_pred C
Confidence 3
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.073 Score=48.64 Aligned_cols=75 Identities=23% Similarity=0.271 Sum_probs=54.7
Q ss_pred ecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEE
Q 020467 83 REDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 83 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~ 161 (326)
.+....|++|++.++.+.-. +. ....+...++.+.+..+.-+... .+-||++.-.||+|+ .|++.
T Consensus 296 de~~y~yl~~kdhgt~is~i-k~------------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gnvt 361 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII-KA------------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVT 361 (488)
T ss_pred CCceEEEEEEecCCceeeee-ec------------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceE
Confidence 34445788888887655311 11 34556677777777766666644 688999999999999 99999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+||.+++..
T Consensus 362 LIDfklsRl~ 371 (488)
T COG5072 362 LIDFKLSRLS 371 (488)
T ss_pred EEEeeeeecc
Confidence 9999999843
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.37 E-value=1.3 Score=39.38 Aligned_cols=31 Identities=39% Similarity=0.712 Sum_probs=25.9
Q ss_pred CceeccCCCCCeEEcCCCc-EEEEeecccccc
Q 020467 141 TIVHRDLKPGNLLIGDDGV-LKLADFGQARIL 171 (326)
Q Consensus 141 ~iiH~dlkp~Nili~~~~~-~~l~Dfg~~~~~ 171 (326)
.++|+|++|.||+++.++. .-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997554 569999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.15 Score=45.81 Aligned_cols=30 Identities=27% Similarity=0.424 Sum_probs=26.0
Q ss_pred CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 140 ~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
.+++|+|+.+.|++++. +.+.++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.39 E-value=4.7 Score=38.43 Aligned_cols=70 Identities=13% Similarity=0.060 Sum_probs=43.2
Q ss_pred EEeeeccccCcEEEEEEEcC--------CCeEEEEEEccchh----hHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 23 ILECVGSGAYSDVYKGRRLS--------DNLIVALKEVHDYQ----SAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~--------~~~~vaiK~~~~~~----~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
-++.|..|-.-.+|++.... .++.|++|+..... ....|..+++.+..+.--+++++.+ . -+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-~----gg~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-S----GGR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-C----CCE
Confidence 45566556677788886432 14678888875322 3456788888876444445666654 2 245
Q ss_pred Eeeeccc
Q 020467 91 VLEFLRT 97 (326)
Q Consensus 91 v~e~~~~ 97 (326)
+.+|+.+
T Consensus 184 I~efi~g 190 (442)
T PTZ00296 184 IEEWLYG 190 (442)
T ss_pred EEEeeCC
Confidence 6788774
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.71 E-value=0.81 Score=42.72 Aligned_cols=60 Identities=23% Similarity=0.260 Sum_probs=39.5
Q ss_pred eEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEcCC
Q 020467 88 AVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH-RNTIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 88 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH-~~~iiH~dlkp~Nili~~~ 157 (326)
..++.+|..| ++..++.... .++.....++.-.+.||--+- -.+++|.|+.|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~----------~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS----------QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc----------ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4566667765 6665655432 444455566666666665444 4589999999999999643
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.63 E-value=0.34 Score=42.85 Aligned_cols=46 Identities=30% Similarity=0.499 Sum_probs=34.8
Q ss_pred HHHHHHHHHHHHHhC--CceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 126 WMVQILSGVDACHRN--TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 126 i~~ql~~aL~~LH~~--~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.+..+-.++.-.+.. -++|+|+.|+|++.++.+.++|+||..+...
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 344444444444433 5899999999999999999999999987654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=91.42 E-value=0.025 Score=60.17 Aligned_cols=99 Identities=14% Similarity=0.048 Sum_probs=61.4
Q ss_pred HHHHHhcCCCeeEEeEEEEe-cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHH-HHHHHHHHhC
Q 020467 64 ALQILQNSPNVVVLHEYFWR-EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQI-LSGVDACHRN 140 (326)
Q Consensus 64 ~l~~l~~h~ni~~l~~~~~~-~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql-~~aL~~LH~~ 140 (326)
.++.. .|+++...+.-... ....-+..++|.. |.+++.+.+....... +.. ......+++ +....-+|+.
T Consensus 1282 e~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~-----ld~-~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1282 ELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPD-----LDR-SPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCc-----chh-chHHHHHHHHHhccchhhhc
Confidence 33334 47777665543311 1123466677765 6777777665433211 222 233334444 6666666643
Q ss_pred -----CceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 141 -----TIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 141 -----~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
-.+|+++++-|.+|..+-.+++.++|+.+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdK 1388 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDK 1388 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCccccccccccc
Confidence 37899999999999999999999999987
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.08 E-value=0.2 Score=41.62 Aligned_cols=30 Identities=33% Similarity=0.463 Sum_probs=26.0
Q ss_pred CceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 141 TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 141 ~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
-.+|+|+.|.|+++..++ ++++||+.+...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 478999999999998777 889999988654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=90.49 E-value=0.43 Score=43.00 Aligned_cols=30 Identities=20% Similarity=0.298 Sum_probs=27.5
Q ss_pred CceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 141 TIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 141 ~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+++|+|+.+.|++++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=90.33 E-value=0.38 Score=50.14 Aligned_cols=102 Identities=18% Similarity=0.269 Sum_probs=59.7
Q ss_pred HHHHHHHHHhcCCCeeEEeEEEEecCCce---EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 020467 60 REIEALQILQNSPNVVVLHEYFWREDEDA---VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135 (326)
Q Consensus 60 ~E~~~l~~l~~h~ni~~l~~~~~~~~~~~---~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~ 135 (326)
-|...+..+ .|+|+..++.+-.+..... .+..+++. .++...+... ..++....+.+..+..++|.
T Consensus 231 ~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---------~~i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 231 IELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---------GSIPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---------cccCHHHHHHHHHHHhhhHH
Confidence 445567777 5999998887753322111 12233333 2444444332 23888899999999999999
Q ss_pred HHHhCCceeccCCCC---CeEEcCCCcEEEE--eecccccc
Q 020467 136 ACHRNTIVHRDLKPG---NLLIGDDGVLKLA--DFGQARIL 171 (326)
Q Consensus 136 ~LH~~~iiH~dlkp~---Nili~~~~~~~l~--Dfg~~~~~ 171 (326)
++|+....|.-+... +.-++..+.+.+. ||+....+
T Consensus 301 ~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l 341 (1351)
T KOG1035|consen 301 YLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPL 341 (1351)
T ss_pred HHHHhccceeEEecccccccccCccceeecchhhhcccccC
Confidence 999885555444333 2223333444444 66655544
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=90.16 E-value=0.16 Score=42.92 Aligned_cols=31 Identities=48% Similarity=0.763 Sum_probs=21.9
Q ss_pred CceeccCCCCCeEE-cCCCcEEEEeecccccc
Q 020467 141 TIVHRDLKPGNLLI-GDDGVLKLADFGQARIL 171 (326)
Q Consensus 141 ~iiH~dlkp~Nili-~~~~~~~l~Dfg~~~~~ 171 (326)
.++|+|+.+.||++ +.++.++++||..+...
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n 175 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGYN 175 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EEE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhhc
Confidence 58899999999999 78899999999987643
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=90.15 E-value=0.73 Score=38.56 Aligned_cols=32 Identities=28% Similarity=0.356 Sum_probs=26.9
Q ss_pred CCceeccCCCCCeEEcCCC-----cEEEEeecccccc
Q 020467 140 NTIVHRDLKPGNLLIGDDG-----VLKLADFGQARIL 171 (326)
Q Consensus 140 ~~iiH~dlkp~Nili~~~~-----~~~l~Dfg~~~~~ 171 (326)
..++|||+.+.|+++..++ .+.++||..+...
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g 156 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYG 156 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCcC
Confidence 4689999999999998653 6899999988754
|
subfamily of choline kinases |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=89.06 E-value=1 Score=41.01 Aligned_cols=80 Identities=23% Similarity=0.226 Sum_probs=44.8
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCceeccCCCCCeEEcCCC-----
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH----RNTIVHRDLKPGNLLIGDDG----- 158 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH----~~~iiH~dlkp~Nili~~~~----- 158 (326)
..+++++...+..+.-...... .+-..-.+-+..++.||+.-.--+. -..++|-||||.||||-+..
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e----~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I 321 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAE----LGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRI 321 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHh----cCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEE
Confidence 4677777665433322211110 0111223445666777655432232 24699999999999995432
Q ss_pred -------------cEEEEeecccccc
Q 020467 159 -------------VLKLADFGQARIL 171 (326)
Q Consensus 159 -------------~~~l~Dfg~~~~~ 171 (326)
.++|-||.++++.
T Consensus 322 ~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 322 KFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred EECCeEEEecccceeeecccCHHHhc
Confidence 3567788887654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 326 | ||||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-21 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-21 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-20 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 4e-08 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 5e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 8e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 5e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 6e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 7e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 9e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 9e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-04 |
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 57/157 (36%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
++ +E +G G Y VYK R +VALK++ +A REI L+ L + P
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-P 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L + + LV EFL DL + + GI + IK ++ Q+L
Sbjct: 63 NIVKLLDVI-HTENKLYLVFEFLHQDLKKFM-------DASALTGIPLPLIKSYLFQLLQ 114
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
G+ CH + ++HRDLKP NLLI +G +KLADFG AR
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-46
Identities = 58/160 (36%), Positives = 92/160 (57%), Gaps = 20/160 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQ---------SAFREIEALQILQ 69
+YE L+ +G G ++ VYK R + N IVA+K++ ++ +A REI+ LQ L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
+ PN++ L + F + LV +F+ TDL +I ++ IK +M+
Sbjct: 71 H-PNIIGLLDAFG-HKSNISLVFDFMETDLEVII--------KDNSLVLTPSHIKAYMLM 120
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
L G++ H++ I+HRDLKP NLL+ ++GVLKLADFG A+
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 18/31 (58%), Positives = 24/31 (77%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
A T V TRW+RAPELL+G+ YG+ VD+W+
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWA 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 6e-46
Identities = 56/159 (35%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
KYE + +G G+Y V+K R IVA+K+ + + A REI L+ L++ P
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-P 62
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L E F R LV E+ + + DR RG+ +K Q L
Sbjct: 63 NLVNLLEVF-RRKRRLHLVFEYCDHTVLHEL--------DRYQRGVPEHLVKSITWQTLQ 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
V+ CH++ +HRD+KP N+LI V+KL DFG AR+L
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 16/32 (50%), Positives = 21/32 (65%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
V TRW+R+PELL G T YG VD+W++
Sbjct: 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAI 189
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQ-----SAFREIEALQILQNSPN 73
+++ LE +G+G Y+ VYKG + + VALKEV D + +A REI ++ L++ N
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-EN 64
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V L++ + LV EF+ DL + + RG+ + +K + Q+L G
Sbjct: 65 IVRLYDVI-HTENKLTLVFEFMDNDLKKYM---DSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ CH N I+HRDLKP NLLI G LKL DFG AR
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 14/31 (45%), Positives = 21/31 (67%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
+S V T W+RAP++L GS +Y +D+WS
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWS 194
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 154 bits (393), Expect = 3e-45
Identities = 60/157 (38%), Positives = 81/157 (51%), Gaps = 17/157 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
KYE LE +G G Y V+K + + IVALK V SA REI L+ L++
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-K 61
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V LH+ D+ LV EF DL D + + +K ++ Q+L
Sbjct: 62 NIVRLHDVL-HSDKKLTLVFEFCDQDLKKYF--------DSCNGDLDPEIVKSFLFQLLK 112
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
G+ CH ++HRDLKP NLLI +G LKLA+FG AR
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 1e-08
Identities = 11/32 (34%), Positives = 20/32 (62%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
++ V T W+R P++L+G+ Y +D+WS
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-45
Identities = 61/166 (36%), Positives = 76/166 (45%), Gaps = 23/166 (13%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQ---------SAFREIEALQILQ 69
+YE + +G GAY VYK R VALK V S RE+ L+ L+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 70 NS--PNVVVLHEYFWREDEDA----VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
PNVV L + D LV E + DL T + + G+ I
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL-------DKAPPPGLPAETI 122
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
K M Q L G+D H N IVHRDLKP N+L+ G +KLADFG AR
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 17/31 (54%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
LT V T W+RAPE+L ST Y VD+WS+
Sbjct: 176 LTPVVVTLWYRAPEVLLQST-YATPVDMWSV 205
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-45
Identities = 58/156 (37%), Positives = 89/156 (57%), Gaps = 16/156 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQ-----SAFREIEALQILQNSPN 73
Y L+ +G G Y+ VYKG+ + +VALKE+ +++ +A RE+ L+ L++ N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-AN 61
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+V LH+ ++ LV E+L DL + D I++ +K ++ Q+L G
Sbjct: 62 IVTLHDII-HTEKSLTLVFEYLDKDLKQYL--------DDCGNIINMHNVKLFLFQLLRG 112
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ CHR ++HRDLKP NLLI + G LKLADFG AR
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 12/31 (38%), Positives = 19/31 (61%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
+ V T W+R P++L GST Y ++D+W
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWG 186
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-45
Identities = 53/159 (33%), Positives = 84/159 (52%), Gaps = 17/159 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
KYE L VG G+Y V K R IVA+K+ + A REI+ L+ L++
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-E 84
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L E ++ + LV EF+ + + + G+ +++++ QI++
Sbjct: 85 NLVNLLEVC-KKKKRWYLVFEFVDHTILDDL--------ELFPNGLDYQVVQKYLFQIIN 135
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+ CH + I+HRD+KP N+L+ GV+KL DFG AR L
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 7e-09
Identities = 16/32 (50%), Positives = 20/32 (62%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
V TRW+RAPELL G YG VD+W++
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAI 211
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-44
Identities = 67/178 (37%), Positives = 88/178 (49%), Gaps = 20/178 (11%)
Query: 1 MEQPLPKSWSIHTRPE--IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-- 56
M S ++ KY+ LE VG G Y VYK + IVALK +
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAED 59
Query: 57 -----SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKRE 111
+A REI L+ L + PN+V L + + LV EF+ DL V+
Sbjct: 60 EGIPSTAIREISLLKELHH-PNIVSLIDVIH-SERCLTLVFEFMEKDLKKVL-------- 109
Query: 112 DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
D G+ +IK ++ Q+L GV CH++ I+HRDLKP NLLI DG LKLADFG AR
Sbjct: 110 DENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 15/31 (48%), Positives = 20/31 (64%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
+ T V T W+RAP++L GS Y VD+WS
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-43
Identities = 57/166 (34%), Positives = 78/166 (46%), Gaps = 21/166 (12%)
Query: 18 IAKYEILECVGSGAYSDVYKGR-RLSDNLIVALKEVHDYQ-------SAFREIEALQILQ 69
+YE + +G GAY V+K R + VALK V S RE+ L+ L+
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 70 NS--PNVV----VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
PNVV V + LV E + DL T + + + G+ I
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL-------DKVPEPGVPTETI 122
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
K M Q+L G+D H + +VHRDLKP N+L+ G +KLADFG AR
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 18/31 (58%), Positives = 22/31 (70%), Gaps = 1/31 (3%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
LTS V T W+RAPE+L S+ Y VDLWS+
Sbjct: 176 LTSVVVTLWYRAPEVLLQSS-YATPVDLWSV 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 149 bits (380), Expect = 2e-43
Identities = 55/157 (35%), Positives = 82/157 (52%), Gaps = 18/157 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
KY LE +G G Y VYK + ALK++ + + REI L+ L++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKH-S 60
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L++ + VLV E L DL ++ D + G+ K +++Q+L+
Sbjct: 61 NIVKLYDVIH-TKKRLVLVFEHLDQDLKKLL--------DVCEGGLESVTAKSFLLQLLN 111
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
G+ CH ++HRDLKP NLLI +G LK+ADFG AR
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 13/31 (41%), Positives = 19/31 (61%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
T + T W+RAP++L GS Y +D+WS
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-42
Identities = 62/166 (37%), Positives = 86/166 (51%), Gaps = 23/166 (13%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQN 70
++KYE L +G G + +V+K R VALK+V +A REI+ LQ+L++
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 71 SPNVVVLHEYFWREDEDAV-------LVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
NVV L E + LV +F DLA ++ ++ EI
Sbjct: 76 -ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL--------SNVLVKFTLSEI 126
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
KR M +L+G+ HRN I+HRD+K N+LI DGVLKLADFG AR
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 15/35 (42%), Positives = 19/35 (54%)
Query: 284 GRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
+ T+ V T W+R PELL G YG +DLW
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 214
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-42
Identities = 54/171 (31%), Positives = 86/171 (50%), Gaps = 20/171 (11%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQI 67
P YE+L +G+G+Y K RR SD I+ KE+ + Q E+ L+
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 68 LQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKR 125
L++ PN+V ++ + +V+E+ DLA+VI + K+R + + + R
Sbjct: 62 LKH-PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-----QYLDEEFVLR 115
Query: 126 WMVQILSGVDACHR-----NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
M Q+ + CHR +T++HRDLKP N+ + +KL DFG ARIL
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 55/169 (32%), Positives = 87/169 (51%), Gaps = 12/169 (7%)
Query: 13 TRPEIIAKYEILEC-VGSGAYSDVYKGRRLS--DNLIVALKEVHDY---QSAFREIEALQ 66
R + +E C VG G Y VYK +R D+ ALK++ SA REI L+
Sbjct: 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR 73
Query: 67 ILQNSPNVVVLHEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
L++ PNV+ L + F + V L+ ++ DL +I + + ++ + G +K
Sbjct: 74 ELKH-PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDD----GVLKLADFGQARI 170
+ QIL G+ H N ++HRDLKP N+L+ + G +K+AD G AR+
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 14/30 (46%), Positives = 19/30 (63%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
L V T W+RAPELL G+ Y +D+W+
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWA 221
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDYQSAFREIEALQILQNSPNV 74
Y ++ +G G +S V L D ALK + D + A RE + ++ N PN+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNI 88
Query: 75 VVLHEYFWREDED---AVLVLEF-LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
+ L Y RE A L+L F R L I ++ +D+G+ ++ +I ++ I
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI----ERLKDKGNF-LTEDQILWLLLGI 143
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G++A H HRDLKP N+L+GD+G L D G
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 41/176 (23%), Positives = 72/176 (40%), Gaps = 25/176 (14%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-HDYQSAFREIEALQILQNS 71
++ +E +GSG + V+K + D +K V ++ + A RE++AL L +
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKL-DH 63
Query: 72 PNVVVLHEYFWREDEDAV---------------LVLEFLRT-DLATVIAESKKKREDRGD 115
N+V + + D D + +EF L I + + ++
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK----- 118
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ QI GVD H +++RDLKP N+ + D +K+ DFG L
Sbjct: 119 --LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 37/160 (23%), Positives = 59/160 (36%), Gaps = 18/160 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSP 72
++ L +G G+Y +V+K R D + A+K D E+ + + + P
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKK-REDRGDRGISVGEIKRWMVQIL 131
V L + W E L E L E + + ++ L
Sbjct: 118 CCVRLEQ-AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQ---------VWGYLRDTL 167
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ H +VH D+KP N+ +G G KL DFG L
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-41
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQN 70
+ KY L+ +G G++ + D +KE++ + + + RE+ L +
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-K 81
Query: 71 SPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKR--EDRGDRGISVGEIKRWM 127
PN+V E F E+ +V+++ DL I K ED +I W
Sbjct: 82 HPNIVQYRESF-EENGSLYIVMDYCEGGDLFKRINAQKGVLFQED---------QILDWF 131
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
VQI + H I+HRD+K N+ + DG ++L DFG AR+L
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-41
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-------SAFREIEALQILQNSP 72
+Y + +G G Y +VYK N VA+K + +A RE+ L+ LQ+
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-R 93
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N++ L + L+ E+ DL + D+ +S+ IK ++ Q+++
Sbjct: 94 NIIELKSVI-HHNHRLHLIFEYAENDLKKYM--------DKN-PDVSMRVIKSFLYQLIN 143
Query: 133 GVDACHRNTIVHRDLKPGNLLI-----GDDGVLKLADFGQAR 169
GV+ CH +HRDLKP NLL+ + VLK+ DFG AR
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 14/31 (45%), Positives = 18/31 (58%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
T + T W+R PE+L GS Y VD+WS
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWS 223
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-------HDYQSAFREIEALQILQ-NS 71
Y IL+ +GSG S V++ I A+K V S EI L LQ +S
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
++ L++Y D+ +V+E DL + + + K E K + +L
Sbjct: 88 DKIIRLYDYEI-TDQYIYMVMECGNIDLNSWLKKKKSIDPW---------ERKSYWKNML 137
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
V H++ IVH DLKP N LI DG+LKL DFG A + +
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 180
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-------HDYQSAFREIEALQILQ-NS 71
Y IL+ +GSG S V++ I A+K V S EI L LQ +S
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
++ L++Y D+ +V+E DL + + + K E K + +L
Sbjct: 69 DKIIRLYDYEI-TDQYIYMVMECGNIDLNSWLKKKKSIDPW---------ERKSYWKNML 118
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
V H++ IVH DLKP N LI DG+LKL DFG A + +
Sbjct: 119 EAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 161
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQ 69
+A + I + +G G +S+VY+ L D + VALK+V +EI+ L+ L
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL- 89
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMV 128
N PNV+ + F ED + +VLE DL+ +I KK++ R I + ++ V
Sbjct: 90 NHPNVIKYYASF-IEDNELNIVLELADAGDLSRMIKHFKKQK-----RLIPERTVWKYFV 143
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
Q+ S ++ H ++HRD+KP N+ I GV+KL D G R
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 51/164 (31%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQ-NS 71
Y IL+ +GSG S V++ I A+K V+ S EI L LQ +S
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
++ L++Y D+ +V+E DL + + + K E K + +L
Sbjct: 116 DKIIRLYDYEI-TDQYIYMVMECGNIDLNSWLKKKKSIDPW---------ERKSYWKNML 165
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
V H++ IVH DLKP N LI DG+LKL DFG A + +
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 208
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 36/177 (20%), Positives = 69/177 (38%), Gaps = 25/177 (14%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV------HDYQSAFREIEALQILQNSPN 73
+E ++C+G G + V++ + D+ A+K + + RE++AL L P
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPG 64
Query: 74 VVVLHEYFWREDEDAV-----------LVLEFLRT-DLATVIAESKKKREDRGDRGISVG 121
+V + ++ + ++ R +L + E
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE------RERS 118
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDA 178
+QI V+ H ++HRDLKP N+ D V+K+ DFG + +E +
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 39/187 (20%), Positives = 68/187 (36%), Gaps = 26/187 (13%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV----HDYQSAFREIEALQILQNSPNVV 75
+E + +G GA+ V K R D+ A+K++ + E+ L L N VV
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVV 65
Query: 76 VLHEYFWREDEDAV------------LVLEFLRT-DLATVIAESKKKREDRGDRGISVGE 122
+ + + +E+ L +I ++ E
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ--------RDE 117
Query: 123 IKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGN 182
R QIL + H I+HRDLKP N+ I + +K+ DFG A+ + + +
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 183 SQPCEPN 189
+
Sbjct: 178 QNLPGSS 184
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 20/76 (26%), Positives = 32/76 (42%), Gaps = 8/76 (10%)
Query: 244 DKDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPEL 303
D+ +V GD F D+ K + LTS +GT + A E+
Sbjct: 150 DESRNVKIGD---FGLAKNVHRSLDILKLDSQNLPGSSDN-----LTSAIGTAMYVATEV 201
Query: 304 LYGSTSYGLEVDLWSL 319
L G+ Y ++D++SL
Sbjct: 202 LDGTGHYNEKIDMYSL 217
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDYQSAFREIEALQILQNSPNV 74
+ + + G ++ VY+ + + ALK + ++ +E+ ++ L PN+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 75 VVLHEYFWREDEDA-------VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWM 127
V E++ +L+ E + L + KK E RG +S + +
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL----KKMESRG--PLSCDTVLKIF 142
Query: 128 VQILSGVDACHRNT--IVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
Q V HR I+HRDLK NLL+ + G +KL DFG A +
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 13/171 (7%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEALQILQNS 71
Y + +G+G++ VY+ + +VA+K+V D + RE++ ++ L +
Sbjct: 48 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH- 106
Query: 72 PNVVVLHEYFW-----REDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
N+V L +F+ +++ LVL+++ + V + R + + V +K +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA-----RHYSRAKQTLPVIYVKLY 161
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLI-GDDGVLKLADFGQARILLGNEF 176
M Q+ + H I HRD+KP NLL+ D VLKL DFG A+ L+ E
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 13/31 (41%), Positives = 22/31 (70%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
S + +R++RAPEL++G+T Y +D+WS
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSA 243
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 54/172 (31%), Positives = 94/172 (54%), Gaps = 14/172 (8%)
Query: 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEALQILQN 70
T + Y + +G+G++ V++ + L ++ VA+K+V D + RE++ ++I+++
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAK-LVESDEVAIKKVLQDKRFKNRELQIMRIVKH 91
Query: 71 SPNVVVLHEYFW----REDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
PNVV L +F+ ++DE + LVLE++ + K ++ + + IK
Sbjct: 92 -PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT-----MPMLLIKL 145
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLI-GDDGVLKLADFGQARILLGNEF 176
+M Q+L + H I HRD+KP NLL+ GVLKL DFG A+IL+ E
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 13/30 (43%), Positives = 23/30 (76%)
Query: 290 TSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
S + +R++RAPEL++G+T+Y +D+WS
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWST 228
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 47/189 (24%), Positives = 76/189 (40%), Gaps = 27/189 (14%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVH 53
P + + P +Y +G G ++ ++ + A K + H
Sbjct: 24 APPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH 83
Query: 54 DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFL-RTDLATVIAESKKKRE 111
+ EI + L + +VV H +F ED D V +VLE R L + K E
Sbjct: 84 QREKMSMEISIHRSLAH-QHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTE 140
Query: 112 DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
E + ++ QI+ G HRN ++HRDLK GNL + +D +K+ DFG
Sbjct: 141 P---------EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG----- 186
Query: 172 LGNEFDAPD 180
L + +
Sbjct: 187 LATKVEYDG 195
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 19/178 (10%)
Query: 11 IHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEA 64
+ ++ + + + +G GA ++V++GR + A+K + RE E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 65 LQILQNSPNVVVLHEYFWREDEDA-VLVLEFLRT-DLATVIAESKKKREDRGDRGISVGE 122
L+ L N N+V L VL++EF L TV+ E G+ E
Sbjct: 61 LKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY------GLPESE 113
Query: 123 IKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG----DDGVLKLADFGQARILLGNEF 176
+ ++ G++ N IVHR++KPGN++ V KL DFG AR L +E
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 46/191 (24%), Positives = 78/191 (40%), Gaps = 39/191 (20%)
Query: 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV-------HDYQSAFREI 62
+ +R ++ LE +GSG + V+K + D I A+K D Q+A RE+
Sbjct: 4 GMKSRYTT--EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61
Query: 63 EALQILQNSPNVVVLHEYF--WREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGIS 119
A +L +VV YF W ED+ ++ E+ LA I+E+ +
Sbjct: 62 YAHAVLGQHSHVV---RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-----SYFK 113
Query: 120 VGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL------------------- 160
E+K ++Q+ G+ H ++VH D+KP N+ I +
Sbjct: 114 EAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 161 KLADFGQARIL 171
K+ D G +
Sbjct: 174 KIGDLGHVTRI 184
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-35
Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 27/186 (14%)
Query: 6 PKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQS 57
+ + P +Y +G G ++ ++ + A K + H +
Sbjct: 2 KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 61
Query: 58 AFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEF-LRTDLATVIAESKKKREDRGD 115
EI + L + +VV H +F ED D V +VLE R L + K E
Sbjct: 62 MSMEISIHRSLAH-QHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEP--- 115
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
E + ++ QI+ G HRN ++HRDLK GNL + +D +K+ DFG L +
Sbjct: 116 ------EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG-----LATK 164
Query: 176 FDAPDG 181
+
Sbjct: 165 VEYDGE 170
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 11 IHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEA 64
+ ++ + + + +G GA ++V++GR + A+K + RE E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 65 LQILQNSPNVVVLHEYFWREDEDA---VLVLEFLRT-DLATVIAESKKKREDRGDRGISV 120
L+ L N N+V L E+ VL++EF L TV+ E G+
Sbjct: 61 LKKL-NHKNIVKLFAIE--EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY------GLPE 111
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG----DDGVLKLADFGQARILLGNEF 176
E + ++ G++ N IVHR++KPGN++ V KL DFG AR L +E
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 17/174 (9%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQS-AFREIEALQILQ--NS 71
+ + ++++ G G + V G+ S + VA+K+V RE++ +Q L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH 78
Query: 72 PNVVVLHEYFW---REDEDAV---LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
PN+V L YF+ D + +V+E++ L + R IK
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCC-----RNYYRRQVAPPPILIKV 133
Query: 126 WMVQILSGVDACHRNT--IVHRDLKPGNLLI-GDDGVLKLADFGQARILLGNEF 176
++ Q++ + H + + HRD+KP N+L+ DG LKL DFG A+ L +E
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 12/32 (37%), Positives = 22/32 (68%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+ + +R++RAPEL++G+ Y VD+WS+
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 51/188 (27%), Positives = 78/188 (41%), Gaps = 29/188 (15%)
Query: 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----------EVHDYQSAFR 60
R A+Y + +G G + V+ G RL+D L VA+K + D +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 61 EIEALQILQNS---PNVVVLHEYFWREDEDA-VLVLEFLRT--DLATVIAESKKKREDRG 114
E+ L + P V+ L + W E ++ +LVLE DL I E E
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLD--WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-- 139
Query: 115 DRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI-GDDGVLKLADFGQARILLG 173
+ + Q+++ + CH +VHRD+K N+LI G KL DFG +L
Sbjct: 140 -------PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192
Query: 174 NEFDAPDG 181
+ DG
Sbjct: 193 EPYTDFDG 200
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--DYQSAFREIEALQILQNSPN 73
Y+++ +G G YS+V++ +++N V +K + + REI+ L+ L+ PN
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPN 92
Query: 74 VVVLHEYFWREDE-DAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
++ L + LV E + TD + + ++ +I+ +M +IL
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYEIL 140
Query: 132 SGVDACHRNTIVHRDLKPGNLLI-GDDGVLKLADFGQAR 169
+D CH I+HRD+KP N++I + L+L D+G A
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 12/31 (38%), Positives = 17/31 (54%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
V +R+F+ PELL Y +D+WSL
Sbjct: 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-32
Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQ 69
I +++ +G G+++ VY+ + L VA+K + Q E++ L+
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 70 NSPNVVVLHEYFWREDEDAV-LVLEFL-RTDLATVIAESKKK-REDRGDRGISVGEIKRW 126
+ P+++ L+ YF ED + V LVLE ++ + K E+ E + +
Sbjct: 70 H-PSILELYNYF--EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN---------EARHF 117
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDG 181
M QI++G+ H + I+HRDL NLL+ + +K+ADFG L + P
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG-----LATQLKMPHE 167
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 25/196 (12%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK---------- 50
+ K + + ++Y++ +GSG + VY G R+SDNL VA+K
Sbjct: 25 NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 84
Query: 51 -EVHDYQSAFREIEALQILQNS-PNVVVLHEYFWREDEDAVLVLEFLRT--DLATVIAES 106
E+ + E+ L+ + + V+ L ++F R D VL+LE DL I E
Sbjct: 85 GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD-SFVLILERPEPVQDLFDFITER 143
Query: 107 KKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI-GDDGVLKLADF 165
+E+ + + Q+L V CH ++HRD+K N+LI + G LKL DF
Sbjct: 144 GALQEE---------LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 166 GQARILLGNEFDAPDG 181
G +L + DG
Sbjct: 195 GSGALLKDTVYTDFDG 210
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 41/179 (22%), Positives = 75/179 (41%), Gaps = 22/179 (12%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQ 66
+ +E+ E +G+G + V + VA+K+ + + EI+ ++
Sbjct: 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 67 ILQNSPNVVVLHEYF-----WREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISV 120
L + PNVV E ++ +L +E+ DL + + + G+
Sbjct: 68 KLNH-PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN------CCGLKE 120
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNEF 176
G I+ + I S + H N I+HRDLKP N+++ + K+ D G A+ L E
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 21/211 (9%)
Query: 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DY 55
+P H+ +I +YEI +G+G+Y V + + +VA+K++ D
Sbjct: 37 KPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC 96
Query: 56 QSAFREIEALQILQNSPNVV----VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKRE 111
+ REI L L N +VV ++ + ++ +VLE +D +
Sbjct: 97 KRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF-------- 147
Query: 112 DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
R ++ IK + +L GV H I+HRDLKP N L+ D +K+ DFG AR +
Sbjct: 148 -RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 172 LGNEFDAPDGNSQPCEPNAPYQDNMSEAPQV 202
E P E +
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 16/59 (27%), Positives = 26/59 (44%)
Query: 261 TTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
S + + + + LT V TRW+RAPEL+ +Y +D+WS+
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 22/159 (13%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----EVHDYQSA---FREIEALQILQ 69
+ +EI +G G + +VY R I+ALK ++ RE+E L+
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 70 NSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWM 127
+ PN++ L+ YF D V L+LE+ + + + K E R ++
Sbjct: 68 H-PNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRT---------ATYI 115
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ + + CH ++HRD+KP NLL+G G LK+ADFG
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 29/176 (16%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----EVHDY 55
+ + + ++I ++I +G G + +VY R + I+ALK ++
Sbjct: 3 LAEMPKRKFTID-------DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE 55
Query: 56 QSA---FREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKR 110
REIE L++ PN++ ++ YF D + L+LEF +L + + +
Sbjct: 56 GVEHQLRREIEIQSHLRH-PNILRMYNYF--HDRKRIYLMLEFAPRGELYKELQKHGRFD 112
Query: 111 EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
E R +M ++ + CH ++HRD+KP NLL+G G LK+ADFG
Sbjct: 113 EQRS---------ATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 38/183 (20%), Positives = 66/183 (36%), Gaps = 21/183 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--DYQSAFREIEALQILQNSPNVVVL 77
+ +G G+ V VA+K + A EI+ L + PNV+
Sbjct: 16 LVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 78 HEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
+ + + + LE +L ++ K D + + QI SGV
Sbjct: 75 YCSE--TTDRFLYIALELCNLNLQDLVE--SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 137 CHRNTIVHRDLKPGNLLI-------------GDDGVLKLADFGQARILLGNEFDAPDGNS 183
H I+HRDLKP N+L+ ++ + ++DFG + L + +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 184 QPC 186
P
Sbjct: 191 NPS 193
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 27/181 (14%)
Query: 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK--------------EVHDYQS 57
H+ YE E +G G S V + A+K ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 58 AFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGD 115
+E++ L+ + PN++ L + + E LV + ++ +L + E E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK--- 124
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
E ++ M +L + A H+ IVHRDLKP N+L+ DD +KL DFG + L E
Sbjct: 125 ------ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 176 F 176
Sbjct: 179 K 179
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 45/188 (23%), Positives = 75/188 (39%), Gaps = 26/188 (13%)
Query: 4 PLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK------------- 50
P + E KY+ + +G G S V + + A+K
Sbjct: 79 PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 51 EVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKK 108
++ RE L+ + P+++ L + + E + LV + +R +L + E
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVA 196
Query: 109 KREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
E E + M +L V H N IVHRDLKP N+L+ D+ ++L+DFG +
Sbjct: 197 LSEK---------ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
Query: 169 RILLGNEF 176
L E
Sbjct: 248 CHLEPGEK 255
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 44/196 (22%), Positives = 82/196 (41%), Gaps = 45/196 (22%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEALQILQNSPNVVVLH 78
KY + + +G+G++ V + + ALK+V D + RE++ +++L + N++ L
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVL-DHVNIIKLV 66
Query: 79 EYFWREDEDAV-------------------------------------LVLEFLRTDLAT 101
+YF+ ++ +++E++ L
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 102 VIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI-GDDGVL 160
V+ + I + I ++ Q+ V H I HRD+KP NLL+ D L
Sbjct: 127 VLKSFIRSGRS-----IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 161 KLADFGQARILLGNEF 176
KL DFG A+ L+ +E
Sbjct: 182 KLCDFGSAKKLIPSEP 197
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 13/31 (41%), Positives = 21/31 (67%)
Query: 288 ALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
+ + +R++RAPEL+ G+T Y +DLWS
Sbjct: 197 PSVAYICSRFYRAPELMLGATEYTPSIDLWS 227
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 49/184 (26%), Positives = 84/184 (45%), Gaps = 30/184 (16%)
Query: 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-------------EVHDYQ 56
S++ + + +Y + + +GSGA +V VA+K E
Sbjct: 2 SVYPK-ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 57 SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGD 115
+ EIE L+ L N P ++ + +F + ED +VLE + +L + +K+ +E
Sbjct: 61 NVETEIEILKKL-NHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEA--- 114
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILL 172
K + Q+L V H N I+HRDLKP N+L+ +D ++K+ DFG ++IL
Sbjct: 115 ------TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 173 GNEF 176
Sbjct: 169 ETSL 172
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 31/174 (17%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNS 71
E+ KY I E +G G + V++ S K V D +EI L I ++
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH- 60
Query: 72 PNVVVLHEYFWREDEDAV-LVLEFL-------RTDLATVIAESKKKREDRGDRGISVGEI 123
N++ LHE F E + + ++ EF+ R + + + E EI
Sbjct: 61 RNILHLHESF--ESMEELVMIFEFISGLDIFER-----INTSAFELNER---------EI 104
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLADFGQARILLGNE 175
++ Q+ + H + I H D++P N++ +K+ +FGQAR L +
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 39/165 (23%), Positives = 62/165 (37%), Gaps = 19/165 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--DYQSAFREIEALQILQNSPNVVVL 77
+ + +G GA + R + DN VA+K + + A RE++ L+ PNV+
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRY 83
Query: 78 HEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
+D + +E L + + E + Q SG+
Sbjct: 84 FCTE--KDRQFQYIAIELCAATLQEYVEQKDFAHLGL--------EPITLLQQTTSGLAH 133
Query: 137 CHRNTIVHRDLKPGNLLIGDDG-----VLKLADFGQARILLGNEF 176
H IVHRDLKP N+LI ++DFG + L
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 10/42 (23%), Positives = 15/42 (35%), Gaps = 2/42 (4%)
Query: 280 DGGDGRQGALTSCVGTRWFRAPELLYGSTS--YGLEVDLWSL 319
G + GT + APE+L VD++S
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 41/180 (22%), Positives = 68/180 (37%), Gaps = 28/180 (15%)
Query: 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK------------ 50
+ + E KY + +GSGA+ V+ N V +K
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 51 -EVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT--DLATVIAES 106
E EI L +++ N++ + + F E++ LV+E + DL I
Sbjct: 68 IEDPKLGKVTLEIAILSRVEH-ANIIKVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRH 124
Query: 107 KKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ E Q++S V I+HRD+K N++I +D +KL DFG
Sbjct: 125 PRLDEP---------LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-------------EVHDYQSAFRE 61
+ +Y + + +GSGA +V VA++ E + E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 62 IEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISV 120
IE L+ L N P ++ + +F + ED +VLE + +L + +K+ +E
Sbjct: 191 IEILKKL-NHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEA-------- 239
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNEF 176
K + Q+L V H N I+HRDLKP N+L+ +D ++K+ DFG ++IL
Sbjct: 240 -TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 24/174 (13%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-------EVHDYQSAFREIEALQI 67
+ Y++ E +G GA+S V + + L A K D+Q RE +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 68 LQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKR 125
LQ+ PN+V LH+ ++E LV + + +L I + E +
Sbjct: 62 LQH-PNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEA---------DASH 109
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNEF 176
+ QIL + CH N IVHR+LKP NLL+ +KLADFG A + +E
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 44/184 (23%), Positives = 76/184 (41%), Gaps = 20/184 (10%)
Query: 3 QPLPKSWSIHTRPEIIAKYEIL-ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFRE 61
+ L + + Y++ + +G G V + ALK ++D A +E
Sbjct: 13 EVLFQGPEPKKYA-VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE 71
Query: 62 IEALQILQNSPNVVVLHEYFWREDEDAV-----LVLEFLRT-DLATVIAESKKKREDRGD 115
++ P++V + + + E+ +++E + +L + I E RGD
Sbjct: 72 VDHHWQASGGPHIVCILDVY--ENMHHGKRCLLIIMECMEGGELFSRIQE-------RGD 122
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILL 172
+ + E M I + + H + I HRD+KP NLL D VLKL DFG A+
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 173 GNEF 176
N
Sbjct: 183 QNAL 186
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 14/34 (41%), Positives = 19/34 (55%), Gaps = 1/34 (2%)
Query: 286 QGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
Q AL + T ++ APE+L G Y D+WSL
Sbjct: 183 QNALQTPCYTPYYVAPEVL-GPEKYDKSCDMWSL 215
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 48/191 (25%), Positives = 84/191 (43%), Gaps = 18/191 (9%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEAL 65
++ KYE+++ +G GAY V+K +VA+K++ D Q FREI L
Sbjct: 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMIL 62
Query: 66 QILQNSPNVVVLHEYFWRED-EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIK 124
L N+V L ++ D LV +++ TDL VI + +
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI-RANILEPVH---------KQ 112
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQ 184
+ Q++ + H ++HRD+KP N+L+ + +K+ADFG +R + +
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 185 PCEPNAPYQDN 195
E + D+
Sbjct: 173 INENTENFDDD 183
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 21/62 (33%), Positives = 29/62 (46%)
Query: 258 ATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLW 317
+ + + + D Q LT V TRW+RAPE+L GST Y +D+W
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMW 215
Query: 318 SL 319
SL
Sbjct: 216 SL 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 24/183 (13%)
Query: 6 PKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-------EVHDYQSA 58
+ ++ + Y++ E +G GA+S V + + L A K D+Q
Sbjct: 16 GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 59 FREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDR 116
RE + LQ+ PN+V LH+ ++E LV + + +L I + E
Sbjct: 76 EREARICRKLQH-PNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEA---- 128
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLG 173
+ + QIL + CH N IVHR+LKP NLL+ +KLADFG A +
Sbjct: 129 -----DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 174 NEF 176
+E
Sbjct: 184 SEA 186
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DY 55
+++ + +Y I+ +G G++ +V K + A+K ++ D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 56 QSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDR 113
+ RE+E L+ L + PN++ L E ED + +V E +L I + K+ E
Sbjct: 66 STILREVELLKKLDH-PNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEH- 121
Query: 114 GDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARI 170
+ R + Q+ SG+ H++ IVHRDLKP N+L+ D +K+ DFG +
Sbjct: 122 --------DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 171 LLGNEF 176
N
Sbjct: 174 FQQNTK 179
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 29/181 (16%)
Query: 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----------EVHDYQSAFR 60
+ ++ Y+I E +GSG ++ V K R S L A K + R
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 61 EIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGI 118
E+ L+ + + NV+ LH+ + E+ V L+LE + +L +A+ + E+
Sbjct: 65 EVSILRQVLH-HNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEE------ 115
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLADFGQARILLGN 174
E ++ QIL GV+ H I H DLKP N+++ +KL DFG A +
Sbjct: 116 ---EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 175 E 175
Sbjct: 173 V 173
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 22/175 (12%)
Query: 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----EVHDYQSAFREIEALQ 66
T+ +I Y + +G G++ +V + + A K V D +EIE ++
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 67 ILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIK 124
L + PN++ L+E F ED + LV+E +L + + RE +
Sbjct: 62 SLDH-PNIIRLYETF--EDNTDIYLVMELCTGGELFERVVHKRVFRES---------DAA 109
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNEF 176
R M +LS V CH+ + HRDLKP N L D LKL DFG A +
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 33/189 (17%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQ 56
++ +P+ + + Y+ILE +GSGA+ V++ + + K ++ D
Sbjct: 35 KKYVPQPVEVKQGS-VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 93
Query: 57 SAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFL-------RTDLATVIAESKK 108
+ EI + L + P ++ LH+ F ED+ + L+LEFL R + AE K
Sbjct: 94 TVKNEISIMNQLHH-PKLINLHDAF--EDKYEMVLILEFLSGGELFDR-----IAAEDYK 145
Query: 109 KREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLADFG 166
E E+ +M Q G+ H ++IVH D+KP N++ +K+ DFG
Sbjct: 146 MSEA---------EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 167 QARILLGNE 175
A L +E
Sbjct: 197 LATKLNPDE 205
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 4 PLPKSWSIHTRPEIIAKYEIL-ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREI 62
P KS + II Y++ + +G G V + ALK + D A RE+
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV 61
Query: 63 EALQILQNSPNVVVLHEYFWREDEDAV-----LVLEFLRT-DLATVIAESKKKREDRGDR 116
E P++V + + + E+ A +V+E L +L + I + RGD+
Sbjct: 62 ELHWRASQCPHIVRIVDVY--ENLYAGRKCLLIVMECLDGGELFSRIQD-------RGDQ 112
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLG 173
+ E M I + H I HRD+KP NLL + +LKL DFG A+ G
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172
Query: 174 NEFDAP 179
++D
Sbjct: 173 EKYDKS 178
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 51/186 (27%), Positives = 75/186 (40%), Gaps = 25/186 (13%)
Query: 15 PEIIAKYEILECV-GSGAYSDVYKGRRLSDNLIVALK-----EVHDYQSAFREIEALQIL 68
Y++ E V G GA++ V L + A+K H FRE+E L
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67
Query: 69 QNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRW 126
Q NV+ L E+F E+ED LV E +R + + I + + E E
Sbjct: 68 QGHRNVLELIEFF--EEEDRFYLVFEKMRGGSILSHIHKRRHFNEL---------EASVV 116
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNEFDAPDGNS 183
+ + S +D H I HRDLKP N+L +K+ DF + N +P
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 184 Q---PC 186
+ PC
Sbjct: 177 ELLTPC 182
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 18/168 (10%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ-SAFREIEALQILQNSPN 73
+ YE+ E +G G+YS + + N+ A+K + + EIE L PN
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPN 77
Query: 74 VVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
++ L + + +D V +V E ++ +L I K E E + I
Sbjct: 78 IITLKDVY--DDGKYVYVVTELMKGGELLDKILRQKFFSER---------EASAVLFTIT 126
Query: 132 SGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLADFGQARILLGNE 175
V+ H +VHRDLKP N+L G+ +++ DFG A+ L
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 47/170 (27%), Positives = 71/170 (41%), Gaps = 19/170 (11%)
Query: 16 EIIAKYEILECV-GSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNV 74
II Y++ V G G V + ALK + D A RE+E P++
Sbjct: 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHI 117
Query: 75 VVLHEYFWREDEDAV-----LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMV 128
V + + + E+ A +V+E L +L + I + RGD+ + E M
Sbjct: 118 VRIVDVY--ENLYAGRKCLLIVMECLDGGELFSRIQD-------RGDQAFTEREASEIMK 168
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNE 175
I + H I HRD+KP NLL + +LKL DFG A+ +
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 46/223 (20%), Positives = 71/223 (31%), Gaps = 48/223 (21%)
Query: 9 WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK----------EVHDYQSA 58
+ + E+ KY + +G G+Y V I A+K D +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 59 FREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFL---------------------- 95
E+ ++ L + PN+ L+E + EDE + LV+E
Sbjct: 76 KTEVRLMKKLHH-PNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 96 ----------RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHR 145
I S + D I M QI S + H I HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 146 DLKPGNLLIGDDG--VLKLADFGQARILLGNEFDAPDGNSQPC 186
D+KP N L + +KL DFG ++ G +
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 20/176 (11%)
Query: 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFRE 61
S H I Y + + +G G + V G VA+K + RE
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 62 IEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISV 120
I+ L++ P+++ L++ D +V+E++ +L I + + E
Sbjct: 62 IQNLKLF-RHPHIIKLYQ-VISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-------- 111
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
E +R QILS VD CHR+ +VHRDLKP N+L+ K+ADFG + ++ EF
Sbjct: 112 -EARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 49/173 (28%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALK-----------EVHDYQSAFREIEALQIL 68
YE+ E +GSG ++ V K R+ A K + RE+ L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 69 QNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRW 126
++ PN++ LH+ F E++ V L+LE + +L +AE + ED E ++
Sbjct: 66 RH-PNIITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTED---------EATQF 113
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLADFGQARILLGNE 175
+ QIL GV H I H DLKP N+++ + +KL DFG A +
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 29/181 (16%)
Query: 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----------EVHDYQSAFR 60
+ ++ Y+I E +GSG ++ V K R S L A K + R
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 61 EIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGI 118
E+ L+ + + PN++ LH+ + E+ V L+LE + +L +A+ + E+
Sbjct: 65 EVSILRQVLH-PNIITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEE------ 115
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLADFGQARILLGN 174
E ++ QIL GV+ H I H DLKP N+++ +KL DFG A +
Sbjct: 116 ---EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 175 E 175
Sbjct: 173 V 173
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-27
Identities = 43/179 (24%), Positives = 77/179 (43%), Gaps = 22/179 (12%)
Query: 11 IHTRPEIIAKYEIL-ECVGSGAYSDVYKGRRLSDNLIVALKEV-------HDYQSAFREI 62
+ Y + + +G G ++ V + S A K + EI
Sbjct: 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEI 79
Query: 63 EALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISV 120
L++ ++ P V+ LHE + E+ + L+LE+ ++ ++ + +S
Sbjct: 80 AVLELAKSCPRVINLHEVY--ENTSEIILILEYAAGGEIFSLCLPELAEM-------VSE 130
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNEF 176
++ R + QIL GV H+N IVH DLKP N+L+ G +K+ DFG +R +
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 33/182 (18%)
Query: 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----EVHDYQSAFREIEA 64
S+ T I + +E +GSGA+S+V+ ++ + ALK S EI
Sbjct: 1 SMQT-TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 65 LQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRTDLAT------VIAESKKKREDRGDRG 117
L+ +++ N+V L + + E LV++ L + I E E
Sbjct: 60 LKKIKH-ENIVTLEDIY--ESTTHYYLVMQ-----LVSGGELFDRILERGVYTEK----- 106
Query: 118 ISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGN 174
+ + Q+LS V H N IVHRDLKP NLL ++ + + DFG +++
Sbjct: 107 ----DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162
Query: 175 EF 176
Sbjct: 163 IM 164
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAF-REIEALQILQNSP 72
Y+I++ +G G S VY N+ VA+K + + F RE+ L +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71
Query: 73 NVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
N+V + E++D LV+E++ L+ I +SV + QI
Sbjct: 72 NIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---------LSVDTAINFTNQI 120
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
L G+ H IVHRD+KP N+LI + LK+ DFG A+ L
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 27/177 (15%)
Query: 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK----------EVHDYQSAFREIEA 64
YE+ E +G G +S V + A+K + RE
Sbjct: 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI 79
Query: 65 LQILQNSPNVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKREDRGDRGISVGE 122
+L++ P++V L E + + + +V EF+ DL I + R D G E
Sbjct: 80 CHMLKH-PHIVELLETY--SSDGMLYMVFEFMDGADLCFEIVK-------RADAGFVYSE 129
Query: 123 IK--RWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGN 174
+M QIL + CH N I+HRD+KP +L+ + +KL FG A L +
Sbjct: 130 AVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-----------EVHDYQSA 58
++ + + Y+ E +GSG ++ V K R S L A K +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 59 FREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKREDRGDR 116
RE+ L+ +Q+ PNV+ LHE + E++ V L+LE + +L +AE + E+
Sbjct: 62 EREVSILKEIQH-PNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEE---- 114
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLADFGQARILL 172
E ++ QIL+GV H I H DLKP N+++ +K+ DFG A +
Sbjct: 115 -----EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 173 GNE 175
Sbjct: 170 FGN 172
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 24/175 (13%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-------EVHDYQSAFREIEAL 65
T +Y++ E +G GA+S V + ++ A D+Q RE
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 66 QILQNSPNVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEI 123
++L++ PN+V LH+ +E L+ + + +L I + E +
Sbjct: 65 RLLKH-PNIVRLHDSI--SEEGHHYLIFDLVTGGELFEDIVAREYYSEA---------DA 112
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNE 175
+ QIL V CH+ +VHR+LKP NLL+ +KLADFG A + G +
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 21/194 (10%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQIL 68
+ Y I +G G+Y VY + VA+K+V+ D + REI L L
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82
Query: 69 QNSPNVVVLHEYF----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIK 124
S ++ L++ + ++ +VLE +DL + E+ IK
Sbjct: 83 -KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEH---------IK 132
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQ 184
+ +L G + H + I+HRDLKP N L+ D +K+ DFG AR + + + +
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 185 PCEPNAPYQDNMSE 198
E P+ N+ +
Sbjct: 193 ENEEPGPHNKNLKK 206
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 17/61 (27%), Positives = 28/61 (45%)
Query: 259 TCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWS 318
T + + + + + + LTS V TRW+RAPEL+ +Y +D+WS
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 319 L 319
Sbjct: 238 T 238
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------D 54
+++ + +Y I+ +G G++ +V K + A+K ++ D
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 55 YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKRED 112
+ RE+E L+ L + PN++ L E ED + +V E +L I + K+ E
Sbjct: 65 TSTILREVELLKKLDH-PNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121
Query: 113 RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQAR 169
+ R + Q+ SG+ H++ IVHRDLKP N+L+ D +K+ DFG +
Sbjct: 122 ---------DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 170 ILLGNE 175
N
Sbjct: 173 CFQQNT 178
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQ 56
+Q P+ I ++ Y+I E +G+GA+ V++ + A K V D +
Sbjct: 141 KQYYPQPVEIKHDH-VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 57 SAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFL-------RTDLATVIAESKK 108
+ +EI+ + +L++ P +V LH+ F ED++ + ++ EF+ + V E K
Sbjct: 200 TVRKEIQTMSVLRH-PTLVNLHDAF--EDDNEMVMIYEFMSGGELFEK-----VADEHNK 251
Query: 109 KREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLADFG 166
ED E +M Q+ G+ H N VH DLKP N++ LKL DFG
Sbjct: 252 MSED---------EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 302
Query: 167 QARILLGNE 175
L +
Sbjct: 303 LTAHLDPKQ 311
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 56/178 (31%), Positives = 75/178 (42%), Gaps = 30/178 (16%)
Query: 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQIL 68
R + +E+ +G GA S VY+ ++ ALK + D + EI L L
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL 105
Query: 69 QNSPNVVVLHEYFWREDEDAV-LVLEFLRTDLAT------VIAESKKKREDRGDRGISVG 121
+ PN++ L E F E + LVLE L T I E E
Sbjct: 106 SH-PNIIKLKEIF--ETPTEISLVLE-----LVTGGELFDRIVEKGYYSER--------- 148
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNEF 176
+ + QIL V H N IVHRDLKP NLL D LK+ADFG ++I+
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 19/174 (10%)
Query: 11 IHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREI 62
+ I Y I E +G G++ V VALK + + REI
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 63 EALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGE 122
L++L P+++ L++ D V+V+E+ +L I E K+ ED E
Sbjct: 61 SYLKLL-RHPHIIKLYD-VITTPTDIVMVIEYAGGELFDYIVEKKRMTED---------E 109
Query: 123 IKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
+R+ QI+ ++ CHR+ IVHRDLKP NLL+ D+ +K+ADFG + I+ F
Sbjct: 110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 34/190 (17%), Positives = 69/190 (36%), Gaps = 31/190 (16%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK----------- 50
+ + + + + I Y I+ + G ++ + + DN ALK
Sbjct: 14 SNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKR 71
Query: 51 -----------EVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT- 97
Y E++ + ++N + + D V ++ E++
Sbjct: 72 DFTKSNNDKISIKSKYDDFKNELQIITDIKN-EYCLTCEGII--TNYDEVYIIYEYMEND 128
Query: 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH-RNTIVHRDLKPGNLLIGD 156
+ ++ I + IK + +L+ H I HRD+KP N+L+
Sbjct: 129 SILKFDEYFFVLDKNYTCF-IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187
Query: 157 DGVLKLADFG 166
+G +KL+DFG
Sbjct: 188 NGRVKLSDFG 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 42/191 (21%), Positives = 79/191 (41%), Gaps = 31/191 (16%)
Query: 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQ 56
+++ + I + +GSGA+ DV+ S L +K ++ +
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 57 SAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLE-------FLRTDLATVIAESKK 108
EIE L+ L + PN++ + E F ED + +V+E R I ++
Sbjct: 66 QIEAEIEVLKSLDH-PNIIKIFEVF--EDYHNMYIVMETCEGGELLER------IVSAQA 116
Query: 109 KREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADF 165
+ + + + M Q+++ + H +VH+DLKP N+L +K+ DF
Sbjct: 117 RGKALSEG-----YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171
Query: 166 GQARILLGNEF 176
G A + +E
Sbjct: 172 GLAELFKSDEH 182
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------D 54
P + H+ +Y+ +G G++ +V + A+K + D
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 55 YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKRED 112
+S RE++ L+ L + PN++ L+E+F ED+ LV E +L I K+ E
Sbjct: 70 KESLLREVQLLKQLDH-PNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126
Query: 113 RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQAR 169
+ R + Q+LSG+ H+N IVHRDLKP NLL+ D +++ DFG +
Sbjct: 127 ---------DAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 170 ILLGNE 175
++
Sbjct: 178 HFEASK 183
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-26
Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQS--AF-----REIEALQILQNSP 72
YE+ E +G G S+V+ R L D+ VA+K + D +F RE + L N P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72
Query: 73 NVVVLHEYFWREDEDAV---LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
+V +++ E +V+E++ L ++ ++ +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIA 123
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
++ H+N I+HRD+KP N++I +K+ DFG AR
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 46/191 (24%), Positives = 76/191 (39%), Gaps = 34/191 (17%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEI--LECVGSGAYSDVYKGRRLSDNLIVALKEVH-----D 54
P + + + Y + E +G G + V+K + L +A K + D
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 55 YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRTDLAT-------VIAES 106
+ EI + L + N++ L++ F E ++ + LV+E +I ES
Sbjct: 130 KEEVKNEISVMNQLDH-ANLIQLYDAF--ESKNDIVLVME-----YVDGGELFDRIIDES 181
Query: 107 KKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLAD 164
E + +M QI G+ H+ I+H DLKP N+L D +K+ D
Sbjct: 182 YNLTEL---------DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID 232
Query: 165 FGQARILLGNE 175
FG AR E
Sbjct: 233 FGLARRYKPRE 243
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-26
Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK-------EVHDYQSAFREI 62
S I Y +L+ +G G ++ V R + VA+K Q FRE+
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV 65
Query: 63 EALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVG 121
++IL + PN+V L E ++ L++E+ ++ + + +E
Sbjct: 66 RIMKILNH-PNIVKLFE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK--------- 114
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDG 181
E + QI+S V CH+ IVHRDLK NLL+ D +K+ADFG NEF
Sbjct: 115 EARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG-----FSNEFTVGGK 169
Query: 182 NSQPCE-PN--AP--YQDNMSEAPQVD 203
C P AP +Q + P+VD
Sbjct: 170 LDAFCGAPPYAAPELFQGKKYDGPEVD 196
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 21/183 (11%)
Query: 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEAL 65
I + +++ +G GAY V IVA+K++ REI+ L
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 66 QILQNSPNVVVLHEYF----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVG 121
+ N++ + + + ++ E ++TDL VI+ ++ +D
Sbjct: 64 KHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-TQMLSDDH-------- 113
Query: 122 EIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDG 181
I+ ++ Q L V H + ++HRDLKP NLLI + LK+ DFG ARI+ + D +
Sbjct: 114 -IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 182 NSQ 184
Q
Sbjct: 173 TGQ 175
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 6e-08
Identities = 16/45 (35%), Positives = 23/45 (51%)
Query: 275 SYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
S G+Q + V TRW+RAPE++ S Y +D+WS
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 35/227 (15%), Positives = 64/227 (28%), Gaps = 58/227 (25%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV------HDYQSAFREIEALQILQNSPN 73
+E ++C+G G + V++ + D+ A+K + + RE++AL L P
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPG 65
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV------------- 120
+V + + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 121 --------------------------------------GEIKRWMVQILSGVDACHRNTI 142
G +QI V+ H +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 143 VHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPN 189
+HRDLKP N+ D V+K+ DFG + +E + P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 41/166 (24%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK---------EVHDYQSAFREIEALQ 66
++I KY + + +G G+Y V + A+K + + +EI+ L+
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 67 ILQNSPNVVVLHEYFWREDEDAV-LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
L NV+ L + + E++ + +V+E+ + ++ +KR V +
Sbjct: 62 RL-RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-------FPVCQAHG 113
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ Q++ G++ H IVH+D+KPGNLL+ G LK++ G A L
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 22/164 (13%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAF-REIEALQI 67
Y + VG G DVY+ IVALK + +++ RE
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGR 90
Query: 68 LQNSPNVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKR 125
LQ P+VV +H++ E + + + + + DLA ++ ++
Sbjct: 91 LQE-PHVVPIHDF--GEIDGQLYVDMRLINGVDLAAMLRR---------QGPLAPPRAVA 138
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ QI S +DA H HRD+KP N+L+ D L DFG A
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS 182
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 52/175 (29%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV--HDYQSAFREIEA 64
K + ++ K + L G G++S K N A+K + + +EI A
Sbjct: 2 KDSPFYQHYDLDLKDKPL---GEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITA 58
Query: 65 LQILQNSPNVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKREDRGDRGISVGE 122
L++ + PN+V LHE F D+ LV+E L +L I + K E E
Sbjct: 59 LKLCEGHPNIVKLHEVF--HDQLHTFLVMELLNGGELFERIKKKKHFSET---------E 107
Query: 123 IKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGN 174
M +++S V H +VHRDLKP NLL D+ +K+ DFG AR+ +
Sbjct: 108 ASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 24/182 (13%)
Query: 6 PKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSA 58
P + + + Y+ ++ +GSGAY +V R ++ A+K +
Sbjct: 24 PGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKL 83
Query: 59 FREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKREDRGDR 116
E+ L++L + PN++ L+++F ED+ LV+E + +L I K E
Sbjct: 84 LEEVAVLKLLDH-PNIMKLYDFF--EDKRNYYLVMECYKGGELFDEIIHRMKFNEV---- 136
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLG 173
+ + Q+LSGV H++ IVHRDLKP NLL+ D ++K+ DFG + +
Sbjct: 137 -----DAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 174 NE 175
+
Sbjct: 192 QK 193
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 20/174 (11%)
Query: 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIE 63
H I Y + + +G G + V G+ VA+K + REI+
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 64 ALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGE 122
L++ P+++ L++ D +V+E++ +L I ++ + E E
Sbjct: 69 NLKLF-RHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK---------E 117
Query: 123 IKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
+R QILSGVD CHR+ +VHRDLKP N+L+ K+ADFG + ++ EF
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 40/160 (25%), Positives = 64/160 (40%), Gaps = 17/160 (10%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVV 75
E + VG G++ +V++ + A+K+V E+ A L +SP +V
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGL-SSPRIV 113
Query: 76 VLHEY--FWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
RE + +E L L +I + ED ++ Q L
Sbjct: 114 ---PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED---------RALYYLGQALE 161
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVL-KLADFGQARIL 171
G++ H I+H D+K N+L+ DG L DFG A L
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 34/182 (18%), Positives = 53/182 (29%), Gaps = 34/182 (18%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQIL--- 68
K +++E + G S V+ R + ALK + + A L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 69 --------------------QNSPNVVVLHE-YFWREDEDAVLVLEFLRTDLATVIAESK 107
Q+ P L + +L++ DL + +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 108 KKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167
RGD GI + Q++ +VH P NL I DG L L D
Sbjct: 183 FVYVFRGDEGILA--LHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 168 AR 169
Sbjct: 241 LW 242
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 43/174 (24%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQS------AFREIEALQILQ 69
++ +Y L +G GAY V + + VA+K++ ++ REI+ L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF- 82
Query: 70 NSPNVVVLHEYF----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
N++ +++ + +D +V + + TDL ++ +++ D I
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDH---------ICY 132
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAP 179
++ QIL G+ H ++HRDLKP NLL+ LK+ DFG AR+ +
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 17/40 (42%), Positives = 23/40 (57%)
Query: 280 DGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
D G LT V TRW+RAPE++ S Y +D+WS+
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 47/206 (22%)
Query: 8 SWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEV--------------- 52
S + +Y + + +G G+Y V +DN A+K +
Sbjct: 2 SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 53 ----------------HDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFL 95
+ ++EI L+ L + PNVV L E +ED + +V E +
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELV 120
Query: 96 RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG 155
+ K ED + + + ++ G++ H I+HRD+KP NLL+G
Sbjct: 121 NQGPVMEVPTLKPLSED---------QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171
Query: 156 DDGVLKLADFGQARILLGNEFDAPDG 181
+DG +K+ADFG + NEF D
Sbjct: 172 EDGHIKIADFG-----VSNEFKGSDA 192
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-25
Identities = 35/153 (22%), Positives = 64/153 (41%), Gaps = 12/153 (7%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNV 74
+ L +G GAY V K I+A+K + + + +++ + + P +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
V + +RE D + +E + T K D I + + + + +
Sbjct: 84 VQFYGALFREG-DCWICMELMSTSFDKFY----KYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 135 DACHRNT-IVHRDLKPGNLLIGDDGVLKLADFG 166
+ N I+HRD+KP N+L+ G +KL DFG
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 32/162 (19%), Positives = 65/162 (40%), Gaps = 27/162 (16%)
Query: 21 YEILECVGSGAYSDVYKGR--RLSDNLIVALKEVH-----DYQSAF-REIEALQILQNSP 72
YE+ C+ G +Y ++ V LK + + Q+ E + L + P
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHP 139
Query: 73 NVVVLHEYFWREDEDAV----LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWM 127
++V + + D +V+E++ L + + V E ++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYL 188
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
++IL + H +V+ DLKP N+++ ++ + KL D G
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVS 229
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 49/193 (25%), Positives = 79/193 (40%), Gaps = 35/193 (18%)
Query: 6 PKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK--------------- 50
P + +I Y + +GSGAY +V + + + A+K
Sbjct: 23 PGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDD 82
Query: 51 ---EVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAE 105
++ + EI L+ L + PN++ L + F ED+ LV EF +L I
Sbjct: 83 NKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVF--EDKKYFYLVTEFYEGGELFEQIIN 139
Query: 106 SKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKL 162
K E + M QILSG+ H++ IVHRD+KP N+L+ +K+
Sbjct: 140 RHKFDEC---------DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190
Query: 163 ADFGQARILLGNE 175
DFG + +
Sbjct: 191 VDFGLSSFFSKDY 203
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 35/192 (18%), Positives = 68/192 (35%), Gaps = 28/192 (14%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNL-----IVALK-----E 51
+ LP + +G GA++ VY+ + N LK
Sbjct: 48 QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107
Query: 52 VHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKR 110
++ + +E L+ + + ++ +VLV E L I K
Sbjct: 108 PWEFYIGTQLMERLKPS-MQHMFMKFYSAHLFQNG-SVLVGELYSYGTLLNAINLYKNTP 165
Query: 111 EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-----------DGV 159
E + + G + + +++L ++ H I+H D+KP N ++G+
Sbjct: 166 E----KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 160 LKLADFGQARIL 171
L L D GQ+ +
Sbjct: 222 LALIDLGQSIDM 233
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEV------HDYQSAFREIEALQILQNSPNV 74
YE+ E +GSGA + V VA+K + +EI+A+ + PN+
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNI 75
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
V + F +DE + V++ L I + + + + I + ++L G+
Sbjct: 76 VSYYTSFVVKDELWL-VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ H+N +HRD+K GN+L+G+DG +++ADFG
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 55/169 (32%), Positives = 82/169 (48%), Gaps = 24/169 (14%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEAL 65
T E+ Y VGSGAY V VA+K++ + A+RE+ L
Sbjct: 18 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77
Query: 66 QILQNSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
+ +Q+ NV+ L + F R D LV+ F++TDL ++ K E++
Sbjct: 78 KHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLKFSEEK------- 127
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
I+ + Q+L G+ H +VHRDLKPGNL + +D LK+ DFG AR
Sbjct: 128 --IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 14/31 (45%), Positives = 20/31 (64%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+T V TRW+RAPE++ Y VD+WS+
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 210
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 22/156 (14%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNV 74
+EI+ +G GA+ VYK + + A K + + + EIE L P +
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYI 78
Query: 75 VVLHEYFWREDEDAVLVLEFLR----TDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
V L ++ + +++EF + + DRG++ +I+ Q+
Sbjct: 79 VKLLGAYYHDG-KLWIMIEFCPGGAVDAIMLEL-----------DRGLTEPQIQVVCRQM 126
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
L ++ H I+HRDLK GN+L+ +G ++LADFG
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFG 162
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 50/181 (27%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQS----------------AF 59
+ + Y + + SG+Y V G S+ + VA+K V + S
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 60 REIEALQILQNSPNVVVLHEYF----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGD 115
REI L + PN++ L + F LV E +RTDLA VI + + +
Sbjct: 78 REIRLLNHFHH-PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ-- 134
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
I+ +M IL G+ H +VHRDL PGN+L+ D+ + + DF AR +
Sbjct: 135 ------HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 176 F 176
Sbjct: 189 N 189
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 14/38 (36%), Positives = 18/38 (47%)
Query: 282 GDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
D T V RW+RAPEL+ + VD+WS
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQ 69
+ +++++ +G GAY +V VA+K V ++ +EI ++L
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMV 128
+ NVV + + RE L LE+ +L I E + +R+
Sbjct: 64 H-ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFH 112
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
Q+++GV H I HRD+KP NLL+ + LK++DFG
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 23/169 (13%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEAL 65
T E+ +Y+ L VGSGAY V L VA+K++ + +RE+ L
Sbjct: 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 66 QILQNSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
+ +++ NV+ L + F E D LV + DL ++ + +K +D
Sbjct: 83 KHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDH------- 133
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
++ + QIL G+ H I+HRDLKP NL + +D LK+ DFG AR
Sbjct: 134 --VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 14/31 (45%), Positives = 20/31 (64%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+T V TRW+RAPE++ Y VD+WS+
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 24/176 (13%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEAL 65
+ ++ +Y+ L+ +GSGA V + VA+K++ + A+RE+ +
Sbjct: 56 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115
Query: 66 QILQNSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
+ + + N++ L F E +D LV+E + +L VI + + +
Sbjct: 116 KCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHE------- 164
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
+ + Q+L G+ H I+HRDLKP N+++ D LK+ DFG AR +
Sbjct: 165 -RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 14/36 (38%), Positives = 21/36 (58%), Gaps = 1/36 (2%)
Query: 284 GRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
G +T V TR++RAPE++ Y VD+WS+
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSV 249
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 30/183 (16%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQN 70
++ ++Y L+ +G G V+ + VA+K++ + A REI+ ++ L +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH 67
Query: 71 SPNVVVLHEYF-------------WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRG 117
N+V + E E +V E++ TDLA V+ E E+
Sbjct: 68 -DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL-EQGPLLEEH---- 121
Query: 118 ISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI-GDDGVLKLADFGQARILLGNEF 176
+ +M Q+L G+ H ++HRDLKP NL I +D VLK+ DFG ARI+ +
Sbjct: 122 -----ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 177 DAP 179
Sbjct: 177 HKG 179
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 12/40 (30%), Positives = 22/40 (55%)
Query: 280 DGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
D +G L+ + T+W+R+P LL +Y +D+W+
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 15/183 (8%), Positives = 45/183 (24%), Gaps = 35/183 (19%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQIL--- 68
+G + + + + E+ L++L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 69 ---------------------QNSPNVVVLHEYFWREDEDA-VLVLEFLRTDLATVIAES 106
++ + + + ++++L T
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 107 KKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ +Q++ + + H +VH L+P ++++ G + L F
Sbjct: 194 LSHSSTHKSLVHHAR--LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 167 QAR 169
Sbjct: 252 HLV 254
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 60/187 (32%), Positives = 91/187 (48%), Gaps = 29/187 (15%)
Query: 1 MEQPLPKSWSIH------TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH- 53
M P P + T E+ A Y L+ VGSGAY V VA+K+++
Sbjct: 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60
Query: 54 ------DYQSAFREIEALQILQNSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATV 102
+ A+RE+ L+ +++ NV+ L + F + D LV+ F+ TDL +
Sbjct: 61 PFQSELFAKRAYRELRLLKHMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL 119
Query: 103 IAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162
+ + +K EDR I+ + Q+L G+ H I+HRDLKPGNL + +D LK+
Sbjct: 120 M-KHEKLGEDR---------IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 169
Query: 163 ADFGQAR 169
DFG AR
Sbjct: 170 LDFGLAR 176
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 14/31 (45%), Positives = 20/31 (64%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+T V TRW+RAPE++ Y VD+WS+
Sbjct: 182 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 29/167 (17%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK-------EVHDYQSAFREIEALQILQNSPN 73
+E++E VG+G Y VYKGR + + A+K E + + +EI L+ + N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRN 82
Query: 74 VVVLHEYFWREDEDAV-----LVLEFLR----TDLATVIAESKKKREDRGDRGISVGEIK 124
+ + F +++ + LV+EF TDL + +E+ I+ I
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEW----IAY--IC 135
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
R +IL G+ H++ ++HRD+K N+L+ ++ +KL DFG + L
Sbjct: 136 R---EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 38/158 (24%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNV 74
E + +G GAY V K R + I+A+K + + + +++ + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
V + +RE D + +E + T L K+ + I + + V I+ +
Sbjct: 69 VTFYGALFREG-DVWICMELMDTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 135 DACHRNT-IVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ H ++HRD+KP N+LI G +K+ DFG + L
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQ 56
E+ L K SI + + KY E +G GA VY ++ VA+++++ +
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 57 SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDR 116
EI ++ + +PN+V + + DE +V+E+L T + E
Sbjct: 63 LIINEILVMRENK-NPNIVNYLDSYLVGDE-LWVVMEYLAGGSLTDVVTETCMDEG---- 116
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+I + L ++ H N ++HRD+K N+L+G DG +KL DFG
Sbjct: 117 -----QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQ 69
+ +++++ +G GAY +V VA+K V ++ +EI ++L
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMV 128
+ NVV + + RE L LE+ +L I E + +R+
Sbjct: 64 H-ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFH 112
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
Q+++GV H I HRD+KP NLL+ + LK++DFG
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-23
Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 17/152 (11%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQ----ILQ--NSPNV 74
+ LE +G G++ +V+KG +VA+K + D + A EIE +Q +L +SP V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
+ + ++ + +++E+L A + E E + I+ I R +IL G+
Sbjct: 83 TKYYGSYLKDTK-LWIIMEYLGGGSALDLLEPGPLDETQ----IAT--ILR---EILKGL 132
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
D H +HRD+K N+L+ + G +KLADFG
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFG 164
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-23
Identities = 29/155 (18%), Positives = 50/155 (32%), Gaps = 22/155 (14%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQ-NSP 72
Y +L G ++ + + VAL V D L++ + + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLS-RTLRLSRIDKP 91
Query: 73 NVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
V + + ++V E++R L V D S R M +
Sbjct: 92 GVARVLDVV-HTRAGGLVVAEWIRGGSLQEVA-----------DTSPSPVGAIRAMQSLA 139
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ DA HR + P + + DG + LA
Sbjct: 140 AAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA 174
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-23
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQNS 71
+ L +G G++ VY R + ++ +VA+K++ +Q +E+ LQ L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-H 113
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
PN + + RE A LV+E+ + ++ KK + EI L
Sbjct: 114 PNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEVHKKP--------LQEVEIAAVTHGAL 164
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G+ H + ++HRD+K GN+L+ + G++KL DFG
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 199
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-23
Identities = 32/153 (20%), Positives = 65/153 (42%), Gaps = 16/153 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNV 74
E L +GSG V+K R ++A+K++ + + +++ + + P +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
V F D + +E + T + + I + + V I+ +
Sbjct: 87 VQCFGTFITNT-DVFIAMELMGTCAEKLKKRMQG--------PIPERILGKMTVAIVKAL 137
Query: 135 DACH-RNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ ++HRD+KP N+L+ + G +KL DFG
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG 170
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 24/161 (14%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVL 77
+G G++ VYKG + VA E+ D Q E E L+ LQ+ PN+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRF 90
Query: 78 HEYF---WREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
++ + + + VLV E + + L T + K + + ++ W QIL G
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKG 141
Query: 134 VDACHRNT--IVHRDLKPGNLLI-GDDGVLKLADFGQARIL 171
+ H T I+HRDLK N+ I G G +K+ D G A +
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 35/152 (23%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNV 74
+ +G G+ V R VA+K + + F E+ ++ Q NV
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNV 104
Query: 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGV 134
V +++ + +E +++EFL+ T I + E+ +I +L +
Sbjct: 105 VEMYKSYLVGEE-LWVLMEFLQGGALTDIVSQVRLNEE---------QIATVCEAVLQAL 154
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
H ++HRD+K ++L+ DG +KL+DFG
Sbjct: 155 AYLHAQGVIHRDIKSDSILLTLDGRVKLSDFG 186
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 44/176 (25%), Positives = 82/176 (46%), Gaps = 24/176 (13%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEAL 65
+ ++ +Y+ L+ +GSGA V VA+K++ + A+RE+ +
Sbjct: 19 STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 78
Query: 66 QILQNSPNVVVLHEYF-----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
+ + + N++ L F E +D +V+E + +L VI + + + +R
Sbjct: 79 KCVNH-KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDH--ER---- 128
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEF 176
+ + Q+L G+ H I+HRDLKP N+++ D LK+ DFG AR +
Sbjct: 129 --MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 1/34 (2%)
Query: 286 QGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
+T V TR++RAPE++ Y VD+WS+
Sbjct: 180 SFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSV 212
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 25 ECVGSGAYSDVYKGRRLSDNLIVALKEV-----HDYQSAFREIEALQILQNSPNVVVLHE 79
+G G Y VY GR LS+ + +A+KE+ Q EI + L N+V +
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIV---Q 83
Query: 80 YFWREDEDAVL--VLEFLRTD-LATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
Y E+ + +E + L+ ++ +D I + QIL G+
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ------TIGFYTKQILEGLKY 137
Query: 137 CHRNTIVHRDLKPGNLLIG-DDGVLKLADFGQARILLGN 174
H N IVHRD+K N+LI GVLK++DFG ++ L G
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 3e-22
Identities = 21/189 (11%), Positives = 52/189 (27%), Gaps = 38/189 (20%)
Query: 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEAL 65
RP + + +L G + + + + E+ L
Sbjct: 76 RPRTLVRGTVL---GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 66 QILQNSPNVVVL-----------------HEYFWREDEDA--------VLVLEFLRTDLA 100
++L+ N + R D + ++++L
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 101 TVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL 160
T + + +Q++ + + H +VH L+P ++++ G +
Sbjct: 193 TFGEVLLSHSSTHKS--LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 250
Query: 161 KLADFGQAR 169
L F
Sbjct: 251 FLTGFEHLV 259
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 20/154 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV---HDYQSAFREIEALQILQNSPNVVV 76
+++LE +G G+Y VYK IVA+K+V D Q +EI +Q SP+VV
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVK 88
Query: 77 LHEYFWREDEDAVLVLEFLR----TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ +++ + +V+E+ +D+ + ++ ++ EI + L
Sbjct: 89 YYGSYFKNTD-LWIVMEYCGAGSVSDIIRLR-----------NKTLTEDEIATILQSTLK 136
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G++ H +HRD+K GN+L+ +G KLADFG
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG 170
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 47/170 (27%), Positives = 72/170 (42%), Gaps = 31/170 (18%)
Query: 16 EI-IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--DYQSAF-REIEALQILQNS 71
I + E+ E VG GA+ V K + VA+K++ + AF E+ L + N
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NH 60
Query: 72 PNVV-----VLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKR 125
PN+V L+ LV+E+ L V+ ++ +
Sbjct: 61 PNIVKLYGACLNPVC--------LVMEYAEGGSLYNVLHGAEPLPY------YTAAHAMS 106
Query: 126 WMVQILSGVD---ACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARIL 171
W +Q GV + ++HRDLKP NLL+ G VLK+ DFG A +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 19/159 (11%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPNV 74
+E + +G+G V+K L++A K +H RE++ L NSP +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 93
Query: 75 VVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
V + F+ + + + +E + L V+ ++ + E + + + ++ G
Sbjct: 94 VGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQ---------ILGKVSIAVIKG 143
Query: 134 VDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ I+HRD+KP N+L+ G +KL DFG + L
Sbjct: 144 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 18/182 (9%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK----EVHDYQS 57
P+ +Y+ ++ +GSG + R +VA+K ++
Sbjct: 3 RAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN 62
Query: 58 AFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDR 116
REI + L PN+V E +++E+ +L I + + ED
Sbjct: 63 VQREIINHRSL-RHPNIVRFKEVILTPT-HLAIIMEYASGGELYERICNAGRFSED---- 116
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV--LKLADFGQARILLGN 174
E + + Q+LSGV CH I HRDLK N L+ LK+ DFG ++ + +
Sbjct: 117 -----EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 175 EF 176
Sbjct: 172 SQ 173
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-21
Identities = 50/166 (30%), Positives = 87/166 (52%), Gaps = 22/166 (13%)
Query: 16 EIIA-KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQ- 69
+ +A +YE+L+ +G G++ V K + VALK V + ++ A EI L+ L+
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK 152
Query: 70 ----NSPNVVVLHEYF-WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIK 124
N+ NV+ + E F +R + E L +L +I ++K +G S+ ++
Sbjct: 153 QDKDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNK-------FQGFSLPLVR 203
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG--VLKLADFGQA 168
++ IL +DA H+N I+H DLKP N+L+ G +K+ DFG +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 9e-20
Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 15/159 (9%)
Query: 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPN 73
+ K+ + +GSG++ ++Y G + N VA+K + + E + +ILQ
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG 64
Query: 74 VVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
+ + +F E + VLV++ L L + +K +S+ + Q+++
Sbjct: 65 IPNVR-WFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--------LSLKTVLMLADQMINR 115
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDG---VLKLADFGQAR 169
V+ H + +HRD+KP N L+G + + DFG A+
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 33/178 (18%), Positives = 58/178 (32%), Gaps = 25/178 (14%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGA--YSDVYKGRRLSDNLIVALKEV------- 52
+ + YE+L +G G V R V ++ +
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 53 HDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR----TDLATVIAESKK 108
E+ ++ N PN+V F ++E +V F+ DL
Sbjct: 68 EMVTFLQGELHVSKLF-NHPNIVPYRATFIADNE-LWVVTSFMAYGSAKDLICT------ 119
Query: 109 KREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G++ I + +L +D H VHR +K ++LI DG + L+
Sbjct: 120 ----HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 173
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 35/156 (22%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNVVV 76
+Y + +GSG++ D+Y G ++ VA+K + E + +++Q +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT 69
Query: 77 LHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
+ + E + V+V+E L L + +K S+ + Q++S ++
Sbjct: 70 IR-WCGAEGDYNVMVMELLGPSLEDLFNFCSRK--------FSLKTVLLLADQMISRIEY 120
Query: 137 CHRNTIVHRDLKPGNLLIG---DDGVLKLADFGQAR 169
H +HRD+KP N L+G ++ + DFG A+
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 31/173 (17%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEV----HDYQSAFREIEALQIL------- 68
+Y ++ +G G +S V+ + + +N VA+K V ++A EI+ LQ +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 69 ---QNSPNVVVLHEYF-WREDEDA--VLVLEFLRTDLATVIAESKKKREDRGDRGISVGE 122
+ +++ L ++F + V+V E L +L +I + + RGI +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE-------HRGIPLIY 132
Query: 123 IKRWMVQILSGVDACHRNT-IVHRDLKPGNLLIGD------DGVLKLADFGQA 168
+K+ Q+L G+D HR I+H D+KP N+L+ +K+AD G A
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 34/158 (21%), Positives = 66/158 (41%), Gaps = 17/158 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALK---EVHDYQSAFREIEALQILQNSPNVVV 76
+ + + +G G + ++ G+ L N VA+K E + L + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 77 LHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
++ YF + +VLE L L + + S+ + +Q++S ++
Sbjct: 70 VY-YFGPCGKYNAMVLELLGPSLEDLFDLCDRT--------FSLKTVLMIAIQLISRMEY 120
Query: 137 CHRNTIVHRDLKPGNLLIGDDG-----VLKLADFGQAR 169
H +++RD+KP N LIG G V+ + DF A+
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 35/185 (18%), Positives = 74/185 (40%), Gaps = 21/185 (11%)
Query: 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAF-RE 61
++I E +G G + K ++ +KE+ + Q F +E
Sbjct: 3 PHRIFR-PSDLI----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 62 IEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISV 120
++ ++ L++ PNV+ +++ + + E++ L +I +
Sbjct: 58 VKVMRCLEH-PNVLKFIGVLYKD-KRLNFITEYIKGGTLRGIIKSMDSQ--------YPW 107
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPD 180
+ + I SG+ H I+HRDL N L+ ++ + +ADFG AR+++ +
Sbjct: 108 SQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167
Query: 181 GNSQP 185
S
Sbjct: 168 LRSLK 172
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-19
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNVVV 76
Y++ +G G++ +++G L +N VA+K D E ++L +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPN 70
Query: 77 LHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
++ YF +E VLV++ L L ++ +K SV + Q+L+ V +
Sbjct: 71 VY-YFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--------FSVKTVAMAAKQMLARVQS 121
Query: 137 CHRNTIVHRDLKPGNLLIGDDG-----VLKLADFGQAR 169
H ++V+RD+KP N LIG ++ + DFG +
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-19
Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAF-REIEALQILQNSPNV 74
I E +G+G++ V++ VA+K + + + F RE+ ++ L PN+
Sbjct: 40 NIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNI 96
Query: 75 VVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
V+ + + +V E+L R L ++ +S + + + + G
Sbjct: 97 VLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQ------LDERRRLSMAYDVAKG 149
Query: 134 VDACHRNT--IVHRDLKPGNLLIGDDGVLKLADFGQARI 170
++ H IVHR+LK NLL+ +K+ DFG +R+
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-19
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 49/197 (24%)
Query: 1 MEQPLPKS--WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSA 58
PKS ++ EI E + +G G + V+KGR + D +VA+K + S
Sbjct: 4 GGSEFPKSRLPTLADN-EI----EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE 58
Query: 59 ------------FREIEALQILQNSPNVV-----VLHEYFWREDEDAVLVLEFLRT-DLA 100
RE+ + L N PN+V + + +V+EF+ DL
Sbjct: 59 GETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPPR--------MVMEFVPCGDLY 109
Query: 101 TVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIGDDG 158
+ + I R M+ I G++ IVHRDL+ N+ +
Sbjct: 110 HRLLDKAHP--------IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161
Query: 159 -----VLKLADFGQARI 170
K+ADFG ++
Sbjct: 162 ENAPVCAKVADFGLSQQ 178
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 22/157 (14%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAF-REIEALQILQNSPNV 74
EI E +G G + VY GR + VA++ + D AF RE+ A + ++ NV
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH-ENV 91
Query: 75 VVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
V+ A ++ L +V+ ++K + V + ++ +I+ G
Sbjct: 92 VLFMGACMSPPHLA-IITSLCKGRTLYSVVRDAKIV--------LDVNKTRQIAQEIVKG 142
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
+ H I+H+DLK N+ D+G + + DFG I
Sbjct: 143 MGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSI 178
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 39/168 (23%), Positives = 74/168 (44%), Gaps = 24/168 (14%)
Query: 16 EIIA-KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQ- 69
E +YEI +G G++ V K + VA+K + + A E+ L+++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK 109
Query: 70 ----NSPNVVVLHEYF-WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIK 124
+V L +F +R LV E L +L ++ + RG+S+ +
Sbjct: 110 HDTEMKYYIVHLKRHFMFR--NHLCLVFEMLSYNLYDLLRNTNF-------RGVSLNLTR 160
Query: 125 RWMVQILSGVDACHRN--TIVHRDLKPGNLLIGDDG--VLKLADFGQA 168
++ Q+ + + +I+H DLKP N+L+ + +K+ DFG +
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 43/203 (21%), Positives = 67/203 (33%), Gaps = 35/203 (17%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALK--EVHDYQSA 58
ME S+ ++LE +G G Y VYKG D VA+K + Q+
Sbjct: 1 MEAA-ASEPSLDLD-----NLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNF 52
Query: 59 FREIEALQILQ-NSPNVVVLHEYFWREDEDAV----LVLEFL-RTDLATVIAESKKKRED 112
E ++ N+ R D LV+E+ L ++
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----- 107
Query: 113 RGDRGISVGEIKRWMVQILSGV---------DACHRNTIVHRDLKPGNLLIGDDGVLKLA 163
R + G+ ++ I HRDL N+L+ +DG ++
Sbjct: 108 -----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162
Query: 164 DFGQARILLGNEFDAPDGNSQPC 186
DFG + L GN P
Sbjct: 163 DFGLSMRLTGNRLVRPGEEDNAA 185
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 22/157 (14%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAF-REIEALQILQNSPNV 74
+ + +GSG++ VYKG+ D VA+K ++ AF E+ L+ ++ N+
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-VNI 82
Query: 75 VVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSG 133
++ + +V ++ + L + S+ K + ++ Q G
Sbjct: 83 LLF--MGYSTAPQLAIVTQWCEGSSLYHHLHASETK--------FEMKKLIDIARQTARG 132
Query: 134 VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
+D H +I+HRDLK N+ + +D +K+ DFG A
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 40/172 (23%), Positives = 64/172 (37%), Gaps = 41/172 (23%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALK--EVHDYQSAFREIEALQILQ-NSPNVV--- 75
+LECVG G Y +V++G +N VA+K D +S FRE E + N++
Sbjct: 11 TLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 76 -------VLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWM 127
W L+ + L + + + R +
Sbjct: 69 ASDMTSRHSSTQLW-------LITHYHEMGSLYDYLQLTT----------LDTVSCLRIV 111
Query: 128 VQILSGVD--------ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ I SG+ + I HRDLK N+L+ +G +AD G A +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 35/183 (19%), Positives = 66/183 (36%), Gaps = 42/183 (22%)
Query: 15 PEIIAK-YEILECVGSGAYSDVYKGRRLSDNLIVALK--EVHDYQSAFREIEALQILQ-N 70
IAK ++++ +G G Y +V+ G+ VA+K + S FRE E Q +
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASWFRETEIYQTVLMR 89
Query: 71 SPNVV----------VLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGIS 119
N++ + L+ ++ L + + +
Sbjct: 90 HENILGFIAADIKGTGSWTQLY-------LITDYHENGSLYDYLKSTT----------LD 132
Query: 120 VGEIKRWMVQILSGVD--------ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ + +SG+ + I HRDLK N+L+ +G +AD G A
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 172 LGN 174
+ +
Sbjct: 193 ISD 195
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 37/173 (21%), Positives = 67/173 (38%), Gaps = 28/173 (16%)
Query: 15 PEIIAK-YEILECVGSGAYSDVYKGRRLSDNLIVALKEV--HDYQSAFREIEALQILQ-N 70
IA+ + E +G G + +V++G+ VA+K + +S FRE E Q +
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLR 94
Query: 71 SPNVVVLHEYFWREDEDAV---LVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRW 126
N++ +++ LV ++ L + ++V + +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKL 144
Query: 127 MVQILSG--------VDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ SG V + I HRDLK N+L+ +G +AD G A
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 23/178 (12%), Positives = 57/178 (32%), Gaps = 26/178 (14%)
Query: 5 LPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAF----- 59
+ K I + ++ L + +++KGR + +K + +
Sbjct: 1 MNKHSGIDFK-QL----NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRD 53
Query: 60 --REIEALQILQNSPNVVVLHEYFWREDEDA-VLVLEFLRT-DLATVIAESKKKREDRGD 115
E L+I + PNV+ + L+ ++ L V+ E
Sbjct: 54 FNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV----- 107
Query: 116 RGISVGEIKRWMVQILSGVDACH--RNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ + ++ + + G+ H I L +++I +D +++
Sbjct: 108 --VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 44/175 (25%), Positives = 70/175 (40%), Gaps = 35/175 (20%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAF---------REIEALQILQNSP 72
+ E +G G + VY+ VA+K +E + +L++ P
Sbjct: 10 TLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-P 66
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
N++ L +E + LV+EF R L V++ + I + W VQI
Sbjct: 67 NIIALRGVCLKE-PNLCLVMEFARGGPLNRVLS----------GKRIPPDILVNWAVQIA 115
Query: 132 SGVDACHRN---TIVHRDLKPGNLLIG--------DDGVLKLADFGQARILLGNE 175
G++ H I+HRDLK N+LI + +LK+ DFG AR
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 45/212 (21%)
Query: 4 PLPKSWSIHTRPEIIAKYEI-------LECVGSGAYSDVYKGRRLSDNLIVA---LKEVH 53
P +I+ K+E+ +G G Y +VY+G +L VA LKE
Sbjct: 198 PKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT 257
Query: 54 DYQSAF-REIEALQILQNSPNVVVLH-------------EYFWREDEDAVLVLEFLRTDL 99
F +E ++ +++ PN+V L E+ + +L++LR
Sbjct: 258 MEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIITEFMTYGN-----LLDYLRE-- 309
Query: 100 ATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159
+ +S + QI S ++ + +HR+L N L+G++ +
Sbjct: 310 -------------CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL 356
Query: 160 LKLADFGQARILLGNEFDAPDGNSQPCEPNAP 191
+K+ADFG +R++ G+ + A G P + AP
Sbjct: 357 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 30/173 (17%), Positives = 64/173 (36%), Gaps = 32/173 (18%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALK----EVHDYQSAFREIEALQILQNSPNVV 75
++ + + +GSG + +Y + A E + F E++ Q + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 76 VLHE-----------YFW------REDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGI 118
E ++ + +V+E L DL + ++
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT---------F 148
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLADFGQAR 169
+ + +++L ++ H N VH D+K NLL+G + + LAD+G +
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 35/179 (19%), Positives = 72/179 (40%), Gaps = 19/179 (10%)
Query: 16 EIIA-KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQN 70
++ + ++ +G G + V + + + A+K V + +SA E + L+ +QN
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN 90
Query: 71 SP----NVVVLHEYF-WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
N+V H F + + L+ E L L +I + G + +IK
Sbjct: 91 DDINNNNIVKYHGKFMYYDH--MCLIFEPLGPSLYEIITRNNY-------NGFHIEDIKL 141
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQ 184
+ ++IL ++ + ++ H DLKP N+L+ D K + ++
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 40/171 (23%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK-----------EVHDYQSAFREIEALQILQ 69
++ + +G G++S V R L+ + A+K +V Y + R++ + L
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV-PYVTRERDV--MSRL- 87
Query: 70 NSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWM 127
+ P V L+ F +D++ + L + + +L I + E + +
Sbjct: 88 DHPFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---------RFYT 136
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDA 178
+I+S ++ H I+HRDLKP N+L+ +D +++ DFG A++L A
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 8e-14
Identities = 44/201 (21%), Positives = 81/201 (40%), Gaps = 22/201 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALK----EVHDYQSAFREIEALQILQNS---- 71
+Y ++ +G G +S V+ + VA+K H ++A EI L+ ++NS
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 72 ---PNVVVLHEYFWREDED---AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
VV L + F + +V E L L I +S +G+ + +K+
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSN-------YQGLPLPCVKK 150
Query: 126 WMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQ 184
+ Q+L G+D H I+H D+KP N+L+ + +A + P G++
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 185 PCEPNAPYQDNMSEAPQVDLE 205
P ++ + E
Sbjct: 211 STAPATAGNFLVNPLEPKNAE 231
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-14
Identities = 37/181 (20%), Positives = 69/181 (38%), Gaps = 45/181 (24%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALK--EVHDYQSAFRE--IEALQILQNSPNVV 75
++LE G + V+K + N VA+K + D QS E + +L +++ N++
Sbjct: 25 PLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKH-ENIL 81
Query: 76 VLHEYFWREDEDAV---LVLEFL------------------RTDLATVIAESKKKREDRG 114
R V L+ F +A +A
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMA---------- 131
Query: 115 DRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174
RG++ ++ + + G+ H+ I HRD+K N+L+ ++ +ADFG A
Sbjct: 132 -RGLA------YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 175 E 175
+
Sbjct: 185 K 185
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 43/197 (21%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQS 57
+ +W I R + ++ + +G+G + +V+ + + VA +K
Sbjct: 175 QKPWEKDAWEIP-RESL----KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVE 228
Query: 58 AF-REIEALQILQNSPNVVVLH------------EYFWREDEDAVLVLEFLRTDLATVIA 104
AF E ++ LQ+ +V LH E+ + +L+FL++
Sbjct: 229 AFLAEANVMKTLQH-DKLVKLHAVVTKEPIYIITEFMAKGS-----LLDFLKS------- 275
Query: 105 ESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164
+ ++ + QI G+ + +HRDL+ N+L+ V K+AD
Sbjct: 276 --------DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIAD 327
Query: 165 FGQARILLGNEFDAPDG 181
FG AR++ NE+ A +G
Sbjct: 328 FGLARVIEDNEYTAREG 344
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 34/184 (18%), Positives = 70/184 (38%), Gaps = 40/184 (21%)
Query: 16 EIIA-KYEILECVGSGAYSDVYKGR-RLSDNLIVALKEVHD----YQSAFREIEALQILQ 69
+ + +YEI+ +G G + V + VALK + + ++A EI L+ ++
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIK 74
Query: 70 -----NSPNVVVLHEYF-WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
N V++ ++F + + E L + + ++ + + +
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGH--MCIAFELLGKNTFEFL-------KENNFQPYPLPHV 125
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV-------------------LKLAD 164
+ Q+ + H N + H DLKP N+L + +++AD
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 165 FGQA 168
FG A
Sbjct: 186 FGSA 189
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 40/165 (24%), Positives = 82/165 (49%), Gaps = 24/165 (14%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQ--NS 71
EIL +G G++ V ++ + A+K ++ + ++ F+E LQI+Q
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE---LQIMQGLEH 74
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
P +V L Y ++++ED +V++ L DL + ++ +E+ +K ++ ++
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET---------VKLFICEL 124
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+ +D I+HRD+KP N+L+ + G + + DF A +L
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 42/184 (22%), Positives = 73/184 (39%), Gaps = 40/184 (21%)
Query: 16 EIIA-KYEILECVGSGAYSDVYKGR-RLSDNLIVALKEVHD----YQSAFREIEALQILQ 69
++++ +YEI++ +G GA+ V + + VA+K V + ++A EI+ L+ L
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 70 -----NSPNVVVLHEYF-WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
++ V + E+F +V E L I E+ + I
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGH--ICIVFELLGLSTYDFIKENGF-------LPFRLDHI 120
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV-------------------LKLAD 164
++ QI V+ H N + H DLKP N+L +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 165 FGQA 168
FG A
Sbjct: 181 FGSA 184
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 43/195 (22%)
Query: 4 PLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQSAF- 59
P W + R +I + +G G Y +VY+G +L VA LKE F
Sbjct: 3 PNYDKWEME-RTDI----TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL 57
Query: 60 REIEALQILQNSPNVVVLHEYFWREDEDAV--------LVLEF-----LRTDLATVIAES 106
+E ++ +++ PN+V L V ++ EF L L
Sbjct: 58 KEAAVMKEIKH-PNLVQLL---------GVCTREPPFYIITEFMTYGNLLDYL------- 100
Query: 107 KKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
RE +S + QI S ++ + +HRDL N L+G++ ++K+ADFG
Sbjct: 101 ---RECNRQE-VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 167 QARILLGNEFDAPDG 181
+R++ G+ + A G
Sbjct: 157 LSRLMTGDTYTAHAG 171
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 29/174 (16%), Positives = 64/174 (36%), Gaps = 31/174 (17%)
Query: 20 KYEILECVGSGAYSDVYKGRRLS--------DNLIVALK----------EVHDYQSAFR- 60
++++ +Y+ S +LK E + +Q A +
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 61 -EIEALQILQNSPNVVV--LHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRG 117
++ + L ++P + + + +D+ LVL L L + + S K
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV------- 155
Query: 118 ISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLADFGQAR 169
+S + + ++L ++ H N VH ++ N+ + D + LA +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 34/184 (18%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQSAF-REIEALQILQNSPNVVVL 77
+ +G G + +V+ G + VA LK AF +E + ++ L++ +V L
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQL 327
Query: 78 HEYFWREDEDAVLV----------LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWM 127
+ E+ + + L+FL+ + + + ++
Sbjct: 328 YAVV---SEEPIYIVTEYMSKGSLLDFLKG---------------ETGKYLRLPQLVDMA 369
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCE 187
QI SG+ R VHRDL+ N+L+G++ V K+ADFG AR++ NE+ A G P +
Sbjct: 370 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429
Query: 188 PNAP 191
AP
Sbjct: 430 WTAP 433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 47/203 (23%)
Query: 2 EQPLPK-SWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DY 55
+ +PK W ++ ++ + E +G G + +V+ GR +DN +VA+K D
Sbjct: 101 HRAVPKDKWVLN-HEDL----VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL 155
Query: 56 QSAF-REIEALQILQNSPNVVVLHEYFWREDEDAV--------LVLEF-----LRTDLAT 101
++ F +E L+ + PN+V L V +V+E T L
Sbjct: 156 KAKFLQEARILKQYSH-PNIVRLI---------GVCTQKQPIYIVMELVQGGDFLTFL-- 203
Query: 102 VIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161
R + + V + + + +G++ +HRDL N L+ + VLK
Sbjct: 204 --------RTEGAR--LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLK 253
Query: 162 LADFGQARILLGNEFDAPDGNSQ 184
++DFG +R + A G Q
Sbjct: 254 ISDFGMSREEADGVYAASGGLRQ 276
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 21/156 (13%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKE------VHDYQSAFREIEALQILQ--NSP 72
+EIL+ +G GA+S+V + + A+K + + + E +L +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER-DVLVNGDRR 121
Query: 73 NVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
+ LH F +DE+ + LV+E+ DL T++ K +R I + ++ +I
Sbjct: 122 WITQLHFAF--QDENYLYLVMEYYVGGDLLTLL----SKFGER----IPAEMARFYLAEI 171
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ +D+ HR VHRD+KP N+L+ G ++LADFG
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-13
Identities = 46/196 (23%), Positives = 86/196 (43%), Gaps = 44/196 (22%)
Query: 3 QPLPKS-WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQSA 58
+P + W + R + +++E +G+G + +V+ G + + VA LK+ A
Sbjct: 1 KPWWEDEWEVP-RETL----KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDA 54
Query: 59 F-REIEALQILQNSPNVVVLHEYFWREDEDAV-------LVLEF-----LRTDLATVIAE 105
F E ++ LQ+ +V L+ AV ++ E+ L L
Sbjct: 55 FLAEANLMKQLQH-QRLVRLY---------AVVTQEPIYIITEYMENGSLVDFL------ 98
Query: 106 SKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165
+ G + +++ ++ QI G+ +HRDL+ N+L+ D K+ADF
Sbjct: 99 ----KTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF 153
Query: 166 GQARILLGNEFDAPDG 181
G AR++ NE+ A +G
Sbjct: 154 GLARLIEDNEYTAREG 169
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 47/186 (25%), Positives = 81/186 (43%), Gaps = 38/186 (20%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQSAF-REIEALQILQNSPNVVVL 77
+ +G G + +V+ G + VA LK AF +E + ++ L++ +V L
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQL 244
Query: 78 H------------EYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
+ EY + +L+FL+ + + + ++
Sbjct: 245 YAVVSEEPIYIVTEYMSKGS-----LLDFLKG---------------ETGKYLRLPQLVD 284
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQP 185
QI SG+ R VHRDL+ N+L+G++ V K+ADFG AR++ NE+ A G P
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 186 CEPNAP 191
+ AP
Sbjct: 345 IKWTAP 350
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 22 EILECVGSGAYSDVYKGR----RLSDNLIVA---LKEVH-DYQSAF-REIEALQILQNSP 72
+ + +G G + V R + +VA L+ D Q F REI+ L+ L +
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-D 84
Query: 73 NVVVLHEYFWREDEDAV-LVLEF-----LRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
+V + ++ LV+E+ LR L + R + + +
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----------QRHRAR--LDASRLLLY 132
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
QI G++ VHRDL N+L+ + +K+ADFG A++L ++
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 43/164 (26%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKE------VHDYQSAFREIEALQILQ--NSP 72
+EIL+ +G GA+ +V + + + + A+K + ++A E +L +S
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER-DVLVNGDSK 134
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+ LH Y +++D + LV+++ DL T++ K EDR + + ++ +++
Sbjct: 135 WITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL----SKFEDR----LPEEMARFYLAEMV 185
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+D+ H+ VHRD+KP N+L+ +G ++LADFG L+ +
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 35/182 (19%), Positives = 70/182 (38%), Gaps = 23/182 (12%)
Query: 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR---RLSDNLIVALKEVHDYQSAF 59
+ + I + + +G G + V + + + VA+K + A
Sbjct: 12 KEKLEDVLIP-EQQFT----LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS 66
Query: 60 REIEAL----QILQ--NSPNV-----VVLHEYFWREDEDAVLVLEFLRT-DLATVIAESK 107
+IE ++ + P+V V L +++L F++ DL +
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL---L 123
Query: 108 KKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167
R + + + R+MV I G++ +HRDL N ++ +D + +ADFG
Sbjct: 124 ASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
Query: 168 AR 169
+R
Sbjct: 184 SR 185
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 28/175 (16%), Positives = 61/175 (34%), Gaps = 33/175 (18%)
Query: 20 KYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEV-HDYQSAFREIEALQILQNSPN 73
+++ +G G + +Y S + +K D F E++ Q
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 74 VVVLHE-------------YFWREDEDA----VLVLEFLRTDLATVIAESKKKREDRGDR 116
+ D++ ++++ +DL + + K+
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR------- 148
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLADFGQAR 169
S + + ++IL ++ H + VH D+K NLL+ + + L D+G A
Sbjct: 149 -FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 38/192 (19%), Positives = 76/192 (39%), Gaps = 28/192 (14%)
Query: 5 LPKSWSIHTRPEIIAKYEI-------LECVGSGAYSDVYKGR-----RLSDNLIVALKEV 52
LP P +K+E + +G GA+ V + + + VA+K +
Sbjct: 6 LPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 65
Query: 53 HDY-----QSAF-REIEALQILQNSPNVVVLHEYFWREDEDAVLVLE---------FLRT 97
+ A E++ L + + NVV L + ++++E +LR+
Sbjct: 66 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157
+ + D +++ + + Q+ G++ +HRDL N+L+ +
Sbjct: 126 KRNEFVPYKVAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 158 GVLKLADFGQAR 169
V+K+ DFG AR
Sbjct: 185 NVVKICDFGLAR 196
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 40/188 (21%), Positives = 66/188 (35%), Gaps = 25/188 (13%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVA---LKEVH 53
+ P W R + + +G+GA+ V + + + VA LK
Sbjct: 11 QLPYDHKWEFP-RNRLS----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65
Query: 54 DYQ--SAF-REIEALQILQNSPNVVVLHEYFWREDEDAVLV--------LEFLRTDLATV 102
A E++ L L N N+V L V+ L FLR +
Sbjct: 66 HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 103 IAESKKKREDRGDRG-ISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161
I D + + ++ + Q+ G+ +HRDL N+L+ + K
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK 185
Query: 162 LADFGQAR 169
+ DFG AR
Sbjct: 186 ICDFGLAR 193
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 39/198 (19%)
Query: 4 PLPKSWSIHTRPEIIAKYEI-------LECVGSGAYSDVYKGRRLSDNLIVA---LKEVH 53
PL + T +EI L+ +G+G + V G+ VA +KE
Sbjct: 2 PLGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGS 60
Query: 54 DYQSAF-REIEALQILQNSPNVVVLHEYFWREDEDAV--------LVLEFLRT-DLATVI 103
+ F E + + L + +V L+ V ++ E++ L +
Sbjct: 61 MSEDEFIEEAKVMMNLSH-EKLVQLY---------GVCTKQRPIFIITEYMANGCLLNYL 110
Query: 104 AESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163
RE R ++ + ++ +HRDL N L+ D GV+K++
Sbjct: 111 ------REMRHR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 162
Query: 164 DFGQARILLGNEFDAPDG 181
DFG +R +L +E+ + G
Sbjct: 163 DFGLSRYVLDDEYTSSVG 180
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 38/169 (22%), Positives = 76/169 (44%), Gaps = 28/169 (16%)
Query: 22 EILECVGSGAYSDVYKGR----RLSDNLIVALK----EVHDYQSAF-REIEALQILQNSP 72
+ L+ +G G + V R + + +VA+K ++ F REIE L+ LQ+
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-D 102
Query: 73 NVVVLHEYFWREDEDAV-LVLEF-----LRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
N+V + + L++E+ LR L ++ + I ++ ++
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----------QKHKER--IDHIKLLQY 150
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
QI G++ +HRDL N+L+ ++ +K+ DFG ++L ++
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 38/169 (22%), Positives = 76/169 (44%), Gaps = 28/169 (16%)
Query: 22 EILECVGSGAYSDVYKGR----RLSDNLIVALK----EVHDYQSAF-REIEALQILQNSP 72
+ L+ +G G + V R + + +VA+K ++ F REIE L+ LQ+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-D 71
Query: 73 NVVVLHEYFWREDEDAV-LVLEF-----LRTDLATVIAESKKKREDRGDRGISVGEIKRW 126
N+V + + L++E+ LR L ++ + I ++ ++
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----------QKHKER--IDHIKLLQY 119
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
QI G++ +HRDL N+L+ ++ +K+ DFG ++L ++
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 41/196 (20%), Positives = 71/196 (36%), Gaps = 49/196 (25%)
Query: 2 EQPL-PKSWSIHTRPEIIAKYEILECVGSGAYSDVYKG--RRLSDNLIVALKEV------ 52
+ + PK + R + + + L GSG + V KG + VA+K +
Sbjct: 3 LEEIRPKEVYLD-RKLLTLEDKEL---GSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 58
Query: 53 HDYQSAF-REIEALQILQNSPNVVVLHEYFWREDEDAV-------LVLEF-----LRTDL 99
+ E +Q L N P +V + + LV+E L L
Sbjct: 59 PALKDELLAEANVMQQLDN-PYIVRMI---------GICEAESWMLVMEMAELGPLNKYL 108
Query: 100 ATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159
+ +R + I + Q+ G+ + VHRDL N+L+
Sbjct: 109 -------------QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY 155
Query: 160 LKLADFGQARILLGNE 175
K++DFG ++ L +E
Sbjct: 156 AKISDFGLSKALRADE 171
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 39/183 (21%)
Query: 19 AKYEI-------LECVGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQSAF-REIEALQI 67
K+ I ++ +GSG + V+ G + VA ++E + F E E +
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMK 59
Query: 68 LQNSPNVVVLHEYFWREDEDAV--------LVLEFLRT-DLATVIAESKKKREDRGDRGI 118
L + P +V L+ V LV EF+ L+ + R RG
Sbjct: 60 LSH-PKLVQLY---------GVCLEQAPICLVTEFMEHGCLSDYL------RTQRGL--F 101
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDA 178
+ + + + G+ ++HRDL N L+G++ V+K++DFG R +L +++ +
Sbjct: 102 AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161
Query: 179 PDG 181
G
Sbjct: 162 STG 164
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 42/188 (22%), Positives = 81/188 (43%), Gaps = 28/188 (14%)
Query: 2 EQPLPKS--WSIHTRPEIIAKYEILECVGSGAYSDVYKGR--RLSDN--LIVA---LKEV 52
++P + + + + +G G + V R DN VA LK
Sbjct: 7 KKPATEVDPTHFE-KRFLK----RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE 61
Query: 53 H--DYQSAF-REIEALQILQNSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESK 107
++ + +EIE L+ L + N+V + + + L++EFL + L + ++K
Sbjct: 62 SGGNHIADLKKEIEILRNLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 108 KKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167
K I++ + ++ VQI G+D VHRDL N+L+ + +K+ DFG
Sbjct: 121 NK--------INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172
Query: 168 ARILLGNE 175
+ + ++
Sbjct: 173 TKAIETDK 180
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 22/181 (12%)
Query: 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR---RLSDNLIVALKEVHDYQSAF 59
Q + I R +I + + +G G + V +G +L VA+K + S+
Sbjct: 23 QNKLEDVVID-RNLLI----LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ 77
Query: 60 REIEAL----QILQ--NSPNVV----VLHEYFWREDEDAVLVLEFLRT-DLATVIAESKK 108
REIE ++ + PNV+ V E + +++L F++ DL T +
Sbjct: 78 REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL---LY 134
Query: 109 KREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
R + G + I + + ++MV I G++ +HRDL N ++ DD + +ADFG +
Sbjct: 135 SRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
Query: 169 R 169
+
Sbjct: 195 K 195
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 25/168 (14%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKE------VHDYQSAFREIEALQILQ--NSP 72
YE+++ +G GA+ +V R S + A+K + SAF E I+ NSP
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER-DIMAFANSP 129
Query: 73 NVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKR--EDRGDRGISVGEIKRWMVQ 129
VV L Y +++D +V+E++ DL ++ E + + +
Sbjct: 130 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWA---------RFYTAE 176
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFD 177
++ +DA H +HRD+KP N+L+ G LKLADFG +
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 38/186 (20%), Positives = 72/186 (38%), Gaps = 37/186 (19%)
Query: 9 WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQSAF-REIEA 64
+ R EI +L+ +GSG + V G+ VA +KE + F +E +
Sbjct: 3 MELK-REEI----TLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQT 56
Query: 65 LQILQNSPNVVVLHEYFWREDEDAV--------LVLEFLRT-DLATVIAESKKKREDRGD 115
+ L + P +V + V +V E++ L + R
Sbjct: 57 MMKLSH-PKLVKFY---------GVCSKEYPIYIVTEYISNGCLLNYL------RSHGKG 100
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+ ++ + G+ + +HRDL N L+ D +K++DFG R +L ++
Sbjct: 101 --LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
Query: 176 FDAPDG 181
+ + G
Sbjct: 159 YVSSVG 164
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 3e-11
Identities = 32/210 (15%), Positives = 67/210 (31%), Gaps = 47/210 (22%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------- 53
Q P +S H P K + E +G G + +V++ +D+ VA+K +
Sbjct: 6 SQKGPVPFS-HCLPT--EKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVN 60
Query: 54 -----DYQSAFREIEALQILQ--------NSPNVVVLHE-YFWREDEDAVLVLEFLRTD- 98
++ EI + L + + L+ + + +L+ + +
Sbjct: 61 GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120
Query: 99 ------------------LATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN 140
+ E + S+ K + Q+ + + +
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 141 -TIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
HRDL GN+L+ + KL +
Sbjct: 181 LRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 41/185 (22%), Positives = 70/185 (37%), Gaps = 38/185 (20%)
Query: 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKG--RRLSDNLIVA---LKEVHDYQS--AF 59
K + +IA E+ G G + V +G R + VA LK+ +
Sbjct: 2 KKLFLKRDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM 57
Query: 60 -REIEALQILQNSPNVVVLHEYFWREDEDAV-------LVLEFLRT-DLATVIAESKKKR 110
RE + + L N P +V L V LV+E L + +++
Sbjct: 58 MREAQIMHQLDN-PYIVRLI---------GVCQAEALMLVMEMAGGGPLHKFLVGKREE- 106
Query: 111 EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
I V + + Q+ G+ VHRDL N+L+ + K++DFG ++
Sbjct: 107 -------IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159
Query: 171 LLGNE 175
L ++
Sbjct: 160 LGADD 164
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 31/187 (16%), Positives = 64/187 (34%), Gaps = 44/187 (23%)
Query: 9 WSIHTRPEIIAKYEILECVGSGAYSDVYKGR----RLSDNLIVA---LKEVHDYQS--AF 59
H + + + +G G + V +VA LK Q +
Sbjct: 26 TVFH-KRYLK----KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW 80
Query: 60 -REIEALQILQNSPNVVVLHEYFWREDEDAVLV----------LEFLRTDLATVIAESKK 108
+EI+ L+ L + +++ ++ + ++L
Sbjct: 81 KQEIDILRTLYH-EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP------------ 127
Query: 109 KREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
I + ++ + QI G+ H +HRDL N+L+ +D ++K+ DFG A
Sbjct: 128 ------RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 169 RILLGNE 175
+ +
Sbjct: 182 KAVPEGH 188
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 51/198 (25%)
Query: 2 EQPLPK-SWSIHTRPEIIAKYEILECVGSGAYSDVYKGR---RLSDNLIVALK------- 50
E PL + I ++ +LE +G G++ V +G + VA+K
Sbjct: 5 EGPLQSLTCLIG-EKDL----RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL 59
Query: 51 EVHDYQSAF-REIEALQILQNSPNVVVLHEYFWREDEDAV-------LVLEF-----LRT 97
+ F RE+ A+ L + N++ L+ V +V E L
Sbjct: 60 SQPEAMDDFIREVNAMHSLDH-RNLIRLY---------GVVLTPPMKMVTELAPLGSLLD 109
Query: 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157
L R+ +G +G + R+ VQ+ G+ +HRDL NLL+
Sbjct: 110 RL----------RKHQGH--FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR 157
Query: 158 GVLKLADFGQARILLGNE 175
++K+ DFG R L N+
Sbjct: 158 DLVKIGDFGLMRALPQND 175
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 38/195 (19%), Positives = 78/195 (40%), Gaps = 37/195 (18%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-------RLSDNLIVALKEVH 53
E P W R ++ + + +G GA+ V + + + VA+K +
Sbjct: 22 YELPEDPKWEF-PRDKLT----LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 54 DYQSA------FREIEALQILQNSPNVVVLH-------------EYFWREDEDAVLVLEF 94
D + E+E ++++ N++ L EY + + + E+
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN-----LREY 131
Query: 95 LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154
LR + S ++ ++ ++ Q+ G++ +HRDL N+L+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQ-MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 155 GDDGVLKLADFGQAR 169
++ V+K+ADFG AR
Sbjct: 191 TENNVMKIADFGLAR 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 39/197 (19%), Positives = 76/197 (38%), Gaps = 41/197 (20%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-------RLSDNLIVALKEVH 53
E P W R ++ + + +G G + V + + + VA+K +
Sbjct: 68 YELPEDPKWEF-PRDKL----TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 122
Query: 54 DY-----QSAF-REIEALQILQNSPNVVVLH-------------EYFWREDEDAVLVLEF 94
D S E+E ++++ N++ L EY + + E+
Sbjct: 123 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL-----REY 177
Query: 95 LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD--ACHRNTIVHRDLKPGNL 152
LR E + ++ ++ Q+ G++ A + +HRDL N+
Sbjct: 178 LR-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV 234
Query: 153 LIGDDGVLKLADFGQAR 169
L+ ++ V+K+ADFG AR
Sbjct: 235 LVTENNVMKIADFGLAR 251
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 45/196 (22%), Positives = 73/196 (37%), Gaps = 48/196 (24%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR----RLSDNLIVA---LKEVHD 54
E P I E + ++ +GSGA+ VYKG + VA L+E
Sbjct: 2 EAPNQALLRILKETEF----KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 55 YQSA---FREIEALQILQNSPNVVVLHEYFWREDEDAV-------LVLEF-----LRTDL 99
++ E + + N P+V L + L+ + L +
Sbjct: 58 PKANKEILDEAYVMASVDN-PHVCRLL---------GICLTSTVQLITQLMPFGCLLDYV 107
Query: 100 ATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159
RE + + I + W VQI G++ +VHRDL N+L+
Sbjct: 108 ----------REHKDN--IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH 155
Query: 160 LKLADFGQARILLGNE 175
+K+ DFG A++L E
Sbjct: 156 VKITDFGLAKLLGAEE 171
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 42/183 (22%), Positives = 75/183 (40%), Gaps = 24/183 (13%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKG--RRLSDNLIVALK------EVH 53
E+ K + +IA E+ G G + V +G R + VA+K E
Sbjct: 323 EELKDKKLFLKRDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA 378
Query: 54 DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKRED 112
D + RE + + L N P +V L + E +LV+E L + +++
Sbjct: 379 DTEEMMREAQIMHQLDN-PYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--- 432
Query: 113 RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172
I V + + Q+ G+ VHR+L N+L+ + K++DFG ++ L
Sbjct: 433 -----IPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487
Query: 173 GNE 175
++
Sbjct: 488 ADD 490
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 35/181 (19%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQS 57
++ W+++ E+ ++L+ +G G + DV G VA +K Q+
Sbjct: 180 QDEFYRSGWALN-MKEL----KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA 232
Query: 58 AFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE---------FLRTDLATVIAESKK 108
E + L++ N+V L E +V E +LR+
Sbjct: 233 FLAEASVMTQLRH-SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS----------- 280
Query: 109 KREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
RG + + ++ + + ++ N VHRDL N+L+ +D V K++DFG
Sbjct: 281 ----RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
Query: 169 R 169
+
Sbjct: 337 K 337
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 22/183 (12%)
Query: 6 PKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR---RLSDNLIVA---LKEVHDYQ--S 57
+ I I+ E +G G + VY G + A L + D S
Sbjct: 79 VQHVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 135
Query: 58 AF-REIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGD 115
F E ++ + PNV+ L R + ++VL +++ DL I R + +
Sbjct: 136 QFLTEGIIMKDFSH-PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHN 188
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+V ++ + +Q+ G+ VHRDL N ++ + +K+ADFG AR + E
Sbjct: 189 --PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 176 FDA 178
FD+
Sbjct: 247 FDS 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 9e-11
Identities = 42/183 (22%), Positives = 76/183 (41%), Gaps = 22/183 (12%)
Query: 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR---RLSDNLIVA---LKEVHDYQ 56
K I + ++ G G + VY G + + + A L + + Q
Sbjct: 8 LAEVKDVLIPHERVVTHSDRVI---GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 57 S--AF-REIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKRED 112
AF RE ++ L + PNV+ L + ++L ++ DL I R
Sbjct: 65 QVEAFLREGLLMRGLNH-PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI------RSP 117
Query: 113 RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172
+ + +V ++ + +Q+ G++ VHRDL N ++ + +K+ADFG AR +L
Sbjct: 118 QRN--PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175
Query: 173 GNE 175
E
Sbjct: 176 DRE 178
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 39/195 (20%), Positives = 76/195 (38%), Gaps = 37/195 (18%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-------RLSDNLIVALKEVH 53
E P W + R ++ + + +G GA+ V + + VA+K +
Sbjct: 56 YELPEDPRWEL-PRDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 110
Query: 54 DY-----QSAF-REIEALQILQNSPNVV-------------VLHEYFWREDEDAVLVLEF 94
S E+E ++++ N++ V+ EY + + + E+
Sbjct: 111 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN-----LREY 165
Query: 95 LRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154
L+ E + +S ++ Q+ G++ +HRDL N+L+
Sbjct: 166 LQA-RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224
Query: 155 GDDGVLKLADFGQAR 169
+D V+K+ADFG AR
Sbjct: 225 TEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 43/199 (21%), Positives = 76/199 (38%), Gaps = 40/199 (20%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVA---LKEV 52
E W R + + +GSGA+ V + ++ VA LKE
Sbjct: 32 REYEYDLKWEFP-RENLE----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 86
Query: 53 HDYQ--SAF-REIEALQILQNSPNVV-------------VLHEYFWREDEDAVLVLEFLR 96
D A E++ + L + N+V ++ EY D +L +LR
Sbjct: 87 ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD-----LLNYLR 141
Query: 97 ------TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPG 150
++ K+ E+ ++ ++ + Q+ G++ + VHRDL
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201
Query: 151 NLLIGDDGVLKLADFGQAR 169
N+L+ V+K+ DFG AR
Sbjct: 202 NVLVTHGKVVKICDFGLAR 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 40/191 (20%), Positives = 74/191 (38%), Gaps = 49/191 (25%)
Query: 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR----RLSDNLIVA---LKEVHDYQS-- 57
+ E+ L+ +GSG + V+KG S + V +++ QS
Sbjct: 6 LARIFK-ETELR----KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 58 AF-REIEALQILQNSPNVVVLHEYFWREDEDAV-------LVLEF-----LRTDLATVIA 104
A + A+ L + ++V L + LV ++ L +
Sbjct: 61 AVTDHMLAIGSLDH-AHIVRLL---------GLCPGSSLQLVTQYLPLGSLLDHV----- 105
Query: 105 ESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164
R+ RG + + W VQI G+ + +VHR+L N+L+ +++AD
Sbjct: 106 -----RQHRGA--LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVAD 158
Query: 165 FGQARILLGNE 175
FG A +L ++
Sbjct: 159 FGVADLLPPDD 169
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 38/189 (20%), Positives = 75/189 (39%), Gaps = 46/189 (24%)
Query: 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR---RLSDNLIVALKEVHDYQSAFREIE 63
+ + I R I E+ C+G G + DV++G + L VA+K + S +
Sbjct: 8 RDYEIQ-RERI----ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 62
Query: 64 ALQ---ILQ--NSPNVVVLHEYFWREDEDAV-------LVLEF-----LRTDLATVIAES 106
LQ ++ + P++V L V +++E LR+ L
Sbjct: 63 FLQEALTMRQFDHPHIVKLI---------GVITENPVWIIMELCTLGELRSFL------- 106
Query: 107 KKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ + + + + + Q+ + + VHRD+ N+L+ + +KL DFG
Sbjct: 107 ---QVRKYS--LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161
Query: 167 QARILLGNE 175
+R + +
Sbjct: 162 LSRYMEDST 170
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 38/194 (19%), Positives = 76/194 (39%), Gaps = 46/194 (23%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR---RLSDNLIVALKEVHDYQSA 58
P + + I R I E+ C+G G + DV++G + + VA+K + S
Sbjct: 378 TMPSTRDYEIQ-RERI----ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 59 FREIEALQ---ILQ--NSPNVVVLHEYFWREDEDAV-------LVLEF-----LRTDLAT 101
+ LQ ++ + P++V L V +++E LR+ L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLI---------GVITENPVWIIMELCTLGELRSFL-- 481
Query: 102 VIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161
+ + + + + + Q+ + + VHRD+ N+L+ + +K
Sbjct: 482 --------QVRKFS--LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 531
Query: 162 LADFGQARILLGNE 175
L DFG +R + +
Sbjct: 532 LGDFGLSRYMEDST 545
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 42/188 (22%), Positives = 76/188 (40%), Gaps = 22/188 (11%)
Query: 6 PKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR---RLSDNLIVA---LKEVHDYQ--S 57
+ I I+ E +G G + VY G + A L + D S
Sbjct: 15 VQHVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 71
Query: 58 AF-REIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGD 115
F E ++ + PNV+ L R + ++VL +++ DL I R + +
Sbjct: 72 QFLTEGIIMKDFSH-PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHN 124
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+V ++ + +Q+ G+ VHRDL N ++ + +K+ADFG AR + E
Sbjct: 125 --PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 176 FDAPDGNS 183
+ + +
Sbjct: 183 YYSVHNKT 190
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 38/176 (21%), Positives = 68/176 (38%), Gaps = 44/176 (25%)
Query: 22 EILECVGSGAYSDVYKGR---RLSDNLIVALKEVHD-----YQSAF-REIEALQILQNSP 72
I + +GSG +V GR ++ VA+K + + F E + + P
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-P 110
Query: 73 NVVVLHEYFWREDEDAV--------LVLEF-----LRTDLATVIAESKKKREDRGDRGIS 119
N++ L V +V E+ L T L R G +
Sbjct: 111 NIIRLE---------GVVTRGRLAMIVTEYMENGSLDTFL----------RTHDGQ--FT 149
Query: 120 VGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+ ++ + + +G+ VHRDL N+L+ + V K++DFG +R+L +
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 18/155 (11%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSPN 73
+G G + +V+ + + + A K + YQ A E + L + +S
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRF 246
Query: 74 VVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+V L F E + + LV+ + D+ I + + G + QI+
Sbjct: 247 IVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIV 299
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
SG++ H+ I++RDLKP N+L+ DDG ++++D G
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG 334
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 3e-10
Identities = 33/184 (17%), Positives = 71/184 (38%), Gaps = 40/184 (21%)
Query: 9 WSIHTRPEIIAKYEILECVGSGAYSDVYKGR---RLSDNLIVA---LKEVHDYQS--AF- 59
+ I R +++ + +G G + +VY+G + + VA K+ + F
Sbjct: 7 YGIA-REDVV----LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM 61
Query: 60 REIEALQILQNSPNVVVLHEYFWREDEDAV-------LVLEFLRT-DLATVIAESKKKRE 111
E ++ L + P++V L + +++E +L +
Sbjct: 62 SEAVIMKNLDH-PHIVKLI---------GIIEEEPTWIIMELYPYGELGHYL------ER 105
Query: 112 DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
++ + V + + +QI + VHRD+ N+L+ +KL DFG +R +
Sbjct: 106 NKNS--LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163
Query: 172 LGNE 175
+
Sbjct: 164 EDED 167
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 39/170 (22%), Positives = 69/170 (40%), Gaps = 31/170 (18%)
Query: 23 ILECVGSGAYSDVYKGR--RLSDNLIVALKEVHDYQSA------FREIEALQILQNSPNV 74
+ +G G + V K R + + A+K + +Y S E+E L L + PN+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 75 VVL------HEYFWREDEDAVLVLE---------FLRTDLATVIAESKKKREDRGDRGIS 119
+ L Y + L +E FLR + + +S
Sbjct: 89 INLLGACEHRGYLY-------LAIEYAPHGNLLDFLRKSRVLE-TDPAFAIANSTASTLS 140
Query: 120 VGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
++ + + G+D + +HRDL N+L+G++ V K+ADFG +R
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 38/180 (21%), Positives = 71/180 (39%), Gaps = 35/180 (19%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQSA 58
++ W+++ E+ ++L+ +G G + DV G VA +K Q+
Sbjct: 9 DEFYRSGWALN-MKEL----KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAF 61
Query: 59 FREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE---------FLRTDLATVIAESKKK 109
E + L++ N+V L E +V E +LR
Sbjct: 62 LAEASVMTQLRH-SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR------------- 107
Query: 110 REDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
RG + + ++ + + ++ N VHRDL N+L+ +D V K++DFG +
Sbjct: 108 --SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 40/192 (20%), Positives = 73/192 (38%), Gaps = 42/192 (21%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVHDYQ 56
+ +P W + R +I + +G G++ VY+G + VA+K V++
Sbjct: 13 DVYVPDEWEV-AREKIT----MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67
Query: 57 SA------FREIEALQILQNSPNVV-------------VLHEYFWREDEDAVLVLEFLRT 97
S E ++ N +VV V+ E R D + +LR
Sbjct: 68 SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGD-----LKSYLR- 120
Query: 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157
+ + S+ ++ + +I G+ + N VHRDL N ++ +D
Sbjct: 121 ------SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174
Query: 158 GVLKLADFGQAR 169
+K+ DFG R
Sbjct: 175 FTVKIGDFGMTR 186
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+++L +G G+Y+ V R + I A+K + D E + N P
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+V LH F E V+E++ DL + +K E+ + + +I
Sbjct: 71 FLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHA---------RFYSAEIS 120
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ H I++RDLK N+L+ +G +KL D+G
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-10
Identities = 45/196 (22%), Positives = 72/196 (36%), Gaps = 48/196 (24%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR----RLSDNLIVA---LKEVHD 54
E P I E ++ +GSGA+ VYKG + VA L+E
Sbjct: 2 EAPNQALLRILKETEFK----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 55 YQS--AF-REIEALQILQNSPNVVVLHEYFWREDEDAV-------LVLEF-----LRTDL 99
++ E + + N P+V L + L+ + L +
Sbjct: 58 PKANKEILDEAYVMASVDN-PHVCRLL---------GICLTSTVQLITQLMPFGCLLDYV 107
Query: 100 ATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159
RE + + I + W VQI G++ +VHRDL N+L+
Sbjct: 108 ----------REHKDN--IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH 155
Query: 160 LKLADFGQARILLGNE 175
+K+ DFG A++L E
Sbjct: 156 VKITDFGLAKLLGAEE 171
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+++L +G G+Y+ V R + I A++ + D E + N P
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+V LH F E V+E++ DL + +K E+ + + +I
Sbjct: 114 FLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHA---------RFYSAEIS 163
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ H I++RDLK N+L+ +G +KL D+G
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 32/157 (20%), Positives = 66/157 (42%), Gaps = 23/157 (14%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQN--S 71
+ +G G + +VY R+ + A+K A E L ++
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 72 PNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
P +V + F D + +L+ + DL +++ E ++ + +
Sbjct: 252 PFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD---------MRFYAAE 300
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
I+ G++ H +V+RDLKP N+L+ + G ++++D G
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 36/157 (22%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEAL----QILQ--NSPN 73
++ ++ +G+G++ V + A+K + ++IE +ILQ N P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 74 VVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+V L F +D + +V+E++ ++ + + + E + + QI+
Sbjct: 103 LVKLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---------RFYAAQIV 151
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
+ H +++RDLKP NLLI G +++ DFG A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 7e-10
Identities = 31/156 (19%), Positives = 73/156 (46%), Gaps = 22/156 (14%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
++IL +G+G++ V+ R + A+K + + E L I+ P
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 66
Query: 73 NVVVLHEYFWREDEDAV-LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
++ + F +D + ++++++ +L +++ +S++ K + ++
Sbjct: 67 FIIRMWGTF--QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA---------KFYAAEV 115
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ H I++RDLKP N+L+ +G +K+ DFG
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-10
Identities = 40/192 (20%), Positives = 70/192 (36%), Gaps = 37/192 (19%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKG-----RRLSDNLIVA---LKEVH 53
+ P + W R + + + +G+GA+ V + + L VA LK
Sbjct: 34 QLPYNEKWEFP-RNNL----QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 54 DYQ--SAF-REIEALQILQNSPNVV-------------VLHEYFWREDEDAVLVLEFLRT 97
A E++ + L N+V V+ EY D +L FLR
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD-----LLNFLRR 143
Query: 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157
+ + + S ++ + Q+ G+ +HRD+ N+L+ +
Sbjct: 144 KSRVLETDPA---FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200
Query: 158 GVLKLADFGQAR 169
V K+ DFG AR
Sbjct: 201 HVAKIGDFGLAR 212
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 34/155 (21%), Positives = 64/155 (41%), Gaps = 19/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+ L +G G++ V R + + A+K + D + E L + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 73 NVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+ LH F + + V+E++ DL I + + +E + +I
Sbjct: 403 FLTQLHSCF-QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA---------VFYAAEIA 452
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G+ I++RDLK N+++ +G +K+ADFG
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 20/156 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+ +G G + +V + + + A K + A E + L+ + NS
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSR 244
Query: 73 NVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
VV L + E +DA+ LVL + DL I G G + +I
Sbjct: 245 FVVSLAYAY--ETKDALCLVLTLMNGGDLKFHI-------YHMGQAGFPEARAVFYAAEI 295
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G++ HR IV+RDLKP N+L+ D G ++++D G
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLG 331
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 38/175 (21%), Positives = 71/175 (40%), Gaps = 43/175 (24%)
Query: 23 ILECVGSGAYSDVYKGR----RLSDNLIVALKEVHDYQSAFREIEALQ---ILQ--NSPN 73
+ +G+G + +VYKG + VA+K + + + ++ L I+ + N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 74 VVVLHEYFWREDEDAV--------LVLEF-----LRTDLATVIAESKKKREDRGDRGISV 120
++ L V ++ E+ L L RE G+ SV
Sbjct: 108 IIRLE---------GVISKYKPMMIITEYMENGALDKFL----------REKDGE--FSV 146
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
++ + I +G+ VHRDL N+L+ + V K++DFG +R+L +
Sbjct: 147 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+E + +G G++ V R + A+K + D + E L + +N P
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+ L F D V+EF+ DL I +S++ E R + + +I+
Sbjct: 85 FLTQLFCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARA---------RFYAAEII 134
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
S + H I++RDLK N+L+ +G KLADFG
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 37/160 (23%), Positives = 83/160 (51%), Gaps = 27/160 (16%)
Query: 22 EILECVGSGAYSDVYKGRRLSDN--------------LIVALKEVHDYQSAFREIEALQI 67
E+L+ +G+GAY V+ R++S + IV + ++ R++ L+
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV--LEH 114
Query: 68 LQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRW 126
++ SP +V LH Y ++ + L+L+++ +L T +++ ++ E ++ +
Sbjct: 115 IRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE---------VQIY 164
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ +I+ ++ H+ I++RD+K N+L+ +G + L DFG
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 33/155 (21%), Positives = 64/155 (41%), Gaps = 19/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+ L +G G++ V R + + A+K + D + E L + P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 73 NVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+ LH ++ + V+E++ DL I + + +E + +I
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA---------VFYAAEIA 131
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G+ I++RDLK N+++ +G +K+ADFG
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 41/175 (23%), Positives = 66/175 (37%), Gaps = 44/175 (25%)
Query: 23 ILECVGSGAYSDVYKGR---RLSDNLIVA---LKE--VHDYQSAF-REIEALQILQNSPN 73
I + VG+G + +V GR + VA LK + F E + + PN
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-PN 107
Query: 74 VVVLHEYFWREDEDAV--------LVLEF-----LRTDLATVIAESKKKREDRGDRGISV 120
++ L V +V E+ L + L R+ +V
Sbjct: 108 IIRLE---------GVVTKSKPVMIVTEYMENGSLDSFL----------RKHDAQ--FTV 146
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
++ + I SG+ VHRDL N+LI + V K++DFG R+L +
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 39/196 (19%), Positives = 78/196 (39%), Gaps = 36/196 (18%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVA---LKEVH 53
+ W R ++ + + +G G + V K + VA LKE
Sbjct: 11 KILEDPKWEFP-RKNLV----LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 54 DYQ--SAF-REIEALQILQNSPNVVVLHEYFWREDEDAVLV--------LEFLRT----- 97
E L+ + + P+V+ L+ ++ ++V FLR
Sbjct: 66 SPSELRDLLSEFNVLKQVNH-PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 98 --DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD--ACHRNTIVHRDLKPGNLL 153
L + + + + +R +++G++ + QI G+ A + +VHRDL N+L
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNIL 182
Query: 154 IGDDGVLKLADFGQAR 169
+ + +K++DFG +R
Sbjct: 183 VAEGRKMKISDFGLSR 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 4e-09
Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 36/163 (22%)
Query: 22 EILECVGSGAYSDVYKGRRLSDN--------------LIVALKEVHDYQSAFREIEALQI 67
E+L+ +G G++ V+ +++S + + V R I
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR--TKMER-----DI 79
Query: 68 LQ--NSPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEI 123
L N P +V LH F + E + L+L+FLR DL T +++ E+ +
Sbjct: 80 LVEVNHPFIVKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMFTEED---------V 128
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
K ++ ++ +D H I++RDLKP N+L+ ++G +KL DFG
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 49/202 (24%), Positives = 79/202 (39%), Gaps = 46/202 (22%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVHDY 55
+ P S R I + +G GA+ V++ R +VA+K + +
Sbjct: 34 LLNPKLLSLEYP-RNNIE----YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE 88
Query: 56 QSA------FREIEALQILQNSPNVV-------------VLHEYFWREDEDAVLVLEFLR 96
SA RE + N PN+V +L EY D + EFLR
Sbjct: 89 ASADMQADFQREAALMAEFDN-PNIVKLLGVCAVGKPMCLLFEYMAYGD-----LNEFLR 142
Query: 97 -------TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD--ACHRNTIVHRDL 147
L+ ++ + G +S E Q+ +G+ + + VHRDL
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDL 200
Query: 148 KPGNLLIGDDGVLKLADFGQAR 169
N L+G++ V+K+ADFG +R
Sbjct: 201 ATRNCLVGENMVVKIADFGLSR 222
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 5e-09
Identities = 39/177 (22%), Positives = 67/177 (37%), Gaps = 30/177 (16%)
Query: 22 EILECVGSGAYSDVYKGR-----RLSDNLIVA---LKEVHDYQSA--FREIEALQILQNS 71
+ +G GA+ V+ D ++VA LK+ RE E L LQ+
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH- 76
Query: 72 PNVVVLH-------------EYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGI 118
++V + EY D + +FLR + + +
Sbjct: 77 EHIVKFYGVCGDGDPLIMVFEYMKHGD-----LNKFLRAHGPDAMILVDGQPRQAKGE-L 130
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+ ++ QI SG+ VHRDL N L+G + ++K+ DFG +R + +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 39/174 (22%), Positives = 61/174 (35%), Gaps = 31/174 (17%)
Query: 22 EILECVGSGAYSDVYKGR-----RLSDNLIVA---LKEVH--DYQSAF-REIEALQILQN 70
+E +G + VYKG VA LK+ + F E LQ+
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 71 SPNVVVLH-------------EYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRG 117
PNVV L Y D + EFL S
Sbjct: 72 -PNVVCLLGVVTKDQPLSMIFSYCSHGD-----LHEFLVMRSPHSDVGSTDDDRTVKSA- 124
Query: 118 ISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ + + QI +G++ + +VH+DL N+L+ D +K++D G R +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 19/154 (12%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSPN 73
L+ +G G++ V R ++ + A+K + + + E L P
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+V LH F + + VL+++ +L + + E R + + +I S
Sbjct: 101 LVGLHFSF-QTADKLYFVLDYINGGELFYHLQRERCFLEPRA---------RFYAAEIAS 150
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ H IV+RDLKP N+L+ G + L DFG
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 37/155 (23%), Positives = 69/155 (44%), Gaps = 19/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEAL----QILQ--NSPN 73
+E L+ +G G + V + + A+K + + A E+ ++LQ P
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 74 VVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ L F + + V+E+ +L ++ + EDR + + +I+S
Sbjct: 210 LTALKYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRA---------RFYGAEIVS 259
Query: 133 GVDACH-RNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+D H +V+RDLK NL++ DG +K+ DFG
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG 294
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 8e-09
Identities = 37/155 (23%), Positives = 63/155 (40%), Gaps = 19/155 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALK--------EVHDYQSAFREIEALQILQNSP 72
+ + + +G G++ V+ N A+K D + E L + P
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
+ + F ++ + V+E+L DL I K R + +I+
Sbjct: 79 FLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLSRA---------TFYAAEII 128
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
G+ H IV+RDLK N+L+ DG +K+ADFG
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 32/188 (17%)
Query: 6 PKSWSIHTRPEI-IAKYEILECVGSGAYSDVYKGR-----RLSDNLIVA---LKEVHDYQ 56
P+ +S I + +G GA+ V+ D ++VA LKE +
Sbjct: 27 PQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA 86
Query: 57 SA--FREIEALQILQNSPNVV-------------VLHEYFWREDEDAVLVLEFLRTDLAT 101
RE E L +LQ+ ++V ++ EY D + FLR+
Sbjct: 87 RQDFQREAELLTMLQH-QHIVRFFGVCTEGRPLLMVFEYMRHGD-----LNRFLRSHGPD 140
Query: 102 VIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161
A+ ED + +G++ Q+ +G+ VHRDL N L+G V+K
Sbjct: 141 --AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198
Query: 162 LADFGQAR 169
+ DFG +R
Sbjct: 199 IGDFGMSR 206
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 24/158 (15%)
Query: 22 EILECVGSGAYSDVYKGRRLS---DNLIVALKEV--HDYQSAFREIEAL----QILQ--N 70
E+L +G G Y V++ R+++ I A+K + ++ IL+
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 71 SPNVVVLHEYFWREDEDAV-LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMV 128
P +V L F + + L+LE+L +L + ED ++
Sbjct: 80 HPFIVDLIYAF--QTGGKLYLILEYLSGGELFMQLEREGIFMEDT---------ACFYLA 128
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+I + H+ I++RDLKP N+++ G +KL DFG
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEAL----QILQ--NSPN 73
++ L+ +G G + V R + A+K + + A E+ ++LQ P
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 74 VVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ L F D V+E+ +L ++ + E+R + + +I+S
Sbjct: 67 LTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERA---------RFYGAEIVS 116
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
++ H +V+RD+K NL++ DG +K+ DFG
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 32/159 (20%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDYQSA-----FR-EIEALQILQNSPNVVVLHEY 80
+G G + VYKG L D VALK +S+ F EIE L ++ P++V L +
Sbjct: 47 IGHGVFGKVYKGV-LRDGAKVALK-RRTPESSQGIEEFETEIETLSFCRH-PHLVSLIGF 103
Query: 81 FWREDEDAVLVLEF-----LRTDLATVIAESK----KKREDRGDRGISVGEIKRWMVQIL 131
E + +L+ ++ L+ L + ++R + I +G +
Sbjct: 104 CD-ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE-----ICIGAAR------- 150
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
G+ H I+HRD+K N+L+ ++ V K+ DFG ++
Sbjct: 151 -GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 36/200 (18%), Positives = 73/200 (36%), Gaps = 60/200 (30%)
Query: 9 WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLI-------VA---LKEVH-DYQS 57
I ++I E +G G ++ ++KG R V L + H +Y
Sbjct: 3 HKIR-NEDLI----FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE 57
Query: 58 AF-REIEALQILQNSPNVVVLHEYFWREDEDAV--------LVLEF-----LRTDLATVI 103
+F + L + ++V+ + V LV EF L T L
Sbjct: 58 SFFEAASMMSKLSH-KHLVLNY---------GVCVCGDENILVQEFVKFGSLDTYL---- 103
Query: 104 AESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI--------G 155
++++ I++ Q+ + + NT++H ++ N+L+ G
Sbjct: 104 ------KKNKNC--INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG 155
Query: 156 DDGVLKLADFGQARILLGNE 175
+ +KL+D G + +L +
Sbjct: 156 NPPFIKLSDPGISITVLPKD 175
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 34/188 (18%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVHDYQ 56
+ + R I ++ +G GA+ +VY+G+ L VA+K + +
Sbjct: 59 TSSISDLKEVP-RKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 113
Query: 57 SA------FREIEALQILQNSPNV-----VVLHEYFWREDEDAVLVLEFLRT-DLATVIA 104
S E + + N+ V L + ++LE + DL + +
Sbjct: 114 SEQDELDFLMEALIISKFNH-QNIVRCIGVSL------QSLPRFILLELMAGGDLKSFLR 166
Query: 105 ESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLK 161
E++ + +++ ++ I G N +HRD+ N L+ G V K
Sbjct: 167 ETRPRPSQ--PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224
Query: 162 LADFGQAR 169
+ DFG AR
Sbjct: 225 IGDFGMAR 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVALKEVHDYQSA-----FR-EIEALQILQNSPNVVVLHEY 80
+G G + VYKGR L+D +VA+K + + ++ F+ E+E + + + N++ L +
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGF 95
Query: 81 FWREDEDAVLVLEFLRTD-LATVIAESKKKRE--DRGDRGISVGEIKRWMVQILSGV--- 134
+ +LV ++ +A+ + E + + D R +I G
Sbjct: 96 C-MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR-----------QRIALGSARG 143
Query: 135 -----DACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNS 183
D C I+HRD+K N+L+ ++ + DFG A+++ ++
Sbjct: 144 LAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM-------DYKDT 189
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 1e-06
Identities = 41/309 (13%), Positives = 90/309 (29%), Gaps = 93/309 (30%)
Query: 9 WSIHTRPEIIAK----------YEIL------ECVGSGAYSDVY---KGRRLSDNLIVAL 49
W++ ++ E + + Y+ L E + +Y + R +DN + A
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK 128
Query: 50 KEVHDYQSAFREIEALQILQNSPNVVVLH--------------------------EYFW- 82
V Q + +AL L+ + NV++ + FW
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLI-DGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187
Query: 83 --REDEDAVLVLEFLRTDLATVIAESKKKREDRGDRG-ISVGEIKRWMVQILSGVDACHR 139
+ VLE L+ L I + R D + + I+ + R
Sbjct: 188 NLKNCNSPETVLEMLQK-LLYQIDPNWTSRSDHSSNIKLRIHSIQAEL-----------R 235
Query: 140 NTIVHRDLKPGNLLIGDD----GVLKLADFGQARILL----GNEFDAPDGNSQPCEPNAP 191
+ + + LL+ + + +ILL D +
Sbjct: 236 RLLKSKPYENC-LLVLLNVQNAKAWNAFNLS-CKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 192 YQDNMSE-------APQVDLEVEDASPE------------GDVNQEQGIMSREDYFRALD 232
+ ++ +D +D E + ++ ++ D ++ ++
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG--LATWDNWKHVN 351
Query: 233 ELKAKNSID 241
K I+
Sbjct: 352 CDKLTTIIE 360
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 36/211 (17%), Positives = 72/211 (34%), Gaps = 69/211 (32%)
Query: 28 GSGAYSDVYKGR-----RLSDNLIVALKEV------HDYQSAFREIEALQILQNSPNVVV 76
G GA+ V + + + VA+K + ++++ E++ L + + NVV
Sbjct: 31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90
Query: 77 LHEYFWREDEDAVLVLE---------FLRT-------------------DLATVIAESKK 108
L + ++++E +LR+ D I K
Sbjct: 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLK 150
Query: 109 KREDRG------------------------------DRGISVGEIKRWMVQILSGVDACH 138
+R D +++ + + Q+ G++
Sbjct: 151 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 210
Query: 139 RNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+HRDL N+L+ + V+K+ DFG AR
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 40/187 (21%), Positives = 75/187 (40%), Gaps = 32/187 (17%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVHDYQ 56
+ + R I ++ +G GA+ +VY+G+ L VA+K + +
Sbjct: 18 TSSISDLKEVP-RKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 57 SAFREIEALQ---ILQ--NSPNV-----VVLHEYFWREDEDAVLVLEFLRT-DLATVIAE 105
S E++ L I+ N N+ V L + +++E + DL + + E
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSL------QSLPRFILMELMAGGDLKSFLRE 126
Query: 106 SKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKL 162
++ + +++ ++ I G N +HRD+ N L+ G V K+
Sbjct: 127 TRPRPSQ--PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184
Query: 163 ADFGQAR 169
DFG AR
Sbjct: 185 GDFGMAR 191
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 5e-06
Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 24/156 (15%)
Query: 27 VGSGAYSDVYKGRRLSDNLIVA---LKEVHDYQSA-----FR-EIEALQILQNSPNVVVL 77
+G G + VYKG +N VA L + D + F EI+ + Q+ N+V L
Sbjct: 39 MGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH-ENLVEL 95
Query: 78 HEYFWREDEDAVLVLEFL-RTDLATVIAESKKKRE-DRGDR-GISVGEIKRWMVQILSGV 134
+ + +D LV ++ L ++ R I+ G +G+
Sbjct: 96 LGFSS-DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG--------AANGI 146
Query: 135 DACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
+ H N +HRD+K N+L+ + K++DFG AR
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 6e-04
Identities = 34/172 (19%), Positives = 54/172 (31%), Gaps = 48/172 (27%)
Query: 21 YEILECVGSGAYSDVYKGR------------RLSDNLIVALKEVHDY----------QSA 58
I + +G G S V+ ++ +KE DY +SA
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151
Query: 59 FREIEALQILQ--NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDR 116
E ALQ LQ P V +++E +
Sbjct: 152 RNEFRALQKLQGLAVPKVYAWEGN--------AVLMELIDAK---------------ELY 188
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168
+ V + IL V + IVH DL N+L+ + + + DF Q+
Sbjct: 189 RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 326 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.98 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.98 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.98 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.98 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.98 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.98 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.98 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.83 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.43 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.91 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.86 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.58 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.49 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.39 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.23 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.97 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.49 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=333.86 Aligned_cols=144 Identities=26% Similarity=0.430 Sum_probs=131.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++++.||+|+||+||+|.++.+++.||||.+.. ...+.+|+++++.+ +||||++++++| ++.+.+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~-~~~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTF-QDDEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEE-ECSSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-EeCCEEE
Confidence 4789999999999999999999999999999999852 34578899999999 699999999999 6677899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. |+|.+++..... +++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 109 ivmEy~~gG~L~~~i~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 9999997 699999876543 999999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 169 RILL 172 (326)
Q Consensus 169 ~~~~ 172 (326)
+.+.
T Consensus 180 ~~~~ 183 (311)
T 4aw0_A 180 KVLS 183 (311)
T ss_dssp EECC
T ss_pred eecC
Confidence 8763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=335.59 Aligned_cols=143 Identities=22% Similarity=0.375 Sum_probs=129.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-----chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
..+.|+++++||+|+||+||+|.++.+++.||||++. ....+.+|+.+++.+ +||||++++++| ...+.+|+|
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~-~~~~~~~iv 149 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSY-LVGDELWVV 149 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEE-EETTEEEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEE-EECCEEEEE
Confidence 4577999999999999999999999999999999985 245578999999999 699999999999 566789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 150 mEy~~gg~L~~~l~~~----------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp ECCCTTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCcee
Confidence 99998 5888877542 199999999999999999999999999999999999999999999999999987
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
+
T Consensus 220 ~ 220 (346)
T 4fih_A 220 V 220 (346)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=325.70 Aligned_cols=144 Identities=34% Similarity=0.609 Sum_probs=124.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.+.||+|+||+||+|.+..+++.||||.++. ...+.+|+++++++ +||||+++++++ .+.+.+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~-~~~~~~ 88 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVI-KSKDEI 88 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEE-ECSSEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEE-EECCEE
Confidence 45899999999999999999999999999999998852 23578899999999 699999999999 667789
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
|++|||++++|.+.+..... +++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 89 ~ivmEy~~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla 159 (275)
T 3hyh_A 89 IMVIEYAGNELFDYIVQRDK---------MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS 159 (275)
T ss_dssp EEEEECCCEEHHHHHHHSCS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred EEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCC
Confidence 99999999999999876432 999999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
+..
T Consensus 160 ~~~ 162 (275)
T 3hyh_A 160 NIM 162 (275)
T ss_dssp ---
T ss_pred eec
Confidence 764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=338.87 Aligned_cols=145 Identities=30% Similarity=0.514 Sum_probs=124.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.++|++++.||+|+||+||+|.+..+++.||||+++. ...+.+|+++++++ +||||+++++++ .+.+.+|+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~-~~~~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESF-EENGSLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-EETTEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEE-EECCEEEE
Confidence 4799999999999999999999999999999999852 34578899999999 699999999999 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
||||+. ++|.+++..... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 101 VmEy~~gg~L~~~i~~~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKG-------VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173 (350)
T ss_dssp EEECCTTCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred EEeCCCCCcHHHHHHHcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccce
Confidence 999997 699999876432 237899999999999999999999999999999999999999999999999997
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 174 ~~ 175 (350)
T 4b9d_A 174 VL 175 (350)
T ss_dssp CC
T ss_pred ee
Confidence 65
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=338.38 Aligned_cols=144 Identities=22% Similarity=0.379 Sum_probs=130.2
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-----chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
+..+.|+++++||+|+||.||+|.+..+++.||||.+. ....+.+|+.+++.+ +||||++++++| ...+.+|+
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~-~~~~~~~i 225 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSY-LVGDELWV 225 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEE-EETTEEEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEE-EECCEEEE
Confidence 34578999999999999999999999999999999985 245688999999999 699999999999 55678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
||||+. |+|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.
T Consensus 226 VmEy~~gG~L~~~i~~~----------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEECCTTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccce
Confidence 999998 5888877542 28999999999999999999999999999999999999999999999999998
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 296 ~~ 297 (423)
T 4fie_A 296 QV 297 (423)
T ss_dssp EC
T ss_pred EC
Confidence 75
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=330.93 Aligned_cols=144 Identities=26% Similarity=0.347 Sum_probs=130.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc-
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR- 96 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~- 96 (326)
.+.|++.++||+|+||.||+|.++.+++.||||+++......+|+.+++.+ +||||+++++++ .+.+.+|+||||+.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l-~HpnIV~l~~~~-~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGL-SSPRIVPLYGAV-REGPWVNIFMELLEG 134 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTC-CCTTBCCEEEEE-EETTEEEEEECCCTT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhC-CCCCCCcEEEEE-EECCEEEEEEeccCC
Confidence 467999999999999999999999999999999998766667899999999 699999999999 56678999999998
Q ss_pred cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEEeeccccccc
Q 020467 97 TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARILL 172 (326)
Q Consensus 97 ~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-~~~l~Dfg~~~~~~ 172 (326)
++|.+++..... +++..+..++.||+.||.|||+++|+||||||+||||+.++ .+||+|||+++.+.
T Consensus 135 g~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 135 GSLGQLIKQMGC---------LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 699999876433 99999999999999999999999999999999999999987 69999999998763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.47 Aligned_cols=143 Identities=28% Similarity=0.512 Sum_probs=122.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++++.||+|+||+||+|++. .+++.||||.++. ...+.+|+++++++ +||||+++++++ .+.+.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~-~~~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAF-QTEGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEE-EETTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEE-EECCE
Confidence 368999999999999999999874 4678999998852 33577899999988 699999999999 56678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
+|++|||+. ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEEEEcCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 999999998 699999876543 9999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
+++..
T Consensus 172 la~~~ 176 (304)
T 3ubd_A 172 LSKES 176 (304)
T ss_dssp EEEC-
T ss_pred cceec
Confidence 99764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=318.64 Aligned_cols=150 Identities=23% Similarity=0.414 Sum_probs=122.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE---- 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~---- 86 (326)
..++|++++.||+|+||+||+|.++.+++.||||.++. ...+.+|+.+++++ +||||++++++|.....
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-----
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccc
Confidence 35679999999999999999999999999999998852 34567899999999 69999999999854432
Q ss_pred -------ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 87 -------DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 87 -------~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
.+|++|||+. ++|.+++....... ......+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~ 155 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD 155 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC
Confidence 3689999997 69998887543211 145667889999999999999999999999999999999999
Q ss_pred cEEEEeecccccccC
Q 020467 159 VLKLADFGQARILLG 173 (326)
Q Consensus 159 ~~~l~Dfg~~~~~~~ 173 (326)
.+||+|||+++.+..
T Consensus 156 ~vKl~DFGla~~~~~ 170 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQ 170 (299)
T ss_dssp CEEECCCCCC-----
T ss_pred cEEEccCccceecCC
Confidence 999999999987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=328.65 Aligned_cols=193 Identities=32% Similarity=0.601 Sum_probs=164.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe-----c
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWR-----E 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~-----~ 84 (326)
+.++|++++.||+|+||+||+|.+..+++.||||++.. ...+.+|+++++.+ +||||+++++++.. +
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccccc
Confidence 45789999999999999999999999999999999853 23467899999999 69999999998743 2
Q ss_pred CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 85 DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 85 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
...+|+||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~D 201 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGD 201 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred CCEEEEEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEee
Confidence 35689999999999998886533 399999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCcccCCCCCCCCCCCCCccccccCCCCCcccccccCCCCCCccccccccchhhhHHhhHHHhhccCCCCCC
Q 020467 165 FGQARILLGNEFDAPDGNSQPCEPNAPYQDNMSEAPQVDLEVEDASPEGDVNQEQGIMSREDYFRALDELKAKNSIDETD 244 (326)
Q Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
||+++.+.....
T Consensus 202 FGla~~~~~~~~-------------------------------------------------------------------- 213 (398)
T 4b99_A 202 FGMARGLCTSPA-------------------------------------------------------------------- 213 (398)
T ss_dssp CTTCBCC-------------------------------------------------------------------------
T ss_pred cceeeecccCcc--------------------------------------------------------------------
Confidence 999986532210
Q ss_pred CCCccCCCCCCcccccCCCCCCccccccccccccCCCCCCCCCCCCCcccccccccchhhhccCCCCcceeeeeehhhhc
Q 020467 245 KDTHVHDGDTSCFATCTTSDVEDDLFKGTYSYDAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYLQ 324 (326)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 324 (326)
.........+||+.|||||++.+..+|+.++||||||||||
T Consensus 214 ---------------------------------------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ 254 (398)
T 4b99_A 214 ---------------------------------------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFG 254 (398)
T ss_dssp -----------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ---------------------------------------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHH
Confidence 01122345689999999999998877899999999999999
Q ss_pred cC
Q 020467 325 NF 326 (326)
Q Consensus 325 el 326 (326)
||
T Consensus 255 el 256 (398)
T 4b99_A 255 EM 256 (398)
T ss_dssp HH
T ss_pred HH
Confidence 96
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=312.52 Aligned_cols=142 Identities=32% Similarity=0.494 Sum_probs=124.4
Q ss_pred cCe-EEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec---CCc
Q 020467 19 AKY-EILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE---DED 87 (326)
Q Consensus 19 ~~y-~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~---~~~ 87 (326)
++| ++.++||+|+||+||+|.+..++..||+|.+.. ...+.+|+++++++ +||||++++++|... ...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcE
Confidence 455 778899999999999999999999999998853 34578899999999 699999999998442 345
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcC-CCcEEEE
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIGD-DGVLKLA 163 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~~-~~~~~l~ 163 (326)
+|++|||+. ++|.+++..... +++..+..|+.||+.||.|||+++ |+||||||+||||+. ++.+||+
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEE
Confidence 899999998 699999876433 899999999999999999999998 999999999999984 7899999
Q ss_pred eeccccc
Q 020467 164 DFGQARI 170 (326)
Q Consensus 164 Dfg~~~~ 170 (326)
|||+++.
T Consensus 175 DFGla~~ 181 (290)
T 3fpq_A 175 DLGLATL 181 (290)
T ss_dssp CTTGGGG
T ss_pred eCcCCEe
Confidence 9999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=313.20 Aligned_cols=169 Identities=22% Similarity=0.342 Sum_probs=129.5
Q ss_pred CCCCCCCCccccCc-cccccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHH
Q 020467 1 MEQPLPKSWSIHTR-PEIIAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQIL 68 (326)
Q Consensus 1 ~~~~~p~~~~~~~~-~~~~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l 68 (326)
||.|.......... +-..+++++.++||+|+||+||+|... .+++.||||.++. ...+.+|+.+++++
T Consensus 7 me~p~~~~~~~~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l 86 (308)
T 4gt4_A 7 MEMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 86 (308)
T ss_dssp ------------CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC
T ss_pred eeccccCccccCCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC
Confidence 56665543332222 223578999999999999999999853 3578999999863 34678999999999
Q ss_pred hcCCCeeEEeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhh-------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 020467 69 QNSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISVGEIKRWMVQILSGVDACHRN 140 (326)
Q Consensus 69 ~~h~ni~~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~ 140 (326)
+||||+++++++ ......++||||+. |+|.+++....... .......+++..+..++.|++.||.|||+.
T Consensus 87 -~HpNIV~l~g~~-~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 164 (308)
T 4gt4_A 87 -QHPNVVCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 164 (308)
T ss_dssp -CCTTBCCEEEEE-CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred -CCCCCCCcceEE-EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 699999999999 66678999999998 79999986532110 000113489999999999999999999999
Q ss_pred CceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 141 TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 141 ~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+|+||||||+|||++.++.+||+|||+++.+
T Consensus 165 ~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~ 195 (308)
T 4gt4_A 165 HVVHKDLATRNVLVYDKLNVKISDLGLFREV 195 (308)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCSCCBCGG
T ss_pred CCCCCCccccceEECCCCCEEECCcccceec
Confidence 9999999999999999999999999999765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=312.52 Aligned_cols=152 Identities=24% Similarity=0.402 Sum_probs=127.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|.+.++||+|+||+||+|.+. .++..||||.++. ...+.+|+++++++ +||||+++++++ .+.+.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~-~~~~~ 89 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVC-VEGDP 89 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEE-eeCCE
Confidence 478999999999999999999864 3578899999863 34578999999999 699999999999 66778
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhh----hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKR----EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~----~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l 162 (326)
.++||||+. |+|.+++....... .......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 999999998 79999997643211 1112234999999999999999999999999999999999999999999999
Q ss_pred Eeecccccc
Q 020467 163 ADFGQARIL 171 (326)
Q Consensus 163 ~Dfg~~~~~ 171 (326)
+|||+++..
T Consensus 170 ~DFGla~~~ 178 (299)
T 4asz_A 170 GDFGMSRDV 178 (299)
T ss_dssp CCCSCHHHH
T ss_pred CCcccceec
Confidence 999999765
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=317.34 Aligned_cols=146 Identities=25% Similarity=0.455 Sum_probs=128.9
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.|++.++|++.++||+|+||+||+|.++ .+++.||+|.+.. .....+|+++++.+.+||||++++++| ...+.
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-~~~~~ 94 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-RKNDH 94 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-EETTE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-EECCE
Confidence 4678899999999999999999999874 4678999998753 345678999999887899999999999 66778
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEEee
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-GVLKLADF 165 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-~~~~l~Df 165 (326)
+|++|||+. ++|.+++.. +++..+..++.||+.||.|||++||+||||||+|||++.+ +.++|+||
T Consensus 95 ~~lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 999999997 688887732 8999999999999999999999999999999999999876 79999999
Q ss_pred ccccccc
Q 020467 166 GQARILL 172 (326)
Q Consensus 166 g~~~~~~ 172 (326)
|+++...
T Consensus 163 Gla~~~~ 169 (361)
T 4f9c_A 163 GLAQGTH 169 (361)
T ss_dssp TTCEECT
T ss_pred CCCcccC
Confidence 9998653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=311.27 Aligned_cols=152 Identities=26% Similarity=0.404 Sum_probs=124.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|.+.++||+|+||+||+|.+. .+++.||||.++. ...+.+|+++++++ +||||+++++++ .+...
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~-~~~~~ 117 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVC-TEGRP 117 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE-EECCE
Confidence 468999999999999999999864 3678999999863 34578999999999 699999999999 66778
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhh------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKR------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 160 (326)
.++||||+. |+|.+++....... .......+++..+..|+.|++.||.|||+.+|+||||||+|||++.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 999999998 79999987543211 11112448999999999999999999999999999999999999999999
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
||+|||+++.+
T Consensus 198 Ki~DFGla~~~ 208 (329)
T 4aoj_A 198 KIGDFGMSRDI 208 (329)
T ss_dssp EECCCC-----
T ss_pred EEcccccceec
Confidence 99999999765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=311.36 Aligned_cols=154 Identities=22% Similarity=0.353 Sum_probs=130.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC-----CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD-----NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|+||+||+|.+... ++.||||.+.. ...+.+|++++.++.+||||++++++|.....
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 57899999999999999999987543 46899998853 34578899999999767999999999866566
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh-------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
.+++||||+. |+|.+++....... .......+++..+..++.|++.||.|||+++||||||||+|||++.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 7999999998 79999997654321 011123488999999999999999999999999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.+||+|||+++.+
T Consensus 223 ~vKi~DFGlar~~ 235 (353)
T 4ase_A 223 VVKICDFGLARDI 235 (353)
T ss_dssp CEEECCCGGGSCT
T ss_pred CEEECcchhhhhc
Confidence 9999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=307.04 Aligned_cols=140 Identities=23% Similarity=0.409 Sum_probs=121.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.+++++.++||+|+||+||+|.+.. .||||.++. ...+.+|+.+++++ +||||+++++++ .+ +.+++
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~-~~-~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYM-TK-DNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CS-SSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-EC-CeEEE
Confidence 4788999999999999999998643 589998852 34578899999999 699999999987 43 45899
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
||||+. |+|.+++.... ..+++..+..|+.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 109 VmEy~~gGsL~~~l~~~~--------~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQE--------TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp EEECCSSCBHHHHHHTSC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred EEEcCCCCCHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCce
Confidence 999998 79999886542 238999999999999999999999999999999999999999999999999997
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 181 ~~ 182 (307)
T 3omv_A 181 VK 182 (307)
T ss_dssp C-
T ss_pred ec
Confidence 65
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=327.14 Aligned_cols=146 Identities=22% Similarity=0.456 Sum_probs=126.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHh--cCCCeeEEeEEEEecC
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQ--NSPNVVVLHEYFWRED 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~~ 85 (326)
.-.++|++++.||+|+||.||+|.++.+++.||||.++. .....+|..++..+. +||||++++++| .+.
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-~~~ 264 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-HTP 264 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-ECS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-EEC
Confidence 457899999999999999999999999999999999853 122344544444432 699999999999 667
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..+|+||||+. |+|.+++..... +++..+..|+.||+.||.|||++||+||||||+||||+.+|++||+|
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecc
Confidence 78999999997 699999876433 99999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++..+
T Consensus 336 FGlA~~~ 342 (689)
T 3v5w_A 336 LGLACDF 342 (689)
T ss_dssp CTTCEEC
T ss_pred cceeeec
Confidence 9999765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=302.26 Aligned_cols=142 Identities=25% Similarity=0.376 Sum_probs=119.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--hhHHHHHH--HHHHHhcCCCeeEEeEEEEecCC---ceE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--QSAFREIE--ALQILQNSPNVVVLHEYFWREDE---DAV 89 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--~~~~~E~~--~l~~l~~h~ni~~l~~~~~~~~~---~~~ 89 (326)
+.++|.+.++||+|+||+||+|.+ +++.||||+++.. .....|.+ .+.++ +||||+++++++..... .++
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEE
Confidence 356799999999999999999987 5889999998643 22334443 34455 69999999999965542 479
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEEcCCCcE
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN--------TIVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------~iiH~dlkp~Nili~~~~~~ 160 (326)
+||||+. ++|.+++.... +++..+..++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 78 lV~Ey~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred EEecCCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 9999998 79999886532 88999999999999999999976 99999999999999999999
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
||+|||+++..
T Consensus 148 Ki~DFGla~~~ 158 (303)
T 3hmm_A 148 CIADLGLAVRH 158 (303)
T ss_dssp EECCCTTCEEE
T ss_pred EEEeCCCCccc
Confidence 99999998765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=318.55 Aligned_cols=147 Identities=31% Similarity=0.504 Sum_probs=130.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
..+.++|++++.||+|+||.||+|.++.+++.||+|.+.. ...+.+|+.+++.+ +||||++++++| .+...+|
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~-~~~~~~~ 230 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAF-EDDNEMV 230 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEE-ECSSEEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEE-EECCEEE
Confidence 3567899999999999999999999999999999998853 34567899999999 699999999999 6677899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC--CcEEEEeec
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD--GVLKLADFG 166 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~--~~~~l~Dfg 166 (326)
++|||+. |+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||
T Consensus 231 iv~E~~~gg~L~~~i~~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH--------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT--------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEeecCCCcHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeecc
Confidence 9999997 69988875432 228999999999999999999999999999999999999854 899999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
+++.+
T Consensus 303 ~a~~~ 307 (573)
T 3uto_A 303 LTAHL 307 (573)
T ss_dssp SCEEC
T ss_pred ceeEc
Confidence 99876
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=283.29 Aligned_cols=145 Identities=26% Similarity=0.425 Sum_probs=128.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
-.++|++.+.||+|+||.||+|.+..+++.||+|.+.. .....+|..++..+.+|+||+++++++ ......
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-~~~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-QTPDRL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-ECSSEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-EeCCEE
Confidence 46899999999999999999999999999999999863 234567888888876799999999998 666789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|..++..... +++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccc
Confidence 99999997 588888866433 99999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 171 a~~~ 174 (353)
T 3txo_A 171 CKEG 174 (353)
T ss_dssp CBCS
T ss_pred eeec
Confidence 8653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=284.04 Aligned_cols=144 Identities=24% Similarity=0.431 Sum_probs=129.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
-.++|++++.||+|+||.||+|.+..+++.||+|+++. ......|..++..+.+||||+++++++ ......
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-~~~~~~ 128 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-QTESRL 128 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-ECSSEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-EECCEE
Confidence 36789999999999999999999999999999998853 234678888988887899999999998 666789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|..++..... +++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGl 199 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecce
Confidence 99999997 588888776433 99999999999999999999999999999999999999999999999999
Q ss_pred ccc
Q 020467 168 ARI 170 (326)
Q Consensus 168 ~~~ 170 (326)
+..
T Consensus 200 a~~ 202 (396)
T 4dc2_A 200 CKE 202 (396)
T ss_dssp CBC
T ss_pred eee
Confidence 875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=277.57 Aligned_cols=148 Identities=32% Similarity=0.547 Sum_probs=131.0
Q ss_pred CccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 13 ~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
......++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+++++.+ +|+||+++++++ ...
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~-~~~ 86 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVI-ETE 86 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ECS
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-EEC
Confidence 344568999999999999999999999999999999998853 23467899999999 699999999998 666
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
+..+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~D 157 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIAD 157 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECS
T ss_pred CEEEEEEECCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEee
Confidence 78999999996 699888866433 89999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 158 FG~a~~~ 164 (328)
T 3fe3_A 158 FGFSNEF 164 (328)
T ss_dssp TTCCGGG
T ss_pred ccCceec
Confidence 9998755
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=277.15 Aligned_cols=146 Identities=25% Similarity=0.427 Sum_probs=128.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
-..++|++.+.||+|+||.||+|.+..+++.||+|.++. ......|..++..+.+||||+++++++ .....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-~~~~~ 92 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-QTKEN 92 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-ECSSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-EeCCE
Confidence 457899999999999999999999999999999999863 234567888888876799999999998 66678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeECh
Confidence 999999996 699888876432 8999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 164 ~a~~~ 168 (345)
T 1xjd_A 164 MCKEN 168 (345)
T ss_dssp TCBCC
T ss_pred hhhhc
Confidence 98653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=272.03 Aligned_cols=144 Identities=41% Similarity=0.658 Sum_probs=128.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.++|++.++||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......++
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~l 78 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVL-HSDKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEE-EETTEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEE-EeCCEEEE
Confidence 3689999999999999999999999999999998852 24567899999998 699999999998 56678999
Q ss_pred EeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 91 VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 91 v~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+|||+.+++.+.+..... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 79 v~e~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EEECCSEEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999988888765332 289999999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 151 ~ 151 (292)
T 3o0g_A 151 F 151 (292)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=276.61 Aligned_cols=143 Identities=22% Similarity=0.377 Sum_probs=127.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.++. .....+|+.+++.+ +||||+++++++ ......+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~-~~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAF-QTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEE-ECSSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEE-EeCCEEE
Confidence 5789999999999999999999999999999999853 23467888888888 699999999998 5667899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|..++..... +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 82 lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 152 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccch
Confidence 9999997 588888765432 899999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 153 ~~~ 155 (337)
T 1o6l_A 153 KEG 155 (337)
T ss_dssp BCS
T ss_pred hhc
Confidence 753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=290.91 Aligned_cols=147 Identities=31% Similarity=0.497 Sum_probs=121.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ +|+||+++++++....
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCccc
Confidence 466899999999999999999999999999999998853 34567899999999 6999999999984332
Q ss_pred -CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 -EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..+|++|||++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~D 199 (458)
T 3rp9_A 129 FDELYVVLEIADSDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD 199 (458)
T ss_dssp CCCEEEEECCCSEEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEEeccccchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecc
Confidence 4689999999999998886532 289999999999999999999999999999999999999999999999
Q ss_pred eccccccc
Q 020467 165 FGQARILL 172 (326)
Q Consensus 165 fg~~~~~~ 172 (326)
||++....
T Consensus 200 FGla~~~~ 207 (458)
T 3rp9_A 200 FGLARTVD 207 (458)
T ss_dssp CTTCBCTT
T ss_pred cccchhcc
Confidence 99998763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=282.07 Aligned_cols=148 Identities=31% Similarity=0.520 Sum_probs=124.2
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-C
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED-E 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-~ 86 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||||.+.. .....+|+.++..+.+|+||+++++++.... .
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 4578999999999999999999999999999999998742 3446789999999967999999999985433 4
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.++++|||++++|...+... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||
T Consensus 85 ~~~lv~e~~~~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRAN----------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCSEEHHHHHHHT----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccCcCHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 68999999999998888653 18899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 167 QARILL 172 (326)
Q Consensus 167 ~~~~~~ 172 (326)
+++.+.
T Consensus 155 ~a~~~~ 160 (388)
T 3oz6_A 155 LSRSFV 160 (388)
T ss_dssp TCEESS
T ss_pred cccccc
Confidence 998763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=276.51 Aligned_cols=145 Identities=25% Similarity=0.419 Sum_probs=128.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|..++..+.+||||+++++++ ......
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-~~~~~~ 85 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-QTESRL 85 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-ECSSEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-EeCCEE
Confidence 46789999999999999999999999999999999863 223567888888876799999999998 666789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~ 156 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccc
Confidence 99999997 688888865432 89999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 157 a~~~ 160 (345)
T 3a8x_A 157 CKEG 160 (345)
T ss_dssp CBCS
T ss_pred cccc
Confidence 8653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=276.41 Aligned_cols=146 Identities=35% Similarity=0.571 Sum_probs=131.7
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
+...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +||||+++++++ ....
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~-~~~~ 82 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVI-TTPT 82 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEE-ECSS
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEE-EeCC
Confidence 4567899999999999999999999999999999998853 23577899999888 699999999998 5667
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
..+++|||++++|.+.+..... +++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKR---------MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EEEEEEECCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEec
Confidence 8999999999999998876533 8999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 154 ~s~~~ 158 (336)
T 3h4j_B 154 LSNIM 158 (336)
T ss_dssp CTBTT
T ss_pred cceec
Confidence 98754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.47 Aligned_cols=147 Identities=31% Similarity=0.478 Sum_probs=131.2
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ +|+||+++++++....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCc
Confidence 467999999999999999999999999999999999853 24567899999999 6999999999984433
Q ss_pred -CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 -EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
...|++|||++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~D 172 (432)
T 3n9x_A 102 FDELYIVLEIADSDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172 (432)
T ss_dssp CCCEEEEEECCSEEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEecCCcCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEcc
Confidence 5689999999999998886532 289999999999999999999999999999999999999999999999
Q ss_pred eccccccc
Q 020467 165 FGQARILL 172 (326)
Q Consensus 165 fg~~~~~~ 172 (326)
||++....
T Consensus 173 FGla~~~~ 180 (432)
T 3n9x_A 173 FGLARTIN 180 (432)
T ss_dssp CTTCEEC-
T ss_pred CCCccccc
Confidence 99998763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=270.98 Aligned_cols=145 Identities=28% Similarity=0.479 Sum_probs=129.3
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-----chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.+..++|++.+.||+|+||.||+|.+..+++.||+|.+. ....+.+|+.+++.+ .|+||+++++++ ......+
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~~~~ 93 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSY-LVGDELW 93 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-EETTEEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEE-EECCEEE
Confidence 457789999999999999999999999999999999874 244567899999988 699999999998 5566799
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++.... +++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 94 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp EEEECCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999996 68888876532 899999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 164 ~~~ 166 (297)
T 3fxz_A 164 AQI 166 (297)
T ss_dssp EEC
T ss_pred eec
Confidence 765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=271.56 Aligned_cols=147 Identities=45% Similarity=0.719 Sum_probs=130.2
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
...+.++|++.++||+|+||.||+|.+. +++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ....
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~ 92 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVI-HSER 92 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEE-CCSS
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEE-ccCC
Confidence 4567899999999999999999999985 588999998852 23567899999999 699999999998 6677
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
..+++|||+.++|.+.+..... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||
T Consensus 93 ~~~lv~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp CEEEEEECCSEEHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCc
Confidence 8999999999999888865432 28999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 165 ~a~~~ 169 (311)
T 3niz_A 165 LARAF 169 (311)
T ss_dssp TCEET
T ss_pred Cceec
Confidence 98765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=276.63 Aligned_cols=145 Identities=22% Similarity=0.382 Sum_probs=127.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.++. ......|..++..+.+|++|+++++++ ......
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-~~~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-QTMDRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-ECSSEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-EcCCEE
Confidence 46899999999999999999999998999999999863 234567777877776799999999998 666789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 99999997 699888875432 89999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 168 a~~~ 171 (353)
T 2i0e_A 168 CKEN 171 (353)
T ss_dssp CBCC
T ss_pred cccc
Confidence 8753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=268.48 Aligned_cols=149 Identities=41% Similarity=0.592 Sum_probs=126.9
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHh--cCCCeeEEeEEEEe
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQ--NSPNVVVLHEYFWR 83 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~ 83 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. .....+|+.+++.+. .|+||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 356899999999999999999999999999999998852 235678888877774 49999999999855
Q ss_pred cCC----ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 84 EDE----DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 84 ~~~----~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
... ..+++||++.++|.+++..... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQDLRTYLDKAPP-------PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CCSSSEEEEEEEEECCCCBHHHHHHTCCT-------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC
T ss_pred cCCCCceeEEEEehhhhcCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC
Confidence 443 4799999999999998876432 22899999999999999999999999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 159 ~kl~Dfg~a~~~ 170 (308)
T 3g33_A 159 VKLADFGLARIY 170 (308)
T ss_dssp EEECSCSCTTTS
T ss_pred EEEeeCcccccc
Confidence 999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=270.32 Aligned_cols=146 Identities=23% Similarity=0.358 Sum_probs=127.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
+.++|++.++||+|+||+||+|.+..+++.||||++.. ......|+..+..+..|+||+++++++ ......+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-~~~~~~~ 133 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-EEGGILY 133 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-EeCCEEE
Confidence 45889999999999999999999998999999998742 223455666666665799999999998 5677899
Q ss_pred EEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 90 LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 90 lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++|||++++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++.
T Consensus 134 lv~e~~~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 134 LQTELCGPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEECCCCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEEeccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeee
Confidence 9999999999988876432 28999999999999999999999999999999999999999999999999986
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 206 ~~ 207 (311)
T 3p1a_A 206 EL 207 (311)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=271.75 Aligned_cols=143 Identities=22% Similarity=0.457 Sum_probs=127.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.++. .....+|..+++.+ +||||+++++++ .+....+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~-~~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTF-QDAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEE-ECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEE-EeCCEEE
Confidence 5789999999999999999999999999999998853 23456788888888 699999999998 6667899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 83 lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a 153 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcc
Confidence 9999997 599888875432 899999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 154 ~~~ 156 (318)
T 1fot_A 154 KYV 156 (318)
T ss_dssp EEC
T ss_pred eec
Confidence 754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=282.65 Aligned_cols=145 Identities=26% Similarity=0.451 Sum_probs=129.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.++||+|+||.||+|.+..+++.||+|+++. ...+.+|..++..+ +|+||+++++++ .+....
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~-~~~~~~ 149 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAF-QDDNNL 149 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEE-ECSSEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-eeCCEE
Confidence 45899999999999999999999999999999999853 22367888899888 799999999998 667789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||+
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFE--------DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999996 79998887532 2299999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 222 a~~~ 225 (437)
T 4aw2_A 222 CLKL 225 (437)
T ss_dssp CEEC
T ss_pred hhhc
Confidence 8765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=281.15 Aligned_cols=143 Identities=29% Similarity=0.486 Sum_probs=128.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ .+....
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~-~~~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAF-QDDRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEE-ECSSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-EECCEE
Confidence 46899999999999999999999999999999998853 23467889999888 699999999999 667789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+
T Consensus 145 ~lV~E~~~gg~L~~~l~~~----------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999996 6888877542 189999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 215 a~~~ 218 (410)
T 3v8s_A 215 CMKM 218 (410)
T ss_dssp CEEC
T ss_pred eEee
Confidence 8765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=273.40 Aligned_cols=145 Identities=23% Similarity=0.416 Sum_probs=129.5
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ .....
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~~ 115 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSF-KDNSN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEE-ECSSE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-EcCCE
Confidence 457899999999999999999999999999999999853 23467788888888 699999999998 56678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccc
Confidence 999999996 699888876432 8999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 187 ~a~~~ 191 (350)
T 1rdq_E 187 FAKRV 191 (350)
T ss_dssp TCEEC
T ss_pred cceec
Confidence 98754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=276.49 Aligned_cols=144 Identities=26% Similarity=0.510 Sum_probs=129.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +||||+++++++ ......
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~-~~~~~~ 90 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSF-QDEEDM 90 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEE-ECSSEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE-EeCCEE
Confidence 46899999999999999999999999999999998853 24567899999998 699999999999 566789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|..++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccce
Confidence 99999996 68888876532 289999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 162 a~~~ 165 (384)
T 4fr4_A 162 AAML 165 (384)
T ss_dssp CEEC
T ss_pred eeec
Confidence 8765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=272.97 Aligned_cols=149 Identities=30% Similarity=0.419 Sum_probs=128.9
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ...
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~-~~~ 98 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETY-SSD 98 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEE-EET
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEE-EeC
Confidence 356889999999999999999999999999999998742 34578899999999 699999999998 556
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc---EE
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV---LK 161 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~---~~ 161 (326)
...+++|||+. ++|.+.+...... ...+++..+..++.||+.||.|||+.+|+||||||+||+++.++. ++
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEE
T ss_pred CEEEEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEE
Confidence 78999999998 6888777654322 123899999999999999999999999999999999999987654 99
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 174 l~Dfg~a~~~ 183 (351)
T 3c0i_A 174 LGGFGVAIQL 183 (351)
T ss_dssp ECCCTTCEEC
T ss_pred EecCcceeEe
Confidence 9999998765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=274.28 Aligned_cols=146 Identities=34% Similarity=0.514 Sum_probs=129.8
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------YQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .||||+++++++ .
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~-~ 85 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVY-E 85 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEE-E
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEE-E
Confidence 4678899999999999999999999999999999998853 23567899999999 599999999998 6
Q ss_pred cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----
Q 020467 84 EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---- 158 (326)
Q Consensus 84 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---- 158 (326)
.....+++|||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCcc
Confidence 6778999999996 79988875432 289999999999999999999999999999999999998776
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 157 ~vkl~DFG~a~~~ 169 (361)
T 2yab_A 157 HIKLIDFGLAHEI 169 (361)
T ss_dssp CEEECCCSSCEEC
T ss_pred CEEEEecCCceEc
Confidence 7999999998765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=285.15 Aligned_cols=144 Identities=31% Similarity=0.508 Sum_probs=124.9
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.. ...+.+|+.+++.+ +|+||+++++++....
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccc
Confidence 356899999999999999999999999999999999853 34567899999998 6999999999984332
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...+++|||+.+++.+.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+
T Consensus 138 ~~~~~~lv~E~~~~~l~~~~~~-----------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~ 206 (464)
T 3ttj_A 138 EFQDVYLVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206 (464)
T ss_dssp TCCEEEEEEECCSEEHHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred cCCeEEEEEeCCCCCHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEE
Confidence 34799999999888777632 18899999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 207 DFG~a~~~ 214 (464)
T 3ttj_A 207 DFGLARTA 214 (464)
T ss_dssp CCCCC---
T ss_pred EEEeeeec
Confidence 99998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=278.63 Aligned_cols=145 Identities=28% Similarity=0.436 Sum_probs=129.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.++. ...+.+|..++..+ +|+||+++++++ .+....
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~-~~~~~~ 136 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAF-QDENYL 136 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEE-ECSSEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEE-eeCCEE
Confidence 46899999999999999999999999999999999853 23467888888888 699999999998 666789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
|++|||+. ++|.+++..... .+++..+..++.||+.||.|||+.+|+||||||+|||++.+++++|+|||+
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 99999996 799998875421 289999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 209 a~~~ 212 (412)
T 2vd5_A 209 CLKL 212 (412)
T ss_dssp CEEC
T ss_pred heec
Confidence 8765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=269.14 Aligned_cols=147 Identities=22% Similarity=0.339 Sum_probs=130.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+.+|+||+++++++ ......+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG-PCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEE-EETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEE-ecCCccEEEEE
Confidence 56889999999999999999999999999999998853 446889999999997799999999998 55677899999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc-----EEEEeeccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV-----LKLADFGQA 168 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~-----~~l~Dfg~~ 168 (326)
|++++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++. ++|+|||++
T Consensus 86 ~~~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 86 LLGPSLEDLFDLCD--------RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp CCCCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred eCCCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99889999987642 22999999999999999999999999999999999999998887 999999999
Q ss_pred cccc
Q 020467 169 RILL 172 (326)
Q Consensus 169 ~~~~ 172 (326)
..+.
T Consensus 158 ~~~~ 161 (330)
T 2izr_A 158 KEYI 161 (330)
T ss_dssp EESB
T ss_pred eeee
Confidence 8753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=273.39 Aligned_cols=147 Identities=33% Similarity=0.582 Sum_probs=126.9
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.....++|++.++||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ....
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~ 106 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVI-HHNH 106 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEE-EETT
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEE-ecCC
Confidence 45578999999999999999999999999999999999853 22356899999999 699999999998 5667
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-----CCCcEE
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG-----DDGVLK 161 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~-----~~~~~~ 161 (326)
..+++|||+.++|.+++..... +++..+..++.||+.||.|||+.+|+||||||+||+++ ..+.++
T Consensus 107 ~~~lv~e~~~~~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp EEEEEEECCSEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred EEEEEEecCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEE
Confidence 8999999999999998876543 89999999999999999999999999999999999995 445699
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 178 l~Dfg~a~~~ 187 (329)
T 3gbz_A 178 IGDFGLARAF 187 (329)
T ss_dssp ECCTTHHHHH
T ss_pred ECcCCCcccc
Confidence 9999998765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=272.27 Aligned_cols=155 Identities=26% Similarity=0.425 Sum_probs=133.2
Q ss_pred ccccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHh----cCCCeeEEeEE
Q 020467 9 WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQ----NSPNVVVLHEY 80 (326)
Q Consensus 9 ~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~----~h~ni~~l~~~ 80 (326)
++......+.++|++.++||+|+||.||+|.+..+++.||+|.+.. ......|+.+++.+. .|+||++++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 3444455678999999999999999999999999999999999864 334567888888885 49999999999
Q ss_pred EEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC----
Q 020467 81 FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---- 156 (326)
Q Consensus 81 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---- 156 (326)
+ ......+++|||++++|.+++..... ..++...+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 105 ~-~~~~~~~lv~e~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 105 F-MYYDHMCLIFEPLGPSLYEIITRNNY-------NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp E-EETTEEEEEECCCCCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred e-eECCeeEEEEcCCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 8 55668999999999999999876542 23899999999999999999999999999999999999975
Q ss_pred ---------------------CCcEEEEeecccccc
Q 020467 157 ---------------------DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ---------------------~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~ 212 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEET
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceec
Confidence 788999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=267.20 Aligned_cols=142 Identities=38% Similarity=0.626 Sum_probs=126.3
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|++.+.||+|+||.||+|.+ .+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVI-HTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEE-ECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEE-ccCCeEEEE
Confidence 6899999999999999999998 6788999998852 24567899999999 699999999998 566789999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||+.++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 79 ~e~~~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCE--------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp EECCSEEHHHHHHTST--------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEecCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 9999999988886532 22899999999999999999999999999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=269.86 Aligned_cols=149 Identities=39% Similarity=0.636 Sum_probs=116.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++ ...+..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVI-HTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEE-CCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEE-EECCeEEEE
Confidence 5789999999999999999999998999999998852 24577899999999 699999999998 666789999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||+.++|.+++....... ....++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 82 ~e~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 82 FEFMDNDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EECCCCBHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEecCCCHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9999999998887543211 1233889999999999999999999999999999999999999999999999998765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=276.76 Aligned_cols=149 Identities=28% Similarity=0.378 Sum_probs=130.3
Q ss_pred ccccCeEEE-eeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEe---cCCceEEE
Q 020467 16 EIIAKYEIL-ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWR---EDEDAVLV 91 (326)
Q Consensus 16 ~~~~~y~i~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~---~~~~~~lv 91 (326)
.+.++|.+. +.||.|+||.||+|.+..+++.||||.+.......+|+.++.++.+|+||+++++++.. ....++++
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 467889887 78999999999999999999999999998878888999998777789999999998843 24568999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEEeecc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DGVLKLADFGQ 167 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~~~~l~Dfg~ 167 (326)
|||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.++|+|||+
T Consensus 138 ~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEeCCCCcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99997 599988875432 22899999999999999999999999999999999999997 78999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 211 a~~~ 214 (400)
T 1nxk_A 211 AKET 214 (400)
T ss_dssp CEEC
T ss_pred cccc
Confidence 8754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.87 Aligned_cols=146 Identities=30% Similarity=0.465 Sum_probs=127.7
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.. ...+.+|+.+++.+ +||||+++++++ .....
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~-~~~~~ 84 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSI-SEEGH 84 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEE-ECSSE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEE-EECCE
Confidence 3577899999999999999999999999999999998853 23467899999999 699999999998 66778
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc---CCCcEEEE
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG---DDGVLKLA 163 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~---~~~~~~l~ 163 (326)
.+++|||+. ++|.+.+..... +++..+..++.||+.||.|||+.||+||||||+||+++ .++.++|+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~---------~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREY---------YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EEEEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEc
Confidence 999999997 588888876432 89999999999999999999999999999999999998 45789999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 156 DFG~a~~~ 163 (444)
T 3soa_A 156 DFGLAIEV 163 (444)
T ss_dssp CCSSCBCC
T ss_pred cCceeEEe
Confidence 99998765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.62 Aligned_cols=146 Identities=33% Similarity=0.489 Sum_probs=129.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+..+..+ +|+||+++++++ ...+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~-~~~~ 84 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVD-EEDD 84 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEE-ECSS
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEee-eeCC
Confidence 3467899999999999999999999999999999998732 23567888888888 699999999998 6677
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeC
Confidence 8999999997 599888866432 899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 156 g~~~~~ 161 (294)
T 4eqm_A 156 GIAKAL 161 (294)
T ss_dssp SSSTTC
T ss_pred CCcccc
Confidence 998765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=276.04 Aligned_cols=144 Identities=24% Similarity=0.410 Sum_probs=120.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHH-HHHhcCCCeeEEeEEEEecCCc
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEAL-QILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l-~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.++.. .....|..++ +.+ +|+||+++++++ .....
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~-~~~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSF-QTADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEE-ECSSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEE-EeCCE
Confidence 468999999999999999999999999999999998532 2234444443 334 799999999998 56678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.|++|||+. ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCc
Confidence 999999997 588888865432 8899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 185 ~a~~~ 189 (373)
T 2r5t_A 185 LCKEN 189 (373)
T ss_dssp BCGGG
T ss_pred ccccc
Confidence 98753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=271.50 Aligned_cols=145 Identities=30% Similarity=0.449 Sum_probs=127.9
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~-~~~~~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHR-REGNIQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEE-ECSSEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEE-ecCCeEE
Confidence 367899999999999999999999999999999998742 34577899999998 699999999998 6677899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp EEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecc
Confidence 9999997 58877664332 2899999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
..+
T Consensus 153 ~~~ 155 (323)
T 3tki_A 153 TVF 155 (323)
T ss_dssp EEC
T ss_pred cee
Confidence 765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=268.92 Aligned_cols=146 Identities=29% Similarity=0.417 Sum_probs=129.2
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++.++|++.+.||+|+||.||+|.+..+++.+|+|.+.. ...+.+|+.+++.+ .||||+++++++ ......+++
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~-~~~~~~~lv 79 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESF-ESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEE-EETTEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEE-ecCCEEEEE
Confidence 467899999999999999999999999999999998853 33467899999988 699999999999 566789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC--CCcEEEEeeccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD--DGVLKLADFGQA 168 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~--~~~~~l~Dfg~~ 168 (326)
|||+. ++|.+.+.... ..+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++
T Consensus 80 ~e~~~g~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 80 FEFISGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEeCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 99997 58888875432 23899999999999999999999999999999999999997 789999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
..+
T Consensus 152 ~~~ 154 (321)
T 1tki_A 152 RQL 154 (321)
T ss_dssp EEC
T ss_pred eEC
Confidence 765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=271.63 Aligned_cols=150 Identities=20% Similarity=0.284 Sum_probs=125.1
Q ss_pred cccCeEEEeeeccccCcEEEEEE-----EcCCCeEEEEEEccc--hhhHHHHHHHHHHHh--cCCCeeEEeEEEEecCCc
Q 020467 17 IIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVHD--YQSAFREIEALQILQ--NSPNVVVLHEYFWREDED 87 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~-----~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~~~~ 87 (326)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.. ...+..|.+.+..+. .|+|++.+++++ ...+.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~-~~~~~ 141 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAH-LFQNG 141 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE-ECSSC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheee-ecCCC
Confidence 35789999999999999999994 567889999999864 345667777777763 289999999998 55668
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC----------
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---------- 156 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---------- 156 (326)
.+++|||+. ++|.+++....... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTP----EKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTST----TCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cEEEEeccCCCcHHHHHHHhhccc----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 999999997 79999987543211 234999999999999999999999999999999999999998
Q ss_pred -CCcEEEEeecccccc
Q 020467 157 -DGVLKLADFGQARIL 171 (326)
Q Consensus 157 -~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++..+
T Consensus 218 ~~~~~kl~DFG~a~~~ 233 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDM 233 (365)
T ss_dssp -CTTEEECCCTTCEEG
T ss_pred ccCCEEEeeCchhhhh
Confidence 899999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=268.88 Aligned_cols=147 Identities=42% Similarity=0.615 Sum_probs=129.5
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec----
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE---- 84 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~---- 84 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccc
Confidence 457899999999999999999999999999999998742 23567899999999 699999999998543
Q ss_pred ---CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 020467 85 ---DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 85 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 161 (326)
.+..+++|||+.+++...+..... .++...+..++.|++.||.|||+.||+||||||+||+++.++.++
T Consensus 93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~k 164 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEHDLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 164 (351)
T ss_dssp ----CEEEEEEECCSEEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred ccCCceEEEEEeccCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEE
Confidence 345899999999998888765432 289999999999999999999999999999999999999999999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++..+
T Consensus 165 l~Dfg~a~~~ 174 (351)
T 3mi9_A 165 LADFGLARAF 174 (351)
T ss_dssp ECCCTTCEEC
T ss_pred Eccchhcccc
Confidence 9999998765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=271.08 Aligned_cols=144 Identities=40% Similarity=0.684 Sum_probs=127.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccchh------hHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQ------SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~------~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .+.+|+.+++.+ .|+||+++++++ ......+++
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDII-HTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEE-ECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEE-eeCCEEEEE
Confidence 368999999999999999999999999999999885321 334688999888 699999999998 566789999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||+.++|.+++..... .++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 79 ~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp EECCSEEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred ecccccCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 99999999988876432 2889999999999999999999999999999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.25 Aligned_cols=147 Identities=29% Similarity=0.441 Sum_probs=128.7
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. .....+|++++.++.+||||+++++++ .+....+++||
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-~~~~~~~lv~E 96 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-DDGKYVYVVTE 96 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-ECSSEEEEEEC
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-EcCCEEEEEEe
Confidence 3578899999999999999999999999999999999864 334568899998887799999999998 66778999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC----CcEEEEeeccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD----GVLKLADFGQA 168 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~----~~~~l~Dfg~~ 168 (326)
|+. ++|.+.+..... +++..+..++.||+.||.|||+.||+||||||+||++... +.++|+|||++
T Consensus 97 ~~~gg~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 97 LMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp CCCSCBHHHHHHTCTT---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 997 689888865432 8999999999999999999999999999999999998543 35999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 168 ~~~ 170 (342)
T 2qr7_A 168 KQL 170 (342)
T ss_dssp EEC
T ss_pred ccC
Confidence 765
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=272.34 Aligned_cols=145 Identities=36% Similarity=0.535 Sum_probs=122.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ +|+||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccc
Confidence 467899999999999999999999999999999999842 23567899999999 5999999999984432
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
..++++|||++++|.+++... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 170 (367)
T 1cm8_A 101 DFTDFYLVMPFMGTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 170 (367)
T ss_dssp TCCCCEEEEECCSEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEecCCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEE
Confidence 346999999988998887652 18999999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 171 Dfg~a~~~ 178 (367)
T 1cm8_A 171 DFGLARQA 178 (367)
T ss_dssp CCTTCEEC
T ss_pred eeeccccc
Confidence 99998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=263.72 Aligned_cols=145 Identities=22% Similarity=0.384 Sum_probs=129.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVL-YKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-EETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEE-ecCCeeEEEE
Confidence 5789999999999999999999999999999998743 34567899999999 699999999999 5566799999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 87 e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp ECCTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9997 599888865322 2899999999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 172 L 172 (326)
Q Consensus 172 ~ 172 (326)
.
T Consensus 159 ~ 159 (310)
T 3s95_A 159 V 159 (310)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=271.38 Aligned_cols=147 Identities=33% Similarity=0.484 Sum_probs=128.4
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
...+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +||||+++++++ ....
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~-~~~~ 101 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI-QEES 101 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ECSS
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-EeCC
Confidence 34567899999999999999999999999999999999853 23567899999999 699999999998 6667
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEE
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---VLKL 162 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---~~~l 162 (326)
..+++|||+. ++|.+.+.... .+++..+..++.||+.||.|||+.+|+||||||+||+++.++ .++|
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEE
Confidence 8999999997 58888775432 289999999999999999999999999999999999998654 5999
Q ss_pred Eeecccccc
Q 020467 163 ADFGQARIL 171 (326)
Q Consensus 163 ~Dfg~~~~~ 171 (326)
+|||++...
T Consensus 173 ~DfG~a~~~ 181 (362)
T 2bdw_A 173 ADFGLAIEV 181 (362)
T ss_dssp CCCTTCBCC
T ss_pred eecCcceEe
Confidence 999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=270.36 Aligned_cols=144 Identities=28% Similarity=0.441 Sum_probs=127.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+..++.+ +|+||+++++++ ......+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~-~~~~~~~lv 94 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVI-LTPTHLAII 94 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEE-ECSSEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEE-eeCCEEEEE
Confidence 346899999999999999999999999999999998863 35577899999999 699999999999 566789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--EEEEeeccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV--LKLADFGQA 168 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~--~~l~Dfg~~ 168 (326)
|||+. ++|.+++..... +++..+..++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++
T Consensus 95 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 95 MEYASGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEeCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 99996 689888865433 899999999999999999999999999999999999987765 999999988
Q ss_pred cc
Q 020467 169 RI 170 (326)
Q Consensus 169 ~~ 170 (326)
..
T Consensus 166 ~~ 167 (361)
T 3uc3_A 166 KS 167 (361)
T ss_dssp --
T ss_pred cc
Confidence 64
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=265.64 Aligned_cols=144 Identities=25% Similarity=0.411 Sum_probs=122.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
..++|++.+.||+|+||.||+|.+. .+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++ ..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~ 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAF-QT 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEE-EC
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEE-Ec
Confidence 4688999999999999999999875 5789999998853 23356789999998 699999999998 56
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
....+++|||+. ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGI---------FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEE
Confidence 678999999997 688888865432 8899999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 164 Dfg~~~~~ 171 (327)
T 3a62_A 164 DFGLCKES 171 (327)
T ss_dssp CCSCC---
T ss_pred eCCccccc
Confidence 99998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=270.82 Aligned_cols=147 Identities=39% Similarity=0.678 Sum_probs=124.1
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
....++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~ 83 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAF-GH 83 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEE-CC
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEE-ee
Confidence 3567899999999999999999999988999999998852 23567899999999 699999999998 66
Q ss_pred CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 85 DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 85 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
....+++|||+.++|...+.... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 155 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNS--------LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLAD 155 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCC--------SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEEcCCCCHHHHHHhcC--------cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEe
Confidence 77899999999998887775432 2278889999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++..+
T Consensus 156 fg~a~~~ 162 (346)
T 1ua2_A 156 FGLAKSF 162 (346)
T ss_dssp CGGGSTT
T ss_pred cccceec
Confidence 9998765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=268.14 Aligned_cols=154 Identities=20% Similarity=0.376 Sum_probs=128.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc-------CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL-------SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~-------~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
..++|++.+.||+|+||.||+|.+. .++..||+|.++. ...+.+|+.+++.+.+|+||+++++++ .
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-T 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE-C
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-c
Confidence 3589999999999999999999864 3456799999863 235678999999986699999999998 6
Q ss_pred cCCceEEEeeecc-cCHHHHHHHhhhhh-------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc
Q 020467 84 EDEDAVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG 155 (326)
Q Consensus 84 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~ 155 (326)
.....+++|||+. ++|.+++....... .......++...+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 6778999999997 59999887643210 001123388999999999999999999999999999999999999
Q ss_pred CCCcEEEEeecccccc
Q 020467 156 DDGVLKLADFGQARIL 171 (326)
Q Consensus 156 ~~~~~~l~Dfg~~~~~ 171 (326)
.++.++|+|||++..+
T Consensus 238 ~~~~~kl~DFG~a~~~ 253 (370)
T 2psq_A 238 ENNVMKIADFGLARDI 253 (370)
T ss_dssp TTCCEEECCCSSCEET
T ss_pred CCCCEEEccccCCccc
Confidence 9999999999998765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=265.63 Aligned_cols=146 Identities=33% Similarity=0.501 Sum_probs=129.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------YQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +||||+++++++ .
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~ 84 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVY-E 84 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE-E
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEE-E
Confidence 3577899999999999999999999999999999998752 24577899999999 699999999998 6
Q ss_pred cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----
Q 020467 84 EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---- 158 (326)
Q Consensus 84 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---- 158 (326)
.....+++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSC
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCC
Confidence 6678999999996 69988875432 289999999999999999999999999999999999999877
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 156 ~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 156 RIKIIDFGLAHKI 168 (326)
T ss_dssp CEEECCCTTCEEC
T ss_pred CEEEEECCCCeEC
Confidence 8999999998765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=272.93 Aligned_cols=149 Identities=32% Similarity=0.518 Sum_probs=130.4
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch----hhHHHHHHHHHHHh-----cCCCeeEEeEEEEecC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQ-----NSPNVVVLHEYFWRED 85 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----~~~~~E~~~l~~l~-----~h~ni~~l~~~~~~~~ 85 (326)
..+..+|++.+.||+|+||.||+|.+..+++.||||.+... ....+|+.+++.+. +|+||+++++++ ...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-TFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-EET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-ccC
Confidence 45778999999999999999999999999999999999653 34567888888885 467999999998 556
Q ss_pred CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--EEEE
Q 020467 86 EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV--LKLA 163 (326)
Q Consensus 86 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~--~~l~ 163 (326)
...+++|||+.++|.+++..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++. ++|+
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKNKF-------QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred CeEEEEEeccCCCHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence 78999999999999998876542 23899999999999999999999999999999999999999887 9999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 245 DFG~a~~~ 252 (429)
T 3kvw_A 245 DFGSSCYE 252 (429)
T ss_dssp CCTTCEET
T ss_pred ecccceec
Confidence 99998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=265.00 Aligned_cols=151 Identities=23% Similarity=0.423 Sum_probs=127.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE--- 86 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~--- 86 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++++ +||||+++++++.....
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchh
Confidence 356889999999999999999999999999999998852 34577899999999 69999999999854332
Q ss_pred -----------------------------------------------------ceEEEeeecc-cCHHHHHHHhhhhhhh
Q 020467 87 -----------------------------------------------------DAVLVLEFLR-TDLATVIAESKKKRED 112 (326)
Q Consensus 87 -----------------------------------------------------~~~lv~e~~~-~~L~~~l~~~~~~~~~ 112 (326)
..+++|||+. ++|.+++......
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--- 158 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--- 158 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---
Confidence 2799999997 5888888764322
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccccC
Q 020467 113 RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLG 173 (326)
Q Consensus 113 ~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 173 (326)
.......++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 159 ---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 216 (332)
T 3qd2_B 159 ---EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216 (332)
T ss_dssp ---GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSC
T ss_pred ---cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccccc
Confidence 1156677899999999999999999999999999999999999999999999987643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=289.54 Aligned_cols=145 Identities=22% Similarity=0.382 Sum_probs=128.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++++.||+|+||.||+|.+..+++.||||.+.. ......|..++..+.+|++|+.+++++ .....+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-~~~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-QTMDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-BCSSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-EeCCEE
Confidence 35789999999999999999999999999999999863 234567888888777899999999998 667789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
|++|||+. ++|.+++..... +++..+..++.||+.||.|||+.+|+||||||+||||+.++.++|+|||+
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred EEEEeCcCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecce
Confidence 99999997 689888876433 89999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 489 a~~~ 492 (674)
T 3pfq_A 489 CKEN 492 (674)
T ss_dssp CEEC
T ss_pred eecc
Confidence 8753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=267.54 Aligned_cols=146 Identities=30% Similarity=0.504 Sum_probs=129.1
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
-.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|++++..+ .|+||+++++++....
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTT
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccc
Confidence 3456799999999999999999999999999999999863 24567899999999 6999999999984332
Q ss_pred -CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 -EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
...+++||++.++|.+++.... +++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|
T Consensus 102 ~~~~~iv~e~~~~~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 102 MKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp CCCEEEEEECCSEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred cceEEEEEcccCcCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEe
Confidence 4689999999999998886432 89999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 172 fg~a~~~ 178 (364)
T 3qyz_A 172 FGLARVA 178 (364)
T ss_dssp CTTCEEC
T ss_pred CcceEec
Confidence 9998765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=258.00 Aligned_cols=148 Identities=24% Similarity=0.387 Sum_probs=131.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+..+..+.+|++++++++++ ......+++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~~~~~lv~ 85 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-QEGLHNVLVI 85 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-EETTEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-CCCceeEEEE
Confidence 467889999999999999999999989999999998853 456788999999997899999999988 6677899999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc-----EEEEeecc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV-----LKLADFGQ 167 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~-----~~l~Dfg~ 167 (326)
||++++|.+++..... .++...+..++.|++.||.|||+.+|+||||||+||+++.++. ++|+|||+
T Consensus 86 e~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 86 DLLGPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp ECCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EecCCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9998899999875432 2899999999999999999999999999999999999987775 99999999
Q ss_pred ccccc
Q 020467 168 ARILL 172 (326)
Q Consensus 168 ~~~~~ 172 (326)
+....
T Consensus 158 ~~~~~ 162 (298)
T 1csn_A 158 VKFYR 162 (298)
T ss_dssp CEESB
T ss_pred ccccc
Confidence 98763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=266.36 Aligned_cols=149 Identities=27% Similarity=0.401 Sum_probs=126.9
Q ss_pred CccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 13 ~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
....+.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+..++.+ +|+||+++++++...
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEE
T ss_pred CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeecc
Confidence 3456789999999999999999999999999999999998632 2456777777777 699999999998544
Q ss_pred CC---ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 020467 85 DE---DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 85 ~~---~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 160 (326)
.. ..+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.+|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV 155 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCE
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCE
Confidence 32 2499999996 699888865432 8999999999999999999999999999999999999999999
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
+|+|||++..+
T Consensus 156 kl~Dfg~a~~~ 166 (311)
T 3ork_A 156 KVMDFGIARAI 166 (311)
T ss_dssp EECCCSCC---
T ss_pred EEeeccCcccc
Confidence 99999998765
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=279.75 Aligned_cols=149 Identities=27% Similarity=0.416 Sum_probs=130.2
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ .....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~-~~~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAF-ETKTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEE-ECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEE-eeCCE
Confidence 346899999999999999999999999999999999853 23467899999998 699999999998 56678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++...... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence 999999997 6888887653311 1238999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 335 la~~~ 339 (543)
T 3c4z_A 335 LAVEL 339 (543)
T ss_dssp TCEEC
T ss_pred eeeec
Confidence 99765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=267.27 Aligned_cols=146 Identities=29% Similarity=0.506 Sum_probs=128.9
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
+..++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ .|+||+++++++ .....
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~-~~~~~ 128 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCY-LREHT 128 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-EETTE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-EECCe
Confidence 345679999999999999999999999999999998852 23467899999999 699999999998 55668
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
.+++|||+.+++.+.+..... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+
T Consensus 129 ~~lv~e~~~g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp EEEEEECCSEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred EEEEEecCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999888765332 289999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 201 a~~~ 204 (348)
T 1u5q_A 201 ASIM 204 (348)
T ss_dssp CBSS
T ss_pred ceec
Confidence 8654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=266.91 Aligned_cols=146 Identities=34% Similarity=0.497 Sum_probs=127.4
Q ss_pred ccccCeEEE---eeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEIL---ECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~---~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.+.++|++. +.||+|+||.||+|.+..+++.||+|.+.. .....+|+..++.+.+|+||+++++++ .+....++
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-~~~~~~~l 83 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-HDQLHTFL 83 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-ECSSEEEE
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-EcCCEEEE
Confidence 356788886 789999999999999999999999999864 345678999999986799999999999 66678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEEeec
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---VLKLADFG 166 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---~~~l~Dfg 166 (326)
+|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .++|+|||
T Consensus 84 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EECCCCSCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 999997 59988887643 289999999999999999999999999999999999998766 89999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 155 ~a~~~ 159 (325)
T 3kn6_A 155 FARLK 159 (325)
T ss_dssp TCEEC
T ss_pred cceec
Confidence 98754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=274.16 Aligned_cols=148 Identities=30% Similarity=0.480 Sum_probs=124.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-hhHHHHHHHHHHHhcCCCeeEEeEEEEecC-----CceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-QSAFREIEALQILQNSPNVVVLHEYFWRED-----EDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-----~~~~lv 91 (326)
..+|++.+.||+|+||.||+|.+..+++.||||.+... ....+|+++++.+ .|+||+++++++.... ..++++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEee
Confidence 45799999999999999999999999999999988643 3345799999999 6999999999885432 236799
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEEeeccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-GVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-~~~~l~Dfg~~~~ 170 (326)
|||+.+++.+.+...... ...+++..+..++.||+.||.|||+.||+||||||+|||++.+ +.++|+|||++..
T Consensus 132 ~e~~~~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EECCCEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred hhcccccHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 999998888776543221 2338999999999999999999999999999999999999965 5789999999976
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
+
T Consensus 207 ~ 207 (420)
T 1j1b_A 207 L 207 (420)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=261.16 Aligned_cols=145 Identities=37% Similarity=0.612 Sum_probs=124.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~ 78 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVF-RRKRRLH 78 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-EETTEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhhee-ecCCeEE
Confidence 35789999999999999999999999999999998743 23456899999999 699999999998 5567799
Q ss_pred EEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 90 LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 90 lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++|||+.+++...+.... ..++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 79 lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQ--------RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR 150 (311)
T ss_dssp EEEECCSEEHHHHHHHTS--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeCCCchHHHHHhhh--------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence 999999965444433321 228999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 151 ~~ 152 (311)
T 4agu_A 151 LL 152 (311)
T ss_dssp EC
T ss_pred hc
Confidence 65
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=270.54 Aligned_cols=150 Identities=29% Similarity=0.490 Sum_probs=126.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---------
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-YQSAFREIEALQILQNSPNVVVLHEYFWRED--------- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--------- 85 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. .....+|+++++.+ +|+||+++++++....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTC-CCTTBCCEEEEEEEC----------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHc-CCCCccchhheeeecCccccccccc
Confidence 356789999999999999999999999999999998753 33445799999998 6999999999984432
Q ss_pred ----------------------------CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 020467 86 ----------------------------EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137 (326)
Q Consensus 86 ----------------------------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~L 137 (326)
...+++|||++++|.+.+...... ...+++..+..++.||+.||.||
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRS-----GRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp ---------------------------CCEEEEEECCCSEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHH
Confidence 237899999999988887653322 23499999999999999999999
Q ss_pred HhCCceeccCCCCCeEEc-CCCcEEEEeecccccc
Q 020467 138 HRNTIVHRDLKPGNLLIG-DDGVLKLADFGQARIL 171 (326)
Q Consensus 138 H~~~iiH~dlkp~Nili~-~~~~~~l~Dfg~~~~~ 171 (326)
|+.||+||||||+||+++ .++.++|+|||++..+
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 192 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEEC
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCccc
Confidence 999999999999999998 6889999999998765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=278.76 Aligned_cols=144 Identities=24% Similarity=0.382 Sum_probs=121.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.+++.+ +|+||+++++++ ......
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~-~~~~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSF-QTHDRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEE-EETTEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEE-eeCCEE
Confidence 468899999999999999999999999999999988632 3345677777777 699999999999 556679
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
+++|||+. ++|.+++..... +++..+..++.||+.||.|||+ .||+||||||+|||++.++.++|+|||
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred EEEEeeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCC
Confidence 99999997 588887765432 8999999999999999999998 999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 295 ~a~~~ 299 (446)
T 4ejn_A 295 LCKEG 299 (446)
T ss_dssp CCCTT
T ss_pred Cceec
Confidence 98653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=268.94 Aligned_cols=137 Identities=28% Similarity=0.448 Sum_probs=118.5
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhc-------CCCeeEEeEEEEe
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQN-------SPNVVVLHEYFWR 83 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~-------h~ni~~l~~~~~~ 83 (326)
..+.++|++.++||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+.+ |+||+++++++..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4456899999999999999999999999999999999864 3456789999999862 7889999999853
Q ss_pred ---cCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCC
Q 020467 84 ---EDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 84 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~ 158 (326)
.....+++|||+++++.+.+..... ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNY-------QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 3457899999999999988876432 2389999999999999999999998 999999999999999775
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=270.43 Aligned_cols=146 Identities=31% Similarity=0.489 Sum_probs=128.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......++
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~-~~~~~~~l 125 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAF-EDKYEMVL 125 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEE-ECSSEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEE-EeCCEEEE
Confidence 567899999999999999999999999999999998853 33567899999988 699999999998 66778999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC--CCcEEEEeecc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD--DGVLKLADFGQ 167 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~--~~~~~l~Dfg~ 167 (326)
+|||+. ++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++. .+.++|+|||+
T Consensus 126 v~E~~~gg~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp EEECCCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEcCCCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 999997 68887775432 23899999999999999999999999999999999999974 46899999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 198 a~~~ 201 (387)
T 1kob_A 198 ATKL 201 (387)
T ss_dssp CEEC
T ss_pred ceec
Confidence 8765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=259.85 Aligned_cols=149 Identities=31% Similarity=0.490 Sum_probs=129.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-Cce
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED-EDA 88 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-~~~ 88 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+++++.+ +|+||+++++++.... ...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceE
Confidence 356889999999999999999999999999999999863 34467899999999 5999999999985443 368
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEE
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLA 163 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili----~~~~~~~l~ 163 (326)
+++|||+. ++|.+++...... ..+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred EEEEeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 99999997 6898888764331 238999999999999999999999999999999999999 777889999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 159 Dfg~a~~~ 166 (319)
T 4euu_A 159 DFGAAREL 166 (319)
T ss_dssp CCTTCEEC
T ss_pred cCCCceec
Confidence 99998765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=265.78 Aligned_cols=147 Identities=18% Similarity=0.252 Sum_probs=122.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC-----CeEEEEEEccc-hhhHHHHHHHHHHHh--------------cCCCeeEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD-----NLIVALKEVHD-YQSAFREIEALQILQ--------------NSPNVVVL 77 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~-~~~~~~E~~~l~~l~--------------~h~ni~~l 77 (326)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.. ......|++++..+. .|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45999999999999999999988654 57899998754 334455666555543 39999999
Q ss_pred eEEEEecC---CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 020467 78 HEYFWRED---EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154 (326)
Q Consensus 78 ~~~~~~~~---~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili 154 (326)
++++.... ...+++|||++++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA--------KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEE
Confidence 99985542 4589999999889999887642 238999999999999999999999999999999999999
Q ss_pred c--CCCcEEEEeeccccccc
Q 020467 155 G--DDGVLKLADFGQARILL 172 (326)
Q Consensus 155 ~--~~~~~~l~Dfg~~~~~~ 172 (326)
+ .++.++|+|||++..+.
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~ 205 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYC 205 (364)
T ss_dssp ESSCTTCEEECCCTTCEESS
T ss_pred ecCCCCeEEEEECCcceecc
Confidence 9 88999999999997763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=280.28 Aligned_cols=147 Identities=26% Similarity=0.395 Sum_probs=129.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.++..+ +|+||+++++++ .....
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~-~~~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAY-ETKDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEE-ECSSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEE-eeCCE
Confidence 456889999999999999999999999999999999853 23467899999998 699999999998 66678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFG 331 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQ-------AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLG 331 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSS-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecc
Confidence 999999996 688888765332 238999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 332 la~~~ 336 (576)
T 2acx_A 332 LAVHV 336 (576)
T ss_dssp TCEEC
T ss_pred cceec
Confidence 98765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=267.93 Aligned_cols=146 Identities=27% Similarity=0.349 Sum_probs=129.7
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------------hhHHHHHHHHHHHhcCCCeeEEeEEE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------------QSAFREIEALQILQNSPNVVVLHEYF 81 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------------~~~~~E~~~l~~l~~h~ni~~l~~~~ 81 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.+++.+ +|+||+++++++
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~ 98 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIF 98 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence 35678999999999999999999999999999999988532 2456799999999 699999999998
Q ss_pred EecCCceEEEeeecc-c-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 82 WREDEDAVLVLEFLR-T-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 82 ~~~~~~~~lv~e~~~-~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
......+++|||+. + +|.+++..... +++..+..++.|++.||.|||+.+|+||||||+||+++.++.
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDRHPR---------LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHTCCC---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc
Confidence 66778999999986 4 88888765432 899999999999999999999999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 169 ~kL~Dfg~a~~~ 180 (335)
T 3dls_A 169 IKLIDFGSAAYL 180 (335)
T ss_dssp EEECCCTTCEEC
T ss_pred EEEeecccceEC
Confidence 999999998765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=265.96 Aligned_cols=147 Identities=36% Similarity=0.470 Sum_probs=121.6
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
...+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++++ .|+||+++++++ ......++
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-~~~~~~~l 125 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIF-ETPTEISL 125 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEE-ECSSEEEE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeE-ecCCeEEE
Confidence 34567889999999999999999999999999999999864 34567899999999 699999999999 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEEeec
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DGVLKLADFG 166 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~~~~l~Dfg 166 (326)
+|||+. ++|.+.+.... .+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||
T Consensus 126 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EECCCCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred EEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 999997 68888875432 2899999999999999999999999999999999999975 8899999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 197 ~a~~~ 201 (349)
T 2w4o_A 197 LSKIV 201 (349)
T ss_dssp -----
T ss_pred ccccc
Confidence 98754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=262.19 Aligned_cols=144 Identities=29% Similarity=0.526 Sum_probs=122.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------------------------------hhHHHHHHHH
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------------------------------QSAFREIEAL 65 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------------------------------~~~~~E~~~l 65 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 468999999999999999999999999999999988532 3467899999
Q ss_pred HHHhcCCCeeEEeEEEEec-CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 020467 66 QILQNSPNVVVLHEYFWRE-DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIV 143 (326)
Q Consensus 66 ~~l~~h~ni~~l~~~~~~~-~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ii 143 (326)
+.+ .|+||+++++++... ....+++|||+. ++|.+++. ...+++..+..++.|++.||.|||+.+|+
T Consensus 91 ~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 159 (298)
T 2zv2_A 91 KKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----------LKPLSEDQARFYFQDLIKGIEYLHYQKII 159 (298)
T ss_dssp HTC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----------SSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HhC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 999 699999999998542 457899999997 45544321 12389999999999999999999999999
Q ss_pred eccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 144 HRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 144 H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||||||+||+++.++.++|+|||++...
T Consensus 160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 187 (298)
T 2zv2_A 160 HRDIKPSNLLVGEDGHIKIADFGVSNEF 187 (298)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccCCCHHHEEECCCCCEEEecCCCcccc
Confidence 9999999999999999999999998765
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=270.28 Aligned_cols=145 Identities=33% Similarity=0.508 Sum_probs=115.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec----
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE---- 84 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~---- 84 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ +|+||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccc
Confidence 467899999999999999999999999999999999853 24567899999999 599999999998432
Q ss_pred -CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 85 -DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 85 -~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
....++++++++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+
T Consensus 105 ~~~~~~lv~e~~~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~ 174 (367)
T 2fst_X 105 EFNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174 (367)
T ss_dssp GCCCCEEEEECCCEECC-----C----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCeEEEEecccCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEe
Confidence 2458999999998888777542 28999999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 175 DFG~a~~~ 182 (367)
T 2fst_X 175 DFGLARHT 182 (367)
T ss_dssp C-------
T ss_pred eccccccc
Confidence 99998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=266.55 Aligned_cols=146 Identities=22% Similarity=0.309 Sum_probs=129.1
Q ss_pred cccCeEEEeeeccc--cCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 17 IIAKYEILECVGSG--AYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G--~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..++|++.++||+| +||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ +|+||+++++++ ...+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-~~~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATF-IADNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-EETTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEE-EECCE
Confidence 46889999999999 999999999999999999999853 23456799999999 699999999999 55668
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFM-------DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCT-------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred EEEEEEccCCCCHHHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence 999999997 688888865422 228999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 174 ~~~~~ 178 (389)
T 3gni_B 174 SNLSM 178 (389)
T ss_dssp GCEEC
T ss_pred cceee
Confidence 88655
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=255.82 Aligned_cols=151 Identities=27% Similarity=0.433 Sum_probs=128.5
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. .....+|+..+..+..|+||+++++++ .....
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-~~~~~ 85 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-AEDDH 85 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-EETTE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-ecCCe
Confidence 4577899999999999999999999998999999998752 345667888888876799999999998 55668
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---------
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD--------- 157 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~--------- 157 (326)
.+++|||+. ++|.+++...... ...+++..+..++.|++.||.|||+.+|+||||||+||+++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRI-----MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------
T ss_pred EEEEEEecCCCcHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccc
Confidence 999999997 5999998765432 1238999999999999999999999999999999999999844
Q ss_pred ----------CcEEEEeecccccc
Q 020467 158 ----------GVLKLADFGQARIL 171 (326)
Q Consensus 158 ----------~~~~l~Dfg~~~~~ 171 (326)
..++|+|||++...
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~ 184 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRI 184 (289)
T ss_dssp ---------CCCEEECCCTTCEET
T ss_pred cccccccCCceEEEEccccccccc
Confidence 47899999988764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=266.86 Aligned_cols=156 Identities=21% Similarity=0.333 Sum_probs=130.5
Q ss_pred ccccCeEEEeeeccccCcEEEEEE-----EcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~-----~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
...++|++.+.||+|+||.||+|. ...+++.||||.+.. ...+.+|++++..+.+|+||+++++++...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 346899999999999999999998 455678999999864 234788999999997799999999998665
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhh----------------------------------------------------
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKRE---------------------------------------------------- 111 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~---------------------------------------------------- 111 (326)
....+++|||+. ++|.+++........
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 666999999997 599988876432100
Q ss_pred -----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 112 -----DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 112 -----~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
......+++..+..++.||+.||.|||+.+|+||||||+||+++.++.++|+|||++..+
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 000122888999999999999999999999999999999999999999999999998765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=266.76 Aligned_cols=144 Identities=30% Similarity=0.495 Sum_probs=124.3
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC---
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED--- 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~--- 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ +|+||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccc
Confidence 357899999999999999999999999999999998853 23467889999988 6999999999984333
Q ss_pred --CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 86 --EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 86 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
...+++|||+.++|.+.+.. .++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+
T Consensus 101 ~~~~~~lv~e~~~~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 169 (371)
T 2xrw_A 101 EFQDVYIVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169 (371)
T ss_dssp TCCEEEEEEECCSEEHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccceEEEEEcCCCCHHHHHhh-----------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEE
Confidence 26899999999998887742 18899999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 170 Dfg~a~~~ 177 (371)
T 2xrw_A 170 DFGLARTA 177 (371)
T ss_dssp CCCC----
T ss_pred Eeeccccc
Confidence 99998654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=268.63 Aligned_cols=150 Identities=33% Similarity=0.525 Sum_probs=124.5
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC-----ce
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEALQILQNSPNVVVLHEYFWREDE-----DA 88 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~-----~~ 88 (326)
.....+|++.+.||+|+||.||+|.+..+++ +|+|++. ......+|+++++.+ +|+||+++++++..... ..
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEE
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEE
Confidence 3456789999999999999999999877665 7777664 334445799999999 69999999999855432 27
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-CCCcEEEEeecc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG-DDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~-~~~~~~l~Dfg~ 167 (326)
+++|||+.+++...+...... ...+++..+..++.||+.||.|||+.||+||||||+||+++ .++.++|+|||+
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEeeccCccHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 899999998887766543221 23389999999999999999999999999999999999999 789999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 189 a~~~ 192 (394)
T 4e7w_A 189 AKIL 192 (394)
T ss_dssp CEEC
T ss_pred cccc
Confidence 8765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=258.64 Aligned_cols=146 Identities=24% Similarity=0.389 Sum_probs=123.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
...++|++.+.||+|+||.||+|.+ ++..||+|.+.. ...+.+|+.+++++ +|+||+++++++ ......
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~~~ 109 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAV-TQPPNL 109 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-CSTTCC
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-EECCce
Confidence 3468999999999999999999976 578899998853 23467899999999 699999999998 666779
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEEEee
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
+++|||+. ++|.+++....... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGARE------QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHH------HSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcCCCC------CCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999997 59988887543211 1889999999999999999999999 999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 184 g~a~~~ 189 (309)
T 3p86_A 184 GLSRLK 189 (309)
T ss_dssp C-----
T ss_pred CCCccc
Confidence 998643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=258.53 Aligned_cols=142 Identities=30% Similarity=0.543 Sum_probs=125.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCceEEEeee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNSPNVVVLHEYFWRE-DEDAVLVLEF 94 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~~lv~e~ 94 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+.+|+||+++++++... ....+++|||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 5889999999999999999999999999999999863 556789999999997799999999998543 4568999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-~~~l~Dfg~~~~~ 171 (326)
+. ++|.+++.. +++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus 115 ~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 115 VNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp CCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred cCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 98 566665532 88899999999999999999999999999999999999776 8999999998765
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=274.34 Aligned_cols=147 Identities=30% Similarity=0.513 Sum_probs=130.2
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
...+.++|++.+.||+|+||.||+|.+..+++.||+|.+. ....+.+|+.+++.+ +||||+++++++ ....
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~-~~~~ 94 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEIL-EDSS 94 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-ECSS
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEE-EcCC
Confidence 4468899999999999999999999999999999999974 234578899999999 699999999998 6677
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc---CCCcEEE
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG---DDGVLKL 162 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~---~~~~~~l 162 (326)
..+++|||+. ++|.+.+..... +++..+..++.||+.||.|||+.||+||||||+||+++ .++.++|
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEE
Confidence 8999999997 688888766433 89999999999999999999999999999999999995 4567999
Q ss_pred Eeecccccc
Q 020467 163 ADFGQARIL 171 (326)
Q Consensus 163 ~Dfg~~~~~ 171 (326)
+|||++...
T Consensus 166 ~Dfg~a~~~ 174 (486)
T 3mwu_A 166 IDFGLSTCF 174 (486)
T ss_dssp CSCSCTTTB
T ss_pred EECCcCeEC
Confidence 999998754
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=257.04 Aligned_cols=145 Identities=41% Similarity=0.686 Sum_probs=128.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ...+..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~l 79 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVI-HTENKLYL 79 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTC-CCTTBCCEEEEE-EETTEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHc-CCCCeeeEEEEE-ecCCceEE
Confidence 4789999999999999999999998999999998853 24567899999998 699999999998 55667999
Q ss_pred EeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 91 VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 91 v~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+|||+.++|.+++..... ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 80 v~e~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 152 (299)
T 2r3i_A 80 VFEFLHQDLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152 (299)
T ss_dssp EEECCSEEHHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred EEEcccCCHHHHHHhhhc-------cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhh
Confidence 999999999988876432 2288999999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 153 ~ 153 (299)
T 2r3i_A 153 F 153 (299)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=259.76 Aligned_cols=146 Identities=34% Similarity=0.495 Sum_probs=129.7
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------YQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++ .
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~ 85 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVY-E 85 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE-E
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEE-e
Confidence 4578899999999999999999999999999999998853 23478899999999 699999999998 6
Q ss_pred cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----
Q 020467 84 EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---- 158 (326)
Q Consensus 84 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---- 158 (326)
.....+++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcC
Confidence 6678999999996 69988886532 288999999999999999999999999999999999999887
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 157 ~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 157 HIKLIDFGLAHEI 169 (321)
T ss_dssp CEEECCCTTCEEC
T ss_pred CEEEccCccceec
Confidence 7999999998765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=275.10 Aligned_cols=146 Identities=32% Similarity=0.532 Sum_probs=129.8
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
....++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ +|+||+++++++ ....
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~-~~~~ 89 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVI-STPS 89 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEE-ECSS
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE-EECC
Confidence 3467899999999999999999999999999999999853 23567899999888 699999999998 5667
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEec
Confidence 8999999996 68888875432 2899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 161 G~a~~~ 166 (476)
T 2y94_A 161 GLSNMM 166 (476)
T ss_dssp SSCEEC
T ss_pred cchhhc
Confidence 998765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=262.67 Aligned_cols=145 Identities=23% Similarity=0.368 Sum_probs=126.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCC---eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDN---LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~---~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..++|++.+.||+|+||.||+|.+..++ ..||||.+.. ...+.+|+.+++.+ +|+||+++++++ .....
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~ 124 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVV-TRGRL 124 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CGGGC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE-EeCCc
Confidence 4689999999999999999999987544 4599999863 34567899999999 699999999998 66778
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++.... ..++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHD--------GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred cEEEeeCCCCCcHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence 999999997 59988885432 228999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 197 ~a~~~ 201 (325)
T 3kul_A 197 LSRVL 201 (325)
T ss_dssp SCEEC
T ss_pred ccccc
Confidence 98765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.74 Aligned_cols=144 Identities=25% Similarity=0.435 Sum_probs=128.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.. ..+.+|+++++.+ +|+||+++++++ ......+++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~-~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVC-TQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEE-CSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-ecCCCcEEE
Confidence 47899999999999999999999889999999998642 3567899999998 699999999998 666779999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+++...... ++...+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..
T Consensus 191 ~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGAR--------LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EECCTTCBHHHHHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEcCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 99997 7999888754322 88999999999999999999999999999999999999999999999999875
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 263 ~ 263 (377)
T 3cbl_A 263 E 263 (377)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=271.94 Aligned_cols=156 Identities=34% Similarity=0.551 Sum_probs=122.2
Q ss_pred cccccCeEE-EeeeccccCcEEEEEEEc--CCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEe-cCCc
Q 020467 15 PEIIAKYEI-LECVGSGAYSDVYKGRRL--SDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWR-EDED 87 (326)
Q Consensus 15 ~~~~~~y~i-~~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~-~~~~ 87 (326)
..+.+.|++ .++||+|+||.||+|.+. .+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++.. ....
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCe
Confidence 346677887 458999999999999965 5688999999864 34678999999999 69999999999854 3457
Q ss_pred eEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEE
Q 020467 88 AVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLA 163 (326)
Q Consensus 88 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili----~~~~~~~l~ 163 (326)
.+++|||+.++|.+++..............+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.++|+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 8999999999999888755432222222348999999999999999999999999999999999999 677899999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 175 Dfg~a~~~ 182 (405)
T 3rgf_A 175 DMGFARLF 182 (405)
T ss_dssp CTTCCC--
T ss_pred ECCCceec
Confidence 99998765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=252.66 Aligned_cols=145 Identities=33% Similarity=0.491 Sum_probs=127.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~ 80 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI-QEESFH 80 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ECSSEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEE-EcCCEE
Confidence 467899999999999999999999999999999998853 23466899999999 699999999998 666778
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc---EEEEe
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV---LKLAD 164 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~---~~l~D 164 (326)
+++|||+. ++|.+.+..... +++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+|
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEee
Confidence 99999997 588887765432 899999999999999999999999999999999999987655 99999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 152 fg~~~~~ 158 (284)
T 3kk8_A 152 FGLAIEV 158 (284)
T ss_dssp CTTCEEC
T ss_pred ceeeEEc
Confidence 9998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=257.67 Aligned_cols=157 Identities=27% Similarity=0.467 Sum_probs=134.0
Q ss_pred CccccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc----chhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 8 SWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 8 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~----~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
.+++.......++|++.+.||+|+||.||+|.+..+++.||+|.+. ....+.+|+.+++++.+|+||+++++++..
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3445566678899999999999999999999999899999999875 245678899999999679999999999855
Q ss_pred c-----CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC
Q 020467 84 E-----DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 84 ~-----~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~ 157 (326)
. ....+++|||+. ++|.+++..... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC
Confidence 3 356899999997 499988876432 128999999999999999999999999999999999999999
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
+.++|+|||++...
T Consensus 166 ~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 166 AEVKLVDFGVSAQL 179 (326)
T ss_dssp CCEEECCCTTTC--
T ss_pred CCEEEeeCcCceec
Confidence 99999999988654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=262.80 Aligned_cols=143 Identities=36% Similarity=0.457 Sum_probs=124.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcC-CCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNS-PNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h-~ni~~l~~~~~~~~~~~ 88 (326)
..++|++.+.||+|+||.||++.+ .+++.||+|.+.. ...+.+|+.++..+.+| +||+++++++ ......
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-ECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-eeCCEE
Confidence 457799999999999999999987 4688899998852 24567899999999633 9999999998 566789
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+++||+.+++|.+++..... +++..+..++.|++.||.|||+.+|+||||||+|||++ ++.++|+|||++
T Consensus 85 ~lv~e~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp EEEECCCSEEHHHHHHHSCC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EEEEeCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence 99999888899999876432 89999999999999999999999999999999999997 678999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
..+
T Consensus 155 ~~~ 157 (343)
T 3dbq_A 155 NQM 157 (343)
T ss_dssp CCC
T ss_pred ccc
Confidence 765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=264.41 Aligned_cols=145 Identities=26% Similarity=0.504 Sum_probs=128.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
..++|++.+.||+|+||.||+|.+. .+++.||||.++. ...+.+|+.++..+.+|+||+++++++ ..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~ 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-QT 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-EE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE-ee
Confidence 3589999999999999999999884 4789999998752 244668999999997899999999998 55
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
....+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEES
T ss_pred CceEEEEeecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEe
Confidence 667999999997 599888865432 8999999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++..+
T Consensus 202 DfG~a~~~ 209 (355)
T 1vzo_A 202 DFGLSKEF 209 (355)
T ss_dssp CSSEEEEC
T ss_pred eCCCCeec
Confidence 99998765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=262.02 Aligned_cols=154 Identities=21% Similarity=0.360 Sum_probs=129.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcC-------CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLS-------DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+.. ...+.+|+++++++.+|+||+++++++ .
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-T 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee-c
Confidence 46899999999999999999998753 336799999863 245678999999996799999999998 6
Q ss_pred cCCceEEEeeecc-cCHHHHHHHhhhhh-------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc
Q 020467 84 EDEDAVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG 155 (326)
Q Consensus 84 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~ 155 (326)
.....+++|||+. ++|.+++....... .......+++..+..++.|++.||.|||+.+|+||||||+||+++
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 6778999999997 59999987653210 001113489999999999999999999999999999999999999
Q ss_pred CCCcEEEEeecccccc
Q 020467 156 DDGVLKLADFGQARIL 171 (326)
Q Consensus 156 ~~~~~~l~Dfg~~~~~ 171 (326)
.++.++|+|||++...
T Consensus 226 ~~~~~kL~DFG~a~~~ 241 (382)
T 3tt0_A 226 EDNVMKIADFGLARDI 241 (382)
T ss_dssp TTCCEEECSCSCCCCS
T ss_pred CCCcEEEcccCccccc
Confidence 9999999999998765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=260.60 Aligned_cols=145 Identities=37% Similarity=0.607 Sum_probs=124.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++ ......+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVC-KKKKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-EETTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEe-ecCCEEE
Confidence 57899999999999999999999999999999998742 23356899999999 599999999998 5667899
Q ss_pred EEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 90 LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 90 lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++|||+.+++...+.... ..++...+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus 101 lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFP--------NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172 (331)
T ss_dssp EEEECCSEEHHHHHHHST--------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEecCCcchHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence 999999976655543322 228999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 173 ~~ 174 (331)
T 4aaa_A 173 TL 174 (331)
T ss_dssp --
T ss_pred ee
Confidence 54
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=257.51 Aligned_cols=146 Identities=25% Similarity=0.428 Sum_probs=126.4
Q ss_pred cccCeEEEeeeccccCcEEEEEE----EcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGR----RLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWRE-DE 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~ 86 (326)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence 46889999999999999999998 556889999999863 24567899999999 699999999988433 35
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++...... ++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGG--------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcccc--------cCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 6899999996 6999998765432 899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 159 g~~~~~ 164 (295)
T 3ugc_A 159 GLTKVL 164 (295)
T ss_dssp CSCC--
T ss_pred cccccc
Confidence 998765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=266.53 Aligned_cols=142 Identities=37% Similarity=0.463 Sum_probs=123.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhc-CCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQN-SPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~-h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.+.||+|+||.||+|.+.. ++.||||.+.. ...+.+|+.++..+.+ |+||+++++++ ......+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~-~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-ECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE-ecCCEEE
Confidence 3569999999999999999998764 88999998852 2456789999999964 69999999998 5566799
Q ss_pred EEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 90 LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 90 lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
++||+.+++|.+++..... +++..+..++.||+.||.|||+.+|+||||||+|||++ ++.++|+|||++.
T Consensus 133 lv~E~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 133 MVMECGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEECCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred EEEecCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 9999777899998876432 88889999999999999999999999999999999995 5899999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 203 ~~ 204 (390)
T 2zmd_A 203 QM 204 (390)
T ss_dssp CC
T ss_pred cc
Confidence 65
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=259.06 Aligned_cols=146 Identities=28% Similarity=0.439 Sum_probs=129.4
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
+...++|++.+.||+|+||.||++.+..+++.+++|.+.. ...+.+|+.+++.+ .|+||+++++++ ....
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~ 114 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFF-EDND 114 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ECSS
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-ecCC
Confidence 4567899999999999999999999999999999998753 24467788899888 699999999998 5667
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeec
Confidence 8999999998 688887765432 899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 186 g~~~~~ 191 (335)
T 2owb_A 186 GLATKV 191 (335)
T ss_dssp TTCEEC
T ss_pred cCceec
Confidence 998765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=253.36 Aligned_cols=144 Identities=29% Similarity=0.534 Sum_probs=127.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
...++|++.+.||+|+||.||+|.+..++..||+|.+.. ...+.+|+.+++.+ .|+||+++++++ .....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~ 83 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYF-HDATR 83 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEE-ECSSE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheE-ecCCE
Confidence 457899999999999999999999999999999998842 33467788888888 599999999998 56678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+.+..... +++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCC
T ss_pred EEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecc
Confidence 999999998 688888765433 8999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 167 QARI 170 (326)
Q Consensus 167 ~~~~ 170 (326)
++..
T Consensus 155 ~~~~ 158 (279)
T 3fdn_A 155 WSVH 158 (279)
T ss_dssp EESC
T ss_pred cccc
Confidence 8754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=259.16 Aligned_cols=141 Identities=23% Similarity=0.340 Sum_probs=124.3
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
..|...+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ .|+||+++++++ ......+++||
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-~~~~~~~lv~e 122 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSY-LVGEELWVLME 122 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEE-EETTEEEEEEC
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE-EECCEEEEEEe
Confidence 348899999999999999999988999999998752 34577899999998 699999999998 55667999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 123 ~~~~~~L~~~l~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 123 FLQGGALTDIVSQV----------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp CCCSCBHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 997 5777765431 2899999999999999999999999999999999999999999999999998765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=262.32 Aligned_cols=154 Identities=25% Similarity=0.415 Sum_probs=130.6
Q ss_pred cccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch----hhHHHHHHHHHHHhcCCC-----eeEEeEE
Q 020467 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQNSPN-----VVVLHEY 80 (326)
Q Consensus 10 ~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~n-----i~~l~~~ 80 (326)
.+.....+.++|++.+.||+|+||.||+|.+..+++.||||.+... .....|+.++..+..|++ ++.++++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3444566789999999999999999999999999999999999743 345567888888866664 8999998
Q ss_pred EEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCeEEc--C
Q 020467 81 FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH--RNTIVHRDLKPGNLLIG--D 156 (326)
Q Consensus 81 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH--~~~iiH~dlkp~Nili~--~ 156 (326)
+ ......+++|||++++|.+++..... ..++...+..++.|++.||.||| +.||+||||||+|||++ .
T Consensus 125 ~-~~~~~~~lv~e~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 125 F-MFRNHLCLVFEMLSYNLYDLLRNTNF-------RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp E-EETTEEEEEEECCCCBHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred e-ccCCceEEEEecCCCCHHHHHhhcCc-------CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence 8 55678999999999999999876532 23899999999999999999999 57999999999999995 4
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 197 ~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQL 211 (382)
T ss_dssp SCCEEECCCTTCEET
T ss_pred CCcEEEEeccCceec
Confidence 778999999998764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=260.83 Aligned_cols=146 Identities=31% Similarity=0.507 Sum_probs=129.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec----C
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE----D 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~----~ 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ .|+||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCcc
Confidence 467899999999999999999999999999999999853 23456899999999 699999999987433 2
Q ss_pred CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 86 EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 86 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
...+++|||+.++|.+.+... .++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 87 ~~~~lv~e~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVISTQ----------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDF 156 (353)
T ss_dssp CCEEEEECCCSEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEeccCccHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEec
Confidence 568999999999998887652 2899999999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q 020467 166 GQARILL 172 (326)
Q Consensus 166 g~~~~~~ 172 (326)
|++....
T Consensus 157 g~a~~~~ 163 (353)
T 2b9h_A 157 GLARIID 163 (353)
T ss_dssp TTCEECC
T ss_pred ccccccc
Confidence 9998763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=252.45 Aligned_cols=148 Identities=22% Similarity=0.368 Sum_probs=123.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc---chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~---~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+. ....+.+|+.+++.+. |++++..+..+.......+++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHT-TSTTCCCEEEEEEETTEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhc-CCCCCCeeeeecCCCCceEEEE
Confidence 46789999999999999999999999999999999764 3456789999999996 5555555555556777889999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEEeecccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQAR 169 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili---~~~~~~~l~Dfg~~~ 169 (326)
||++++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||++.
T Consensus 85 e~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 85 ELLGPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp ECCCCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EccCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9998899998875322 28999999999999999999999999999999999999 788999999999998
Q ss_pred ccc
Q 020467 170 ILL 172 (326)
Q Consensus 170 ~~~ 172 (326)
...
T Consensus 157 ~~~ 159 (296)
T 4hgt_A 157 KYR 159 (296)
T ss_dssp ECB
T ss_pred ecc
Confidence 763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=254.48 Aligned_cols=146 Identities=25% Similarity=0.360 Sum_probs=126.7
Q ss_pred cccCeEEEeeeccccCcEEEEEE----EcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-
Q 020467 17 IIAKYEILECVGSGAYSDVYKGR----RLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED- 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~- 85 (326)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++....
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG 97 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC
Confidence 45779999999999999999998 466899999999863 25577899999999 6999999999985443
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
...+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECc
Confidence 56899999997 599988865432 289999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 170 fg~~~~~ 176 (302)
T 4e5w_A 170 FGLTKAI 176 (302)
T ss_dssp CTTCEEC
T ss_pred ccccccc
Confidence 9998765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=265.16 Aligned_cols=151 Identities=23% Similarity=0.361 Sum_probs=125.3
Q ss_pred cccCeEEEeeeccccCcEEEEEE-----EcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~-----~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
..++|++.+.||+|+||.||+|. +..+++.||||.+.. ...+.+|+.+++.+ +|+||+++++++ ...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~-~~~ 146 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVS-LQS 146 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-CSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEE-ecC
Confidence 45889999999999999999998 445678999999853 23467889999998 699999999998 666
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEE
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---VLK 161 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---~~~ 161 (326)
...+++|||+. ++|.+++....... .....++...++.++.|++.||.|||+.||+||||||+|||++.++ .++
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 77899999996 69999887654211 1123488999999999999999999999999999999999999555 599
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++..+
T Consensus 225 L~DFG~a~~~ 234 (367)
T 3l9p_A 225 IGDFGMARDI 234 (367)
T ss_dssp ECCCHHHHHH
T ss_pred ECCCcccccc
Confidence 9999998755
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.61 Aligned_cols=148 Identities=22% Similarity=0.368 Sum_probs=127.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc---chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~---~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+. ....+.+|+.+++.+. |++++..+..+.......+++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHT-TSTTCCCEEEEEEETTEEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhh-cCCCCCccccccCCCCceEEEE
Confidence 46789999999999999999999999999999999875 2456789999999996 5554444555556677889999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEEeecccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQAR 169 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili---~~~~~~~l~Dfg~~~ 169 (326)
||++++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||++.
T Consensus 85 e~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp ECCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EecCCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 9998899998864332 28999999999999999999999999999999999999 478899999999987
Q ss_pred ccc
Q 020467 170 ILL 172 (326)
Q Consensus 170 ~~~ 172 (326)
...
T Consensus 157 ~~~ 159 (296)
T 3uzp_A 157 KYR 159 (296)
T ss_dssp ECB
T ss_pred ccc
Confidence 653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=251.29 Aligned_cols=146 Identities=30% Similarity=0.494 Sum_probs=129.7
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++.++|++.+.||+|+||.||+|.+..++..+++|.+.. ...+.+|+++++.+ +|+||+++++++ ......+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~ 82 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETF-EDNTDIY 82 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEE-ECSSEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEE-ecCCeEE
Confidence 4578899999999999999999999999999999998753 45678899999999 699999999998 5667899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEEee
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADF 165 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili---~~~~~~~l~Df 165 (326)
++|||+. ++|.+.+..... +++..+..++.|++.||.|||+.+++|+||||+||++ +.++.++|+||
T Consensus 83 lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRV---------FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEeccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 9999997 588888765432 8999999999999999999999999999999999999 77889999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 154 g~~~~~ 159 (277)
T 3f3z_A 154 GLAARF 159 (277)
T ss_dssp TTCEEC
T ss_pred ccceec
Confidence 998765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=253.52 Aligned_cols=146 Identities=29% Similarity=0.495 Sum_probs=128.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.++..+ +|+||+++++++ ...+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~ 85 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYF-EDSNY 85 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEE-ECSSE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEE-ccCCe
Confidence 4568899999999999999999999889999999998532 4567888888888 699999999998 56678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV--------KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeec
Confidence 999999997 58888776432 238999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 158 ~~~~~ 162 (278)
T 3cok_A 158 LATQL 162 (278)
T ss_dssp TCEEC
T ss_pred ceeec
Confidence 98764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=264.67 Aligned_cols=144 Identities=35% Similarity=0.519 Sum_probs=124.3
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC--
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE-- 86 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~-- 86 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++.....
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSST
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcc
Confidence 367899999999999999999999999999999999863 34567899999999 69999999999843332
Q ss_pred ---ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 87 ---DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 87 ---~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
..+++|||+.++|.+.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+
T Consensus 118 ~~~~~~lv~e~~~~~l~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~ 186 (371)
T 4exu_A 118 NFYDFYLVMPFMQTDLQKIMGM-----------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 186 (371)
T ss_dssp TCCCCEEEEECCCEEHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred cceeEEEEEccccccHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEE
Confidence 2399999999988776521 28999999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 187 Dfg~a~~~ 194 (371)
T 4exu_A 187 DFGLARHA 194 (371)
T ss_dssp STTCC---
T ss_pred ecCccccc
Confidence 99998653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=272.86 Aligned_cols=148 Identities=30% Similarity=0.528 Sum_probs=126.9
Q ss_pred CccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 13 ~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
....+.++|++.+.||+|+||.||+|.+..++..+|+|.+.. ...+.+|+.+++.+ +||||+++++++ ...
T Consensus 31 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~-~~~ 108 (494)
T 3lij_A 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFF-EDK 108 (494)
T ss_dssp CBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEE-ECS
T ss_pred CCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEE-EeC
Confidence 345677899999999999999999999999999999998752 34577899999998 699999999999 667
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEE
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD---GVLK 161 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~---~~~~ 161 (326)
...+++|||+. ++|.+.+..... +++..+..++.||+.||.|||+.||+||||||+||+++.. +.++
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 179 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred CEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEE
Confidence 78999999997 588888765433 8999999999999999999999999999999999999764 4599
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 180 l~DfG~a~~~ 189 (494)
T 3lij_A 180 IVDFGLSAVF 189 (494)
T ss_dssp ECCCTTCEEC
T ss_pred EEECCCCeEC
Confidence 9999998765
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=250.84 Aligned_cols=148 Identities=28% Similarity=0.428 Sum_probs=130.2
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------------hhhHHHHHHHHHHHhcCCCeeEEeE
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------------YQSAFREIEALQILQNSPNVVVLHE 79 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------------~~~~~~E~~~l~~l~~h~ni~~l~~ 79 (326)
...+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++++.+|+||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 34678999999999999999999999999999999998842 2345688999999967999999999
Q ss_pred EEEecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 80 YFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 80 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
++ ......+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++
T Consensus 92 ~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 92 TY-ETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM 161 (298)
T ss_dssp EE-ECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred ee-ccCCeEEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC
Confidence 98 66678999999997 699888865432 89999999999999999999999999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 162 ~~kl~dfg~~~~~ 174 (298)
T 1phk_A 162 NIKLTDFGFSCQL 174 (298)
T ss_dssp CEEECCCTTCEEC
T ss_pred cEEEecccchhhc
Confidence 9999999998765
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=262.60 Aligned_cols=147 Identities=19% Similarity=0.203 Sum_probs=128.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC--------CCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeE-------------
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS--------DNLIVALKEVHDYQSAFREIEALQILQNSPNVVV------------- 76 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~--------~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~------------- 76 (326)
.++|++.+.||+|+||.||+|.+.. .++.||+|.+.....+.+|+.+++.+ .|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHH-CCHHHHHHHHHHTTCTTCSC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHh-cccchhhhhhhhccCCccCc
Confidence 4799999999999999999999876 47899999998888899999999999 5888776
Q ss_pred --EeEEEEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 020467 77 --LHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154 (326)
Q Consensus 77 --l~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili 154 (326)
+++++.......+++|||++++|.+++..... ..+++..+..++.|++.||.|||+.+|+||||||+||++
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK-------HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred cchhhccccCCcEEEEEecCCCcCHHHHHHhCCc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 67777555778999999998899999876522 129999999999999999999999999999999999999
Q ss_pred cCCC--cEEEEeeccccccc
Q 020467 155 GDDG--VLKLADFGQARILL 172 (326)
Q Consensus 155 ~~~~--~~~l~Dfg~~~~~~ 172 (326)
+.++ .++|+|||++..+.
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~ 212 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYC 212 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSS
T ss_pred cCCCCceEEEecCcceeecc
Confidence 9988 99999999997663
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=256.83 Aligned_cols=153 Identities=21% Similarity=0.382 Sum_probs=126.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-------CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-------SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-------~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
.++|++.+.||+|+||.||+|.+. .++..||+|.+.. ...+.+|+.+++++..|+||+++++++ ..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-TQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-cc
Confidence 578999999999999999999875 3567899999863 234678999999996799999999998 66
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhh-------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKRE-------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD 156 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~ 156 (326)
.+..+++|||+. ++|.+++........ ......++...+..++.|++.||.|||+.+|+|+||||+||+++.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 678999999997 599998875432100 001123889999999999999999999999999999999999999
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 193 ~~~~kL~Dfg~~~~~ 207 (334)
T 2pvf_A 193 NNVMKIADFGLARDI 207 (334)
T ss_dssp TCCEEECCCTTCEEC
T ss_pred CCCEEEccccccccc
Confidence 999999999998765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=249.30 Aligned_cols=144 Identities=22% Similarity=0.347 Sum_probs=127.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVC-SKEYPIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEE-CSSSSEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEE-ccCCceEEEE
Confidence 3678999999999999999999765 567799999863 44578899999999 599999999998 6677899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++...... +++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus 83 e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKG--------LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp ECCTTCBHHHHHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred EccCCCcHHHHHHHcCCC--------CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceec
Confidence 9996 6788888664322 899999999999999999999999999999999999999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=255.18 Aligned_cols=145 Identities=21% Similarity=0.283 Sum_probs=126.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCC-------eEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDN-------LIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~-------~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
..++|++.+.||+|+||.||+|.+..++ ..|++|.+.. ...+.+|+.+++.+ +|+||+++++++ ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVC-VC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEE-CC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEE-Ee
Confidence 4678999999999999999999887665 5799998853 34577889999999 699999999998 56
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc----
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV---- 159 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~---- 159 (326)
.+..+++|||+. ++|.+++...... ++...+..++.|++.||.|||+.+|+||||||+||+++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGG--------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGT
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccc
Confidence 677899999998 6999988765432 889999999999999999999999999999999999998886
Q ss_pred ----EEEEeecccccc
Q 020467 160 ----LKLADFGQARIL 171 (326)
Q Consensus 160 ----~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 156 ~~~~~kl~Dfg~~~~~ 171 (289)
T 4fvq_A 156 NPPFIKLSDPGISITV 171 (289)
T ss_dssp BCCEEEECCCCSCTTT
T ss_pred ccceeeeccCcccccc
Confidence 999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=251.56 Aligned_cols=145 Identities=30% Similarity=0.539 Sum_probs=128.9
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
...++|++.+.||+|+||.||+|.+..+++.|++|.+.. ...+.+|+.+++.+ +|+||+++++++ .....
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~ 88 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYF-HDRKR 88 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEE-ECSSE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEE-EcCCE
Confidence 456899999999999999999999999999999998852 24567889999998 699999999998 56678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGR---------FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccc
Confidence 999999997 599888876432 8999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 160 ~~~~~ 164 (284)
T 2vgo_A 160 WSVHA 164 (284)
T ss_dssp TCEEC
T ss_pred ccccC
Confidence 87653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=256.32 Aligned_cols=151 Identities=28% Similarity=0.425 Sum_probs=128.4
Q ss_pred cCccccccCeEEEeeeccccCcEEEEEEE-cCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCC------CeeEEeEE
Q 020467 12 HTRPEIIAKYEILECVGSGAYSDVYKGRR-LSDNLIVALKEVHD----YQSAFREIEALQILQNSP------NVVVLHEY 80 (326)
Q Consensus 12 ~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~-~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~------ni~~l~~~ 80 (326)
+....+.++|++.+.||+|+||.||+|.+ ..+++.||+|.+.. .....+|+.+++.+. |+ ++++++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN-TTDPNSTFRCVQMLEW 85 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCEEEE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhh-hcCCCCceeeEeeecc
Confidence 34455778999999999999999999998 56789999999864 345678888888885 43 59999999
Q ss_pred EEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC----
Q 020467 81 FWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---- 156 (326)
Q Consensus 81 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---- 156 (326)
+ ......+++|||++++|.+++..... ..++...+..++.|++.||.|||+.+|+||||||+||+++.
T Consensus 86 ~-~~~~~~~lv~e~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 86 F-EHHGHICIVFELLGLSTYDFIKENGF-------LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp E-EETTEEEEEEECCCCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEE
T ss_pred c-ccCCcEEEEEcCCCCCHHHHHHhcCC-------CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccc
Confidence 8 55668999999999999999876432 23889999999999999999999999999999999999987
Q ss_pred ---------------CCcEEEEeecccccc
Q 020467 157 ---------------DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ---------------~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~ 187 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYD 187 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEET
T ss_pred cccCCccccccccccCCCceEeeCcccccC
Confidence 567999999988653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=251.77 Aligned_cols=143 Identities=24% Similarity=0.411 Sum_probs=126.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.. ...+.+|+.+++++ +|+||+++++++ ......+++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC-LEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEE-CSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEE-ecCCceEEEEE
Confidence 478999999999999999999876 467799999863 45678899999999 599999999998 66678999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... .++...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus 86 ~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp CCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred eCCCCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence 997 588888765332 2899999999999999999999999999999999999999999999999998765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=253.00 Aligned_cols=150 Identities=27% Similarity=0.455 Sum_probs=129.8
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
..+.++|++.++||+|+||.||+|.+..++..+++|.+.. ...+.+|+++++.+ +|+||+++++++ ......
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~~~~ 95 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVF-EDYHNM 95 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEE-ECSSEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHhe-ecCCeE
Confidence 3578999999999999999999999999999999998853 24577899999999 699999999998 566789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc---CCCcEEEEe
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG---DDGVLKLAD 164 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~---~~~~~~l~D 164 (326)
+++|||+. ++|.+.+...... ...+++..+..++.|++.||.|||+.+|+||||||+||+++ .++.++|+|
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 99999997 5888888654322 12389999999999999999999999999999999999994 457899999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 171 fg~a~~~ 177 (285)
T 3is5_A 171 FGLAELF 177 (285)
T ss_dssp CCCCCC-
T ss_pred eecceec
Confidence 9998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.02 Aligned_cols=147 Identities=28% Similarity=0.435 Sum_probs=129.7
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
.+...++|++.+.||+|+||.||+|.+..+++.+++|.+.. ...+.+|+.+++.+ .|+||+++++++ ...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~ 87 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFF-EDN 87 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ECS
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeee-ccC
Confidence 34678899999999999999999999999999999998753 23466788889888 699999999998 566
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
...+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 158 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD 158 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEe
Confidence 78999999998 688877765432 89999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 159 fg~~~~~ 165 (294)
T 2rku_A 159 FGLATKV 165 (294)
T ss_dssp CTTCEEC
T ss_pred ccCceec
Confidence 9998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=271.49 Aligned_cols=147 Identities=31% Similarity=0.493 Sum_probs=128.4
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------------------hhhHHHHHHHHHHHhcCCCee
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------------------YQSAFREIEALQILQNSPNVV 75 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------------------~~~~~~E~~~l~~l~~h~ni~ 75 (326)
...+.++|++.++||+|+||.||+|.+..+++.+|+|.+.. ...+.+|+.+++.+ .||||+
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv 109 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNII 109 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCC
Confidence 45678999999999999999999999999999999998753 23467899999999 699999
Q ss_pred EEeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 020467 76 VLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154 (326)
Q Consensus 76 ~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili 154 (326)
++++++ ......+++|||+. ++|.+.+..... +++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 110 ~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 110 KLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILL 179 (504)
T ss_dssp CEEEEE-ECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred eEEEEE-EcCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEE
Confidence 999999 66778999999997 588888865433 8999999999999999999999999999999999999
Q ss_pred cCCC---cEEEEeecccccc
Q 020467 155 GDDG---VLKLADFGQARIL 171 (326)
Q Consensus 155 ~~~~---~~~l~Dfg~~~~~ 171 (326)
+.++ .++|+|||++...
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~ 199 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFF 199 (504)
T ss_dssp SSTTCCSSEEECCCTTCEEC
T ss_pred ecCCCCccEEEEECCCCEEc
Confidence 9776 6999999998765
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=256.84 Aligned_cols=156 Identities=22% Similarity=0.372 Sum_probs=130.7
Q ss_pred CCCccccCccccccCeEEEeeeccccCcEEEEEEEcCCC-eEEEEEEccc----hhhHHHHHHHHHHHhcCCC------e
Q 020467 6 PKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDN-LIVALKEVHD----YQSAFREIEALQILQNSPN------V 74 (326)
Q Consensus 6 p~~~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~-~~vaiK~~~~----~~~~~~E~~~l~~l~~h~n------i 74 (326)
...+.+.....+.++|++.+.||+|+||.||+|.+..++ +.||+|.+.. ...+.+|+.+++.+. |++ +
T Consensus 6 ~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~ 84 (355)
T 2eu9_A 6 EGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIK-EKDKENKFLC 84 (355)
T ss_dssp TSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHH-HHCTTSCSCB
T ss_pred CCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHh-hcCCCCceeE
Confidence 334445555667899999999999999999999997766 7899999864 345667888998885 443 8
Q ss_pred eEEeEEEEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 020467 75 VVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154 (326)
Q Consensus 75 ~~l~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili 154 (326)
+.+++++ ......+++|||+++++.+.+..... ..++...+..++.||+.||.|||+.+|+||||||+||++
T Consensus 85 ~~~~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll 156 (355)
T 2eu9_A 85 VLMSDWF-NFHGHMCIAFELLGKNTFEFLKENNF-------QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156 (355)
T ss_dssp CCEEEEE-EETTEEEEEEECCCCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred EEeeeee-eeCCeEEEEEeccCCChHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 8888888 55668999999999999988876432 238999999999999999999999999999999999999
Q ss_pred -------------------cCCCcEEEEeeccccc
Q 020467 155 -------------------GDDGVLKLADFGQARI 170 (326)
Q Consensus 155 -------------------~~~~~~~l~Dfg~~~~ 170 (326)
+.++.++|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 191 (355)
T 2eu9_A 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191 (355)
T ss_dssp SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEE
T ss_pred ecccccccccccccccccccCCCcEEEeecCcccc
Confidence 5678999999999865
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=259.72 Aligned_cols=146 Identities=29% Similarity=0.439 Sum_probs=129.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------------hhhHHHHHHHHHHHhcCCCeeEEeEEEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------------YQSAFREIEALQILQNSPNVVVLHEYFW 82 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------------~~~~~~E~~~l~~l~~h~ni~~l~~~~~ 82 (326)
.+.++|++.+.||.|+||.||+|.+..+++.||||++.. ...+.+|+.+++.+.+|+||+++++++
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~- 169 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY- 169 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE-
Confidence 355789999999999999999999988999999998752 234568889999986799999999998
Q ss_pred ecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 020467 83 REDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 83 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 161 (326)
......+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.||+|+||||+||+++.++.++
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVA---------LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 66778999999998 588888865332 89999999999999999999999999999999999999999999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++..+
T Consensus 241 l~DfG~~~~~ 250 (365)
T 2y7j_A 241 LSDFGFSCHL 250 (365)
T ss_dssp ECCCTTCEEC
T ss_pred EEecCccccc
Confidence 9999998765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=257.65 Aligned_cols=149 Identities=33% Similarity=0.544 Sum_probs=129.4
Q ss_pred CccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-----------hhHHHHHHHHHHHhc-CCCeeEEeEE
Q 020467 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-----------QSAFREIEALQILQN-SPNVVVLHEY 80 (326)
Q Consensus 13 ~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-----------~~~~~E~~~l~~l~~-h~ni~~l~~~ 80 (326)
....+.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.+++.+.. |+|+++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3456789999999999999999999999999999999988532 345689999999963 7999999999
Q ss_pred EEecCCceEEEeeecc--cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-CC
Q 020467 81 FWREDEDAVLVLEFLR--TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG-DD 157 (326)
Q Consensus 81 ~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~-~~ 157 (326)
+ ......++++|++. ++|.+++..... +++..+..++.|++.||.|||+.+|+||||||+||+++ .+
T Consensus 117 ~-~~~~~~~lv~e~~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 117 F-ERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp E-ECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred E-ecCCcEEEEEEcCCCCccHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence 8 56677999999986 689888876432 89999999999999999999999999999999999999 78
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
+.++|+|||++...
T Consensus 187 ~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 187 GELKLIDFGSGALL 200 (320)
T ss_dssp TEEEECCCTTCEEC
T ss_pred CCEEEeeCcccccc
Confidence 89999999998765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=254.25 Aligned_cols=154 Identities=20% Similarity=0.337 Sum_probs=129.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEE-----cCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRR-----LSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
..++|++.+.||+|+||.||+|.+ ..+++.||+|.+.. ...+.+|+.++.++.+|+||+++++++ ...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-~~~ 99 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-TIG 99 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE-ecC
Confidence 367999999999999999999985 35678999999863 345678999999996799999999998 666
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhh---------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKR---------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG 155 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~---------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~ 155 (326)
...+++|||+. ++|.+++....... .......+++..+..++.|++.||.|||+.+++|+||||+||+++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 78999999997 59999887643210 000112389999999999999999999999999999999999999
Q ss_pred CCCcEEEEeecccccc
Q 020467 156 DDGVLKLADFGQARIL 171 (326)
Q Consensus 156 ~~~~~~l~Dfg~~~~~ 171 (326)
.++.++|+|||++...
T Consensus 180 ~~~~~kl~Dfg~~~~~ 195 (313)
T 1t46_A 180 HGRITKICDFGLARDI 195 (313)
T ss_dssp TTTEEEECCCGGGSCT
T ss_pred CCCCEEEccccccccc
Confidence 9999999999998765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=260.09 Aligned_cols=141 Identities=24% Similarity=0.287 Sum_probs=121.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCC---ceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDE---DAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~---~~~l 90 (326)
.++|++.+.||+|+||.||+|.+. ++.||||.+... .....|+..+..+ +|+||+++++++..... ..++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEE
Confidence 478999999999999999999874 789999998632 2234567777777 69999999999865432 3799
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCCeEEcCCCc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN----------TIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~----------~iiH~dlkp~Nili~~~~~ 159 (326)
+|||+. ++|.+++.... +++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 100 v~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred EEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 999997 59998886532 88999999999999999999999 9999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++..+
T Consensus 170 ~kL~DFg~a~~~ 181 (322)
T 3soc_A 170 ACIADFGLALKF 181 (322)
T ss_dssp EEECCCTTCEEE
T ss_pred EEEccCCccccc
Confidence 999999999765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=254.90 Aligned_cols=146 Identities=29% Similarity=0.414 Sum_probs=124.8
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
....++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.++..+ .|+||+++++++ ...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~-~~~~ 107 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFG-EIDG 107 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-EETT
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEE-eeCC
Confidence 45679999999999999999999999989999999998632 4467888888888 699999999998 5566
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Df 178 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGP---------LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSC
T ss_pred eEEEEEEecCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecC
Confidence 8999999998 599888875432 899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 179 g~~~~~ 184 (309)
T 2h34_A 179 GIASAT 184 (309)
T ss_dssp CC----
T ss_pred ccCccc
Confidence 998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=251.45 Aligned_cols=149 Identities=26% Similarity=0.399 Sum_probs=130.1
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-hhhHHHHHHHHHHHhcCCCeeEEeEEEEe----------
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-YQSAFREIEALQILQNSPNVVVLHEYFWR---------- 83 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-~~~~~~E~~~l~~l~~h~ni~~l~~~~~~---------- 83 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+++++.+ .|+||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC------
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccc
Confidence 3467899999999999999999999988999999998863 45678899999999 69999999998743
Q ss_pred -----cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC
Q 020467 84 -----EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 84 -----~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~ 157 (326)
.....+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-------EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 1334799999998 499998875432 228999999999999999999999999999999999999999
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
+.++|+|||++...
T Consensus 159 ~~~kl~Dfg~~~~~ 172 (284)
T 2a19_B 159 KQVKIGDFGLVTSL 172 (284)
T ss_dssp TEEEECCCTTCEES
T ss_pred CCEEECcchhheec
Confidence 99999999998765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=257.51 Aligned_cols=146 Identities=28% Similarity=0.395 Sum_probs=127.7
Q ss_pred ccccCeEEE-eeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 16 EIIAKYEIL-ECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 16 ~~~~~y~i~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.+.++|++. +.||+|+||.||+|.+..+++.||||.+.. ...+.+|++++.++.+|+||+++++++ ...+..+
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-~~~~~~~ 87 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-EEEDRFY 87 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-EETTEEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-eeCCEEE
Confidence 467889995 789999999999999988999999999853 355788999998876799999999998 5567899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc---EEEEee
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV---LKLADF 165 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~---~~l~Df 165 (326)
++|||+. ++|.+++..... +++..+..++.|++.||.|||+.+|+||||||+||+++.++. ++|+||
T Consensus 88 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 9999997 799888876432 899999999999999999999999999999999999998775 999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 159 g~~~~~ 164 (316)
T 2ac3_A 159 DLGSGI 164 (316)
T ss_dssp TCCC--
T ss_pred cCcccc
Confidence 998755
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=252.93 Aligned_cols=149 Identities=24% Similarity=0.387 Sum_probs=119.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... .....|...+.+...|+||+++++++ ......++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-~~~~~~~l 83 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL-FREGDVWI 83 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSSEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee-eccCCEEE
Confidence 468899999999999999999999999999999988632 12223333323333799999999998 56678999
Q ss_pred EeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||++++|.+++...... ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.
T Consensus 84 v~e~~~~~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEECCSEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEehhccchHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 9999999988887653322 23399999999999999999999998 99999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 159 ~~ 160 (290)
T 3fme_A 159 YL 160 (290)
T ss_dssp --
T ss_pred cc
Confidence 65
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=251.72 Aligned_cols=145 Identities=20% Similarity=0.329 Sum_probs=125.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
-..++|++.+.||+|+||.||++.+. ++..||+|.+.. ...+.+|+++++.+ .|+||+++++++ ......+++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 97 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC-TKQRPIFII 97 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEE-CSSSSEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEE-ecCCCeEEE
Confidence 34689999999999999999999875 677899999863 45578899999999 599999999998 667789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+++..... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..
T Consensus 98 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp ECCCTTCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred EeccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99996 689888865332 289999999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 170 ~ 170 (283)
T 3gen_A 170 V 170 (283)
T ss_dssp B
T ss_pred c
Confidence 5
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=263.44 Aligned_cols=146 Identities=19% Similarity=0.150 Sum_probs=111.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHh-cCCCeeEEe-------EEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQ-NSPNVVVLH-------EYF 81 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~-~h~ni~~l~-------~~~ 81 (326)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.++..+. .||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4569999999999999999999999999999999864 223456766666665 499988755 444
Q ss_pred EecC----------------CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHh
Q 020467 82 WRED----------------EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI------KRWMVQILSGVDACHR 139 (326)
Q Consensus 82 ~~~~----------------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~------~~i~~ql~~aL~~LH~ 139 (326)
...+ ...+++|||++++|.+++...... +....+ ..++.||+.||.|||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~--------~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV--------YVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc--------cchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 3222 237999999999999999875332 334444 6677999999999999
Q ss_pred CCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 140 ~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.+|+||||||+|||++.++.++|+|||++...
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~ 244 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEET
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeec
Confidence 99999999999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=269.69 Aligned_cols=152 Identities=11% Similarity=0.106 Sum_probs=121.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHh--cCCCeeEEe-------E
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQ--NSPNVVVLH-------E 79 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~--~h~ni~~l~-------~ 79 (326)
..++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+. .||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 35889999999999999999999988899999999752 245678885544443 699999888 6
Q ss_pred EEEecCC----------------ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 020467 80 YFWREDE----------------DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIV 143 (326)
Q Consensus 80 ~~~~~~~----------------~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ii 143 (326)
++...+. ..+++|||++++|.+++........ ....+++..+..++.||+.||.|||+.||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTT--TTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcccccc--ccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 6633221 3789999999999999986543110 001133578888999999999999999999
Q ss_pred eccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 144 HRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 144 H~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
||||||+|||++.++.++|+|||++..
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~ 255 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVR 255 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCCCHHHEEEcCCCCEEEEechhhee
Confidence 999999999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=274.12 Aligned_cols=149 Identities=31% Similarity=0.493 Sum_probs=130.9
Q ss_pred cCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 12 ~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
.....+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ +||||+++++++ .
T Consensus 19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~-~ 96 (484)
T 3nyv_A 19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFF-E 96 (484)
T ss_dssp CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEE-E
T ss_pred cCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEE-E
Confidence 3445678999999999999999999999999999999998742 34578899999999 699999999998 6
Q ss_pred cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCc
Q 020467 84 EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGV 159 (326)
Q Consensus 84 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili---~~~~~ 159 (326)
.....+++|||+. ++|.+.+..... +++..+..++.||+.||.|||+.||+||||||+||++ +.++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSC---------CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC
T ss_pred eCCEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCc
Confidence 6778999999997 688888765432 8999999999999999999999999999999999999 46789
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++..+
T Consensus 168 ~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 168 IRIIDFGLSTHF 179 (484)
T ss_dssp EEECCTTHHHHB
T ss_pred EEEEeeeeeEEc
Confidence 999999998765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=258.10 Aligned_cols=144 Identities=25% Similarity=0.405 Sum_probs=123.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeE----EEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLI----VALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~----vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..++|++.+.||+|+||.||+|.+..++.. |++|.+.. ...+.+|+.++..+ +|+||+++++++ . ..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLC-P-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEE-C-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEE-c-CC
Confidence 357899999999999999999998777665 77777642 24567888898888 699999999987 3 45
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|+|+. ++|.+++...... +++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGG--------SCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSC
T ss_pred ccEEEEEeCCCCCHHHHHHHcccc--------CCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCC
Confidence 6889999997 7998888654321 888899999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 160 g~a~~~ 165 (325)
T 3kex_A 160 GVADLL 165 (325)
T ss_dssp SGGGGS
T ss_pred Cccccc
Confidence 999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=259.68 Aligned_cols=154 Identities=27% Similarity=0.431 Sum_probs=132.5
Q ss_pred cccCccccccCeEEE-eeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEE
Q 020467 10 SIHTRPEIIAKYEIL-ECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYF 81 (326)
Q Consensus 10 ~~~~~~~~~~~y~i~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~ 81 (326)
.++....+.++|.+. +.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.++..+.+|+||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 345556788999998 899999999999999999999999998853 346788999999998889999999998
Q ss_pred EecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---C
Q 020467 82 WREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---D 157 (326)
Q Consensus 82 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~ 157 (326)
......+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+||+++. +
T Consensus 99 -~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 99 -ENTSEIILILEYAAGGEIFSLCLPEL-------AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp -ECSSEEEEEEECCTTEEGGGGGSSCC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTB
T ss_pred -EeCCeEEEEEEecCCCcHHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCC
Confidence 66778999999997 47776653321 133899999999999999999999999999999999999997 7
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
+.++|+|||++...
T Consensus 171 ~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 171 GDIKIVDFGMSRKI 184 (327)
T ss_dssp CCEEECCGGGCEEC
T ss_pred CcEEEeeCcccccc
Confidence 89999999998765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=252.40 Aligned_cols=147 Identities=24% Similarity=0.439 Sum_probs=131.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
...++|++.+.||+|+||.||+|.+..++..||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+++
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~~v 87 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVC-TREPPFYII 87 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEE-CSSSSEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-ccCCCEEEE
Confidence 357889999999999999999999998999999999864 34567899999999 699999999998 667789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+++..... ..++...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EECCTTEEHHHHHHHCCT-------TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEcCCCCcHHHHHHhccc-------CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99998 699988876432 2389999999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 161 ~ 161 (288)
T 3kfa_A 161 M 161 (288)
T ss_dssp S
T ss_pred c
Confidence 5
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=258.03 Aligned_cols=151 Identities=28% Similarity=0.521 Sum_probs=116.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC----
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDE---- 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~---- 86 (326)
....++|++.+.||+|+||.||+|.+..+++.||||.+.. ......+++.+..+ +|+||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTT
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccc
Confidence 3467899999999999999999999999999999998743 33456667777777 69999999999854332
Q ss_pred --ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCeEEcC-CCcEE
Q 020467 87 --DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH--RNTIVHRDLKPGNLLIGD-DGVLK 161 (326)
Q Consensus 87 --~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH--~~~iiH~dlkp~Nili~~-~~~~~ 161 (326)
..+++|||+.+++...+...... ...++...+..++.|++.||.||| +.||+||||||+||+++. ++.++
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred ceeEEEEeecccccHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 27899999999887766543221 233889999999999999999999 999999999999999997 89999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 173 l~Dfg~a~~~ 182 (360)
T 3e3p_A 173 LCDFGSAKKL 182 (360)
T ss_dssp ECCCTTCBCC
T ss_pred EeeCCCceec
Confidence 9999998765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=256.65 Aligned_cols=154 Identities=23% Similarity=0.353 Sum_probs=128.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.. ...+.+|+.++.++..||||+++++++ ...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-TLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-CSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-eeC
Confidence 3589999999999999999999872 4567899999853 345788999999996799999999998 666
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhh--------------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKR--------------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPG 150 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~--------------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~ 150 (326)
...+++|||+. ++|.+++....... .......+++..+..++.||+.||.|||+.||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 78999999997 69999887543210 0000123789999999999999999999999999999999
Q ss_pred CeEEcCCCcEEEEeecccccc
Q 020467 151 NLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 151 Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+++.++.++|+|||++...
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~ 222 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDI 222 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCG
T ss_pred hEEEcCCCcEEeCCCccCccc
Confidence 999999999999999998765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=255.00 Aligned_cols=145 Identities=26% Similarity=0.394 Sum_probs=123.2
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHH-hcCCCeeEEeEEEEec---CCce
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQIL-QNSPNVVVLHEYFWRE---DEDA 88 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l-~~h~ni~~l~~~~~~~---~~~~ 88 (326)
..+.++|++.+.||+|+||.||+|.+ +++.||+|.+.. ......|.+++... .+|+||+++++++... ....
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 34678999999999999999999987 688999999864 33456677777663 2799999999987443 2458
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCeEEcCCCc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH--------RNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~~iiH~dlkp~Nili~~~~~ 159 (326)
+++|||+. ++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 82 ~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred EEehhhccCCCHHHHHhhc----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence 99999998 5998888432 2899999999999999999999 999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 152 ~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 152 CCIADLGLAVMH 163 (301)
T ss_dssp EEECCCTTCEEE
T ss_pred EEEeeCCCeeec
Confidence 999999998765
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=249.30 Aligned_cols=144 Identities=33% Similarity=0.533 Sum_probs=127.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++ ...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~ 80 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIF-ENK 80 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE-ECS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhhee-cCC
Confidence 45789999999999999999999998999999998752 34578899999999 599999999998 566
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----cE
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG----VL 160 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~----~~ 160 (326)
...+++|||+. ++|.+++..... ++...+..++.|++.||.|||+.+++|+||+|+||+++.++ .+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKES---------LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCE
T ss_pred CeEEEEEeecCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCce
Confidence 77999999996 799888865432 89999999999999999999999999999999999998877 89
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
+|+|||++...
T Consensus 152 kl~dfg~~~~~ 162 (283)
T 3bhy_A 152 KLIDFGIAHKI 162 (283)
T ss_dssp EECCCTTCEEC
T ss_pred EEEecccceec
Confidence 99999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=254.32 Aligned_cols=144 Identities=30% Similarity=0.467 Sum_probs=127.5
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++ ......++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~l 83 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIY-ESTTHYYL 83 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEE-ECSSEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhc-ccCCEEEE
Confidence 577899999999999999999999998999999998853 34467899999999 699999999998 66678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEEeec
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFG 166 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili---~~~~~~~l~Dfg 166 (326)
+|||+. ++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||
T Consensus 84 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGV---------YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp EECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred EEEcCCCccHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 999997 689888765432 8999999999999999999999999999999999999 778899999999
Q ss_pred cccc
Q 020467 167 QARI 170 (326)
Q Consensus 167 ~~~~ 170 (326)
++..
T Consensus 155 ~~~~ 158 (304)
T 2jam_A 155 LSKM 158 (304)
T ss_dssp TTCC
T ss_pred ccee
Confidence 8754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=257.21 Aligned_cols=144 Identities=27% Similarity=0.463 Sum_probs=120.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeE----EEEEEcc------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLI----VALKEVH------DYQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~----vaiK~~~------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..++|++.+.||+|+||.||+|.+..+++. |++|.+. ....+.+|+.+++++ +|+||+++++++.. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT-S- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEES-S-
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEec-C-
Confidence 357899999999999999999998766654 5888774 234578899999999 69999999999843 3
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++++++. ++|.+++..... .++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred CeEEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccC
Confidence 4778888887 789888866432 2899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++..+
T Consensus 162 g~a~~~ 167 (327)
T 3poz_A 162 GLAKLL 167 (327)
T ss_dssp THHHHH
T ss_pred cceeEc
Confidence 999765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=271.86 Aligned_cols=146 Identities=24% Similarity=0.441 Sum_probs=130.5
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
..++|++.+.||+|+||.||+|.+..++..||||.++. ...+.+|+.+++++ +|+||+++++++ ......+++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~-~~~~~~~lv~ 295 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVC-TREPPFYIIT 295 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-CSSSSCEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEE-ecCCcEEEEE
Confidence 35789999999999999999999988899999999863 45678899999999 699999999998 6667899999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++..... ..++...+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++...
T Consensus 296 E~~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp ECCTTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EccCCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9998 799998875432 22889999999999999999999999999999999999999999999999998765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=259.86 Aligned_cols=156 Identities=26% Similarity=0.362 Sum_probs=127.8
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
..++.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ .
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~-~ 98 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVY-E 98 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEE-E
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhh-c
Confidence 45678999999999999999999999999999999998753 24577899999999 699999999999 6
Q ss_pred cCCceEEEeeecc-cCHHHHHHHhhhhh-------------------------------hhcCCCCCCHHHHHHHHHHHH
Q 020467 84 EDEDAVLVLEFLR-TDLATVIAESKKKR-------------------------------EDRGDRGISVGEIKRWMVQIL 131 (326)
Q Consensus 84 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------------------------------~~~~~~~l~~~~~~~i~~ql~ 131 (326)
.....+++|||+. ++|.+++....... .......+++..++.++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 6778999999996 68887764110000 000011146777889999999
Q ss_pred HHHHHHHhCCceeccCCCCCeEEcCCC--cEEEEeecccccc
Q 020467 132 SGVDACHRNTIVHRDLKPGNLLIGDDG--VLKLADFGQARIL 171 (326)
Q Consensus 132 ~aL~~LH~~~iiH~dlkp~Nili~~~~--~~~l~Dfg~~~~~ 171 (326)
.||.|||+.+|+||||||+||+++.++ .++|+|||++..+
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~ 220 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF 220 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEG
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccc
Confidence 999999999999999999999998776 8999999998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=258.28 Aligned_cols=154 Identities=25% Similarity=0.380 Sum_probs=128.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
...++|++.+.||+|+||.||+|.+. .+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVC-AV 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-CS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-cc
Confidence 35689999999999999999999986 3458999999864 24567899999999 699999999998 66
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhh---------------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKR---------------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLK 148 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlk 148 (326)
....+++|||+. ++|.+++....... .......++...++.++.||+.||.|||+.+|+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 778999999997 59999887632110 00001348999999999999999999999999999999
Q ss_pred CCCeEEcCCCcEEEEeecccccc
Q 020467 149 PGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 149 p~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+||+++.++.++|+|||++...
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~ 224 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNI 224 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHH
T ss_pred cceEEECCCCeEEEeecCCCccc
Confidence 99999999999999999998765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=261.11 Aligned_cols=145 Identities=29% Similarity=0.450 Sum_probs=119.9
Q ss_pred cccCeEE--EeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 17 IIAKYEI--LECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 17 ~~~~y~i--~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
+.+.|.+ .+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~-~~~~~~~ 162 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAF-ESKNDIV 162 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-ECSSEEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEE-EECCEEE
Confidence 3455665 6789999999999999999999999998863 34567899999998 699999999998 5667899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE--cCCCcEEEEeec
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI--GDDGVLKLADFG 166 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili--~~~~~~~l~Dfg 166 (326)
++|||+. ++|.+.+...... +++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||
T Consensus 163 lv~E~~~~~~L~~~l~~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG 234 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESYN--------LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG 234 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred EEEeCCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCC
Confidence 9999997 6888887654322 8899999999999999999999999999999999999 566789999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 235 ~a~~~ 239 (373)
T 2x4f_A 235 LARRY 239 (373)
T ss_dssp SCEEC
T ss_pred Cceec
Confidence 98765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=267.22 Aligned_cols=149 Identities=24% Similarity=0.410 Sum_probs=129.4
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc---chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~---~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
+.+.++|++.++||+|+||.||+|.+..+++.||||.+. ....+..|+++++.+.+++++..+..++ ......+++
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~-~~~~~~~lv 81 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG-VEGDYNVLV 81 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE-EETTEEEEE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE-eeCCEEEEE
Confidence 457799999999999999999999999999999999875 3456889999999997556666665554 667788999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEEeeccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQA 168 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili---~~~~~~~l~Dfg~~ 168 (326)
|||++++|.+++..... .+++..++.++.||+.||.|||+.+|+||||||+|||| +.++.++|+|||++
T Consensus 82 me~~g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 82 MDLLGPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EECCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EECCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 99999999999875332 29999999999999999999999999999999999999 68899999999999
Q ss_pred cccc
Q 020467 169 RILL 172 (326)
Q Consensus 169 ~~~~ 172 (326)
..+.
T Consensus 154 ~~~~ 157 (483)
T 3sv0_A 154 KKYR 157 (483)
T ss_dssp EECB
T ss_pred eecc
Confidence 8763
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=252.73 Aligned_cols=149 Identities=40% Similarity=0.614 Sum_probs=128.3
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEc-CCCeEEEEEEccc-------hhhHHHHHHHHHHHh--cCCCeeEEeEEEEe--
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRL-SDNLIVALKEVHD-------YQSAFREIEALQILQ--NSPNVVVLHEYFWR-- 83 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~-~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~-- 83 (326)
...++|++.+.||+|+||.||+|.+. .+++.||+|.+.. .....+|+.+++.+. .|+||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45689999999999999999999985 6789999998752 235678888888775 69999999999852
Q ss_pred --cCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 020467 84 --EDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 84 --~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 161 (326)
.....+++|||+.++|.+++..... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCT-------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCceEEEEEecCCCCHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEE
Confidence 3456899999999999998876432 2388999999999999999999999999999999999999999999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 161 l~Dfg~~~~~ 170 (326)
T 1blx_A 161 LADFGLARIY 170 (326)
T ss_dssp ECSCCSCCCC
T ss_pred EecCcccccc
Confidence 9999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=250.05 Aligned_cols=145 Identities=22% Similarity=0.434 Sum_probs=119.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcC---CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLS---DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
...++|++.+.||+|+||.||+|.+.. .+..|++|.+.. ...+.+|+..++.+ +|+||+++++++ . .+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~-~~ 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-T-EN 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-C-SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEE-c-cC
Confidence 346899999999999999999998864 356799998753 34567888899888 699999999987 3 34
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred ccEEEEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence 6899999998 589888865431 2899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 161 g~~~~~ 166 (281)
T 1mp8_A 161 GLSRYM 166 (281)
T ss_dssp ------
T ss_pred cccccc
Confidence 998765
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=248.08 Aligned_cols=145 Identities=31% Similarity=0.521 Sum_probs=129.2
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
...++|++.+.||+|+||.||+|.+..+++.|++|.+.. ...+.+|+..++.+ .|+||+++++++ .....
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~ 85 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVI-STPTD 85 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEE-ECSSE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEE-ecCCe
Confidence 457899999999999999999999988999999998853 23567889999888 699999999998 56678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... +++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecc
Confidence 999999997 699888865432 8999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 157 ~~~~~ 161 (276)
T 2h6d_A 157 LSNMM 161 (276)
T ss_dssp GGGCC
T ss_pred ccccc
Confidence 98764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=259.76 Aligned_cols=148 Identities=34% Similarity=0.546 Sum_probs=126.1
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------------hhhHHHHHHHHHHHhcCCCeeEE
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------------YQSAFREIEALQILQNSPNVVVL 77 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------------~~~~~~E~~~l~~l~~h~ni~~l 77 (326)
...+.++|++.+.||+|+||.||+|.+.. ++.||||.+.. ...+.+|+.+++.+ +|+||+++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 94 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGL 94 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccce
Confidence 34578999999999999999999998754 88999998742 15578999999999 69999999
Q ss_pred eEEEEecC----CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 020467 78 HEYFWRED----EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLL 153 (326)
Q Consensus 78 ~~~~~~~~----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nil 153 (326)
++++.... ...+++|||+.++|.+.+.... ..+++..+..++.|++.||.|||+.+|+|+||||+||+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR--------IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL 166 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred eeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEE
Confidence 99985432 3579999999999998887532 23899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEeecccccc
Q 020467 154 IGDDGVLKLADFGQARIL 171 (326)
Q Consensus 154 i~~~~~~~l~Dfg~~~~~ 171 (326)
++.++.++|+|||++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 167 LADNNDITICDFNLARED 184 (362)
T ss_dssp ECTTCCEEECCTTC----
T ss_pred EcCCCCEEEEecCccccc
Confidence 999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=251.59 Aligned_cols=144 Identities=31% Similarity=0.454 Sum_probs=126.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
+.++|++.+.||+|+||.||+|.+..+++.|++|.+.. ...+.+|+.+++.+ +|+||+++++++ ...+..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHR-REGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEE-EETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEE-EcCCEEEE
Confidence 57899999999999999999999998999999998853 24567888888888 699999999998 55677899
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 153 (276)
T ss_dssp EEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcc
Confidence 999997 48877664322 28999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 154 ~~ 155 (276)
T 2yex_A 154 VF 155 (276)
T ss_dssp EC
T ss_pred cc
Confidence 65
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=251.52 Aligned_cols=149 Identities=36% Similarity=0.596 Sum_probs=123.3
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ...+.
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~ 106 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASF-IEDNE 106 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-EETTE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-EcCCc
Confidence 457899999999999999999999988999999998752 23467889999998 699999999998 45668
Q ss_pred eEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+.+ +|.+++...... ...++...++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg 181 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 181 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-
T ss_pred EEEEEecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecc
Confidence 9999999984 888888654322 2338999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 182 ~~~~~ 186 (310)
T 2wqm_A 182 LGRFF 186 (310)
T ss_dssp -----
T ss_pred ceeee
Confidence 98654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=259.04 Aligned_cols=146 Identities=18% Similarity=0.234 Sum_probs=116.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcC---CCeEEEEEEccch-hh---------------HHHHHHHHHHHhcCCCeeEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLS---DNLIVALKEVHDY-QS---------------AFREIEALQILQNSPNVVVL 77 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~~-~~---------------~~~E~~~l~~l~~h~ni~~l 77 (326)
..++|++.+.||+|+||.||+|.+.. ++..+|+|.+... .. +.+|+..+..+ .|+||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCccee
Confidence 35789999999999999999999976 7888999987532 12 23344444445 69999999
Q ss_pred eEEEEec---CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 020467 78 HEYFWRE---DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154 (326)
Q Consensus 78 ~~~~~~~---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili 154 (326)
++++... ....+++|||++++|.+++..... +++..+..++.||+.||.|||+.+|+||||||+||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT---------FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGB---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ecccccccCCCcEEEEEEeccCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE
Confidence 9998553 567899999998899888765432 8999999999999999999999999999999999999
Q ss_pred cCCC--cEEEEeeccccccc
Q 020467 155 GDDG--VLKLADFGQARILL 172 (326)
Q Consensus 155 ~~~~--~~~l~Dfg~~~~~~ 172 (326)
+.++ .++|+|||++..+.
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~ 204 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYC 204 (345)
T ss_dssp ESSSTTSEEECCCTTCEESS
T ss_pred ccCCCCcEEEEeCCCceecc
Confidence 9887 99999999997763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=250.14 Aligned_cols=144 Identities=28% Similarity=0.457 Sum_probs=127.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++ ......+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~ 96 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSY-LKDTKLW 96 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEE-EETTEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEE-ecCCeEE
Confidence 456889999999999999999999999999999998852 35577899999988 699999999998 5566799
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++.. ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 97 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP----------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp EEEECCTTEEHHHHHTT----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccc
Confidence 9999998 488777643 12899999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 167 ~~~ 169 (303)
T 3a7i_A 167 GQL 169 (303)
T ss_dssp EEC
T ss_pred eec
Confidence 765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.54 Aligned_cols=146 Identities=33% Similarity=0.499 Sum_probs=121.9
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEe------
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWR------ 83 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~------ 83 (326)
-.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccccccc
Confidence 3577899999999999999999999999999999998752 34567899999999 69999999998732
Q ss_pred -------cCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-
Q 020467 84 -------EDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG- 155 (326)
Q Consensus 84 -------~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~- 155 (326)
.....+++|||+.++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMETDLANVLEQ----------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155 (320)
T ss_dssp C----CCSCSEEEEEEECCSEEHHHHHTT----------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred cccccccccCceeEEeeccCCCHHHHhhc----------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 2356899999999999888743 2288999999999999999999999999999999999997
Q ss_pred CCCcEEEEeecccccc
Q 020467 156 DDGVLKLADFGQARIL 171 (326)
Q Consensus 156 ~~~~~~l~Dfg~~~~~ 171 (326)
.++.++|+|||++...
T Consensus 156 ~~~~~kl~Dfg~~~~~ 171 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIM 171 (320)
T ss_dssp TTTEEEECCCTTCBCC
T ss_pred CCCeEEEccCcccccc
Confidence 5679999999998765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=258.83 Aligned_cols=154 Identities=25% Similarity=0.372 Sum_probs=129.8
Q ss_pred cccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 10 SIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 10 ~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
+........++|++.+.||+|+||.||+|.+ .+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ..
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~ 106 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFC-DE 106 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEEC-CC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-cC
Confidence 3445566789999999999999999999985 4688999998753 34567888888888 699999999998 66
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
.+..+++|||+. ++|.+++...... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEEC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEe
Confidence 678999999997 5887766432211 1238899999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 182 Dfg~~~~~ 189 (321)
T 2qkw_B 182 DFGISKKG 189 (321)
T ss_dssp CCTTCEEC
T ss_pred eccccccc
Confidence 99998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=267.24 Aligned_cols=144 Identities=30% Similarity=0.505 Sum_probs=124.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------------hhHHHHHHHHHHHhcCCCeeEEeEEEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------------QSAFREIEALQILQNSPNVVVLHEYFW 82 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------------~~~~~E~~~l~~l~~h~ni~~l~~~~~ 82 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.+++++ +|+||+++++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~- 209 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF- 209 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEE-
Confidence 4578999999999999999999999999999999988532 2467899999999 699999999997
Q ss_pred ecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---
Q 020467 83 REDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG--- 158 (326)
Q Consensus 83 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~--- 158 (326)
. ....+++|||+. ++|.+.+... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++
T Consensus 210 ~-~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~ 279 (419)
T 3i6u_A 210 D-AEDYYIVLELMEGGELFDKVVGN---------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC 279 (419)
T ss_dssp E-SSEEEEEEECCTTCBGGGGTSSS---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSC
T ss_pred e-cCceEEEEEcCCCCcHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcc
Confidence 3 335899999997 5776665432 2389999999999999999999999999999999999997544
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 280 ~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 280 LIKITDFGHSKIL 292 (419)
T ss_dssp CEEECCSSTTTSC
T ss_pred eEEEeecccceec
Confidence 5999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=263.73 Aligned_cols=149 Identities=31% Similarity=0.490 Sum_probs=128.5
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-Cce
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED-EDA 88 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-~~~ 88 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+++++.+ +|+||+++++++.... ...
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCee
Confidence 356889999999999999999999999999999999863 34567899999999 6999999999985443 368
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEE
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI----GDDGVLKLA 163 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili----~~~~~~~l~ 163 (326)
+++|||+. ++|.+++..... ...+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSN------AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGG------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EEEEecCCCCCHHHHHHhhhc------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 99999997 688888765432 1238999999999999999999999999999999999999 777789999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 159 DFG~a~~~ 166 (396)
T 4eut_A 159 DFGAAREL 166 (396)
T ss_dssp CGGGCEEC
T ss_pred cCCCceEc
Confidence 99998765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=251.95 Aligned_cols=147 Identities=27% Similarity=0.415 Sum_probs=127.9
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-------
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWRE------- 84 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~------- 84 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC--
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhh
Confidence 356889999999999999999999998999999998863 34467888999888 699999999988542
Q ss_pred -----CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 85 -----DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 85 -----~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
....+++|||+. ++|.+++...... ++...++.++.|++.||.|||+.+++|+||+|+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLN--------QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGG--------GCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccc--------cchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC
Confidence 345899999997 5999988754321 78889999999999999999999999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 154 ~~kl~dfg~~~~~ 166 (303)
T 1zy4_A 154 NVKIGDFGLAKNV 166 (303)
T ss_dssp CEEECCCCCCSCT
T ss_pred CEEEeeCcchhhc
Confidence 9999999998765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=252.74 Aligned_cols=153 Identities=24% Similarity=0.434 Sum_probs=127.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGAC-SQD 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEE-ecC
Confidence 4689999999999999999999873 4458899999864 24567889999888 699999999998 667
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhh---------------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKRE---------------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKP 149 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp 149 (326)
...+++|||+. ++|.+++........ ......++...+..++.|++.||.|||+.+|+|+||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 78999999997 799998876432100 00112378899999999999999999999999999999
Q ss_pred CCeEEcCCCcEEEEeecccccc
Q 020467 150 GNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 150 ~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+||+++.++.++|+|||++...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~ 200 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDV 200 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEEC
T ss_pred heEEEcCCCCEEEccccccccc
Confidence 9999999999999999998765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=253.75 Aligned_cols=150 Identities=23% Similarity=0.380 Sum_probs=129.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEe-------c
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWR-------E 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~-------~ 84 (326)
...+|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+..+.++.+|+||+++++++.. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 35689999999999999999999999999999998742 34567889999999679999999999842 2
Q ss_pred CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEE
Q 020467 85 DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 85 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~l 162 (326)
...++++|||+.++|.+++..... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMES------RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHT------TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CceEEEEEEecCCCHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 234799999999999998865332 123899999999999999999999999 999999999999999999999
Q ss_pred Eeeccccccc
Q 020467 163 ADFGQARILL 172 (326)
Q Consensus 163 ~Dfg~~~~~~ 172 (326)
+|||++....
T Consensus 180 ~Dfg~~~~~~ 189 (337)
T 3ll6_A 180 CDFGSATTIS 189 (337)
T ss_dssp CCCTTCBCCS
T ss_pred ecCccceecc
Confidence 9999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=251.49 Aligned_cols=147 Identities=31% Similarity=0.502 Sum_probs=122.8
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
....++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+++
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSY-FKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEE-EETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEE-EeCCEEEEE
Confidence 3457899999999999999999999998999999998863 35678899999998 699999999998 456679999
Q ss_pred eeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+.+ +|.+++.... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 103 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EECCTTEEHHHHHHHHT--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 999974 8888876332 2389999999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 175 ~ 175 (314)
T 3com_A 175 L 175 (314)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=260.87 Aligned_cols=144 Identities=26% Similarity=0.440 Sum_probs=127.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ......++
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~~l 108 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAF-YSDGEISI 108 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEE-EETTEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEE-EECCEEEE
Confidence 46899999999999999999999999999999998853 24567888888888 699999999998 55667999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+|||+. ++|.+++..... +++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++
T Consensus 109 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp EECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEECCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 999997 599988876433 89999999999999999999986 9999999999999999999999999988
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 180 ~~~ 182 (360)
T 3eqc_A 180 GQL 182 (360)
T ss_dssp HHH
T ss_pred ccc
Confidence 654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=254.20 Aligned_cols=154 Identities=21% Similarity=0.325 Sum_probs=129.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCC-----eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDN-----LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~-----~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
..++|++.+.||+|+||.||+|.+..++ +.|++|.+.. ...+.+|+.++..+..|+||+++++++ ...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC-THG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-ecC
Confidence 4688999999999999999999987655 3799998863 245678999999996699999999998 666
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKRED-----RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~-----~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
...+++|||+. ++|.+++......... .....++...+..++.|++.||.|||+.+|+||||||+||+++.++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 78999999997 5999988765432110 00123789999999999999999999999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 203 ~kl~Dfg~~~~~ 214 (333)
T 2i1m_A 203 AKIGDFGLARDI 214 (333)
T ss_dssp EEBCCCGGGCCG
T ss_pred EEECcccccccc
Confidence 999999998765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=264.32 Aligned_cols=143 Identities=23% Similarity=0.393 Sum_probs=126.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.++|++.+.||+|+||.||+|.+. ++.||||.++. ...+.+|+.+++++ +|+||+++++++.......+++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEEEe
Confidence 578999999999999999999874 67999999864 45678899999999 6999999999986666679999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+. ++|.+++..... ..++...+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++..
T Consensus 269 ~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp CTTCBHHHHHHHHCT-------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 97 699999876432 1278899999999999999999999999999999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=256.14 Aligned_cols=149 Identities=26% Similarity=0.373 Sum_probs=126.9
Q ss_pred ccccCeEEEe-eeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEec---CCceEEE
Q 020467 16 EIIAKYEILE-CVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWRE---DEDAVLV 91 (326)
Q Consensus 16 ~~~~~y~i~~-~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~---~~~~~lv 91 (326)
.+.++|++.+ .||+|+||.||+|.+..+++.||+|.+........|+..+.+...|+||+++++++... ....+++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 4778999965 69999999999999999999999999987777777777766666899999999998442 3458999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEEeecc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DGVLKLADFGQ 167 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~~~~l~Dfg~ 167 (326)
|||+. ++|.+++..... ..+++..++.++.|++.||.|||+.||+||||||+||+++. ++.++|+|||+
T Consensus 105 ~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EECCTTEEHHHHHHTC-C-------CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99997 599988876432 23899999999999999999999999999999999999986 44599999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 178 ~~~~ 181 (336)
T 3fhr_A 178 AKET 181 (336)
T ss_dssp CEEC
T ss_pred ceec
Confidence 8754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=259.02 Aligned_cols=143 Identities=35% Similarity=0.511 Sum_probs=123.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC---
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE--- 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~--- 86 (326)
+.++|.+.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++.+ +|+||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccccc
Confidence 56899999999999999999999999999999999853 23467889999998 69999999999844332
Q ss_pred --ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 87 --DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 87 --~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..+++|||+.++|.+.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~D 169 (353)
T 3coi_A 101 FYDFYLVMPFMQTDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILD 169 (353)
T ss_dssp CCCCEEEEECCSEEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECS
T ss_pred ceeEEEEeccccCCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEee
Confidence 3599999999887655421 289999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 170 fg~~~~~ 176 (353)
T 3coi_A 170 FGLARHA 176 (353)
T ss_dssp TTCTTC-
T ss_pred cccccCC
Confidence 9988653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=253.98 Aligned_cols=156 Identities=22% Similarity=0.337 Sum_probs=129.3
Q ss_pred ccccCeEEEeeeccccCcEEEEEEE-----cCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRR-----LSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
-..++|++.+.||+|+||.||+|.+ ..+++.||+|.+.. ...+.+|+.++..+.+|+||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3468999999999999999999985 34678999999863 234678999999997799999999998655
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhh-------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD 156 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~ 156 (326)
....+++|||+. ++|.+++....... .......++...+..++.|++.||.|||+.+|+||||||+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 666999999998 59998887643210 0000122788999999999999999999999999999999999999
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 184 ~~~~kl~Dfg~~~~~ 198 (316)
T 2xir_A 184 KNVVKICDFGLARDI 198 (316)
T ss_dssp GGCEEECCCGGGSCT
T ss_pred CCCEEECCCcccccc
Confidence 999999999998765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=259.73 Aligned_cols=156 Identities=22% Similarity=0.405 Sum_probs=132.5
Q ss_pred CccccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEE
Q 020467 8 SWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYF 81 (326)
Q Consensus 8 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~ 81 (326)
.|+........++|++.+.||+|+||.||+|.+ .+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 96 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 96 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEE
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEE
Confidence 344555556789999999999999999999974 4688999999863 22567899999888 699999999998
Q ss_pred EecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEEcCC
Q 020467 82 WREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN---TIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 82 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~iiH~dlkp~Nili~~~ 157 (326)
......+++|||+. ++|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.+
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 97 -MTPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp -CCSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred -ecCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 66677899999997 5898888754322 23389999999999999999999999 99999999999999999
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
+.++|+|||++...
T Consensus 171 ~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 171 FEAVVGDFGLAKLM 184 (326)
T ss_dssp CCEEECCCSSCEEC
T ss_pred CCEEeccCcccccc
Confidence 99999999998765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=262.78 Aligned_cols=144 Identities=25% Similarity=0.420 Sum_probs=121.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.+.||+|+||.||+|.+. .++..||||.++. ...+.+|+.++.++ +|+||+++++++ ......
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVV-TKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-eeCCce
Confidence 568999999999999999999876 4577899999863 23567899999998 699999999998 666789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++.... ..++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEEEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999996 69988886532 2289999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 194 a~~~ 197 (373)
T 2qol_A 194 GRVL 197 (373)
T ss_dssp ----
T ss_pred cccc
Confidence 8765
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=251.84 Aligned_cols=148 Identities=26% Similarity=0.469 Sum_probs=126.4
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe-cC
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWR-ED 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~-~~ 85 (326)
.+.++|++.+.||+|+||.||+|.+..+++.+++|.+.. ...+.+|+.+++.+ +|+||+++++++.. ..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC--
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Confidence 367899999999999999999999999999999999863 24567889999998 69999999999843 34
Q ss_pred CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 86 EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 86 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
...+++|||+.+++.+++..... ..++...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~df 153 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPE-------KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISAL 153 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTT-------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred CeEEEEehhccCCHHHHHHhCcc-------cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecc
Confidence 57899999999888877765432 23899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 154 g~~~~~ 159 (305)
T 2wtk_C 154 GVAEAL 159 (305)
T ss_dssp TTCEEC
T ss_pred cccccc
Confidence 998765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=254.42 Aligned_cols=152 Identities=22% Similarity=0.383 Sum_probs=116.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCe---EEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNL---IVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
...++|++.+.||+|+||.||+|.+..++. .||+|.+.. ...+.+|+.+++.+ +|+||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccc
Confidence 456889999999999999999998876654 799998853 34567899999998 6999999999985433
Q ss_pred C-----ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 86 E-----DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 86 ~-----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
. ..+++|||+. ++|.+++....... ....++...+..++.|++.||.|||+.||+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 2 1389999997 58988886544211 1123899999999999999999999999999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 176 ~kl~Dfg~a~~~ 187 (323)
T 3qup_A 176 VCVADFGLSRKI 187 (323)
T ss_dssp EEECCCCC----
T ss_pred EEEeeccccccc
Confidence 999999998765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=253.21 Aligned_cols=145 Identities=25% Similarity=0.395 Sum_probs=127.2
Q ss_pred ccCeEEEeeeccccCcEEEEEE----EcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEe-cCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGR----RLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWR-EDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~-~~~~ 87 (326)
.++|++.+.||+|+||.||+|. +..+++.||+|.+.. ...+.+|+++++.+ +|+||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCce
Confidence 4799999999999999999998 466889999999853 23467899999999 69999999998854 3456
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++...... +++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRAR--------LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred EEEEEeecCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 899999995 7899888764332 8999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 173 ~~~~~ 177 (327)
T 3lxl_A 173 LAKLL 177 (327)
T ss_dssp GCEEC
T ss_pred cceec
Confidence 98765
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=249.70 Aligned_cols=151 Identities=34% Similarity=0.553 Sum_probs=129.5
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe-cCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWR-EDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~-~~~ 86 (326)
|...++|++.+.||+|+||.||+|.+..+++.|++|.+.. ...+.+|+.+++.+ +|+||+++++++.. ...
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGT
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCc
Confidence 3467899999999999999999999999999999998852 23467899999999 69999999998754 356
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCeEEcCCCcE
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT-----IVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~-----iiH~dlkp~Nili~~~~~~ 160 (326)
..+++|||+. ++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred eEEEEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 7899999997 5999988765432 123899999999999999999999998 9999999999999999999
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
+|+|||++...
T Consensus 156 kl~dfg~~~~~ 166 (279)
T 2w5a_A 156 KLGDFGLARIL 166 (279)
T ss_dssp EECCCCHHHHC
T ss_pred EEecCchheee
Confidence 99999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=250.24 Aligned_cols=149 Identities=28% Similarity=0.463 Sum_probs=128.7
Q ss_pred cCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 12 HTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 12 ~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
+...++.++|++.+.||+|+||.||+|.+..+++.+++|.+.. ...+.+|+.+++.+ .|+||+++++++ ....
T Consensus 12 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~ 89 (302)
T 2j7t_A 12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAY-YHDG 89 (302)
T ss_dssp BSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEE-ECC-
T ss_pred ccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeee-eeCC
Confidence 3345678999999999999999999999998999999998753 35577899999998 699999999998 5566
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++.... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 161 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELD--------RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF 161 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEEC
Confidence 8999999997 57777665432 22899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 166 GQARI 170 (326)
Q Consensus 166 g~~~~ 170 (326)
|++..
T Consensus 162 g~~~~ 166 (302)
T 2j7t_A 162 GVSAK 166 (302)
T ss_dssp HHHHH
T ss_pred CCCcc
Confidence 98754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=254.18 Aligned_cols=144 Identities=31% Similarity=0.486 Sum_probs=124.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------------hhHHHHHHHHHHHhcCCCeeEEeEEEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------------QSAFREIEALQILQNSPNVVVLHEYFW 82 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------------~~~~~E~~~l~~l~~h~ni~~l~~~~~ 82 (326)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+... ..+.+|+.+++.+ +|+||+++++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEc
Confidence 4678999999999999999999999999999999987532 2467899999999 6999999999984
Q ss_pred ecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--
Q 020467 83 REDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV-- 159 (326)
Q Consensus 83 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~-- 159 (326)
.. ..+++|||+. ++|.+.+.... .+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.
T Consensus 86 -~~-~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~ 154 (322)
T 2ycf_A 86 -AE-DYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC 154 (322)
T ss_dssp -SS-SEEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSC
T ss_pred -CC-ceEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCC
Confidence 33 4899999997 58887775432 2899999999999999999999999999999999999987664
Q ss_pred -EEEEeecccccc
Q 020467 160 -LKLADFGQARIL 171 (326)
Q Consensus 160 -~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 155 ~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 155 LIKITDFGHSKIL 167 (322)
T ss_dssp CEEECCCTTCEEC
T ss_pred eEEEccCccceec
Confidence 999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=251.02 Aligned_cols=154 Identities=22% Similarity=0.337 Sum_probs=128.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
...++|++.+.||+|+||.||+|.+. .+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVV-SQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEE-CS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEE-cc
Confidence 34689999999999999999999875 3578899999863 23466888888888 699999999998 66
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKREDR-GDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l 162 (326)
....+++|||+. ++|.+++.......... ....++...+..++.|++.||.|||+.||+||||||+||+++.++.++|
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 678999999997 59999887644321111 1123788999999999999999999999999999999999999999999
Q ss_pred Eeecccccc
Q 020467 163 ADFGQARIL 171 (326)
Q Consensus 163 ~Dfg~~~~~ 171 (326)
+|||++...
T Consensus 180 ~Dfg~~~~~ 188 (322)
T 1p4o_A 180 GDFGMTRDI 188 (322)
T ss_dssp CCTTCCCGG
T ss_pred CcCcccccc
Confidence 999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=262.95 Aligned_cols=144 Identities=22% Similarity=0.404 Sum_probs=126.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
..++|++.+.||+|+||.||+|.+. ++..||||.++. ...+.+|+.+++.+ +|+||+++++++ . ....+++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~-~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVV-T-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEE-C-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEE-e-CCccEEEE
Confidence 4688999999999999999999875 467899999863 45678999999999 699999999987 3 45689999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++....... ++...+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++...
T Consensus 262 e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred eecCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 9997 69999987543221 888899999999999999999999999999999999999999999999999765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=248.98 Aligned_cols=142 Identities=24% Similarity=0.346 Sum_probs=124.1
Q ss_pred ccCeEEEe-eeccccCcEEEEEEE--cCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILE-CVGSGAYSDVYKGRR--LSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~-~Lg~G~~g~Vy~a~~--~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++.+ .||+|+||.||+|.+ ..+++.|++|.+.. ...+.+|+.+++.+ .|+||+++++++ . ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~-~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-E-AES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-E-SSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-C-CCC
Confidence 57899999 999999999999954 55678999998863 34567899999998 699999999998 3 456
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... ++...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred cEEEEEeCCCCCHHHHHHhCcC---------CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 899999997 689888865432 8999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 163 ~~~~~ 167 (291)
T 1xbb_A 163 LSKAL 167 (291)
T ss_dssp TCEEC
T ss_pred cceee
Confidence 98765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=244.46 Aligned_cols=143 Identities=24% Similarity=0.404 Sum_probs=126.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.+.||+|+||.||+|.+. ++..|++|.+.. ...+.+|+.+++.+ +|+||+++++++ ......+++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC-LEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEE-CSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEE-ccCCCeEEEEe
Confidence 478999999999999999999886 567899999863 35678899999999 699999999998 66678999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. ++|.+++..... .++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp CCTTCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred CCCCCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccc
Confidence 997 689888865422 2889999999999999999999999999999999999999999999999998765
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=249.56 Aligned_cols=152 Identities=34% Similarity=0.427 Sum_probs=127.7
Q ss_pred CccccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhc-CCCeeEEeE
Q 020467 8 SWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQN-SPNVVVLHE 79 (326)
Q Consensus 8 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~-h~ni~~l~~ 79 (326)
.+.++......++|++.+.||+|+||.||+|.+. +++.||+|.+.. ...+.+|+.++..+.+ |+||+++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 3444555556788999999999999999999875 588899998842 2456789999999964 699999999
Q ss_pred EEEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 020467 80 YFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 80 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 159 (326)
++ ......+++||+.+++|.+++..... ++...+..++.|++.||.|||+.+|+|+||||+||++++ +.
T Consensus 96 ~~-~~~~~~~lv~e~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~ 164 (313)
T 3cek_A 96 YE-ITDQYIYMVMECGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM 164 (313)
T ss_dssp EE-ECSSEEEEEECCCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE
T ss_pred Ee-ecCCEEEEEEecCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce
Confidence 98 55667999999877899999876432 889999999999999999999999999999999999964 89
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 165 ~kL~Dfg~~~~~ 176 (313)
T 3cek_A 165 LKLIDFGIANQM 176 (313)
T ss_dssp EEECCCSSSCC-
T ss_pred EEEeeccccccc
Confidence 999999998765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=248.75 Aligned_cols=147 Identities=24% Similarity=0.397 Sum_probs=125.1
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcC---CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLS---DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
....+|++.+.||+|+||.||+|.+.. +...+++|.+.. ...+.+|+.+++++ +|+||+++++++....+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSS
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCC
Confidence 345789999999999999999998653 334688998753 24467889999998 69999999999766677
Q ss_pred ceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+.+ +|.+++.... ..++...+..++.|++.||.|||+.+++||||||+||+++.++.++|+||
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df 172 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADF 172 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcc
Confidence 88999999984 9988886432 22889999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 173 g~a~~~ 178 (298)
T 3f66_A 173 GLARDM 178 (298)
T ss_dssp GGGCCC
T ss_pred cccccc
Confidence 998765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=246.68 Aligned_cols=142 Identities=30% Similarity=0.426 Sum_probs=123.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++ ..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~ 94 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLM-HN 94 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEE-TT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheee-cC
Confidence 46899999999999999999999999999999998842 14577899999999 699999999988 33
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCc--
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIGDDGV-- 159 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~~~~~-- 159 (326)
. .+++|||+. ++|.+.+.... ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 95 ~--~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~ 164 (287)
T 4f0f_A 95 P--PRMVMEFVPCGDLYHRLLDKA--------HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164 (287)
T ss_dssp T--TEEEEECCTTCBHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred C--CeEEEEecCCCCHHHHHhccc--------CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCC
Confidence 3 379999998 78888876533 23899999999999999999999999 999999999999988776
Q ss_pred ---EEEEeeccccc
Q 020467 160 ---LKLADFGQARI 170 (326)
Q Consensus 160 ---~~l~Dfg~~~~ 170 (326)
++|+|||++..
T Consensus 165 ~~~~kl~Dfg~~~~ 178 (287)
T 4f0f_A 165 PVCAKVADFGLSQQ 178 (287)
T ss_dssp SCCEEECCCTTCBC
T ss_pred ceeEEeCCCCcccc
Confidence 99999998864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=255.64 Aligned_cols=148 Identities=31% Similarity=0.447 Sum_probs=125.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHh----------cCCCeeEEeEEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQ----------NSPNVVVLHEYFW 82 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~----------~h~ni~~l~~~~~ 82 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.. .....+|+.+++++. .|+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999999999999999999873 345677888888875 2789999999985
Q ss_pred ecC---CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcC--
Q 020467 83 RED---EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGD-- 156 (326)
Q Consensus 83 ~~~---~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~-- 156 (326)
... ...+++||+++++|.+++..... ..++...+..++.||+.||.|||+. ||+||||||+||+++.
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhc-------cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 433 26899999998899998876432 2389999999999999999999998 9999999999999953
Q ss_pred ----CCcEEEEeecccccc
Q 020467 157 ----DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ----~~~~~l~Dfg~~~~~ 171 (326)
.+.++|+|||++...
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~ 188 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWY 188 (373)
T ss_dssp TTTTEEEEEECCCTTCEET
T ss_pred CCcCcceEEEccccccccc
Confidence 347999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=245.99 Aligned_cols=145 Identities=23% Similarity=0.389 Sum_probs=122.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
..++|++.+.||+|+||.||++.+ +++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++.......+++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEEEe
Confidence 468999999999999999999987 478999999864 34567899999998 699999999997566667999999
Q ss_pred eccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+.+ +|.+++....... +++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus 96 ~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSV-------LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp CCTTEEHHHHHHHHHHHH-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred cCCCCCHHHHHHhccccc-------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 9974 9999887654322 788999999999999999999999999999999999999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=261.66 Aligned_cols=144 Identities=26% Similarity=0.414 Sum_probs=124.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
..++|++.++||+|+||.||+|.+.. +..||||.++. ...+.+|+.+++.+ +|+||+++++++ .. ...+++|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~~-~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-SE-EPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-CS-SSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEE-cC-CceEEEe
Confidence 45789999999999999999998864 46799999863 34678999999999 699999999988 43 5689999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++...... .++...+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++...
T Consensus 258 e~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CCCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred hhhcCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 9997 6999988653321 2889999999999999999999999999999999999999999999999998765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=243.29 Aligned_cols=144 Identities=23% Similarity=0.391 Sum_probs=124.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcC---CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLS---DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+.. ...+.+|+.+++.+ +|+||+++++++ .. ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGII-EE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEE-CS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEE-cC-CC
Confidence 46889999999999999999998643 345699998863 34567899999999 699999999987 43 35
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred CEEEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 789999998 689888865432 28999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 159 ~~~~~ 163 (281)
T 3cc6_A 159 LSRYI 163 (281)
T ss_dssp GGGCC
T ss_pred CCccc
Confidence 98765
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=251.46 Aligned_cols=147 Identities=33% Similarity=0.554 Sum_probs=120.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-----------hhHHHHHHHHHHHh---cCCCeeEEeEE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-----------QSAFREIEALQILQ---NSPNVVVLHEY 80 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-----------~~~~~E~~~l~~l~---~h~ni~~l~~~ 80 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.++.++. .|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 45678999999999999999999999889999999998532 23457888998885 59999999999
Q ss_pred EEecCCceEEEeee-cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-CC
Q 020467 81 FWREDEDAVLVLEF-LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG-DD 157 (326)
Q Consensus 81 ~~~~~~~~~lv~e~-~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~-~~ 157 (326)
+ ......++++++ +. ++|.+++..... +++..+..++.|++.||.|||+.+|+|+||+|+||+++ .+
T Consensus 107 ~-~~~~~~~~v~e~~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 107 F-ETQEGFMLVLERPLPAQDLFDYITEKGP---------LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp C------CEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTT
T ss_pred E-ecCCeEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCC
Confidence 8 555678899998 44 799988876432 89999999999999999999999999999999999999 78
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
+.++|+|||++...
T Consensus 177 ~~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 177 GCAKLIDFGSGALL 190 (312)
T ss_dssp TEEEECCCSSCEEC
T ss_pred CeEEEEEcchhhhc
Confidence 99999999998765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=251.21 Aligned_cols=146 Identities=23% Similarity=0.360 Sum_probs=122.8
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--hhHHHHHHHHHHH-hcCCCeeEEeEEEEecC---Cc
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--QSAFREIEALQIL-QNSPNVVVLHEYFWRED---ED 87 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--~~~~~E~~~l~~l-~~h~ni~~l~~~~~~~~---~~ 87 (326)
...+.++|++.+.||+|+||.||+|.+. ++.||+|.+... .....|.+++... ..|+||+++++++.... ..
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3456789999999999999999999874 889999998542 3344555555443 26999999999985543 56
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEEcCCC
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN--------TIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------~iiH~dlkp~Nili~~~~ 158 (326)
.+++|||+. ++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred eEEEEeccCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 899999997 5999988543 288999999999999999999998 999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++|+|||++..+
T Consensus 180 ~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 180 TCCIADLGLAVKF 192 (337)
T ss_dssp CEEECCCTTCEEC
T ss_pred CEEEEeCCCceee
Confidence 9999999998765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=253.17 Aligned_cols=143 Identities=27% Similarity=0.472 Sum_probs=119.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeE----EEEEEcc------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLI----VALKEVH------DYQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~----vaiK~~~------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++.+.||+|+||.||+|.+..+++. |++|.+. ....+.+|+.+++.+ +|+||+++++++.. . .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~-~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT-S-T 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEES-S-S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEec-C-C
Confidence 58899999999999999999998777664 4677663 245678899999999 69999999999843 3 3
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++++++. ++|.+++..... .++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG 162 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred ceEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCc
Confidence 777888876 689888876432 28999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 163 ~a~~~ 167 (327)
T 3lzb_A 163 LAKLL 167 (327)
T ss_dssp C----
T ss_pred ceeEc
Confidence 98765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=243.12 Aligned_cols=144 Identities=22% Similarity=0.397 Sum_probs=125.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
..++|++.+.||+|+||.||+|.+. ++..|++|.+.. ...+.+|+++++.+ .|+||+++++++ . .+..+++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~-~~~~~~v~ 86 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVV-T-QEPIYIIT 86 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-C-SSSCEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEE-c-CCCcEEEE
Confidence 4688999999999999999999865 567899998863 45577899999999 699999999987 3 34589999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++...... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 87 e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp ECCTTCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 9996 6998887654321 1899999999999999999999999999999999999999999999999998765
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=244.75 Aligned_cols=144 Identities=31% Similarity=0.442 Sum_probs=124.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec---CCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE---DED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~---~~~ 87 (326)
.+.|++.+.||+|+||.||+|.+..++..|++|.+.. ...+.+|+.+++.+ +|+||+++++++... ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCce
Confidence 4568999999999999999999999999999998753 23467888899888 699999999998543 345
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEc-CCCcEEEE
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIG-DDGVLKLA 163 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~-~~~~~~l~ 163 (326)
.+++|||+. ++|.+++..... ++...+..++.|++.||.|||+.+ ++|+||||+||+++ .++.++|+
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EEEEEEecCCCCHHHHHHHccC---------CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence 899999996 599888865432 899999999999999999999999 99999999999998 78899999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 175 Dfg~~~~~ 182 (290)
T 1t4h_A 175 DLGLATLK 182 (290)
T ss_dssp CTTGGGGC
T ss_pred eCCCcccc
Confidence 99998643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-33 Score=246.31 Aligned_cols=145 Identities=25% Similarity=0.390 Sum_probs=122.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCC---eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDN---LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~---~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.-.|.+.++||+|+||.||+|.+..++ ..+|+|.+.. ...+.+|+.+++.+ +|+||+++++++.......
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCc
Confidence 446778899999999999999875443 3799998863 24567889999998 6999999999995555556
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++++|+. ++|.+++.... ..++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQ--------RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred EEEEecccCCCHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 99999986 78988886532 2388899999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 171 ~~~~ 174 (298)
T 3pls_A 171 ARDI 174 (298)
T ss_dssp SCTT
T ss_pred cccc
Confidence 8755
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=9.5e-33 Score=250.77 Aligned_cols=145 Identities=23% Similarity=0.369 Sum_probs=122.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCC----CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSD----NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~----~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+.. ...+.+|+.+++.+ .|+||+++++++ ....
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVI-SKYK 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-CSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE-ecCC
Confidence 457899999999999999999987644 34699998863 23467888999888 699999999998 6677
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++.... ..++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKD--------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTT--------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CcEEEEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCC
Confidence 8999999997 48888876532 22899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 192 g~~~~~ 197 (333)
T 1mqb_A 192 GLSRVL 197 (333)
T ss_dssp CC----
T ss_pred Ccchhh
Confidence 998765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-33 Score=252.32 Aligned_cols=152 Identities=24% Similarity=0.409 Sum_probs=127.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEE--EEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIV--ALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~v--aiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.+.||+|+||.||+|.+..++..+ ++|.+.. ...+.+|+++++++.+|+||+++++++ ......+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-EETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-eeCCceE
Confidence 589999999999999999999988888755 8887753 345778999999986799999999998 5667899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhh-------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 020467 90 LVLEFLR-TDLATVIAESKKKRE-------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 161 (326)
++|||+. ++|.+++........ ......+++..++.++.||+.||.|||+.||+||||||+||+++.++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 9999996 699998875431100 01123489999999999999999999999999999999999999999999
Q ss_pred EEeeccccc
Q 020467 162 LADFGQARI 170 (326)
Q Consensus 162 l~Dfg~~~~ 170 (326)
|+|||++..
T Consensus 183 L~Dfg~~~~ 191 (327)
T 1fvr_A 183 IADFGLSRG 191 (327)
T ss_dssp ECCTTCEES
T ss_pred EcccCcCcc
Confidence 999998863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=242.31 Aligned_cols=140 Identities=31% Similarity=0.529 Sum_probs=116.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.+.||+|+||.||+|.+ ++..+|+|.+.. ...+.+|+.+++.+ +|+||+++++++ ...+..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~ 81 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVC-LKEPNL 81 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEE-CCC--C
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEE-ecCCce
Confidence 57899999999999999999987 478899998752 24567889999988 699999999998 666779
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCeEEcC--------
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT---IVHRDLKPGNLLIGD-------- 156 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---iiH~dlkp~Nili~~-------- 156 (326)
+++|||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 82 ~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~ 151 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG----------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151 (271)
T ss_dssp EEEEECCTTEEHHHHHTS----------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred EEEEEcCCCCCHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence 99999997 577666632 22899999999999999999999999 899999999999986
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++|+|||++...
T Consensus 152 ~~~~kl~Dfg~~~~~ 166 (271)
T 3dtc_A 152 NKILKITDFGLAREW 166 (271)
T ss_dssp SCCEEECCCCC----
T ss_pred CcceEEccCCccccc
Confidence 678999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-33 Score=257.46 Aligned_cols=144 Identities=25% Similarity=0.417 Sum_probs=118.0
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCC---CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSD---NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
..|++.+.||+|+||.||+|.+..+ ...+|+|.++. ...+.+|+.+++++ .|+||+++++++....+..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeE
Confidence 4588999999999999999987533 35689998753 24567888888888 69999999998756666789
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++.... ..++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++
T Consensus 168 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp EEEECCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEECCCCCCHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccc
Confidence 9999998 59998886432 22788899999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 240 ~~~ 242 (373)
T 3c1x_A 240 RDM 242 (373)
T ss_dssp ---
T ss_pred ccc
Confidence 765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=250.24 Aligned_cols=147 Identities=22% Similarity=0.350 Sum_probs=125.1
Q ss_pred ccccccCe-EEEeeeccccCcEEEEEEE----cCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEE
Q 020467 14 RPEIIAKY-EILECVGSGAYSDVYKGRR----LSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFW 82 (326)
Q Consensus 14 ~~~~~~~y-~i~~~Lg~G~~g~Vy~a~~----~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~ 82 (326)
...+.++| ++.++||+|+||.||++.+ ..+++.||+|.+.. ...+.+|+++++.+ .|+||+++++++.
T Consensus 25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCE 103 (318)
T ss_dssp CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred CceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEe
Confidence 34456667 9999999999999988754 34789999999864 23467899999999 5999999999996
Q ss_pred ec-CCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 020467 83 RE-DEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 83 ~~-~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 160 (326)
.. ....+++|||+. ++|.+++.... +++..+..++.|++.||.|||+.+|+|+||||+||+++.++.+
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~ 173 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLV 173 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCE
Confidence 54 356899999997 58888875421 8899999999999999999999999999999999999999999
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
+|+|||++...
T Consensus 174 kl~Dfg~a~~~ 184 (318)
T 3lxp_A 174 KIGDFGLAKAV 184 (318)
T ss_dssp EECCGGGCEEC
T ss_pred EECCccccccc
Confidence 99999998765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=265.15 Aligned_cols=144 Identities=26% Similarity=0.414 Sum_probs=125.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
..++|++.++||+|+||.||+|.+.. +..||||.++. ...+.+|+++++.+ +|+||+++++++ .. ...+++|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~-~~-~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-SE-EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-CS-SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEE-ee-ccceEee
Confidence 46789999999999999999998864 46799999863 34678999999999 699999999988 43 5689999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+. ++|.+++...... .++...+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++...
T Consensus 341 e~~~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp CCCTTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ehhcCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 9997 5999988653321 2889999999999999999999999999999999999999999999999998765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=249.01 Aligned_cols=151 Identities=22% Similarity=0.344 Sum_probs=122.1
Q ss_pred cccCeEEEeeeccccCcEEEEEE-----EcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~-----~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++ ...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~ 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVS-LQS 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-CSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEE-cCC
Confidence 46899999999999999999998 456788999999853 33567889999998 699999999998 566
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEE
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DGVLK 161 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~~~~ 161 (326)
...+++|||+. ++|.+++....... .....++...++.++.|++.||.|||+.+|+||||||+||+++. +..++
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 67899999995 79999887643211 01123889999999999999999999999999999999999994 44699
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 184 l~Dfg~~~~~ 193 (327)
T 2yfx_A 184 IGDFGMARDI 193 (327)
T ss_dssp ECCCHHHHHH
T ss_pred ECcccccccc
Confidence 9999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=9.4e-33 Score=245.66 Aligned_cols=141 Identities=25% Similarity=0.392 Sum_probs=116.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
..++|++.++||+|+||.||+|.+.. .+++|.++. ...+.+|+.+++.+ .|+||++++++. .....+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~--~~~~~~ 95 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS--TAPQLA 95 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE--CSSSCE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec--cCCccE
Confidence 46789999999999999999997643 489998852 24467899999998 699999999964 445689
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++..... .++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++
T Consensus 96 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp EEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred EEEEecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence 9999997 688877754322 2899999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 168 ~~~ 170 (289)
T 3og7_A 168 TEK 170 (289)
T ss_dssp ---
T ss_pred ccc
Confidence 654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-33 Score=249.15 Aligned_cols=152 Identities=29% Similarity=0.472 Sum_probs=116.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.++..+ .|+||+++++++ ......++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSF-VVKDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEE-ESSSCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEE-eecCCcEE
Confidence 46889999999999999999999888899999998753 23456777888777 699999999998 55667999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++........ .....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTT-TTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EehhccCCchHHHHHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999996 688888865322111 112348999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 170 ~~ 171 (303)
T 2vwi_A 170 FL 171 (303)
T ss_dssp HC
T ss_pred ee
Confidence 65
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=242.57 Aligned_cols=143 Identities=24% Similarity=0.399 Sum_probs=122.6
Q ss_pred ccCeEEEe-eeccccCcEEEEEEEc--CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILE-CVGSGAYSDVYKGRRL--SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~-~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|.+.+ .||+|+||.||+|.+. .++..||+|.+.. ...+.+|+++++.+ +|+||+++++++ . ....
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~-~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-Q-AEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-E-SSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-c-CCCc
Confidence 56788887 9999999999999864 4678899999864 34467899999999 699999999998 3 3468
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEeCCCCCHHHHHHhCC--------ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence 99999998 58888775322 2289999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+...
T Consensus 157 ~~~~ 160 (287)
T 1u59_A 157 SKAL 160 (287)
T ss_dssp CEEC
T ss_pred eeee
Confidence 8765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=242.13 Aligned_cols=146 Identities=29% Similarity=0.494 Sum_probs=127.9
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..+.++|++.+.||+|+||.||+|.+..+++.|++|.+.. ...+.+|+.+++++ +|+||+++++++ .....
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEIL-EDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEE-ECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEE-eCCCe
Confidence 3577899999999999999999999988999999998742 34577899999999 699999999998 55678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEE
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD---GVLKLA 163 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~---~~~~l~ 163 (326)
.++++|++. ++|.+.+..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEe
Confidence 999999996 688887765432 8999999999999999999999999999999999999764 469999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 167 Dfg~~~~~ 174 (287)
T 2wei_A 167 DFGLSTCF 174 (287)
T ss_dssp STTGGGTB
T ss_pred ccCcceee
Confidence 99988754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=248.21 Aligned_cols=150 Identities=22% Similarity=0.354 Sum_probs=123.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... .....|+..+.+...|+||+++++++ ...+..++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~-~~~~~~~l 98 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL-FREGDCWI 98 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE-ECSSEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE-EeCCceEE
Confidence 358999999999999999999999989999999988532 23344555333333799999999998 55668999
Q ss_pred EeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+.++|.+++...... ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.
T Consensus 99 v~e~~~~~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 99 CMELMSTSFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EECCCSEEHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEeecCCChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999988887653221 123489999999999999999999998 99999999999999999999999999986
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 175 ~~ 176 (327)
T 3aln_A 175 QL 176 (327)
T ss_dssp C-
T ss_pred ec
Confidence 54
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=247.30 Aligned_cols=146 Identities=25% Similarity=0.421 Sum_probs=125.5
Q ss_pred cccCeEEEeeeccccCcEEEEEE----EcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-C
Q 020467 17 IIAKYEILECVGSGAYSDVYKGR----RLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWRED-E 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-~ 86 (326)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.. ...+.+|+.+++.+ +|+||+++++++.... .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCC
Confidence 35779999999999999999998 356789999999853 23567899999999 6999999999874433 4
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred ceEEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 6899999997 599988876432 2889999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++...
T Consensus 190 g~~~~~ 195 (326)
T 2w1i_A 190 GLTKVL 195 (326)
T ss_dssp TTCEEC
T ss_pred cchhhc
Confidence 998765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=249.91 Aligned_cols=143 Identities=26% Similarity=0.349 Sum_probs=117.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHH--HHhcCCCeeEEeEEEEe----cCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQ--ILQNSPNVVVLHEYFWR----EDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~--~l~~h~ni~~l~~~~~~----~~~~~ 88 (326)
-.++|++.+.||+|+||.||+|.+ +++.||+|.+.. ......|.+++. .+ .|+||+++++.+.. ....+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceE
Confidence 368999999999999999999976 678999999863 233344444433 24 79999999986532 12347
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCeEEcCCC
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN---------TIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---------~iiH~dlkp~Nili~~~~ 158 (326)
+++|||+. ++|.+++.... .+...+..++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred EEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 89999996 69998886532 67888999999999999999999 999999999999999999
Q ss_pred cEEEEeeccccccc
Q 020467 159 VLKLADFGQARILL 172 (326)
Q Consensus 159 ~~~l~Dfg~~~~~~ 172 (326)
.++|+|||++..+.
T Consensus 158 ~~kL~DFG~a~~~~ 171 (336)
T 3g2f_A 158 TCVISDFGLSMRLT 171 (336)
T ss_dssp CEEECCCTTCEECS
T ss_pred cEEEeeccceeecc
Confidence 99999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=244.71 Aligned_cols=151 Identities=24% Similarity=0.390 Sum_probs=121.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcC---CCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLS---DNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.. ...+.+|+.+++.+ +|+||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence 46899999999999999999998754 556899999862 23467889999998 69999999999854332
Q ss_pred ----ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 020467 87 ----DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 87 ----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 161 (326)
..+++|||+. ++|.+++....... ....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 3599999998 58988875432211 123489999999999999999999999999999999999999999999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 188 l~Dfg~~~~~ 197 (313)
T 3brb_A 188 VADFGLSKKI 197 (313)
T ss_dssp ECSCSCC---
T ss_pred EeecCcceec
Confidence 9999998765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=240.67 Aligned_cols=144 Identities=15% Similarity=0.202 Sum_probs=123.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~ 88 (326)
..++|++.+.||+|+||.||+|.+. +..+|+|.+.. ...+.+|+.+++.+ +|+||+++++++... ....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence 4678999999999999999999874 78899998863 23467788888888 699999999998433 2678
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEEEee
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+++.||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTN-------FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSS-------CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred EeeecccCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence 99999998 599998875432 23899999999999999999999999 999999999999999999999999
Q ss_pred ccccc
Q 020467 166 GQARI 170 (326)
Q Consensus 166 g~~~~ 170 (326)
++...
T Consensus 158 ~~~~~ 162 (271)
T 3kmu_A 158 DVKFS 162 (271)
T ss_dssp GSCCT
T ss_pred cceee
Confidence 87643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=244.85 Aligned_cols=148 Identities=32% Similarity=0.468 Sum_probs=125.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEec---CCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWRE---DEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~---~~~~~ 89 (326)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ .|+||+++++++... ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeE
Confidence 4789999999999999999999989999999998742 34567889999888 699999999998532 34689
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++...... ...+++..++.++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 9999998 4998888764321 233899999999999999999999999999999999999999999999999987
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 182 ~~~ 184 (317)
T 2buj_A 182 NQA 184 (317)
T ss_dssp EES
T ss_pred hhc
Confidence 654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=243.51 Aligned_cols=142 Identities=31% Similarity=0.464 Sum_probs=118.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.++|++.+.||+|+||.||+|.+ .++.||+|.+.. ...+.+|+..++++ +|+||+++++++ . +..+++|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~-~--~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGAC-L--NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBC-T--TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEE-c--CCcEEEEEc
Confidence 57899999999999999999987 468899999864 34567899999999 699999999977 3 358999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCCeEEcCCCc-EEEEeecccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR---NTIVHRDLKPGNLLIGDDGV-LKLADFGQAR 169 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~---~~iiH~dlkp~Nili~~~~~-~~l~Dfg~~~ 169 (326)
+. ++|.+++...... ..++...+..++.|++.||.|||+ .+|+||||||+||+++.++. ++|+|||++.
T Consensus 81 ~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp CTTCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred CCCCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 97 6998888653321 127888999999999999999999 89999999999999998886 7999999986
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 155 ~~ 156 (307)
T 2eva_A 155 DI 156 (307)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-33 Score=252.16 Aligned_cols=153 Identities=20% Similarity=0.356 Sum_probs=127.4
Q ss_pred ccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch----------------------hhHHHHHHHHHHHhcC
Q 020467 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----------------------QSAFREIEALQILQNS 71 (326)
Q Consensus 14 ~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----------------------~~~~~E~~~l~~l~~h 71 (326)
.....++|++.+.||+|+||.||+|.+ +++.||+|.+... ..+.+|+.++..+ +|
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 102 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KN 102 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CC
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CC
Confidence 344678999999999999999999998 8999999988531 6778999999999 59
Q ss_pred CCeeEEeEEEEecCCceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCC
Q 020467 72 PNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKP 149 (326)
Q Consensus 72 ~ni~~l~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp 149 (326)
+||+++++++ ......+++|||+.+ +|.+++....... ......+++..+..++.|++.||.|||+ .|++|+||+|
T Consensus 103 ~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~l~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p 180 (348)
T 2pml_X 103 EYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLD-KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180 (348)
T ss_dssp TTBCCCSEEE-ESSSEEEEEEECCTTCBSSEESSSEESSC-SSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred CCcceEEEEE-eeCCeEEEEEeccCCCcHHHHHHHhhhhh-hccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence 9999999998 556789999999985 7776621100000 0002348999999999999999999999 9999999999
Q ss_pred CCeEEcCCCcEEEEeecccccc
Q 020467 150 GNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 150 ~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+||+++.++.++|+|||++...
T Consensus 181 ~Nil~~~~~~~kl~dfg~~~~~ 202 (348)
T 2pml_X 181 SNILMDKNGRVKLSDFGESEYM 202 (348)
T ss_dssp GGEEECTTSCEEECCCTTCEEC
T ss_pred HhEEEcCCCcEEEecccccccc
Confidence 9999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=246.85 Aligned_cols=145 Identities=25% Similarity=0.364 Sum_probs=125.4
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHH-hcCCCeeEEeEEEEecC---Cce
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQIL-QNSPNVVVLHEYFWRED---EDA 88 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l-~~h~ni~~l~~~~~~~~---~~~ 88 (326)
..+.++|++.+.||+|+||.||+|.+ +++.||+|.+.. ...+.+|.+++..+ ..|+||+++++++.... ...
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 44678999999999999999999987 588999999864 34567788888773 27999999999985544 268
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCeEEcCCCc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH--------RNTIVHRDLKPGNLLIGDDGV 159 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~~iiH~dlkp~Nili~~~~~ 159 (326)
+++|||+. ++|.+++... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 116 ~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred EEEEeecCCCcHHHHHhcc----------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 99999998 4999888642 2889999999999999999999 899999999999999999999
Q ss_pred EEEEeecccccc
Q 020467 160 LKLADFGQARIL 171 (326)
Q Consensus 160 ~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 186 ~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 186 CCIADLGLAVRH 197 (342)
T ss_dssp EEECCCTTCEEE
T ss_pred EEEEECCCceec
Confidence 999999998765
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=256.35 Aligned_cols=152 Identities=24% Similarity=0.245 Sum_probs=119.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.+.+.|.+.+.||+|+||+||.+. ..+++.||||.+.. .....+|+.++..+.+||||+++++++ ......+++||
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-~~~~~~~lv~E 89 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-TTDRFLYIALE 89 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-ECSSEEEEEEC
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-ecCCeEEEEEe
Confidence 456677788999999999998753 45789999998754 345678999998876799999999998 66678999999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-------------CcE
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD-------------GVL 160 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~-------------~~~ 160 (326)
|+.++|.+++......... ....++..+..++.||+.||.|||+.+|+||||||+||+++.+ +.+
T Consensus 90 ~~~gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 90 LCNLNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCSEEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred cCCCCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 9999999998764321100 0001233457799999999999999999999999999999754 489
Q ss_pred EEEeecccccc
Q 020467 161 KLADFGQARIL 171 (326)
Q Consensus 161 ~l~Dfg~~~~~ 171 (326)
+|+|||++..+
T Consensus 168 kL~DFG~a~~~ 178 (434)
T 2rio_A 168 LISDFGLCKKL 178 (434)
T ss_dssp EECCCTTCEEC
T ss_pred EEcccccceec
Confidence 99999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=265.87 Aligned_cols=141 Identities=24% Similarity=0.347 Sum_probs=120.7
Q ss_pred CeEEE-eeeccccCcEEEEEEE--cCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 20 KYEIL-ECVGSGAYSDVYKGRR--LSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 20 ~y~i~-~~Lg~G~~g~Vy~a~~--~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.+.+. ++||+|+||.||+|.+ ..+++.||||.++. ...+.+|+++++.+ +|+||+++++++ . ....+
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~-~-~~~~~ 445 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-E-AESWM 445 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEE-E-SSSEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-e-cCCEE
Confidence 34443 4899999999999955 45678999999863 24578899999999 699999999988 3 34589
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++..... +++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++
T Consensus 446 lv~E~~~~g~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred EEEEccCCCCHHHHHhhCCC---------CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 9999997 689888865332 899999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 169 RILL 172 (326)
Q Consensus 169 ~~~~ 172 (326)
..+.
T Consensus 517 ~~~~ 520 (635)
T 4fl3_A 517 KALR 520 (635)
T ss_dssp HHTT
T ss_pred cccc
Confidence 8653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=243.10 Aligned_cols=138 Identities=26% Similarity=0.354 Sum_probs=119.5
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.+.||+|+||.||+|.+ ++..|++|.+.. ...+.+|+.+++.+ .|+||+++++++ ......+++|||
T Consensus 36 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~lv~e~ 111 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFS-SDGDDLCLVYVY 111 (307)
T ss_dssp CCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEE-CSSSSCEEEEEC
T ss_pred CCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEE-ecCCceEEEEEe
Confidence 38999999999999976 578899998752 24567899999999 699999999998 666789999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+. ++|.+++..... ...++...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus 112 ~~~~~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 112 MPNGSLLDRLSCLDG------TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183 (307)
T ss_dssp CTTCBHHHHHHTGGG------CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 96 688888864332 233899999999999999999999999999999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=264.05 Aligned_cols=143 Identities=24% Similarity=0.383 Sum_probs=122.3
Q ss_pred ccCeEEEe-eeccccCcEEEEEEEc--CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILE-CVGSGAYSDVYKGRRL--SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~-~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.+++.+.+ .||+|+||.||+|.+. .++..||||.++. ...+.+|+++++.+ +|+||+++++++.. ...
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~--~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA--EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES--SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc--CCe
Confidence 35666666 8999999999999775 3567799999863 34578899999999 69999999999843 469
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++.... ..++...+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||+
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred EEEEEeCCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 99999997 58888875432 2289999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 483 a~~~ 486 (613)
T 2ozo_A 483 SKAL 486 (613)
T ss_dssp TTTC
T ss_pred cccc
Confidence 9765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=243.06 Aligned_cols=147 Identities=23% Similarity=0.383 Sum_probs=112.6
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY------QSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
...++|++.+.||+|+||.||+|.+..+++.||+|.+... .....|...+.+...|+||+++++++ ......+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-ITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-ECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-ecCCcEE
Confidence 3468999999999999999999999989999999998532 12333443333333799999999998 5566899
Q ss_pred EEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN-TIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+++.+..+..... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++
T Consensus 101 lv~e~~~~~~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQ--------GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EEECCCSEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999765555544322 2289999999999999999999985 9999999999999999999999999988
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 173 ~~~ 175 (318)
T 2dyl_A 173 GRL 175 (318)
T ss_dssp ---
T ss_pred hhc
Confidence 654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=256.90 Aligned_cols=143 Identities=26% Similarity=0.300 Sum_probs=118.3
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeecc
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR 96 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~ 96 (326)
.+|.+.+.||+|+||+||.. ...+++.||||++.. .....+|+.+++.+..|+||+++++++ ......+++|||+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-KDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-EETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-ecCCEEEEEEECCC
Confidence 46999999999999997643 345788999998853 344678999999986799999999998 56678999999999
Q ss_pred cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---C--CcEEEEeecccccc
Q 020467 97 TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---D--GVLKLADFGQARIL 171 (326)
Q Consensus 97 ~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~--~~~~l~Dfg~~~~~ 171 (326)
++|.+++...... +....+..++.||+.||.|||+.+|+||||||+||+++. + ..++|+|||++..+
T Consensus 102 g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 102 ATLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EEHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CCHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9999988754321 344456789999999999999999999999999999953 2 35889999999765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=240.49 Aligned_cols=144 Identities=25% Similarity=0.411 Sum_probs=117.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcC-CC--eEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLS-DN--LIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~-~~--~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
..++|++.+.||+|+||.||+|.+.. ++ ..|++|.++. ...+.+|+.+++.+ .|+||+++++++. ..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~ 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVL-TP 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEc-cC
Confidence 35789999999999999999998643 33 3689998752 24567899999999 6999999999984 33
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..++++||+. ++|.+++...... +++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGG--------SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred -CceeeEecccCCCHHHHHHhccCC--------cCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcc
Confidence 4889999997 6998888764322 88999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 165 fg~~~~~ 171 (291)
T 1u46_A 165 FGLMRAL 171 (291)
T ss_dssp CTTCEEC
T ss_pred ccccccc
Confidence 9998765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=247.25 Aligned_cols=142 Identities=21% Similarity=0.277 Sum_probs=121.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------------hhHHHHHHHHHHHh--------cCCCeeE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------------QSAFREIEALQILQ--------NSPNVVV 76 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------------~~~~~E~~~l~~l~--------~h~ni~~ 76 (326)
.++|++.+.||+|+||.||+|.+ +++.||||.+... ..+.+|+.+++.+. .|+|++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 57899999999999999999987 6799999998632 56789999999996 5999998
Q ss_pred EeEEEEe-----------------------------cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHH
Q 020467 77 LHEYFWR-----------------------------EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRW 126 (326)
Q Consensus 77 l~~~~~~-----------------------------~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i 126 (326)
+.+++.. .....+++|||+. +++.+.+.. ..+++..+..+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----------~~~~~~~~~~i 166 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----------KLSSLATAKSI 166 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----------TCCCHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----------cCCCHHHHHHH
Confidence 8887642 1567999999986 445555432 12899999999
Q ss_pred HHHHHHHHHHHH-hCCceeccCCCCCeEEcCCC--------------------cEEEEeecccccc
Q 020467 127 MVQILSGVDACH-RNTIVHRDLKPGNLLIGDDG--------------------VLKLADFGQARIL 171 (326)
Q Consensus 127 ~~ql~~aL~~LH-~~~iiH~dlkp~Nili~~~~--------------------~~~l~Dfg~~~~~ 171 (326)
+.||+.||.||| +.+|+||||||+|||++.++ .++|+|||+++..
T Consensus 167 ~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~ 232 (336)
T 2vuw_A 167 LHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232 (336)
T ss_dssp HHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred HHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence 999999999999 99999999999999999887 8999999999765
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=239.27 Aligned_cols=146 Identities=32% Similarity=0.443 Sum_probs=122.9
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.++|.....||+|+||.||+|.+..+++.|++|.+.. ...+.+|+.+++.+ .|+||+++++++ ......+++|
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~ 98 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSF-SENGFIKIFM 98 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEE-EETTEEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEE-EeCCcEEEEE
Confidence 3444445589999999999999999999999998753 34567889999888 699999999998 5566799999
Q ss_pred eecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEEeeccccc
Q 020467 93 EFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLKLADFGQARI 170 (326)
Q Consensus 93 e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~~~~~l~Dfg~~~~ 170 (326)
||+. ++|.+++..... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++..
T Consensus 99 e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWG------PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp ECCSEEEHHHHHHHTTC------CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred EeCCCCCHHHHHHhhcc------CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 9996 688888765421 122678889999999999999999999999999999999997 88999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 173 ~ 173 (295)
T 2clq_A 173 L 173 (295)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=259.99 Aligned_cols=144 Identities=22% Similarity=0.438 Sum_probs=124.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcC---CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLS---DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
..++|++.+.||+|+||.||+|.+.. .+..+|+|.+.. ...+.+|+.+++.+ +||||+++++++ . .+.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~-~-~~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-T-ENP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-C-SSS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-e-cCc
Confidence 45789999999999999999998754 356799998753 24567899999998 699999999987 3 346
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++..... .++...+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred eEEEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecC
Confidence 899999998 699888865432 28899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 537 ~a~~~ 541 (656)
T 2j0j_A 537 LSRYM 541 (656)
T ss_dssp CCCSC
T ss_pred CCeec
Confidence 98765
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=264.97 Aligned_cols=143 Identities=23% Similarity=0.415 Sum_probs=120.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcC-CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc-
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLS-DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED- 87 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~- 87 (326)
.+.++|++.+.||+|+||.||+|.+.. +++.|+||.+.. ...+.+|+.++..+ +|+||+++++++......
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCC
Confidence 355899999999999999999999875 789999998853 23456888888888 699999999999654432
Q ss_pred ---eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 88 ---AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 88 ---~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
.|+||||+. ++|.+.+.. .+++..+..++.||+.+|.|||+.||+||||||+|||++.+ .++|+
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp CEEEEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEEC
T ss_pred CceeEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEE
Confidence 699999998 566655432 28999999999999999999999999999999999999875 89999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 224 DFG~a~~~ 231 (681)
T 2pzi_A 224 DLGAVSRI 231 (681)
T ss_dssp CCTTCEET
T ss_pred ecccchhc
Confidence 99998754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=232.10 Aligned_cols=150 Identities=27% Similarity=0.382 Sum_probs=132.4
Q ss_pred ccccccCeEEE-eeeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEe---cCCceE
Q 020467 14 RPEIIAKYEIL-ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWR---EDEDAV 89 (326)
Q Consensus 14 ~~~~~~~y~i~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~---~~~~~~ 89 (326)
...+.++|.+. +.||+|+||.||+|.+..+++.||+|.+.......+|+.++.++..|+||+++++++.. .....+
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 34688899998 78999999999999999999999999998888889999999777789999999999843 245689
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEEee
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DGVLKLADF 165 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~~~~l~Df 165 (326)
++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++|+||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT-------CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 9999997 599998876432 23899999999999999999999999999999999999998 789999999
Q ss_pred ccccc
Q 020467 166 GQARI 170 (326)
Q Consensus 166 g~~~~ 170 (326)
|++..
T Consensus 165 g~a~~ 169 (299)
T 3m2w_A 165 GFAKE 169 (299)
T ss_dssp TTCEE
T ss_pred ccccc
Confidence 98754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=261.60 Aligned_cols=152 Identities=27% Similarity=0.390 Sum_probs=122.6
Q ss_pred CccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe---
Q 020467 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWR--- 83 (326)
Q Consensus 13 ~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~--- 83 (326)
......++|++.+.||.|+||.||+|.+..+++.||+|.+.. ...+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQK 86 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCC
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeeccccc
Confidence 344567999999999999999999999988999999998753 34567899999999 69999999998622
Q ss_pred --cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc-
Q 020467 84 --EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGV- 159 (326)
Q Consensus 84 --~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~- 159 (326)
.....+++|||+. ++|.+++..... ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~------~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFEN------CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSC------TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSS
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhccc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCc
Confidence 2556899999996 699888865332 123888899999999999999999999999999999999997764
Q ss_pred --EEEEeecccccc
Q 020467 160 --LKLADFGQARIL 171 (326)
Q Consensus 160 --~~l~Dfg~~~~~ 171 (326)
++|+|||++...
T Consensus 161 ~~vKL~DFG~a~~~ 174 (676)
T 3qa8_A 161 LIHKIIDLGYAKEL 174 (676)
T ss_dssp CEEEECSCCCCCBT
T ss_pred eeEEEccccccccc
Confidence 999999998765
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=239.73 Aligned_cols=143 Identities=24% Similarity=0.386 Sum_probs=118.8
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
+...++|++.+.||+|+||.||+|.+.. .+++|.+.. ...+.+|+.+++.+ .|+||+++++++ .....
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~ 103 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGAC-MSPPH 103 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEE-ECSSC
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEE-ecCCc
Confidence 3456899999999999999999998754 488998752 23456788888888 699999999998 55667
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++ ++.++|+|||
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC--------CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred eEEEeecccCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 999999997 68887775432 2388899999999999999999999999999999999998 6799999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 175 ~~~~~ 179 (319)
T 2y4i_B 175 LFSIS 179 (319)
T ss_dssp CCC--
T ss_pred Ccccc
Confidence 87654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=225.38 Aligned_cols=134 Identities=22% Similarity=0.235 Sum_probs=117.2
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--------hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--------QSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+|+..+..+ +|+||+++++++ ...+..
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~-~~~~~~ 106 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVV-HTRAGG 106 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-EETTEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEE-EECCcE
Confidence 558899999999999999999999989999999998632 4577888888888 699999999998 556679
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
|++|||+. ++|.+++... .....+..++.|++.||.|||+.||+||||||+||+++.++.++|+
T Consensus 107 ~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEE
Confidence 99999997 6888887421 4455688899999999999999999999999999999999988876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=241.52 Aligned_cols=152 Identities=11% Similarity=0.065 Sum_probs=111.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCC----------------
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPN---------------- 73 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~n---------------- 73 (326)
..+|.+.+.||+|+||.||+|.+..+++.||||++.. ...+.+|+.+++.+.+..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4568999999999999999999999999999998862 3345677777776642121
Q ss_pred -----eeEEeEEEEec----CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 020467 74 -----VVVLHEYFWRE----DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVH 144 (326)
Q Consensus 74 -----i~~l~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH 144 (326)
...+..++... ...++++|++..++|.+++........ ....+++..+..++.|++.||.|||+.+|+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTT--TSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 11111111111 234788888888999988854321110 0112677788999999999999999999999
Q ss_pred ccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 145 RDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 145 ~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||||+|||++.++.++|+|||++...
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~ 261 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRD 261 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred CCcccceEEEecCCeEEEEeccceeec
Confidence 999999999999999999999997653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=244.07 Aligned_cols=132 Identities=19% Similarity=0.150 Sum_probs=104.7
Q ss_pred eccccCcEEEEEEEcCCCeEEEEEEccc---------------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 27 VGSGAYSDVYKGRRLSDNLIVALKEVHD---------------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 27 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---------------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++.|+.|....++....|+.+++|.+.. ...+.+|+++|+++..|+||+++++++ ++....|||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-ed~~~~yLV 320 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-ENAQSGWLV 320 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-ECSSEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EECCEEEEE
Confidence 4456666555555555688899998842 245788999999998899999999999 777789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||++ ++|.+.+..... ++.. .++.||+.||.|+|++|||||||||+|||++.+|.+||+|||+++.
T Consensus 321 MEyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCee
Confidence 99998 599998876432 5554 4789999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 389 ~ 389 (569)
T 4azs_A 389 T 389 (569)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.1e-24 Score=205.70 Aligned_cols=127 Identities=20% Similarity=0.261 Sum_probs=96.6
Q ss_pred EEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 22 ~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
...+.||+|+||.||+|.. .+..+++|.... ...+.+|+++++++ +|+||+.+..++ ......
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~-~~~~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFD-VDLDNK 414 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEE-EETTTT
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEE-EeCCcc
Confidence 4567999999999999943 567788887531 22368899999999 699999444444 245567
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++.. +..++.|++.+|.|||+.+|+||||||+|||++. .++|+|||+
T Consensus 415 ~lVmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp EEEEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECcc
Confidence 99999997 788877643 3568999999999999999999999999999998 999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
++..
T Consensus 476 a~~~ 479 (540)
T 3en9_A 476 GKIS 479 (540)
T ss_dssp CEEC
T ss_pred CEEC
Confidence 9876
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=173.71 Aligned_cols=125 Identities=24% Similarity=0.266 Sum_probs=100.3
Q ss_pred EEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------------------hhhHHHHHHHHHHHhcCCCeeEEe
Q 020467 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------------------YQSAFREIEALQILQNSPNVVVLH 78 (326)
Q Consensus 22 ~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------------------~~~~~~E~~~l~~l~~h~ni~~l~ 78 (326)
.+.+.||+|+||.||+|.+ .+++.||+|.++. ...+.+|+.+++++. | ++++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---~~v~ 167 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---LAVP 167 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---SSSC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---CCcC
Confidence 3449999999999999998 7899999999852 234678999999985 4 4444
Q ss_pred EEEEecCCceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC
Q 020467 79 EYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 79 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~ 157 (326)
+++.. +..+++|||+++ +|.+ +. . .....++.|++.||.|||+.||+||||||+|||++ +
T Consensus 168 ~~~~~--~~~~lvmE~~~g~~L~~-l~-------------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 168 KVYAW--EGNAVLMELIDAKELYR-VR-------------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp CEEEE--ETTEEEEECCCCEEGGG-CC-------------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T
T ss_pred eEEec--cceEEEEEecCCCcHHH-cc-------------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C
Confidence 54422 457999999974 7765 21 1 12346999999999999999999999999999999 9
Q ss_pred CcEEEEeeccccc
Q 020467 158 GVLKLADFGQARI 170 (326)
Q Consensus 158 ~~~~l~Dfg~~~~ 170 (326)
+.++|+|||++..
T Consensus 229 ~~vkl~DFG~a~~ 241 (282)
T 1zar_A 229 EGIWIIDFPQSVE 241 (282)
T ss_dssp TEEEECCCTTCEE
T ss_pred CcEEEEECCCCeE
Confidence 9999999998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=8.9e-19 Score=153.05 Aligned_cols=131 Identities=21% Similarity=0.242 Sum_probs=102.8
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeE--EEEEEccch-----------------------------hhHHHHHHHHHHHh
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLI--VALKEVHDY-----------------------------QSAFREIEALQILQ 69 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~--vaiK~~~~~-----------------------------~~~~~E~~~l~~l~ 69 (326)
|.+.+.||+|+||.||+|.+..+++. ||||.++.. ..+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999998678888 999986321 14678899999985
Q ss_pred cCCC--eeEEeEEEEecCCceEEEeeeccc------CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hC
Q 020467 70 NSPN--VVVLHEYFWREDEDAVLVLEFLRT------DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACH-RN 140 (326)
Q Consensus 70 ~h~n--i~~l~~~~~~~~~~~~lv~e~~~~------~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH-~~ 140 (326)
|++ ++.++.. ...+++|||+++ .|.+.... .++..+..++.|++.+|.+|| +.
T Consensus 129 -~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 129 -EAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp -HTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred -hCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHC
Confidence 554 3344432 257899999953 55544221 223346789999999999999 99
Q ss_pred CceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 141 TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 141 ~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+||||||+|||++. .++|+|||++...
T Consensus 191 givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999998 8999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=139.07 Aligned_cols=129 Identities=17% Similarity=0.181 Sum_probs=92.8
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch-------------------hh--------HHHHHHHHHHHhcCCC
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY-------------------QS--------AFREIEALQILQNSPN 73 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~-------------------~~--------~~~E~~~l~~l~~h~n 73 (326)
|.+.++||.|++|.||+|.+. +|+.||||+++.. .. ..+|...+.++. +.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcC
Confidence 899999999999999999874 6889999986410 01 124556666663 333
Q ss_pred e--eEEeEEEEecCCceEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 020467 74 V--VVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPG 150 (326)
Q Consensus 74 i--~~l~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~ 150 (326)
+ +..++. ...+++|||+++ .|..+ ........++.|++.+|.+||+.|||||||||.
T Consensus 175 v~vp~p~~~-----~~~~LVME~i~G~~L~~l---------------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~ 234 (397)
T 4gyi_A 175 FPVPEPIAQ-----SRHTIVMSLVDALPMRQV---------------SSVPDPASLYADLIALILRLAKHGLIHGDFNEF 234 (397)
T ss_dssp CSCCCEEEE-----ETTEEEEECCSCEEGGGC---------------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred CCCCeeeec-----cCceEEEEecCCccHhhh---------------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHH
Confidence 3 222222 134799999985 33211 111234567899999999999999999999999
Q ss_pred CeEEcCCC----------cEEEEeecccccc
Q 020467 151 NLLIGDDG----------VLKLADFGQARIL 171 (326)
Q Consensus 151 Nili~~~~----------~~~l~Dfg~~~~~ 171 (326)
|||++.++ .+.|+||+-+...
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99998876 3899999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=2.9e-11 Score=105.17 Aligned_cols=139 Identities=18% Similarity=0.154 Sum_probs=107.0
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
...+.|++...++.|+.+.||++.. .+..+++|.... ...+.+|..+++.+..+..++++++++ ...+..|+
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-~~~~~~~l 87 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-RHDGWSNL 87 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-EETTEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE-ecCCceEE
Confidence 4567899999999888999999864 357899998753 345889999999996677788888887 45567899
Q ss_pred Eeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------
Q 020467 91 VLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR------------------------------ 139 (326)
Q Consensus 91 v~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~------------------------------ 139 (326)
+|++++| ++.+.+ .+......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~--------------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T 3tm0_A 88 LMSEADGVLCSEEY--------------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEECCSSEEHHHHC--------------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred EEEecCCeehhhcc--------------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence 9999997 443321 0111234577889999999998
Q ss_pred -----------------------------CCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 140 -----------------------------NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 140 -----------------------------~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
..++|+|++|.||+++.++.+.|+||+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 34899999999999987656679999987543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=2.9e-10 Score=98.28 Aligned_cols=139 Identities=12% Similarity=0.086 Sum_probs=94.1
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--hhHHHHHHHHHHHhcCCC-eeEEeEEEEecCCceEEE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--QSAFREIEALQILQNSPN-VVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--~~~~~E~~~l~~l~~h~n-i~~l~~~~~~~~~~~~lv 91 (326)
......+.+....+.|..+.||++.. .++..+++|..... ..+..|..+++.+..+.- +++++.+. ...+..+++
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-~~~~~~~~v 93 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-TEAGRDWLL 93 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-ECSSCEEEE
T ss_pred HHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEec-cCCCCCEEE
Confidence 34456677655544566789999864 45677999987653 557889999999965522 56677776 445568999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRN------------------------------- 140 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~------------------------------- 140 (326)
|++++|.... ... ... ..++.+++..|..||+.
T Consensus 94 ~e~i~G~~l~-~~~------------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (264)
T 1nd4_A 94 LGEVPGQDLL-SSH------------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 157 (264)
T ss_dssp EECCSSEETT-TSC------------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred EEecCCcccC-cCc------------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence 9999863212 100 111 13445555555555543
Q ss_pred ---------------------------CceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 141 ---------------------------TIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 141 ---------------------------~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
.++|+|++|.||+++.++.+.|+||+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 2999999999999987766679999997654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.1e-08 Score=92.92 Aligned_cols=136 Identities=17% Similarity=0.193 Sum_probs=98.9
Q ss_pred EEEeeeccccCcEEEEEEEcCCCeEEEEEEcc--c------hhhHHHHHHHHHHHhc-CCCeeEEeEEEEecC---CceE
Q 020467 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH--D------YQSAFREIEALQILQN-SPNVVVLHEYFWRED---EDAV 89 (326)
Q Consensus 22 ~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~--~------~~~~~~E~~~l~~l~~-h~ni~~l~~~~~~~~---~~~~ 89 (326)
.-.+.|+.|.++.||++... +..+++|... . ...+.+|..+++.+.. +..+++++.++ .+. +..|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~-~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALC-EDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEE-CCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEEC-CCCCccCCeE
Confidence 34678899999999998753 4578888776 2 2357789999999853 34577888776 333 3479
Q ss_pred EEeeecccCHH-HHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------
Q 020467 90 LVLEFLRTDLA-TVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR----------------------------- 139 (326)
Q Consensus 90 lv~e~~~~~L~-~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~----------------------------- 139 (326)
++||+++|... +.. ...++......++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~~-----------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS-----------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY 186 (359)
T ss_dssp EEEECCCCBCCCCTT-----------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc-----------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence 99999986321 100 1126677788889999999999996
Q ss_pred -----------------------------CCceeccCCCCCeEEcCCCc--EEEEeecccccc
Q 020467 140 -----------------------------NTIVHRDLKPGNLLIGDDGV--LKLADFGQARIL 171 (326)
Q Consensus 140 -----------------------------~~iiH~dlkp~Nili~~~~~--~~l~Dfg~~~~~ 171 (326)
..++|+|+++.||+++.++. +.++||+.+..-
T Consensus 187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997653 689999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.8e-06 Score=74.80 Aligned_cols=132 Identities=16% Similarity=0.182 Sum_probs=87.0
Q ss_pred eeccccCc-EEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeeccc-CHHH
Q 020467 26 CVGSGAYS-DVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLAT 101 (326)
Q Consensus 26 ~Lg~G~~g-~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~-~L~~ 101 (326)
.+..|..+ .||+......+..+++|.... ...+.+|...++.+..+-.+++++.++ ...+..+++|++++| ++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFI-RTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEE-EETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEE-EECCeEEEEEEeeCCccccc
Confidence 34445544 689887666677889998753 334678889998886655677888877 555678999999986 4333
Q ss_pred HHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 020467 102 VIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR------------------------------------------ 139 (326)
Q Consensus 102 ~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~------------------------------------------ 139 (326)
...... .....+..++...|..||.
T Consensus 110 ~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 110 VLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp HHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 322111 0112233334444444432
Q ss_pred ----------------CCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 140 ----------------NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 140 ----------------~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
..++|+|+.+.|||++.++.+-|+||+.+..-
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 12799999999999998777779999987654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1e-05 Score=71.65 Aligned_cols=69 Identities=16% Similarity=0.069 Sum_probs=47.6
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCC--CeeEEeEEEEecCCceEEEeeeccc
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSP--NVVVLHEYFWREDEDAVLVLEFLRT 97 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~--ni~~l~~~~~~~~~~~~lv~e~~~~ 97 (326)
.+.++.|....||.. +..+++|.-.. ...+.+|.++++.+..+. .++.++.+.....+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 445777888889987 35578887643 245678999999996442 2456665553344557899999986
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.29 E-value=1.9e-06 Score=76.19 Aligned_cols=131 Identities=15% Similarity=0.200 Sum_probs=86.2
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccch---hhHHHHHHHHHHHhcCCC--eeEEeEEEEecCC---ceEEEeeec
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDY---QSAFREIEALQILQNSPN--VVVLHEYFWREDE---DAVLVLEFL 95 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~---~~~~~E~~~l~~l~~h~n--i~~l~~~~~~~~~---~~~lv~e~~ 95 (326)
.+.++.|....||++. ..+++|..... ..+.+|.++++.+..+.. ++.++... .... ..|++|+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~-~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG-MPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC-CCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeec-CCCCCCCcceEEEccc
Confidence 3457889999999863 35788886543 456789999988854433 33444332 2222 347889999
Q ss_pred cc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 020467 96 RT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR----------------------------------- 139 (326)
Q Consensus 96 ~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~----------------------------------- 139 (326)
+| .+....... ++..+...++.+++..|..||+
T Consensus 99 ~G~~l~~~~~~~-----------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 99 KGVPLTPLLLNN-----------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CCEECCHHHHHT-----------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred CCeECCcccccc-----------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 86 332221110 4555555666666666666664
Q ss_pred -----------------------CCceeccCCCCCeEEcC--CCcEEEEeecccccc
Q 020467 140 -----------------------NTIVHRDLKPGNLLIGD--DGVLKLADFGQARIL 171 (326)
Q Consensus 140 -----------------------~~iiH~dlkp~Nili~~--~~~~~l~Dfg~~~~~ 171 (326)
..++|+|++|.||+++. ...+.++||+.+...
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 24799999999999998 456789999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=8.2e-05 Score=68.20 Aligned_cols=72 Identities=21% Similarity=0.123 Sum_probs=47.1
Q ss_pred EEeeeccccCcEEEEEEEcCCCeEEEEEEccc------------hhhHHHHHHHHHHHhcC--CCeeEEeEEEEecCCce
Q 020467 23 ILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------------YQSAFREIEALQILQNS--PNVVVLHEYFWREDEDA 88 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------------~~~~~~E~~~l~~l~~h--~ni~~l~~~~~~~~~~~ 88 (326)
-.+.||.|..+.||++....+++.+++|.... ......|.++++.+... ..++.++.+ +....
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~---d~~~~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS---DTEMA 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE---ETTTT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE---cCCcc
Confidence 36688999999999997555567899996431 22357788888887543 234455543 23456
Q ss_pred EEEeeeccc
Q 020467 89 VLVLEFLRT 97 (326)
Q Consensus 89 ~lv~e~~~~ 97 (326)
+++||++.+
T Consensus 111 ~lvmE~l~g 119 (397)
T 2olc_A 111 VTVMEDLSH 119 (397)
T ss_dssp EEEECCCTT
T ss_pred EEEEEeCCC
Confidence 899999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=5.4e-05 Score=68.26 Aligned_cols=76 Identities=7% Similarity=0.020 Sum_probs=52.3
Q ss_pred eEEEeee-ccccCcEEEEEEEc--C----CCeEEEEEEccch--------hhHHHHHHHHHHHhcC--CCeeEEeEEEEe
Q 020467 21 YEILECV-GSGAYSDVYKGRRL--S----DNLIVALKEVHDY--------QSAFREIEALQILQNS--PNVVVLHEYFWR 83 (326)
Q Consensus 21 y~i~~~L-g~G~~g~Vy~a~~~--~----~~~~vaiK~~~~~--------~~~~~E~~~l~~l~~h--~ni~~l~~~~~~ 83 (326)
....+.| +.|....+|+.... . .+..+++|..... ....+|..+++.+..+ -.+++++.+. .
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~-~ 100 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIE-T 100 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEE-C
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEc-c
Confidence 3445778 78888899987642 1 1567888976532 3578899999888654 3567777765 3
Q ss_pred cC---CceEEEeeeccc
Q 020467 84 ED---EDAVLVLEFLRT 97 (326)
Q Consensus 84 ~~---~~~~lv~e~~~~ 97 (326)
+. ...+++|++++|
T Consensus 101 ~~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEG 117 (357)
T ss_dssp SSTTTSSCEEEEECCCC
T ss_pred CCCccCCceEEEEecCC
Confidence 33 346899999975
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00045 Score=61.45 Aligned_cols=31 Identities=23% Similarity=0.503 Sum_probs=27.9
Q ss_pred CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 140 ~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
..++|+|+++.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00081 Score=59.06 Aligned_cols=65 Identities=11% Similarity=-0.015 Sum_probs=43.2
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec-cc
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL-RT 97 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~-~~ 97 (326)
.+.|+.|....+|++ ..+++|..... ....+|...++.+..+.-.++++.. ....-+++++|+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~---~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV---DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE---CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE---ECCCCEEEEeecCCC
Confidence 677888889999998 34788877532 2345788888887644333555543 233457889999 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0015 Score=60.33 Aligned_cols=33 Identities=18% Similarity=0.337 Sum_probs=28.3
Q ss_pred HhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 138 H~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+...++|+|++|.|||++.++ +.++||+.+..-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 356799999999999998776 999999887654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.008 Score=55.62 Aligned_cols=70 Identities=13% Similarity=0.083 Sum_probs=48.5
Q ss_pred EEeeeccccCcEEEEEEEcC-------CCeEEEEEEccc--h-hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 23 ILECVGSGAYSDVYKGRRLS-------DNLIVALKEVHD--Y-QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~--~-~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
-.+.|+.|....+|++.... .+..+++|+... . ..+..|..+++.+..+...+++++.+ .+ .+++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-~~----g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-SG----GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-TT----EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-CC----CEEE
Confidence 35677778888999997642 256788998843 2 45668999988886554446666654 22 3788
Q ss_pred eeccc
Q 020467 93 EFLRT 97 (326)
Q Consensus 93 e~~~~ 97 (326)
+|++|
T Consensus 152 e~l~G 156 (429)
T 1nw1_A 152 EYIPS 156 (429)
T ss_dssp CCCCE
T ss_pred EEeCC
Confidence 98874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0089 Score=52.84 Aligned_cols=73 Identities=19% Similarity=0.148 Sum_probs=53.9
Q ss_pred EEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcC--CCeeEEeEEEEecCCceEEEeeeccc
Q 020467 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNS--PNVVVLHEYFWREDEDAVLVLEFLRT 97 (326)
Q Consensus 22 ~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h--~ni~~l~~~~~~~~~~~~lv~e~~~~ 97 (326)
.-.+.|+.|....+|+... ++..+++|.... ...+..|...++.+... ..+++++.+. ......+++||++++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~-~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIG-NSQGHSFLLLEALNK 115 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEE-ECSSEEEEEEECCCC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEe-ecCCceEEEEEeccC
Confidence 3467788999999999864 456788898753 34467888888888643 4577777776 445678999999985
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.007 Score=55.03 Aligned_cols=142 Identities=19% Similarity=0.206 Sum_probs=80.0
Q ss_pred EeeeccccCcEEEEEEEcC-------CCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 24 LECVGSGAYSDVYKGRRLS-------DNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.+.|..|-...+|++.... .+..+++|+... .....+|..+++.+..+.-.++++..+ .+ .+++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-PE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-TT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-CC----ccEE
Confidence 3456667778899987532 346788998743 334568899998887555556776655 32 3889
Q ss_pred eecccC-H----------HHHHHHh-hhhhhh--cCCCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 020467 93 EFLRTD-L----------ATVIAES-KKKRED--RGDRGI--SVGEIKRWMVQILS-------------------GVDAC 137 (326)
Q Consensus 93 e~~~~~-L----------~~~l~~~-~~~~~~--~~~~~l--~~~~~~~i~~ql~~-------------------aL~~L 137 (326)
+|++|. + ...+... ...-.. ...... -...+..+..++-. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 998741 1 1111111 000000 001111 23455555544322 12333
Q ss_pred H----h----CCceeccCCCCCeEEcCC----CcEEEEeeccccc
Q 020467 138 H----R----NTIVHRDLKPGNLLIGDD----GVLKLADFGQARI 170 (326)
Q Consensus 138 H----~----~~iiH~dlkp~Nili~~~----~~~~l~Dfg~~~~ 170 (326)
. . ..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 2 259999999999999876 6899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.009 Score=53.01 Aligned_cols=32 Identities=31% Similarity=0.443 Sum_probs=27.5
Q ss_pred CCceeccCCCCCeEEcCC----CcEEEEeecccccc
Q 020467 140 NTIVHRDLKPGNLLIGDD----GVLKLADFGQARIL 171 (326)
Q Consensus 140 ~~iiH~dlkp~Nili~~~----~~~~l~Dfg~~~~~ 171 (326)
..++|||+.+.|||++.+ +.+.++||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999874 68999999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.02 Score=50.33 Aligned_cols=146 Identities=15% Similarity=0.077 Sum_probs=75.6
Q ss_pred EEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCC-CeeEEeEE-----EEecCCceEEEee
Q 020467 23 ILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSP-NVVVLHEY-----FWREDEDAVLVLE 93 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~-ni~~l~~~-----~~~~~~~~~lv~e 93 (326)
-.+.|+.|....+|+.... ++ .+++|.... ...+..|..++..+..+. .++.++.. +....+..+++++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 3566777888889998653 23 578898764 345667888888876432 13333321 0011234688999
Q ss_pred ecccCH------H------HHHHHhhhhhhhc-CC--CCCCHHHHHH---------------HHHHHHHHHHHHHh----
Q 020467 94 FLRTDL------A------TVIAESKKKREDR-GD--RGISVGEIKR---------------WMVQILSGVDACHR---- 139 (326)
Q Consensus 94 ~~~~~L------~------~~l~~~~~~~~~~-~~--~~l~~~~~~~---------------i~~ql~~aL~~LH~---- 139 (326)
+++|.- . ..+..--...... .. .......-.. +...+...+..+..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 987521 0 1110000000000 00 0001000000 00113334444442
Q ss_pred ---CCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 140 ---NTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 140 ---~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
.+++|+|+.+.||+++.++.+.++||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999998876668999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.01 Score=53.55 Aligned_cols=69 Identities=13% Similarity=0.092 Sum_probs=42.5
Q ss_pred EeeeccccCcEEEEEEEcC--------CCeEEEEEEccchh----hHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 24 LECVGSGAYSDVYKGRRLS--------DNLIVALKEVHDYQ----SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~--------~~~~vaiK~~~~~~----~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
.+.|+.|....+|++.... .+..+++|...... ....|..+++.+..+...++++... . -+++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF---N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE---T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec---C--CcEE
Confidence 4567778888899987542 12578889875321 2357888888886554345666543 1 3688
Q ss_pred eeeccc
Q 020467 92 LEFLRT 97 (326)
Q Consensus 92 ~e~~~~ 97 (326)
++|++|
T Consensus 113 ~e~i~G 118 (369)
T 3c5i_A 113 EEWLYG 118 (369)
T ss_dssp EECCCS
T ss_pred EEEecC
Confidence 999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.071 Score=46.07 Aligned_cols=72 Identities=18% Similarity=0.133 Sum_probs=51.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCC--CeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSP--NVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~--ni~~l~~~~~~~~~~~~lv 91 (326)
.+..-.+.+|.|..+.||+... .+|+.+++|.... ...+..|...|+.+.... .+++++.+. ..+++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----CceEE
Confidence 4566788999999999999874 4678899998643 234678999999885332 344555432 34788
Q ss_pred eeecc
Q 020467 92 LEFLR 96 (326)
Q Consensus 92 ~e~~~ 96 (326)
||++.
T Consensus 89 ~e~l~ 93 (288)
T 3f7w_A 89 MEWVD 93 (288)
T ss_dssp EECCC
T ss_pred EEeec
Confidence 99876
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.034 Score=51.83 Aligned_cols=69 Identities=16% Similarity=0.132 Sum_probs=45.6
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeeccc
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRT 97 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~~~ 97 (326)
.+.|+.|-...+|++.....+..+++|+.... ....+|..++..+..+.-.++++..+ . + .++++|++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-T--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-T--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-C--C--eEEEEeeCC
Confidence 56777788889999976543578889987431 12358899999986544446777665 2 2 358999874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.23 E-value=0.036 Score=48.84 Aligned_cols=71 Identities=13% Similarity=0.035 Sum_probs=42.9
Q ss_pred eeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCC-CeeEEeEE----EEecCCceEEEeeec
Q 020467 25 ECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSP-NVVVLHEY----FWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~-ni~~l~~~----~~~~~~~~~lv~e~~ 95 (326)
+.|+ |....||.+.. .+++.+++|.... ......|..++..+..+. .++.++.. +....+..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3455 77788998753 3455788999852 345667888888876432 23333332 001123457899998
Q ss_pred cc
Q 020467 96 RT 97 (326)
Q Consensus 96 ~~ 97 (326)
+|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 75
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.53 E-value=0.38 Score=44.20 Aligned_cols=69 Identities=12% Similarity=0.113 Sum_probs=46.8
Q ss_pred EeeeccccCcEEEEEEEcCC-------CeEEEEEEccch----hhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 24 LECVGSGAYSDVYKGRRLSD-------NLIVALKEVHDY----QSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~-------~~~vaiK~~~~~----~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.+.|..|-...+|++..... +..+++|+.... ....+|..+++.+..+.-.+++++.+ . -++++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~---~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF---P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE---T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc---C--CCEEE
Confidence 55666677888999876421 577889987532 23468888888886555556666543 1 37889
Q ss_pred eeccc
Q 020467 93 EFLRT 97 (326)
Q Consensus 93 e~~~~ 97 (326)
+|++|
T Consensus 150 efI~G 154 (424)
T 3mes_A 150 EFIDG 154 (424)
T ss_dssp ECCCS
T ss_pred EEeCC
Confidence 99875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.36 E-value=0.49 Score=43.00 Aligned_cols=30 Identities=30% Similarity=0.443 Sum_probs=25.3
Q ss_pred ceeccCCCCCeEEc------CCCcEEEEeecccccc
Q 020467 142 IVHRDLKPGNLLIG------DDGVLKLADFGQARIL 171 (326)
Q Consensus 142 iiH~dlkp~Nili~------~~~~~~l~Dfg~~~~~ 171 (326)
++|+|+.+.|||+. .+..+.++||..+...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 67999999999993 4567999999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.97 E-value=0.12 Score=42.89 Aligned_cols=58 Identities=19% Similarity=0.182 Sum_probs=41.2
Q ss_pred CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEE
Q 020467 98 DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 98 ~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
+|.+.+.... .+++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.+.+.
T Consensus 34 SL~eIL~~~~--------~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~ 92 (229)
T 2yle_A 34 SLEEILRLYN--------QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLA 92 (229)
T ss_dssp EHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEEC
T ss_pred cHHHHHHHcC--------CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecc
Confidence 7777776543 349999999999999999887632 111133345688888888887654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.49 E-value=0.26 Score=43.70 Aligned_cols=32 Identities=22% Similarity=0.601 Sum_probs=27.9
Q ss_pred CCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 140 ~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
..++|+|+.+.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999877654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 326 | ||||
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-34 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 0.003 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-05 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 0.001 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-04 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-28 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 0.002 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-28 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-27 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 0.004 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-26 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-26 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-26 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-25 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-25 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-22 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-22 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-17 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-37
Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 23/173 (13%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEAL 65
+R E YE+L +G+G+Y K RR SD I+ KE+ + Q E+ L
Sbjct: 1 SRAE---DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 57
Query: 66 QILQNSPNVVVLHEYFWREDEDAV-LVLEFL-RTDLATVIAESKKKREDRGDRGISVGEI 123
+ L PN+V ++ + +V+E+ DLA+VI + K+R+ + +
Sbjct: 58 REL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-----YLDEEFV 111
Query: 124 KRWMVQILSGVDACHR-----NTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
R M Q+ + CHR +T++HRDLKP N+ + +KL DFG ARIL
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-36
Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVV 75
+EI+ +G GA+ VYK + +++ A K + + + EI+ L + PN+V
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIV 72
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
L + F+ + + +++EF + ++ ++ +I+ Q L ++
Sbjct: 73 KLLDAFY-YENNLWILIEFCAGGAVDAVMLELERP-------LTESQIQVVCKQTLDALN 124
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
H N I+HRDLK GN+L DG +KLADFG +
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 15/170 (8%)
Query: 14 RPEIIAKYEIL-ECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSP 72
+ II Y++ + +G G V + ALK + D A RE+E P
Sbjct: 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCP 65
Query: 73 NVVVLHEYF---WREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
++V + + + + + ++V+E L +L + I +DRGD+ + E M
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFTEREASEIMK 118
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARILLGNE 175
I + H I HRD+KP NLL + +LKL DFG A+ +
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-34
Identities = 38/160 (23%), Positives = 72/160 (45%), Gaps = 19/160 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPN 73
+E + +G+G V+K L++A K +H RE++ L NSP
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPY 65
Query: 74 VVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+V + F D + + +E + L V+ ++ + E + + + ++
Sbjct: 66 IVGFYGAF-YSDGEISICMEHMDGGSLDQVLKKAGRIPEQ---------ILGKVSIAVIK 115
Query: 133 GVDACH-RNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+ ++ I+HRD+KP N+L+ G +KL DFG + L
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.6 bits (84), Expect = 0.003
Identities = 13/31 (41%), Positives = 20/31 (64%), Gaps = 1/31 (3%)
Query: 289 LTSCVGTRWFRAPELLYGSTSYGLEVDLWSL 319
S VGTR + +PE L G+ Y ++ D+WS+
Sbjct: 160 ANSFVGTRSYMSPERLQGTH-YSVQSDIWSM 189
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-34
Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 16/175 (9%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQ 56
E+ L K SI + + KY E +G GA VY ++ VA+++++ +
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 57 SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDR 116
EI ++ +N PN+V + + ++ +V+E+L + +
Sbjct: 63 LIINEILVMRENKN-PNIVNYLDSY-LVGDELWVVMEYLAGGS---------LTDVVTET 111
Query: 117 GISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ G+I + L ++ H N ++HRD+K N+L+G DG +KL DFG +
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 125 bits (315), Expect = 5e-34
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQN 70
++ Y+I E +G+GA+ V++ + A K V D ++ +EI+ + +L
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-R 81
Query: 71 SPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
P +V LH+ F +D + V++ EF+ +L +A+ K +S E +M Q
Sbjct: 82 HPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQ 132
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLADFGQARIL 171
+ G+ H N VH DLKP N++ LKL DFG L
Sbjct: 133 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 125 bits (315), Expect = 5e-34
Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 19/183 (10%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQ 56
++ +P+ + + + Y+ILE +GSGA+ V++ + + K ++ D
Sbjct: 13 KKYVPQPVEV-KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 57 SAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGD 115
+ EI + L + P ++ LH+ F + + VL+LEFL +L IA K
Sbjct: 72 TVKNEISIMNQL-HHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYK------ 123
Query: 116 RGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI--GDDGVLKLADFGQARILLG 173
+S E+ +M Q G+ H ++IVH D+KP N++ +K+ DFG A L
Sbjct: 124 --MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181
Query: 174 NEF 176
+E
Sbjct: 182 DEI 184
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 5e-34
Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQNS 71
+ L +G G++ VY R + ++ +VA+K++ +Q +E+ LQ L++
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
PN + + + A LV+E+ + ++ KK + EI L
Sbjct: 75 PNTIQYRGCY-LREHTAWLVMEYCLGSASDLLEVHKKP--------LQEVEIAAVTHGAL 125
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+ H + ++HRD+K GN+L+ + G++KL DFG A I+
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-33
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNS 71
+ +++++ +G GAY +V VA+K V ++ +EI ++L N
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NH 62
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
NVV + + + L LE+ + D G+ + +R+ Q++
Sbjct: 63 ENVVKFYGHRREGNIQ-YLFLEYCSGG--------ELFDRIEPDIGMPEPDAQRFFHQLM 113
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+GV H I HRD+KP NLL+ + LK++DFG A + N
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (97), Expect = 6e-05
Identities = 14/41 (34%), Positives = 19/41 (46%)
Query: 283 DGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323
+ R+ L GT + APELL + VD+WS L
Sbjct: 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 196
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 6e-33
Identities = 41/166 (24%), Positives = 76/166 (45%), Gaps = 23/166 (13%)
Query: 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEAL 65
RPE ++ + +G G++S V R L+ + A+K + RE + +
Sbjct: 6 RPE---DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 66 QILQNSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIK 124
L + P V L+ F ++DE L + + +L I + E +
Sbjct: 63 SRL-DHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------CTR 111
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
+ +I+S ++ H I+HRDLKP N+L+ +D +++ DFG A++
Sbjct: 112 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 157
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 120 bits (302), Expect = 1e-32
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------------DYQSAFREIEAL 65
YE E +G G S V + A+K + ++ +E++ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 66 QILQNSPNVVVLHEYFWREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIK 124
+ + PN++ L + + + LV + ++ +L + E E E +
Sbjct: 64 RKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK---------ETR 113
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+ M +L + A H+ IVHRDLKP N+L+ DD +KL DFG + L E
Sbjct: 114 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-32
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNS 71
E+ KY I E +G G + V++ S K V D +EI L I
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RH 60
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
N++ LHE F E+ V++ EF+ D+ I S + ++ EI ++ Q+
Sbjct: 61 RNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFE--------LNEREIVSYVHQV 111
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLADFGQARIL 171
+ H + I H D++P N++ +K+ +FGQAR L
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 6e-32
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 21/183 (11%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQ 69
++ +Y L +G GAY V + + VA+K++ Q REI+ L
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF- 63
Query: 70 NSPNVVVLHEYF----WREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
N++ +++ + +D LV + DL ++ + +S I
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----------QHLSNDHICY 113
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQP 185
++ QIL G+ H ++HRDLKP NLL+ LK+ DFG AR+ +
Sbjct: 114 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 186 CEP 188
Sbjct: 174 ATR 176
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 6e-32
Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 25/183 (13%)
Query: 7 KSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSA 58
+ W++ +EI +G G + +VY R I+ALK +
Sbjct: 1 RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 59 FREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGI 118
RE+E L++ PN++ L+ YF + L+LE+ RE +
Sbjct: 54 RREVEIQSHLRH-PNILRLYGYF-HDATRVYLILEYAPLGTV--------YRELQKLSKF 103
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDA 178
++ ++ + + CH ++HRD+KP NLL+G G LK+ADFG + +
Sbjct: 104 DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT 163
Query: 179 PDG 181
G
Sbjct: 164 LCG 166
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-32
Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 4/193 (2%)
Query: 14 RPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-DYQSAFREIEALQILQNSP 72
RP+ + Y + +G+G++ VY+ + +VA+K+V D + RE++ ++ L +
Sbjct: 16 RPQEV-SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHC 73
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L +F+ E V L D + R + + V +K +M Q+
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARILLGNEFDAPDGNSQPCEPNAP 191
+ H I HRD+KP NLL+ D VLKL DFG A+ L+ E + S+
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 192 YQDNMSEAPQVDL 204
+D+
Sbjct: 194 IFGATDYTSSIDV 206
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 9e-32
Identities = 40/189 (21%), Positives = 82/189 (43%), Gaps = 15/189 (7%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVV 75
+++E +G+G + +V+ G + + VA+K + + E ++ LQ+ +V
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLV 71
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
L+ E ++ E++ + +++ ++ QI G+
Sbjct: 72 RLYAVV--TQEPIYIITEYMENGS------LVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAP-YQD 194
+HRDL+ N+L+ D K+ADFG AR++ NE+ A +G P + AP +
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 195 NMSEAPQVD 203
+ + D
Sbjct: 184 YGTFTIKSD 192
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-31
Identities = 65/183 (35%), Positives = 88/183 (48%), Gaps = 23/183 (12%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQN 70
++KYE L +G G + +V+K R VALK+V +A REI+ LQ+L
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-K 67
Query: 71 SPNVVVLHEYFW-------REDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEI 123
NVV L E R LV +F DLA +++ K EI
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS--------EI 119
Query: 124 KRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNS 183
KR M +L+G+ HRN I+HRD+K N+LI DGVLKLADFG AR + P+ +
Sbjct: 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 184 QPC 186
Sbjct: 180 NRV 182
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.001
Identities = 15/45 (33%), Positives = 21/45 (46%)
Query: 279 EDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323
+ + T+ V T W+R PELL G YG +DLW +
Sbjct: 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 6e-31
Identities = 35/156 (22%), Positives = 66/156 (42%), Gaps = 14/156 (8%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVV 76
+ ++L+ +G G + DV G VA+K + + Q+ E + L N+V
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQ 64
Query: 77 LHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
L E +V E++ + L + RG + + ++ + + ++
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYL-------RSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
N VHRDL N+L+ +D V K++DFG +
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (286), Expect = 2e-30
Identities = 44/194 (22%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 3 QPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSA 58
P W + + +G G Y +VY+G +L VA+K + + +
Sbjct: 6 SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60
Query: 59 FREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGI 118
+E ++ + PN+V L RE ++ +L + E ++ +
Sbjct: 61 LKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------V 112
Query: 119 SVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDA 178
S + QI S ++ + +HRDL N L+G++ ++K+ADFG +R++ G+ + A
Sbjct: 113 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
Query: 179 PDGNSQPCEPNAPY 192
G P + AP
Sbjct: 173 HAGAKFPIKWTAPE 186
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-29
Identities = 38/201 (18%), Positives = 76/201 (37%), Gaps = 32/201 (15%)
Query: 1 MEQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVH-- 53
E W E + +GSGA+ V + ++ VA+K +
Sbjct: 24 REYEYDLKWEFP-----RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 78
Query: 54 ----DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKK 108
+ ++ E++ + L + N+V L L+ E+ DL + ++
Sbjct: 79 ADSSEREALMSELKMMTQLGSHENIVNLLGAC-TLSGPIYLIFEYCCYGDLLNYLRSKRE 137
Query: 109 K--------------REDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLI 154
K E+ ++ ++ + Q+ G++ + VHRDL N+L+
Sbjct: 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 197
Query: 155 GDDGVLKLADFGQARILLGNE 175
V+K+ DFG AR ++ +
Sbjct: 198 THGKVVKICDFGLARDIMSDS 218
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (286), Expect = 1e-29
Identities = 36/197 (18%), Positives = 79/197 (40%), Gaps = 22/197 (11%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQ 69
+ + + +G G + +VY R+ + A+K + A E L ++
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 70 --NSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRW 126
+ P +V + F + +L+ + DL +++ E +++ +
Sbjct: 63 TGDCPFIVCMSYAF-HTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---------DMRFY 112
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPC 186
+I+ G++ H +V+RDLKP N+L+ + G ++++D G A + A G +
Sbjct: 113 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-THGY 171
Query: 187 EPNAPYQDNMSEAPQVD 203
Q ++ D
Sbjct: 172 MAPEVLQKGVAYDSSAD 188
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-29
Identities = 56/160 (35%), Positives = 89/160 (55%), Gaps = 20/160 (12%)
Query: 22 EILECVGSGAYSDVYKGRRLSDNLIVALKEVH----------DYQSAFREIEALQILQNS 71
E L+ +G G ++ VYK R + N IVA+K++ ++A REI+ LQ L +
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SH 59
Query: 72 PNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
PN++ L + + + LV +F+ TDL +I ++ IK +M+ L
Sbjct: 60 PNIIGLLDA-FGHKSNISLVFDFMETDLEVIIKDNSLVLTPS--------HIKAYMLMTL 110
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G++ H++ I+HRDLKP NLL+ ++GVLKLADFG A+
Sbjct: 111 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 150
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 2e-04
Identities = 18/34 (52%), Positives = 25/34 (73%)
Query: 290 TSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323
T V TRW+RAPELL+G+ YG+ VD+W++ L
Sbjct: 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 191
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (278), Expect = 6e-29
Identities = 45/190 (23%), Positives = 86/190 (45%), Gaps = 17/190 (8%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--DYQSAFREIEALQILQNSPNVVVL 77
Y+++ +G G YS+V++ +++N V +K + + REI+ L+ L+ PN++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95
Query: 78 HEYFWREDED-AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
+ LV E + TD + + ++ +I+ +M +IL +D
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYEILKALD 143
Query: 136 ACHRNTIVHRDLKPGNLLIG-DDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAPYQD 194
CH I+HRD+KP N++I + L+L D+G A + S+ + D
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 195 NMSEAPQVDL 204
+D+
Sbjct: 204 YQMYDYSLDM 213
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 6e-29
Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 18/193 (9%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSP 72
KYE LE +G G Y V+K + + IVALK V SA REI L+ L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHK 61
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V LH+ + + ++ + + + + +K ++ Q+L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE---------IVKSFLFQLLK 112
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL-LGNEFDAPDGNSQPCEPNAP 191
G+ CH ++HRDLKP NLLI +G LKLA+FG AR + + + + P
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 192 YQDNMSEAPQVDL 204
+ +D+
Sbjct: 173 LFGAKLYSTSIDM 185
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 7e-29
Identities = 33/189 (17%), Positives = 70/189 (37%), Gaps = 27/189 (14%)
Query: 4 PLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVH----- 53
P W + + +G+GA+ V + + + VA+K +
Sbjct: 13 PYDHKWEFPRN-----RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 54 -DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKRE 111
+ ++ E++ L L N N+V L +++ E+ DL + +
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 112 ---------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162
+ + + + ++ + Q+ G+ +HRDL N+L+ + K+
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI 186
Query: 163 ADFGQARIL 171
DFG AR +
Sbjct: 187 CDFGLARDI 195
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 110 bits (275), Expect = 7e-29
Identities = 56/193 (29%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSP 72
KY LE +G G Y VYK + + ALK++ + REI L+ L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHS 60
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L++ + VLV E L DL ++ D + G+ K +++Q+L+
Sbjct: 61 NIVKLYDVIH-TKKRLVLVFEHLDQDLKKLL--------DVCEGGLESVTAKSFLLQLLN 111
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPC-EPNAP 191
G+ CH ++HRDLKP NLLI +G LK+ADFG AR
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 192 YQDNMSEAPQVDL 204
+ + +D+
Sbjct: 172 LMGSKKYSTTIDI 184
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 9e-29
Identities = 58/159 (36%), Positives = 82/159 (51%), Gaps = 16/159 (10%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSP 72
++ +E +G G Y VYK R +VALK++ +A REI L+ L N P
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHP 61
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
N+V L + + LV EFL DL + + GI + IK ++ Q+L
Sbjct: 62 NIVKLLDV-IHTENKLYLVFEFLHQDLKKFM-------DASALTGIPLPLIKSYLFQLLQ 113
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+ CH + ++HRDLKP NLLI +G +KLADFG AR
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 152
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (274), Expect = 1e-28
Identities = 35/164 (21%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 17 IIA-KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSP 72
++ Y++ +G G++ +++G L +N VA+K D E ++L
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 73 NVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+ ++ + +E VLV++ L L ++ +K + + Q+L+
Sbjct: 62 GIPNVYYFG-QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVK--------TVAMAAKQMLA 112
Query: 133 GVDACHRNTIVHRDLKPGNLLIGD-----DGVLKLADFGQARIL 171
V + H ++V+RD+KP N LIG ++ + DFG +
Sbjct: 113 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-28
Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 22/160 (13%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQILQNSP 72
+ + + +GSG++ VYKG+ D VA+K ++ Q+ E+ L+
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHV 64
Query: 73 NVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQIL 131
N+++ Y +V ++ + L + + K + ++ Q
Sbjct: 65 NILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTA 114
Query: 132 SGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
G+D H +I+HRDLK N+ + +D +K+ DFG A +
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (274), Expect = 1e-28
Identities = 34/158 (21%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNVVV 76
+Y + +GSG++ D+Y G ++ VA+K + E + +++Q +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQG-GVGIP 66
Query: 77 LHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
+ E + V+V+E L L + + R S+ + Q++S ++
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSL--------EDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 137 CHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARIL 171
H +HRD+KP N L+ ++ + DFG A+
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (275), Expect = 1e-28
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 21/162 (12%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------DYQSAFREIEALQILQNSPN 73
Y+ + +G+GA+S+V +VA+K + S EI L + PN
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPN 68
Query: 74 VVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
+V L + + L+++ + +L I E E + R + Q+L
Sbjct: 69 IVALDDIY-ESGGHLYLIMQLVSGGELFDRIVEKGFYTER---------DASRLIFQVLD 118
Query: 133 GVDACHRNTIVHRDLKPGNLLI---GDDGVLKLADFGQARIL 171
V H IVHRDLKP NLL +D + ++DFG +++
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-28
Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 19/163 (11%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQ 69
I + + + +G G++ V+ N A+K + D + E L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
P + + F + E+ V+E+L DL I K +
Sbjct: 61 EHPFLTHMFCTF-QTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---------RATFYAA 110
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+I+ G+ H IV+RDLK N+L+ DG +K+ADFG +
Sbjct: 111 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-28
Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----------DYQSAFREIEALQIL 68
+Y++ +GSG + VY G R+SDNL VA+K V + E+ L+ +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 69 QNS-PNVVVLHEYFWREDEDAVLVLEFL--RTDLATVIAESKKKREDRGDRGISVGEIKR 125
+ V+ L ++F R D VL+LE DL I E +E+ +
Sbjct: 65 SSGFSGVIRLLDWFERPDS-FVLILERPEPVQDLFDFITERGALQEE---------LARS 114
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLI-GDDGVLKLADFGQARILLGNEFDAPDG 181
+ Q+L V CH ++HRD+K N+LI + G LKL DFG +L + DG
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG 171
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (85), Expect = 0.002
Identities = 13/47 (27%), Positives = 18/47 (38%)
Query: 277 DAEDGGDGRQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323
D G + T GTR + PE + +G +WSL L
Sbjct: 154 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 3e-28
Identities = 31/162 (19%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQ 69
+ ++IL +G+G++ V+ R + A+K + + E L I+
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV- 61
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
P ++ + F + +++ +L +++ +S++ K + +
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---------VAKFYAAE 112
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ ++ H I++RDLKP N+L+ +G +K+ DFG A+ +
Sbjct: 113 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 24/165 (14%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPN 73
+ +G G++ VYKG + VA E+ D Q E E L+ LQ+ PN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69
Query: 74 VVVLHEYF---WREDEDAVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
+V ++ + + + VLV E + + L T + K + ++ W Q
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIK---------VLRSWCRQ 120
Query: 130 ILSGVDACHRN--TIVHRDLKPGNLLI-GDDGVLKLADFGQARIL 171
IL G+ H I+HRDLK N+ I G G +K+ D G A +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.1 bits (83), Expect = 0.004
Identities = 10/39 (25%), Positives = 17/39 (43%), Gaps = 2/39 (5%)
Query: 285 RQGALTSCVGTRWFRAPELLYGSTSYGLEVDLWSLAAYL 323
R + +GT F APE+ Y VD+++ +
Sbjct: 166 RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCM 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-27
Identities = 54/171 (31%), Positives = 82/171 (47%), Gaps = 23/171 (13%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEAL 65
T E+ A Y L+ VGSGAY V VA+K+++ + A+RE+ L
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 66 QILQNSPNVVVLHEYFWREDE-----DAVLVLEFLRTDLATVIAESKKKREDRGDRGISV 120
+ + NV+ L + F ++ D LV+ F+ TDL ++ K +
Sbjct: 72 KHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----------LGE 120
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
I+ + Q+L G+ H I+HRDLKPGNL + +D LK+ DFG AR
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (267), Expect = 3e-27
Identities = 33/177 (18%), Positives = 72/177 (40%), Gaps = 19/177 (10%)
Query: 2 EQPLPKSWSIHTRPEI-IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH------- 53
++ K W ++ + +++ ++ +G+G++ V + A+K +
Sbjct: 23 KEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 54 -DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKRED 112
+ E LQ + N P +V L F +++ ++ + + + E
Sbjct: 83 KQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 113 RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169
+ + QI+ + H +++RDLKP NLLI G +++ DFG A+
Sbjct: 142 ---------HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-27
Identities = 32/162 (19%), Positives = 64/162 (39%), Gaps = 18/162 (11%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEALQILQ 69
+ ++ L+ +G G + V R + A+K + + E LQ
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 62
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
P + L F D ++ +L ++ + E+R + + +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER---------ARFYGAE 113
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
I+S ++ H +V+RD+K NL++ DG +K+ DFG +
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 4e-27
Identities = 40/166 (24%), Positives = 71/166 (42%), Gaps = 17/166 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLI--VALKEVHDYQSA------FREIEALQILQNSP 72
+ + +G G + V K R D L A+K + +Y S E+E L L + P
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 73 NVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKRED-------RGDRGISVGEIK 124
N++ L L +E+ +L + +S+ D +S ++
Sbjct: 72 NIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 125 RWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
+ + G+D + +HRDL N+L+G++ V K+ADFG +R
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 176
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 8e-27
Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 14/178 (7%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVV 75
+ +G G + +V+ G + VA+K + ++ +E + ++ L++ +V
Sbjct: 18 SLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLV 75
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
L+ E +V E++ + + + + ++ QI SG+
Sbjct: 76 QLYAVVSEEP--IYIVTEYMSKGS------LLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAPYQ 193
R VHRDL+ N+L+G++ V K+ADFG AR++ NE+ A G P + AP
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-26
Identities = 59/166 (35%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 20 KYEILECVGSGAYSDVYKGR-RLSDNLIVALKEVH-------DYQSAFREIEALQILQ-- 69
+YE + +G GAY V+K R + VALK V S RE+ L+ L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 70 NSPNVVVLHEYFWREDEDA----VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
PNVV L + D LV E + DL T + + + G+ IK
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-------GVPTETIKD 120
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
M Q+L G+D H + +VHRDLKP N+L+ G +KLADFG ARI
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-26
Identities = 34/175 (19%), Positives = 80/175 (45%), Gaps = 19/175 (10%)
Query: 20 KYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVH------DYQSAFREIEALQIL 68
+ ++ + +G GA+ V + + + VA+K + ++++ E++ L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISV 120
+ NVV L + ++++EF + +L+T + + + ED +++
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+ + Q+ G++ +HRDL N+L+ + V+K+ DFG AR + +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (259), Expect = 2e-26
Identities = 40/191 (20%), Positives = 74/191 (38%), Gaps = 22/191 (11%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDN---LIVALKEVH------DYQSAFREIEALQIL 68
I+ +I + +G+G + +V G + VA+K + + E +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
+ PNV+ L + +++ EF+ S + D +V ++ +
Sbjct: 85 DH-PNVIHLEGVVT-KSTPVMIITEFMENG-------SLDSFLRQNDGQFTVIQLVGMLR 135
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFD----APDGNSQ 184
I +G+ VHRDL N+L+ + V K++DFG +R L + D + G
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195
Query: 185 PCEPNAPYQDN 195
P AP
Sbjct: 196 PIRWTAPEAIQ 206
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-26
Identities = 38/166 (22%), Positives = 67/166 (40%), Gaps = 21/166 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDN---LIVALKEVH--------DYQSAFREIEALQILQ 69
+LE +G G++ V +G + + + VA+K + RE+ A+ L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL- 68
Query: 70 NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
+ N++ L+ +V E S R + +G + R+ VQ
Sbjct: 69 DHRNLIRLYGVV--LTPPMKMVTELAPLG-------SLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+ G+ +HRDL NLL+ ++K+ DFG R L N+
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 103 bits (257), Expect = 4e-26
Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 29/190 (15%)
Query: 20 KYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVH-----DYQSAF-REIEALQIL 68
E + +G GA+ V++ R +VA+K + D Q+ F RE +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVI---------------AESKKKRED 112
N V +L + L+ E++ DL + ++ +
Sbjct: 74 DNPNIVKLL--GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 113 RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172
G +S E Q+ +G+ VHRDL N L+G++ V+K+ADFG +R +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 173 GNEFDAPDGN 182
++ DGN
Sbjct: 192 SADYYKADGN 201
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 6e-26
Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 12/157 (7%)
Query: 18 IAK-YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--DYQSAFREIEALQILQ-NSPN 73
IA+ + E +G G + +V++G+ VA+K + +S FRE E Q + N
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHEN 58
Query: 74 VVVLHEYFWREDEDAV---LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQ 129
++ +++ LV ++ L + ++ G +++
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHL 116
Query: 130 ILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166
+ V + I HRDLK N+L+ +G +AD G
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 7e-26
Identities = 33/175 (18%), Positives = 68/175 (38%), Gaps = 14/175 (8%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVVV 76
L+ +G+G + V G+ VA+K + E + + L + +V
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQ 63
Query: 77 LHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
L+ + ++ E++ + R ++ + ++
Sbjct: 64 LYGVCT-KQRPIFIITEYMANGCLLNYLREMRHR-------FQTQQLLEMCKDVCEAMEY 115
Query: 137 CHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAP 191
+HRDL N L+ D GV+K++DFG +R +L +E+ + G+ P + P
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 8e-26
Identities = 42/195 (21%), Positives = 93/195 (47%), Gaps = 21/195 (10%)
Query: 18 IAKYEILECVGSGAYSDVYKGRRLSDNL---IVALKEVH---------DYQSAFREIEAL 65
I +E+L+ +G+GAY V+ R++S + + A+K + + E + L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 66 QILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
+ ++ SP +V LH F E + +++ +L T +++ ++ E E++
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH---------EVQI 133
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQP 185
++ +I+ ++ H+ I++RD+K N+L+ +G + L DFG ++ + +E +
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 186 CEPNAPYQDNMSEAP 200
E AP ++
Sbjct: 194 IEYMAPDIVRGGDSG 208
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 1e-25
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 17 IIAKYEILECVGSGAYSDVYKG--RRLSDNLIVALKEVH------DYQSAFREIEALQIL 68
+IA E+ G G + V +G R + VA+K + D + RE + + L
Sbjct: 11 LIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWM 127
N P +V L + E +LV+E L + +++ I V + +
Sbjct: 67 DN-PYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELL 115
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
Q+ G+ VHRDL N+L+ + K++DFG ++ L ++
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 3e-25
Identities = 31/161 (19%), Positives = 65/161 (40%), Gaps = 19/161 (11%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDN---LIVALKEVHDYQS------AFREIEALQILQN 70
+ E+ C+G G + DV++G +S L VA+K + S +E ++ +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-D 66
Query: 71 SPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
P++V L + +++E + + + + + Q+
Sbjct: 67 HPHIVKLIGVI--TENPVWIIMELCTLG-------ELRSFLQVRKYSLDLASLILYAYQL 117
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ + VHRD+ N+L+ + +KL DFG +R +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 3e-25
Identities = 36/191 (18%), Positives = 77/191 (40%), Gaps = 27/191 (14%)
Query: 2 EQPLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGR-------RLSDNLIVALKEVH- 53
E P W + + + + +G GA+ V + + VA+K +
Sbjct: 1 ELPEDPRWELPRD-----RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 55
Query: 54 -----DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESK 107
D E+E ++++ N++ L +D +++E+ + +L + +
Sbjct: 56 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARR 114
Query: 108 KKRED-------RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVL 160
+ + +S ++ Q+ G++ +HRDL N+L+ +D V+
Sbjct: 115 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 174
Query: 161 KLADFGQARIL 171
K+ADFG AR +
Sbjct: 175 KIADFGLARDI 185
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 4e-25
Identities = 37/175 (21%), Positives = 71/175 (40%), Gaps = 14/175 (8%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVVV 76
++ +GSG + V+ G + VA+K + + E E + L + P +V
Sbjct: 7 LTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQ 64
Query: 77 LHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDA 136
L+ E LV EF+ + + + + G+
Sbjct: 65 LYGVCL-EQAPICLVFEFMEHG-------CLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 116
Query: 137 CHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAP 191
++HRDL N L+G++ V+K++DFG R +L +++ + G P + +P
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 100 bits (249), Expect = 4e-25
Identities = 43/207 (20%), Positives = 79/207 (38%), Gaps = 25/207 (12%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH--------DYQSAFREIEA 64
T + +YE+ E +G G S+V+ R L + VA+K + Y RE +
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 65 LQILQNSPNVVVLHEYFWREDEDAV---LVLEFLR-TDLATVIAESKKKREDRGDRGISV 120
L N P +V +++ E +V+E++ L ++
Sbjct: 61 AAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-------- 111
Query: 121 GEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPD 180
+ ++ H+N I+HRD+KP N++I +K+ DFG AR + +
Sbjct: 112 -RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 181 GNSQPCEPN--APYQDNMSEA-PQVDL 204
+ +P Q + D+
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDV 197
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 4e-25
Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 20/165 (12%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDN----LIVALKEVHDYQSA------FREIEALQILQN 70
++ ++ +GSGA+ VYKG + + + VA+KE+ + S E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 69
Query: 71 SPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
+P+V L L+ + + I + W VQI
Sbjct: 70 NPHVCRLLGIC--LTSTVQLITQLMPFG-------CLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
G++ +VHRDL N+L+ +K+ DFG A++L E
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 4e-25
Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 27/168 (16%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----------DYQSAFREIEALQIL 68
Y+ E +GSG ++ V K R S L A K + + RE+ L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFLRTD-LATVIAESKKKREDRGDRGISVGEIKRWM 127
PNV+ LHE + D +L+LE + L +AE + E+ ++
Sbjct: 71 -QHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEE---------ATEFL 119
Query: 128 VQILSGVDACHRNTIVHRDLKPGNLLIGDDGV----LKLADFGQARIL 171
QIL+GV H I H DLKP N+++ D V +K+ DFG A +
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 9e-25
Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 14/162 (8%)
Query: 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEALQIL 68
++ +Y+ L+ +GSGA V + VA+K++ + A+RE+ ++ +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMV 128
N N++ L F + +L +L + + +
Sbjct: 74 -NHKNIISLLNVFTPQKTLEEFQDVYLVMELM------DANLCQVIQMELDHERMSYLLY 126
Query: 129 QILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170
Q+L G+ H I+HRDLKP N+++ D LK+ DFG AR
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-24
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 13/166 (7%)
Query: 13 TRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-------DYQSAFREIEAL 65
T E+ +Y+ L VGSGAY V L VA+K++ + +RE+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 66 QILQNSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
+ + NV+ L + F +L T L + K + ++ ++
Sbjct: 72 KHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQF 125
Query: 126 WMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
+ QIL G+ H I+HRDLKP NL + +D LK+ DFG AR
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 5e-23
Identities = 37/177 (20%), Positives = 72/177 (40%), Gaps = 17/177 (9%)
Query: 25 ECVGSGAYSDVYKGRRLSDN---LIVALKEVH------DYQSAFREIEALQILQNSPNVV 75
E +G G + VY G L ++ + A+K ++ + E ++ + PNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 91
Query: 76 VLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVD 135
L R + ++VL +++ + +V ++ + +Q+ G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 136 ACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNEFDAPDGNSQPCEPNAPY 192
VHRDL N ++ + +K+ADFG AR + EFD+ + P
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 1e-22
Identities = 33/165 (20%), Positives = 68/165 (41%), Gaps = 19/165 (11%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDN----LIVALKEVH------DYQSAFREIEALQILQN 70
+ +G+G + +VYKG + + + VA+K + E + +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 71 SPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQI 130
N++ L + + +++ E++ + K D SV ++ + I
Sbjct: 69 -HNIIRLEGVIS-KYKPMMIITEYMENG-------ALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 131 LSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+G+ VHRDL N+L+ + V K++DFG +R+L +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 2e-22
Identities = 35/169 (20%), Positives = 71/169 (42%), Gaps = 15/169 (8%)
Query: 20 KYEILECVGSGAYSDVYKGR-----RLSDNLIVALKEVH------DYQSAFREIEALQIL 68
K + +G G++ VY+G + VA+K V+ + E ++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 69 QNSPNVVVLHEYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRG-ISVGEIKRW 126
N +VV L + ++++E + R DL + + + + S+ ++ +
Sbjct: 81 -NCHHVVRLLGVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 127 MVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGNE 175
+I G+ + N VHRDL N ++ +D +K+ DFG R + +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.3 bits (226), Expect = 5e-22
Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 22/157 (14%)
Query: 28 GSGAYSDVYKG--RRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLH 78
GSG + V KG + VA+K + + E +Q L N P +V +
Sbjct: 16 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMI 74
Query: 79 EYFWREDEDAVLVLEFL-RTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDAC 137
E +LV+E L + +++ ++ I + Q+ G+
Sbjct: 75 GICEAESW--MLVMEMAELGPLNKYLQQNRHVKDK---------NIIELVHQVSMGMKYL 123
Query: 138 HRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILLGN 174
+ VHRDL N+L+ K++DFG ++ L +
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.4 bits (202), Expect = 3e-18
Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 25/173 (14%)
Query: 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQ------ 69
+Y ++ +G G +S V+ + + +N VA+K V ++A EI+ LQ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 70 ----NSPNVVVLHEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKR 125
+ +++ L ++F + + V V+ ++A KK RGI + +K+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQ 129
Query: 126 WMVQILSGVD-ACHRNTIVHRDLKPGNLLIGDDGV------LKLADFGQARIL 171
Q+L G+D R I+H D+KP N+L+ +K+AD G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 75.6 bits (185), Expect = 6e-17
Identities = 27/159 (16%), Positives = 56/159 (35%), Gaps = 16/159 (10%)
Query: 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEY 80
I + +G G S V+ +K ++F++++ + + V+
Sbjct: 2 DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 81 FWRE--------DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILS 132
E V + + + ++K+ R V + IL
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMILE 114
Query: 133 GVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171
V + IVH DL N+L+ ++G+ + DF Q+ +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 326 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.18 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.59 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=319.60 Aligned_cols=145 Identities=30% Similarity=0.446 Sum_probs=128.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
+.++|++.+.||+|+||+||+|.++.+++.||||.++. ...+.+|+.+++++ +||||+++++++ .+.+..|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~-~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHR-REGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEE-EETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeee-ccCceeEE
Confidence 46789999999999999999999999999999998752 34578899999999 699999999999 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 81 vmEy~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp EEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhhe
Confidence 999997 58887775432 29999999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 170 ILL 172 (326)
Q Consensus 170 ~~~ 172 (326)
.+.
T Consensus 152 ~~~ 154 (271)
T d1nvra_ 152 VFR 154 (271)
T ss_dssp ECE
T ss_pred eec
Confidence 753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=311.15 Aligned_cols=143 Identities=29% Similarity=0.547 Sum_probs=129.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.+.||+|+||+||+|.++.+++.||+|.+.. ...+.+|+++++.+ +||||+++++++ .+.+..+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~-~~~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYF-HDATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEE-ECSSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEE-EECCEEE
Confidence 5789999999999999999999999999999998752 34567899999999 699999999999 6677899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 83 ivmEy~~~g~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a 153 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 153 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred EEEeecCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeeccccee
Confidence 9999998 698888876433 999999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 154 ~~~ 156 (263)
T d2j4za1 154 VHA 156 (263)
T ss_dssp SCC
T ss_pred eec
Confidence 654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-44 Score=315.41 Aligned_cols=144 Identities=28% Similarity=0.487 Sum_probs=128.7
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc-----chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH-----DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~-----~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
+..++|++.++||+|+||+||+|.+..+++.||||.+. ..+.+.+|+.+++.+ +||||+++++++ ...+.+|+
T Consensus 17 dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~-~~~~~~~i 94 (293)
T d1yhwa1 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSY-LVGDELWV 94 (293)
T ss_dssp CTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-EETTEEEE
T ss_pred CcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEE-EECCEEEE
Confidence 44678999999999999999999999999999999875 234578999999999 699999999999 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 95 vmEy~~gg~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEECCTTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 999998 5877765432 28999999999999999999999999999999999999999999999999998
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
.+
T Consensus 165 ~~ 166 (293)
T d1yhwa1 165 QI 166 (293)
T ss_dssp EC
T ss_pred ee
Confidence 65
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=312.86 Aligned_cols=144 Identities=26% Similarity=0.430 Sum_probs=129.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.+.||+|+||+||+|.+..+++.||||.+.. ...+.+|+++++++ +||||+++++++ .+.+.+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~-~~~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTF-QDDEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEE-ECSSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEE-EECCEEE
Confidence 4689999999999999999999999999999998852 23577899999999 699999999999 6667899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++..... +++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++
T Consensus 85 ivmEy~~gg~L~~~~~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEccCCCCHHHhhhccCC---------CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccc
Confidence 9999998 688888776543 999999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 169 RILL 172 (326)
Q Consensus 169 ~~~~ 172 (326)
+.+.
T Consensus 156 ~~~~ 159 (288)
T d1uu3a_ 156 KVLS 159 (288)
T ss_dssp EECC
T ss_pred eecc
Confidence 8763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-43 Score=309.60 Aligned_cols=157 Identities=25% Similarity=0.483 Sum_probs=136.5
Q ss_pred CCCCCCCC--ccccCccccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCe
Q 020467 1 MEQPLPKS--WSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNV 74 (326)
Q Consensus 1 ~~~~~p~~--~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni 74 (326)
|+++.|.- |.+. .++|++.+.||+|+||+||+|.+..+++.||||.++. .+.+.+|+++++++ +||||
T Consensus 2 ~~p~~p~~~~wei~-----~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnI 75 (287)
T d1opja_ 2 MDPSSPNYDKWEME-----RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNL 75 (287)
T ss_dssp CCTTSTTCCTTBCC-----GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTB
T ss_pred cCCCCCCCcccEec-----HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCE
Confidence 66666642 4332 5789999999999999999999999999999999853 45678999999999 69999
Q ss_pred eEEeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 020467 75 VVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLL 153 (326)
Q Consensus 75 ~~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nil 153 (326)
+++++++ .+.+..+++|||+. |+|.+++..... ..+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 76 v~~~~~~-~~~~~~~iv~E~~~~g~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NIL 147 (287)
T d1opja_ 76 VQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 147 (287)
T ss_dssp CCEEEEE-CSSSSCEEEEECCTTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCccE-eeCCeeEEEeecccCcchHHHhhhccc-------cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEE
Confidence 9999998 66778999999998 688888765432 23899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEeecccccc
Q 020467 154 IGDDGVLKLADFGQARIL 171 (326)
Q Consensus 154 i~~~~~~~l~Dfg~~~~~ 171 (326)
++.++.+||+|||+++..
T Consensus 148 l~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 148 VGENHLVKVADFGLSRLM 165 (287)
T ss_dssp ECGGGCEEECCCCCTTTC
T ss_pred ECCCCcEEEccccceeec
Confidence 999999999999998765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=313.88 Aligned_cols=143 Identities=22% Similarity=0.377 Sum_probs=129.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++++.||+|+||.||+|+++.+++.||||+++. ...+.+|+.+++++ +||||+++++++ .+...+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~-~~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAF-QTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEE-ECSSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeee-ccccccc
Confidence 5789999999999999999999999999999999852 34467899999998 699999999999 6677899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++
T Consensus 82 iv~ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a 152 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cceeccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccc
Confidence 9999998 688888776443 899999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
+..
T Consensus 153 ~~~ 155 (337)
T d1o6la_ 153 KEG 155 (337)
T ss_dssp BCS
T ss_pred ccc
Confidence 765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=318.78 Aligned_cols=144 Identities=26% Similarity=0.441 Sum_probs=128.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
..++|++.++||+|+||+||+|.+..+++.||+|.++. ...+.+|+.+++.+ +||||++++++| .+...+++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~-~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAF-YSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEE-ECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE-EECCEEEE
Confidence 35789999999999999999999999999999998752 24567899999998 699999999999 56678999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
||||+. ++|.+++..... +++..+..++.|++.||.|||+ +||+||||||+||||+.++.++|+|||++
T Consensus 82 VmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp EEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 999998 588888875433 8999999999999999999997 59999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
..+
T Consensus 153 ~~~ 155 (322)
T d1s9ja_ 153 GQL 155 (322)
T ss_dssp HHH
T ss_pred ccc
Confidence 765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=307.97 Aligned_cols=148 Identities=35% Similarity=0.564 Sum_probs=122.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE-DEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~~ 89 (326)
.++|++.+.||+|+||+||+|.++.+++.||+|.+.. ...+.+|+++++++ +||||+++++++... .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 5789999999999999999999999999999998853 23467889999888 699999999998543 45689
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCeEEcCCCcEEEE
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT-----IVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~-----iiH~dlkp~Nili~~~~~~~l~ 163 (326)
++|||+. ++|.+++....... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.++|+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKER-----QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 9999997 69999886544321 23999999999999999999999865 9999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++..+
T Consensus 157 DFG~a~~~ 164 (269)
T d2java1 157 DFGLARIL 164 (269)
T ss_dssp CHHHHHHC
T ss_pred eccceeec
Confidence 99999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-42 Score=314.14 Aligned_cols=147 Identities=31% Similarity=0.504 Sum_probs=130.0
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++.++|++.+.||+|+||.||+|.+..+++.||||++.. ...+.+|+.+++++ +||||+++++++ .+.+.+|
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~-~~~~~~~ 99 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAF-EDDNEMV 99 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEE-EETTEEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEE-EECCEEE
Confidence 3678999999999999999999999999999999998853 34567899999999 699999999999 5677899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC--CCcEEEEeec
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD--DGVLKLADFG 166 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~--~~~~~l~Dfg 166 (326)
++|||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||
T Consensus 100 ivmE~~~gg~L~~~l~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEH--------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEECCCCSCBHHHHHTCTT--------SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecc
Confidence 9999997 68888875432 23899999999999999999999999999999999999964 5789999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 172 ~a~~~ 176 (350)
T d1koaa2 172 LTAHL 176 (350)
T ss_dssp TCEEC
T ss_pred hheec
Confidence 98765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-43 Score=308.45 Aligned_cols=145 Identities=31% Similarity=0.484 Sum_probs=128.8
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
..+.|++++.||+|+||.||+|.+..+++.||+|.+.. ...+.+|+++++.+ +||||+++++++ ...+..+++
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~-~~~~~~~lv 87 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAF-YYENNLWIL 87 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEE-EETTEEEEE
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-eeCCeEEEE
Confidence 35679999999999999999999999999999998842 35678999999999 699999999999 566789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
|||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 88 mEy~~~g~L~~~~~~~~--------~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELE--------RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EECCTTEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhc
Confidence 99998 57877765432 2389999999999999999999999999999999999999999999999999875
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 160 ~ 160 (288)
T d2jfla1 160 N 160 (288)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-42 Score=309.16 Aligned_cols=145 Identities=28% Similarity=0.502 Sum_probs=125.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
+.+.|++++.||+|+||+||+|.+..+++.||||.++. ...+.+|+.+++++ +||||+++++++ .+.+..
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~-~~~~~~ 90 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCY-LREHTA 90 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-EETTEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEE-EECCEE
Confidence 44569999999999999999999999999999998752 23467899999999 699999999998 556789
Q ss_pred EEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 89 VLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 89 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
|++|||+.+++.+.+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 91 ~iv~E~~~~g~l~~~~~~~--------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHK--------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp EEEEECCSEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred EEEEEecCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccc
Confidence 9999999865555443322 23999999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 163 ~~~ 165 (309)
T d1u5ra_ 163 SIM 165 (309)
T ss_dssp BSS
T ss_pred ccc
Confidence 654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-42 Score=309.64 Aligned_cols=146 Identities=29% Similarity=0.464 Sum_probs=123.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++.++|++.+.||+|+||+||+|.++.+++.||||.+.. ...+.+|+.+++.+ +||||+++++++ .+.+.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~-~~~~~~ 82 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIY-ESGGHL 82 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEE-ECSSEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEE-EECCEE
Confidence 4678889999999999999999999999999999998852 23456899999999 699999999999 667789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc---CCCcEEEEe
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG---DDGVLKLAD 164 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~---~~~~~~l~D 164 (326)
|++|||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+||++. .++.++|+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEec
Confidence 99999998 79999886533 299999999999999999999999999999999999995 478999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 154 FG~a~~~ 160 (307)
T d1a06a_ 154 FGLSKME 160 (307)
T ss_dssp C------
T ss_pred cceeEEc
Confidence 9998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-42 Score=307.47 Aligned_cols=143 Identities=22% Similarity=0.457 Sum_probs=126.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++++.||+|+||+||+|.++.+++.||||+++. ...+.+|+.+++.+ +||||+++++++ .+....|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~-~~~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTF-QDAQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEE-ECSSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeE-eeCCeee
Confidence 4689999999999999999999999999999999852 34567899999998 699999999999 6677899
Q ss_pred EEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|||+.+ ++...+..... +++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 81 ivmE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEeeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccc
Confidence 99999984 66666654432 888999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 152 ~~~ 154 (316)
T d1fota_ 152 KYV 154 (316)
T ss_dssp EEC
T ss_pred eEe
Confidence 765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-42 Score=310.04 Aligned_cols=143 Identities=23% Similarity=0.426 Sum_probs=128.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++++.||+|+||.||+|.++.+++.||||.+.. ...+.+|+.+++.+ +||||+++++++ ......+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~-~~~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSF-KDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEE-ECSSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccc-ccccccc
Confidence 5899999999999999999999999999999998852 23467899999998 699999999999 6667789
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
++|+|+. ++|...+..... +++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred cccccccccchhhhHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceee
Confidence 9999997 688887765433 999999999999999999999999999999999999999999999999999
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
+.+
T Consensus 189 ~~~ 191 (350)
T d1rdqe_ 189 KRV 191 (350)
T ss_dssp EEC
T ss_pred eec
Confidence 765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.4e-42 Score=311.23 Aligned_cols=146 Identities=31% Similarity=0.490 Sum_probs=129.2
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.+.++|++++.||+|+||.||+|.+..+++.||||.++. ...+.+|+.+++++ +||||++++++| .+...+|+
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~-~~~~~~~i 103 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAF-EDKYEMVL 103 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEE-ECSSEEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEE-EECCEEEE
Confidence 577899999999999999999999999999999998853 33567899999999 699999999999 66778999
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc--CCCcEEEEeecc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIG--DDGVLKLADFGQ 167 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~--~~~~~~l~Dfg~ 167 (326)
+|||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.||+||||||+|||++ .++.++|+|||+
T Consensus 104 vmE~~~gg~L~~~~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEECCCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEcCCCChHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccc
Confidence 999998 68877664432 2389999999999999999999999999999999999998 578999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
+..+
T Consensus 176 a~~~ 179 (352)
T d1koba_ 176 ATKL 179 (352)
T ss_dssp CEEC
T ss_pred ceec
Confidence 9876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=299.50 Aligned_cols=146 Identities=33% Similarity=0.500 Sum_probs=130.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEe
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------YQSAFREIEALQILQNSPNVVVLHEYFWR 83 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~ 83 (326)
..+.++|++.+.||+|+||+||+|.+..+++.||||.++. ...+.+|+.+++++ +||||+++++++ .
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~-~ 83 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVY-E 83 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE-E
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEE-E
Confidence 3577899999999999999999999999999999998742 34578999999999 699999999999 6
Q ss_pred cCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----
Q 020467 84 EDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG---- 158 (326)
Q Consensus 84 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~---- 158 (326)
+.+.+|++|||+. ++|.+++..... +++..+..++.|++.||.|||+.+|+||||||+||+++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~~---------l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSC
T ss_pred ECCEEEEEEEcCCCccccchhccccc---------cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCccc
Confidence 6778999999997 699888876433 99999999999999999999999999999999999998776
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.++++|||++...
T Consensus 155 ~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 155 RIKIIDFGLAHKI 167 (293)
T ss_dssp CEEECCCTTCEEC
T ss_pred ceEecchhhhhhc
Confidence 5999999998765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=302.18 Aligned_cols=144 Identities=26% Similarity=0.444 Sum_probs=127.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.+.||+|+||+||+|.++.+++.||||+++. ......|..++.+..+||||+++++++ .+.+..|
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-~~~~~~y 79 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-QTKENLF 79 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-ECSSEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-ccCCcee
Confidence 3789999999999999999999999999999999852 224567777776544799999999999 6677899
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccc
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQA 168 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~ 168 (326)
+||||+. ++|.+++..... +++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++
T Consensus 80 ivmEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchh
Confidence 9999998 699888876443 899999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 151 ~~~ 153 (320)
T d1xjda_ 151 KEN 153 (320)
T ss_dssp BCC
T ss_pred hhc
Confidence 764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.6e-41 Score=307.23 Aligned_cols=144 Identities=22% Similarity=0.470 Sum_probs=124.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHh--cCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQ--NSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++.++||+|+||.||+|.+..+++.||||.+.. .....+|...+..+. +||||+++++++ ...+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-~~~~~ 81 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-HTPDK 81 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-ECSSE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-EECCE
Confidence 5789999999999999999999999999999999852 222345544444443 599999999999 66678
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
+|++|||+. ++|.+++..... +++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFG 152 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 152 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred EEEEEEecCCCcHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeec
Confidence 999999998 799888876543 8899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++..+
T Consensus 153 la~~~ 157 (364)
T d1omwa3 153 LACDF 157 (364)
T ss_dssp TCEEC
T ss_pred eeeec
Confidence 98765
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=295.94 Aligned_cols=143 Identities=31% Similarity=0.483 Sum_probs=123.3
Q ss_pred cCe-EEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec---CCc
Q 020467 19 AKY-EILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE---DED 87 (326)
Q Consensus 19 ~~y-~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~---~~~ 87 (326)
++| ++.++||+|+||+||+|.+..+++.||+|.+.. ...+.+|+++++++ +||||+++++++... ...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCE
Confidence 455 678899999999999999999999999998753 23467899999999 699999999998542 345
Q ss_pred eEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEc-CCCcEEEE
Q 020467 88 AVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNT--IVHRDLKPGNLLIG-DDGVLKLA 163 (326)
Q Consensus 88 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--iiH~dlkp~Nili~-~~~~~~l~ 163 (326)
++++|||+. ++|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++ .++.++|+
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHhcccc---------ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 899999997 688888865433 899999999999999999999998 99999999999997 57899999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 158 DFGla~~~ 165 (270)
T d1t4ha_ 158 DLGLATLK 165 (270)
T ss_dssp CTTGGGGC
T ss_pred ecCcceec
Confidence 99998653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=305.74 Aligned_cols=150 Identities=27% Similarity=0.370 Sum_probs=131.6
Q ss_pred cccccCeEEEe-eeccccCcEEEEEEEcCCCeEEEEEEccchhhHHHHHHHHHHHhcCCCeeEEeEEEEe---cCCceEE
Q 020467 15 PEIIAKYEILE-CVGSGAYSDVYKGRRLSDNLIVALKEVHDYQSAFREIEALQILQNSPNVVVLHEYFWR---EDEDAVL 90 (326)
Q Consensus 15 ~~~~~~y~i~~-~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~---~~~~~~l 90 (326)
..+.++|.+.+ .||+|+||+||+|.+..+++.||||.++......+|+.++.++.+||||++++++|.. ....+|+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 35789999875 5999999999999999999999999999888899999998877689999999999843 2356899
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEEeec
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DGVLKLADFG 166 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~~~~l~Dfg 166 (326)
+|||+. |+|.+++..... ..+++..+..++.||+.||.|||+.||+||||||+|||++. .+.++|+|||
T Consensus 87 vmEy~~gg~L~~~i~~~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEECCCSEEHHHHHHSCSC-------CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEECCCCCcHHHHHHhcCC-------CCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 999997 699999875322 23899999999999999999999999999999999999985 4579999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 160 ~a~~~ 164 (335)
T d2ozaa1 160 FAKET 164 (335)
T ss_dssp TCEEC
T ss_pred eeeec
Confidence 99765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-40 Score=292.62 Aligned_cols=145 Identities=29% Similarity=0.442 Sum_probs=131.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------------hhhHHHHHHHHHHHhcCCCeeEEeEEEE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------------YQSAFREIEALQILQNSPNVVVLHEYFW 82 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------------~~~~~~E~~~l~~l~~h~ni~~l~~~~~ 82 (326)
+.++|++.+.||+|+||+||+|++..+++.||||+++. ...+.+|+.+++++..||||+++++++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 79 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 79 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec-
Confidence 35799999999999999999999999999999999752 124678999999996699999999999
Q ss_pred ecCCceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 020467 83 REDEDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 83 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 161 (326)
.+.+..|++|||+. ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.++
T Consensus 80 ~~~~~~~ivmE~~~~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~k 150 (277)
T d1phka_ 80 ETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 150 (277)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred ccCcceEEEEEcCCCchHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeE
Confidence 66778999999997 699999876433 99999999999999999999999999999999999999999999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++..+
T Consensus 151 l~DFG~a~~~ 160 (277)
T d1phka_ 151 LTDFGFSCQL 160 (277)
T ss_dssp ECCCTTCEEC
T ss_pred EccchheeEc
Confidence 9999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=294.44 Aligned_cols=142 Identities=25% Similarity=0.420 Sum_probs=122.5
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
++|++.+.||+|+||+||+|.+. ++..||||.++. ...+.+|+++++++ +||||+++++++ ...+..+++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~-~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC-LEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-CSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCccccccee-ccCCceEEEEEe
Confidence 57999999999999999999875 567899999863 45678999999999 699999999999 666789999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+. ++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp CTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred cCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence 98 688888765432 2889999999999999999999999999999999999999999999999998765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-41 Score=294.42 Aligned_cols=147 Identities=27% Similarity=0.407 Sum_probs=128.6
Q ss_pred cccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 15 PEIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 15 ~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
..+.++|++.+.||+|+||.||+|.+..+++.||||.++. ...+.+|+++++.+ +||||+++++++.....
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP 81 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccC
Confidence 4577899999999999999999999999999999999852 23467899999888 69999999999855432
Q ss_pred ---ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 020467 87 ---DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 87 ---~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l 162 (326)
..|++|||+. ++|.+.+..... +++..+..++.||+.||.|||+.||+||||||+|||++.++..++
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEE
T ss_pred CCceEEEEEECCCCCEehhhhcccCC---------CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccccee
Confidence 3789999998 578777665433 899999999999999999999999999999999999999999999
Q ss_pred Eeecccccc
Q 020467 163 ADFGQARIL 171 (326)
Q Consensus 163 ~Dfg~~~~~ 171 (326)
+|||++...
T Consensus 153 ~d~~~~~~~ 161 (277)
T d1o6ya_ 153 MDFGIARAI 161 (277)
T ss_dssp CCCTTCEEC
T ss_pred ehhhhhhhh
Confidence 999988654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=299.61 Aligned_cols=139 Identities=40% Similarity=0.693 Sum_probs=121.2
Q ss_pred EEeeeccccCcEEEEEEEcCCCeEEEEEEccc----------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEe
Q 020467 23 ILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVL 92 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~ 92 (326)
.+++||+|+||+||+|.+..+++.||||+++. ...+.+|+.+++.+ +||||+++++++ ...+..+++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~-~~~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAF-GHKSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEE-CCTTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeee-ccCCceeehh
Confidence 46899999999999999999999999998852 23567899999999 699999999999 6677899999
Q ss_pred eecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 93 EFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 93 e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
||+.+++...+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 80 E~~~~~~~~~~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNS--------LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp ECCSEEHHHHHTTCC--------SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred hhhcchHHhhhhhcc--------cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCcccccc
Confidence 999977665554322 23888999999999999999999999999999999999999999999999998765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=294.47 Aligned_cols=145 Identities=34% Similarity=0.537 Sum_probs=125.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------hhhHHHHHHHHHHHh-cCCCeeEEeEEEEec
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------YQSAFREIEALQILQ-NSPNVVVLHEYFWRE 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------~~~~~~E~~~l~~l~-~h~ni~~l~~~~~~~ 84 (326)
+.++|++.+.||+|+||.||+|.+..+++.||||.+.. ...+.+|+.+++++. .|+||+++++++ ..
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~-~~ 80 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-ER 80 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-EC
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-ee
Confidence 46789999999999999999999999999999998752 123568999999985 389999999999 66
Q ss_pred CCceEEEeeecc--cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEE
Q 020467 85 DEDAVLVLEFLR--TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-DGVLK 161 (326)
Q Consensus 85 ~~~~~lv~e~~~--~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-~~~~~ 161 (326)
.+..+++|||+. +++.+++..... +++..+..++.||+.||.|||+.+|+||||||+|||++. ++.++
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vk 151 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 151 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEE
Confidence 778999999986 466666655432 999999999999999999999999999999999999985 47999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 152 l~DFG~a~~~ 161 (273)
T d1xwsa_ 152 LIDFGSGALL 161 (273)
T ss_dssp ECCCTTCEEC
T ss_pred ECccccceec
Confidence 9999998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-41 Score=297.23 Aligned_cols=145 Identities=41% Similarity=0.686 Sum_probs=129.4
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.++|++++.||+|+||+||+|.+..+++.||||+++. ...+.+|+++++++ +||||+++++++ .+...+++
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~-~~~~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVI-HTENKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEE-EETTEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEecccc-ccccceeE
Confidence 3789999999999999999999999999999999842 34577899999998 699999999999 66778999
Q ss_pred EeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 91 VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 91 v~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+|||+.+++...+..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..
T Consensus 79 v~e~~~~~~~~~~~~~~~-------~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 151 (298)
T ss_dssp EEECCSEEHHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred EEeecCCchhhhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCccee
Confidence 999999887777654432 2399999999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 152 ~ 152 (298)
T d1gz8a_ 152 F 152 (298)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=292.64 Aligned_cols=144 Identities=22% Similarity=0.407 Sum_probs=125.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.+.||+|+||.||+|.+. ++..||||.++. ...+.+|+.+++++ +||||+++++++ .+ +..+++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~-~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVV-TQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-CS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeee-cc-CCeEEEEE
Confidence 478999999999999999999875 578899999863 44578999999999 699999999987 43 45799999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 172 (326)
|+. ++|.+++....... +++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 88 y~~~g~L~~~~~~~~~~~-------l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp CCTTCBHHHHTTSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred eCCCCcHHHHHhhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 998 68877665443322 8999999999999999999999999999999999999999999999999998763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=299.36 Aligned_cols=146 Identities=29% Similarity=0.415 Sum_probs=129.4
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++.++|++.+.||+|+||+||+|.++.+++.||+|.++. ...+.+|+++++.+ +||||++++++| .+.+.+|++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~-~~~~~~~lv 79 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESF-ESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEE-EETTEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEE-EECCEEEEE
Confidence 578999999999999999999999999999999999863 33467899999999 699999999999 566789999
Q ss_pred eeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC--CcEEEEeeccc
Q 020467 92 LEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD--GVLKLADFGQA 168 (326)
Q Consensus 92 ~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~--~~~~l~Dfg~~ 168 (326)
|||+. ++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+ ..++|+|||++
T Consensus 80 mE~~~gg~L~~~i~~~~--------~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchh
Confidence 99998 58988886532 128999999999999999999999999999999999999854 48999999998
Q ss_pred ccc
Q 020467 169 RIL 171 (326)
Q Consensus 169 ~~~ 171 (326)
...
T Consensus 152 ~~~ 154 (321)
T d1tkia_ 152 RQL 154 (321)
T ss_dssp EEC
T ss_pred hcc
Confidence 765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-40 Score=296.79 Aligned_cols=153 Identities=24% Similarity=0.359 Sum_probs=127.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCC-----eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDN-----LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~-----~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.++||+|+||+||+|.+..++ ..||+|.+.. ...+.+|+.++.++.+||||+++++++ ...+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-TLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-eeCC
Confidence 478999999999999999999876543 3689998742 345678999999997799999999999 6677
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh--------------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR--------------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGN 151 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~--------------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~N 151 (326)
..+++|||+. ++|.+++....... .......+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 8999999997 79999986543210 01112348999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEEeecccccc
Q 020467 152 LLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 152 ili~~~~~~~l~Dfg~~~~~ 171 (326)
|+++.++.++|+|||+++..
T Consensus 195 ill~~~~~~Kl~DFGla~~~ 214 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDI 214 (325)
T ss_dssp EEEETTTEEEECCCGGGSCG
T ss_pred cccccCCeEEEeeccccccc
Confidence 99999999999999999765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-40 Score=294.99 Aligned_cols=145 Identities=23% Similarity=0.404 Sum_probs=119.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe---EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL---IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.+.||+|+||+||+|.+..+++ .||||.+.. ...+.+|+++++++ +||||+++++++ ......
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~-~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVV-TKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEE-eeCCEE
Confidence 5789999999999999999999876543 688998752 34578899999999 699999999998 666789
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. ++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEEEEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCccc
Confidence 99999998 578777664322 289999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 168 ARILL 172 (326)
Q Consensus 168 ~~~~~ 172 (326)
++.+.
T Consensus 175 a~~~~ 179 (299)
T d1jpaa_ 175 SRFLE 179 (299)
T ss_dssp -----
T ss_pred ceEcc
Confidence 98763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=292.84 Aligned_cols=140 Identities=24% Similarity=0.368 Sum_probs=121.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.++|++.++||+|+||+||+|... ..||||.++. ...+.+|+.+++++ +||||+++++++ . .+..++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~-~-~~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-T-APQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEE-C-SSSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEE-e-ccEEEE
Confidence 577999999999999999999753 3599999852 34567899999999 699999999986 3 346899
Q ss_pred Eeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 91 VLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 91 v~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
+|||+. ++|.+++..... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 81 v~Ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEecCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence 999998 799988865432 28999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q 020467 170 IL 171 (326)
Q Consensus 170 ~~ 171 (326)
..
T Consensus 153 ~~ 154 (276)
T d1uwha_ 153 VK 154 (276)
T ss_dssp C-
T ss_pred ec
Confidence 65
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=289.37 Aligned_cols=154 Identities=21% Similarity=0.349 Sum_probs=121.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-----CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.++||+|+||.||+|.+.. +++.||||.++. ...+.+|...+.++.+|+||+.+++++.....
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 4789999999999999999998753 357899999863 33466778888888789999999998866667
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhh-------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKRE-------DRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG 158 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~ 158 (326)
.++++|||+. ++|.+++........ ......+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 7999999998 799998876433110 01122388999999999999999999999999999999999999999
Q ss_pred cEEEEeecccccc
Q 020467 159 VLKLADFGQARIL 171 (326)
Q Consensus 159 ~~~l~Dfg~~~~~ 171 (326)
.+||+|||+++..
T Consensus 172 ~~Kl~DFGla~~~ 184 (299)
T d1ywna1 172 VVKICDFGLARDI 184 (299)
T ss_dssp CEEECC------C
T ss_pred cEEEccCcchhhc
Confidence 9999999999765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=288.27 Aligned_cols=145 Identities=23% Similarity=0.371 Sum_probs=119.6
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCC----eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCc
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDN----LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDED 87 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~----~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~ 87 (326)
.++|++.++||+|+||.||+|.+..++ ..||||.++. ...+.+|+.++.++ +||||+++++++ .....
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~-~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVI-SKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-CSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEE-ecCCc
Confidence 467999999999999999999876543 5799998853 23467899999999 699999999998 66678
Q ss_pred eEEEeeeccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 88 AVLVLEFLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 88 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++|||+.+ ++.+.+.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKD--------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTT--------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEEecccCcchhhhhccc--------ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccc
Confidence 9999999984 5666554432 228999999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 167 QARILL 172 (326)
Q Consensus 167 ~~~~~~ 172 (326)
+++.+.
T Consensus 156 la~~~~ 161 (283)
T d1mqba_ 156 LSRVLE 161 (283)
T ss_dssp C-----
T ss_pred hhhccc
Confidence 997753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=284.69 Aligned_cols=143 Identities=21% Similarity=0.367 Sum_probs=126.4
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc----chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH----DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~----~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
++|++.++||+|+||.||+|+++ +++.||||.++ ....+.+|+.+++++ +||||+++++++ .+.+..+++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~-~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC-TKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEE-CCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEE-eeCCceEEEEEc
Confidence 67899999999999999999974 77889999885 345678999999999 699999999998 666789999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 172 (326)
+. +++..++...... +++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+.
T Consensus 81 ~~~g~l~~~~~~~~~~--------~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp CTTEEHHHHHHSGGGC--------CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred cCCCcHHHhhhccccC--------CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence 97 6777776554432 8889999999999999999999999999999999999999999999999987653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=288.22 Aligned_cols=147 Identities=40% Similarity=0.625 Sum_probs=123.5
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC-CeEEEEEEccc-------hhhHHHHHHHHHHHh--cCCCeeEEeEEEEec---
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD-NLIVALKEVHD-------YQSAFREIEALQILQ--NSPNVVVLHEYFWRE--- 84 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~-~~~vaiK~~~~-------~~~~~~E~~~l~~l~--~h~ni~~l~~~~~~~--- 84 (326)
.++|+++++||+|+||+||+|.+..+ ++.||||+++. .....+|+.+++.+. +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999999765 67899998742 335678888888774 699999999998432
Q ss_pred -CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEE
Q 020467 85 -DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLA 163 (326)
Q Consensus 85 -~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~ 163 (326)
....+++||++.+++..+...... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT-------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeec
Confidence 245899999999877665543322 238999999999999999999999999999999999999999999999
Q ss_pred eecccccc
Q 020467 164 DFGQARIL 171 (326)
Q Consensus 164 Dfg~~~~~ 171 (326)
|||++...
T Consensus 159 dfg~~~~~ 166 (305)
T d1blxa_ 159 DFGLARIY 166 (305)
T ss_dssp SCCSCCCC
T ss_pred chhhhhhh
Confidence 99987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=286.30 Aligned_cols=144 Identities=24% Similarity=0.380 Sum_probs=122.4
Q ss_pred ccCeEEEee-eccccCcEEEEEEEcC--CCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILEC-VGSGAYSDVYKGRRLS--DNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~-Lg~G~~g~Vy~a~~~~--~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|.+.+. ||+|+||.||+|.+.. ++..||||.++. ...+.+|+++++++ +||||+++++++. . +..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~-~-~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQ-A-EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE-S-SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeec-c-CeE
Confidence 367888884 9999999999997753 456899998852 34577899999999 6999999999883 3 458
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||++ ++|.+++..... .+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchh
Confidence 99999998 588887644322 289999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 168 ARILL 172 (326)
Q Consensus 168 ~~~~~ 172 (326)
++.+.
T Consensus 156 a~~~~ 160 (285)
T d1u59a_ 156 SKALG 160 (285)
T ss_dssp CEECT
T ss_pred hhccc
Confidence 98763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=293.60 Aligned_cols=144 Identities=35% Similarity=0.530 Sum_probs=121.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRED---- 85 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~---- 85 (326)
+.++|+++++||+|+||+||+|.+..+++.||||+++. ...+.+|+++++.+ +|+||++++++|....
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccc
Confidence 57899999999999999999999999999999999863 23567899999999 6999999999984433
Q ss_pred -CceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 -EDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
..++++|||++.+|....... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|
T Consensus 95 ~~~~~lv~e~~~~~l~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 95 FTDFYLVMPFMGTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp CCCCEEEEECCSEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred cceEEEEEecccccHHHHHHhc----------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccc
Confidence 247999999988877766432 299999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 165 fg~a~~~ 171 (346)
T d1cm8a_ 165 FGLARQA 171 (346)
T ss_dssp CTTCEEC
T ss_pred ccceecc
Confidence 9998754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.7e-39 Score=283.46 Aligned_cols=147 Identities=24% Similarity=0.400 Sum_probs=130.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
+.++|++.++||+|+||+||+|.+..+++.||||.+.. ...+.+|++.++.+.+|+|++.+++++ ......+++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~~~~~~vme 81 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-QEGLHNVLVID 81 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-EETTEEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-ecCCccEEEEE
Confidence 46799999999999999999999999999999998743 455788999999998779999999988 66778999999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-----CCcEEEEeeccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD-----DGVLKLADFGQA 168 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~-----~~~~~l~Dfg~~ 168 (326)
|++++|.+.+..... .++...+..++.|++.||.|||+.||+||||||+|||++. ++.++|+|||++
T Consensus 82 ~~~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 82 LLGPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp CCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ecCCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 999999988765432 2899999999999999999999999999999999999974 568999999999
Q ss_pred cccc
Q 020467 169 RILL 172 (326)
Q Consensus 169 ~~~~ 172 (326)
+.+.
T Consensus 154 ~~~~ 157 (293)
T d1csna_ 154 KFYR 157 (293)
T ss_dssp EESB
T ss_pred EEcc
Confidence 8763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-39 Score=289.90 Aligned_cols=143 Identities=27% Similarity=0.474 Sum_probs=120.1
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCe----EEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNL----IVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
++|++++.||+|+||+||+|.+..+++ +||+|.++. ...+.+|+.+++++ +||||+++++++. +. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~-~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICL-TS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cC-Ce
Confidence 569999999999999999999877665 588887742 34578999999999 6999999999984 34 45
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++++++. ++|.+.+..... .+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred eEEEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccc
Confidence 66666665 788887765432 389999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 168 ARILL 172 (326)
Q Consensus 168 ~~~~~ 172 (326)
+..+.
T Consensus 158 a~~~~ 162 (317)
T d1xkka_ 158 AKLLG 162 (317)
T ss_dssp HHHTT
T ss_pred ceecc
Confidence 98753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-39 Score=283.69 Aligned_cols=143 Identities=27% Similarity=0.422 Sum_probs=123.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
.++|++.+.||+|+||+||+|.+..+ ..||||+++. ...+.+|+.+++++ +|+||+++++++ .+ +..+++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~-~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-SE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEE-CS-SSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEE-ec-CCeEEEEE
Confidence 57899999999999999999988654 5799999863 45688999999999 699999999987 44 45899999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|+. |+|..++...... .+++..+..++.||+.||.|||+.+|+||||||+||||+.++.++|+|||+++..
T Consensus 92 y~~~g~l~~~~~~~~~~-------~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred ecCCCchhhhhhhcccc-------cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 998 5777776544322 2899999999999999999999999999999999999999999999999998765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-39 Score=290.84 Aligned_cols=144 Identities=31% Similarity=0.502 Sum_probs=123.0
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC----C
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRED----E 86 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~----~ 86 (326)
+.++|+++++||+|+||+||+|.+..+++.||||+++. ...+.+|+.+++.+ +|+|++++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccc
Confidence 55789999999999999999999999999999999863 23567899999999 6999999999984332 2
Q ss_pred ceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeec
Q 020467 87 DAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFG 166 (326)
Q Consensus 87 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg 166 (326)
.+++++++.+++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~----------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG 154 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 154 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeecCCchhhhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccC
Confidence 36677776778999988642 29999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 020467 167 QARIL 171 (326)
Q Consensus 167 ~~~~~ 171 (326)
++...
T Consensus 155 ~a~~~ 159 (345)
T d1pmea_ 155 LARVA 159 (345)
T ss_dssp TCEEC
T ss_pred ceeec
Confidence 99765
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-39 Score=291.38 Aligned_cols=146 Identities=30% Similarity=0.490 Sum_probs=124.4
Q ss_pred CeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC-----CceEEEee
Q 020467 20 KYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-YQSAFREIEALQILQNSPNVVVLHEYFWRED-----EDAVLVLE 93 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~-----~~~~lv~e 93 (326)
+|+..++||+|+||+||+|++..+++.||||++.. .....+|+++++++ +|+||++++++|.... .+++++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 69999999999999999999999999999999864 33446899999999 6999999999985432 34789999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEEeecccccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-~~~l~Dfg~~~~~ 171 (326)
|+++++...+...... ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++..+
T Consensus 100 y~~~~~~~~l~~~~~~-----~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp CCSEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred ccCCccHHHHHhhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9998877666543221 23399999999999999999999999999999999999999775 8999999998765
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-39 Score=285.01 Aligned_cols=143 Identities=38% Similarity=0.618 Sum_probs=127.2
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.++|+++++||+|+||+||+|.++ +++.||||+++. ...+.+|+.+++++ +||||+++++++ ...+..++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~-~~~~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVI-HTKKRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEE-ECSSCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeec-ccCCceeE
Confidence 379999999999999999999885 779999999853 34678999999999 699999999999 66778999
Q ss_pred EeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccc
Q 020467 91 VLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARI 170 (326)
Q Consensus 91 v~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~ 170 (326)
+++++.+++...+.... +.+++..+..++.||+.||+|||+.+|+||||||+|||++.++.++++|||++..
T Consensus 78 ~~e~~~~~~~~~~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCE--------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp EEECCSEEHHHHHHTST--------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred EEEeehhhhHHHHHhhc--------CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEeccccccee
Confidence 99999987777765433 2399999999999999999999999999999999999999999999999999876
Q ss_pred c
Q 020467 171 L 171 (326)
Q Consensus 171 ~ 171 (326)
.
T Consensus 150 ~ 150 (286)
T d1ob3a_ 150 F 150 (286)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=283.97 Aligned_cols=135 Identities=25% Similarity=0.375 Sum_probs=117.3
Q ss_pred eeeccccCcEEEEEEEc--CCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeeec
Q 020467 25 ECVGSGAYSDVYKGRRL--SDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEFL 95 (326)
Q Consensus 25 ~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~~ 95 (326)
++||+|+||+||+|.+. .+++.||||.++. ...+.+|+++++++ +||||+++++++ .. +..+++|||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~-~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEe-cc-CCEEEEEEcC
Confidence 46999999999999764 4567899998852 24578899999999 699999999988 43 3578999999
Q ss_pred c-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 96 R-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 96 ~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
. ++|.+++..... +++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||+++.+
T Consensus 90 ~~g~L~~~l~~~~~---------l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 90 ELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp TTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcHHHHHhhccC---------CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhc
Confidence 8 688888765433 899999999999999999999999999999999999999999999999999765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=285.53 Aligned_cols=147 Identities=42% Similarity=0.604 Sum_probs=125.6
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE----- 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~----- 84 (326)
-.++|+++++||+|+||+||+|.+..+++.||||++.. ...+.+|+.+++.+ +|+|++++++++...
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeeccccccc
Confidence 36999999999999999999999999999999998742 34577999999999 699999999988442
Q ss_pred --CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 020467 85 --DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKL 162 (326)
Q Consensus 85 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l 162 (326)
....+++|||+.+++........ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+++
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~--------~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVL--------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTT--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred ccCceEEEEEeccCCCccchhhhcc--------cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEe
Confidence 24589999999977766554332 23899999999999999999999999999999999999999999999
Q ss_pred Eeeccccccc
Q 020467 163 ADFGQARILL 172 (326)
Q Consensus 163 ~Dfg~~~~~~ 172 (326)
+|||++....
T Consensus 159 ~dfg~~~~~~ 168 (318)
T d3blha1 159 ADFGLARAFS 168 (318)
T ss_dssp CCCTTCEECC
T ss_pred eecceeeecc
Confidence 9999997653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-39 Score=279.73 Aligned_cols=144 Identities=23% Similarity=0.395 Sum_probs=123.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEeee
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLEF 94 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e~ 94 (326)
.++|++.+.||+|+||.||+|.+ ++..||||.++. .+.+.+|+++++++ +||||+++++++.+..+.++++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEec
Confidence 46799999999999999999987 467899999964 45678999999999 6999999999985556678999999
Q ss_pred cc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 95 LR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 95 ~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
+. ++|.+++....... +++..+..++.||+.||.|||+.+|+||||||+||+++.++.++++|||+++..
T Consensus 83 ~~~g~L~~~l~~~~~~~-------l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSV-------LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp CTTEEHHHHHHHHHHHH-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred cCCCCHHHHHHhcCCCC-------CCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 97 69999886544322 899999999999999999999999999999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-39 Score=280.65 Aligned_cols=143 Identities=22% Similarity=0.452 Sum_probs=117.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCC---CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCce
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSD---NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDA 88 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~ 88 (326)
.++|++.+.||+|+||.||+|.+..+ +..||||.++. ...+.+|+.+++++ +||||+++++++ . .+..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~-~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-T-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-C-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE-e-cCeE
Confidence 46899999999999999999988643 45788998752 34567899999998 699999999998 4 3568
Q ss_pred EEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecc
Q 020467 89 VLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQ 167 (326)
Q Consensus 89 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~ 167 (326)
+++|||+. +++.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~--------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK--------YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT--------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEEEEeccCCcHHhhhhccC--------CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence 99999998 57777665432 2289999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q 020467 168 ARIL 171 (326)
Q Consensus 168 ~~~~ 171 (326)
++.+
T Consensus 155 a~~~ 158 (273)
T d1mp8a_ 155 SRYM 158 (273)
T ss_dssp ----
T ss_pred heec
Confidence 8765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-38 Score=286.74 Aligned_cols=143 Identities=29% Similarity=0.530 Sum_probs=124.3
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-CCceEEEee
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNSPNVVVLHEYFWRE-DEDAVLVLE 93 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~-~~~~~lv~e 93 (326)
..++|+++++||+|+||+||+|++..+++.||||+++. ...+.+|+.+++.+.+|+||++++++|... ....+++||
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 35789999999999999999999999999999999864 456779999999997799999999998543 356899999
Q ss_pred eccc-CHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEEeecccccc
Q 020467 94 FLRT-DLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDG-VLKLADFGQARIL 171 (326)
Q Consensus 94 ~~~~-~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~-~~~l~Dfg~~~~~ 171 (326)
|+.+ +|.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++ .++|+|||++..+
T Consensus 113 ~~~~~~L~~~~------------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 113 HVNNTDFKQLY------------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp CCCSCBGGGTT------------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred ecCCCcHHHHh------------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceec
Confidence 9984 553321 2299999999999999999999999999999999999999655 6899999998765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-38 Score=281.12 Aligned_cols=147 Identities=23% Similarity=0.384 Sum_probs=124.7
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEcc---chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVH---DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~---~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
+.++|++.++||+|+||.||+|.+..+++.||||.+. ....+..|+++++.+.+|++++.+..++ ......+++||
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~-~~~~~~~ivme 83 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG-AEGDYNVMVME 83 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEE-EETTEEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEE-ecCCEEEEEEE
Confidence 5578999999999999999999999999999999875 3456788999999996555555555554 66778999999
Q ss_pred ecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEEeeccccc
Q 020467 94 FLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD---DGVLKLADFGQARI 170 (326)
Q Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~---~~~~~l~Dfg~~~~ 170 (326)
|+++++...+..... .++...+..++.|++.||+|||++||+||||||+|||++. +..++|+|||++..
T Consensus 84 ~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp CCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EcCCchhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999988877655432 3999999999999999999999999999999999999864 45799999999987
Q ss_pred cc
Q 020467 171 LL 172 (326)
Q Consensus 171 ~~ 172 (326)
+.
T Consensus 156 ~~ 157 (299)
T d1ckia_ 156 YR 157 (299)
T ss_dssp CB
T ss_pred cc
Confidence 64
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-38 Score=282.04 Aligned_cols=155 Identities=25% Similarity=0.377 Sum_probs=128.8
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
...++|++.+.||+|+||.||+|+++ .++..||||+++. ...+.+|+++++++ +|+||+++++++ ..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~-~~ 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVC-AV 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-CS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeee-cc
Confidence 34678999999999999999999875 3567899999863 34578999999999 699999999998 66
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhh---------------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKR---------------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLK 148 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlk 148 (326)
....+++|||+. ++|.+++....... .......++...+..++.|++.||+|||+.+++|||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 778999999997 78988886432110 01112348889999999999999999999999999999
Q ss_pred CCCeEEcCCCcEEEEeeccccccc
Q 020467 149 PGNLLIGDDGVLKLADFGQARILL 172 (326)
Q Consensus 149 p~Nili~~~~~~~l~Dfg~~~~~~ 172 (326)
|+||+++.++.+||+|||+++.+.
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~ 191 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIY 191 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHT
T ss_pred ccceEECCCCcEEEccchhheecc
Confidence 999999999999999999997653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=277.10 Aligned_cols=154 Identities=21% Similarity=0.363 Sum_probs=122.0
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCC-------eEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDN-------LIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWRE 84 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~-------~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~ 84 (326)
.++|++.+.||+|+||.||+|+...++ ..||||.++. ...+.+|...+.++.+||||+++++++ .+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~-~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-TQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc-cc
Confidence 578999999999999999999875443 4799998853 345677888888886799999999999 56
Q ss_pred CCceEEEeeecc-cCHHHHHHHhhhhh-------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 020467 85 DEDAVLVLEFLR-TDLATVIAESKKKR-------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD 156 (326)
Q Consensus 85 ~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~ 156 (326)
....+++|||+. ++|.+++....... .......+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 678999999998 68888886442110 0111234899999999999999999999999999999999999999
Q ss_pred CCcEEEEeeccccccc
Q 020467 157 DGVLKLADFGQARILL 172 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~~ 172 (326)
++.++|+|||++....
T Consensus 171 ~~~~kl~dfg~~~~~~ 186 (299)
T d1fgka_ 171 DNVMKIADFGLARDIH 186 (299)
T ss_dssp TCCEEECSTTCCCCGG
T ss_pred CCCeEeccchhhcccc
Confidence 9999999999987663
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=276.19 Aligned_cols=143 Identities=41% Similarity=0.657 Sum_probs=125.6
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEE
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLV 91 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv 91 (326)
++|+++++||+|+||+||+|++..+++.||||+++. ...+.+|+.+++.+ +|+||+++++++ ......+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~-~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVL-HSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEE-ECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccc-ccccceeEE
Confidence 689999999999999999999999999999998742 34567999999998 699999999999 667788999
Q ss_pred eeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeecccccc
Q 020467 92 LEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 92 ~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~ 171 (326)
++++.+.....+.... +.+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||.+...
T Consensus 80 ~~~~~~~~l~~~~~~~--------~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp EECCSEEHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eeeccccccccccccc--------cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcc
Confidence 9999865554444332 23899999999999999999999999999999999999999999999999998765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=275.93 Aligned_cols=153 Identities=20% Similarity=0.349 Sum_probs=128.3
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc-----CCCeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL-----SDNLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.++||+|+||.||+|.+. .+++.||||+++. ...+.+|+.+++.+.+||||+++++++ ....
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~-~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-TIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE-eeCC
Confidence 589999999999999999999753 4568899999863 334678999999997799999999999 6677
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhh---------hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKR---------EDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGD 156 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~---------~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~ 156 (326)
..+++|||+. ++|.+++....... .......+++..+..++.||+.||+|||+++++||||||+||+++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 8999999998 68888876543210 0111234899999999999999999999999999999999999999
Q ss_pred CCcEEEEeecccccc
Q 020467 157 DGVLKLADFGQARIL 171 (326)
Q Consensus 157 ~~~~~l~Dfg~~~~~ 171 (326)
++.++++|||+++..
T Consensus 181 ~~~~ki~DfG~~~~~ 195 (311)
T d1t46a_ 181 GRITKICDFGLARDI 195 (311)
T ss_dssp TTEEEECCCGGGSCT
T ss_pred cCcccccccchheec
Confidence 999999999998765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=278.73 Aligned_cols=144 Identities=26% Similarity=0.518 Sum_probs=127.8
Q ss_pred ccCeEEEeeeccccCcEEEEEEEc---CCCeEEEEEEccc---------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRL---SDNLIVALKEVHD---------YQSAFREIEALQILQNSPNVVVLHEYFWRED 85 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~---------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~ 85 (326)
.++|++++.||+|+||+||+|.+. .+++.||||.++. ...+.+|+++++++.+|+||+++++++ .+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-~~~ 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-QTE 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-EET
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-ccC
Confidence 588999999999999999999873 4689999998742 345678999999997669999999998 666
Q ss_pred CceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 86 EDAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 86 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
...+++|||+. ++|.+.+..... +++..+..++.||+.||.|||+.+|+||||||+||+++.++.++|+|
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred CceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEee
Confidence 78999999998 688888876543 88899999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++..+
T Consensus 173 FG~a~~~ 179 (322)
T d1vzoa_ 173 FGLSKEF 179 (322)
T ss_dssp SSEEEEC
T ss_pred ccchhhh
Confidence 9998765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-38 Score=273.93 Aligned_cols=143 Identities=25% Similarity=0.422 Sum_probs=117.1
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcC-C--CeEEEEEEccc--------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCC
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLS-D--NLIVALKEVHD--------YQSAFREIEALQILQNSPNVVVLHEYFWREDE 86 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~-~--~~~vaiK~~~~--------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~ 86 (326)
.++|++.+.||+|+||.||+|.... + ...||||.+.. ...+.+|+.+++++ +||||+++++++ .+ +
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~-~~-~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVV-LT-P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-CS-S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-ee-c
Confidence 3679999999999999999998643 2 34789998752 24578999999999 699999999998 44 3
Q ss_pred ceEEEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEee
Q 020467 87 DAVLVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADF 165 (326)
Q Consensus 87 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Df 165 (326)
..+++|||+. +++.+.+...... ++...+..++.|++.||.|||+++|+||||||+||+++.++.++|+||
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~--------l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGG--------SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred chheeeeeecCcchhhhhhcccCC--------CCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 5789999997 6888776654332 899999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 020467 166 GQARIL 171 (326)
Q Consensus 166 g~~~~~ 171 (326)
|++..+
T Consensus 156 Gl~~~~ 161 (273)
T d1u46a_ 156 GLMRAL 161 (273)
T ss_dssp TTCEEC
T ss_pred hhhhhc
Confidence 999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=282.97 Aligned_cols=144 Identities=33% Similarity=0.503 Sum_probs=120.1
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE----- 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~----- 84 (326)
+.++|+++++||+|+||+||+|++..+++.||||+++. ...+.+|+.+++.+ +|+|++++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc
Confidence 35799999999999999999999999999999999853 23467899999999 699999999998422
Q ss_pred CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 85 DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 85 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
....++++++.+++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~----------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~d 164 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 164 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEEeecCCchhhhcccc----------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccc
Confidence 2335666665568898877432 299999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 165 fg~a~~~ 171 (348)
T d2gfsa1 165 FGLARHT 171 (348)
T ss_dssp C----CC
T ss_pred cchhccc
Confidence 9998654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=278.06 Aligned_cols=153 Identities=25% Similarity=0.395 Sum_probs=127.7
Q ss_pred ccCeEEEeeeccccCcEEEEEEEcCCCe--EEEEEEcc------chhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 18 IAKYEILECVGSGAYSDVYKGRRLSDNL--IVALKEVH------DYQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 18 ~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~--~vaiK~~~------~~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++|++.++||+|+||.||+|.+..++. .||||.++ ....+.+|++++.++.+||||+++++++ ...+..+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-~~~~~~~ 87 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLY 87 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-EETTEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE-ecCCeeE
Confidence 4789999999999999999999887775 46777764 2345789999999986699999999998 5567899
Q ss_pred EEeeecc-cCHHHHHHHhhhh-------hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 020467 90 LVLEFLR-TDLATVIAESKKK-------REDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLK 161 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 161 (326)
++|||+. ++|.+++...... ........+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 9999998 7999988654211 0111123489999999999999999999999999999999999999999999
Q ss_pred EEeecccccc
Q 020467 162 LADFGQARIL 171 (326)
Q Consensus 162 l~Dfg~~~~~ 171 (326)
|+|||++...
T Consensus 168 l~DfG~a~~~ 177 (309)
T d1fvra_ 168 IADFGLSRGQ 177 (309)
T ss_dssp ECCTTCEESS
T ss_pred Eccccccccc
Confidence 9999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=281.85 Aligned_cols=143 Identities=31% Similarity=0.500 Sum_probs=121.9
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-------hhhHHHHHHHHHHHhcCCCeeEEeEEEEec-----
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-------YQSAFREIEALQILQNSPNVVVLHEYFWRE----- 84 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~----- 84 (326)
+.++|+++++||+|+||+||+|.+..+++.||||++.. ...+.+|+.+++.+ +||||++++++|...
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeccccccc
Confidence 56899999999999999999999999999999999852 23467899999998 699999999998432
Q ss_pred CCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEe
Q 020467 85 DEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLAD 164 (326)
Q Consensus 85 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~D 164 (326)
....|++|||+.+++.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~d 162 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_dssp CCEEEEEEECCSEEHHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceeEEEEeccchHHHHhhhc-----------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeec
Confidence 357899999999888776532 289999999999999999999999999999999999999999999999
Q ss_pred ecccccc
Q 020467 165 FGQARIL 171 (326)
Q Consensus 165 fg~~~~~ 171 (326)
||++...
T Consensus 163 f~~~~~~ 169 (355)
T d2b1pa1 163 FGLARTA 169 (355)
T ss_dssp CCC----
T ss_pred hhhhhcc
Confidence 9987654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=275.57 Aligned_cols=143 Identities=25% Similarity=0.362 Sum_probs=119.4
Q ss_pred cccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch--hhHHHHHHHH--HHHhcCCCeeEEeEEEEecCC---ceE
Q 020467 17 IIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY--QSAFREIEAL--QILQNSPNVVVLHEYFWREDE---DAV 89 (326)
Q Consensus 17 ~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~--~~~~~E~~~l--~~l~~h~ni~~l~~~~~~~~~---~~~ 89 (326)
+..+|.+.+.||+|+||.||+|+. +++.||||.++.. .....|.+++ ..+ +||||+++++++..... ..|
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEE
Confidence 356899999999999999999986 6889999998643 2333444443 344 69999999999865543 479
Q ss_pred EEeeecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCCeEEcCCCcE
Q 020467 90 LVLEFLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR--------NTIVHRDLKPGNLLIGDDGVL 160 (326)
Q Consensus 90 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~--------~~iiH~dlkp~Nili~~~~~~ 160 (326)
++|||+. ++|.+++.... +++..+..++.|++.||.|+|. .+|+||||||+|||++.++.+
T Consensus 78 lv~Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred EEEecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 9999997 69998886532 8899999999999999999996 599999999999999999999
Q ss_pred EEEeeccccccc
Q 020467 161 KLADFGQARILL 172 (326)
Q Consensus 161 ~l~Dfg~~~~~~ 172 (326)
||+|||++....
T Consensus 148 Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 148 CIADLGLAVRHD 159 (303)
T ss_dssp EECCCTTCEEEE
T ss_pred EEEecCcccccc
Confidence 999999988763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-37 Score=273.13 Aligned_cols=161 Identities=22% Similarity=0.375 Sum_probs=132.1
Q ss_pred CCCCCccccCccccccCeEEEeeeccccCcEEEEEEEcC-----CCeEEEEEEccc------hhhHHHHHHHHHHHhcCC
Q 020467 4 PLPKSWSIHTRPEIIAKYEILECVGSGAYSDVYKGRRLS-----DNLIVALKEVHD------YQSAFREIEALQILQNSP 72 (326)
Q Consensus 4 ~~p~~~~~~~~~~~~~~y~i~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ 72 (326)
..|..|.+. .++|++.+.||+|+||.||+|.+.. ++..||||+++. ...+.+|+.+++++ +|+
T Consensus 10 ~~~~~~ei~-----~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~ 83 (308)
T d1p4oa_ 10 YVPDEWEVA-----REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCH 83 (308)
T ss_dssp CCCCTTBCC-----GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCT
T ss_pred cCccceeec-----HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCC
Confidence 345556544 4789999999999999999998742 357899999863 23467899999998 699
Q ss_pred CeeEEeEEEEecCCceEEEeeecc-cCHHHHHHHhhhhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 020467 73 NVVVLHEYFWREDEDAVLVLEFLR-TDLATVIAESKKKRED-RGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPG 150 (326)
Q Consensus 73 ni~~l~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~ 150 (326)
||+++++++ ......+++|||+. ++|.+++......... .....++...+..++.|++.||.|||+.+|+||||||+
T Consensus 84 nIv~~~~~~-~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~ 162 (308)
T d1p4oa_ 84 HVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 162 (308)
T ss_dssp TBCCEEEEE-CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred CEeeeeeEE-ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCC
Confidence 999999998 66678999999997 7888887654332211 11233688899999999999999999999999999999
Q ss_pred CeEEcCCCcEEEEeecccccc
Q 020467 151 NLLIGDDGVLKLADFGQARIL 171 (326)
Q Consensus 151 Nili~~~~~~~l~Dfg~~~~~ 171 (326)
|||++.++.+||+|||+++.+
T Consensus 163 NiLld~~~~~Kl~DFGla~~~ 183 (308)
T d1p4oa_ 163 NCMVAEDFTVKIGDFGMTRDI 183 (308)
T ss_dssp GEEECTTCCEEECCTTCCCGG
T ss_pred ceeecCCceEEEeecccceec
Confidence 999999999999999998765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-37 Score=272.17 Aligned_cols=141 Identities=26% Similarity=0.435 Sum_probs=119.7
Q ss_pred EEeeeccccCcEEEEEEEcCC---CeEEEEEEccc------hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEEEee
Q 020467 23 ILECVGSGAYSDVYKGRRLSD---NLIVALKEVHD------YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVLVLE 93 (326)
Q Consensus 23 i~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~------~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~lv~e 93 (326)
+.++||+|+||+||+|.+..+ ...||||.++. ...+.+|++++.++ +||||+++++++....+..+++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEE
Confidence 367899999999999987653 34689998852 34578999999999 699999999998666678999999
Q ss_pred ecc-cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEEeeccccccc
Q 020467 94 FLR-TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDDGVLKLADFGQARILL 172 (326)
Q Consensus 94 ~~~-~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 172 (326)
|+. ++|.+++..... .++...+..++.|++.||.|||+.+|+||||||+|||+++++.++|+|||+++...
T Consensus 110 ~~~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp CCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EeecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 998 577776654322 27788899999999999999999999999999999999999999999999998763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=3.1e-32 Score=247.90 Aligned_cols=146 Identities=30% Similarity=0.450 Sum_probs=115.2
Q ss_pred cCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccch----hhHHHHHHHHHHHh----------cCCCeeEEeEEEEec
Q 020467 19 AKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHDY----QSAFREIEALQILQ----------NSPNVVVLHEYFWRE 84 (326)
Q Consensus 19 ~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~----~~~~~E~~~l~~l~----------~h~ni~~l~~~~~~~ 84 (326)
+||+++++||+|+||+||+|++..+++.||||+++.. ....+|+.+++.+. .|+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4699999999999999999999999999999998753 34567888887774 368899999988543
Q ss_pred C-CceEEEeeecc--cCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCC--
Q 020467 85 D-EDAVLVLEFLR--TDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHR-NTIVHRDLKPGNLLIGDDG-- 158 (326)
Q Consensus 85 ~-~~~~lv~e~~~--~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~iiH~dlkp~Nili~~~~-- 158 (326)
. ...++++.+.. ++......... ...+++..+..++.|++.||.|||+ .||+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYE-------HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTT-------TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred cccceeeeeeeccccccccccccccc-------ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 3 44555666554 33333333222 2338999999999999999999997 8999999999999998765
Q ss_pred ----cEEEEeecccccc
Q 020467 159 ----VLKLADFGQARIL 171 (326)
Q Consensus 159 ----~~~l~Dfg~~~~~ 171 (326)
.++++|||.+...
T Consensus 166 ~~~~~~kl~dfg~s~~~ 182 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWY 182 (362)
T ss_dssp TTEEEEEECCCTTCEET
T ss_pred cccceeeEeeccccccc
Confidence 4899999988654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.3e-22 Score=167.42 Aligned_cols=128 Identities=23% Similarity=0.214 Sum_probs=99.0
Q ss_pred eEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----------------------hhhHHHHHHHHHHHhcCCCeeEE
Q 020467 21 YEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----------------------YQSAFREIEALQILQNSPNVVVL 77 (326)
Q Consensus 21 y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----------------------~~~~~~E~~~l~~l~~h~ni~~l 77 (326)
+.+.++||+|+||.||+|.+. +++.||||.++. .....+|...+.++ .|.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 457899999999999999874 688999997641 11223466677777 58888877
Q ss_pred eEEEEecCCceEEEeeecccCHHHHHHHhhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC
Q 020467 78 HEYFWREDEDAVLVLEFLRTDLATVIAESKKKREDRGDRGISVGEIKRWMVQILSGVDACHRNTIVHRDLKPGNLLIGDD 157 (326)
Q Consensus 78 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~iiH~dlkp~Nili~~~ 157 (326)
+++. ..+++|||+++.... . ++......++.|++.+|.|||+.||+||||||+|||++++
T Consensus 80 ~~~~-----~~~lvme~~~~~~~~------~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~ 139 (191)
T d1zara2 80 YAWE-----GNAVLMELIDAKELY------R---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE 139 (191)
T ss_dssp EEEE-----TTEEEEECCCCEEGG------G---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT
T ss_pred EEec-----CCEEEEEeecccccc------c---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC
Confidence 7643 247999999863211 0 4444566789999999999999999999999999999865
Q ss_pred CcEEEEeecccccc
Q 020467 158 GVLKLADFGQARIL 171 (326)
Q Consensus 158 ~~~~l~Dfg~~~~~ 171 (326)
.++|+|||++...
T Consensus 140 -~~~liDFG~a~~~ 152 (191)
T d1zara2 140 -GIWIIDFPQSVEV 152 (191)
T ss_dssp -EEEECCCTTCEET
T ss_pred -CEEEEECCCcccC
Confidence 5899999988654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=1.2e-06 Score=73.48 Aligned_cols=79 Identities=20% Similarity=0.166 Sum_probs=56.5
Q ss_pred ccccCeEEEeeeccccCcEEEEEEEcCCCeEEEEEEccc-----hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceEE
Q 020467 16 EIIAKYEILECVGSGAYSDVYKGRRLSDNLIVALKEVHD-----YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAVL 90 (326)
Q Consensus 16 ~~~~~y~i~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~-----~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~l 90 (326)
.....|++.+..+.+..+.||+.. .++..+++|.... .....+|...+..+..+-.+++++.+. ...+..++
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-~~~~~~~l 87 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-RHDGWSNL 87 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-EETTEEEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-ecCCceEE
Confidence 456788887776555567899875 3455677887753 334678888888886555567777766 55567899
Q ss_pred Eeeeccc
Q 020467 91 VLEFLRT 97 (326)
Q Consensus 91 v~e~~~~ 97 (326)
+|++++|
T Consensus 88 v~~~l~G 94 (263)
T d1j7la_ 88 LMSEADG 94 (263)
T ss_dssp EEECCSS
T ss_pred EEEeccc
Confidence 9999986
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.73 E-value=0.00011 Score=65.31 Aligned_cols=71 Identities=21% Similarity=0.131 Sum_probs=46.2
Q ss_pred EeeeccccCcEEEEEEEcCCCeEEEEEEcc------------chhhHHHHHHHHHHHhcC--CCeeEEeEEEEecCCceE
Q 020467 24 LECVGSGAYSDVYKGRRLSDNLIVALKEVH------------DYQSAFREIEALQILQNS--PNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 24 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~------------~~~~~~~E~~~l~~l~~h--~ni~~l~~~~~~~~~~~~ 89 (326)
.+.||.|....||++....+++.+++|.-. ...+...|.+.+..+..+ ..+++++.+ +....+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~---d~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS---DTEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE---ETTTTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE---cCCCCE
Confidence 557899999999999877777889998532 122356688888877543 235555543 344568
Q ss_pred EEeeeccc
Q 020467 90 LVLEFLRT 97 (326)
Q Consensus 90 lv~e~~~~ 97 (326)
++||++++
T Consensus 108 lvmE~L~~ 115 (392)
T d2pula1 108 TVMEDLSH 115 (392)
T ss_dssp EEECCCTT
T ss_pred EEEeccCC
Confidence 89999863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.59 E-value=0.0002 Score=59.03 Aligned_cols=70 Identities=13% Similarity=0.080 Sum_probs=46.6
Q ss_pred eecccc-CcEEEEEEEcCCCeEEEEEEccc--hhhHHHHHHHHHHHhcCC-CeeEEeEEEEecCCceEEEeeeccc
Q 020467 26 CVGSGA-YSDVYKGRRLSDNLIVALKEVHD--YQSAFREIEALQILQNSP-NVVVLHEYFWREDEDAVLVLEFLRT 97 (326)
Q Consensus 26 ~Lg~G~-~g~Vy~a~~~~~~~~vaiK~~~~--~~~~~~E~~~l~~l~~h~-ni~~l~~~~~~~~~~~~lv~e~~~~ 97 (326)
.+..|. ...||+... .++..+++|.... ...+..|...++.+..+. .+++++.+. .+.+..+++|++++|
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-TEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-ECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-ccccceEEEEEeeec
Confidence 444454 357898864 4455678887653 335678888888775432 356667665 556678999999974
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.18 E-value=0.012 Score=51.57 Aligned_cols=72 Identities=13% Similarity=0.099 Sum_probs=48.1
Q ss_pred CeEEEeeeccccCcEEEEEEEcC-------CCeEEEEEEccc---hhhHHHHHHHHHHHhcCCCeeEEeEEEEecCCceE
Q 020467 20 KYEILECVGSGAYSDVYKGRRLS-------DNLIVALKEVHD---YQSAFREIEALQILQNSPNVVVLHEYFWREDEDAV 89 (326)
Q Consensus 20 ~y~i~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~---~~~~~~E~~~l~~l~~h~ni~~l~~~~~~~~~~~~ 89 (326)
.++ ++.|+.|-.-.+|++.... ..+.+++++... .....+|..+++.+..+.-.++++.++ . -.
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-~----~g 117 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-S----GG 117 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-T----TE
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-C----Cc
Confidence 444 4577777788899987542 245677777542 233567888888887665566887776 2 25
Q ss_pred EEeeeccc
Q 020467 90 LVLEFLRT 97 (326)
Q Consensus 90 lv~e~~~~ 97 (326)
++++|+.+
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 78888774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.54 E-value=0.0093 Score=50.76 Aligned_cols=37 Identities=16% Similarity=0.060 Sum_probs=27.3
Q ss_pred CcEEEEEEEcCCCeEEEEEEccc----hhhHHHHHHHHHHHh
Q 020467 32 YSDVYKGRRLSDNLIVALKEVHD----YQSAFREIEALQILQ 69 (326)
Q Consensus 32 ~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~E~~~l~~l~ 69 (326)
.-.||++.. .+|..+++|..+. ...+..|...+..+.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLV 75 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence 457999864 5677899998853 455677888888876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.59 E-value=0.015 Score=49.06 Aligned_cols=30 Identities=30% Similarity=0.344 Sum_probs=27.1
Q ss_pred CCceeccCCCCCeEEcCCCcEEEEeecccc
Q 020467 140 NTIVHRDLKPGNLLIGDDGVLKLADFGQAR 169 (326)
Q Consensus 140 ~~iiH~dlkp~Nili~~~~~~~l~Dfg~~~ 169 (326)
.|+||+|+.+.|++++.+...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988878899999875
|